,source,native,name,p_value,significant,description,term_size,query_size,intersection_size,effective_domain_size,precision,recall,query,parents
0,GO:CC,GO:0022626,cytosolic ribosome,3.627471787141593e-141,True,"""A ribosome located in the cytosol."" [GOC:mtg_sensu]",117,105,70,22097,0.6666666666666666,0.5982905982905983,Module 3,"['GO:0005829', 'GO:0005840']"
1,REAC,REAC:R-HSA-156842,Eukaryotic Translation Elongation,2.4346573548465497e-134,True,Eukaryotic Translation Elongation,94,97,70,10842,0.7216494845360825,0.7446808510638298,Module 3,['REAC:R-HSA-72766']
2,REAC,REAC:R-HSA-156902,Peptide chain elongation,1.0940464747061934e-133,True,Peptide chain elongation,90,97,69,10842,0.711340206185567,0.7666666666666667,Module 3,['REAC:R-HSA-156842']
3,REAC,REAC:R-HSA-192823,Viral mRNA Translation,1.2689815857491913e-130,True,Viral mRNA Translation,90,97,68,10842,0.7010309278350515,0.7555555555555555,Module 3,['REAC:R-HSA-168273']
4,REAC,REAC:R-HSA-72764,Eukaryotic Translation Termination,2.5610541215760057e-128,True,Eukaryotic Translation Termination,94,97,68,10842,0.7010309278350515,0.723404255319149,Module 3,['REAC:R-HSA-72766']
5,REAC,REAC:R-HSA-2408557,Selenocysteine synthesis,2.5610541215760057e-128,True,Selenocysteine synthesis,94,97,68,10842,0.7010309278350515,0.723404255319149,Module 3,['REAC:R-HSA-2408522']
6,REAC,REAC:R-HSA-975956,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),3.07311696773625e-127,True,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),96,97,68,10842,0.7010309278350515,0.7083333333333334,Module 3,['REAC:R-HSA-927802']
7,REAC,REAC:R-HSA-72689,Formation of a pool of free 40S subunits,3.028092929368736e-124,True,Formation of a pool of free 40S subunits,102,97,68,10842,0.7010309278350515,0.6666666666666666,Module 3,['REAC:R-HSA-72737']
8,REAC,REAC:R-HSA-9633012,Response of EIF2AK4 (GCN2) to amino acid deficiency,3.028092929368736e-124,True,Response of EIF2AK4 (GCN2) to amino acid deficiency,102,97,68,10842,0.7010309278350515,0.6666666666666666,Module 3,['REAC:R-HSA-9711097']
9,GO:BP,GO:0002181,cytoplasmic translation,2.709225948765779e-121,True,"""The chemical reactions and pathways resulting in the formation of a protein in the cytoplasm. This is a ribosome-mediated process in which the information in messenger RNA (mRNA) is used to specify the sequence of amino acids in the protein."" [GOC:hjd]",156,105,68,21031,0.6476190476190476,0.4358974358974359,Module 3,['GO:0006412']
10,REAC,REAC:R-HSA-156827,L13a-mediated translational silencing of Ceruloplasmin expression,6.724990574269193e-120,True,L13a-mediated translational silencing of Ceruloplasmin expression,112,97,68,10842,0.7010309278350515,0.6071428571428571,Module 3,['REAC:R-HSA-72613']
11,REAC,REAC:R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,1.6842222698462922e-119,True,SRP-dependent cotranslational protein targeting to membrane,113,97,68,10842,0.7010309278350515,0.6017699115044248,Module 3,['REAC:R-HSA-72766']
12,REAC,REAC:R-HSA-72706,GTP hydrolysis and joining of the 60S ribosomal subunit,1.6842222698462922e-119,True,GTP hydrolysis and joining of the 60S ribosomal subunit,113,97,68,10842,0.7010309278350515,0.6017699115044248,Module 3,['REAC:R-HSA-72737']
13,WP,WP:WP477,Cytoplasmic ribosomal proteins,1.9103433650666784e-119,True,Cytoplasmic ribosomal proteins,88,101,67,8286,0.6633663366336634,0.7613636363636364,Module 3,['WP:000000']
14,REAC,REAC:R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),2.448431238379745e-118,True,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),116,97,68,10842,0.7010309278350515,0.5862068965517241,Module 3,['REAC:R-HSA-927802']
15,REAC,REAC:R-HSA-927802,Nonsense-Mediated Decay (NMD),2.448431238379745e-118,True,Nonsense-Mediated Decay (NMD),116,97,68,10842,0.7010309278350515,0.5862068965517241,Module 3,['REAC:R-HSA-8953854']
16,GO:CC,GO:0044391,ribosomal subunit,2.610455420560536e-118,True,"""Either of the two subunits of a ribosome: the ribosomal large subunit or the ribosomal small subunit."" [GOC:jl]",192,105,69,22097,0.6571428571428571,0.359375,Module 3,"['GO:0005840', 'GO:1990904']"
17,REAC,REAC:R-HSA-2408522,Selenoamino acid metabolism,5.830678103211551e-118,True,Selenoamino acid metabolism,117,97,68,10842,0.7010309278350515,0.5811965811965812,Module 3,['REAC:R-HSA-71291']
18,REAC,REAC:R-HSA-72613,Eukaryotic Translation Initiation,7.350370617068643e-117,True,Eukaryotic Translation Initiation,120,97,68,10842,0.7010309278350515,0.5666666666666667,Module 3,['REAC:R-HSA-72766']
19,REAC,REAC:R-HSA-72737,Cap-dependent Translation Initiation,7.350370617068643e-117,True,Cap-dependent Translation Initiation,120,97,68,10842,0.7010309278350515,0.5666666666666667,Module 3,['REAC:R-HSA-72613']
20,REAC,REAC:R-HSA-168273,Influenza Viral RNA Transcription and Replication,3.9475515673208818e-115,True,Influenza Viral RNA Transcription and Replication,133,97,69,10842,0.711340206185567,0.518796992481203,Module 3,['REAC:R-HSA-168255']
21,REAC,REAC:R-HSA-168255,Influenza Infection,1.0657487647374597e-109,True,Influenza Infection,152,97,69,10842,0.711340206185567,0.45394736842105265,Module 3,['REAC:R-HSA-9824446']
22,REAC,REAC:R-HSA-9711097,Cellular response to starvation,5.704227895517218e-106,True,Cellular response to starvation,157,97,68,10842,0.7010309278350515,0.43312101910828027,Module 3,['REAC:R-HSA-2262752']
23,REAC,REAC:R-HSA-9010553,Regulation of expression of SLITs and ROBOs,9.690188650854121e-103,True,Regulation of expression of SLITs and ROBOs,171,97,68,10842,0.7010309278350515,0.39766081871345027,Module 3,['REAC:R-HSA-376176']
24,KEGG,KEGG:03010,Ribosome,1.9118256986311912e-100,True,Ribosome,153,97,68,8484,0.7010309278350515,0.4444444444444444,Module 3,['KEGG:00000']
25,REAC,REAC:R-HSA-6791226,Major pathway of rRNA processing in the nucleolus and cytosol,1.953353228000384e-100,True,Major pathway of rRNA processing in the nucleolus and cytosol,182,97,68,10842,0.7010309278350515,0.37362637362637363,Module 3,['REAC:R-HSA-8868773']
26,REAC,REAC:R-HSA-8868773,rRNA processing in the nucleus and cytosol,1.7226556453636173e-98,True,rRNA processing in the nucleus and cytosol,192,97,68,10842,0.7010309278350515,0.3541666666666667,Module 3,['REAC:R-HSA-72312']
27,REAC,REAC:R-HSA-72312,rRNA processing,1.1431650506746894e-96,True,rRNA processing,202,97,68,10842,0.7010309278350515,0.33663366336633666,Module 3,['REAC:R-HSA-8953854']
28,REAC,REAC:R-HSA-376176,Signaling by ROBO receptors,2.3045933627989856e-96,True,Signaling by ROBO receptors,217,97,69,10842,0.711340206185567,0.31797235023041476,Module 3,['REAC:R-HSA-422475']
29,CORUM,CORUM:306,"Ribosome, cytoplasmic",5.534141576228683e-96,True,"Ribosome, cytoplasmic",74,83,61,3383,0.7349397590361446,0.8243243243243243,Module 3,['CORUM:0000000']
30,GO:CC,GO:0005840,ribosome,1.3044135362597814e-88,True,"""An intracellular organelle, about 200 A in diameter, consisting of RNA and protein. It is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It consists of two subunits, one large and one small, each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients, expressed in Svedberg units (symbol: S). Hence, the prokaryotic ribosome (70S) comprises a large (50S) subunit and a small (30S) subunit, while the eukaryotic ribosome (80S) comprises a large (60S) subunit and a small (40S) subunit. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site). Ribosomes from prokaryotes, eukaryotes, mitochondria, and chloroplasts have characteristically distinct ribosomal proteins."" [ISBN:0198506732]",520,105,71,22097,0.6761904761904762,0.13653846153846153,Module 3,['GO:0043232']
31,REAC,REAC:R-HSA-72766,Translation,3.871610951142478e-88,True,Translation,292,97,70,10842,0.7216494845360825,0.23972602739726026,Module 3,['REAC:R-HSA-392499']
32,KEGG,KEGG:05171,Coronavirus disease - COVID-19,1.5266639689373311e-87,True,Coronavirus disease - COVID-19,231,97,69,8484,0.711340206185567,0.2987012987012987,Module 3,['KEGG:00000']
33,GO:MF,GO:0003735,structural constituent of ribosome,2.38773835733253e-86,True,"""The action of a molecule that contributes to the structural integrity of the ribosome."" [GOC:mah]",450,105,69,20212,0.6571428571428571,0.15333333333333332,Module 3,['GO:0005198']
34,GO:CC,GO:0022625,cytosolic large ribosomal subunit,1.2359451757941995e-83,True,"""The large subunit of a ribosome located in the cytosol."" [GOC:mtg_sensu]",57,105,41,22097,0.3904761904761905,0.7192982456140351,Module 3,"['GO:0015934', 'GO:0022626']"
35,GO:BP,GO:0006412,translation,4.609782631146324e-83,True,"""The cellular metabolic process in which a protein is formed, using the sequence of a mature mRNA or circRNA molecule to specify the sequence of amino acids in a polypeptide chain. Translation is mediated by the ribosome, and begins with the formation of a ternary complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, which subsequently associates with the small subunit of the ribosome and an mRNA or circRNA. Translation ends with the release of a polypeptide chain from the ribosome."" [GOC:go_curators]",723,105,75,21031,0.7142857142857143,0.1037344398340249,Module 3,"['GO:0009059', 'GO:0010467', 'GO:0019538', 'GO:0043043']"
36,GO:BP,GO:0043043,peptide biosynthetic process,9.891008644752535e-82,True,"""The chemical reactions and pathways resulting in the formation of peptides, compounds of 2 or more (but usually less than 100) amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another. This may include the translation of a precursor protein and its subsequent processing into a functional peptide."" [GOC:dph, GOC:jl]",752,105,75,21031,0.7142857142857143,0.09973404255319149,Module 3,"['GO:0006518', 'GO:0043604', 'GO:1901566']"
37,REAC,REAC:R-HSA-71291,Metabolism of amino acids and derivatives,3.337767281544799e-78,True,Metabolism of amino acids and derivatives,370,97,69,10842,0.711340206185567,0.1864864864864865,Module 3,['REAC:R-HSA-1430728']
38,GO:BP,GO:0043604,amide biosynthetic process,3.5253051618037633e-76,True,"""The chemical reactions and pathways resulting in the formation of an amide, any derivative of an oxoacid in which an acidic hydroxy group has been replaced by an amino or substituted amino group."" [GOC:curators]",887,105,75,21031,0.7142857142857143,0.08455467869222097,Module 3,"['GO:0043603', 'GO:0044271']"
39,GO:BP,GO:0006518,peptide metabolic process,2.7503030126873895e-75,True,"""The chemical reactions and pathways involving peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another."" [GOC:go_curators]",911,105,75,21031,0.7142857142857143,0.08232711306256861,Module 3,"['GO:0043603', 'GO:1901564']"
40,REAC,REAC:R-HSA-422475,Axon guidance,7.755250178935097e-71,True,Axon guidance,549,97,72,10842,0.7422680412371134,0.13114754098360656,Module 3,['REAC:R-HSA-9675108']
41,REAC,REAC:R-HSA-9675108,Nervous system development,2.2507927384320337e-69,True,Nervous system development,574,97,72,10842,0.7422680412371134,0.1254355400696864,Module 3,['REAC:R-HSA-1266738']
42,GO:CC,GO:0005737,cytoplasm,6.445702958395699e-68,True,"""The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures."" [ISBN:0198547684]",12345,813,687,22097,0.8450184501845018,0.05565006075334143,Module 0,"['GO:0005622', 'GO:0110165']"
43,GO:BP,GO:1901566,organonitrogen compound biosynthetic process,1.1920830239911647e-67,True,"""The chemical reactions and pathways resulting in the formation of organonitrogen compound."" [GOC:pr, GOC:TermGenie]",1761,105,84,21031,0.8,0.04770017035775128,Module 3,"['GO:1901564', 'GO:1901576']"
44,GO:BP,GO:0043603,amide metabolic process,2.5016247986037493e-66,True,"""The chemical reactions and pathways involving an amide, any derivative of an oxoacid in which an acidic hydroxy group has been replaced by an amino or substituted amino group, as carried out by individual cells."" [GOC:curators]",1194,105,75,21031,0.7142857142857143,0.06281407035175879,Module 3,['GO:0006807']
45,GO:CC,GO:0015934,large ribosomal subunit,1.1328525781621641e-65,True,"""The larger of the two subunits of a ribosome. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site)."" [ISBN:0198506732]",117,105,41,22097,0.3904761904761905,0.3504273504273504,Module 3,['GO:0044391']
46,GO:MF,GO:0005198,structural molecule activity,9.068572386380806e-62,True,"""The action of a molecule that contributes to the structural integrity of a complex."" [GOC:mah, GOC:vw]",1100,105,71,20212,0.6761904761904762,0.06454545454545454,Module 3,['GO:0003674']
47,HPA,HPA:0471471,skin 2; lymphocytes[≥Low],3.9638834615474425e-61,True,skin 2; lymphocytes[≥Low],802,612,177,11019,0.28921568627450983,0.22069825436408977,Module 0,['HPA:0470000']
48,REAC,REAC:R-HSA-2262752,Cellular responses to stress,4.547075906949303e-61,True,Cellular responses to stress,780,97,73,10842,0.7525773195876289,0.09358974358974359,Module 3,['REAC:R-HSA-8953897']
49,REAC,REAC:R-HSA-8953897,Cellular responses to stimuli,1.7175594505249806e-60,True,Cellular responses to stimuli,794,97,73,10842,0.7525773195876289,0.09193954659949623,Module 3,['REAC:0000000']
50,REAC,REAC:R-HSA-9824446,Viral Infection Pathways,6.938665291841205e-60,True,Viral Infection Pathways,809,97,73,10842,0.7525773195876289,0.09023485784919653,Module 3,['REAC:R-HSA-5663205']
51,REAC,REAC:R-HSA-8953854,Metabolism of RNA,5.309287813209014e-58,True,Metabolism of RNA,701,97,69,10842,0.711340206185567,0.09843081312410841,Module 3,['REAC:0000000']
52,CORUM,CORUM:3055,Nop56p-associated pre-rRNA complex,1.8842339024301706e-56,True,Nop56p-associated pre-rRNA complex,93,83,48,3383,0.5783132530120482,0.5161290322580645,Module 3,['CORUM:0000000']
53,REAC,REAC:R-HSA-5663205,Infectious disease,3.640910379107018e-56,True,Infectious disease,999,97,75,10842,0.7731958762886598,0.07507507507507508,Module 3,['REAC:R-HSA-1643685']
54,HPA,HPA:0471441,skin 2; fibrohistiocytic cells[≥Low],8.782731145584163e-56,True,skin 2; fibrohistiocytic cells[≥Low],1021,612,193,11019,0.315359477124183,0.1890303623898139,Module 0,['HPA:0470000']
55,HPA,HPA:0471472,skin 2; lymphocytes[≥Medium],3.386209947634066e-55,True,skin 2; lymphocytes[≥Medium],647,612,152,11019,0.24836601307189543,0.23493044822256567,Module 0,['HPA:0471471']
56,HPA,HPA:0461441,skin 1; fibrohistiocytic cells[≥Low],5.998446071098095e-55,True,skin 1; fibrohistiocytic cells[≥Low],885,612,178,11019,0.2908496732026144,0.20112994350282487,Module 0,['HPA:0460000']
57,GO:CC,GO:0022627,cytosolic small ribosomal subunit,2.2622755723998934e-53,True,"""The small subunit of a ribosome located in the cytosol."" [GOC:mtg_sensu]",44,105,28,22097,0.26666666666666666,0.6363636363636364,Module 3,"['GO:0015935', 'GO:0022626']"
58,HPA,HPA:0600000,tonsil,3.17431354359325e-53,True,tonsil,7788,612,582,11019,0.9509803921568627,0.07473035439137134,Module 0,['HPA:0000000']
59,HPA,HPA:0461471,skin 1; lymphocytes[≥Low],3.303442659463209e-53,True,skin 1; lymphocytes[≥Low],712,612,157,11019,0.2565359477124183,0.2205056179775281,Module 0,['HPA:0460000']
60,HPA,HPA:0600431,tonsil; germinal center cells[≥Low],7.564289840993235e-53,True,tonsil; germinal center cells[≥Low],5987,612,511,11019,0.8349673202614379,0.085351595122766,Module 0,['HPA:0600000']
61,CORUM,CORUM:308,"60S ribosomal subunit, cytoplasmic",8.750844740955901e-53,True,"60S ribosomal subunit, cytoplasmic",43,83,36,3383,0.43373493975903615,0.8372093023255814,Module 3,['CORUM:0000000']
62,HPA,HPA:0471442,skin 2; fibrohistiocytic cells[≥Medium],8.295759156042251e-51,True,skin 2; fibrohistiocytic cells[≥Medium],833,612,167,11019,0.272875816993464,0.20048019207683074,Module 0,['HPA:0471441']
63,HPA,HPA:0471391,skin 2; cells in basal layer[≥Low],1.164170385806299e-50,True,skin 2; cells in basal layer[≥Low],962,612,180,11019,0.29411764705882354,0.18711018711018712,Module 0,['HPA:0470000']
64,HPA,HPA:0471461,skin 2; langerhans cells[≥Low],8.254672364715164e-50,True,skin 2; langerhans cells[≥Low],789,612,161,11019,0.2630718954248366,0.20405576679340937,Module 0,['HPA:0470000']
65,HPA,HPA:0600441,tonsil; non-germinal center cells[≥Low],1.164383480502422e-49,True,tonsil; non-germinal center cells[≥Low],6117,612,512,11019,0.8366013071895425,0.08370116069968939,Module 0,['HPA:0600000']
66,HPA,HPA:0471392,skin 2; cells in basal layer[≥Medium],1.2453860298327531e-49,True,skin 2; cells in basal layer[≥Medium],754,612,157,11019,0.2565359477124183,0.20822281167108753,Module 0,['HPA:0471391']
67,REAC,REAC:R-HSA-9735869,SARS-CoV-1 modulates host translation machinery,3.266937510407439e-49,True,SARS-CoV-1 modulates host translation machinery,37,97,28,10842,0.28865979381443296,0.7567567567567568,Module 3,['REAC:R-HSA-9692914']
68,HPA,HPA:0470671,skin 2; melanocytes[≥Low],4.458323060561612e-49,True,skin 2; melanocytes[≥Low],724,612,153,11019,0.25,0.21132596685082872,Module 0,['HPA:0470000']
69,REAC,REAC:R-HSA-1266738,Developmental Biology,8.177581093846413e-49,True,Developmental Biology,1144,97,73,10842,0.7525773195876289,0.06381118881118882,Module 3,['REAC:0000000']
70,HPA,HPA:0461391,skin 1; cells in basal layer[≥Low],1.2135114192524003e-48,True,skin 1; cells in basal layer[≥Low],881,612,169,11019,0.2761437908496732,0.19182746878547105,Module 0,['HPA:0460000']
71,HPA,HPA:0461461,skin 1; langerhans cells[≥Low],3.1755604885660075e-48,True,skin 1; langerhans cells[≥Low],716,612,151,11019,0.24673202614379086,0.21089385474860337,Module 0,['HPA:0460000']
72,HPA,HPA:0460201,skin 1; endothelial cells[≥Low],2.786583837165464e-47,True,skin 1; endothelial cells[≥Low],841,612,163,11019,0.26633986928104575,0.1938168846611177,Module 0,['HPA:0460000']
73,HPA,HPA:0470201,skin 2; endothelial cells[≥Low],1.0235289081680216e-46,True,skin 2; endothelial cells[≥Low],888,612,167,11019,0.272875816993464,0.18806306306306306,Module 0,['HPA:0470000']
74,HPA,HPA:0310441,lymph node; non-germinal center cells[≥Low],1.192983865294306e-45,True,lymph node; non-germinal center cells[≥Low],6061,612,503,11019,0.8218954248366013,0.08298960567563109,Module 0,['HPA:0310000']
75,HPA,HPA:0310000,lymph node,1.2878038321339991e-45,True,lymph node,6530,612,524,11019,0.8562091503267973,0.08024502297090352,Module 0,['HPA:0000000']
76,HPA,HPA:0470672,skin 2; melanocytes[≥Medium],1.6388031998144942e-45,True,skin 2; melanocytes[≥Medium],640,612,139,11019,0.22712418300653595,0.2171875,Module 0,['HPA:0470671']
77,HPA,HPA:0461472,skin 1; lymphocytes[≥Medium],3.583749656594857e-45,True,skin 1; lymphocytes[≥Medium],574,612,131,11019,0.21405228758169934,0.22822299651567945,Module 0,['HPA:0461471']
78,HPA,HPA:0461411,skin 1; cells in spinous layer[≥Low],1.0128069751709807e-44,True,skin 1; cells in spinous layer[≥Low],760,612,151,11019,0.24673202614379086,0.1986842105263158,Module 0,['HPA:0460000']
79,GO:CC,GO:0015935,small ribosomal subunit,9.12427875012112e-44,True,"""The smaller of the two subunits of a ribosome."" [GOC:mah]",79,105,28,22097,0.26666666666666666,0.35443037974683544,Module 3,['GO:0044391']
80,HPA,HPA:0471411,skin 2; cells in spinous layer[≥Low],4.87026317488414e-43,True,skin 2; cells in spinous layer[≥Low],871,612,160,11019,0.26143790849673204,0.18369690011481057,Module 0,['HPA:0470000']
81,HPA,HPA:0461392,skin 1; cells in basal layer[≥Medium],9.774405559896726e-43,True,skin 1; cells in basal layer[≥Medium],637,612,135,11019,0.22058823529411764,0.2119309262166405,Module 0,['HPA:0461391']
82,HPA,HPA:0471462,skin 2; langerhans cells[≥Medium],3.5365525199983344e-42,True,skin 2; langerhans cells[≥Medium],662,612,137,11019,0.2238562091503268,0.20694864048338368,Module 0,['HPA:0471461']
83,HPA,HPA:0461442,skin 1; fibrohistiocytic cells[≥Medium],3.547772736357472e-42,True,skin 1; fibrohistiocytic cells[≥Medium],699,612,141,11019,0.23039215686274508,0.2017167381974249,Module 0,['HPA:0461441']
84,REAC,REAC:R-HSA-1430728,Metabolism,1.1553057179212538e-41,True,Metabolism,2074,97,82,10842,0.845360824742268,0.03953712632594021,Module 3,['REAC:0000000']
85,GO:CC,GO:1902494,catalytic complex,1.345702565671888e-41,True,"""A protein complex which is capable of catalytic activity."" [GOC:bhm, GOC:TermGenie, PMID:8077207]",1776,813,192,22097,0.23616236162361623,0.10810810810810811,Module 0,['GO:0032991']
86,GO:CC,GO:0043227,membrane-bounded organelle,3.770829514225823e-41,True,"""Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane."" [GOC:go_curators]",15671,813,736,22097,0.9052890528905289,0.04696573288239423,Module 0,['GO:0043226']
87,REAC,REAC:R-HSA-9754678,SARS-CoV-2 modulates host translation machinery,8.472977203432958e-41,True,SARS-CoV-2 modulates host translation machinery,51,97,27,10842,0.27835051546391754,0.5294117647058824,Module 3,['REAC:R-HSA-9705683']
88,HPA,HPA:0530721,spleen; cells in white pulp[≥Low],9.973729275198771e-41,True,spleen; cells in white pulp[≥Low],4339,612,405,11019,0.6617647058823529,0.0933394791426596,Module 0,['HPA:0530000']
89,REAC,REAC:R-HSA-72695,"Formation of the ternary complex, and subsequently, the 43S complex",1.7513581921488792e-40,True,"Formation of the ternary complex, and subsequently, the 43S complex",52,97,27,10842,0.27835051546391754,0.5192307692307693,Module 3,['REAC:R-HSA-72737']
90,HPA,HPA:0530000,spleen,2.064342099958273e-40,True,spleen,5893,612,486,11019,0.7941176470588235,0.08247072798235194,Module 0,['HPA:0000000']
91,REAC,REAC:R-HSA-1643685,Disease,2.2625802289730722e-40,True,Disease,1767,97,77,10842,0.7938144329896907,0.04357668364459536,Module 3,['REAC:0000000']
92,HPA,HPA:0470181,skin 2; cells in granular layer[≥Low],3.0197961079823666e-39,True,skin 2; cells in granular layer[≥Low],719,612,139,11019,0.22712418300653595,0.1933240611961057,Module 0,['HPA:0470000']
93,HPA,HPA:0600432,tonsil; germinal center cells[≥Medium],4.108177806177257e-39,True,tonsil; germinal center cells[≥Medium],4100,612,388,11019,0.6339869281045751,0.09463414634146342,Module 0,['HPA:0600431']
94,GO:BP,GO:0044271,cellular nitrogen compound biosynthetic process,4.575288290598492e-39,True,"""The chemical reactions and pathways resulting in the formation of organic and inorganic nitrogenous compounds."" [GOC:jl, ISBN:0198506732]",4836,105,90,21031,0.8571428571428571,0.018610421836228287,Module 3,"['GO:0034641', 'GO:0044249']"
95,GO:CC,GO:1990904,ribonucleoprotein complex,5.5429837676526374e-39,True,"""A macromolecular complex that contains both RNA and protein molecules."" [GOC:krc, GOC:vesicles]",2793,105,73,22097,0.6952380952380952,0.026136770497672754,Module 3,['GO:0032991']
96,HPA,HPA:0030000,appendix,6.949463066091783e-39,True,appendix,7831,612,566,11019,0.9248366013071896,0.0722768484229345,Module 0,['HPA:0000000']
97,HPA,HPA:0471473,skin 2; lymphocytes[High],7.097493337964468e-39,True,skin 2; lymphocytes[High],456,612,109,11019,0.1781045751633987,0.23903508771929824,Module 0,['HPA:0471472']
98,REAC,REAC:R-HSA-72649,Translation initiation complex formation,1.6988190870512888e-38,True,Translation initiation complex formation,59,97,27,10842,0.27835051546391754,0.4576271186440678,Module 3,['REAC:R-HSA-72662']
99,REAC,REAC:R-HSA-72702,Ribosomal scanning and start codon recognition,1.6988190870512888e-38,True,Ribosomal scanning and start codon recognition,59,97,27,10842,0.27835051546391754,0.4576271186440678,Module 3,['REAC:R-HSA-72737']
100,REAC,REAC:R-HSA-72662,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",3.0694337897248747e-38,True,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",60,97,27,10842,0.27835051546391754,0.45,Module 3,['REAC:R-HSA-72737']
101,HPA,HPA:0460202,skin 1; endothelial cells[≥Medium],3.360220631139576e-38,True,skin 1; endothelial cells[≥Medium],593,612,124,11019,0.20261437908496732,0.209106239460371,Module 0,['HPA:0460201']
102,GO:CC,GO:0098798,mitochondrial protein-containing complex,6.898722876645383e-38,True,"""A protein complex that is part of a mitochondrion."" [GOC:dos]",306,813,75,22097,0.09225092250922509,0.24509803921568626,Module 0,"['GO:0005739', 'GO:0032991']"
103,GO:CC,GO:0005829,cytosol,8.306587257987356e-38,True,"""The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes."" [GOC:hjd, GOC:jl]",5487,813,373,22097,0.45879458794587946,0.06797885912156006,Module 0,"['GO:0005737', 'GO:0110165']"
104,HPA,HPA:0460181,skin 1; cells in granular layer[≥Low],9.677771276286598e-38,True,skin 1; cells in granular layer[≥Low],711,612,136,11019,0.2222222222222222,0.19127988748241911,Module 0,['HPA:0460000']
105,HPA,HPA:0471412,skin 2; cells in spinous layer[≥Medium],5.393526124125346e-37,True,skin 2; cells in spinous layer[≥Medium],683,612,132,11019,0.21568627450980393,0.19326500732064422,Module 0,['HPA:0471411']
106,GO:BP,GO:0002376,immune system process,1.0550943549190285e-36,True,"""Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats."" [GO_REF:0000022, GOC:add]",2776,226,112,21031,0.49557522123893805,0.040345821325648415,Module 1,['GO:0008150']
107,GO:CC,GO:0005622,intracellular anatomical structure,1.766108961872415e-36,True,"""A component of a cell contained within (but not including) the plasma membrane. In eukaryotes it includes the nucleus and cytoplasm."" [ISBN:0198506732]",17834,813,780,22097,0.959409594095941,0.04373668274083212,Module 0,['GO:0110165']
108,HPA,HPA:0470202,skin 2; endothelial cells[≥Medium],3.342147405278694e-36,True,skin 2; endothelial cells[≥Medium],637,612,126,11019,0.20588235294117646,0.1978021978021978,Module 0,['HPA:0470201']
109,GO:BP,GO:0046649,lymphocyte activation,3.42629161518939e-36,True,"""A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor."" [GOC:mgi_curators, ISBN:0781735149]",783,226,65,21031,0.28761061946902655,0.08301404853128991,Module 1,['GO:0045321']
110,GO:MF,GO:0005515,protein binding,3.7544731242959526e-36,True,"""Binding to a protein."" [GOC:go_curators]",14838,808,738,20212,0.9133663366336634,0.04973716134249899,Module 0,['GO:0005488']
111,HPA,HPA:0470000,skin 2,5.98550109877731e-36,True,skin 2,7036,612,530,11019,0.8660130718954249,0.07532689027856737,Module 0,['HPA:0000000']
112,HPA,HPA:0310431,lymph node; germinal center cells[≥Low],7.057475050221129e-36,True,lymph node; germinal center cells[≥Low],5061,612,435,11019,0.7107843137254902,0.08595139300533491,Module 0,['HPA:0310000']
113,HPA,HPA:0600442,tonsil; non-germinal center cells[≥Medium],8.343544859324212e-36,True,tonsil; non-germinal center cells[≥Medium],4200,612,387,11019,0.6323529411764706,0.09214285714285714,Module 0,['HPA:0600441']
114,GO:BP,GO:0006955,immune response,1.8370100898298388e-35,True,"""Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat."" [GO_REF:0000022, GOC:add]",1988,226,95,21031,0.42035398230088494,0.04778672032193159,Module 1,"['GO:0002376', 'GO:0050896']"
115,HPA,HPA:0300000,lung,3.4810930411938277e-35,True,lung,7379,612,543,11019,0.8872549019607843,0.07358720693860957,Module 0,['HPA:0000000']
116,HPA,HPA:0461462,skin 1; langerhans cells[≥Medium],4.746528922923321e-35,True,skin 1; langerhans cells[≥Medium],578,612,118,11019,0.19281045751633988,0.2041522491349481,Module 0,['HPA:0461461']
117,GO:CC,GO:0043231,intracellular membrane-bounded organelle,1.0334805311167598e-34,True,"""Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane."" [GOC:go_curators]",14605,813,695,22097,0.8548585485854858,0.04758644299897295,Module 0,"['GO:0043227', 'GO:0043229']"
118,GO:CC,GO:0043226,organelle,1.0734221280671243e-34,True,"""Organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton, and prokaryotic structures such as anammoxosomes and pirellulosomes. Excludes the plasma membrane."" [GOC:go_curators]",16808,813,754,22097,0.9274292742927429,0.04485959067110899,Module 0,['GO:0110165']
119,CORUM,CORUM:305,"40S ribosomal subunit, cytoplasmic",1.3193651339490546e-34,True,"40S ribosomal subunit, cytoplasmic",31,83,25,3383,0.30120481927710846,0.8064516129032258,Module 3,['CORUM:0000000']
120,GO:CC,GO:0005925,focal adhesion,1.6494597953989047e-34,True,"""A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ)."" [GOC:aruk, GOC:bc, ISBN:0124325653, ISBN:0815316208, PMID:10419689, PMID:12191915, PMID:15246682, PMID:1643657, PMID:16805308, PMID:19197329, PMID:23033047, PMID:26923917, PMID:28796323, PMID:8314002]",422,105,37,22097,0.3523809523809524,0.08767772511848342,Module 3,['GO:0030055']
121,GO:CC,GO:0098800,inner mitochondrial membrane protein complex,2.119960255157755e-34,True,"""Any protein complex that is part of the inner mitochondrial membrane."" [GOC:dos]",162,813,54,22097,0.06642066420664207,0.3333333333333333,Module 0,"['GO:0005743', 'GO:0098796', 'GO:0098798']"
122,GO:BP,GO:0045321,leukocyte activation,3.900527850408975e-34,True,"""A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor."" [GOC:add]",946,226,68,21031,0.3008849557522124,0.07188160676532769,Module 1,"['GO:0001775', 'GO:0002376']"
123,GO:CC,GO:0030055,cell-substrate junction,3.955853642293144e-34,True,"""A cell junction that forms a connection between a cell and the extracellular matrix."" [GOC:aruk, GOC:bc, GOC:hb, GOC:mah, PMID:10419689, PMID:1643657, PMID:16805308, PMID:26923917, PMID:8314002]",432,105,37,22097,0.3523809523809524,0.08564814814814815,Module 3,['GO:0070161']
124,HPA,HPA:0310432,lymph node; germinal center cells[≥Medium],3.996806855521173e-34,True,lymph node; germinal center cells[≥Medium],3302,612,329,11019,0.5375816993464052,0.0996365838885524,Module 0,['HPA:0310431']
125,GO:MF,GO:0003723,RNA binding,7.571339557553272e-34,True,"""Binding to an RNA molecule or a portion thereof."" [GOC:jl, GOC:mah]",3123,105,74,20212,0.7047619047619048,0.023695164905539544,Module 3,['GO:0003676']
126,CORUM,CORUM:338,"40S ribosomal subunit, cytoplasmic",1.2304175622062122e-33,True,"40S ribosomal subunit, cytoplasmic",29,83,24,3383,0.2891566265060241,0.8275862068965517,Module 3,['CORUM:0000000']
127,REAC,REAC:R-HSA-9692914,SARS-CoV-1-host interactions,1.7028498454259275e-33,True,SARS-CoV-1-host interactions,95,97,28,10842,0.28865979381443296,0.29473684210526313,Module 3,['REAC:R-HSA-9678108']
128,HPA,HPA:0530711,spleen; cells in red pulp[≥Low],2.6283795345502812e-33,True,spleen; cells in red pulp[≥Low],5333,612,444,11019,0.7254901960784313,0.08325520345021564,Module 0,['HPA:0530000']
129,KEGG,KEGG:00190,Oxidative phosphorylation,4.986192588770182e-33,True,Oxidative phosphorylation,134,439,54,8484,0.12300683371298406,0.40298507462686567,Module 0,['KEGG:00000']
130,HP,HP:0012133,Erythroid hypoplasia,6.175218876382582e-33,True,"Decreased count of erythroid precursor cells, that is, erythroid lineage cells in the bone marrow.",31,44,20,4958,0.45454545454545453,0.6451612903225806,Module 3,['HP:0012131']
131,HP,HP:0030270,Elevated red cell adenosine deaminase activity,9.643320582553803e-33,True,"Increase in the level of adenosine deaminase (ADA), an enzyme involved in purine metabolism, within erythrocytes. ADA is involved in the catabolism of adenosine.",26,44,19,4958,0.4318181818181818,0.7307692307692307,Module 3,['HP:4000209']
132,HP,HP:0031640,Abnormal radial artery morphology,9.643320582553803e-33,True,Any structural anomaly of the radial artery.,26,44,19,4958,0.4318181818181818,0.7307692307692307,Module 3,['HP:0011004']
133,HP,HP:0020118,Radial artery aplasia,9.643320582553803e-33,True,Congenital absence of the radial artery.,26,44,19,4958,0.4318181818181818,0.7307692307692307,Module 3,['HP:0031640']
134,HPA,HPA:0310442,lymph node; non-germinal center cells[≥Medium],9.990653991044731e-33,True,lymph node; non-germinal center cells[≥Medium],3989,612,368,11019,0.6013071895424836,0.09225369766858862,Module 0,['HPA:0310441']
135,GO:CC,GO:0043229,intracellular organelle,1.6736229720215877e-32,True,"""Organized structure of distinctive morphology and function, occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane."" [GOC:go_curators]",16018,813,730,22097,0.897908979089791,0.045573729554251464,Module 0,"['GO:0005622', 'GO:0043226']"
136,HP,HP:4000209,Abnormal erythrocyte adenosine deaminase activity,3.2389504980762404e-32,True,Activity of adenosine deaminase in red blood cells outside the limits of normal.,27,44,19,4958,0.4318181818181818,0.7037037037037037,Module 3,['HP:0030272']
137,HPA,HPA:0461473,skin 1; lymphocytes[High],3.385467823875375e-32,True,skin 1; lymphocytes[High],394,612,93,11019,0.15196078431372548,0.23604060913705585,Module 0,['HPA:0461472']
138,GO:CC,GO:0005829,cytosol,3.4952739519132866e-32,True,"""The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes."" [GOC:hjd, GOC:jl]",5487,105,86,22097,0.819047619047619,0.015673409877893202,Module 3,"['GO:0005737', 'GO:0110165']"
139,HP,HP:0005532,Macrocytic dyserythropoietic anemia,1.002820910632649e-31,True,Macrocytic dyserythropoietic anemia,28,44,19,4958,0.4318181818181818,0.6785714285714286,Module 3,['HP:0001972']
140,HPA,HPA:0350000,pancreas,1.7319600321222457e-31,True,pancreas,7409,612,538,11019,0.8790849673202614,0.07261438790660008,Module 0,['HPA:0000000']
141,KEGG,KEGG:05012,Parkinson disease,1.8057154577846472e-31,True,Parkinson disease,265,439,72,8484,0.16400911161731208,0.27169811320754716,Module 0,['KEGG:00000']
142,KEGG,KEGG:05016,Huntington disease,2.072505713441457e-31,True,Huntington disease,305,439,77,8484,0.17539863325740318,0.25245901639344265,Module 0,['KEGG:00000']
143,REAC,REAC:R-HSA-392499,Metabolism of proteins,2.7346958160131663e-31,True,Metabolism of proteins,1946,97,72,10842,0.7422680412371134,0.03699897225077081,Module 3,['REAC:0000000']
144,HPA,HPA:0461412,skin 1; cells in spinous layer[≥Medium],3.282855473206392e-31,True,skin 1; cells in spinous layer[≥Medium],592,612,114,11019,0.18627450980392157,0.19256756756756757,Module 0,['HPA:0461411']
145,HP,HP:0012410,Pure red cell aplasia,7.855175735481469e-31,True,"A type of anemia resulting from suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production. Erythroblasts are virtually absent in bone marrow; however, leukocyte and platelet production show little or no reduction.",30,44,19,4958,0.4318181818181818,0.6333333333333333,Module 3,['HP:0012131']
146,HPA,HPA:0040081,bone marrow; hematopoietic cells[≥Low],1.2317866350747634e-30,True,bone marrow; hematopoietic cells[≥Low],6496,612,496,11019,0.8104575163398693,0.07635467980295567,Module 0,['HPA:0040000']
147,HPA,HPA:0040000,bone marrow,1.2317866350747634e-30,True,bone marrow,6496,612,496,11019,0.8104575163398693,0.07635467980295567,Module 0,['HPA:0000000']
148,GO:BP,GO:0009060,aerobic respiration,1.4989816865152997e-30,True,"""The enzymatic release of energy from inorganic and organic compounds (especially carbohydrates and fats) which requires oxygen as the terminal electron acceptor."" [GOC:das, GOC:jl, ISBN:0140513590]",196,787,56,21031,0.07115628970775095,0.2857142857142857,Module 0,['GO:0045333']
149,HPA,HPA:0300411,lung; macrophages[≥Low],1.9670366167075298e-30,True,lung; macrophages[≥Low],6787,612,509,11019,0.8316993464052288,0.07499631648740239,Module 0,['HPA:0300000']
150,GO:BP,GO:0006119,oxidative phosphorylation,2.651349818694713e-30,True,"""The phosphorylation of ADP to ATP that accompanies the oxidation of a metabolite through the operation of the respiratory chain. Oxidation of compounds establishes a proton gradient across the membrane, providing the energy for ATP synthesis."" [ISBN:0198506732, ISBN:0471331309]",145,787,49,21031,0.062261753494282084,0.33793103448275863,Module 0,['GO:0009060']
151,GO:BP,GO:0001775,cell activation,3.0338159506013156e-30,True,"""A multicellular organismal process by which exposure to an activating factor such as a cellular or soluble ligand results in a change in the morphology or behavior of a cell."" [GOC:mgi_curators]",1092,226,68,21031,0.3008849557522124,0.06227106227106227,Module 1,"['GO:0009987', 'GO:0032501']"
152,HPA,HPA:0530722,spleen; cells in white pulp[≥Medium],5.342318076225677e-30,True,spleen; cells in white pulp[≥Medium],2720,612,282,11019,0.46078431372549017,0.1036764705882353,Module 0,['HPA:0530721']
153,GO:BP,GO:0045333,cellular respiration,7.507935233482103e-30,True,"""The enzymatic release of energy from inorganic and organic compounds (especially carbohydrates and fats) which either requires oxygen (aerobic respiration) or does not (anaerobic respiration)."" [GOC:das, ISBN:0140513590, ISBN:0198506732]",244,787,61,21031,0.07750952986022872,0.25,Module 0,['GO:0015980']
154,HPA,HPA:0460000,skin 1,9.200868023273921e-30,True,skin 1,7246,612,528,11019,0.8627450980392157,0.0728677891250345,Module 0,['HPA:0000000']
155,HPA,HPA:0390000,prostate,1.9363497471280737e-29,True,prostate,6677,612,502,11019,0.8202614379084967,0.07518346562827617,Module 0,['HPA:0000000']
156,HPA,HPA:0390051,prostate; glandular cells[≥Low],1.9363497471280737e-29,True,prostate; glandular cells[≥Low],6677,612,502,11019,0.8202614379084967,0.07518346562827617,Module 0,['HPA:0390000']
157,HPA,HPA:0470182,skin 2; cells in granular layer[≥Medium],2.6963699502797605e-29,True,skin 2; cells in granular layer[≥Medium],562,612,108,11019,0.17647058823529413,0.19217081850533807,Module 0,['HPA:0470181']
158,HPA,HPA:0020051,adrenal gland; glandular cells[≥Low],4.124071992344337e-29,True,adrenal gland; glandular cells[≥Low],7415,612,534,11019,0.8725490196078431,0.0720161834120027,Module 0,['HPA:0020000']
159,HP,HP:0040276,Adenocarcinoma of the colon,5.698661179910174e-29,True,Adenocarcinoma of the colon,35,44,19,4958,0.4318181818181818,0.5428571428571428,Module 3,"['HP:0040275', 'HP:0100273']"
160,HP,HP:0001227,Abnormality of the thenar eminence,5.698661179910174e-29,True,"An abnormality of the thenar eminence, i.e., of the muscle on the palm of the human hand just beneath the thumb.",35,44,19,4958,0.4318181818181818,0.5428571428571428,Module 3,['HP:0001421']
161,HPA,HPA:0020000,adrenal gland,5.975220944873238e-29,True,adrenal gland,7422,612,534,11019,0.8725490196078431,0.0719482619240097,Module 0,['HPA:0000000']
162,HPA,HPA:0610832,urinary bladder; urothelial cells[≥Medium],1.0049019955122178e-28,True,urinary bladder; urothelial cells[≥Medium],5958,612,466,11019,0.761437908496732,0.07821416582745888,Module 0,['HPA:0610831']
163,HP,HP:0011904,Persistence of hemoglobin F,1.200955512157562e-28,True,"Hemoglobin F (HbF) contains two globin alpha chains and two globin gamma chains. It is the main form of hemoglobin in the fetus during the last seven months of intrauterine development and in the half year of postnatal life. In adults it normally makes up less than one percent of all hemoglobin. This term refers to an increase in HbF above this limit. In beta thalassemia major, it may represent over 90 percent of all hemoglobin, and in beta thalassemia minor it may make up between 0.5 to 4 percent.",36,44,19,4958,0.4318181818181818,0.5277777777777778,Module 3,['HP:0011902']
164,HP,HP:0002669,Osteosarcoma,2.456723396445846e-28,True,"A malignant bone tumor that usually develops during adolescence and usually affects the long bones including the tibia, femur, and humerus. The typical symptoms of osteosarcoma comprise bone pain, fracture, limitation of motion, and tenderness or swelling at the site of the tumor.",37,44,19,4958,0.4318181818181818,0.5135135135135135,Module 3,"['HP:0010622', 'HP:0100242']"
165,HP,HP:0001896,Reticulocytopenia,2.456723396445846e-28,True,A reduced number of reticulocytes in the peripheral blood.,37,44,19,4958,0.4318181818181818,0.5135135135135135,Module 3,['HP:0004312']
166,REAC,REAC:R-HSA-9678108,SARS-CoV-1 Infection,3.0975490614395396e-28,True,SARS-CoV-1 Infection,140,97,28,10842,0.28865979381443296,0.2,Module 3,['REAC:R-HSA-9679506']
167,TF,TF:M01660_1,Factor: GABP-alpha; motif: CTTCCK; match class: 1,3.118808827783221e-28,True,Factor: GABP-alpha; motif: CTTCCK; match class: 1,5249,826,369,20045,0.4467312348668281,0.07029910459135073,Module 0,['TF:M01660']
168,HPA,HPA:0160051,endometrium 1; glandular cells[≥Low],3.225078725891001e-28,True,endometrium 1; glandular cells[≥Low],6818,612,506,11019,0.826797385620915,0.07421531240833089,Module 0,['HPA:0160000']
169,KEGG,KEGG:05020,Prion disease,3.838414988213592e-28,True,Prion disease,271,439,69,8484,0.1571753986332574,0.25461254612546125,Module 0,['KEGG:00000']
170,REAC,REAC:R-HSA-163200,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",4.364422337668595e-28,True,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",127,586,50,10842,0.08532423208191127,0.3937007874015748,Module 0,['REAC:R-HSA-1428517']
171,HP,HP:0006758,Malignant genitourinary tract tumor,4.889742613491932e-28,True,The presence of a malignant neoplasm of the genital system.,38,44,19,4958,0.4318181818181818,0.5,Module 3,['HP:0007379']
172,WP,WP:WP111,Electron transport chain OXPHOS system in mitochondria,5.908151080713822e-28,True,Electron transport chain OXPHOS system in mitochondria,104,472,46,8286,0.09745762711864407,0.4423076923076923,Module 0,['WP:000000']
173,TF,TF:M02065_1,Factor: ER81; motif: RCCGGAARYN; match class: 1,6.518564067271155e-28,True,Factor: ER81; motif: RCCGGAARYN; match class: 1,7184,826,457,20045,0.5532687651331719,0.06361358574610244,Module 0,['TF:M02065']
174,HPA,HPA:0420000,salivary gland,8.21333311378141e-28,True,salivary gland,6902,612,509,11019,0.8316993464052288,0.07374674007534048,Module 0,['HPA:0000000']
175,HPA,HPA:0420051,salivary gland; glandular cells[≥Low],8.21333311378141e-28,True,salivary gland; glandular cells[≥Low],6902,612,509,11019,0.8316993464052288,0.07374674007534048,Module 0,['HPA:0420000']
176,HP,HP:0030272,Abnormal erythrocyte enzyme level,9.488989611080687e-28,True,An altered level of any enzyme to act as catalysts within erythrocytes. This term includes changes due to altered activity of an enzyme.,39,44,19,4958,0.4318181818181818,0.48717948717948717,Module 3,"['HP:0001877', 'HP:0034684']"
177,HP,HP:0040275,Adenocarcinoma of the large intestine,9.488989611080687e-28,True,A malignant epithelial tumor with a glandular organization that originates in the large intestine.,39,44,19,4958,0.4318181818181818,0.48717948717948717,Module 3,"['HP:0040273', 'HP:0100834']"
178,HP,HP:0001895,Normochromic anemia,9.488989611080687e-28,True,Normochromic anemia,39,44,19,4958,0.4318181818181818,0.48717948717948717,Module 3,['HP:0010972']
179,GO:BP,GO:1901564,organonitrogen compound metabolic process,9.559478322681622e-28,True,"""The chemical reactions and pathways involving organonitrogen compound."" [GOC:pr, GOC:TermGenie]",5986,105,87,21031,0.8285714285714286,0.014533912462412295,Module 3,"['GO:0006807', 'GO:0071704']"
180,GO:CC,GO:0005654,nucleoplasm,1.0566424597240628e-27,True,"""That part of the nuclear content other than the chromosomes or the nucleolus."" [GOC:ma, ISBN:0124325653]",4220,813,291,22097,0.35793357933579334,0.06895734597156399,Module 0,"['GO:0031981', 'GO:0110165']"
181,HPA,HPA:0180000,epididymis,1.097810718544229e-27,True,epididymis,7337,612,528,11019,0.8627450980392157,0.07196401799100449,Module 0,['HPA:0000000']
182,HPA,HPA:0180051,epididymis; glandular cells[≥Low],1.097810718544229e-27,True,epididymis; glandular cells[≥Low],7337,612,528,11019,0.8627450980392157,0.07196401799100449,Module 0,['HPA:0180000']
183,HPA,HPA:0590000,thyroid gland,1.1054340008859691e-27,True,thyroid gland,7131,612,519,11019,0.8480392156862745,0.07278081615481699,Module 0,['HPA:0000000']
184,HPA,HPA:0590051,thyroid gland; glandular cells[≥Low],1.1054340008859691e-27,True,thyroid gland; glandular cells[≥Low],7131,612,519,11019,0.8480392156862745,0.07278081615481699,Module 0,['HPA:0590000']
185,HPA,HPA:0460182,skin 1; cells in granular layer[≥Medium],1.4221289098253382e-27,True,skin 1; cells in granular layer[≥Medium],558,612,105,11019,0.1715686274509804,0.1881720430107527,Module 0,['HPA:0460181']
186,HPA,HPA:0050000,breast,1.7253454802527628e-27,True,breast,7185,612,521,11019,0.8513071895424836,0.07251217814892136,Module 0,['HPA:0000000']
187,HPA,HPA:0610000,urinary bladder,2.1772835290688493e-27,True,urinary bladder,7304,612,526,11019,0.8594771241830066,0.07201533406352684,Module 0,['HPA:0000000']
188,HPA,HPA:0610831,urinary bladder; urothelial cells[≥Low],2.1772835290688493e-27,True,urinary bladder; urothelial cells[≥Low],7304,612,526,11019,0.8594771241830066,0.07201533406352684,Module 0,['HPA:0610000']
189,GO:CC,GO:0031982,vesicle,2.435450440880034e-27,True,"""Any small, fluid-filled, spherical organelle enclosed by membrane."" [GOC:mah, GOC:pz, GOC:vesicles]",4004,813,280,22097,0.34440344403444034,0.06993006993006994,Module 0,['GO:0043227']
190,HP,HP:0009942,Duplication of thumb phalanx,3.798110071418622e-27,True,"Complete or partial duplication of the phalanges of the thumb. Depending on the severity, the appearance on x-ray can vary from a notched phalanx (the duplicated bone is almost completely fused with the phalanx), a partially fused appearance of the two bones (bifid), two separate bones appearing side to side, or completely duplicated phalanges (proximal and distal phalanx of the thumb and/or 1st metacarpal). In contrast to the phalanges of the digits 2-5 (proximal, middle and distal), the proximal phalanx of the thumb is embryologically equivalent to the middle phalanges of the other digits, whereas the first metacarpal is embryologically of phalangeal origin and as such equivalent to the proximal phalanges of the other digits.",61,44,21,4958,0.4772727272727273,0.3442622950819672,Module 3,"['HP:0009602', 'HP:0009997']"
191,TF,TF:M00025_1,Factor: Elk-1; motif: NNNNCCGGAARTNN; match class: 1,4.347555765163264e-27,True,Factor: Elk-1; motif: NNNNCCGGAARTNN; match class: 1,4534,826,331,20045,0.400726392251816,0.07300397000441111,Module 0,['TF:M00025']
192,GO:CC,GO:0005746,mitochondrial respirasome,5.018207609331892e-27,True,"""The protein complexes that form the mitochondrial electron transport system (the respiratory chain), associated with the inner mitochondrial membrane. The respiratory chain complexes transfer electrons from an electron donor to an electron acceptor and are associated with a proton pump to create a transmembrane electrochemical gradient."" [GOC:curators, GOC:ecd, ISBN:0198547684]",96,813,38,22097,0.046740467404674045,0.3958333333333333,Module 0,"['GO:0005743', 'GO:0070469']"
193,HP,HP:0012131,Abnormal number of erythroid precursors,5.151799392289407e-27,True,"A deviation from the normal count of erythroid precursor cells, that is, erythroid lineage cells in the bone marrow.",51,44,20,4958,0.45454545454545453,0.39215686274509803,Module 3,['HP:0001877']
194,HP,HP:0009944,Partial duplication of thumb phalanx,6.062323257114668e-27,True,"A partial duplication, depending on severity leading to a broad or bifid appearance, affecting one or more of the phalanges of the thumb. As opposed to a complete duplication there is still a variable degree of fusion between the duplicated bones.",42,44,19,4958,0.4318181818181818,0.4523809523809524,Module 3,"['HP:0009942', 'HP:0009999']"
195,GO:CC,GO:0070469,respirasome,1.0495309304667973e-26,True,"""The protein complexes that form the electron transport system (the respiratory chain), associated with a cell membrane, usually the plasma membrane (in prokaryotes) or the inner mitochondrial membrane (on eukaryotes). The respiratory chain complexes transfer electrons from an electron donor to an electron acceptor and are associated with a proton pump to create a transmembrane electrochemical gradient."" [GOC:ecd, GOC:mah, ISBN:0198547684, Wikipedia:Respirasome]",104,813,39,22097,0.04797047970479705,0.375,Module 0,"['GO:0016020', 'GO:0110165']"
196,GO:BP,GO:0042254,ribosome biogenesis,1.0674550797073328e-26,True,"""A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of ribosome subunits; includes transport to the sites of protein synthesis."" [GOC:ma, PMID:26404467, Wikipedia:Ribosome_biogenesis]",322,105,30,21031,0.2857142857142857,0.09316770186335403,Module 3,['GO:0022613']
197,HP,HP:0040273,Adenocarcinoma of the intestines,1.0809214571982258e-26,True,A malignant epithelial tumor with a glandular organization that originates in the intestines.,43,44,19,4958,0.4318181818181818,0.4418604651162791,Module 3,['HP:0002672']
198,GO:CC,GO:0070062,extracellular exosome,1.170651532261032e-26,True,"""A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm."" [GOC:BHF, GOC:mah, GOC:vesicles, PMID:15908444, PMID:17641064, PMID:19442504, PMID:19498381, PMID:22418571, PMID:24009894]",2109,813,183,22097,0.22509225092250923,0.08677098150782361,Module 0,"['GO:0005615', 'GO:1903561']"
199,HP,HP:0001894,Thrombocytosis,1.2651064571188951e-26,True,Increased numbers of platelets in the peripheral blood.,64,44,21,4958,0.4772727272727273,0.328125,Module 3,['HP:0011873']
200,GO:CC,GO:0005743,mitochondrial inner membrane,1.311724083196461e-26,True,"""The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae."" [GOC:ai]",512,813,81,22097,0.0996309963099631,0.158203125,Module 0,"['GO:0019866', 'GO:0031966']"
201,GO:BP,GO:0002682,regulation of immune system process,1.4406480827601464e-26,True,"""Any process that modulates the frequency, rate, or extent of an immune system process."" [GOC:add]",1512,226,74,21031,0.3274336283185841,0.04894179894179894,Module 1,"['GO:0002376', 'GO:0050789']"
202,HPA,HPA:0170051,endometrium 2; glandular cells[≥Low],1.7551464356342343e-26,True,endometrium 2; glandular cells[≥Low],6723,612,498,11019,0.8137254901960784,0.07407407407407407,Module 0,['HPA:0170000']
203,HP,HP:0009999,Partial duplication of the phalanx of hand,1.8932338370779675e-26,True,"A partial duplication, depending on severity leading to a broad or bifid appearance, affecting one or more of the phalanges of the hand. As opposed to a complete duplication there is still a variable degree of fusion between the duplicated bones.",44,44,19,4958,0.4318181818181818,0.4318181818181818,Module 3,['HP:0009997']
204,HPA,HPA:0050051,breast; glandular cells[≥Low],2.1193997936102684e-26,True,breast; glandular cells[≥Low],6813,612,502,11019,0.8202614379084967,0.07368266549244092,Module 0,['HPA:0050000']
205,GO:CC,GO:0098803,respiratory chain complex,2.2392433471471348e-26,True,"""Any protein complex that is part of a respiratory chain."" [GOC:dos]",93,813,37,22097,0.04551045510455105,0.3978494623655914,Module 0,"['GO:0070469', 'GO:0098796']"
206,HPA,HPA:0300412,lung; macrophages[≥Medium],2.3551785419611894e-26,True,lung; macrophages[≥Medium],4898,612,405,11019,0.6617647058823529,0.08268681094324214,Module 0,['HPA:0300411']
207,GO:BP,GO:0015986,proton motive force-driven ATP synthesis,2.5710538223562315e-26,True,"""The transport of protons across a membrane to generate an electrochemical gradient (proton-motive force) that powers ATP synthesis."" [ISBN:0716731363]",77,787,35,21031,0.044472681067344345,0.45454545454545453,Module 0,['GO:0006754']
208,HPA,HPA:0030072,appendix; lymphoid tissue[≥Medium],2.73068828408733e-26,True,appendix; lymphoid tissue[≥Medium],2987,612,291,11019,0.47549019607843135,0.09742216270505524,Module 0,['HPA:0030071']
209,TF,TF:M02062,Factor: Erg; motif: ACCGGAAGTN,3.5552646816537077e-26,True,Factor: Erg; motif: ACCGGAAGTN,8226,826,497,20045,0.6016949152542372,0.06041818623875517,Module 0,['TF:M00000']
210,HPA,HPA:0540051,stomach 1; glandular cells[≥Low],3.561693667743209e-26,True,stomach 1; glandular cells[≥Low],7664,612,539,11019,0.880718954248366,0.07032881002087683,Module 0,['HPA:0540000']
211,HPA,HPA:0540000,stomach 1,3.561693667743209e-26,True,stomach 1,7664,612,539,11019,0.880718954248366,0.07032881002087683,Module 0,['HPA:0000000']
212,TF,TF:M04714,Factor: Elf-1; motif: ACTTCCGGG,3.8241640688028927e-26,True,Factor: Elf-1; motif: ACTTCCGGG,7992,826,487,20045,0.589588377723971,0.060935935935935936,Module 0,['TF:M00000']
213,GO:CC,GO:1903561,extracellular vesicle,4.7614346524546076e-26,True,"""Any vesicle that is part of the extracellular region."" [GO_REF:0000064, GOC:pm, GOC:TermGenie, PMID:24769233]",2133,813,183,22097,0.22509225092250923,0.08579465541490858,Module 0,"['GO:0031982', 'GO:0065010']"
214,HPA,HPA:0170000,endometrium 2,4.9594114518373317e-26,True,endometrium 2,6917,612,506,11019,0.826797385620915,0.07315310105537083,Module 0,['HPA:0000000']
215,GO:CC,GO:0043230,extracellular organelle,5.0451835909960724e-26,True,"""Organized structure of distinctive morphology and function, occurring outside the cell. Includes, for example, extracellular membrane vesicles (EMVs) and the cellulosomes of anaerobic bacteria and fungi."" [GOC:jl, PMID:9914479]",2134,813,183,22097,0.22509225092250923,0.08575445173383317,Module 0,"['GO:0005576', 'GO:0043226']"
216,GO:CC,GO:0065010,extracellular membrane-bounded organelle,5.0451835909960724e-26,True,"""Organized structure of distinctive morphology and function, bounded by a lipid bilayer membrane and occurring outside the cell."" [GOC:isa_complete]",2134,813,183,22097,0.22509225092250923,0.08575445173383317,Module 0,"['GO:0043227', 'GO:0043230']"
217,HP,HP:0000185,Cleft soft palate,5.099567437214856e-26,True,"Cleft of the soft palate (also known as the velum, or muscular palate) as a result of a developmental defect occurring between the 7th and 12th week of pregnancy. Cleft soft palate can cause functional abnormalities of the Eustachian tube with resulting middle ear anomalies and hearing difficulties, as well as speech problems associated with hypernasal speech due to velopharyngeal insufficiency.",56,44,20,4958,0.45454545454545453,0.35714285714285715,Module 3,"['HP:0000175', 'HP:0100736']"
218,HPA,HPA:0350471,pancreas; exocrine glandular cells[≥Low],5.795025686643589e-26,True,pancreas; exocrine glandular cells[≥Low],6942,612,507,11019,0.8284313725490197,0.07303370786516854,Module 0,['HPA:0350000']
219,GO:CC,GO:0005740,mitochondrial envelope,6.176383586262546e-26,True,"""The double lipid bilayer enclosing the mitochondrion and separating its contents from the cell cytoplasm; includes the intermembrane space."" [GOC:ai, GOC:pz]",831,813,104,22097,0.12792127921279212,0.12515042117930206,Module 0,"['GO:0005739', 'GO:0031967']"
220,REAC,REAC:R-HSA-1428517,The citric acid (TCA) cycle and respiratory electron transport,6.560144619179055e-26,True,The citric acid (TCA) cycle and respiratory electron transport,177,586,56,10842,0.09556313993174062,0.3163841807909605,Module 0,['REAC:R-HSA-1430728']
221,HPA,HPA:0160000,endometrium 1,6.663114207451721e-26,True,endometrium 1,7055,612,512,11019,0.8366013071895425,0.07257264351523741,Module 0,['HPA:0000000']
222,GO:BP,GO:0015980,energy derivation by oxidation of organic compounds,7.214079745574114e-26,True,"""The chemical reactions and pathways by which a cell derives energy from organic compounds; results in the oxidation of the compounds from which energy is released."" [GOC:mah]",335,787,66,21031,0.08386277001270648,0.19701492537313434,Module 0,['GO:0006091']
223,HP,HP:0009777,Absent thumb,7.819485325205982e-26,True,"Absent thumb, i.e., the absence of both phalanges of a thumb and the associated soft tissues.",57,44,20,4958,0.45454545454545453,0.3508771929824561,Module 3,"['HP:0009380', 'HP:0009601']"
224,GO:CC,GO:0031974,membrane-enclosed lumen,8.257421044882292e-26,True,"""The enclosed volume within a sealed membrane or between two sealed membranes. Encompasses the volume enclosed by the membranes of a particular organelle, e.g. endoplasmic reticulum lumen, or the space between the two lipid bilayers of a double membrane surrounding an organelle, e.g. nuclear envelope lumen."" [GOC:add, GOC:mah]",6657,813,392,22097,0.4821648216482165,0.058885383806519455,Module 0,['GO:0110165']
225,GO:CC,GO:0070013,intracellular organelle lumen,8.257421044882292e-26,True,"""An organelle lumen that is part of an intracellular organelle."" [GOC:mah]",6657,813,392,22097,0.4821648216482165,0.058885383806519455,Module 0,"['GO:0043229', 'GO:0043233']"
226,GO:CC,GO:0043233,organelle lumen,8.257421044882292e-26,True,"""The internal volume enclosed by the membranes of a particular organelle; includes the volume enclosed by a single organelle membrane, e.g. endoplasmic reticulum lumen, or the volume enclosed by the innermost of the two lipid bilayers of an organelle envelope, e.g. nuclear lumen."" [GOC:jl, GOC:mah]",6657,813,392,22097,0.4821648216482165,0.058885383806519455,Module 0,"['GO:0031974', 'GO:0043226']"
227,TF,TF:M11396,Factor: Erg; motif: NACCGGAARTN,1.2053943696538318e-25,True,Factor: Erg; motif: NACCGGAARTN,11019,826,607,20045,0.7348668280871671,0.055086668481713404,Module 0,['TF:M00000']
228,GO:CC,GO:0031966,mitochondrial membrane,1.3494556669844972e-25,True,"""Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope."" [GOC:mah, NIF_Subcellular:sao1045389829]",782,813,100,22097,0.12300123001230012,0.1278772378516624,Module 0,"['GO:0005740', 'GO:0031090']"
229,GO:CC,GO:0019866,organelle inner membrane,1.5094788668215435e-25,True,"""The inner, i.e. lumen-facing, lipid bilayer of an organelle envelope; usually highly selective to most ions and metabolites."" [GOC:mah]",568,813,84,22097,0.1033210332103321,0.14788732394366197,Module 0,"['GO:0031090', 'GO:0031967']"
230,HPA,HPA:0540052,stomach 1; glandular cells[≥Medium],1.9417736669342354e-25,True,stomach 1; glandular cells[≥Medium],6351,612,478,11019,0.7810457516339869,0.07526373799401669,Module 0,['HPA:0540051']
231,TF,TF:M11435_1,Factor: Elk-1; motif: NNCCGGAAGTN; match class: 1,2.279264869533314e-25,True,Factor: Elk-1; motif: NNCCGGAAGTN; match class: 1,5881,826,391,20045,0.47336561743341404,0.06648529161707192,Module 0,['TF:M11435']
232,TF,TF:M11400,Factor: Fli-1; motif: NACCGGAARTN,2.6702554133733624e-25,True,Factor: Fli-1; motif: NACCGGAARTN,10184,826,574,20045,0.6949152542372882,0.05636292223095051,Module 0,['TF:M00000']
233,REAC,REAC:R-HSA-9705683,SARS-CoV-2-host interactions,2.8293871030372974e-25,True,SARS-CoV-2-host interactions,197,97,29,10842,0.29896907216494845,0.14720812182741116,Module 3,['REAC:R-HSA-9694516']
234,GO:BP,GO:0042773,ATP synthesis coupled electron transport,3.293222462664e-25,True,"""The transfer of electrons through a series of electron donors and acceptors, generating energy that is ultimately used for synthesis of ATP."" [ISBN:0716731363]",100,787,38,21031,0.048284625158831,0.38,Module 0,"['GO:0006119', 'GO:0022904']"
235,GO:BP,GO:0042775,mitochondrial ATP synthesis coupled electron transport,3.293222462664e-25,True,"""The transfer of electrons through a series of electron donors and acceptors, generating energy that is ultimately used for synthesis of ATP, as it occurs in the mitochondrial inner membrane or chloroplast thylakoid membrane."" [GOC:mtg_sensu, ISBN:0716731363]",100,787,38,21031,0.048284625158831,0.38,Module 0,['GO:0042773']
236,HPA,HPA:0460671,skin 1; melanocytes[≥Low],3.4546834574740094e-25,True,skin 1; melanocytes[≥Low],5302,612,424,11019,0.6928104575163399,0.07996982270841192,Module 0,['HPA:0460000']
237,KEGG,KEGG:05014,Amyotrophic lateral sclerosis,3.6496623209820725e-25,True,Amyotrophic lateral sclerosis,363,439,76,8484,0.17312072892938496,0.209366391184573,Module 0,['KEGG:00000']
238,HPA,HPA:0100000,cerebral cortex,4.0968185182202066e-25,True,cerebral cortex,8106,612,555,11019,0.9068627450980392,0.06846780162842339,Module 0,['HPA:0000000']
239,TF,TF:M09904,Factor: Elk-1; motif: RCCGGAAGTGN,4.275742499633336e-25,True,Factor: Elk-1; motif: RCCGGAAGTGN,8347,826,499,20045,0.6041162227602905,0.05978195758955313,Module 0,['TF:M00000']
240,TF,TF:M02052,Factor: EHF; motif: CSCGGAARTN,4.8234290511327985e-25,True,Factor: EHF; motif: CSCGGAARTN,10305,826,578,20045,0.6997578692493946,0.05608927704997574,Module 0,['TF:M00000']
241,GO:CC,GO:0030054,cell junction,5.120278684072165e-25,True,"""A cellular component that forms a specialized region of connection between two or more cells, or between a cell and the extracellular matrix, or between two membrane-bound components of a cell, such as flagella."" [GOC:aruk, GOC:bc, GOC:mah, http://www.vivo.colostate.edu/hbooks/cmb/cells/pmemb/junctions_a.html, ISBN:0198506732, PMID:26820516, PMID:28096264]",2230,105,55,22097,0.5238095238095238,0.02466367713004484,Module 3,['GO:0110165']
242,GO:BP,GO:0019538,protein metabolic process,5.53777094289135e-25,True,"""The chemical reactions and pathways involving a protein. Includes protein modification."" [GOC:ma]",4912,105,78,21031,0.7428571428571429,0.015879478827361564,Module 3,"['GO:0043170', 'GO:0044238', 'GO:1901564']"
243,TF,TF:M11434,Factor: Elk-1; motif: NRSCGGAAGNN,6.259447109284711e-25,True,Factor: Elk-1; motif: NRSCGGAAGNN,8430,826,502,20045,0.6077481840193705,0.05954922894424674,Module 0,['TF:M00000']
244,GO:CC,GO:0042611,MHC protein complex,7.192255151112187e-25,True,"""A transmembrane protein complex composed of an MHC alpha chain and, in most cases, either an MHC class II beta chain or an invariant beta2-microglobin chain, and with or without a bound peptide, lipid, or polysaccharide antigen."" [GOC:add, GOC:jl, ISBN:0781735149, PMID:15928678, PMID:16153240]",24,17,10,22097,0.5882352941176471,0.4166666666666667,Module 6,['GO:0098797']
245,GO:BP,GO:0002684,positive regulation of immune system process,7.458308149655934e-25,True,"""Any process that activates or increases the frequency, rate, or extent of an immune system process."" [GOC:add]",1054,226,61,21031,0.26991150442477874,0.05787476280834915,Module 1,"['GO:0002376', 'GO:0002682', 'GO:0048518']"
246,TF,TF:M11435,Factor: Elk-1; motif: NNCCGGAAGTN,9.56417254882659e-25,True,Factor: Elk-1; motif: NNCCGGAAGTN,11976,826,640,20045,0.774818401937046,0.053440213760855046,Module 0,['TF:M00000']
247,HPA,HPA:0380000,placenta,9.573400227420927e-25,True,placenta,7517,612,530,11019,0.8660130718954249,0.07050685113742185,Module 0,['HPA:0000000']
248,HP,HP:0005518,Increased mean corpuscular volume,9.871409010108697e-25,True,Larger than normal size of erythrocytes.,52,44,19,4958,0.4318181818181818,0.36538461538461536,Module 3,['HP:0025065']
249,HPA,HPA:0400000,rectum,9.940527422548948e-25,True,rectum,7973,612,549,11019,0.8970588235294118,0.06885739370375016,Module 0,['HPA:0000000']
250,HPA,HPA:0550051,stomach 2; glandular cells[≥Low],1.0300279336512453e-24,True,stomach 2; glandular cells[≥Low],7612,612,534,11019,0.8725490196078431,0.07015239096163951,Module 0,['HPA:0550000']
251,HPA,HPA:0550000,stomach 2,1.0300279336512453e-24,True,stomach 2,7612,612,534,11019,0.8725490196078431,0.07015239096163951,Module 0,['HPA:0000000']
252,TF,TF:M11427_1,Factor: PEA3; motif: NACCGGAAGTN; match class: 1,1.326211008929666e-24,True,Factor: PEA3; motif: NACCGGAAGTN; match class: 1,4710,826,333,20045,0.40314769975786924,0.07070063694267516,Module 0,['TF:M11427']
253,GO:CC,GO:0005739,mitochondrion,1.6320324527901324e-24,True,"""A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration."" [GOC:giardia, ISBN:0198506732]",1689,813,155,22097,0.1906519065190652,0.09177027827116636,Module 0,"['GO:0005737', 'GO:0043231']"
254,GO:BP,GO:0006950,response to stress,1.666612797008723e-24,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis, usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation)."" [GOC:mah]",3855,215,110,21031,0.5116279069767442,0.028534370946822308,Module 2,['GO:0050896']
255,GO:CC,GO:0031982,vesicle,2.1957062788365832e-24,True,"""Any small, fluid-filled, spherical organelle enclosed by membrane."" [GOC:mah, GOC:pz, GOC:vesicles]",4004,221,110,22097,0.497737556561086,0.027472527472527472,Module 2,['GO:0043227']
256,HPA,HPA:0030071,appendix; lymphoid tissue[≥Low],2.277692080461237e-24,True,appendix; lymphoid tissue[≥Low],4734,612,391,11019,0.6388888888888888,0.08259400084495142,Module 0,['HPA:0030000']
257,HPA,HPA:0630000,cervix,2.349341444700925e-24,True,cervix,6930,612,503,11019,0.8218954248366013,0.07258297258297258,Module 0,['HPA:0000000']
258,HP,HP:0000912,Sprengel anomaly,2.3511993347332748e-24,True,"A congenital skeletal deformity characterized by the elevation of one scapula (thus, one scapula is located superior to the other).",54,44,19,4958,0.4318181818181818,0.35185185185185186,Module 3,['HP:0000782']
259,HPA,HPA:0210000,fallopian tube,2.376561709887824e-24,True,fallopian tube,7466,612,527,11019,0.8611111111111112,0.07058665952317171,Module 0,['HPA:0000000']
260,HPA,HPA:0461443,skin 1; fibrohistiocytic cells[High],2.5270330971641817e-24,True,skin 1; fibrohistiocytic cells[High],408,612,84,11019,0.13725490196078433,0.20588235294117646,Module 0,['HPA:0461442']
261,HPA,HPA:0351181,pancreas; pancreatic endocrine cells[≥Low],2.5873653318129417e-24,True,pancreas; pancreatic endocrine cells[≥Low],5628,612,439,11019,0.7173202614379085,0.07800284292821606,Module 0,['HPA:0350000']
262,HPA,HPA:0530712,spleen; cells in red pulp[≥Medium],2.9880286238151862e-24,True,spleen; cells in red pulp[≥Medium],3143,612,296,11019,0.48366013071895425,0.09417753738466433,Module 0,['HPA:0530711']
263,TF,TF:M08759,Factor: c-Ets-2; motif: NCCGGAAGTG,3.0626698045211446e-24,True,Factor: c-Ets-2; motif: NCCGGAAGTG,8502,826,503,20045,0.6089588377723971,0.05916254998823806,Module 0,['TF:M00000']
264,HPA,HPA:0430000,seminal vesicle,3.113158809675692e-24,True,seminal vesicle,6828,612,498,11019,0.8137254901960784,0.07293497363796134,Module 0,['HPA:0000000']
265,HPA,HPA:0430051,seminal vesicle; glandular cells[≥Low],3.113158809675692e-24,True,seminal vesicle; glandular cells[≥Low],6828,612,498,11019,0.8137254901960784,0.07293497363796134,Module 0,['HPA:0430000']
266,TF,TF:M11448,Factor: Elf-1; motif: NANGCGGAAGTN,3.900949921846972e-24,True,Factor: Elf-1; motif: NANGCGGAAGTN,7777,826,472,20045,0.5714285714285714,0.06069178346406069,Module 0,['TF:M00000']
267,TF,TF:M01752_1,Factor: ERG; motif: ACCGGAART; match class: 1,4.1180293225885885e-24,True,Factor: ERG; motif: ACCGGAART; match class: 1,3782,826,285,20045,0.3450363196125908,0.07535695399259651,Module 0,['TF:M01752']
268,TF,TF:M02063,Factor: c-ets-1; motif: ACCGGAWGTN,5.324235107400364e-24,True,Factor: c-ets-1; motif: ACCGGAWGTN,7763,826,471,20045,0.5702179176755447,0.06067242045600928,Module 0,['TF:M00000']
269,TF,TF:M02065,Factor: ER81; motif: RCCGGAARYN,5.371811340453866e-24,True,Factor: ER81; motif: RCCGGAARYN,13076,826,677,20045,0.8196125907990315,0.05177424288773325,Module 0,['TF:M00000']
270,TF,TF:M03977,Factor: ETS1; motif: ACCGGAARYN,5.7460737146062256e-24,True,Factor: ETS1; motif: ACCGGAARYN,10772,826,593,20045,0.7179176755447942,0.05505012996658002,Module 0,['TF:M00000']
271,TF,TF:M11427,Factor: PEA3; motif: NACCGGAAGTN,7.776952753038616e-24,True,Factor: PEA3; motif: NACCGGAAGTN,10834,826,595,20045,0.7203389830508474,0.05491969724940004,Module 0,['TF:M00000']
272,HPA,HPA:0550052,stomach 2; glandular cells[≥Medium],7.901001729948091e-24,True,stomach 2; glandular cells[≥Medium],6284,612,471,11019,0.7696078431372549,0.07495225970719287,Module 0,['HPA:0550051']
273,TF,TF:M03970,Factor: ELK1; motif: ACCGGAAGTN,8.243460449875562e-24,True,Factor: ELK1; motif: ACCGGAAGTN,4899,826,340,20045,0.4116222760290557,0.0694019187589304,Module 0,['TF:M00000']
274,GO:BP,GO:0042113,B cell activation,9.893874629590307e-24,True,"""The change in morphology and behavior of a mature or immature B cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific."" [GOC:mgi_curators, ISBN:0781735149]",281,226,35,21031,0.15486725663716813,0.12455516014234876,Module 1,['GO:0046649']
275,GO:CC,GO:0032991,protein-containing complex,9.980285110211421e-24,True,"""A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together."" [GOC:dos, GOC:mah]",8588,105,93,22097,0.8857142857142857,0.010829063809967397,Module 3,['GO:0005575']
276,HPA,HPA:0090000,cerebellum,1.0276558869850908e-23,True,cerebellum,7202,612,514,11019,0.8398692810457516,0.07136906414884754,Module 0,['HPA:0000000']
277,TF,TF:M11430,Factor: PEA3; motif: NACCGGAAGTN,1.084636592554583e-23,True,Factor: PEA3; motif: NACCGGAAGTN,11108,826,605,20045,0.7324455205811138,0.05446525027007562,Module 0,['TF:M00000']
278,HP,HP:0000519,Developmental cataract,1.109893331291081e-23,True,"A cataract that occurs congenitally as the result of a developmental defect, in contrast to the majority of cataracts that occur in adulthood as the result of degenerative changes of the lens.",139,44,24,4958,0.5454545454545454,0.17266187050359713,Module 3,"['HP:0000518', 'HP:0007700']"
279,TF,TF:M13031,Factor: ETV4; motif: ACCGGAAGTN,1.1293622908353155e-23,True,Factor: ETV4; motif: ACCGGAAGTN,11030,826,602,20045,0.7288135593220338,0.05457842248413418,Module 0,['TF:M00000']
280,GO:BP,GO:0002376,immune system process,1.1624394161341438e-23,True,"""Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats."" [GO_REF:0000022, GOC:add]",2776,215,92,21031,0.42790697674418604,0.03314121037463977,Module 2,['GO:0008150']
281,GO:BP,GO:0042776,proton motive force-driven mitochondrial ATP synthesis,1.2644238211069267e-23,True,"""The transport of protons across a mitochondrial membrane to generate an electrochemical gradient (proton-motive force) that powers ATP synthesis."" [GOC:mtg_sensu, ISBN:0716731363]",66,787,31,21031,0.03939008894536213,0.4696969696969697,Module 0,"['GO:0006119', 'GO:0015986']"
282,TF,TF:M03988,Factor: FLI1; motif: ACCGGAARTN,1.2801504488513891e-23,True,Factor: FLI1; motif: ACCGGAARTN,8498,826,501,20045,0.6065375302663438,0.05895504824664627,Module 0,['TF:M00000']
283,TF,TF:M02066,Factor: PEA3; motif: RCCGGAAGYN,1.3213691450400963e-23,True,Factor: PEA3; motif: RCCGGAAGYN,7214,826,446,20045,0.5399515738498789,0.061824230662600496,Module 0,['TF:M00000']
284,GO:BP,GO:1901564,organonitrogen compound metabolic process,1.337035119847615e-23,True,"""The chemical reactions and pathways involving organonitrogen compound."" [GOC:pr, GOC:TermGenie]",5986,787,363,21031,0.46124523506988563,0.06064149682592716,Module 0,"['GO:0006807', 'GO:0071704']"
285,REAC,REAC:R-HSA-72172,mRNA Splicing,1.4732638245276844e-23,True,mRNA Splicing,209,586,58,10842,0.09897610921501707,0.27751196172248804,Module 0,['REAC:R-HSA-72203']
286,TF,TF:M11392,Factor: Erg; motif: NACCGGAARYN,1.5603215450940595e-23,True,Factor: Erg; motif: NACCGGAARYN,8890,826,517,20045,0.62590799031477,0.05815523059617548,Module 0,['TF:M00000']
287,REAC,REAC:R-HSA-72163,mRNA Splicing - Major Pathway,1.5836784052569337e-23,True,mRNA Splicing - Major Pathway,202,586,57,10842,0.09726962457337884,0.28217821782178215,Module 0,['REAC:R-HSA-72172']
288,HPA,HPA:0050091,breast; myoepithelial cells[≥Low],1.6300509761842168e-23,True,breast; myoepithelial cells[≥Low],5666,612,439,11019,0.7173202614379085,0.07747970349452876,Module 0,['HPA:0050000']
289,TF,TF:M11451,Factor: Elf-1; motif: NANCCGGAAGTN,1.7413255751488874e-23,True,Factor: Elf-1; motif: NANCCGGAAGTN,7063,826,439,20045,0.5314769975786925,0.06215489168908396,Module 0,['TF:M00000']
290,HPA,HPA:0600221,tonsil; squamous epithelial cells[≥Low],1.7647693248158744e-23,True,tonsil; squamous epithelial cells[≥Low],6652,612,488,11019,0.7973856209150327,0.07336139506915214,Module 0,['HPA:0600000']
291,TF,TF:M02067,Factor: ER71; motif: ACCGGAARYN,1.977495951244295e-23,True,Factor: ER71; motif: ACCGGAARYN,6067,826,394,20045,0.47699757869249393,0.06494148673149827,Module 0,['TF:M00000']
292,HPA,HPA:0630051,cervix; glandular cells[≥Low],2.2487260237828607e-23,True,cervix; glandular cells[≥Low],5692,612,440,11019,0.7189542483660131,0.07730147575544624,Module 0,['HPA:0630000']
293,HPA,HPA:0270000,kidney,2.399146342611568e-23,True,kidney,8237,612,557,11019,0.9101307189542484,0.06762170693213548,Module 0,['HPA:0000000']
294,HP,HP:0025065,Abnormal mean corpuscular volume,2.5427502519616076e-23,True,"A deviation from normal of the mean corpuscular volume, or mean cell volume (MCV) of red blood cells, usually taken to be 80 to 100 femtoliters.",60,44,19,4958,0.4318181818181818,0.31666666666666665,Module 3,['HP:0001877']
295,HP,HP:0001972,Macrocytic anemia,2.57669036772849e-23,True,A type of anemia characterized by increased size of erythrocytes with increased mean corpuscular volume (MCV) and increased mean corpuscular hemoglobin (MCH).,73,44,20,4958,0.45454545454545453,0.273972602739726,Module 3,['HP:0010972']
296,HPA,HPA:0130000,colon,2.683916424477384e-23,True,colon,8342,612,561,11019,0.9166666666666666,0.06725005993766482,Module 0,['HPA:0000000']
297,TF,TF:M11430_1,Factor: PEA3; motif: NACCGGAAGTN; match class: 1,2.9078620584920765e-23,True,Factor: PEA3; motif: NACCGGAAGTN; match class: 1,5014,826,344,20045,0.41646489104116224,0.06860789788591942,Module 0,['TF:M11430']
298,GO:CC,GO:0070062,extracellular exosome,3.294128707629728e-23,True,"""A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm."" [GOC:BHF, GOC:mah, GOC:vesicles, PMID:15908444, PMID:17641064, PMID:19442504, PMID:19498381, PMID:22418571, PMID:24009894]",2109,221,78,22097,0.35294117647058826,0.03698435277382646,Module 2,"['GO:0005615', 'GO:1903561']"
299,TF,TF:M01078,Factor: c-Ets-1; motif: NNNRCCGGAWRYNNNN,3.314937854483894e-23,True,Factor: c-Ets-1; motif: NNNRCCGGAWRYNNNN,7725,826,467,20045,0.5653753026634383,0.06045307443365696,Module 0,['TF:M00000']
300,TF,TF:M02052_1,Factor: EHF; motif: CSCGGAARTN; match class: 1,3.47551248196403e-23,True,Factor: EHF; motif: CSCGGAARTN; match class: 1,4145,826,301,20045,0.3644067796610169,0.07261761158021712,Module 0,['TF:M02052']
301,HP,HP:0004808,Acute myeloid leukemia,3.514516025681267e-23,True,A form of leukemia characterized by overproduction of an early myeloid cell.,74,44,20,4958,0.45454545454545453,0.2702702702702703,Module 3,['HP:0002488']
302,HPA,HPA:0220000,gallbladder,4.1903109522700576e-23,True,gallbladder,7664,612,533,11019,0.8709150326797386,0.06954592901878914,Module 0,['HPA:0000000']
303,HPA,HPA:0220051,gallbladder; glandular cells[≥Low],4.1903109522700576e-23,True,gallbladder; glandular cells[≥Low],7664,612,533,11019,0.8709150326797386,0.06954592901878914,Module 0,['HPA:0220000']
304,GO:BP,GO:0019646,aerobic electron transport chain,4.4855261621051437e-23,True,"""A process in which a series of electron carriers operate together to transfer electrons from donors such as NADH and FADH2 to oxygen to generate a transmembrane electrochemical gradient."" [GOC:ai, GOC:mtg_electron_transport]",92,787,35,21031,0.044472681067344345,0.3804347826086957,Module 0,"['GO:0006119', 'GO:0009060', 'GO:0022904']"
305,GO:BP,GO:0006091,generation of precursor metabolites and energy,4.5557145448785866e-23,True,"""The chemical reactions and pathways resulting in the formation of precursor metabolites, substances from which energy is derived, and any process involved in the liberation of energy from these substances."" [GOC:jl]",515,787,78,21031,0.09911054637865312,0.15145631067961166,Module 0,['GO:0044237']
306,HPA,HPA:0310443,lymph node; non-germinal center cells[High],4.914260121235692e-23,True,lymph node; non-germinal center cells[High],1209,612,156,11019,0.2549019607843137,0.12903225806451613,Module 0,['HPA:0310442']
307,TF,TF:M11447,Factor: Elf-1; motif: NAMCCGGAAGTN,5.1956894355447416e-23,True,Factor: Elf-1; motif: NAMCCGGAAGTN,7902,826,474,20045,0.5738498789346247,0.05998481397114654,Module 0,['TF:M00000']
308,TF,TF:M11449,Factor: Elf-1; motif: NANCCGGAAGTN,5.5224843745777e-23,True,Factor: Elf-1; motif: NANCCGGAAGTN,4376,826,312,20045,0.37772397094430993,0.0712979890310786,Module 0,['TF:M00000']
309,GO:CC,GO:0031975,envelope,5.756695095099086e-23,True,"""A multilayered structure surrounding all or part of a cell; encompasses one or more lipid bilayers, and may include a cell wall layer; also includes the space between layers."" [GOC:mah, GOC:pz]",1299,813,129,22097,0.15867158671586715,0.09930715935334873,Module 0,['GO:0110165']
310,GO:CC,GO:0031967,organelle envelope,5.756695095099086e-23,True,"""A double membrane structure enclosing an organelle, including two lipid bilayers and the region between them. In some cases, an organelle envelope may have more than two membranes."" [GOC:mah, GOC:pz]",1299,813,129,22097,0.15867158671586715,0.09930715935334873,Module 0,"['GO:0031975', 'GO:0043227', 'GO:0043229']"
311,REAC,REAC:R-HSA-611105,Respiratory electron transport,6.18939234386522e-23,True,Respiratory electron transport,103,586,41,10842,0.06996587030716724,0.39805825242718446,Module 0,['REAC:R-HSA-163200']
312,TF,TF:M00025,Factor: Elk-1; motif: NNNNCCGGAARTNN,6.549810660662567e-23,True,Factor: Elk-1; motif: NNNNCCGGAARTNN,10256,826,570,20045,0.6900726392251816,0.05557722308892356,Module 0,['TF:M00000']
313,GO:CC,GO:1903561,extracellular vesicle,6.832523126634334e-23,True,"""Any vesicle that is part of the extracellular region."" [GO_REF:0000064, GOC:pm, GOC:TermGenie, PMID:24769233]",2133,221,78,22097,0.35294117647058826,0.03656821378340366,Module 2,"['GO:0031982', 'GO:0065010']"
314,GO:CC,GO:0065010,extracellular membrane-bounded organelle,7.041800457038201e-23,True,"""Organized structure of distinctive morphology and function, bounded by a lipid bilayer membrane and occurring outside the cell."" [GOC:isa_complete]",2134,221,78,22097,0.35294117647058826,0.03655107778819119,Module 2,"['GO:0043227', 'GO:0043230']"
315,GO:CC,GO:0043230,extracellular organelle,7.041800457038201e-23,True,"""Organized structure of distinctive morphology and function, occurring outside the cell. Includes, for example, extracellular membrane vesicles (EMVs) and the cellulosomes of anaerobic bacteria and fungi."" [GOC:jl, PMID:9914479]",2134,221,78,22097,0.35294117647058826,0.03655107778819119,Module 2,"['GO:0005576', 'GO:0043226']"
316,HP,HP:0001790,Nonimmune hydrops fetalis,7.513927978952457e-23,True,A type of hydrops fetalis in which there is no identifiable circulating antibody to red blood cell antigens .,63,44,19,4958,0.4318181818181818,0.30158730158730157,Module 3,['HP:0001789']
317,TF,TF:M11450,Factor: Elf-1; motif: NANSCGGAAGTR,8.400200149569975e-23,True,Factor: Elf-1; motif: NANSCGGAAGTR,5718,826,376,20045,0.4552058111380145,0.06575725778244142,Module 0,['TF:M00000']
318,TF,TF:M11396_1,Factor: Erg; motif: NACCGGAARTN; match class: 1,1.0400898262983774e-22,True,Factor: Erg; motif: NACCGGAARTN; match class: 1,5068,826,345,20045,0.41767554479418884,0.06807419100236779,Module 0,['TF:M11396']
319,TF,TF:M02055,Factor: ESE-1; motif: NSMGGAARTN,1.0974844322780477e-22,True,Factor: ESE-1; motif: NSMGGAARTN,7715,826,465,20045,0.562953995157385,0.060272197018794556,Module 0,['TF:M00000']
320,TF,TF:M01214,Factor: ESE-1; motif: NSMGGAARTN,1.0974844322780477e-22,True,Factor: ESE-1; motif: NSMGGAARTN,7715,826,465,20045,0.562953995157385,0.060272197018794556,Module 0,['TF:M00000']
321,TF,TF:M03975,Factor: ERG; motif: ACCGGAARTN,1.159465440582609e-22,True,Factor: ERG; motif: ACCGGAARTN,10198,826,567,20045,0.6864406779661016,0.055599137085703076,Module 0,['TF:M00000']
322,GO:BP,GO:0022904,respiratory electron transport chain,1.2101755374907269e-22,True,"""A process in which a series of electron carriers operate together to transfer electrons from donors such as NADH and FADH2 to any of several different terminal electron acceptors to generate a transmembrane electrochemical gradient."" [GOC:mtg_electron_transport, ISBN:0716720094]",122,787,39,21031,0.04955527318932656,0.319672131147541,Module 0,"['GO:0022900', 'GO:0045333']"
323,TF,TF:M09605,Factor: Elf-1; motif: NAANCMGGAAGTGN,1.3389362838095677e-22,True,Factor: Elf-1; motif: NAANCMGGAAGTGN,5925,826,385,20045,0.4661016949152542,0.06497890295358649,Module 0,['TF:M00000']
324,GO:CC,GO:0140534,endoplasmic reticulum protein-containing complex,1.4661460130752924e-22,True,"""A protein complex that is part of an endoplasmic reticulum."" [GOC:pg]",126,73,18,22097,0.2465753424657534,0.14285714285714285,Module 4,"['GO:0005783', 'GO:0032991']"
325,TF,TF:M02059,Factor: ELK-1; motif: ACCGGAAGTN,1.5668176245687823e-22,True,Factor: ELK-1; motif: ACCGGAAGTN,9628,826,544,20045,0.6585956416464891,0.05650186954715413,Module 0,['TF:M00000']
326,GO:CC,GO:0070161,anchoring junction,1.6266351914811263e-22,True,"""A cell junction that mechanically attaches a cell (and its cytoskeleton) to neighboring cells or to the extracellular matrix."" [ISBN:0815332181]",905,105,37,22097,0.3523809523809524,0.04088397790055249,Module 3,['GO:0030054']
327,HPA,HPA:0040082,bone marrow; hematopoietic cells[≥Medium],1.6294513106629903e-22,True,bone marrow; hematopoietic cells[≥Medium],4256,612,359,11019,0.5866013071895425,0.0843515037593985,Module 0,['HPA:0040081']
328,TF,TF:M11452,Factor: Elf-1; motif: NANGCGGAAGTR,1.8088498804063482e-22,True,Factor: Elf-1; motif: NANGCGGAAGTR,6415,826,407,20045,0.4927360774818402,0.06344505066250974,Module 0,['TF:M00000']
329,TF,TF:M09905,Factor: SAP-1; motif: NNCCGGAAGTGN,1.8104535010660462e-22,True,Factor: SAP-1; motif: NNCCGGAAGTGN,8485,826,497,20045,0.6016949152542372,0.058573954036535064,Module 0,['TF:M00000']
330,GO:BP,GO:0006754,ATP biosynthetic process,1.868189434611847e-22,True,"""The chemical reactions and pathways resulting in the formation of ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator."" [GOC:go_curators, ISBN:0198506732]",102,787,36,21031,0.045743329097839895,0.35294117647058826,Module 0,"['GO:0009152', 'GO:0009206', 'GO:0046034']"
331,TF,TF:M02071,Factor: ETV7; motif: NCCGGAANNN,2.05193715521175e-22,True,Factor: ETV7; motif: NCCGGAANNN,10370,826,573,20045,0.6937046004842615,0.055255544840887176,Module 0,['TF:M00000']
332,HPA,HPA:0390052,prostate; glandular cells[≥Medium],2.2803192590882842e-22,True,prostate; glandular cells[≥Medium],4809,612,390,11019,0.6372549019607843,0.08109794135995009,Module 0,['HPA:0390051']
333,TF,TF:M02059_1,Factor: ELK-1; motif: ACCGGAAGTN; match class: 1,2.856362630052501e-22,True,Factor: ELK-1; motif: ACCGGAAGTN; match class: 1,3840,826,283,20045,0.34261501210653755,0.07369791666666667,Module 0,['TF:M02059']
334,GO:CC,GO:0070062,extracellular exosome,2.9865476769505827e-22,True,"""A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm."" [GOC:BHF, GOC:mah, GOC:vesicles, PMID:15908444, PMID:17641064, PMID:19442504, PMID:19498381, PMID:22418571, PMID:24009894]",2109,105,51,22097,0.4857142857142857,0.02418207681365576,Module 3,"['GO:0005615', 'GO:1903561']"
335,TF,TF:M11404,Factor: Fli-1; motif: NACCGGAARTN,2.997750545975384e-22,True,Factor: Fli-1; motif: NACCGGAARTN,8935,826,515,20045,0.6234866828087167,0.05763850027979855,Module 0,['TF:M00000']
336,TF,TF:M01752,Factor: ERG; motif: ACCGGAART,3.1811242044434287e-22,True,Factor: ERG; motif: ACCGGAART,9651,826,544,20045,0.6585956416464891,0.05636721583255621,Module 0,['TF:M00000']
337,HPA,HPA:0150000,duodenum,3.8369538911629713e-22,True,duodenum,7899,612,541,11019,0.8839869281045751,0.068489682238258,Module 0,['HPA:0000000']
338,GO:CC,GO:0032040,small-subunit processome,3.8928497441671447e-22,True,"""A large ribonucleoprotein complex that is an early preribosomal complex. In S. cerevisiae, it has a size of 80S and consists of the 35S pre-rRNA, early-associating ribosomal proteins most of which are part of the small ribosomal subunit, the U3 snoRNA and associated proteins."" [GOC:krc, GOC:vw, PMID:12068309, PMID:12957375, PMID:15120992, PMID:15590835]",73,105,17,22097,0.1619047619047619,0.2328767123287671,Module 3,['GO:0030684']
339,GO:CC,GO:1903561,extracellular vesicle,5.026336040120543e-22,True,"""Any vesicle that is part of the extracellular region."" [GO_REF:0000064, GOC:pm, GOC:TermGenie, PMID:24769233]",2133,105,51,22097,0.4857142857142857,0.02390998593530239,Module 3,"['GO:0031982', 'GO:0065010']"
340,GO:CC,GO:0065010,extracellular membrane-bounded organelle,5.13580059419174e-22,True,"""Organized structure of distinctive morphology and function, bounded by a lipid bilayer membrane and occurring outside the cell."" [GOC:isa_complete]",2134,105,51,22097,0.4857142857142857,0.023898781630740395,Module 3,"['GO:0043227', 'GO:0043230']"
341,GO:CC,GO:0043230,extracellular organelle,5.13580059419174e-22,True,"""Organized structure of distinctive morphology and function, occurring outside the cell. Includes, for example, extracellular membrane vesicles (EMVs) and the cellulosomes of anaerobic bacteria and fungi."" [GOC:jl, PMID:9914479]",2134,105,51,22097,0.4857142857142857,0.023898781630740395,Module 3,"['GO:0005576', 'GO:0043226']"
342,GO:CC,GO:0005615,extracellular space,5.5976329722317015e-22,True,"""That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid."" [ISBN:0198547684]",3303,221,96,22097,0.4343891402714932,0.029064486830154404,Module 2,"['GO:0005576', 'GO:0110165']"
343,HP,HP:0009380,Aplasia of the fingers,6.112696529835999e-22,True,Aplasia of one or more fingers.,84,44,20,4958,0.45454545454545453,0.23809523809523808,Module 3,['HP:0006265']
344,HPA,HPA:0020052,adrenal gland; glandular cells[≥Medium],6.716072410663974e-22,True,adrenal gland; glandular cells[≥Medium],6018,612,453,11019,0.7401960784313726,0.07527417746759721,Module 0,['HPA:0020051']
345,TF,TF:M09904_1,Factor: Elk-1; motif: RCCGGAAGTGN; match class: 1,6.834422784240836e-22,True,Factor: Elk-1; motif: RCCGGAAGTGN; match class: 1,2818,826,228,20045,0.27602905569007263,0.08090844570617459,Module 0,['TF:M09904']
346,HPA,HPA:0290000,liver,6.886252034065285e-22,True,liver,6298,612,467,11019,0.7630718954248366,0.07415052397586536,Module 0,['HPA:0000000']
347,HPA,HPA:0301371,lung; alveolar cells type II[≥Low],6.900942950982711e-22,True,lung; alveolar cells type II[≥Low],1533,612,179,11019,0.29248366013071897,0.11676451402478799,Module 0,['HPA:0300000']
348,TF,TF:M08913_1,Factor: FLI-1; motif: NAYTTCCGGT; match class: 1,7.311402713845184e-22,True,Factor: FLI-1; motif: NAYTTCCGGT; match class: 1,3115,826,244,20045,0.29539951573849876,0.078330658105939,Module 0,['TF:M08913']
349,TF,TF:M02063_1,Factor: c-ets-1; motif: ACCGGAWGTN; match class: 1,7.369030686722842e-22,True,Factor: c-ets-1; motif: ACCGGAWGTN; match class: 1,2442,826,207,20045,0.2506053268765133,0.08476658476658476,Module 0,['TF:M02063']
350,HP,HP:0001199,Triphalangeal thumb,7.519862168332081e-22,True,"A thumb with three phalanges in a single, proximo-distal axis. Thus, this term applies if the thumb has an accessory phalanx, leading to a digit like appearance of the thumb.",70,44,19,4958,0.4318181818181818,0.2714285714285714,Module 3,['HP:0009602']
351,TF,TF:M03975_1,Factor: ERG; motif: ACCGGAARTN; match class: 1,7.585548454780176e-22,True,Factor: ERG; motif: ACCGGAARTN; match class: 1,4100,826,295,20045,0.35714285714285715,0.07195121951219512,Module 0,['TF:M03975']
352,GO:CC,GO:0005576,extracellular region,7.626454659637103e-22,True,"""The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite."" [GOC:go_curators]",4213,221,109,22097,0.49321266968325794,0.025872300023736056,Module 2,['GO:0110165']
353,GO:BP,GO:0042274,ribosomal small subunit biogenesis,7.819381791173822e-22,True,"""A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a small ribosomal subunit; includes transport to the sites of protein synthesis."" [GOC:jl]",101,105,19,21031,0.18095238095238095,0.18811881188118812,Module 3,"['GO:0022613', 'GO:0042254']"
354,GO:CC,GO:0009897,external side of plasma membrane,7.846392461882452e-22,True,"""The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface."" [GOC:dos, GOC:tb]",384,238,37,22097,0.15546218487394958,0.09635416666666667,Module 1,"['GO:0005886', 'GO:0009986', 'GO:0098552']"
355,GO:BP,GO:0009206,purine ribonucleoside triphosphate biosynthetic process,8.498702801482716e-22,True,"""The chemical reactions and pathways resulting in the formation of purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",113,787,37,21031,0.04701397712833545,0.3274336283185841,Module 0,"['GO:0009145', 'GO:0009201', 'GO:0009205']"
356,HPA,HPA:0180052,epididymis; glandular cells[≥Medium],8.888289659731401e-22,True,epididymis; glandular cells[≥Medium],5693,612,436,11019,0.7124183006535948,0.07658528016862814,Module 0,['HPA:0180051']
357,TF,TF:M08759_1,Factor: c-Ets-2; motif: NCCGGAAGTG; match class: 1,1.0793925404458517e-21,True,Factor: c-Ets-2; motif: NCCGGAAGTG; match class: 1,2993,826,237,20045,0.28692493946731235,0.07918476445038423,Module 0,['TF:M08759']
358,TF,TF:M13031_1,Factor: ETV4; motif: ACCGGAAGTN; match class: 1,1.2103789471802906e-21,True,Factor: ETV4; motif: ACCGGAAGTN; match class: 1,5008,826,339,20045,0.41041162227602906,0.06769169329073482,Module 0,['TF:M13031']
359,GO:BP,GO:0009145,purine nucleoside triphosphate biosynthetic process,1.2144171441407036e-21,True,"""The chemical reactions and pathways resulting in the formation of purine nucleoside triphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",114,787,37,21031,0.04701397712833545,0.32456140350877194,Module 0,"['GO:0009142', 'GO:0009144']"
360,HPA,HPA:0160052,endometrium 1; glandular cells[≥Medium],1.286839327535297e-21,True,endometrium 1; glandular cells[≥Medium],5155,612,407,11019,0.6650326797385621,0.07895247332686713,Module 0,['HPA:0160051']
361,HP,HP:0011902,Abnormal hemoglobin,1.3813232341505428e-21,True,"Anomaly in the level or the function of hemoglobin, the oxygen-carrying protein of erythrocytes.",72,44,19,4958,0.4318181818181818,0.2638888888888889,Module 3,['HP:0001877']
362,HPA,HPA:0160251,endometrium 1; cells in endometrial stroma[≥Low],1.4590864037580296e-21,True,endometrium 1; cells in endometrial stroma[≥Low],4077,612,346,11019,0.565359477124183,0.0848663232769193,Module 0,['HPA:0160000']
363,HPA,HPA:0170052,endometrium 2; glandular cells[≥Medium],1.699072953342961e-21,True,endometrium 2; glandular cells[≥Medium],4887,612,392,11019,0.6405228758169934,0.08021280949457744,Module 0,['HPA:0170051']
364,GO:BP,GO:0009605,response to external stimulus,1.7059537149641284e-21,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an external stimulus."" [GOC:hb]",2723,215,88,21031,0.40930232558139534,0.032317297098788104,Module 2,['GO:0050896']
365,HPA,HPA:0080000,caudate,1.895210086828188e-21,True,caudate,6964,612,498,11019,0.8137254901960784,0.07151062607696726,Module 0,['HPA:0000000']
366,HPA,HPA:0430052,seminal vesicle; glandular cells[≥Medium],1.960576260880646e-21,True,seminal vesicle; glandular cells[≥Medium],5238,612,411,11019,0.6715686274509803,0.07846506300114547,Module 0,['HPA:0430051']
367,HPA,HPA:0420052,salivary gland; glandular cells[≥Medium],1.9645790236653113e-21,True,salivary gland; glandular cells[≥Medium],4872,612,391,11019,0.6388888888888888,0.08025451559934318,Module 0,['HPA:0420051']
368,HPA,HPA:0340461,ovary; ovarian stroma cells[≥Low],2.4985721271977473e-21,True,ovary; ovarian stroma cells[≥Low],3986,612,340,11019,0.5555555555555556,0.08529854490717512,Module 0,['HPA:0340000']
369,TF,TF:M12600,Factor: ELF1; motif: NNNASCCGGAAGTGGNNNN,2.5698215507189715e-21,True,Factor: ELF1; motif: NNNASCCGGAAGTGGNNNN,8859,826,509,20045,0.6162227602905569,0.057455694773676486,Module 0,['TF:M00000']
370,HPA,HPA:0590052,thyroid gland; glandular cells[≥Medium],2.672346369424973e-21,True,thyroid gland; glandular cells[≥Medium],5602,612,430,11019,0.7026143790849673,0.0767583006069261,Module 0,['HPA:0590051']
371,HPA,HPA:0220052,gallbladder; glandular cells[≥Medium],2.8188816327142407e-21,True,gallbladder; glandular cells[≥Medium],6615,612,481,11019,0.7859477124183006,0.072713529856387,Module 0,['HPA:0220051']
372,GO:MF,GO:0044183,protein folding chaperone,2.854273910624244e-21,True,"""Binding to a protein or a protein-containing complex to assist the protein folding process."" [GOC:mtg_cambridge_2009]",60,20,11,20212,0.55,0.18333333333333332,Module 9,['GO:0003674']
373,GO:BP,GO:0051249,regulation of lymphocyte activation,3.157180384189799e-21,True,"""Any process that modulates the frequency, rate or extent of lymphocyte activation."" [GOC:ai]",497,226,41,21031,0.18141592920353983,0.08249496981891348,Module 1,"['GO:0002694', 'GO:0046649']"
374,HP,HP:0001087,Developmental glaucoma,3.316076184692171e-21,True,Glaucoma which forms during the early years of a child's life is called developmental or congenital glaucoma.,75,44,19,4958,0.4318181818181818,0.25333333333333335,Module 3,"['HP:0000501', 'HP:0007700']"
375,HP,HP:0006749,Malignant gastrointestinal tract tumors,3.316076184692171e-21,True,Malignant gastrointestinal tract tumors,75,44,19,4958,0.4318181818181818,0.25333333333333335,Module 3,['HP:0007378']
376,HP,HP:0002672,Gastrointestinal carcinoma,3.316076184692171e-21,True,Gastrointestinal carcinoma,75,44,19,4958,0.4318181818181818,0.25333333333333335,Module 3,['HP:0006749']
377,TF,TF:M11425_1,Factor: PEA3; motif: NACCGGAAGTN; match class: 1,3.483770558126958e-21,True,Factor: PEA3; motif: NACCGGAAGTN; match class: 1,2383,826,202,20045,0.24455205811138014,0.08476710029374737,Module 0,['TF:M11425']
378,HPA,HPA:0250000,hippocampus,3.713175538201537e-21,True,hippocampus,6830,612,491,11019,0.8022875816993464,0.07188872620790629,Module 0,['HPA:0000000']
379,GO:BP,GO:0048518,positive regulation of biological process,3.772318739104998e-21,True,"""Any process that activates or increases the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule."" [GOC:jid]",6250,226,141,21031,0.6238938053097345,0.02256,Module 1,"['GO:0008150', 'GO:0050789']"
380,TF,TF:M11425,Factor: PEA3; motif: NACCGGAAGTN,3.7928285723082756e-21,True,Factor: PEA3; motif: NACCGGAAGTN,7570,826,454,20045,0.549636803874092,0.05997357992073976,Module 0,['TF:M00000']
381,GO:CC,GO:0045202,synapse,4.256896537224961e-21,True,"""The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane."" [GOC:aruk, ISBN:0198506732, PMID:24619342, PMID:29383328, PMID:31998110]",1468,105,43,22097,0.4095238095238095,0.029291553133514985,Module 3,['GO:0030054']
382,GO:CC,GO:0043232,intracellular non-membrane-bounded organelle,4.92127190949703e-21,True,"""Organized structure of distinctive morphology and function, not bounded by a lipid bilayer membrane and occurring within the cell. Includes ribosomes, the cytoskeleton and chromosomes."" [GOC:go_curators]",6591,105,81,22097,0.7714285714285715,0.012289485662266727,Module 3,"['GO:0043228', 'GO:0043229']"
383,GO:CC,GO:0043228,non-membrane-bounded organelle,4.974932894030734e-21,True,"""Organized structure of distinctive morphology and function, not bounded by a lipid bilayer membrane. Includes ribosomes, the cytoskeleton and chromosomes."" [GOC:go_curators]",6592,105,81,22097,0.7714285714285715,0.0122876213592233,Module 3,['GO:0043226']
384,KEGG,KEGG:05415,Diabetic cardiomyopathy,5.151677689530808e-21,True,Diabetic cardiomyopathy,202,439,52,8484,0.11845102505694761,0.25742574257425743,Module 0,['KEGG:00000']
385,REAC,REAC:R-HSA-168256,Immune System,5.964493136656111e-21,True,Immune System,2052,173,91,10842,0.5260115606936416,0.04434697855750487,Module 2,['REAC:0000000']
386,GO:MF,GO:0003676,nucleic acid binding,6.361184625630841e-21,True,"""Binding to a nucleic acid."" [GOC:jl]",5491,105,78,20212,0.7428571428571429,0.014205062830085595,Module 3,['GO:0097159']
387,GO:BP,GO:0009201,ribonucleoside triphosphate biosynthetic process,6.808156393301169e-21,True,"""The chemical reactions and pathways resulting in the formation of a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",119,787,37,21031,0.04701397712833545,0.31092436974789917,Module 0,"['GO:0009142', 'GO:0009199']"
388,TF,TF:M02064,Factor: c-ets-2; motif: ACCGGAWRTN,6.946963836650425e-21,True,Factor: c-ets-2; motif: ACCGGAWRTN,11163,826,599,20045,0.725181598062954,0.053659410552718806,Module 0,['TF:M00000']
389,HPA,HPA:0460672,skin 1; melanocytes[≥Medium],7.97858373131963e-21,True,skin 1; melanocytes[≥Medium],3708,612,322,11019,0.5261437908496732,0.08683926645091694,Module 0,['HPA:0460671']
390,GO:BP,GO:0044271,cellular nitrogen compound biosynthetic process,8.145542063980922e-21,True,"""The chemical reactions and pathways resulting in the formation of organic and inorganic nitrogenous compounds."" [GOC:jl, ISBN:0198506732]",4836,787,305,21031,0.3875476493011436,0.0630686517783292,Module 0,"['GO:0034641', 'GO:0044249']"
391,KEGG,KEGG:05010,Alzheimer disease,8.1978432720318e-21,True,Alzheimer disease,382,439,72,8484,0.16400911161731208,0.18848167539267016,Module 0,['KEGG:00000']
392,TF,TF:M13032_1,Factor: ETV5; motif: ACCGGAAGTN; match class: 1,8.365467169707996e-21,True,Factor: ETV5; motif: ACCGGAAGTN; match class: 1,3627,826,268,20045,0.324455205811138,0.07389026743865454,Module 0,['TF:M13032']
393,GO:BP,GO:0050896,response to stimulus,8.537276361674109e-21,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus and ends with a change in state or activity or the cell or organism."" [GOC:ai, GOC:bf]",8976,226,171,21031,0.7566371681415929,0.019050802139037433,Module 1,['GO:0008150']
394,HPA,HPA:0471443,skin 2; fibrohistiocytic cells[High],8.935720303253071e-21,True,skin 2; fibrohistiocytic cells[High],467,612,85,11019,0.1388888888888889,0.18201284796573874,Module 0,['HPA:0471442']
395,TF,TF:M11424,Factor: Erm; motif: NNSCGGAWGYN,1.048182869514172e-20,True,Factor: Erm; motif: NNSCGGAWGYN,8353,826,486,20045,0.5883777239709443,0.058182688854303846,Module 0,['TF:M00000']
396,TF,TF:M03977_1,Factor: ETS1; motif: ACCGGAARYN; match class: 1,1.0878100173910594e-20,True,Factor: ETS1; motif: ACCGGAARYN; match class: 1,4797,826,326,20045,0.3946731234866828,0.06795914112987284,Module 0,['TF:M03977']
397,HPA,HPA:0050052,breast; glandular cells[≥Medium],1.0919763796661642e-20,True,breast; glandular cells[≥Medium],5109,612,402,11019,0.6568627450980392,0.07868467410452143,Module 0,['HPA:0050051']
398,TF,TF:M03982,Factor: ETV4; motif: ACCGGAAGTN,1.1149090771145383e-20,True,Factor: ETV4; motif: ACCGGAAGTN,6986,826,427,20045,0.5169491525423728,0.061122244488977955,Module 0,['TF:M00000']
399,TF,TF:M02064_1,Factor: c-ets-2; motif: ACCGGAWRTN; match class: 1,1.116457341033331e-20,True,Factor: c-ets-2; motif: ACCGGAWRTN; match class: 1,4674,826,320,20045,0.387409200968523,0.06846384253316218,Module 0,['TF:M02064']
400,HPA,HPA:0461391,skin 1; cells in basal layer[≥Low],1.1636712460589014e-20,True,skin 1; cells in basal layer[≥Low],881,69,37,11019,0.5362318840579711,0.04199772985244041,Module 5,['HPA:0460000']
401,TF,TF:M12601,Factor: ELF4; motif: NCCACTTCCGGNNNN,1.2592962176072211e-20,True,Factor: ELF4; motif: NCCACTTCCGGNNNN,5795,826,373,20045,0.4515738498789346,0.06436583261432269,Module 0,['TF:M00000']
402,CORUM,CORUM:5380,"TRBP containing complex (DICER, RPL7A, EIF6, MOV10 and subunits of the 60S ribosomal particle)",1.3008414952731356e-20,True,"TRBP containing complex (DICER, RPL7A, EIF6, MOV10 and subunits of the 60S ribosomal particle)",21,83,16,3383,0.1927710843373494,0.7619047619047619,Module 3,['CORUM:0000000']
403,HPA,HPA:0190222,esophagus; squamous epithelial cells[≥Medium],1.3101302889202528e-20,True,esophagus; squamous epithelial cells[≥Medium],5058,612,399,11019,0.6519607843137255,0.07888493475682087,Module 0,['HPA:0190221']
404,TF,TF:M09935,Factor: GABP-alpha; motif: NNNRCCGGAAGTGN,1.3196223123159454e-20,True,Factor: GABP-alpha; motif: NNNRCCGGAAGTGN,4535,826,313,20045,0.3789346246973366,0.06901874310915104,Module 0,['TF:M00000']
405,HPA,HPA:0510000,soft tissue 2,1.4326237276851005e-20,True,soft tissue 2,5207,612,407,11019,0.6650326797385621,0.07816400998655657,Module 0,['HPA:0000000']
406,HPA,HPA:0250132,hippocampus; neuronal cells[≥Medium],1.716587894585624e-20,True,hippocampus; neuronal cells[≥Medium],4230,612,352,11019,0.5751633986928104,0.08321513002364066,Module 0,['HPA:0250131']
407,GO:BP,GO:0006952,defense response,1.768569992616406e-20,True,"""Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack."" [GOC:go_curators]",1791,215,70,21031,0.32558139534883723,0.03908431044109436,Module 2,['GO:0006950']
408,GO:MF,GO:0051082,unfolded protein binding,1.8028269487222283e-20,True,"""Binding to an unfolded protein."" [GOC:ai]",113,20,12,20212,0.6,0.10619469026548672,Module 9,['GO:0005515']
409,TF,TF:M12600_1,Factor: ELF1; motif: NNNASCCGGAAGTGGNNNN; match class: 1,1.9137663569953647e-20,True,Factor: ELF1; motif: NNNASCCGGAAGTGGNNNN; match class: 1,3262,826,248,20045,0.30024213075060535,0.07602697731453097,Module 0,['TF:M12600']
410,HPA,HPA:0471391,skin 2; cells in basal layer[≥Low],1.939451236775561e-20,True,skin 2; cells in basal layer[≥Low],962,69,38,11019,0.5507246376811594,0.0395010395010395,Module 5,['HPA:0470000']
411,TF,TF:M11428,Factor: PEA3; motif: NACCGGAAGTN,2.2541205377700127e-20,True,Factor: PEA3; motif: NACCGGAAGTN,7327,826,441,20045,0.5338983050847458,0.06018834447932305,Module 0,['TF:M00000']
412,TF,TF:M09901,Factor: nerf; motif: NNNCCGGAAGTGN,2.2847210831544502e-20,True,Factor: nerf; motif: NNNCCGGAAGTGN,5490,826,358,20045,0.43341404358353514,0.06520947176684881,Module 0,['TF:M00000']
413,REAC,REAC:R-HSA-9694516,SARS-CoV-2 Infection,2.946238003906347e-20,True,SARS-CoV-2 Infection,292,97,29,10842,0.29896907216494845,0.09931506849315068,Module 3,['REAC:R-HSA-9679506']
414,HPA,HPA:0340000,ovary,3.117878201739186e-20,True,ovary,5429,612,418,11019,0.6830065359477124,0.0769939215325106,Module 0,['HPA:0000000']
415,TF,TF:M03969,Factor: ELF5; motif: ANSMGGAAGTN,3.144069247641313e-20,True,Factor: ELF5; motif: ANSMGGAAGTN,3407,826,255,20045,0.30871670702179177,0.07484590548869974,Module 0,['TF:M00000']
416,GO:CC,GO:0031090,organelle membrane,3.4206527231762706e-20,True,"""A membrane that is one of the two lipid bilayers of an organelle envelope or the outermost membrane of single membrane bound organelle."" [GOC:dos, GOC:mah]",3770,813,250,22097,0.3075030750307503,0.06631299734748011,Module 0,"['GO:0016020', 'GO:0043227']"
417,GO:BP,GO:0002694,regulation of leukocyte activation,3.534507375868547e-20,True,"""Any process that modulates the frequency, rate, or extent of leukocyte activation."" [GOC:add]",561,226,42,21031,0.18584070796460178,0.0748663101604278,Module 1,"['GO:0002682', 'GO:0045321', 'GO:0050865']"
418,HPA,HPA:0150052,duodenum; glandular cells[≥Medium],3.62551638005728e-20,True,duodenum; glandular cells[≥Medium],6106,612,453,11019,0.7401960784313726,0.07418932197838192,Module 0,['HPA:0150051']
419,HP,HP:0004312,Abnormal reticulocyte morphology,3.655003829967832e-20,True,A reticulocyte abnormality.,84,44,19,4958,0.4318181818181818,0.2261904761904762,Module 3,['HP:0001877']
420,HP,HP:0100273,Neoplasm of the colon,3.655003829967832e-20,True,Neoplasm of the colon,84,44,19,4958,0.4318181818181818,0.2261904761904762,Module 3,['HP:0100834']
421,HPA,HPA:0350472,pancreas; exocrine glandular cells[≥Medium],4.046150168061503e-20,True,pancreas; exocrine glandular cells[≥Medium],5304,612,411,11019,0.6715686274509803,0.07748868778280543,Module 0,['HPA:0350471']
422,HP,HP:0000465,Webbed neck,4.85628117610427e-20,True,Pterygium colli is a congenital skin fold that runs along the sides of the neck down to the shoulders. It involves an ectopic fibrotic facial band superficial to the trapezius muscle. Excess hair-bearing skin is also present and extends down the cervical region well beyond the normal hairline.,122,44,21,4958,0.4772727272727273,0.1721311475409836,Module 3,['HP:0025668']
423,HPA,HPA:0360000,parathyroid gland,5.048014486711491e-20,True,parathyroid gland,5898,612,442,11019,0.7222222222222222,0.07494065785011868,Module 0,['HPA:0000000']
424,HPA,HPA:0360051,parathyroid gland; glandular cells[≥Low],5.048014486711491e-20,True,parathyroid gland; glandular cells[≥Low],5898,612,442,11019,0.7222222222222222,0.07494065785011868,Module 0,['HPA:0360000']
425,TF,TF:M01660,Factor: GABP-alpha; motif: CTTCCK,5.583740111855842e-20,True,Factor: GABP-alpha; motif: CTTCCK,11340,826,603,20045,0.7300242130750605,0.05317460317460317,Module 0,['TF:M00000']
426,HPA,HPA:0291161,liver; cholangiocytes[≥Low],5.70100180380685e-20,True,liver; cholangiocytes[≥Low],3965,612,335,11019,0.5473856209150327,0.08448928121059268,Module 0,['HPA:0290000']
427,GO:BP,GO:0006955,immune response,5.703538326082e-20,True,"""Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat."" [GO_REF:0000022, GOC:add]",1988,215,73,21031,0.3395348837209302,0.036720321931589535,Module 2,"['GO:0002376', 'GO:0050896']"
428,GO:CC,GO:0042613,MHC class II protein complex,6.045777128702903e-20,True,"""A transmembrane protein complex composed of an MHC class II alpha and MHC class II beta chain, and with or without a bound peptide or polysaccharide antigen."" [GOC:add, GOC:jl, ISBN:0120781859, PMID:15928678]",17,17,8,22097,0.47058823529411764,0.47058823529411764,Module 6,['GO:0042611']
429,KEGG,KEGG:04141,Protein processing in endoplasmic reticulum,6.405344152028397e-20,True,Protein processing in endoplasmic reticulum,168,43,19,8484,0.4418604651162791,0.1130952380952381,Module 4,['KEGG:00000']
430,GO:MF,GO:0009055,electron transfer activity,7.06238753565394e-20,True,"""A molecular function representing the directed movement of electrons from one molecular entity to another, typically mediated by electron carriers or acceptors, resulting in the transfer of energy and/or the reduction-oxidation (redox) transformation of chemical species. This activity is fundamental to various biological processes, including cellular respiration and photosynthesis, as well as numerous enzymatic reactions involved in metabolic pathways."" [Wikipedia:Electron_transfer]",115,808,36,20212,0.04455445544554455,0.3130434782608696,Module 0,['GO:0003674']
431,TF,TF:M08913,Factor: FLI-1; motif: NAYTTCCGGT,7.1964144426015e-20,True,Factor: FLI-1; motif: NAYTTCCGGT,8512,826,490,20045,0.5932203389830508,0.05756578947368421,Module 0,['TF:M00000']
432,HPA,HPA:0320000,nasopharynx,7.498352119657322e-20,True,nasopharynx,7196,612,505,11019,0.8251633986928104,0.07017787659811006,Module 0,['HPA:0000000']
433,GO:CC,GO:0005737,cytoplasm,7.566370250620252e-20,True,"""The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures."" [ISBN:0198547684]",12345,105,102,22097,0.9714285714285714,0.008262454434993925,Module 3,"['GO:0005622', 'GO:0110165']"
434,HPA,HPA:0600443,tonsil; non-germinal center cells[High],8.140870275687352e-20,True,tonsil; non-germinal center cells[High],1321,612,158,11019,0.2581699346405229,0.11960635881907646,Module 0,['HPA:0600442']
435,GO:BP,GO:0009142,nucleoside triphosphate biosynthetic process,8.864339313377947e-20,True,"""The chemical reactions and pathways resulting in the formation of a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",127,787,37,21031,0.04701397712833545,0.29133858267716534,Module 0,"['GO:0009141', 'GO:1901293']"
436,HPA,HPA:0210052,fallopian tube; glandular cells[≥Medium],9.419009606270866e-20,True,fallopian tube; glandular cells[≥Medium],4704,612,377,11019,0.6160130718954249,0.08014455782312925,Module 0,['HPA:0210051']
437,TF,TF:M04826_1,Factor: p300; motif: ACNTCCG; match class: 1,1.0354885023750049e-19,True,Factor: p300; motif: ACNTCCG; match class: 1,15605,826,749,20045,0.9067796610169492,0.04799743671900032,Module 0,['TF:M04826']
438,GO:BP,GO:0006954,inflammatory response,1.0658541391412399e-19,True,"""The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages."" [GO_REF:0000022, ISBN:0198506732]",829,215,48,21031,0.22325581395348837,0.05790108564535585,Module 2,['GO:0006952']
439,TF,TF:M09607,Factor: SAP-1; motif: ACCGGAAGTNN,1.0725515839391992e-19,True,Factor: SAP-1; motif: ACCGGAAGTNN,4797,826,323,20045,0.3910411622276029,0.06733375026057953,Module 0,['TF:M00000']
440,TF,TF:M11447_1,Factor: Elf-1; motif: NAMCCGGAAGTN; match class: 1,1.361906206786437e-19,True,Factor: Elf-1; motif: NAMCCGGAAGTN; match class: 1,2653,826,213,20045,0.25786924939467315,0.08028646814926499,Module 0,['TF:M11447']
441,TF,TF:M11382_1,Factor: ESE-1; motif: NWTRCGGAWGCN; match class: 1,1.486254765221193e-19,True,Factor: ESE-1; motif: NWTRCGGAWGCN; match class: 1,4233,826,295,20045,0.35714285714285715,0.0696905268131349,Module 0,['TF:M11382']
442,GO:BP,GO:0050865,regulation of cell activation,1.5454495069755911e-19,True,"""Any process that modulates the frequency, rate or extent of cell activation, the change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand."" [GOC:ai]",616,226,43,21031,0.1902654867256637,0.0698051948051948,Module 1,"['GO:0001775', 'GO:0050794', 'GO:0051239']"
443,HPA,HPA:0270351,kidney; cells in glomeruli[≥Low],1.5891560245631966e-19,True,kidney; cells in glomeruli[≥Low],5168,612,402,11019,0.6568627450980392,0.07778637770897832,Module 0,['HPA:0270000']
444,TF,TF:M09900,Factor: Elf-1; motif: NNANCCGGAAGTGS,1.603095928224442e-19,True,Factor: Elf-1; motif: NNANCCGGAAGTGS,5333,826,348,20045,0.4213075060532688,0.06525407837989874,Module 0,['TF:M00000']
445,TF,TF:M11434_1,Factor: Elk-1; motif: NRSCGGAAGNN; match class: 1,1.623227041919713e-19,True,Factor: Elk-1; motif: NRSCGGAAGNN; match class: 1,3008,826,232,20045,0.28087167070217917,0.07712765957446809,Module 0,['TF:M11434']
446,KEGG,KEGG:05022,Pathways of neurodegeneration - multiple diseases,1.728074541950951e-19,True,Pathways of neurodegeneration - multiple diseases,474,439,79,8484,0.17995444191343962,0.16666666666666666,Module 0,['KEGG:00000']
447,TF,TF:M11432,Factor: Elk-1; motif: NACMGGAAGTN,1.7719630173150086e-19,True,Factor: Elk-1; motif: NACMGGAAGTN,6267,826,391,20045,0.47336561743341404,0.0623902983883836,Module 0,['TF:M00000']
448,GO:BP,GO:0006996,organelle organization,2.088664219297711e-19,True,"""A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an organelle within a cell. An organelle is an organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane."" [GOC:mah]",3613,787,245,21031,0.3113087674714104,0.06781068364240243,Module 0,['GO:0016043']
449,GO:BP,GO:0042110,T cell activation,2.0969506749552553e-19,True,"""The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific."" [GOC:mgi_curators, ISBN:0781735149]",555,226,41,21031,0.18141592920353983,0.07387387387387387,Module 1,['GO:0046649']
450,TF,TF:M08917,Factor: GABP-ALPHA; motif: RCCGGAARTNN,2.134050118575219e-19,True,Factor: GABP-ALPHA; motif: RCCGGAARTNN,2754,826,218,20045,0.2639225181598063,0.07915758896151052,Module 0,['TF:M00000']
451,GO:BP,GO:0002429,immune response-activating cell surface receptor signaling pathway,2.1556179039292982e-19,True,"""The series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of a cell, leading to the activation or perpetuation of an immune response."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",299,226,32,21031,0.1415929203539823,0.10702341137123746,Module 1,"['GO:0002757', 'GO:0002768']"
452,HPA,HPA:0060102,bronchus; respiratory epithelial cells[≥Medium],2.1923181766352033e-19,True,bronchus; respiratory epithelial cells[≥Medium],4938,612,389,11019,0.6356209150326797,0.07877683272579993,Module 0,['HPA:0060101']
453,TF,TF:M12557,Factor: ETV5; motif: NNACTTCCGNN,2.196521025985318e-19,True,Factor: ETV5; motif: NNACTTCCGNN,4528,826,309,20045,0.37409200968523004,0.06824204946996466,Module 0,['TF:M00000']
454,GO:BP,GO:1901566,organonitrogen compound biosynthetic process,2.3523924005029824e-19,True,"""The chemical reactions and pathways resulting in the formation of organonitrogen compound."" [GOC:pr, GOC:TermGenie]",1761,787,151,21031,0.19186785260482847,0.08574673480976717,Module 0,"['GO:1901564', 'GO:1901576']"
455,TF,TF:M11433,Factor: Elk-1; motif: NRCCGGAAGTN,2.3763975878555126e-19,True,Factor: Elk-1; motif: NRCCGGAAGTN,7843,826,460,20045,0.5569007263922519,0.05865102639296188,Module 0,['TF:M00000']
456,HPA,HPA:0250131,hippocampus; neuronal cells[≥Low],2.3800297674655353e-19,True,hippocampus; neuronal cells[≥Low],6228,612,457,11019,0.7467320261437909,0.07337829158638408,Module 0,['HPA:0250000']
457,TF,TF:M03967,Factor: ELF3; motif: WACCCGGAAGTAN,2.469074455844685e-19,True,Factor: ELF3; motif: WACCCGGAAGTAN,7751,826,456,20045,0.5520581113801453,0.05883111856534641,Module 0,['TF:M00000']
458,TF,TF:M13032,Factor: ETV5; motif: ACCGGAAGTN,2.5019325081442093e-19,True,Factor: ETV5; motif: ACCGGAAGTN,9651,826,535,20045,0.6476997578692494,0.05543466998238525,Module 0,['TF:M00000']
459,HP,HP:0002863,Myelodysplasia,2.6875028093897235e-19,True,"Clonal hematopoietic stem cell disorders characterized by dysplasia (ineffective production) in one or more hematopoietic cell lineages, leading to anemia and cytopenia.",111,44,20,4958,0.45454545454545453,0.18018018018018017,Module 3,['HP:0004377']
460,GO:MF,GO:0015453,oxidoreduction-driven active transmembrane transporter activity,2.7016239029009726e-19,True,"""Primary active transport of a solute across a membrane, driven by exothermic flow of electrons from a reduced substrate to an oxidized substrate. Primary active transport is catalysis of the transport of a solute across a membrane, up the solute's concentration gradient, by binding the solute and undergoing a series of conformational changes. Transport works equally well in either direction and is driven by a primary energy source."" [GOC:mtg_transport, ISBN:0815340729, TC:3.D.-.-.-]",66,808,28,20212,0.034653465346534656,0.42424242424242425,Module 0,['GO:0015399']
461,GO:BP,GO:0002768,immune response-regulating cell surface receptor signaling pathway,2.8763257482197244e-19,True,"""The series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of the target cell capable of activating, perpetuating, or inhibiting an immune response."" [GOC:add, ISBN:0781735149, PMID:15771571]",327,226,33,21031,0.14601769911504425,0.10091743119266056,Module 1,"['GO:0002764', 'GO:0007166']"
462,GO:BP,GO:0050776,regulation of immune response,2.977617696378664e-19,True,"""Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus."" [GOC:ai]",881,226,50,21031,0.22123893805309736,0.056753688989784334,Module 1,"['GO:0002682', 'GO:0006955', 'GO:0048583']"
463,HPA,HPA:0480000,small intestine,3.0536302612041696e-19,True,small intestine,7877,612,534,11019,0.8725490196078431,0.06779230671575473,Module 0,['HPA:0000000']
464,HPA,HPA:0190221,esophagus; squamous epithelial cells[≥Low],3.0736985606844103e-19,True,esophagus; squamous epithelial cells[≥Low],6679,612,479,11019,0.7826797385620915,0.0717173229525378,Module 0,['HPA:0190000']
465,HPA,HPA:0190000,esophagus,3.0736985606844103e-19,True,esophagus,6679,612,479,11019,0.7826797385620915,0.0717173229525378,Module 0,['HPA:0000000']
466,HPA,HPA:0330000,oral mucosa,3.537120758016148e-19,True,oral mucosa,6257,612,458,11019,0.7483660130718954,0.07319801821959405,Module 0,['HPA:0000000']
467,HPA,HPA:0330221,oral mucosa; squamous epithelial cells[≥Low],3.537120758016148e-19,True,oral mucosa; squamous epithelial cells[≥Low],6257,612,458,11019,0.7483660130718954,0.07319801821959405,Module 0,['HPA:0330000']
468,HPA,HPA:0060000,bronchus,3.576793799652953e-19,True,bronchus,7428,612,514,11019,0.8398692810457516,0.06919763058696823,Module 0,['HPA:0000000']
469,GO:BP,GO:0009607,response to biotic stimulus,3.6568745164221127e-19,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a biotic stimulus, a stimulus caused or produced by a living organism."" [GOC:hb]",1586,226,66,21031,0.2920353982300885,0.0416141235813367,Module 1,['GO:0050896']
470,TF,TF:M08526_1,Factor: E2F-3:HES-7; motif: NNNSGCGCSNNNNNCRCGYGNN; match class: 1,3.899732599070403e-19,True,Factor: E2F-3:HES-7; motif: NNNSGCGCSNNNNNCRCGYGNN; match class: 1,15386,826,741,20045,0.8970944309927361,0.04816066554010139,Module 0,['TF:M08526']
471,KEGG,KEGG:05208,Chemical carcinogenesis - reactive oxygen species,4.465514697072509e-19,True,Chemical carcinogenesis - reactive oxygen species,221,439,52,8484,0.11845102505694761,0.23529411764705882,Module 0,['KEGG:00000']
472,GO:BP,GO:0006952,defense response,4.601202727298076e-19,True,"""Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack."" [GOC:go_curators]",1791,226,70,21031,0.30973451327433627,0.03908431044109436,Module 1,['GO:0006950']
473,GO:CC,GO:0005737,cytoplasm,4.885057929862873e-19,True,"""The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures."" [ISBN:0198547684]",12345,177,157,22097,0.8870056497175142,0.01271769947347104,Module Singleton,"['GO:0005622', 'GO:0110165']"
474,TF,TF:M11428_1,Factor: PEA3; motif: NACCGGAAGTN; match class: 1,5.035159805329161e-19,True,Factor: PEA3; motif: NACCGGAAGTN; match class: 1,2196,826,186,20045,0.22518159806295399,0.08469945355191257,Module 0,['TF:M11428']
475,GO:CC,GO:0030684,preribosome,5.314780802009813e-19,True,"""Any complex of pre-rRNAs, ribosomal proteins, and associated proteins formed during ribosome biogenesis."" [PMID:10567516]",108,105,17,22097,0.1619047619047619,0.1574074074074074,Module 3,['GO:1990904']
476,GO:CC,GO:0005681,spliceosomal complex,5.320830082229381e-19,True,"""Any of a series of ribonucleoprotein complexes that contain snRNA(s) and small nuclear ribonucleoproteins (snRNPs), and are formed sequentially during the spliceosomal splicing of one or more substrate RNAs, and which also contain the RNA substrate(s) from the initial target RNAs of splicing, the splicing intermediate RNA(s), to the final RNA products. During cis-splicing, the initial target RNA is a single, contiguous RNA transcript, whether mRNA, snoRNA, etc., and the released products are a spliced RNA and an excised intron, generally as a lariat structure. During trans-splicing, there are two initial substrate RNAs, the spliced leader RNA and a pre-mRNA."" [GOC:editors, GOC:mah, ISBN:0198547684, PMID:19239890]",206,813,44,22097,0.05412054120541206,0.21359223300970873,Module 0,"['GO:0140513', 'GO:1990904']"
477,TF,TF:M02073,Factor: Fli-1; motif: ACCGGAAGYN,6.78788576087942e-19,True,Factor: Fli-1; motif: ACCGGAAGYN,5979,826,376,20045,0.4552058111380145,0.06288677036293695,Module 0,['TF:M00000']
478,TF,TF:M02061,Factor: ERF; motif: ACCGGAARYN,7.508125953035362e-19,True,Factor: ERF; motif: ACCGGAARYN,2634,826,210,20045,0.2542372881355932,0.07972665148063782,Module 0,['TF:M00000']
479,HPA,HPA:0630052,cervix; glandular cells[≥Medium],7.526236080979264e-19,True,cervix; glandular cells[≥Medium],4036,612,336,11019,0.5490196078431373,0.08325074331020813,Module 0,['HPA:0630051']
480,TF,TF:M02068,Factor: etv3; motif: ACCGGAAGYN,9.798739240971962e-19,True,Factor: etv3; motif: ACCGGAAGYN,3547,826,258,20045,0.31234866828087166,0.07273752466873414,Module 0,['TF:M00000']
481,HP,HP:0002488,Acute leukemia,9.909039257711172e-19,True,"A clonal (malignant) hematopoietic disorder with an acute onset, affecting the bone marrow and the peripheral blood. The malignant cells show minimal differentiation and are called blasts, either myeloid blasts (myeloblasts) or lymphoid blasts (lymphoblasts).",118,44,20,4958,0.45454545454545453,0.1694915254237288,Module 3,['HP:0001909']
482,GO:BP,GO:0034641,cellular nitrogen compound metabolic process,1.1319552239765054e-18,True,"""The chemical reactions and pathways involving various organic and inorganic nitrogenous compounds, as carried out by individual cells."" [GOC:mah]",8692,105,91,21031,0.8666666666666667,0.010469397146801656,Module 3,"['GO:0006807', 'GO:0044237']"
483,HPA,HPA:0510651,soft tissue 2; fibroblasts[≥Low],1.13517676013381e-18,True,soft tissue 2; fibroblasts[≥Low],4130,612,341,11019,0.5571895424836601,0.08256658595641647,Module 0,['HPA:0510000']
484,TF,TF:M03966,Factor: ELF1; motif: AACCCGGAAGTR,1.1904085642238282e-18,True,Factor: ELF1; motif: AACCCGGAAGTR,6750,826,410,20045,0.4963680387409201,0.06074074074074074,Module 0,['TF:M00000']
485,KEGG,KEGG:04932,Non-alcoholic fatty liver disease,1.1999632685986446e-18,True,Non-alcoholic fatty liver disease,154,439,43,8484,0.0979498861047836,0.2792207792207792,Module 0,['KEGG:00000']
486,TF,TF:M03988_1,Factor: FLI1; motif: ACCGGAARTN; match class: 1,1.3385440440725538e-18,True,Factor: FLI1; motif: ACCGGAARTN; match class: 1,2999,826,229,20045,0.2772397094430993,0.07635878626208736,Module 0,['TF:M03988']
487,TF,TF:M03990,Factor: GABPA; motif: ACCGGAAGTN,1.352768257881891e-18,True,Factor: GABPA; motif: ACCGGAAGTN,5374,826,347,20045,0.42009685230024213,0.06457015258652772,Module 0,['TF:M00000']
488,GO:BP,GO:0044419,biological process involved in interspecies interaction between organisms,1.357384604501816e-18,True,"""Any process evolved to enable an interaction with an organism of a different species."" [GOC:cc]",1724,226,68,21031,0.3008849557522124,0.03944315545243619,Module 1,['GO:0008150']
489,HPA,HPA:0471411,skin 2; cells in spinous layer[≥Low],1.3690747057151019e-18,True,skin 2; cells in spinous layer[≥Low],871,69,35,11019,0.5072463768115942,0.040183696900114814,Module 5,['HPA:0470000']
490,GO:CC,GO:0030141,secretory granule,1.5075892486353044e-18,True,"""A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules."" [GOC:mah, ISBN:0198506732]",896,221,47,22097,0.21266968325791855,0.052455357142857144,Module 2,"['GO:0012505', 'GO:0099503']"
491,GO:BP,GO:0044419,biological process involved in interspecies interaction between organisms,1.6202939823691269e-18,True,"""Any process evolved to enable an interaction with an organism of a different species."" [GOC:cc]",1724,215,66,21031,0.30697674418604654,0.0382830626450116,Module 2,['GO:0008150']
492,TF,TF:M02066_1,Factor: PEA3; motif: RCCGGAAGYN; match class: 1,1.7098001466436037e-18,True,Factor: PEA3; motif: RCCGGAAGYN; match class: 1,2326,826,192,20045,0.2324455205811138,0.0825451418744626,Module 0,['TF:M02066']
493,GO:MF,GO:0042605,peptide antigen binding,1.7468694935028474e-18,True,"""Binding to an antigen peptide."" [GOC:add, GOC:jl, GOC:rv]",42,17,9,20212,0.5294117647058824,0.21428571428571427,Module 6,"['GO:0003823', 'GO:0042277']"
494,REAC,REAC:R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,1.896714171570567e-18,True,Processing of Capped Intron-Containing Pre-mRNA,276,586,60,10842,0.10238907849829351,0.21739130434782608,Module 0,['REAC:R-HSA-8953854']
495,TF,TF:M11422,Factor: Erm; motif: NRCMGGAAGTN,1.947126788020064e-18,True,Factor: Erm; motif: NRCMGGAAGTN,4774,826,318,20045,0.38498789346246975,0.06661080854629242,Module 0,['TF:M00000']
496,TF,TF:M10438_1,Factor: ZF5; motif: GGSGCGCGS; match class: 1,2.0079892988755594e-18,True,Factor: ZF5; motif: GGSGCGCGS; match class: 1,15279,826,736,20045,0.8910411622276029,0.04817069179920152,Module 0,['TF:M10438']
497,GO:CC,GO:0031410,cytoplasmic vesicle,2.023976234088402e-18,True,"""A vesicle found in the cytoplasm of a cell."" [GOC:ai, GOC:mah, GOC:vesicles]",2513,221,78,22097,0.35294117647058826,0.03103859928372463,Module 2,"['GO:0005737', 'GO:0097708']"
498,TF,TF:M02062_1,Factor: Erg; motif: ACCGGAAGTN; match class: 1,2.2536191370440797e-18,True,Factor: Erg; motif: ACCGGAAGTN; match class: 1,2768,826,216,20045,0.26150121065375304,0.07803468208092486,Module 0,['TF:M02062']
499,GO:CC,GO:0097708,intracellular vesicle,2.2854124206378772e-18,True,"""Any vesicle that is part of the intracellular region."" [GOC:vesicles]",2518,221,78,22097,0.35294117647058826,0.030976965845909452,Module 2,"['GO:0031982', 'GO:0043231']"
500,GO:BP,GO:0002757,immune response-activating signaling pathway,2.519040482751032e-18,True,"""The series of molecular signals generated by a ligand binding to its receptor that lead to the activation or perpetuation of an immune response."" [GOC:add]",465,226,37,21031,0.16371681415929204,0.07956989247311828,Module 1,"['GO:0002253', 'GO:0002764']"
501,GO:CC,GO:0098553,lumenal side of endoplasmic reticulum membrane,2.682036630842784e-18,True,"""The side (leaflet) of the plasma membrane that faces the lumen."" [GOC:ab, GOC:dos]",25,17,8,22097,0.47058823529411764,0.32,Module 6,"['GO:0005789', 'GO:0098576']"
502,GO:BP,GO:0009607,response to biotic stimulus,2.758434849439363e-18,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a biotic stimulus, a stimulus caused or produced by a living organism."" [GOC:hb]",1586,215,63,21031,0.2930232558139535,0.03972257250945776,Module 2,['GO:0050896']
503,HPA,HPA:0461411,skin 1; cells in spinous layer[≥Low],2.826603979924394e-18,True,skin 1; cells in spinous layer[≥Low],760,69,33,11019,0.4782608695652174,0.04342105263157895,Module 5,['HPA:0460000']
504,HPA,HPA:0330222,oral mucosa; squamous epithelial cells[≥Medium],2.9958077482050895e-18,True,oral mucosa; squamous epithelial cells[≥Medium],4358,612,353,11019,0.576797385620915,0.08100045892611289,Module 0,['HPA:0330221']
505,HPA,HPA:0100131,cerebral cortex; neuronal cells[≥Low],3.0874521393342586e-18,True,cerebral cortex; neuronal cells[≥Low],6712,612,478,11019,0.7810457516339869,0.07121573301549464,Module 0,['HPA:0100000']
506,GO:BP,GO:0006457,protein folding,3.091178915930378e-18,True,"""The process of assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure."" [GOC:go_curators, GOC:rb]",217,21,13,21031,0.6190476190476191,0.059907834101382486,Module 9,"['GO:0009987', 'GO:0051604']"
507,REAC,REAC:R-HSA-168256,Immune System,3.1945386138016033e-18,True,Immune System,2052,164,84,10842,0.5121951219512195,0.04093567251461988,Module 1,['REAC:0000000']
508,KEGG,KEGG:05330,Allograft rejection,3.2307124376994717e-18,True,Allograft rejection,34,13,9,8484,0.6923076923076923,0.2647058823529412,Module 6,['KEGG:00000']
509,GO:BP,GO:0022900,electron transport chain,3.4803868145335555e-18,True,"""A process in which a series of electron carriers operate together to transfer electrons from donors to any of several different terminal electron acceptors."" [GOC:mtg_electron_transport]",175,787,41,21031,0.052096569250317665,0.2342857142857143,Module 0,['GO:0006091']
510,HPA,HPA:0360052,parathyroid gland; glandular cells[≥Medium],3.553630797979567e-18,True,parathyroid gland; glandular cells[≥Medium],4414,612,356,11019,0.5816993464052288,0.08065246941549614,Module 0,['HPA:0360051']
511,HP,HP:0010622,Neoplasm of the skeletal system,3.6639699936858556e-18,True,A tumor (abnormal growth of tissue) of the skeleton.,105,44,19,4958,0.4318181818181818,0.18095238095238095,Module 3,"['HP:0011793', 'HP:0011842']"
512,GO:CC,GO:1990204,oxidoreductase complex,4.091075338115922e-18,True,"""Any protein complex that possesses oxidoreductase activity."" [GOC:bhm, PMID:18982432]",132,813,35,22097,0.04305043050430504,0.26515151515151514,Module 0,['GO:1902494']
513,HPA,HPA:0600441,tonsil; non-germinal center cells[≥Low],4.1131385830302486e-18,True,tonsil; non-germinal center cells[≥Low],6117,185,161,11019,0.8702702702702703,0.026320091548144516,Module 1,['HPA:0600000']
514,GO:BP,GO:0051707,response to other organism,4.1830239231994465e-18,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from another living organism."" [GOC:ai]",1548,215,62,21031,0.28837209302325584,0.040051679586563305,Module 2,"['GO:0043207', 'GO:0044419']"
515,TF,TF:M11655_1,Factor: HSF1; motif: NGAANGTTCKRGAAN; match class: 1,4.5572279505248166e-18,True,Factor: HSF1; motif: NGAANGTTCKRGAAN; match class: 1,89,21,11,20045,0.5238095238095238,0.12359550561797752,Module 9,['TF:M11655']
516,GO:BP,GO:0043207,response to external biotic stimulus,4.619748598885587e-18,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an external biotic stimulus, an external stimulus caused by, or produced by living things."" [GOC:go_curators]",1551,215,62,21031,0.28837209302325584,0.039974210186976146,Module 2,"['GO:0009605', 'GO:0009607']"
517,KEGG,KEGG:04714,Thermogenesis,4.667720346398445e-18,True,Thermogenesis,232,439,52,8484,0.11845102505694761,0.22413793103448276,Module 0,['KEGG:00000']
518,TF,TF:M04698,Factor: GABP-alpha; motif: CACTTCCGG,4.796446953362902e-18,True,Factor: GABP-alpha; motif: CACTTCCGG,3276,826,242,20045,0.2929782082324455,0.07387057387057387,Module 0,['TF:M00000']
519,HP,HP:0001882,Leukopenia,5.4189867955619336e-18,True,An abnormal decreased number of leukocytes in the blood.,151,44,21,4958,0.4772727272727273,0.1390728476821192,Module 3,['HP:0011893']
520,HPA,HPA:0210051,fallopian tube; glandular cells[≥Low],5.7825475176911146e-18,True,fallopian tube; glandular cells[≥Low],5776,612,430,11019,0.7026143790849673,0.07444598337950138,Module 0,['HPA:0210000']
521,HPA,HPA:0500000,soft tissue 1,6.254106154070563e-18,True,soft tissue 1,5363,612,408,11019,0.6666666666666666,0.07607682267387657,Module 0,['HPA:0000000']
522,TF,TF:M09905_1,Factor: SAP-1; motif: NNCCGGAAGTGN; match class: 1,6.723108654831766e-18,True,Factor: SAP-1; motif: NNCCGGAAGTGN; match class: 1,3055,826,230,20045,0.2784503631961259,0.07528641571194762,Module 0,['TF:M09905']
523,GO:BP,GO:0002682,regulation of immune system process,6.729744088266531e-18,True,"""Any process that modulates the frequency, rate, or extent of an immune system process."" [GOC:add]",1512,215,61,21031,0.2837209302325581,0.04034391534391534,Module 2,"['GO:0002376', 'GO:0050789']"
524,HPA,HPA:0030051,appendix; glandular cells[≥Low],6.742248135225935e-18,True,appendix; glandular cells[≥Low],6751,612,479,11019,0.7826797385620915,0.07095245148866834,Module 0,['HPA:0030000']
525,HPA,HPA:0600442,tonsil; non-germinal center cells[≥Medium],7.07731478881467e-18,True,tonsil; non-germinal center cells[≥Medium],4200,185,132,11019,0.7135135135135136,0.03142857142857143,Module 1,['HPA:0600441']
526,REAC,REAC:R-HSA-8953854,Metabolism of RNA,7.419046849770337e-18,True,Metabolism of RNA,701,586,101,10842,0.17235494880546076,0.14407988587731813,Module 0,['REAC:0000000']
527,KEGG,KEGG:05332,Graft-versus-host disease,7.652800438231763e-18,True,Graft-versus-host disease,37,13,9,8484,0.6923076923076923,0.24324324324324326,Module 6,['KEGG:00000']
528,HPA,HPA:0600222,tonsil; squamous epithelial cells[≥Medium],8.642714818907291e-18,True,tonsil; squamous epithelial cells[≥Medium],4949,612,385,11019,0.6290849673202614,0.07779349363507779,Module 0,['HPA:0600221']
529,KEGG,KEGG:04612,Antigen processing and presentation,9.802309983991145e-18,True,Antigen processing and presentation,69,13,10,8484,0.7692307692307693,0.14492753623188406,Module 6,['KEGG:00000']
530,TF,TF:M11404_1,Factor: Fli-1; motif: NACCGGAARTN; match class: 1,1.0832630191340947e-17,True,Factor: Fli-1; motif: NACCGGAARTN; match class: 1,3238,826,239,20045,0.28934624697336564,0.07381099444101297,Module 0,['TF:M11404']
531,HPA,HPA:0030052,appendix; glandular cells[≥Medium],1.1461245327424388e-17,True,appendix; glandular cells[≥Medium],5508,612,415,11019,0.6781045751633987,0.07534495279593319,Module 0,['HPA:0030051']
532,GO:CC,GO:0012507,ER to Golgi transport vesicle membrane,1.2567512663024711e-17,True,"""The lipid bilayer surrounding a vesicle transporting substances from the endoplasmic reticulum to the Golgi."" [GOC:ai, GOC:ascb_2009, GOC:dph, GOC:tb]",59,17,9,22097,0.5294117647058824,0.15254237288135594,Module 6,"['GO:0030134', 'GO:0030658', 'GO:0030662']"
533,HPA,HPA:0480052,small intestine; glandular cells[≥Medium],1.3713033190487061e-17,True,small intestine; glandular cells[≥Medium],6067,612,444,11019,0.7254901960784313,0.07318279215427724,Module 0,['HPA:0480051']
534,GO:BP,GO:0051707,response to other organism,1.4038477054087495e-17,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from another living organism."" [GOC:ai]",1548,226,63,21031,0.27876106194690264,0.040697674418604654,Module 1,"['GO:0043207', 'GO:0044419']"
535,TF,TF:M11437,Factor: SAP-1; motif: NRCCGGAWGYN,1.4649780771400006e-17,True,Factor: SAP-1; motif: NRCCGGAWGYN,2847,826,218,20045,0.2639225181598063,0.07657182999648753,Module 0,['TF:M00000']
536,GO:BP,GO:0009260,ribonucleotide biosynthetic process,1.531765520895292e-17,True,"""The chemical reactions and pathways resulting in the formation of a ribonucleotide, a compound consisting of ribonucleoside (a base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:go_curators, ISBN:0198506732]",231,787,46,21031,0.05844980940279543,0.19913419913419914,Module 0,"['GO:0009165', 'GO:0009259', 'GO:0046390']"
537,GO:BP,GO:0043207,response to external biotic stimulus,1.5511814863110093e-17,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an external biotic stimulus, an external stimulus caused by, or produced by living things."" [GOC:go_curators]",1551,226,63,21031,0.27876106194690264,0.04061895551257253,Module 1,"['GO:0009605', 'GO:0009607']"
538,GO:BP,GO:0048522,positive regulation of cellular process,1.6332262362892047e-17,True,"""Any process that activates or increases the frequency, rate or extent of a cellular process, any of those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level."" [GOC:jid]",5717,226,128,21031,0.5663716814159292,0.02238936505160049,Module 1,"['GO:0009987', 'GO:0048518', 'GO:0050794']"
539,KEGG,KEGG:04940,Type I diabetes mellitus,1.6799347897286968e-17,True,Type I diabetes mellitus,40,13,9,8484,0.6923076923076923,0.225,Module 6,['KEGG:00000']
540,GO:BP,GO:0002764,immune response-regulating signaling pathway,1.734152920163143e-17,True,"""The cascade of processes by which a signal interacts with a receptor, causing a change in the level or activity of a second messenger or other downstream target, and ultimately leading to the activation, perpetuation, or inhibition of an immune response."" [GOC:add, ISBN:0781735149, PMID:15771571]",492,226,37,21031,0.16371681415929204,0.07520325203252033,Module 1,"['GO:0007165', 'GO:0050776']"
541,TF,TF:M09606,Factor: nerf; motif: NRRNSCGGAAGNRNNNN,1.7826891673352938e-17,True,Factor: nerf; motif: NRRNSCGGAAGNRNNNN,6435,826,392,20045,0.4745762711864407,0.06091686091686092,Module 0,['TF:M00000']
542,GO:BP,GO:0002252,immune effector process,1.9423564476948278e-17,True,"""Any process of the immune system that executes a component of an immune response. An effector immune process takes place after its activation."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",698,226,43,21031,0.1902654867256637,0.06160458452722063,Module 1,['GO:0002376']
543,GO:CC,GO:0032991,protein-containing complex,2.0816620043157172e-17,True,"""A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together."" [GOC:dos, GOC:mah]",8588,813,442,22097,0.5436654366543665,0.051467163483931065,Module 0,['GO:0005575']
544,TF,TF:M04714_1,Factor: Elf-1; motif: ACTTCCGGG; match class: 1,2.1268972091660542e-17,True,Factor: Elf-1; motif: ACTTCCGGG; match class: 1,2725,826,211,20045,0.25544794188861986,0.07743119266055046,Module 0,['TF:M04714']
545,GO:BP,GO:0030098,lymphocyte differentiation,2.2536342462100738e-17,True,"""The process in which a relatively unspecialized precursor cell acquires specialized features of a lymphocyte. A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin."" [CL:0000542, GOC:go_curators]",434,226,35,21031,0.15486725663716813,0.08064516129032258,Module 1,"['GO:0046649', 'GO:1903131']"
546,HP,HP:0000085,Horseshoe kidney,2.3013972270434383e-17,True,A connection of the right and left kidney by an isthmus of functioning renal parenchyma or fibrous tissue that crosses the midline.,137,44,20,4958,0.45454545454545453,0.145985401459854,Module 3,['HP:0100542']
547,TF,TF:M11451_1,Factor: Elf-1; motif: NANCCGGAAGTN; match class: 1,2.3289284794549196e-17,True,Factor: Elf-1; motif: NANCCGGAAGTN; match class: 1,2165,826,180,20045,0.2179176755447942,0.08314087759815242,Module 0,['TF:M11451']
548,TF,TF:M02070,Factor: TEL1; motif: CNCGGAANNN,2.4131468869852803e-17,True,Factor: TEL1; motif: CNCGGAANNN,11085,826,585,20045,0.7082324455205811,0.05277401894451962,Module 0,['TF:M00000']
549,GO:BP,GO:0072522,purine-containing compound biosynthetic process,2.706313387882422e-17,True,"""The chemical reactions and pathways resulting in the formation of a purine-containing compound, i.e. any compound that contains purine or a formal derivative thereof."" [GOC:mah]",266,787,49,21031,0.062261753494282084,0.18421052631578946,Module 0,"['GO:0018130', 'GO:0019438', 'GO:0044271', 'GO:0072521', 'GO:1901362', 'GO:1901566']"
550,HP,HP:0100834,Neoplasm of the large intestine,2.7435385700468518e-17,True,The presence of a neoplasm of the large intestine.,116,44,19,4958,0.4318181818181818,0.16379310344827586,Module 3,"['HP:0002250', 'HP:0007378']"
551,HPA,HPA:0471392,skin 2; cells in basal layer[≥Medium],2.803864117614946e-17,True,skin 2; cells in basal layer[≥Medium],754,69,32,11019,0.463768115942029,0.042440318302387266,Module 5,['HPA:0471391']
552,TF,TF:M13119,Factor: ZBTB11; motif: RCTTCCGGNNSNNNN,3.095395901886311e-17,True,Factor: ZBTB11; motif: RCTTCCGGNNSNNNN,5858,826,365,20045,0.44188861985472155,0.06230795493342438,Module 0,['TF:M00000']
553,GO:CC,GO:0098796,membrane protein complex,3.299130339814674e-17,True,"""Any protein complex that is part of a membrane."" [GOC:dos]",1401,813,123,22097,0.15129151291512916,0.08779443254817987,Module 0,"['GO:0016020', 'GO:0032991']"
554,GO:CC,GO:0031981,nuclear lumen,3.558836180169659e-17,True,"""The volume enclosed by the nuclear inner membrane."" [GOC:mah, GOC:pz]",5521,813,318,22097,0.39114391143911437,0.05759826118456801,Module 0,"['GO:0005634', 'GO:0070013']"
555,HPA,HPA:0610833,urinary bladder; urothelial cells[High],3.6715085870196624e-17,True,urinary bladder; urothelial cells[High],2038,612,204,11019,0.3333333333333333,0.10009813542688911,Module 0,['HPA:0610832']
556,GO:BP,GO:0006164,purine nucleotide biosynthetic process,3.6836222130386723e-17,True,"""The chemical reactions and pathways resulting in the formation of a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:go_curators, ISBN:0198506732]",257,787,48,21031,0.060991105463786534,0.1867704280155642,Module 0,"['GO:0006163', 'GO:0009165', 'GO:0072522']"
557,TF,TF:M11424_1,Factor: Erm; motif: NNSCGGAWGYN; match class: 1,3.8932602029769226e-17,True,Factor: Erm; motif: NNSCGGAWGYN; match class: 1,2907,826,220,20045,0.26634382566585957,0.07567939456484347,Module 0,['TF:M11424']
558,TF,TF:M01163,Factor: Elk-1; motif: AACCGGAAGTR,4.223809908288642e-17,True,Factor: Elk-1; motif: AACCGGAAGTR,5371,826,342,20045,0.41404358353510895,0.06367529324148204,Module 0,['TF:M00000']
559,GO:BP,GO:0009152,purine ribonucleotide biosynthetic process,4.2914143636364054e-17,True,"""The chemical reactions and pathways resulting in the formation of a purine ribonucleotide, a compound consisting of ribonucleoside (a purine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:go_curators, ISBN:0198506732]",216,787,44,21031,0.05590851334180432,0.2037037037037037,Module 0,"['GO:0006164', 'GO:0009150', 'GO:0009260']"
560,HPA,HPA:0150051,duodenum; glandular cells[≥Low],4.3159686758430686e-17,True,duodenum; glandular cells[≥Low],7108,612,494,11019,0.8071895424836601,0.0694991558806978,Module 0,['HPA:0150000']
561,GO:BP,GO:0002399,MHC class II protein complex assembly,4.3646029749805434e-17,True,"""The aggregation, arrangement and bonding together of a set of components to form an MHC class II protein complex."" [GOC:add, ISBN:0781735149, PMID:15771591]",13,15,7,21031,0.4666666666666667,0.5384615384615384,Module 6,['GO:0002396']
562,GO:BP,GO:0002503,peptide antigen assembly with MHC class II protein complex,4.3646029749805434e-17,True,"""The binding of a peptide to the antigen binding groove of an MHC class II protein complex."" [GOC:add, ISBN:0781735149, PMID:15771591]",13,15,7,21031,0.4666666666666667,0.5384615384615384,Module 6,"['GO:0002399', 'GO:0002495', 'GO:0002501']"
563,TF,TF:M11384,Factor: ESE-1; motif: ACCCGGAAGTRNNNNNNNWWWWW,4.427877059977021e-17,True,Factor: ESE-1; motif: ACCCGGAAGTRNNNNNNNWWWWW,3311,826,241,20045,0.2917675544794189,0.07278767743884022,Module 0,['TF:M00000']
564,HPA,HPA:0240000,heart muscle,4.539766650628468e-17,True,heart muscle,6332,612,456,11019,0.7450980392156863,0.07201516108654453,Module 0,['HPA:0000000']
565,HPA,HPA:0241101,heart muscle; cardiomyocytes[≥Low],4.539766650628468e-17,True,heart muscle; cardiomyocytes[≥Low],6332,612,456,11019,0.7450980392156863,0.07201516108654453,Module 0,['HPA:0240000']
566,GO:CC,GO:0005783,endoplasmic reticulum,4.648516667901326e-17,True,"""The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached)."" [ISBN:0198506732]",2055,73,37,22097,0.5068493150684932,0.01800486618004866,Module 4,"['GO:0005737', 'GO:0012505', 'GO:0043231']"
567,HPA,HPA:0310442,lymph node; non-germinal center cells[≥Medium],4.6922047237653164e-17,True,lymph node; non-germinal center cells[≥Medium],3989,185,127,11019,0.6864864864864865,0.031837553271496614,Module 1,['HPA:0310441']
568,HP,HP:0001254,Lethargy,5.0801254072711056e-17,True,"A state of disinterest, listlessness, and indifference, resulting in difficulty performing simple tasks or concentrating.",225,44,23,4958,0.5227272727272727,0.10222222222222223,Module 3,['HP:0000745']
569,TF,TF:M12603,Factor: ERM; motif: NNCACTTCCGGNN,5.1251261507052534e-17,True,Factor: ERM; motif: NNCACTTCCGGNN,7238,826,426,20045,0.5157384987893463,0.058856037579441835,Module 0,['TF:M00000']
570,GO:BP,GO:0046390,ribose phosphate biosynthetic process,5.495455199802307e-17,True,"""The chemical reactions and pathways resulting in the formation of ribose phosphate, any phosphorylated ribose sugar."" [GOC:ai]",238,787,46,21031,0.05844980940279543,0.19327731092436976,Module 0,"['GO:0019693', 'GO:0090407', 'GO:1901137']"
571,GO:CC,GO:0030964,NADH dehydrogenase complex,5.778147548216302e-17,True,"""An integral membrane complex that possesses NADH oxidoreductase activity. The complex is one of the components of the electron transport chain. It catalyzes the transfer of a pair of electrons from NADH to a quinone."" [GOC:mah]",53,813,23,22097,0.028290282902829027,0.4339622641509434,Module 0,"['GO:0098796', 'GO:1990204']"
572,GO:CC,GO:0045271,respiratory chain complex I,5.778147548216302e-17,True,"""Respiratory chain complex I is an enzyme of the respiratory chain. It consists of several polypeptide chains and is L-shaped, with a horizontal arm lying in the membrane and a vertical arm that projects into the matrix. The electrons of NADH enter the chain at this complex."" [GOC:imk, GOC:jid, ISBN:0716749556]",53,813,23,22097,0.028290282902829027,0.4339622641509434,Module 0,"['GO:0030964', 'GO:0098803', 'GO:1902495']"
573,GO:CC,GO:0005747,mitochondrial respiratory chain complex I,5.778147548216302e-17,True,"""A protein complex located in the mitochondrial inner membrane that forms part of the mitochondrial respiratory chain. It contains about 25 different polypeptide subunits, including NADH dehydrogenase (ubiquinone), flavin mononucleotide and several different iron-sulfur clusters containing non-heme iron. The iron undergoes oxidation-reduction between Fe(II) and Fe(III), and catalyzes proton translocation linked to the oxidation of NADH by ubiquinone."" [GOC:mtg_sensu, ISBN:0198547684]",53,813,23,22097,0.028290282902829027,0.4339622641509434,Module 0,"['GO:0005746', 'GO:0045271', 'GO:0098800']"
574,TF,TF:M03925,Factor: YY2; motif: NCCGCCATNTY,5.826769674804301e-17,True,Factor: YY2; motif: NCCGCCATNTY,4747,826,312,20045,0.37772397094430993,0.06572572150832104,Module 0,['TF:M00000']
575,GO:CC,GO:0009986,cell surface,6.227847471843521e-17,True,"""The external part of the cell wall and/or plasma membrane."" [GOC:jl, GOC:mtg_sensu, GOC:sm]",903,238,47,22097,0.19747899159663865,0.05204872646733112,Module 1,['GO:0110165']
576,HP,HP:0009778,Short thumb,6.389281657948461e-17,True,Hypoplasia (congenital reduction in size) of the thumb.,121,44,19,4958,0.4318181818181818,0.15702479338842976,Module 3,"['HP:0009381', 'HP:0009601']"
577,GO:BP,GO:0019882,antigen processing and presentation,6.715202930920366e-17,True,"""The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex."" [GO_REF:0000022, GOC:add, ISBN:0781735149, PMID:15771591, PMID:15928678]",115,15,10,21031,0.6666666666666666,0.08695652173913043,Module 6,['GO:0002376']
578,HPA,HPA:0620222,vagina; squamous epithelial cells[≥Medium],6.92955722567137e-17,True,vagina; squamous epithelial cells[≥Medium],4050,612,331,11019,0.5408496732026143,0.0817283950617284,Module 0,['HPA:0620221']
579,TF,TF:M02071_1,Factor: ETV7; motif: NCCGGAANNN; match class: 1,6.965138770677539e-17,True,Factor: ETV7; motif: NCCGGAANNN; match class: 1,4586,826,304,20045,0.36803874092009686,0.06628870475359791,Module 0,['TF:M02071']
580,TF,TF:M03983,Factor: ETV5; motif: NCCGGAWGYN,7.054689969161387e-17,True,Factor: ETV5; motif: NCCGGAWGYN,3226,826,236,20045,0.2857142857142857,0.0731556106633602,Module 0,['TF:M00000']
581,WP,WP:WP4396,Nonalcoholic fatty liver disease,7.078279535000063e-17,True,Nonalcoholic fatty liver disease,153,472,43,8286,0.09110169491525423,0.28104575163398693,Module 0,['WP:000000']
582,REAC,REAC:R-HSA-9679506,SARS-CoV Infections,7.369550198553866e-17,True,SARS-CoV Infections,459,97,31,10842,0.31958762886597936,0.06753812636165578,Module 3,['REAC:R-HSA-9824446']
583,HPA,HPA:0170251,endometrium 2; cells in endometrial stroma[≥Low],7.405129023368049e-17,True,endometrium 2; cells in endometrial stroma[≥Low],3517,612,299,11019,0.48856209150326796,0.08501563832812056,Module 0,['HPA:0170000']
584,GO:CC,GO:0098576,lumenal side of membrane,7.473946700449213e-17,True,"""Any side (leaflet) of a membrane that faces the lumen of an organelle."" [GOC:dos]",36,17,8,22097,0.47058823529411764,0.2222222222222222,Module 6,"['GO:0031090', 'GO:0098552']"
585,HP,HP:0001421,Abnormality of the musculature of the hand,7.530814195953764e-17,True,Abnormality of the musculature of the hand,122,44,19,4958,0.4318181818181818,0.1557377049180328,Module 3,"['HP:0001155', 'HP:0001446']"
586,HP,HP:0009601,Aplasia/Hypoplasia of the thumb,8.650342480633351e-17,True,Hypoplastic/small or absent thumb.,146,44,20,4958,0.45454545454545453,0.136986301369863,Module 3,"['HP:0001172', 'HP:0006265']"
587,GO:BP,GO:1903131,mononuclear cell differentiation,8.816850897503302e-17,True,"""The process in which a relatively unspecialized cell acquires the specialized features of a mononuclear cell."" [CL:0000842, GO_REF:0000086, GOC:TermGenie, PMID:24759906]",484,226,36,21031,0.1592920353982301,0.0743801652892562,Module 1,['GO:0002521']
588,HP,HP:0001789,Hydrops fetalis,8.86299708494719e-17,True,"The abnormal accumulation of fluid in two or more fetal compartments, including ascites, pleural effusion, pericardial effusion, and skin edema.",123,44,19,4958,0.4318181818181818,0.15447154471544716,Module 3,"['HP:0000969', 'HP:0034058']"
589,GO:BP,GO:0050851,antigen receptor-mediated signaling pathway,9.148948830820473e-17,True,"""The series of molecular signals initiated by the cross-linking of an antigen receptor on a B or T cell."" [GOC:add]",191,226,25,21031,0.11061946902654868,0.13089005235602094,Module 1,['GO:0002429']
590,TF,TF:M00032,Factor: c-Ets-1(p54); motif: NCMGGAWGYN,9.203101433408695e-17,True,Factor: c-Ets-1(p54); motif: NCMGGAWGYN,7977,826,457,20045,0.5532687651331719,0.05728970791024195,Module 0,['TF:M00000']
591,TF,TF:M02054,Factor: ELF2; motif: CCCGGAARYN,9.866454404177976e-17,True,Factor: ELF2; motif: CCCGGAARYN,3119,826,230,20045,0.2784503631961259,0.07374158384097468,Module 0,['TF:M00000']
592,TF,TF:M02074,Factor: GABPalpha; motif: RCCGGAWRYN,1.0571349369166522e-16,True,Factor: GABPalpha; motif: RCCGGAWRYN,4702,826,309,20045,0.37409200968523004,0.06571671629094003,Module 0,['TF:M00000']
593,HPA,HPA:0470673,skin 2; melanocytes[High],1.0982711827848969e-16,True,skin 2; melanocytes[High],357,612,67,11019,0.10947712418300654,0.1876750700280112,Module 0,['HPA:0470672']
594,HPA,HPA:0010011,adipose tissue; adipocytes[≥Low],1.1644195338625946e-16,True,adipose tissue; adipocytes[≥Low],3943,612,324,11019,0.5294117647058824,0.08217093583565813,Module 0,['HPA:0010000']
595,HPA,HPA:0010000,adipose tissue,1.1644195338625946e-16,True,adipose tissue,3943,612,324,11019,0.5294117647058824,0.08217093583565813,Module 0,['HPA:0000000']
596,GO:CC,GO:0098552,side of membrane,1.1769335187130225e-16,True,"""A cellular component consisting of one leaflet of a membrane bilayer and any proteins embedded or anchored in it or attached to its surface."" [GOC:dos]",721,238,42,22097,0.17647058823529413,0.05825242718446602,Module 1,"['GO:0016020', 'GO:0110165']"
597,HPA,HPA:0570732,testis; Leydig cells[≥Medium],1.2164962832759684e-16,True,testis; Leydig cells[≥Medium],5378,612,405,11019,0.6617647058823529,0.0753068055039048,Module 0,['HPA:0570731']
598,KEGG,KEGG:05320,Autoimmune thyroid disease,1.2573675643466077e-16,True,Autoimmune thyroid disease,49,13,9,8484,0.6923076923076923,0.1836734693877551,Module 6,['KEGG:00000']
599,GO:BP,GO:0009605,response to external stimulus,1.4155101163642785e-16,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an external stimulus."" [GOC:hb]",2723,226,83,21031,0.3672566371681416,0.03048108703635696,Module 1,['GO:0050896']
600,GO:BP,GO:0010033,response to organic substance,1.5245535790567553e-16,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus."" [GOC:sm, PMID:23356676]",2637,215,79,21031,0.3674418604651163,0.029958285930982178,Module 2,['GO:0042221']
601,TF,TF:M11400_1,Factor: Fli-1; motif: NACCGGAARTN; match class: 1,1.5347093212974253e-16,True,Factor: Fli-1; motif: NACCGGAARTN; match class: 1,4300,826,289,20045,0.3498789346246973,0.0672093023255814,Module 0,['TF:M11400']
602,GO:BP,GO:0048002,antigen processing and presentation of peptide antigen,1.567306572262917e-16,True,"""The process in which an antigen-presenting cell expresses peptide antigen in association with an MHC protein complex on its cell surface, including proteolysis and transport steps for the peptide antigen both prior to and following assembly with the MHC protein complex. The peptide antigen is typically, but not always, processed from an endogenous or exogenous protein."" [GOC:add, ISBN:0781735149, PMID:15771591]",68,15,9,21031,0.6,0.1323529411764706,Module 6,['GO:0019882']
603,HPA,HPA:0400052,rectum; glandular cells[≥Medium],1.5907367189296554e-16,True,rectum; glandular cells[≥Medium],6107,612,443,11019,0.7238562091503268,0.07253970853119371,Module 0,['HPA:0400051']
604,TF,TF:M02070_1,Factor: TEL1; motif: CNCGGAANNN; match class: 1,1.6626613215714016e-16,True,Factor: TEL1; motif: CNCGGAANNN; match class: 1,4988,826,322,20045,0.3898305084745763,0.06455493183640738,Module 0,['TF:M02070']
605,TF,TF:M01165,Factor: Elk-1; motif: RACCGGAAGTR,1.7931751204432493e-16,True,Factor: Elk-1; motif: RACCGGAAGTR,7907,826,453,20045,0.5484261501210653,0.057291007967623625,Module 0,['TF:M00000']
606,TF,TF:M12599_1,Factor: E2F4; motif: YCCCGCCNCNNSSNNSNN; match class: 1,1.8090553174682724e-16,True,Factor: E2F4; motif: YCCCGCCNCNNSSNNSNN; match class: 1,16076,826,756,20045,0.9152542372881356,0.047026623538193583,Module 0,['TF:M12599']
607,TF,TF:M11419,Factor: ER81; motif: NNCCGGAWGYN,2.0293014205631157e-16,True,Factor: ER81; motif: NNCCGGAWGYN,5831,826,361,20045,0.437046004842615,0.06191047847710513,Module 0,['TF:M00000']
608,GO:BP,GO:0006364,rRNA processing,2.127846860939697e-16,True,"""Any process involved in the conversion of a primary ribosomal RNA (rRNA) transcript into one or more mature rRNA molecules."" [GOC:curators]",224,105,20,21031,0.19047619047619047,0.08928571428571429,Module 3,"['GO:0016072', 'GO:0034470', 'GO:0042254']"
609,GO:BP,GO:0002253,activation of immune response,2.281678495893087e-16,True,"""Any process that initiates an immune response."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",531,226,37,21031,0.16371681415929204,0.0696798493408663,Module 1,"['GO:0002376', 'GO:0050778']"
610,HPA,HPA:0620000,vagina,2.3343852088270708e-16,True,vagina,6000,612,437,11019,0.7140522875816994,0.07283333333333333,Module 0,['HPA:0000000']
611,HPA,HPA:0620221,vagina; squamous epithelial cells[≥Low],2.3343852088270708e-16,True,vagina; squamous epithelial cells[≥Low],6000,612,437,11019,0.7140522875816994,0.07283333333333333,Module 0,['HPA:0620000']
612,TF,TF:M13138,Factor: ETV4; motif: NNCCGGAAGYNNN,2.3794053046397296e-16,True,Factor: ETV4; motif: NNCCGGAAGYNNN,8389,826,473,20045,0.572639225181598,0.056383359160805814,Module 0,['TF:M00000']
613,TF,TF:M02053,Factor: ELF1; motif: NCCGGAARTN,2.422635935363852e-16,True,Factor: ELF1; motif: NCCGGAARTN,6166,826,376,20045,0.4552058111380145,0.06097956535841713,Module 0,['TF:M00000']
614,HPA,HPA:0100132,cerebral cortex; neuronal cells[≥Medium],2.9044252192701476e-16,True,cerebral cortex; neuronal cells[≥Medium],4996,612,383,11019,0.6258169934640523,0.0766613290632506,Module 0,['HPA:0100131']
615,GO:BP,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,2.910329737915883e-16,True,"""The process in which an antigen-presenting cell expresses antigen (peptide or polysaccharide) on its cell surface in association with an MHC class II protein complex."" [GOC:add, ISBN:0781735149, PMID:15531770, PMID:15771591, PMID:16153240]",36,15,8,21031,0.5333333333333333,0.2222222222222222,Module 6,['GO:0019882']
616,HPA,HPA:0500651,soft tissue 1; fibroblasts[≥Low],3.054023716542749e-16,True,soft tissue 1; fibroblasts[≥Low],4238,612,340,11019,0.5555555555555556,0.08022652194431336,Module 0,['HPA:0500000']
617,HPA,HPA:0050011,breast; adipocytes[≥Low],3.120283824740857e-16,True,breast; adipocytes[≥Low],2781,612,251,11019,0.41013071895424835,0.09025530384753686,Module 0,['HPA:0050000']
618,HPA,HPA:0570731,testis; Leydig cells[≥Low],3.255309483543512e-16,True,testis; Leydig cells[≥Low],7157,612,494,11019,0.8071895424836601,0.06902333379907782,Module 0,['HPA:0570000']
619,TF,TF:M09901_1,Factor: nerf; motif: NNNCCGGAAGTGN; match class: 1,3.5839886501976336e-16,True,Factor: nerf; motif: NNNCCGGAAGTGN; match class: 1,1399,826,132,20045,0.15980629539951574,0.0943531093638313,Module 0,['TF:M09901']
620,GO:BP,GO:0050778,positive regulation of immune response,3.985008684341966e-16,True,"""Any process that activates or increases the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus."" [GOC:ai]",718,226,42,21031,0.18584070796460178,0.0584958217270195,Module 1,"['GO:0002684', 'GO:0006955', 'GO:0048584', 'GO:0050776']"
621,GO:MF,GO:0140662,ATP-dependent protein folding chaperone,4.137007127131287e-16,True,"""Binding to a protein or a protein-containing complex to assist the protein folding process, driven by ATP hydrolysis."" [PMID:27365453]",31,20,8,20212,0.4,0.25806451612903225,Module 9,"['GO:0044183', 'GO:0140657']"
622,GO:BP,GO:0070887,cellular response to chemical stimulus,4.361799648680956e-16,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemical stimulus."" [GOC:mah]",2683,215,79,21031,0.3674418604651163,0.029444651509504285,Module 2,"['GO:0042221', 'GO:0051716']"
623,TF,TF:M01078_1,Factor: c-Ets-1; motif: NNNRCCGGAWRYNNNN; match class: 1,4.371579675464401e-16,True,Factor: c-Ets-1; motif: NNNRCCGGAWRYNNNN; match class: 1,2497,826,195,20045,0.2360774818401937,0.07809371245494594,Module 0,['TF:M01078']
624,GO:BP,GO:0002478,antigen processing and presentation of exogenous peptide antigen,4.700573652445418e-16,True,"""The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell."" [GOC:add, ISBN:0781735149]",38,15,8,21031,0.5333333333333333,0.21052631578947367,Module 6,"['GO:0019884', 'GO:0048002']"
625,GO:BP,GO:0002501,peptide antigen assembly with MHC protein complex,4.939963630390677e-16,True,"""The binding of a peptide to the antigen binding groove of an MHC protein complex."" [GOC:add, ISBN:0781735149, PMID:15771591]",17,15,7,21031,0.4666666666666667,0.4117647058823529,Module 6,"['GO:0002396', 'GO:0048002', 'GO:0065003']"
626,GO:BP,GO:0002396,MHC protein complex assembly,4.939963630390677e-16,True,"""The aggregation, arrangement and bonding together of a set of components to form an MHC protein complex."" [GOC:add, ISBN:0781735149, PMID:15771591, PMID:15928678]",17,15,7,21031,0.4666666666666667,0.4117647058823529,Module 6,['GO:0065003']
627,TF,TF:M11414,Factor: GABP-alpha; motif: NACCGGAAGTN,5.287879376296642e-16,True,Factor: GABP-alpha; motif: NACCGGAAGTN,2988,826,221,20045,0.2675544794188862,0.07396251673360107,Module 0,['TF:M00000']
628,REAC,REAC:R-HSA-168249,Innate Immune System,5.87166374436055e-16,True,Innate Immune System,1101,173,60,10842,0.3468208092485549,0.05449591280653951,Module 2,['REAC:R-HSA-168256']
629,HPA,HPA:0490000,smooth muscle,5.926673282893785e-16,True,smooth muscle,5454,612,407,11019,0.6650326797385621,0.07462412907957462,Module 0,['HPA:0000000']
630,HPA,HPA:0490691,smooth muscle; smooth muscle cells[≥Low],5.926673282893785e-16,True,smooth muscle; smooth muscle cells[≥Low],5454,612,407,11019,0.6650326797385621,0.07462412907957462,Module 0,['HPA:0490000']
631,GO:CC,GO:0140535,intracellular protein-containing complex,5.937851337127695e-16,True,"""A protein-containing complex located intracellularly."" [GOC:pg]",951,813,94,22097,0.11562115621156212,0.09884332281808622,Module 0,['GO:0032991']
632,TF,TF:M02069,Factor: Erm; motif: ACCGGAAGTN,5.959365212803193e-16,True,Factor: Erm; motif: ACCGGAAGTN,7049,826,414,20045,0.5012106537530266,0.058731734997872036,Module 0,['TF:M00000']
633,REAC,REAC:R-HSA-6798695,Neutrophil degranulation,5.95955907907271e-16,True,Neutrophil degranulation,476,173,40,10842,0.23121387283236994,0.08403361344537816,Module 2,['REAC:R-HSA-168249']
634,GO:CC,GO:0030134,COPII-coated ER to Golgi transport vesicle,6.29517892800189e-16,True,"""A vesicle with a coat formed of the COPII coat complex proteins. The COPII coat complex is formed by the Sec23p/Sec24p and the Sec13p/Sec31p heterodimers. COPII-associated vesicles transport proteins from the rough endoplasmic reticulum to the Golgi apparatus (anterograde transport)."" [PMID:11252894, PMID:17499046, PMID:22160157, PMID:8004676, Wikipedia:COPII]",89,17,9,22097,0.5294117647058824,0.10112359550561797,Module 6,['GO:0030135']
635,TF,TF:M08377_1,Factor: meis1:Elf-1; motif: NTGCCGGAAGTN; match class: 1,6.476134966131492e-16,True,Factor: meis1:Elf-1; motif: NTGCCGGAAGTN; match class: 1,5157,826,328,20045,0.39709443099273606,0.0636028698855924,Module 0,['TF:M08377']
636,HPA,HPA:0301361,lung; alveolar cells type I[≥Low],6.514347075831285e-16,True,lung; alveolar cells type I[≥Low],1091,612,131,11019,0.21405228758169934,0.12007332722273144,Module 0,['HPA:0300000']
637,HPA,HPA:0530723,spleen; cells in white pulp[High],7.229199567090248e-16,True,spleen; cells in white pulp[High],847,612,111,11019,0.18137254901960784,0.13105076741440377,Module 0,['HPA:0530722']
638,GO:BP,GO:0051607,defense response to virus,7.338959494056695e-16,True,"""Reactions triggered in response to the presence of a virus that act to protect the cell or organism."" [GOC:ai]",312,34,15,21031,0.4411764705882353,0.04807692307692308,Module 7,"['GO:0009615', 'GO:0140546']"
639,TF,TF:M07415,Factor: Elf-1; motif: AWCCCGGAAGTN,7.982835325443817e-16,True,Factor: Elf-1; motif: AWCCCGGAAGTN,8149,826,461,20045,0.5581113801452785,0.056571358448889435,Module 0,['TF:M00000']
640,GO:BP,GO:0007166,cell surface receptor signaling pathway,8.008661288573423e-16,True,"""The series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription."" [GOC:bf, GOC:mah, GOC:pr, GOC:signaling]",2799,226,83,21031,0.3672566371681416,0.02965344765987853,Module 1,['GO:0007165']
641,GO:BP,GO:0009615,response to virus,8.562131012589931e-16,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus."" [GOC:hb]",406,34,16,21031,0.47058823529411764,0.03940886699507389,Module 7,['GO:0051707']
642,HPA,HPA:0291162,liver; cholangiocytes[≥Medium],9.540571563464935e-16,True,liver; cholangiocytes[≥Medium],1964,612,195,11019,0.31862745098039214,0.09928716904276985,Module 0,['HPA:0291161']
643,GO:BP,GO:0051716,cellular response to stimulus,9.890079735294797e-16,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus by a cell and ends with a change in state or activity or the cell."" [GOC:bf, GOC:jl]",7394,226,145,21031,0.6415929203539823,0.019610494995942657,Module 1,"['GO:0009987', 'GO:0050896']"
644,TF,TF:M02072,Factor: Pet-1; motif: ACCGGAWRTN,1.0464174018152354e-15,True,Factor: Pet-1; motif: ACCGGAWRTN,2443,826,191,20045,0.23123486682808717,0.0781825624232501,Module 0,['TF:M00000']
645,GO:BP,GO:0046034,ATP metabolic process,1.05853497325334e-15,True,"""The chemical reactions and pathways involving ATP, adenosine triphosphate, a universally important coenzyme and enzyme regulator."" [GOC:go_curators]",223,787,43,21031,0.054637865311308764,0.19282511210762332,Module 0,"['GO:0009150', 'GO:0009205']"
646,HPA,HPA:0130201,colon; endothelial cells[≥Low],1.0705434248042515e-15,True,colon; endothelial cells[≥Low],5675,612,418,11019,0.6830065359477124,0.07365638766519823,Module 0,['HPA:0130000']
647,HPA,HPA:0471442,skin 2; fibrohistiocytic cells[≥Medium],1.0754728663755724e-15,True,skin 2; fibrohistiocytic cells[≥Medium],833,166,50,11019,0.30120481927710846,0.060024009603841535,Module 2,['HPA:0471441']
648,TF,TF:M13138_1,Factor: ETV4; motif: NNCCGGAAGYNNN; match class: 1,1.089080092707311e-15,True,Factor: ETV4; motif: NNCCGGAAGYNNN; match class: 1,2499,826,194,20045,0.23486682808716708,0.07763105242096839,Module 0,['TF:M13138']
649,GO:BP,GO:0098542,defense response to other organism,1.1038409021041818e-15,True,"""Reactions triggered in response to the presence of another organism that act to protect the cell or organism from damage caused by that organism."" [GOC:dos]",1220,215,52,21031,0.24186046511627907,0.04262295081967213,Module 2,"['GO:0006952', 'GO:0051707']"
650,GO:BP,GO:0002521,leukocyte differentiation,1.1102804215396351e-15,True,"""The process in which a relatively unspecialized hemopoietic precursor cell acquires the specialized features of a leukocyte. A leukocyte is an achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue."" [CL:0000738, GOC:add, PMID:16551264]",627,226,39,21031,0.17256637168141592,0.06220095693779904,Module 1,"['GO:0030097', 'GO:0030154']"
651,TF,TF:M11656_1,Factor: HSF1; motif: RGAANRTTCYRGAAN; match class: 1,1.170605094314855e-15,True,Factor: HSF1; motif: RGAANRTTCYRGAAN; match class: 1,220,21,12,20045,0.5714285714285714,0.05454545454545454,Module 9,['TF:M11656']
652,TF,TF:M12273,Factor: YY1; motif: GGCSGCCATTTTGN,1.239232197466737e-15,True,Factor: YY1; motif: GGCSGCCATTTTGN,6265,826,378,20045,0.4576271186440678,0.060335195530726256,Module 0,['TF:M00000']
653,TF,TF:M11439,Factor: Net; motif: NRCCGGAAGTN,1.3546068720686979e-15,True,Factor: Net; motif: NRCCGGAAGTN,2321,826,184,20045,0.22276029055690072,0.07927617406290392,Module 0,['TF:M00000']
654,TF,TF:M00803,Factor: E2F; motif: GGCGSG,1.359339564442283e-15,True,Factor: E2F; motif: GGCGSG,13566,826,671,20045,0.8123486682808717,0.04946189001916556,Module 0,['TF:M00000']
655,KEGG,KEGG:05416,Viral myocarditis,1.4398779115157055e-15,True,Viral myocarditis,63,13,9,8484,0.6923076923076923,0.14285714285714285,Module 6,['KEGG:00000']
656,GO:CC,GO:0031410,cytoplasmic vesicle,1.4413961728620227e-15,True,"""A vesicle found in the cytoplasm of a cell."" [GOC:ai, GOC:mah, GOC:vesicles]",2513,813,177,22097,0.2177121771217712,0.07043374452845205,Module 0,"['GO:0005737', 'GO:0097708']"
657,HPA,HPA:0100121,cerebral cortex; glial cells[≥Low],1.4517261558815488e-15,True,cerebral cortex; glial cells[≥Low],4927,612,377,11019,0.6160130718954249,0.07651715039577836,Module 0,['HPA:0100000']
658,HPA,HPA:0080131,caudate; neuronal cells[≥Low],1.4985393332805868e-15,True,caudate; neuronal cells[≥Low],6163,612,443,11019,0.7238562091503268,0.07188057764075938,Module 0,['HPA:0080000']
659,GO:BP,GO:0019538,protein metabolic process,1.556677793546894e-15,True,"""The chemical reactions and pathways involving a protein. Includes protein modification."" [GOC:ma]",4912,787,292,21031,0.3710292249047014,0.059446254071661236,Module 0,"['GO:0043170', 'GO:0044238', 'GO:1901564']"
660,TF,TF:M11531,Factor: E2F-2; motif: GCGCGCGCGYW,1.673778152816642e-15,True,Factor: E2F-2; motif: GCGCGCGCGYW,13659,826,674,20045,0.8159806295399515,0.04934475437440516,Module 0,['TF:M00000']
661,GO:CC,GO:0097708,intracellular vesicle,1.7631706174614374e-15,True,"""Any vesicle that is part of the intracellular region."" [GOC:vesicles]",2518,813,177,22097,0.2177121771217712,0.07029388403494838,Module 0,"['GO:0031982', 'GO:0043231']"
662,HPA,HPA:0300201,lung; endothelial cells[≥Low],1.833003240266368e-15,True,lung; endothelial cells[≥Low],798,612,106,11019,0.17320261437908496,0.13283208020050125,Module 0,['HPA:0300000']
663,GO:CC,GO:0099503,secretory vesicle,1.835116438443165e-15,True,"""A cytoplasmic, membrane bound vesicle that is capable of fusing to the plasma membrane to release its contents into the extracellular space."" [GOC:dos]",1069,221,47,22097,0.21266968325791855,0.04396632366697849,Module 2,['GO:0031410']
664,HP,HP:0009602,Abnormality of thumb phalanx,1.85228121420216e-15,True,A structural anomaly of one or more phalanges of the thumb.,198,44,21,4958,0.4772727272727273,0.10606060606060606,Module 3,['HP:0001172']
665,GO:CC,GO:0099503,secretory vesicle,1.9789671938191734e-15,True,"""A cytoplasmic, membrane bound vesicle that is capable of fusing to the plasma membrane to release its contents into the extracellular space."" [GOC:dos]",1069,813,100,22097,0.12300123001230012,0.09354536950420954,Module 0,['GO:0031410']
666,TF,TF:M11420,Factor: ER81; motif: NACCGGAAGTN,1.981982114803481e-15,True,Factor: ER81; motif: NACCGGAAGTN,3291,826,235,20045,0.2845036319612591,0.07140686721361289,Module 0,['TF:M00000']
667,HP,HP:0000294,Low anterior hairline,1.9979592961342936e-15,True,"Distance between the hairline (trichion) and the glabella (the most prominent point on the frontal bone above the root of the nose), in the midline, more than two SD below the mean. Alternatively, an apparently decreased distance between the hairline and the glabella.",144,44,19,4958,0.4318181818181818,0.13194444444444445,Module 3,['HP:0000599']
668,TF,TF:M02056,Factor: ELF4; motif: NCCGGAARTN,2.00727101553626e-15,True,Factor: ELF4; motif: NCCGGAARTN,5450,826,340,20045,0.4116222760290557,0.062385321100917435,Module 0,['TF:M00000']
669,HPA,HPA:0461451,skin 1; hair follicles[≥Low],2.1014391084194843e-15,True,skin 1; hair follicles[≥Low],367,612,66,11019,0.10784313725490197,0.17983651226158037,Module 0,['HPA:0460000']
670,REAC,REAC:R-HSA-913531,Interferon Signaling,2.1049819480348467e-15,True,Interferon Signaling,193,28,14,10842,0.5,0.07253886010362694,Module 7,['REAC:R-HSA-1280215']
671,TF,TF:M09900_1,Factor: Elf-1; motif: NNANCCGGAAGTGS; match class: 1,2.1095096118055128e-15,True,Factor: Elf-1; motif: NNANCCGGAAGTGS; match class: 1,1187,826,117,20045,0.14164648910411623,0.09856781802864364,Module 0,['TF:M09900']
672,HPA,HPA:0480051,small intestine; glandular cells[≥Low],2.3195413435397518e-15,True,small intestine; glandular cells[≥Low],7080,612,488,11019,0.7973856209150327,0.06892655367231638,Module 0,['HPA:0480000']
673,HPA,HPA:0530000,spleen,2.3497600735372698e-15,True,spleen,5893,185,154,11019,0.8324324324324325,0.026132699813337858,Module 1,['HPA:0000000']
674,HP,HP:0001909,Leukemia,2.5118166473169958e-15,True,A cancer of the blood and bone marrow characterized by an abnormal proliferation of leukocytes.,172,44,20,4958,0.45454545454545453,0.11627906976744186,Module 3,"['HP:0001881', 'HP:0004377']"
675,GO:BP,GO:0009165,nucleotide biosynthetic process,2.531901783577106e-15,True,"""The chemical reactions and pathways resulting in the formation of nucleotides, any nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic-nucleotides (nucleoside cyclic phosphates)."" [GOC:go_curators]",295,787,49,21031,0.062261753494282084,0.16610169491525423,Module 0,"['GO:0009117', 'GO:1901293']"
676,TF,TF:M01258,Factor: GABP; motif: CACTTCCGGNNN,2.8538151105121786e-15,True,Factor: GABP; motif: CACTTCCGGNNN,2915,826,215,20045,0.2602905569007264,0.07375643224699828,Module 0,['TF:M00000']
677,GO:BP,GO:0019884,antigen processing and presentation of exogenous antigen,3.0144936797654534e-15,True,"""The process in which an antigen-presenting cell expresses antigen (peptide or lipid) of exogenous origin on its cell surface in association with an MHC protein complex."" [GOC:add, ISBN:0781735149, PMID:15771591, PMID:15928678]",47,15,8,21031,0.5333333333333333,0.1702127659574468,Module 6,['GO:0019882']
678,TF,TF:M11415,Factor: GABP-alpha; motif: NRCCGGAAGTN,3.0146999641913926e-15,True,Factor: GABP-alpha; motif: NRCCGGAAGTN,3341,826,237,20045,0.28692493946731235,0.0709368452559114,Module 0,['TF:M00000']
679,HPA,HPA:0130052,colon; glandular cells[≥Medium],3.1225151954784037e-15,True,colon; glandular cells[≥Medium],5988,612,433,11019,0.7075163398692811,0.07231128924515698,Module 0,['HPA:0130051']
680,TF,TF:M03981,Factor: ETV3; motif: ACCGGAAGTN,3.1553680795190802e-15,True,Factor: ETV3; motif: ACCGGAAGTN,2376,826,186,20045,0.22518159806295399,0.07828282828282829,Module 0,['TF:M00000']
681,GO:BP,GO:1901293,nucleoside phosphate biosynthetic process,3.3857329254054234e-15,True,"""The chemical reactions and pathways resulting in the formation of a nucleoside phosphate."" [GOC:TermGenie]",297,787,49,21031,0.062261753494282084,0.16498316498316498,Module 0,"['GO:0006753', 'GO:0034654', 'GO:0090407']"
682,GO:BP,GO:0140546,defense response to symbiont,3.814372419616071e-15,True,"""Reactions triggered in response to the presence of a symbiont that act to protect or prevent damage to the host."" [GOC:pg]",1113,215,49,21031,0.22790697674418606,0.0440251572327044,Module 2,['GO:0098542']
683,HPA,HPA:0080121,caudate; glial cells[≥Low],3.820066290749287e-15,True,caudate; glial cells[≥Low],4577,612,356,11019,0.5816993464052288,0.07778020537469958,Module 0,['HPA:0080000']
684,TF,TF:M02067_1,Factor: ER71; motif: ACCGGAARYN; match class: 1,3.851212901585268e-15,True,Factor: ER71; motif: ACCGGAARYN; match class: 1,1656,826,145,20045,0.17554479418886199,0.08756038647342995,Module 0,['TF:M02067']
685,GO:CC,GO:0005615,extracellular space,3.854110826196944e-15,True,"""That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid."" [ISBN:0198547684]",3303,105,53,22097,0.5047619047619047,0.01604601877081441,Module 3,"['GO:0005576', 'GO:0110165']"
686,HPA,HPA:0320102,nasopharynx; respiratory epithelial cells[≥Medium],4.006885728242167e-15,True,nasopharynx; respiratory epithelial cells[≥Medium],4773,612,367,11019,0.5996732026143791,0.0768908443327048,Module 0,['HPA:0320101']
687,HP,HP:0000782,Abnormal scapula morphology,4.010268983462335e-15,True,"Any abnormality of the scapula, also known as the shoulder blade.",176,44,20,4958,0.45454545454545453,0.11363636363636363,Module 3,['HP:0000765']
688,HP,HP:0001680,Coarctation of aorta,4.437303392016461e-15,True,Coarctation of the aorta is a narrowing or constriction of a segment of the aorta.,150,44,19,4958,0.4318181818181818,0.12666666666666668,Module 3,['HP:0001679']
689,HPA,HPA:0301372,lung; alveolar cells type II[≥Medium],4.766451129589363e-15,True,lung; alveolar cells type II[≥Medium],1233,612,140,11019,0.22875816993464052,0.11354420113544202,Module 0,['HPA:0301371']
690,GO:BP,GO:0009144,purine nucleoside triphosphate metabolic process,5.087188289181106e-15,True,"""The chemical reactions and pathways involving purine nucleoside triphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",254,787,45,21031,0.05717916137229987,0.17716535433070865,Module 0,['GO:0009141']
691,GO:BP,GO:0009199,ribonucleoside triphosphate metabolic process,5.087188289181106e-15,True,"""The chemical reactions and pathways involving a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",254,787,45,21031,0.05717916137229987,0.17716535433070865,Module 0,['GO:0009141']
692,REAC,REAC:R-HSA-69278,"Cell Cycle, Mitotic",5.089283757055229e-15,True,"Cell Cycle, Mitotic",547,59,25,10842,0.423728813559322,0.04570383912248629,Module 5,['REAC:R-HSA-1640170']
693,GO:BP,GO:0016072,rRNA metabolic process,5.1752233368755064e-15,True,"""The chemical reactions and pathways involving rRNA, ribosomal RNA, a structural constituent of ribosomes."" [ISBN:0198506732]",263,105,20,21031,0.19047619047619047,0.07604562737642585,Module 3,['GO:0034660']
694,WP,WP:WP623,Oxidative phosphorylation,5.861679674808915e-15,True,Oxidative phosphorylation,60,472,26,8286,0.05508474576271186,0.43333333333333335,Module 0,['WP:000000']
695,GO:MF,GO:0015399,primary active transmembrane transporter activity,6.057413213828474e-15,True,"""Enables the transfer of a solute from one side of a membrane to the other, up the solute's concentration gradient, by binding the solute and undergoing a series of conformational changes. Transport works equally well in either direction and is powered by a primary energy source. Primary energy sources known to be coupled to transport are chemical such as ATP hydrolysis, redox energy and photon energy."" [GOC:mtg_transport, PMID:31613498]",166,808,37,20212,0.04579207920792079,0.22289156626506024,Module 0,['GO:0022804']
696,GO:CC,GO:0005684,U2-type spliceosomal complex,6.144499028331931e-15,True,"""Any spliceosomal complex that forms during the splicing of a messenger RNA primary transcript to excise an intron that has canonical consensus sequences near the 5' and 3' ends."" [GOC:krc, GOC:mah, PMID:11343900]",92,813,27,22097,0.033210332103321034,0.29347826086956524,Module 0,['GO:0005681']
697,GO:MF,GO:0023026,MHC class II protein complex binding,6.177378711153466e-15,True,"""Binding to a class II major histocompatibility complex."" [GOC:mtg_signal, GOC:vw]",24,17,7,20212,0.4117647058823529,0.2916666666666667,Module 6,['GO:0023023']
698,HP,HP:0000980,Pallor,6.526302713624395e-15,True,Abnormally pale skin.,153,44,19,4958,0.4318181818181818,0.12418300653594772,Module 3,['HP:0011121']
699,TF,TF:M11421,Factor: ER81; motif: NACCGGAAGTN,7.050476216490259e-15,True,Factor: ER81; motif: NACCGGAAGTN,2394,826,186,20045,0.22518159806295399,0.07769423558897243,Module 0,['TF:M00000']
700,GO:BP,GO:0002250,adaptive immune response,7.565671058816639e-15,True,"""An immune response mediated by cells expressing specific receptors for antigens produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory)."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",739,226,41,21031,0.18141592920353983,0.05548037889039242,Module 1,['GO:0006955']
701,TF,TF:M11392_1,Factor: Erg; motif: NACCGGAARYN; match class: 1,7.67328141963332e-15,True,Factor: Erg; motif: NACCGGAARYN; match class: 1,3307,826,234,20045,0.28329297820823246,0.07075899606894466,Module 0,['TF:M11392']
702,GO:MF,GO:0008137,NADH dehydrogenase (ubiquinone) activity,7.84775361597701e-15,True,"""Catalysis of the reaction: NADH + ubiquinone + 5 H+(in) = NAD+ + ubiquinol + 4 H+(out)."" [RHEA:29091]",41,808,20,20212,0.024752475247524754,0.4878048780487805,Module 0,"['GO:0009055', 'GO:0015453', 'GO:0050136']"
703,HP,HP:0001877,Abnormal erythrocyte morphology,8.447751905657504e-15,True,Any structural abnormality of erythrocytes (red-blood cells).,672,44,31,4958,0.7045454545454546,0.046130952380952384,Module 3,['HP:0001871']
704,HPA,HPA:0600433,tonsil; germinal center cells[High],8.479280411081723e-15,True,tonsil; germinal center cells[High],1228,612,139,11019,0.22712418300653595,0.11319218241042345,Module 0,['HPA:0600432']
705,HPA,HPA:0471441,skin 2; fibrohistiocytic cells[≥Low],9.158146162089981e-15,True,skin 2; fibrohistiocytic cells[≥Low],1021,166,54,11019,0.3253012048192771,0.05288932419196866,Module 2,['HPA:0470000']
706,HP,HP:0001903,Anemia,9.410011753948292e-15,True,A reduction in erythrocytes volume or hemoglobin concentration.,614,44,30,4958,0.6818181818181818,0.048859934853420196,Module 3,['HP:0001877']
707,GO:BP,GO:0009205,purine ribonucleoside triphosphate metabolic process,9.827650799224846e-15,True,"""The chemical reactions and pathways involving purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",247,787,44,21031,0.05590851334180432,0.17813765182186234,Module 0,"['GO:0009144', 'GO:0009199']"
708,HP,HP:0007700,Ocular anterior segment dysgenesis,1.0301487256610855e-14,True,Abnormal development (dysgenesis) of the anterior segment of the eye globe. These structures are mainly of mesenchymal origin.,322,44,24,4958,0.5454545454545454,0.07453416149068323,Module 3,['HP:0004328']
709,GO:BP,GO:0009141,nucleoside triphosphate metabolic process,1.0555752847575475e-14,True,"""The chemical reactions and pathways involving a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",270,787,46,21031,0.05844980940279543,0.17037037037037037,Module 0,['GO:0006753']
710,TF,TF:M02073_1,Factor: Fli-1; motif: ACCGGAAGYN; match class: 1,1.0691853905991934e-14,True,Factor: Fli-1; motif: ACCGGAAGYN; match class: 1,1506,826,135,20045,0.16343825665859565,0.08964143426294821,Module 0,['TF:M02073']
711,TF,TF:M11654_1,Factor: HSF1; motif: RGAANRTTCYRGAAN; match class: 1,1.154269578446623e-14,True,Factor: HSF1; motif: RGAANRTTCYRGAAN; match class: 1,111,21,10,20045,0.47619047619047616,0.09009009009009009,Module 9,['TF:M11654']
712,GO:BP,GO:0012501,programmed cell death,1.2169591125906995e-14,True,"""A process which begins when a cell receives an internal or external signal and activates a series of biochemical events (signaling pathway). The process ends with the death of the cell."" [GOC:lr, GOC:mtg_apoptosis]",1984,215,65,21031,0.3023255813953488,0.03276209677419355,Module 2,['GO:0008219']
713,HPA,HPA:0320101,nasopharynx; respiratory epithelial cells[≥Low],1.2275644449605883e-14,True,nasopharynx; respiratory epithelial cells[≥Low],5794,612,421,11019,0.6879084967320261,0.07266137383500172,Module 0,['HPA:0320000']
714,GO:CC,GO:0005764,lysosome,1.2482838350647006e-14,True,"""A small lytic vacuole that has cell cycle-independent morphology found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions."" [GOC:mah, ISBN:0198506732]",762,221,39,22097,0.17647058823529413,0.051181102362204724,Module 2,['GO:0000323']
715,GO:CC,GO:0000323,lytic vacuole,1.2482838350647006e-14,True,"""A vacuole that is maintained at an acidic pH and which contains degradative enzymes, including a wide variety of acid hydrolases."" [GOC:krc]",762,221,39,22097,0.17647058823529413,0.051181102362204724,Module 2,['GO:0005773']
716,GO:CC,GO:0071011,precatalytic spliceosome,1.3393353147621169e-14,True,"""A spliceosomal complex that is formed by the recruitment of a preassembled U5-containing tri-snRNP to the prespliceosome. Although all 5 snRNPs are present, the precatalytic spliceosome is catalytically inactive. The precatalytic spliceosome includes many proteins in addition to those found in the associated snRNPs."" [GOC:ab, GOC:krc, GOC:mah, PMID:18322460, PMID:19239890]",52,813,21,22097,0.025830258302583026,0.40384615384615385,Module 0,['GO:0005681']
717,GO:BP,GO:0008219,cell death,1.3478054242422997e-14,True,"""Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538)."" [GOC:mah, GOC:mtg_apoptosis, PMID:25236395]",1988,215,65,21031,0.3023255813953488,0.032696177062374245,Module 2,['GO:0009987']
718,GO:MF,GO:0050136,NADH dehydrogenase (quinone) activity,1.4425746347439574e-14,True,"""Catalysis of the reaction: NADH + H+ + a quinone = NAD+ + a quinol."" [EC:1.6.5.11, GOC:mah]",42,808,20,20212,0.024752475247524754,0.47619047619047616,Module 0,"['GO:0003954', 'GO:0003955']"
719,GO:BP,GO:0048584,positive regulation of response to stimulus,1.4780165476346747e-14,True,"""Any process that activates, maintains or increases the rate of a response to a stimulus. Response to stimulus is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus."" [GOC:jid]",2274,226,72,21031,0.3185840707964602,0.0316622691292876,Module 1,"['GO:0048518', 'GO:0048583', 'GO:0050896']"
720,REAC,REAC:R-HSA-3371568,Attenuation phase,1.5488354071836355e-14,True,Attenuation phase,14,19,7,10842,0.3684210526315789,0.5,Module 9,['REAC:R-HSA-3371571']
721,HPA,HPA:0400051,rectum; glandular cells[≥Low],1.6072345308735936e-14,True,rectum; glandular cells[≥Low],7067,612,485,11019,0.7924836601307189,0.06862883826234611,Module 0,['HPA:0400000']
722,HPA,HPA:0310441,lymph node; non-germinal center cells[≥Low],1.614611785288508e-14,True,lymph node; non-germinal center cells[≥Low],6061,185,155,11019,0.8378378378378378,0.025573337733047354,Module 1,['HPA:0310000']
723,HPA,HPA:0550053,stomach 2; glandular cells[High],1.679133489388673e-14,True,stomach 2; glandular cells[High],2431,612,223,11019,0.36437908496732024,0.09173179761415055,Module 0,['HPA:0550052']
724,GO:BP,GO:0044249,cellular biosynthetic process,1.7448360279205506e-14,True,"""The chemical reactions and pathways resulting in the formation of substances, carried out by individual cells."" [GOC:jl]",10565,105,94,21031,0.8952380952380953,0.00889730241362991,Module 3,"['GO:0009058', 'GO:0044237']"
725,GO:BP,GO:0006518,peptide metabolic process,1.7867678834242406e-14,True,"""The chemical reactions and pathways involving peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another."" [GOC:go_curators]",911,787,91,21031,0.1156289707750953,0.09989023051591657,Module 0,"['GO:0043603', 'GO:1901564']"
726,WP,WP:WP4217,Ebola virus infection in host,1.8239759484180842e-14,True,Ebola virus infection in host,128,13,10,8286,0.7692307692307693,0.078125,Module 6,['WP:000000']
727,GO:BP,GO:0006412,translation,1.896524132405564e-14,True,"""The cellular metabolic process in which a protein is formed, using the sequence of a mature mRNA or circRNA molecule to specify the sequence of amino acids in a polypeptide chain. Translation is mediated by the ribosome, and begins with the formation of a ternary complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, which subsequently associates with the small subunit of the ribosome and an mRNA or circRNA. Translation ends with the release of a polypeptide chain from the ribosome."" [GOC:go_curators]",723,787,79,21031,0.10038119440914867,0.10926694329183956,Module 0,"['GO:0009059', 'GO:0010467', 'GO:0019538', 'GO:0043043']"
728,GO:BP,GO:0061077,chaperone-mediated protein folding,1.948361925751925e-14,True,"""The process of inhibiting aggregation and assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure that is dependent on interaction with a chaperone."" [GOC:dph, GOC:vw]",73,21,9,21031,0.42857142857142855,0.1232876712328767,Module 9,['GO:0006457']
729,GO:BP,GO:0042221,response to chemical,2.0217800910472567e-14,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemical stimulus."" [GOC:jl]",3957,215,95,21031,0.4418604651162791,0.024008086934546372,Module 2,['GO:0050896']
730,TF,TF:M11442,Factor: Net; motif: NACCGGAAGTN,2.036937715482744e-14,True,Factor: Net; motif: NACCGGAAGTN,2055,826,166,20045,0.2009685230024213,0.08077858880778589,Module 0,['TF:M00000']
731,TF,TF:M11433_1,Factor: Elk-1; motif: NRCCGGAAGTN; match class: 1,2.0369947126127006e-14,True,Factor: Elk-1; motif: NRCCGGAAGTN; match class: 1,2308,826,180,20045,0.2179176755447942,0.0779896013864818,Module 0,['TF:M11433']
732,TF,TF:M01165_1,Factor: Elk-1; motif: RACCGGAAGTR; match class: 1,2.039463362113378e-14,True,Factor: Elk-1; motif: RACCGGAAGTR; match class: 1,2217,826,175,20045,0.211864406779661,0.07893549842129004,Module 0,['TF:M01165']
733,HPA,HPA:0471471,skin 2; lymphocytes[≥Low],2.0973824461824393e-14,True,skin 2; lymphocytes[≥Low],802,69,30,11019,0.43478260869565216,0.03740648379052369,Module 5,['HPA:0470000']
734,HPA,HPA:0310000,lymph node,2.176164197484158e-14,True,lymph node,6530,185,161,11019,0.8702702702702703,0.02465543644716692,Module 1,['HPA:0000000']
735,HPA,HPA:0471441,skin 2; fibrohistiocytic cells[≥Low],2.3538321801547624e-14,True,skin 2; fibrohistiocytic cells[≥Low],1021,69,33,11019,0.4782608695652174,0.03232125367286973,Module 5,['HPA:0470000']
736,TF,TF:M08525_1,Factor: E2F-1:HES-7; motif: GGCRCGTGSYNNWNGGCGCSM; match class: 1,2.454848729273676e-14,True,Factor: E2F-1:HES-7; motif: GGCRCGTGSYNNWNGGCGCSM; match class: 1,15663,826,738,20045,0.8934624697336562,0.04711741045776671,Module 0,['TF:M08525']
737,TF,TF:M03982_1,Factor: ETV4; motif: ACCGGAAGTN; match class: 1,2.4599882384199955e-14,True,Factor: ETV4; motif: ACCGGAAGTN; match class: 1,2059,826,166,20045,0.2009685230024213,0.08062166100048568,Module 0,['TF:M03982']
738,GO:BP,GO:0006458,'de novo' protein folding,2.5344869197591475e-14,True,"""The process of assisting in the folding of a nascent peptide chain into its correct tertiary structure."" [GOC:mb]",40,21,8,21031,0.38095238095238093,0.2,Module 9,['GO:0006457']
739,TF,TF:M10018,Factor: NRF-1; motif: CNSTGCGCATGCGCNNS,2.5493564824305293e-14,True,Factor: NRF-1; motif: CNSTGCGCATGCGCNNS,1865,826,155,20045,0.18765133171912832,0.08310991957104558,Module 0,['TF:M00000']
740,HP,HP:0000745,Diminished motivation,2.591317815448602e-14,True,"A reduction in goal-directed behavior, that is, motivation, is the determinant of behavior and adaptation that allows individuals to get started, be energized to perform a sustained and directed action.",636,44,30,4958,0.6818181818181818,0.04716981132075472,Module 3,['HP:5200275']
741,HPA,HPA:0440341,skeletal muscle; myocytes[≥Low],2.6282607738360195e-14,True,skeletal muscle; myocytes[≥Low],5909,612,426,11019,0.696078431372549,0.07209341682179726,Module 0,['HPA:0440000']
742,HPA,HPA:0440000,skeletal muscle,2.6282607738360195e-14,True,skeletal muscle,5909,612,426,11019,0.696078431372549,0.07209341682179726,Module 0,['HPA:0000000']
743,GO:BP,GO:0007165,signal transduction,2.6476531890135276e-14,True,"""The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell."" [GOC:go_curators, GOC:mtg_signaling_feb11]",5959,226,125,21031,0.5530973451327433,0.020976673938580298,Module 1,"['GO:0007154', 'GO:0009987', 'GO:0023052', 'GO:0050794', 'GO:0051716']"
744,TF,TF:M08213,Factor: Elk-1:TBR2; motif: TNRCACCGGAAGN,2.6677906281540744e-14,True,Factor: Elk-1:TBR2; motif: TNRCACCGGAAGN,6394,826,379,20045,0.45883777239709445,0.05927431967469503,Module 0,['TF:M00000']
745,HPA,HPA:0130051,colon; glandular cells[≥Low],2.8166870874763365e-14,True,colon; glandular cells[≥Low],6999,612,481,11019,0.7859477124183006,0.06872410344334905,Module 0,['HPA:0130000']
746,GO:CC,GO:0005730,nucleolus,2.989296765132855e-14,True,"""A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome."" [ISBN:0198506732]",2001,105,41,22097,0.3904761904761905,0.02048975512243878,Module 3,"['GO:0031981', 'GO:0043232']"
747,GO:BP,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,2.9965631638788784e-14,True,"""The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein."" [GOC:add, ISBN:0781735149, PMID:15771591]",28,15,7,21031,0.4666666666666667,0.25,Module 6,"['GO:0002478', 'GO:0002495']"
748,TF,TF:M00716_1,Factor: ZF5; motif: GSGCGCGR; match class: 1,3.019945796301841e-14,True,Factor: ZF5; motif: GSGCGCGR; match class: 1,14519,826,700,20045,0.847457627118644,0.048212686824161445,Module 0,['TF:M00716']
749,GO:BP,GO:0032101,regulation of response to external stimulus,3.085519015091e-14,True,"""Any process that modulates the frequency, rate or extent of a response to an external stimulus."" [GOC:mah]",1077,215,47,21031,0.2186046511627907,0.0436397400185701,Module 2,"['GO:0009605', 'GO:0048583']"
750,GO:BP,GO:1901576,organic substance biosynthetic process,3.3010642060413506e-14,True,"""The chemical reactions and pathways resulting in the formation of an organic substance, any molecular entity containing carbon."" [GOC:pr, GOC:TermGenie]",10646,105,94,21031,0.8952380952380953,0.00882960736426827,Module 3,"['GO:0009058', 'GO:0071704']"
751,HP,HP:0009997,Duplication of phalanx of hand,3.304069453882713e-14,True,"This term applies if one or more of the phalanges of the hand are either partially duplicated, depending on severity leading to a broad or bifid appearance of the phalanges, or completely duplicated.",227,44,21,4958,0.4772727272727273,0.09251101321585903,Module 3,"['HP:0004275', 'HP:0005918']"
752,TF,TF:M12275,Factor: YY1; motif: NGCCGCCATYTTGN,3.364665252164161e-14,True,Factor: YY1; motif: NGCCGCCATYTTGN,7080,826,409,20045,0.49515738498789347,0.057768361581920905,Module 0,['TF:M00000']
753,MIRNA,MIRNA:hsa-miR-652-3p,hsa-miR-652-3p,3.479072405183575e-14,True,hsa-miR-652-3p,162,104,18,14819,0.17307692307692307,0.1111111111111111,Module 3,['MIRNA:000000']
754,HP,HP:0009142,Duplication of bones involving the upper extremities,3.622444635925949e-14,True,Duplication of bones involving the upper extremities,228,44,21,4958,0.4772727272727273,0.09210526315789473,Module 3,['HP:0002817']
755,HP,HP:0004275,Duplication of hand bones,3.622444635925949e-14,True,Duplication of hand bones,228,44,21,4958,0.4772727272727273,0.09210526315789473,Module 3,"['HP:0005922', 'HP:0009142']"
756,HP,HP:5200275,Abnormal motivation,3.709771037825997e-14,True,"Behavioral patterns and/or energy/activity levels that are statistically uncommon within a particular culture, maladaptive, and result in personal distress and impairment in the individual's functioning.",644,44,30,4958,0.6818181818181818,0.046583850931677016,Module 3,['HP:0000708']
757,HPA,HPA:0100201,cerebral cortex; endothelial cells[≥Low],3.753988674942373e-14,True,cerebral cortex; endothelial cells[≥Low],4634,612,356,11019,0.5816993464052288,0.07682347863616745,Module 0,['HPA:0100000']
758,HPA,HPA:0290401,liver; hepatocytes[≥Low],3.824386583983236e-14,True,liver; hepatocytes[≥Low],5748,612,417,11019,0.6813725490196079,0.07254697286012526,Module 0,['HPA:0290000']
759,GO:BP,GO:0050896,response to stimulus,4.144810034601115e-14,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus and ends with a change in state or activity or the cell or organism."" [GOC:ai, GOC:bf]",8976,215,153,21031,0.7116279069767442,0.017045454545454544,Module 2,['GO:0008150']
760,HPA,HPA:0270362,kidney; cells in tubules[≥Medium],4.169994312806435e-14,True,kidney; cells in tubules[≥Medium],5826,612,421,11019,0.6879084967320261,0.07226227257123241,Module 0,['HPA:0270361']
761,HP,HP:0010972,Anemia of inadequate production,4.330574137426554e-14,True,A kind of anemia characterized by inadequate production of erythrocytes.,198,44,20,4958,0.45454545454545453,0.10101010101010101,Module 3,['HP:0001903']
762,GO:MF,GO:0003954,NADH dehydrogenase activity,4.5841135414113776e-14,True,"""Catalysis of the reaction: NADH + H+ + acceptor = NAD+ + reduced acceptor."" [RHEA:11356]",44,808,20,20212,0.024752475247524754,0.45454545454545453,Module 0,['GO:0016651']
763,HP,HP:0000104,Renal agenesis,4.7914059934850694e-14,True,"Agenesis, that is, failure of the kidney to develop during embryogenesis and development.",199,44,20,4958,0.45454545454545453,0.10050251256281408,Module 3,['HP:0008678']
764,HPA,HPA:0461452,skin 1; hair follicles[≥Medium],4.8059395094088325e-14,True,skin 1; hair follicles[≥Medium],293,612,56,11019,0.0915032679738562,0.19112627986348124,Module 0,['HPA:0461451']
765,HPA,HPA:0630222,cervix; squamous epithelial cells[≥Medium],4.8525482935751e-14,True,cervix; squamous epithelial cells[≥Medium],3730,612,303,11019,0.4950980392156863,0.08123324396782843,Module 0,['HPA:0630221']
766,HPA,HPA:0471463,skin 2; langerhans cells[High],5.0958311708209186e-14,True,skin 2; langerhans cells[High],266,612,53,11019,0.08660130718954248,0.19924812030075187,Module 0,['HPA:0471462']
767,GO:BP,GO:0006986,response to unfolded protein,5.109790278575528e-14,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus."" [GOC:jl]",137,21,10,21031,0.47619047619047616,0.072992700729927,Module 9,['GO:0035966']
768,GO:BP,GO:0009058,biosynthetic process,5.1914820997723114e-14,True,"""The chemical reactions and pathways resulting in the formation of substances; typically the energy-requiring part of metabolism in which simpler substances are transformed into more complex ones."" [GOC:curators, ISBN:0198547684]",10704,105,94,21031,0.8952380952380953,0.008781763826606876,Module 3,['GO:0008152']
769,GO:BP,GO:0034976,response to endoplasmic reticulum stress,5.3906830054598796e-14,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stress acting at the endoplasmic reticulum. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen."" [GOC:cjm, GOC:mah]",220,72,16,21031,0.2222222222222222,0.07272727272727272,Module 4,['GO:0033554']
770,GO:MF,GO:0097159,organic cyclic compound binding,5.568127871720838e-14,True,"""Binding to an organic cyclic compound, any molecular entity that contains carbon arranged in a cyclic molecular structure."" [GOC:sjw, PMID:7583672]",7546,105,81,20212,0.7714285714285715,0.010734163795388284,Module 3,['GO:0005488']
771,TF,TF:M09608,Factor: Erg; motif: NNACCGGAARTSN,6.203219595583972e-14,True,Factor: Erg; motif: NNACCGGAARTSN,8337,826,462,20045,0.559322033898305,0.055415617128463476,Module 0,['TF:M00000']
772,REAC,REAC:R-HSA-1640170,Cell Cycle,6.476970895639999e-14,True,Cell Cycle,677,59,26,10842,0.4406779661016949,0.03840472673559823,Module 5,['REAC:0000000']
773,HPA,HPA:0570801,testis; sertoli cells[≥Low],6.618896626241526e-14,True,testis; sertoli cells[≥Low],2535,612,228,11019,0.37254901960784315,0.08994082840236686,Module 0,['HPA:0570000']
774,TF,TF:M12601_1,Factor: ELF4; motif: NCCACTTCCGGNNNN; match class: 1,6.658460929383311e-14,True,Factor: ELF4; motif: NCCACTTCCGGNNNN; match class: 1,1556,826,136,20045,0.16464891041162227,0.08740359897172237,Module 0,['TF:M12601']
775,HPA,HPA:0351182,pancreas; pancreatic endocrine cells[≥Medium],7.543676631716878e-14,True,pancreas; pancreatic endocrine cells[≥Medium],3624,612,296,11019,0.48366013071895425,0.08167770419426049,Module 0,['HPA:0351181']
776,GO:MF,GO:0023023,MHC protein complex binding,7.5952025560658e-14,True,"""Binding to a major histocompatibility complex."" [GOC:mtg_signal, GOC:vw]",33,17,7,20212,0.4117647058823529,0.21212121212121213,Module 6,['GO:0044877']
777,GO:MF,GO:0003955,NAD(P)H dehydrogenase (quinone) activity,7.945048994998114e-14,True,"""Catalysis of the reaction: NAD(P)H + H+ + a quinone = NAD(P)+ + a hydroquinone."" [EC:1.6.5.2]",45,808,20,20212,0.024752475247524754,0.4444444444444444,Module 0,['GO:0016655']
778,GO:BP,GO:0051239,regulation of multicellular organismal process,8.322831002964339e-14,True,"""Any process that modulates the frequency, rate or extent of a multicellular organismal process, the processes pertinent to the function of a multicellular organism above the cellular level; includes the integrated processes of tissues and organs."" [GOC:ai, GOC:dph, GOC:tb]",2955,226,82,21031,0.36283185840707965,0.02774957698815567,Module 1,"['GO:0032501', 'GO:0050789']"
779,GO:BP,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,8.506944855650193e-14,True,"""The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein."" [GOC:add, ISBN:0781735149, PMID:15531770, PMID:15771591]",32,15,7,21031,0.4666666666666667,0.21875,Module 6,"['GO:0002504', 'GO:0048002']"
780,HPA,HPA:0600433,tonsil; germinal center cells[High],8.590983236459385e-14,True,tonsil; germinal center cells[High],1228,69,35,11019,0.5072463768115942,0.028501628664495113,Module 5,['HPA:0600432']
781,TF,TF:M11402,Factor: Fli-1; motif: NACCGGAARTN,8.636871711587157e-14,True,Factor: Fli-1; motif: NACCGGAARTN,3954,826,263,20045,0.31840193704600483,0.06651492159838139,Module 0,['TF:M00000']
782,TF,TF:M11446,Factor: Elf-1; motif: RANSMGGAAGTR,8.649271973026317e-14,True,Factor: Elf-1; motif: RANSMGGAAGTR,2963,826,213,20045,0.25786924939467315,0.07188660141748228,Module 0,['TF:M00000']
783,WP,WP:WP2328,Allograft rejection,9.550233529848076e-14,True,Allograft rejection,88,13,9,8286,0.6923076923076923,0.10227272727272728,Module 6,['WP:000000']
784,HP,HP:0008551,Microtia,9.760797317625266e-14,True,Underdevelopment of the external ear.,176,44,19,4958,0.4318181818181818,0.10795454545454546,Module 3,['HP:0008772']
785,HP,HP:0100242,Sarcoma,1.2120348997078258e-13,True,A connective tissue neoplasm formed by proliferation of mesodermal cells. Bone and soft tissue sarcomas are the main types of sarcoma. Sarcoma is usually highly malignant.,178,44,19,4958,0.4318181818181818,0.10674157303370786,Module 3,['HP:0011792']
786,TF,TF:M11382,Factor: ESE-1; motif: NWTRCGGAWGCN,1.2591273420219357e-13,True,Factor: ESE-1; motif: NWTRCGGAWGCN,10545,826,551,20045,0.6670702179176755,0.05225225225225225,Module 0,['TF:M00000']
787,GO:BP,GO:0035966,response to topologically incorrect protein,1.2952329492601503e-13,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a protein that is not folded in its correct three-dimensional structure."" [GOC:bf]",150,21,10,21031,0.47619047619047616,0.06666666666666667,Module 9,"['GO:0006950', 'GO:0010033']"
788,KEGG,KEGG:05310,Asthma,1.3077197778423911e-13,True,Asthma,27,13,7,8484,0.5384615384615384,0.25925925925925924,Module 6,['KEGG:00000']
789,GO:BP,GO:0051239,regulation of multicellular organismal process,1.3519082266592562e-13,True,"""Any process that modulates the frequency, rate or extent of a multicellular organismal process, the processes pertinent to the function of a multicellular organism above the cellular level; includes the integrated processes of tissues and organs."" [GOC:ai, GOC:dph, GOC:tb]",2955,215,79,21031,0.3674418604651163,0.02673434856175973,Module 2,"['GO:0032501', 'GO:0050789']"
790,HPA,HPA:0380521,placenta; trophoblastic cells[≥Low],1.42458507615476e-13,True,placenta; trophoblastic cells[≥Low],6360,612,447,11019,0.7303921568627451,0.07028301886792453,Module 0,['HPA:0380000']
791,HP,HP:0034684,Abnormal enzyme concentration or activity,1.4856691048612677e-13,True,Concentration or activity of an enzyme is above or below the limits of normal.,676,44,30,4958,0.6818181818181818,0.04437869822485207,Module 3,['HP:0001939']
792,TF,TF:M00738,Factor: E2F-4:DP-1; motif: TTTSGCGC,1.5051029071479898e-13,True,Factor: E2F-4:DP-1; motif: TTTSGCGC,10100,826,533,20045,0.6452784503631961,0.05277227722772277,Module 0,['TF:M00000']
793,GO:BP,GO:0033108,mitochondrial respiratory chain complex assembly,1.7527559776537157e-13,True,"""The aggregation, arrangement and bonding together of a set of components to form a mitochondrial respiratory chain complex."" [GOC:mah]",104,787,28,21031,0.035578144853875476,0.2692307692307692,Module 0,"['GO:0007005', 'GO:0065003']"
794,TF,TF:M11413,Factor: ER71; motif: NACCGGAARTN,1.761483579536073e-13,True,Factor: ER71; motif: NACCGGAARTN,2156,826,169,20045,0.2046004842615012,0.07838589981447125,Module 0,['TF:M00000']
795,HPA,HPA:0270361,kidney; cells in tubules[≥Low],1.7760315552321195e-13,True,kidney; cells in tubules[≥Low],7027,612,480,11019,0.7843137254901961,0.06830795503059627,Module 0,['HPA:0270000']
796,TF,TF:M03966_1,Factor: ELF1; motif: AACCCGGAAGTR; match class: 1,1.81511567964496e-13,True,Factor: ELF1; motif: AACCCGGAAGTR; match class: 1,1609,826,138,20045,0.16707021791767554,0.08576755748912368,Module 0,['TF:M03966']
797,GO:BP,GO:0043043,peptide biosynthetic process,1.8412699917453214e-13,True,"""The chemical reactions and pathways resulting in the formation of peptides, compounds of 2 or more (but usually less than 100) amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another. This may include the translation of a precursor protein and its subsequent processing into a functional peptide."" [GOC:dph, GOC:jl]",752,787,79,21031,0.10038119440914867,0.10505319148936171,Module 0,"['GO:0006518', 'GO:0043604', 'GO:1901566']"
798,HPA,HPA:0350473,pancreas; exocrine glandular cells[High],1.8781396730152357e-13,True,pancreas; exocrine glandular cells[High],1960,79,46,11019,0.5822784810126582,0.02346938775510204,Module 3,['HPA:0350472']
799,GO:BP,GO:0098542,defense response to other organism,1.9665267041979927e-13,True,"""Reactions triggered in response to the presence of another organism that act to protect the cell or organism from damage caused by that organism."" [GOC:dos]",1220,34,20,21031,0.5882352941176471,0.01639344262295082,Module 7,"['GO:0006952', 'GO:0051707']"
800,TF,TF:M11379,Factor: ESE-1; motif: ACCCGGAAGTRNNNNNNNNWWWW,2.1288878873564592e-13,True,Factor: ESE-1; motif: ACCCGGAAGTRNNNNNNNNWWWW,3240,826,226,20045,0.2736077481840194,0.06975308641975309,Module 0,['TF:M00000']
801,HPA,HPA:0300202,lung; endothelial cells[≥Medium],2.179750472179137e-13,True,lung; endothelial cells[≥Medium],651,612,89,11019,0.1454248366013072,0.13671274961597543,Module 0,['HPA:0300201']
802,GO:BP,GO:0065007,biological regulation,2.1851425715591057e-13,True,"""Any process that modulates a measurable attribute of any biological process, quality or function."" [GOC:dph, GOC:isa_complete, GOC:mah, GOC:pr, GOC:vw]",12680,226,193,21031,0.8539823008849557,0.015220820189274448,Module 1,['GO:0008150']
803,HPA,HPA:0540053,stomach 1; glandular cells[High],2.2201697151087258e-13,True,stomach 1; glandular cells[High],2453,612,221,11019,0.3611111111111111,0.09009376273950265,Module 0,['HPA:0540052']
804,HPA,HPA:0080132,caudate; neuronal cells[≥Medium],2.3459089641646777e-13,True,caudate; neuronal cells[≥Medium],4124,612,324,11019,0.5294117647058824,0.07856450048496605,Module 0,['HPA:0080131']
805,TF,TF:M00425,Factor: E2F; motif: TTTCGCGC,2.522131930085355e-13,True,Factor: E2F; motif: TTTCGCGC,11393,826,583,20045,0.7058111380145279,0.051171772140788205,Module 0,['TF:M00000']
806,TF,TF:M11603_1,Factor: TCF-1; motif: ACATCGRGRCGCTGW; match class: 1,2.6063719080011463e-13,True,Factor: TCF-1; motif: ACATCGRGRCGCTGW; match class: 1,13544,826,663,20045,0.8026634382566586,0.04895156526875369,Module 0,['TF:M11603']
807,HPA,HPA:0600000,tonsil,2.9126292537332925e-13,True,tonsil,7788,185,174,11019,0.9405405405405406,0.02234206471494607,Module 1,['HPA:0000000']
808,REAC,REAC:R-HSA-909733,Interferon alpha/beta signaling,2.931199264910309e-13,True,Interferon alpha/beta signaling,71,28,10,10842,0.35714285714285715,0.14084507042253522,Module 7,['REAC:R-HSA-913531']
809,TF,TF:M11419_1,Factor: ER81; motif: NNCCGGAWGYN; match class: 1,3.2150795855018743e-13,True,Factor: ER81; motif: NNCCGGAWGYN; match class: 1,1450,826,128,20045,0.1549636803874092,0.08827586206896551,Module 0,['TF:M11419']
810,HPA,HPA:0060101,bronchus; respiratory epithelial cells[≥Low],3.2419913638397884e-13,True,bronchus; respiratory epithelial cells[≥Low],5938,612,424,11019,0.6928104575163399,0.07140451330414281,Module 0,['HPA:0060000']
811,HP,HP:0410030,Cleft lip,3.243083752874061e-13,True,A gap in the lip or lips.,219,44,20,4958,0.45454545454545453,0.091324200913242,Module 3,['HP:0000159']
812,HPA,HPA:0471412,skin 2; cells in spinous layer[≥Medium],3.3215034580296913e-13,True,skin 2; cells in spinous layer[≥Medium],683,69,27,11019,0.391304347826087,0.03953147877013177,Module 5,['HPA:0471411']
813,MIRNA,MIRNA:hsa-miR-100-5p,hsa-miR-100-5p,3.6400170049205845e-13,True,hsa-miR-100-5p,250,104,20,14819,0.19230769230769232,0.08,Module 3,['MIRNA:000000']
814,HP,HP:0001874,Abnormality of neutrophils,3.716804750111915e-13,True,A neutrophil abnormality.,255,44,21,4958,0.4772727272727273,0.08235294117647059,Module 3,['HP:0001911']
815,GO:BP,GO:0042026,protein refolding,4.4211312671917066e-13,True,"""The process carried out by a cell that restores the biological activity of an unfolded or misfolded protein, using helper proteins such as chaperones."" [GOC:mb]",27,21,7,21031,0.3333333333333333,0.25925925925925924,Module 9,['GO:0006457']
816,HPA,HPA:0460203,skin 1; endothelial cells[High],4.4441320183767766e-13,True,skin 1; endothelial cells[High],317,612,57,11019,0.09313725490196079,0.17981072555205047,Module 0,['HPA:0460202']
817,HPA,HPA:0530711,spleen; cells in red pulp[≥Low],4.664905604580358e-13,True,spleen; cells in red pulp[≥Low],5333,185,142,11019,0.7675675675675676,0.026626664166510407,Module 1,['HPA:0530000']
818,TF,TF:M09606_1,Factor: nerf; motif: NRRNSCGGAAGNRNNNN; match class: 1,4.699547746456793e-13,True,Factor: nerf; motif: NRRNSCGGAAGNRNNNN; match class: 1,1749,826,145,20045,0.17554479418886199,0.08290451686678102,Module 0,['TF:M09606']
819,HPA,HPA:0630221,cervix; squamous epithelial cells[≥Low],4.712232691453672e-13,True,cervix; squamous epithelial cells[≥Low],5460,612,398,11019,0.6503267973856209,0.0728937728937729,Module 0,['HPA:0630000']
820,HPA,HPA:0301362,lung; alveolar cells type I[≥Medium],4.770133162008528e-13,True,lung; alveolar cells type I[≥Medium],887,612,108,11019,0.17647058823529413,0.12175873731679819,Module 0,['HPA:0301361']
821,GO:BP,GO:0051604,protein maturation,4.817996502782395e-13,True,"""Any process leading to the attainment of the full functional capacity of a protein."" [GOC:ai]",540,21,13,21031,0.6190476190476191,0.024074074074074074,Module 9,"['GO:0010467', 'GO:0019538']"
822,GO:BP,GO:0006163,purine nucleotide metabolic process,4.931113594597018e-13,True,"""The chemical reactions and pathways involving a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:go_curators, ISBN:0198506732]",538,787,64,21031,0.08132147395171538,0.11895910780669144,Module 0,"['GO:0009117', 'GO:0072521']"
823,GO:BP,GO:0050789,regulation of biological process,5.094365717495308e-13,True,"""Any process that modulates the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule."" [GOC:ai, GOC:go_curators]",12287,226,189,21031,0.8362831858407079,0.01538211117441198,Module 1,"['GO:0008150', 'GO:0065007']"
824,TF,TF:M00333,Factor: ZF5; motif: NRNGNGCGCGCWN,5.163630819454131e-13,True,Factor: ZF5; motif: NRNGNGCGCGCWN,15464,826,728,20045,0.8813559322033898,0.0470770822555613,Module 0,['TF:M00000']
825,HPA,HPA:0461443,skin 1; fibrohistiocytic cells[High],5.168475053457832e-13,True,skin 1; fibrohistiocytic cells[High],408,69,22,11019,0.3188405797101449,0.05392156862745098,Module 5,['HPA:0461442']
826,GO:BP,GO:0050864,regulation of B cell activation,5.382309391706548e-13,True,"""Any process that modulates the frequency, rate or extent of B cell activation."" [GOC:ai]",132,226,19,21031,0.084070796460177,0.14393939393939395,Module 1,"['GO:0042113', 'GO:0051249']"
827,TF,TF:M11529_1,Factor: E2F-2; motif: GCGCGCGCNCS; match class: 1,5.382770509112686e-13,True,Factor: E2F-2; motif: GCGCGCGCNCS; match class: 1,14894,826,709,20045,0.8583535108958837,0.04760306163555794,Module 0,['TF:M11529']
828,TF,TF:M09950_1,Factor: HSF1; motif: NRGAANNTTCYRGAA; match class: 1,5.536414026416807e-13,True,Factor: HSF1; motif: NRGAANNTTCYRGAA; match class: 1,250,21,11,20045,0.5238095238095238,0.044,Module 9,['TF:M09950']
829,HP,HP:0100736,Abnormal soft palate morphology,5.551562125941235e-13,True,An abnormality of the soft palate.,260,44,21,4958,0.4772727272727273,0.08076923076923077,Module 3,['HP:0000174']
830,TF,TF:M08451,Factor: Elk-1:HOXA1; motif: ACCGGAAGTAATTA,5.589514440402092e-13,True,Factor: Elk-1:HOXA1; motif: ACCGGAAGTAATTA,8567,826,468,20045,0.5665859564164649,0.054628224582701064,Module 0,['TF:M00000']
831,HP,HP:0011004,Abnormal systemic arterial morphology,5.700602963007564e-13,True,"An abnormality of the systemic arterial tree, which consists of the aorta and other systemic arteries.",531,44,27,4958,0.6136363636363636,0.05084745762711865,Module 3,['HP:0033353']
832,HP,HP:0010701,Abnormal immunoglobulin level,5.717322465481153e-13,True,An abnormal deviation from normal levels of immunoglobulins in blood.,261,71,26,4958,0.36619718309859156,0.09961685823754789,Module 1,"['HP:0005368', 'HP:0005372']"
833,GO:CC,GO:0005773,vacuole,5.729221635155571e-13,True,"""A closed structure, found only in eukaryotic cells, that is completely surrounded by unit membrane and contains liquid material. Cells contain one or several vacuoles, that may have different functions from each other. Vacuoles have a diverse array of functions. They can act as a storage organelle for nutrients or waste products, as a degradative compartment, as a cost-effective way of increasing cell size, and as a homeostatic regulator controlling both turgor pressure and pH of the cytosol."" [GOC:mtg_sensu, ISBN:0198506732]",855,221,39,22097,0.17647058823529413,0.0456140350877193,Module 2,"['GO:0005737', 'GO:0043231']"
834,GO:CC,GO:0005829,cytosol,5.850605938074417e-13,True,"""The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes."" [GOC:hjd, GOC:jl]",5487,177,93,22097,0.5254237288135594,0.01694915254237288,Module Singleton,"['GO:0005737', 'GO:0110165']"
835,GO:BP,GO:0048583,regulation of response to stimulus,5.941503458078035e-13,True,"""Any process that modulates the frequency, rate or extent of a response to a stimulus. Response to stimulus is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus."" [GOC:jid]",3939,215,92,21031,0.42790697674418604,0.023356181772023355,Module 2,"['GO:0050789', 'GO:0050896']"
836,HPA,HPA:0461392,skin 1; cells in basal layer[≥Medium],6.223153368561592e-13,True,skin 1; cells in basal layer[≥Medium],637,69,26,11019,0.37681159420289856,0.04081632653061224,Module 5,['HPA:0461391']
837,HP,HP:0005372,Abnormality of B cell physiology,6.288941454256094e-13,True,An abnormality of the physiological functioning of B cells.,262,71,26,4958,0.36619718309859156,0.09923664122137404,Module 1,['HP:0031409']
838,HPA,HPA:0570802,testis; sertoli cells[≥Medium],6.32845466975009e-13,True,testis; sertoli cells[≥Medium],1864,612,180,11019,0.29411764705882354,0.09656652360515021,Module 0,['HPA:0570801']
839,GO:MF,GO:0019899,enzyme binding,6.392864628203061e-13,True,"""Binding to an enzyme, a protein with catalytic activity."" [GOC:jl]",2103,808,159,20212,0.1967821782178218,0.07560627674750357,Module 0,['GO:0005515']
840,TF,TF:M12603_1,Factor: ERM; motif: NNCACTTCCGGNN; match class: 1,6.42356313272729e-13,True,Factor: ERM; motif: NNCACTTCCGGNN; match class: 1,2004,826,159,20045,0.19249394673123488,0.07934131736526946,Module 0,['TF:M12603']
841,GO:BP,GO:0006915,apoptotic process,6.452513016849113e-13,True,"""A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died."" [GOC:cjm, GOC:dhl, GOC:ecd, GOC:go_curators, GOC:mtg_apoptosis, GOC:tb, ISBN:0198506732, PMID:18846107, PMID:21494263]",1913,215,61,21031,0.2837209302325581,0.03188708834291688,Module 2,['GO:0012501']
842,GO:BP,GO:0071310,cellular response to organic substance,6.463817867666579e-13,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus."" [GOC:mah]",1971,215,62,21031,0.28837209302325584,0.03145611364789447,Module 2,"['GO:0010033', 'GO:0070887']"
843,HPA,HPA:0420053,salivary gland; glandular cells[High],6.658363437827812e-13,True,salivary gland; glandular cells[High],1483,612,153,11019,0.25,0.10316925151719487,Module 0,['HPA:0420052']
844,GO:BP,GO:0002443,leukocyte mediated immunity,6.996522391072009e-13,True,"""Any process involved in the carrying out of an immune response by a leukocyte."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",460,226,31,21031,0.13716814159292035,0.06739130434782609,Module 1,['GO:0002252']
845,GO:CC,GO:0034774,secretory granule lumen,7.161907511691146e-13,True,"""The volume enclosed by the membrane of a secretory granule."" [GOC:rph]",320,221,25,22097,0.11312217194570136,0.078125,Module 2,"['GO:0030141', 'GO:0060205']"
846,TF,TF:M00716,Factor: ZF5; motif: GSGCGCGR,7.652864262909914e-13,True,Factor: ZF5; motif: GSGCGCGR,16490,826,760,20045,0.9200968523002422,0.04608853850818678,Module 0,['TF:M00000']
847,GO:BP,GO:0032981,mitochondrial respiratory chain complex I assembly,7.843957627889589e-13,True,"""The aggregation, arrangement and bonding together of a set of components to form mitochondrial respiratory chain complex I."" [GOC:rph]",63,787,22,21031,0.02795425667090216,0.3492063492063492,Module 0,"['GO:0010257', 'GO:0033108']"
848,GO:BP,GO:0010257,NADH dehydrogenase complex assembly,7.843957627889589e-13,True,"""The aggregation, arrangement and bonding together of a set of components to form an NADH dehydrogenase complex."" [GOC:sm]",63,787,22,21031,0.02795425667090216,0.3492063492063492,Module 0,['GO:0065003']
849,HP,HP:0100542,Abnormal localization of kidney,7.858430802367834e-13,True,An abnormal site of the kidney.,229,44,20,4958,0.45454545454545453,0.08733624454148471,Module 3,['HP:0012210']
850,HPA,HPA:0470203,skin 2; endothelial cells[High],7.921890044765392e-13,True,skin 2; endothelial cells[High],321,612,57,11019,0.09313725490196079,0.17757009345794392,Module 0,['HPA:0470202']
851,GO:BP,GO:0140546,defense response to symbiont,8.087624278954325e-13,True,"""Reactions triggered in response to the presence of a symbiont that act to protect or prevent damage to the host."" [GOC:pg]",1113,34,19,21031,0.5588235294117647,0.017070979335130278,Module 7,['GO:0098542']
852,GO:BP,GO:0023052,signaling,8.140982157992096e-13,True,"""The entirety of a process in which information is transmitted within a biological system. This process begins with an active signal and ends when a cellular response has been triggered."" [GOC:mtg_signal, GOC:mtg_signaling_feb11, GOC:signaling]",6447,226,128,21031,0.5663716814159292,0.019854195749961223,Module 1,['GO:0050789']
853,TF,TF:M02055_1,Factor: ESE-1; motif: NSMGGAARTN; match class: 1,8.668161031265007e-13,True,Factor: ESE-1; motif: NSMGGAARTN; match class: 1,2229,826,171,20045,0.20702179176755447,0.07671601615074024,Module 0,['TF:M02055']
854,TF,TF:M01214_1,Factor: ESE-1; motif: NSMGGAARTN; match class: 1,8.668161031265007e-13,True,Factor: ESE-1; motif: NSMGGAARTN; match class: 1,2229,826,171,20045,0.20702179176755447,0.07671601615074024,Module 0,['TF:M01214']
855,TF,TF:M08205,Factor: E2F-1:Elk-1; motif: SGCGCSNNAMCGGAAGT,8.719097043321464e-13,True,Factor: E2F-1:Elk-1; motif: SGCGCSNNAMCGGAAGT,14824,826,706,20045,0.8547215496368039,0.04762547220723152,Module 0,['TF:M00000']
856,GO:CC,GO:0060205,cytoplasmic vesicle lumen,8.893173136093974e-13,True,"""The volume enclosed by a cytoplasmic vesicle."" [GOC:dph, GOC:vesicles]",323,221,25,22097,0.11312217194570136,0.07739938080495357,Module 2,"['GO:0031410', 'GO:0031983', 'GO:0070013']"
857,GO:BP,GO:0007154,cell communication,8.999942098644694e-13,True,"""Any process that mediates interactions between a cell and its surroundings. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment."" [GOC:mah]",6537,226,129,21031,0.5707964601769911,0.01973382285452042,Module 1,['GO:0009987']
858,HP,HP:0008772,Aplasia/Hypoplasia of the external ear,9.207295953097383e-13,True,The presence of aplasia or developmental hypoplasia of all or part of the external ear.,198,44,19,4958,0.4318181818181818,0.09595959595959595,Module 3,"['HP:0000377', 'HP:0008771']"
859,GO:BP,GO:0043604,amide biosynthetic process,9.345457346688601e-13,True,"""The chemical reactions and pathways resulting in the formation of an amide, any derivative of an oxoacid in which an acidic hydroxy group has been replaced by an amino or substituted amino group."" [GOC:curators]",887,787,86,21031,0.10927573062261753,0.09695603156708005,Module 0,"['GO:0043603', 'GO:0044271']"
860,GO:CC,GO:0031983,vesicle lumen,9.553738945491946e-13,True,"""The volume enclosed by the membrane or protein that forms a vesicle."" [GOC:mah, GOC:vesicles]",324,221,25,22097,0.11312217194570136,0.07716049382716049,Module 2,"['GO:0031982', 'GO:0043233']"
861,GO:CC,GO:0005789,endoplasmic reticulum membrane,9.569923724298627e-13,True,"""The lipid bilayer surrounding the endoplasmic reticulum."" [GOC:mah]",1194,73,26,22097,0.3561643835616438,0.021775544388609715,Module 4,"['GO:0031090', 'GO:0042175', 'GO:0098827']"
862,GO:BP,GO:0051707,response to other organism,9.912381236681405e-13,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from another living organism."" [GOC:ai]",1548,34,21,21031,0.6176470588235294,0.013565891472868217,Module 7,"['GO:0043207', 'GO:0044419']"
863,HPA,HPA:0461442,skin 1; fibrohistiocytic cells[≥Medium],9.933332863323908e-13,True,skin 1; fibrohistiocytic cells[≥Medium],699,166,42,11019,0.25301204819277107,0.060085836909871244,Module 2,['HPA:0461441']
864,GO:BP,GO:0043207,response to external biotic stimulus,1.0306831056819062e-12,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an external biotic stimulus, an external stimulus caused by, or produced by living things."" [GOC:go_curators]",1551,34,21,21031,0.6176470588235294,0.013539651837524178,Module 7,"['GO:0009605', 'GO:0009607']"
865,GO:BP,GO:0000278,mitotic cell cycle,1.0343687882195228e-12,True,"""Progression through the phases of the mitotic cell cycle, the most common eukaryotic cell cycle, which canonically comprises four successive phases called G1, S, G2, and M and includes replication of the genome and the subsequent segregation of chromosomes into daughter cells. In some variant cell cycles nuclear replication or nuclear division may not be followed by cell division, or G1 and G2 phases may be absent."" [GOC:mah, ISBN:0815316194, Reactome:69278]",895,77,25,21031,0.3246753246753247,0.027932960893854747,Module 5,['GO:0007049']
866,TF,TF:M09605_1,Factor: Elf-1; motif: NAANCMGGAAGTGN; match class: 1,1.0683198399011447e-12,True,Factor: Elf-1; motif: NAANCMGGAAGTGN; match class: 1,1338,826,120,20045,0.14527845036319612,0.08968609865470852,Module 0,['TF:M09605']
867,GO:CC,GO:0030662,coated vesicle membrane,1.0723999277658924e-12,True,"""The lipid bilayer surrounding a coated vesicle."" [GOC:mah]",199,17,9,22097,0.5294117647058824,0.04522613065326633,Module 6,"['GO:0030135', 'GO:0030659', 'GO:0098588']"
868,GO:CC,GO:0098827,endoplasmic reticulum subcompartment,1.0776876430158072e-12,True,"""A distinct region of the endoplasmic reticulum."" [GOC:dos]",1200,73,26,22097,0.3561643835616438,0.021666666666666667,Module 4,"['GO:0005783', 'GO:0031984']"
869,HP,HP:0001875,Neutropenia,1.1136206936447526e-12,True,An abnormally low number of neutrophils in the peripheral blood.,200,44,19,4958,0.4318181818181818,0.095,Module 3,['HP:0011991']
870,HPA,HPA:0461412,skin 1; cells in spinous layer[≥Medium],1.1583807474827175e-12,True,skin 1; cells in spinous layer[≥Medium],592,69,25,11019,0.36231884057971014,0.04222972972972973,Module 5,['HPA:0461411']
871,HP,HP:0001446,Abnormality of the musculature of the upper limbs,1.207962658276468e-12,True,Abnormality of the musculature of the upper limbs,270,44,21,4958,0.4772727272727273,0.07777777777777778,Module 3,"['HP:0002817', 'HP:0009127']"
872,GO:MF,GO:0003823,antigen binding,1.2199434043083578e-12,True,"""Binding to an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen. Antigen binding by an MHC protein complex allows the antigen to be displayed to a T cell or NK cell."" [GOC:jl, ISBN:0198506732, ISBN:0721662544]",174,17,9,20212,0.5294117647058824,0.05172413793103448,Module 6,['GO:0005488']
873,GO:BP,GO:0006120,"mitochondrial electron transport, NADH to ubiquinone",1.2377787706181148e-12,True,"""The transfer of electrons from NADH to ubiquinone that occurs during oxidative phosphorylation."" [ISBN:0716731363]",51,787,20,21031,0.025412960609911054,0.39215686274509803,Module 0,"['GO:0019646', 'GO:0042775']"
874,HPA,HPA:0380511,placenta; decidual cells[≥Low],1.2433767353283763e-12,True,placenta; decidual cells[≥Low],4850,612,363,11019,0.5931372549019608,0.07484536082474227,Module 0,['HPA:0380000']
875,TF,TF:M09894_1,Factor: E2F-4; motif: SNGGGCGGGAANN; match class: 1,1.3011540825858053e-12,True,Factor: E2F-4; motif: SNGGGCGGGAANN; match class: 1,14345,826,689,20045,0.8341404358353511,0.04803067270826072,Module 0,['TF:M09894']
876,GO:BP,GO:0051085,chaperone cofactor-dependent protein refolding,1.3061050930693079e-12,True,"""The process of assisting in the correct posttranslational noncovalent assembly of proteins, which is dependent on additional protein cofactors. This process occurs over one or several cycles of nucleotide hydrolysis-dependent binding and release."" [GOC:rb]",31,21,7,21031,0.3333333333333333,0.22580645161290322,Module 9,"['GO:0051084', 'GO:0061077']"
877,TF,TF:M01035,Factor: YY1; motif: NYNKCCATNTT,1.3337833651954392e-12,True,Factor: YY1; motif: NYNKCCATNTT,5958,826,353,20045,0.42736077481840196,0.05924806982208795,Module 0,['TF:M00000']
878,GO:MF,GO:0016655,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor",1.373586279871012e-12,True,"""Catalysis of an oxidation-reduction (redox) reaction in which NADH or NADPH acts as a hydrogen or electron donor and reduces a quinone or a similar acceptor molecule."" [GOC:ai]",57,808,21,20212,0.02599009900990099,0.3684210526315789,Module 0,['GO:0016651']
879,GO:CC,GO:0042175,nuclear outer membrane-endoplasmic reticulum membrane network,1.5034362122912568e-12,True,"""The continuous network of membranes encompassing the nuclear outer membrane and the endoplasmic reticulum membrane."" [GOC:bf, GOC:jl, GOC:mah, GOC:mcc, GOC:pr, GOC:vw]",1217,73,26,22097,0.3561643835616438,0.021364009860312245,Module 4,"['GO:0012505', 'GO:0016020']"
880,REAC,REAC:R-HSA-3371571,HSF1-dependent transactivation,1.546858789111297e-12,True,HSF1-dependent transactivation,24,19,7,10842,0.3684210526315789,0.2916666666666667,Module 9,['REAC:R-HSA-3371556']
881,GO:BP,GO:0009607,response to biotic stimulus,1.6155262825804707e-12,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a biotic stimulus, a stimulus caused or produced by a living organism."" [GOC:hb]",1586,34,21,21031,0.6176470588235294,0.013240857503152586,Module 7,['GO:0050896']
882,GO:CC,GO:0071005,U2-type precatalytic spliceosome,1.6466539241269798e-12,True,"""A spliceosomal complex that is formed by the recruitment of the preassembled U4/U6.U5 tri-snRNP to the prespliceosome. Although all 5 snRNPs are present, the precatalytic spliceosome is catalytically inactive. The precatalytic spliceosome includes many proteins in addition to those found in the U1, U2 and U4/U6.U5 snRNPs."" [GOC:ab, GOC:krc, GOC:mah, PMID:18322460, PMID:19239890]",50,813,19,22097,0.023370233702337023,0.38,Module 0,"['GO:0005684', 'GO:0071011']"
883,HPA,HPA:0160053,endometrium 1; glandular cells[High],1.697030158537225e-12,True,endometrium 1; glandular cells[High],1471,612,151,11019,0.24673202614379086,0.1026512576478586,Module 0,['HPA:0160052']
884,KEGG,KEGG:03040,Spliceosome,1.7035004412081528e-12,True,Spliceosome,174,439,38,8484,0.08656036446469248,0.21839080459770116,Module 0,['KEGG:00000']
885,WP,WP:WP411,mRNA processing,1.7128988309818982e-12,True,mRNA processing,126,472,34,8286,0.07203389830508475,0.2698412698412698,Module 0,['WP:000000']
886,HPA,HPA:0030441,appendix; non-germinal center cells[≥Low],1.74040415572476e-12,True,appendix; non-germinal center cells[≥Low],336,185,31,11019,0.16756756756756758,0.09226190476190477,Module 1,['HPA:0030000']
887,GO:BP,GO:0072521,purine-containing compound metabolic process,1.7737323974542163e-12,True,"""The chemical reactions and pathways involving a purine-containing compound, i.e. any compound that contains purine or a formal derivative thereof."" [GOC:mah]",567,787,65,21031,0.08259212198221093,0.1146384479717813,Module 0,"['GO:0006725', 'GO:0034641', 'GO:0046483', 'GO:1901360', 'GO:1901564']"
888,HP,HP:0008771,Aplasia/Hypoplasia of the ear,1.775480012803716e-12,True,The presence of aplasia or developmental hypoplasia of the ear.,205,44,19,4958,0.4318181818181818,0.09268292682926829,Module 3,['HP:0031703']
889,HPA,HPA:0310433,lymph node; germinal center cells[High],1.792760755879208e-12,True,lymph node; germinal center cells[High],944,69,30,11019,0.43478260869565216,0.03177966101694915,Module 5,['HPA:0310432']
890,HPA,HPA:0250121,hippocampus; glial cells[≥Low],1.7949247082606348e-12,True,hippocampus; glial cells[≥Low],4142,612,322,11019,0.5261437908496732,0.07774022211492033,Module 0,['HPA:0250000']
891,TF,TF:M08982,Factor: YY1; motif: NAANATGGCGNNN,1.813851432324232e-12,True,Factor: YY1; motif: NAANATGGCGNNN,7209,826,408,20045,0.4939467312348668,0.05659592176446109,Module 0,['TF:M00000']
892,GO:BP,GO:0051240,positive regulation of multicellular organismal process,1.9177110685171074e-12,True,"""Any process that activates or increases the frequency, rate or extent of an organismal process, any of the processes pertinent to the function of an organism above the cellular level; includes the integrated processes of tissues and organs."" [GOC:ai]",1637,226,57,21031,0.252212389380531,0.03481979230299328,Module 1,"['GO:0032501', 'GO:0048518', 'GO:0051239']"
893,TF,TF:M02102,Factor: NRF-1; motif: YGCGCMTGCGC,1.9348836947383163e-12,True,Factor: NRF-1; motif: YGCGCMTGCGC,2083,826,162,20045,0.19612590799031476,0.07777244359097456,Module 0,['TF:M00000']
894,TF,TF:M07234,Factor: YY1; motif: CAARATGGCNGC,2.071258589663722e-12,True,Factor: YY1; motif: CAARATGGCNGC,6085,826,358,20045,0.43341404358353514,0.05883319638455218,Module 0,['TF:M00000']
895,TF,TF:M04694,Factor: NRF-1; motif: CNCTGCGCATGCGC,2.103543640000426e-12,True,Factor: NRF-1; motif: CNCTGCGCATGCGC,1588,826,134,20045,0.162227602905569,0.08438287153652393,Module 0,['TF:M00000']
896,HP,HP:0000599,Abnormality of the frontal hairline,2.1321682788272387e-12,True,"An anomaly in the placement or shape of the hairline (trichion) on the forehead, that is, the border between skin on the forehead that has head hair and that does not.",207,44,19,4958,0.4318181818181818,0.09178743961352658,Module 3,"['HP:0000290', 'HP:0009553']"
897,TF,TF:M11448_1,Factor: Elf-1; motif: NANGCGGAAGTN; match class: 1,2.3905364459666306e-12,True,Factor: Elf-1; motif: NANGCGGAAGTN; match class: 1,2383,826,178,20045,0.21549636803874092,0.07469576164498531,Module 0,['TF:M11448']
898,HPA,HPA:0600443,tonsil; non-germinal center cells[High],2.4046878002536083e-12,True,tonsil; non-germinal center cells[High],1321,185,62,11019,0.33513513513513515,0.046934140802422405,Module 1,['HPA:0600442']
899,HP,HP:0009553,Abnormality of the hairline,2.547589689862698e-12,True,The hairline refers to the outline of hair of the head. An abnormality of the hairline can refer to an unusually low or high border between areas of the scalp with and without hair or to abnormal projections of scalp hair.,280,44,21,4958,0.4772727272727273,0.075,Module 3,"['HP:0011361', 'HP:0100037']"
900,HPA,HPA:0131332,colon; mucosal lymphoid cells[≥Medium],2.579404769216589e-12,True,colon; mucosal lymphoid cells[≥Medium],365,185,32,11019,0.17297297297297298,0.08767123287671233,Module 1,['HPA:0131331']
901,HPA,HPA:0340462,ovary; ovarian stroma cells[≥Medium],2.6011640141396336e-12,True,ovary; ovarian stroma cells[≥Medium],2067,612,192,11019,0.3137254901960784,0.09288824383164006,Module 0,['HPA:0340461']
902,GO:CC,GO:0005737,cytoplasm,2.660920525908807e-12,True,"""The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures."" [ISBN:0198547684]",12345,221,178,22097,0.8054298642533937,0.014418793033616848,Module 2,"['GO:0005622', 'GO:0110165']"
903,HPA,HPA:0050092,breast; myoepithelial cells[≥Medium],2.691091346709534e-12,True,breast; myoepithelial cells[≥Medium],3779,612,300,11019,0.49019607843137253,0.07938608097380259,Module 0,['HPA:0050091']
904,HPA,HPA:0461441,skin 1; fibrohistiocytic cells[≥Low],2.7801916064710378e-12,True,skin 1; fibrohistiocytic cells[≥Low],885,69,29,11019,0.42028985507246375,0.0327683615819209,Module 5,['HPA:0460000']
905,GO:CC,GO:0031982,vesicle,2.866904145603202e-12,True,"""Any small, fluid-filled, spherical organelle enclosed by membrane."" [GOC:mah, GOC:pz, GOC:vesicles]",4004,238,94,22097,0.3949579831932773,0.023476523476523476,Module 1,['GO:0043227']
906,TF,TF:M11432_1,Factor: Elk-1; motif: NACMGGAAGTN; match class: 1,2.9191218993225347e-12,True,Factor: Elk-1; motif: NACMGGAAGTN; match class: 1,1560,826,132,20045,0.15980629539951574,0.08461538461538462,Module 0,['TF:M11432']
907,GO:CC,GO:0030141,secretory granule,2.9634651487365245e-12,True,"""A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules."" [GOC:mah, ISBN:0198506732]",896,813,83,22097,0.10209102091020911,0.09263392857142858,Module 0,"['GO:0012505', 'GO:0099503']"
908,HPA,HPA:0160252,endometrium 1; cells in endometrial stroma[≥Medium],2.964773694746176e-12,True,endometrium 1; cells in endometrial stroma[≥Medium],2234,612,203,11019,0.33169934640522875,0.09086839749328558,Module 0,['HPA:0160251']
909,GO:BP,GO:0030097,hemopoiesis,2.969033898740144e-12,True,"""The process whose specific outcome is the progression of the myeloid and lymphoid derived organ/tissue systems of the blood and other parts of the body over time, from formation to the mature structure. The site of hemopoiesis is variable during development, but occurs primarily in bone marrow or kidney in many adult vertebrates."" [GOC:dgh, ISBN:0198506732]",965,226,43,21031,0.1902654867256637,0.04455958549222798,Module 1,['GO:0048468']
910,GO:BP,GO:0012501,programmed cell death,3.0644098127249626e-12,True,"""A process which begins when a cell receives an internal or external signal and activates a series of biochemical events (signaling pathway). The process ends with the death of the cell."" [GOC:lr, GOC:mtg_apoptosis]",1984,226,63,21031,0.27876106194690264,0.031754032258064516,Module 1,['GO:0008219']
911,TF,TF:M09935_1,Factor: GABP-alpha; motif: NNNRCCGGAAGTGN; match class: 1,3.090882495919404e-12,True,Factor: GABP-alpha; motif: NNNRCCGGAAGTGN; match class: 1,1079,826,103,20045,0.12469733656174334,0.09545875810936053,Module 0,['TF:M09935']
912,GO:CC,GO:0071013,catalytic step 2 spliceosome,3.153766248234622e-12,True,"""A spliceosomal complex that contains three snRNPs, including U5, bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the associated snRNPs."" [GOC:ab, GOC:krc, GOC:mah, ISBN:0879695897, ISBN:0879697393, PMID:18322460, PMID:19239890]",89,813,24,22097,0.02952029520295203,0.2696629213483146,Module 0,"['GO:0005681', 'GO:1902494']"
913,TF,TF:M11452_1,Factor: Elf-1; motif: NANGCGGAAGTR; match class: 1,3.2008120281425487e-12,True,Factor: Elf-1; motif: NANGCGGAAGTR; match class: 1,1736,826,142,20045,0.17191283292978207,0.08179723502304148,Module 0,['TF:M11452']
914,TF,TF:M08225_1,Factor: Elk-1:Pax-5; motif: ACCGGAACYACGCWTSANYG; match class: 1,3.238370378869532e-12,True,Factor: Elk-1:Pax-5; motif: ACCGGAACYACGCWTSANYG; match class: 1,8211,826,450,20045,0.5447941888619855,0.05480453050785532,Module 0,['TF:M08225']
915,GO:BP,GO:0008219,cell death,3.370874374900828e-12,True,"""Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538)."" [GOC:mah, GOC:mtg_apoptosis, PMID:25236395]",1988,226,63,21031,0.27876106194690264,0.03169014084507042,Module 1,['GO:0009987']
916,TF,TF:M11529,Factor: E2F-2; motif: GCGCGCGCNCS,3.4034163166328104e-12,True,Factor: E2F-2; motif: GCGCGCGCNCS,16674,826,764,20045,0.9249394673123487,0.045819839270720884,Module 0,['TF:M00000']
917,TF,TF:M02044,Factor: YY1; motif: GCCGCCATTTTG,3.418776049922474e-12,True,Factor: YY1; motif: GCCGCCATTTTG,6282,826,366,20045,0.4430992736077482,0.05826170009551098,Module 0,['TF:M00000']
918,TF,TF:M03967_1,Factor: ELF3; motif: WACCCGGAAGTAN; match class: 1,3.5385375237463445e-12,True,Factor: ELF3; motif: WACCCGGAAGTAN; match class: 1,2006,826,157,20045,0.1900726392251816,0.07826520438683948,Module 0,['TF:M03967']
919,HPA,HPA:0310431,lymph node; germinal center cells[≥Low],3.616250005106518e-12,True,lymph node; germinal center cells[≥Low],5061,69,62,11019,0.8985507246376812,0.012250543370875321,Module 5,['HPA:0310000']
920,TF,TF:M08207_1,Factor: E2F-3:TBR2; motif: ANGTGYKANGGCGCSTTNNCRNNT; match class: 1,3.742737880820875e-12,True,Factor: E2F-3:TBR2; motif: ANGTGYKANGGCGCSTTNNCRNNT; match class: 1,15846,826,738,20045,0.8934624697336562,0.046573267701628174,Module 0,['TF:M08207']
921,TF,TF:M07206,Factor: E2F-1; motif: NGGGCGGGARV,3.901871468831805e-12,True,Factor: E2F-1; motif: NGGGCGGGARV,14971,826,709,20045,0.8583535108958837,0.047358225903413265,Module 0,['TF:M00000']
922,HPA,HPA:0130241,colon; peripheral nerve/ganglion[≥Low],3.912724576646893e-12,True,colon; peripheral nerve/ganglion[≥Low],5043,612,372,11019,0.6078431372549019,0.07376561570493753,Module 0,['HPA:0130000']
923,KEGG,KEGG:04145,Phagosome,4.037757618794619e-12,True,Phagosome,147,13,9,8484,0.6923076923076923,0.061224489795918366,Module 6,['KEGG:00000']
924,TF,TF:M08377,Factor: meis1:Elf-1; motif: NTGCCGGAAGTN,4.095267110122379e-12,True,Factor: meis1:Elf-1; motif: NTGCCGGAAGTN,11536,826,584,20045,0.7070217917675545,0.05062413314840499,Module 0,['TF:M00000']
925,HPA,HPA:0320103,nasopharynx; respiratory epithelial cells[High],4.132098443414051e-12,True,nasopharynx; respiratory epithelial cells[High],1798,612,173,11019,0.2826797385620915,0.09621802002224694,Module 0,['HPA:0320102']
926,GO:BP,GO:0051084,'de novo' post-translational protein folding,4.134201602958118e-12,True,"""The process of assisting in the correct noncovalent folding of newly formed polypeptides or folding intermediates of polypeptides that have exited the ribosome and/or have been stabilized and transferred by other chaperone proteins. This process could involve several cycles of ATP hydrolysis."" [GOC:rb]",36,21,7,21031,0.3333333333333333,0.19444444444444445,Module 9,['GO:0006458']
927,TF,TF:M03791,Factor: GABPalpha_GABPbeta; motif: CTTCCKGY,4.138276571548598e-12,True,Factor: GABPalpha_GABPbeta; motif: CTTCCKGY,3048,826,212,20045,0.2566585956416465,0.06955380577427822,Module 0,['TF:M00000']
928,TF,TF:M08451_1,Factor: Elk-1:HOXA1; motif: ACCGGAAGTAATTA; match class: 1,4.267817940819166e-12,True,Factor: Elk-1:HOXA1; motif: ACCGGAAGTAATTA; match class: 1,2624,826,190,20045,0.23002421307506055,0.07240853658536585,Module 0,['TF:M08451']
929,TF,TF:M07415_1,Factor: Elf-1; motif: AWCCCGGAAGTN; match class: 1,4.467720536497966e-12,True,Factor: Elf-1; motif: AWCCCGGAAGTN; match class: 1,2436,826,180,20045,0.2179176755447942,0.07389162561576355,Module 0,['TF:M07415']
930,GO:CC,GO:0030658,transport vesicle membrane,4.8698326678664594e-12,True,"""The lipid bilayer surrounding a transport vesicle."" [GOC:mah]",235,17,9,22097,0.5294117647058824,0.03829787234042553,Module 6,"['GO:0030133', 'GO:0030659', 'GO:0098588']"
931,TF,TF:M10438,Factor: ZF5; motif: GGSGCGCGS,4.914612720400602e-12,True,Factor: ZF5; motif: GGSGCGCGS,16621,826,762,20045,0.9225181598062954,0.04584561699055412,Module 0,['TF:M00000']
932,GO:MF,GO:0005515,protein binding,4.997610069166242e-12,True,"""Binding to a protein."" [GOC:go_curators]",14838,232,216,20212,0.9310344827586207,0.014557217953902144,Module 1,['GO:0005488']
933,HPA,HPA:0471442,skin 2; fibrohistiocytic cells[≥Medium],5.098822174389272e-12,True,skin 2; fibrohistiocytic cells[≥Medium],833,69,28,11019,0.4057971014492754,0.03361344537815126,Module 5,['HPA:0471441']
934,HP,HP:0011991,Abnormal neutrophil count,5.176028592901945e-12,True,A deviation from the normal range of neutrophil cell counts in the circulation.,217,44,19,4958,0.4318181818181818,0.08755760368663594,Module 3,"['HP:0001874', 'HP:0032309']"
935,GO:BP,GO:0009617,response to bacterium,5.3212255653561515e-12,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium."" [GOC:hb]",720,215,36,21031,0.16744186046511628,0.05,Module 2,['GO:0051707']
936,GO:CC,GO:0005773,vacuole,5.4667279610568195e-12,True,"""A closed structure, found only in eukaryotic cells, that is completely surrounded by unit membrane and contains liquid material. Cells contain one or several vacuoles, that may have different functions from each other. Vacuoles have a diverse array of functions. They can act as a storage organelle for nutrients or waste products, as a degradative compartment, as a cost-effective way of increasing cell size, and as a homeostatic regulator controlling both turgor pressure and pH of the cytosol."" [GOC:mtg_sensu, ISBN:0198506732]",855,813,80,22097,0.0984009840098401,0.0935672514619883,Module 0,"['GO:0005737', 'GO:0043231']"
937,KEGG,KEGG:04672,Intestinal immune network for IgA production,5.583839279751701e-12,True,Intestinal immune network for IgA production,44,13,7,8484,0.5384615384615384,0.1590909090909091,Module 6,['KEGG:00000']
938,KEGG,KEGG:04514,Cell adhesion molecules,5.830680917527467e-12,True,Cell adhesion molecules,153,13,9,8484,0.6923076923076923,0.058823529411764705,Module 6,['KEGG:00000']
939,HP,HP:0005368,Abnormality of humoral immunity,6.011422864441286e-12,True,"An abnormality of the humoral immune system, which comprises antibodies produced by B cells as well as the complement system.",315,71,27,4958,0.38028169014084506,0.08571428571428572,Module 1,['HP:0010978']
940,GO:BP,GO:0098542,defense response to other organism,6.1874968967079095e-12,True,"""Reactions triggered in response to the presence of another organism that act to protect the cell or organism from damage caused by that organism."" [GOC:dos]",1220,226,48,21031,0.21238938053097345,0.03934426229508197,Module 1,"['GO:0006952', 'GO:0051707']"
941,GO:BP,GO:1901700,response to oxygen-containing compound,6.195327481136843e-12,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oxygen-containing compound stimulus."" [GOC:pr, GOC:TermGenie]",1663,215,55,21031,0.2558139534883721,0.03307276007215875,Module 2,['GO:0042221']
942,HPA,HPA:0131331,colon; mucosal lymphoid cells[≥Low],6.258667150753287e-12,True,colon; mucosal lymphoid cells[≥Low],509,185,37,11019,0.2,0.07269155206286837,Module 1,['HPA:0130000']
943,HP,HP:0001518,Small for gestational age,6.511566877687077e-12,True,"Smaller than normal size according to sex and gestational age related norms, defined as a weight below the 10th percentile for the gestational age.",255,44,20,4958,0.45454545454545453,0.0784313725490196,Module 3,['HP:0004325']
944,TF,TF:M00803_1,Factor: E2F; motif: GGCGSG; match class: 1,6.709026321474647e-12,True,Factor: E2F; motif: GGCGSG; match class: 1,10535,826,544,20045,0.6585956416464891,0.051637399145704796,Module 0,['TF:M00803']
945,GO:BP,GO:0050794,regulation of cellular process,7.069192387850877e-12,True,"""Any process that modulates the frequency, rate or extent of a cellular process, any of those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level."" [GOC:go_curators]",11738,226,182,21031,0.8053097345132744,0.015505196796728574,Module 1,"['GO:0009987', 'GO:0050789']"
946,HPA,HPA:0300413,lung; macrophages[High],7.093672134789375e-12,True,lung; macrophages[High],1371,612,142,11019,0.23202614379084968,0.10357403355215171,Module 0,['HPA:0300412']
947,HPA,HPA:0400053,rectum; glandular cells[High],7.44367373481724e-12,True,rectum; glandular cells[High],2575,612,224,11019,0.3660130718954248,0.08699029126213592,Module 0,['HPA:0400052']
948,TF,TF:M08266_1,Factor: ER71:Pax-5; motif: ACCGGAACYACGCWTSANTG; match class: 1,7.766847122889676e-12,True,Factor: ER71:Pax-5; motif: ACCGGAACYACGCWTSANTG; match class: 1,9206,826,490,20045,0.5932203389830508,0.053226156854225506,Module 0,['TF:M08266']
949,TF,TF:M09641,Factor: NRF-1; motif: SYGCGCMTGCGCRNNGSN,7.840752051290941e-12,True,Factor: NRF-1; motif: SYGCGCMTGCGCRNNGSN,3323,826,225,20045,0.27239709443099275,0.06770990069214565,Module 0,['TF:M00000']
950,TF,TF:M08205_1,Factor: E2F-1:Elk-1; motif: SGCGCSNNAMCGGAAGT; match class: 1,7.875489098315245e-12,True,Factor: E2F-1:Elk-1; motif: SGCGCSNNAMCGGAAGT; match class: 1,10744,826,552,20045,0.6682808716707022,0.05137751303052867,Module 0,['TF:M08205']
951,GO:BP,GO:0048583,regulation of response to stimulus,7.899573753641095e-12,True,"""Any process that modulates the frequency, rate or extent of a response to a stimulus. Response to stimulus is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus."" [GOC:jid]",3939,226,93,21031,0.41150442477876104,0.02361005331302361,Module 1,"['GO:0050789', 'GO:0050896']"
952,REAC,REAC:R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,7.95479511247477e-12,True,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,57,19,8,10842,0.42105263157894735,0.14035087719298245,Module 9,['REAC:R-HSA-2262752']
953,HPA,HPA:0461441,skin 1; fibrohistiocytic cells[≥Low],8.026016212547386e-12,True,skin 1; fibrohistiocytic cells[≥Low],885,166,46,11019,0.27710843373493976,0.0519774011299435,Module 2,['HPA:0460000']
954,GO:BP,GO:0055086,nucleobase-containing small molecule metabolic process,8.126602346906758e-12,True,"""The cellular chemical reactions and pathways involving a nucleobase-containing small molecule: a nucleobase, a nucleoside, or a nucleotide."" [GOC:vw]",677,787,71,21031,0.09021601016518424,0.10487444608567208,Module 0,"['GO:0006139', 'GO:0044281']"
955,GO:BP,GO:0044419,biological process involved in interspecies interaction between organisms,8.623998142617488e-12,True,"""Any process evolved to enable an interaction with an organism of a different species."" [GOC:cc]",1724,34,21,21031,0.6176470588235294,0.012180974477958236,Module 7,['GO:0008150']
956,GO:BP,GO:0009117,nucleotide metabolic process,8.734046615659187e-12,True,"""The chemical reactions and pathways involving a nucleotide, a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic nucleotides (nucleoside cyclic phosphates)."" [GOC:ma]",601,787,66,21031,0.08386277001270648,0.10981697171381032,Module 0,['GO:0006753']
957,GO:CC,GO:0071735,IgG immunoglobulin complex,8.839418535265756e-12,True,"""A protein complex composed of two identical immunoglobulin heavy chains of an IgG isotype and two identical immunoglobulin light chains, held together by disulfide bonds. An IgG immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph."" [GOC:add, ISBN:0781765196]",8,73,6,22097,0.0821917808219178,0.75,Module 4,['GO:0019814']
958,HPA,HPA:0401331,rectum; mucosal lymphoid cells[≥Low],8.856459024438376e-12,True,rectum; mucosal lymphoid cells[≥Low],543,185,38,11019,0.20540540540540542,0.06998158379373849,Module 1,['HPA:0400000']
959,GO:BP,GO:0044237,cellular metabolic process,8.905610620169016e-12,True,"""The chemical reactions and pathways by which individual cells transform chemical substances."" [GOC:go_curators]",12881,105,99,21031,0.9428571428571428,0.007685738684884714,Module 3,"['GO:0008152', 'GO:0009987']"
960,HPA,HPA:0471472,skin 2; lymphocytes[≥Medium],8.93038778738918e-12,True,skin 2; lymphocytes[≥Medium],647,69,25,11019,0.36231884057971014,0.03863987635239567,Module 5,['HPA:0471471']
961,HPA,HPA:0090161,cerebellum; Purkinje cells[≥Low],8.939819949833003e-12,True,cerebellum; Purkinje cells[≥Low],5579,612,400,11019,0.6535947712418301,0.0716974368166338,Module 0,['HPA:0090000']
962,KEGG,KEGG:04640,Hematopoietic cell lineage,9.397862324897605e-12,True,Hematopoietic cell lineage,92,13,8,8484,0.6153846153846154,0.08695652173913043,Module 6,['KEGG:00000']
963,TF,TF:M08887,Factor: IRF; motif: NNGAAANTGAAANN,9.45913404085537e-12,True,Factor: IRF; motif: NNGAAANTGAAANN,1305,36,20,20045,0.5555555555555556,0.01532567049808429,Module 7,['TF:M00000']
964,HPA,HPA:0461461,skin 1; langerhans cells[≥Low],1.0056629434222686e-11,True,skin 1; langerhans cells[≥Low],716,69,26,11019,0.37681159420289856,0.036312849162011177,Module 5,['HPA:0460000']
965,HP,HP:0031409,Abnormal lymphocyte physiology,1.0807741251187002e-11,True,Any anomaly of lymphocyte function.,294,71,26,4958,0.36619718309859156,0.08843537414965986,Module 1,"['HP:0011017', 'HP:0033796']"
966,HP,HP:0033796,Abnormal leukocyte physiology,1.0807741251187002e-11,True,A functional abnormality of a white blood cell.,294,71,26,4958,0.36619718309859156,0.08843537414965986,Module 1,"['HP:0001871', 'HP:0010978']"
967,HP,HP:0410242,Abnormal circulating IgG level,1.0882575956867827e-11,True,An abnormal deviation from normal levels of IgG immunoglobulin in blood.,112,71,18,4958,0.2535211267605634,0.16071428571428573,Module 1,['HP:0010701']
968,REAC,REAC:R-HSA-877300,Interferon gamma signaling,1.1027958036609064e-11,True,Interferon gamma signaling,87,14,8,10842,0.5714285714285714,0.09195402298850575,Module 6,['REAC:R-HSA-913531']
969,GO:BP,GO:0010467,gene expression,1.1197734770127014e-11,True,"""The process in which a gene's sequence is converted into a mature gene product (protein or RNA). This includes the production of an RNA transcript and its processing, as well as translation and maturation for protein-coding genes."" [GOC:txnOH-2018, PMID:25934543, PMID:31580950]",9214,105,85,21031,0.8095238095238095,0.00922509225092251,Module 3,['GO:0009059']
970,HPA,HPA:0470203,skin 2; endothelial cells[High],1.1466260097835283e-11,True,skin 2; endothelial cells[High],321,69,19,11019,0.2753623188405797,0.059190031152647975,Module 5,['HPA:0470202']
971,HP,HP:0002721,Immunodeficiency,1.1800650127224866e-11,True,"Failure of the immune system to protect the body adequately from infection, due to the absence or insufficiency of some component process or substance.",217,71,23,4958,0.323943661971831,0.10599078341013825,Module 1,['HP:0010978']
972,HP,HP:0001911,Abnormal granulocyte morphology,1.1914053087467851e-11,True,Any structural abnormality or abnormal count of granulocytes.,302,44,21,4958,0.4772727272727273,0.0695364238410596,Module 3,['HP:0010974']
973,GO:BP,GO:0045087,innate immune response,1.2576276287852015e-11,True,"""Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens."" [GO_REF:0000022, GOC:add, GOC:ebc, GOC:mtg_sensu]",965,215,41,21031,0.19069767441860466,0.04248704663212435,Module 2,"['GO:0006955', 'GO:0140546']"
974,TF,TF:M04696,Factor: YY1; motif: GCCGCCATNTTGNNNNNGGNCN,1.3030407644104733e-11,True,Factor: YY1; motif: GCCGCCATNTTGNNNNNGGNCN,7892,826,434,20045,0.5254237288135594,0.054992397364419666,Module 0,['TF:M00000']
975,GO:BP,GO:0007049,cell cycle,1.3826163877265073e-11,True,"""The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division."" [GOC:go_curators, GOC:mtg_cell_cycle]",1819,77,32,21031,0.4155844155844156,0.017592083562396922,Module 5,['GO:0009987']
976,TF,TF:M08760,Factor: ETV7; motif: NNSCGGAAGTR,1.4867543446390615e-11,True,Factor: ETV7; motif: NNSCGGAAGTR,2410,826,177,20045,0.21428571428571427,0.07344398340248963,Module 0,['TF:M00000']
977,HPA,HPA:0040083,bone marrow; hematopoietic cells[High],1.5592486743602873e-11,True,bone marrow; hematopoietic cells[High],1453,69,35,11019,0.5072463768115942,0.024088093599449415,Module 5,['HPA:0040082']
978,HPA,HPA:0030053,appendix; glandular cells[High],1.5772865650547473e-11,True,appendix; glandular cells[High],1882,612,177,11019,0.28921568627450983,0.09404888416578108,Module 0,['HPA:0030052']
979,REAC,REAC:R-HSA-202430,Translocation of ZAP-70 to Immunological synapse,1.5805951377841932e-11,True,Translocation of ZAP-70 to Immunological synapse,20,14,6,10842,0.42857142857142855,0.3,Module 6,['REAC:R-HSA-202403']
980,TF,TF:M00740,Factor: Rb:E2F-1:DP-1; motif: TTTSGCGC,1.6285676755712273e-11,True,Factor: Rb:E2F-1:DP-1; motif: TTTSGCGC,10725,826,550,20045,0.6658595641646489,0.05128205128205128,Module 0,['TF:M00000']
981,GO:BP,GO:0006753,nucleoside phosphate metabolic process,1.6598167879240156e-11,True,"""The chemical reactions and pathways involving any phosphorylated nucleoside."" [GOC:mah]",609,787,66,21031,0.08386277001270648,0.10837438423645321,Module 0,"['GO:0006796', 'GO:0019637', 'GO:0055086']"
982,HPA,HPA:0471443,skin 2; fibrohistiocytic cells[High],1.6932781558063953e-11,True,skin 2; fibrohistiocytic cells[High],467,166,33,11019,0.19879518072289157,0.07066381156316917,Module 2,['HPA:0471442']
983,HPA,HPA:0360053,parathyroid gland; glandular cells[High],1.6988860358302283e-11,True,parathyroid gland; glandular cells[High],1553,612,154,11019,0.25163398692810457,0.09916291049581455,Module 0,['HPA:0360052']
984,TF,TF:M04710_1,Factor: CHD2; motif: TCTCGCGAG; match class: 1,1.7168049043117463e-11,True,Factor: CHD2; motif: TCTCGCGAG; match class: 1,11754,826,590,20045,0.7142857142857143,0.050195678067041005,Module 0,['TF:M04710']
985,HP,HP:0011361,Congenital abnormal hair pattern,1.7757722920168026e-11,True,A congenital abnormality of the distribution of hair growth.,308,44,21,4958,0.4772727272727273,0.06818181818181818,Module 3,['HP:0010720']
986,TF,TF:M11531_1,Factor: E2F-2; motif: GCGCGCGCGYW; match class: 1,1.8132114220354917e-11,True,Factor: E2F-2; motif: GCGCGCGCGYW; match class: 1,12708,826,626,20045,0.7578692493946732,0.049260308467107335,Module 0,['TF:M11531']
987,GO:BP,GO:0043603,amide metabolic process,1.8239616052481105e-11,True,"""The chemical reactions and pathways involving an amide, any derivative of an oxoacid in which an acidic hydroxy group has been replaced by an amino or substituted amino group, as carried out by individual cells."" [GOC:curators]",1194,787,101,21031,0.12833545108005082,0.08458961474036851,Module 0,['GO:0006807']
988,HPA,HPA:0600432,tonsil; germinal center cells[≥Medium],1.886717153556394e-11,True,tonsil; germinal center cells[≥Medium],4100,69,56,11019,0.8115942028985508,0.013658536585365854,Module 5,['HPA:0600431']
989,TF,TF:M00426,Factor: E2F; motif: TTTSGCGS,1.9125220364854543e-11,True,Factor: E2F; motif: TTTSGCGS,12231,826,608,20045,0.7360774818401937,0.04970975390401439,Module 0,['TF:M00000']
990,HPA,HPA:0310442,lymph node; non-germinal center cells[≥Medium],1.980542637378891e-11,True,lymph node; non-germinal center cells[≥Medium],3989,140,94,11019,0.6714285714285714,0.023564803208824266,Module Singleton,['HPA:0310441']
991,HPA,HPA:0310000,lymph node,2.017272137518275e-11,True,lymph node,6530,140,123,11019,0.8785714285714286,0.01883614088820827,Module Singleton,['HPA:0000000']
992,TF,TF:M09608_1,Factor: Erg; motif: NNACCGGAARTSN; match class: 1,2.042652653911574e-11,True,Factor: Erg; motif: NNACCGGAARTSN; match class: 1,2437,826,178,20045,0.21549636803874092,0.07304062371768567,Module 0,['TF:M09608']
993,HPA,HPA:0420000,salivary gland,2.0583666539110865e-11,True,salivary gland,6902,79,77,11019,0.9746835443037974,0.011156186612576065,Module 3,['HPA:0000000']
994,HPA,HPA:0420051,salivary gland; glandular cells[≥Low],2.0583666539110865e-11,True,salivary gland; glandular cells[≥Low],6902,79,77,11019,0.9746835443037974,0.011156186612576065,Module 3,['HPA:0420000']
995,HPA,HPA:0471413,skin 2; cells in spinous layer[High],2.0666276600822845e-11,True,skin 2; cells in spinous layer[High],248,612,47,11019,0.07679738562091504,0.18951612903225806,Module 0,['HPA:0471412']
996,HP,HP:0007379,Neoplasm of the genitourinary tract,2.1169883437596887e-11,True,A tumor (abnormal growth of tissue) of the genitourinary system.,234,44,19,4958,0.4318181818181818,0.0811965811965812,Module 3,"['HP:0000119', 'HP:0011793']"
997,TF,TF:M00032_1,Factor: c-Ets-1(p54); motif: NCMGGAWGYN; match class: 1,2.572233183835443e-11,True,Factor: c-Ets-1(p54); motif: NCMGGAWGYN; match class: 1,2218,826,166,20045,0.2009685230024213,0.07484220018034266,Module 0,['TF:M00032']
998,GO:CC,GO:0005764,lysosome,2.5828008370758355e-11,True,"""A small lytic vacuole that has cell cycle-independent morphology found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions."" [GOC:mah, ISBN:0198506732]",762,813,73,22097,0.0897908979089791,0.09580052493438321,Module 0,['GO:0000323']
999,GO:CC,GO:0000323,lytic vacuole,2.5828008370758355e-11,True,"""A vacuole that is maintained at an acidic pH and which contains degradative enzymes, including a wide variety of acid hydrolases."" [GOC:krc]",762,813,73,22097,0.0897908979089791,0.09580052493438321,Module 0,['GO:0005773']
1000,REAC,REAC:R-HSA-162906,HIV Infection,2.6549456065760853e-11,True,HIV Infection,225,586,44,10842,0.07508532423208192,0.19555555555555557,Module 0,['REAC:R-HSA-9824446']
1001,GO:MF,GO:0031625,ubiquitin protein ligase binding,2.7396304321051972e-11,True,"""Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins."" [GOC:vp]",308,20,10,20212,0.5,0.032467532467532464,Module 9,['GO:0044389']
1002,GO:MF,GO:0019843,rRNA binding,2.7408768462663913e-11,True,"""Binding to a ribosomal RNA."" [GOC:jl]",67,105,11,20212,0.10476190476190476,0.16417910447761194,Module 3,['GO:0003723']
1003,REAC,REAC:R-HSA-6799198,Complex I biogenesis,2.8096300821324315e-11,True,Complex I biogenesis,57,586,22,10842,0.03754266211604096,0.38596491228070173,Module 0,['REAC:R-HSA-611105']
1004,TF,TF:M11655,Factor: HSF1; motif: NGAANGTTCKRGAAN,2.8108620560296376e-11,True,Factor: HSF1; motif: NGAANGTTCKRGAAN,1192,21,15,20045,0.7142857142857143,0.012583892617449664,Module 9,['TF:M00000']
1005,HPA,HPA:0401332,rectum; mucosal lymphoid cells[≥Medium],2.92564101399461e-11,True,rectum; mucosal lymphoid cells[≥Medium],398,185,32,11019,0.17297297297297298,0.08040201005025126,Module 1,['HPA:0401331']
1006,HPA,HPA:0220053,gallbladder; glandular cells[High],2.930617494852046e-11,True,gallbladder; glandular cells[High],2874,612,241,11019,0.3937908496732026,0.0838552540013918,Module 0,['HPA:0220052']
1007,GO:CC,GO:0005576,extracellular region,3.031287749255153e-11,True,"""The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite."" [GOC:go_curators]",4213,105,54,22097,0.5142857142857142,0.012817469736529788,Module 3,['GO:0110165']
1008,TF,TF:M12599,Factor: E2F4; motif: YCCCGCCNCNNSSNNSNN,3.079320147309582e-11,True,Factor: E2F4; motif: YCCCGCCNCNNSSNNSNN,17574,826,788,20045,0.9539951573849879,0.044838966655286215,Module 0,['TF:M00000']
1009,GO:BP,GO:0006259,DNA metabolic process,3.231064455785803e-11,True,"""Any cellular metabolic process involving deoxyribonucleic acid. This is one of the two main types of nucleic acid, consisting of a long, unbranched macromolecule formed from one, or more commonly, two, strands of linked deoxyribonucleotides."" [ISBN:0198506732]",1040,77,25,21031,0.3246753246753247,0.02403846153846154,Module 5,['GO:0090304']
1010,GO:BP,GO:0043067,regulation of programmed cell death,3.25062323934782e-11,True,"""Any process that modulates the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes."" [GOC:jl]",1506,215,51,21031,0.2372093023255814,0.03386454183266932,Module 2,"['GO:0012501', 'GO:0050794']"
1011,GO:BP,GO:0045087,innate immune response,3.314445964100173e-11,True,"""Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens."" [GO_REF:0000022, GOC:add, GOC:ebc, GOC:mtg_sensu]",965,34,17,21031,0.5,0.017616580310880828,Module 7,"['GO:0006955', 'GO:0140546']"
1012,HPA,HPA:0510701,soft tissue 2; peripheral nerve[≥Low],3.3769990509325086e-11,True,soft tissue 2; peripheral nerve[≥Low],3199,612,261,11019,0.4264705882352941,0.08158799624882776,Module 0,['HPA:0510000']
1013,HPA,HPA:0461491,skin 1; vascular mural cells[≥Low],3.44817040781422e-11,True,skin 1; vascular mural cells[≥Low],242,612,46,11019,0.07516339869281045,0.19008264462809918,Module 0,['HPA:0460000']
1014,HPA,HPA:0310433,lymph node; germinal center cells[High],3.461453353347987e-11,True,lymph node; germinal center cells[High],944,612,108,11019,0.17647058823529413,0.11440677966101695,Module 0,['HPA:0310432']
1015,GO:BP,GO:0051246,regulation of protein metabolic process,3.4720795292375535e-11,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a protein."" [GOC:ai]",2102,787,148,21031,0.1880559085133418,0.07040913415794481,Module 0,"['GO:0019538', 'GO:0051171', 'GO:0060255', 'GO:0080090']"
1016,HPA,HPA:0461492,skin 1; vascular mural cells[≥Medium],3.808748935195857e-11,True,skin 1; vascular mural cells[≥Medium],189,612,40,11019,0.06535947712418301,0.21164021164021163,Module 0,['HPA:0461491']
1017,GO:BP,GO:0019693,ribose phosphate metabolic process,3.897031263315095e-11,True,"""The chemical reactions and pathways involving ribose phosphate, any phosphorylated ribose sugar."" [GOC:ai]",485,787,57,21031,0.0724269377382465,0.11752577319587629,Module 0,"['GO:0006796', 'GO:0019637', 'GO:1901135']"
1018,GO:BP,GO:0009259,ribonucleotide metabolic process,4.0604324821304065e-11,True,"""The chemical reactions and pathways involving a ribonucleotide, a compound consisting of ribonucleoside (a base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:go_curators, ISBN:0198506732]",471,787,56,21031,0.07115628970775095,0.11889596602972399,Module 0,"['GO:0009117', 'GO:0019693']"
1019,REAC,REAC:R-HSA-202427,Phosphorylation of CD3 and TCR zeta chains,4.1087026605060335e-11,True,Phosphorylation of CD3 and TCR zeta chains,23,14,6,10842,0.42857142857142855,0.2608695652173913,Module 6,['REAC:R-HSA-202403']
1020,TF,TF:M00678,Factor: Tel-2; motif: YTACTTCCTG,4.3777482819495345e-11,True,Factor: Tel-2; motif: YTACTTCCTG,5364,826,320,20045,0.387409200968523,0.05965697240865026,Module 0,['TF:M00000']
1021,GO:MF,GO:0045296,cadherin binding,4.489888989608816e-11,True,"""Binding to cadherin, a type I membrane protein involved in cell adhesion."" [GOC:bf]",335,808,47,20212,0.05816831683168317,0.14029850746268657,Module 0,['GO:0050839']
1022,REAC,REAC:R-HSA-162909,Host Interactions of HIV factors,4.514970933238532e-11,True,Host Interactions of HIV factors,126,586,32,10842,0.05460750853242321,0.25396825396825395,Module 0,['REAC:R-HSA-162906']
1023,HPA,HPA:0170252,endometrium 2; cells in endometrial stroma[≥Medium],4.591663762242489e-11,True,endometrium 2; cells in endometrial stroma[≥Medium],1801,612,170,11019,0.2777777777777778,0.09439200444197668,Module 0,['HPA:0170251']
1024,GO:BP,GO:0009266,response to temperature stimulus,4.765720784816056e-11,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a temperature stimulus."" [GOC:hb]",169,21,9,21031,0.42857142857142855,0.05325443786982249,Module 9,['GO:0009628']
1025,GO:MF,GO:0044389,ubiquitin-like protein ligase binding,4.834727479651287e-11,True,"""Binding to a ubiquitin-like protein ligase, such as ubiquitin-ligase."" [GOC:jl]",326,20,10,20212,0.5,0.03067484662576687,Module 9,['GO:0019899']
1026,TF,TF:M04691_1,Factor: Kaiso; motif: TCTCGCGAG; match class: 1,4.861184379998633e-11,True,Factor: Kaiso; motif: TCTCGCGAG; match class: 1,10748,826,549,20045,0.6646489104116223,0.05107927056196502,Module 0,['TF:M04691']
1027,GO:BP,GO:0048525,negative regulation of viral process,4.88093516738639e-11,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of a multi-organism process in which a virus is a participant."" [GOC:bf, GOC:jl]",95,34,9,21031,0.2647058823529412,0.09473684210526316,Module 7,"['GO:0016032', 'GO:0048519', 'GO:0050792']"
1028,GO:CC,GO:0031982,vesicle,4.89969508200655e-11,True,"""Any small, fluid-filled, spherical organelle enclosed by membrane."" [GOC:mah, GOC:pz, GOC:vesicles]",4004,177,74,22097,0.4180790960451977,0.01848151848151848,Module Singleton,['GO:0043227']
1029,TF,TF:M09894,Factor: E2F-4; motif: SNGGGCGGGAANN,4.916258972741811e-11,True,Factor: E2F-4; motif: SNGGGCGGGAANN,16606,826,759,20045,0.9188861985472155,0.045706371191135735,Module 0,['TF:M00000']
1030,TF,TF:M01023_1,Factor: HSF1; motif: NTTCTRGAAVNTTCTYM; match class: 1,5.1565077652319366e-11,True,Factor: HSF1; motif: NTTCTRGAAVNTTCTYM; match class: 1,253,21,10,20045,0.47619047619047616,0.039525691699604744,Module 9,['TF:M01023']
1031,HPA,HPA:0530721,spleen; cells in white pulp[≥Low],5.215705353733923e-11,True,spleen; cells in white pulp[≥Low],4339,79,63,11019,0.7974683544303798,0.014519474533302604,Module 3,['HPA:0530000']
1032,GO:BP,GO:0009408,response to heat,5.4616541147399463e-11,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism."" [GOC:lr]",99,21,8,21031,0.38095238095238093,0.08080808080808081,Module 9,"['GO:0006950', 'GO:0009266']"
1033,REAC,REAC:R-HSA-389948,PD-1 signaling,5.4747995187007666e-11,True,PD-1 signaling,24,14,6,10842,0.42857142857142855,0.25,Module 6,['REAC:R-HSA-388841']
1034,TF,TF:M04059,Factor: NRF-1; motif: YGCGCATGCGCN,5.5096176554761336e-11,True,Factor: NRF-1; motif: YGCGCATGCGCN,1498,826,125,20045,0.1513317191283293,0.08344459279038718,Module 0,['TF:M00000']
1035,REAC,REAC:R-HSA-180585,Vif-mediated degradation of APOBEC3G,5.721685356409724e-11,True,Vif-mediated degradation of APOBEC3G,53,586,21,10842,0.03583617747440273,0.39622641509433965,Module 0,['REAC:R-HSA-162909']
1036,HPA,HPA:0570733,testis; Leydig cells[High],5.938313123750214e-11,True,testis; Leydig cells[High],1777,612,168,11019,0.27450980392156865,0.09454136184580754,Module 0,['HPA:0570732']
1037,KEGG,KEGG:05169,Epstein-Barr virus infection,6.152498803775674e-11,True,Epstein-Barr virus infection,198,13,9,8484,0.6923076923076923,0.045454545454545456,Module 6,['KEGG:00000']
1038,REAC,REAC:R-HSA-5663205,Infectious disease,6.189490700940482e-11,True,Infectious disease,999,586,110,10842,0.18771331058020477,0.11011011011011011,Module 0,['REAC:R-HSA-1643685']
1039,GO:CC,GO:0012505,endomembrane system,6.27928867303772e-11,True,"""A collection of membranous structures involved in transport within the cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles."" [GOC:lh]",4777,813,264,22097,0.3247232472324723,0.05526481055055474,Module 0,['GO:0110165']
1040,GO:CC,GO:0030135,coated vesicle,6.324950760409606e-11,True,"""Small membrane-bounded organelle formed by pinching off of a coated region of membrane. Some coats are made of clathrin, whereas others are made from other proteins."" [ISBN:0815316194]",312,17,9,22097,0.5294117647058824,0.028846153846153848,Module 6,['GO:0031410']
1041,HP,HP:0010974,Abnormal myeloid leukocyte morphology,6.325599306114478e-11,True,An abnormality of myeloid leukocytes.,328,44,21,4958,0.4772727272727273,0.06402439024390244,Module 3,['HP:0001881']
1042,HPA,HPA:0380522,placenta; trophoblastic cells[≥Medium],6.348894132913397e-11,True,placenta; trophoblastic cells[≥Medium],5050,612,368,11019,0.6013071895424836,0.07287128712871287,Module 0,['HPA:0380521']
1043,GO:CC,GO:0000502,proteasome complex,6.46422606604769e-11,True,"""A large multisubunit complex which catalyzes protein degradation, found in eukaryotes, archaea and some bacteria. In eukaryotes, this complex consists of the barrel shaped proteasome core complex and one or two associated proteins or complexes that act in regulating entry into or exit from the core."" [GOC:rb, Wikipedia:Proteasome]",67,813,20,22097,0.024600246002460024,0.29850746268656714,Module 0,"['GO:0140535', 'GO:1905369']"
1044,HPA,HPA:0030442,appendix; non-germinal center cells[≥Medium],6.60017819977888e-11,True,appendix; non-germinal center cells[≥Medium],263,185,26,11019,0.14054054054054055,0.09885931558935361,Module 1,['HPA:0030441']
1045,GO:BP,GO:1902600,proton transmembrane transport,6.743385440726687e-11,True,"""The directed movement of a proton across a membrane."" [GO_REF:0000069, GOC:pr, GOC:TermGenie]",159,787,31,21031,0.03939008894536213,0.1949685534591195,Module 0,"['GO:0098655', 'GO:0098662']"
1046,TF,TF:M00738_1,Factor: E2F-4:DP-1; motif: TTTSGCGC; match class: 1,6.753055448057914e-11,True,Factor: E2F-4:DP-1; motif: TTTSGCGC; match class: 1,4124,826,261,20045,0.3159806295399516,0.06328806983511154,Module 0,['TF:M00738']
1047,GO:BP,GO:0033993,response to lipid,6.88381568802701e-11,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus."" [GOC:sl]",920,215,39,21031,0.1813953488372093,0.042391304347826085,Module 2,['GO:0010033']
1048,TF,TF:M11685,Factor: IRF-8; motif: NCGAAACYGAAACYN,6.999496842126669e-11,True,Factor: IRF-8; motif: NCGAAACYGAAACYN,1672,36,21,20045,0.5833333333333334,0.012559808612440191,Module 7,['TF:M00000']
1049,REAC,REAC:R-HSA-72165,mRNA Splicing - Minor Pathway,7.070733272663378e-11,True,mRNA Splicing - Minor Pathway,48,586,20,10842,0.034129692832764506,0.4166666666666667,Module 0,['REAC:R-HSA-72172']
1050,KEGG,KEGG:05321,Inflammatory bowel disease,7.086342540190688e-11,True,Inflammatory bowel disease,62,13,7,8484,0.5384615384615384,0.11290322580645161,Module 6,['KEGG:00000']
1051,GO:CC,GO:0031982,vesicle,7.503024189528621e-11,True,"""Any small, fluid-filled, spherical organelle enclosed by membrane."" [GOC:mah, GOC:pz, GOC:vesicles]",4004,105,52,22097,0.49523809523809526,0.012987012987012988,Module 3,['GO:0043227']
1052,HP,HP:0002250,Abnormal large intestine morphology,7.596499123179306e-11,True,Any abnormality of the large intestine.,331,44,21,4958,0.4772727272727273,0.0634441087613293,Module 3,['HP:0002242']
1053,HPA,HPA:0270352,kidney; cells in glomeruli[≥Medium],7.645629019444837e-11,True,kidney; cells in glomeruli[≥Medium],3090,612,253,11019,0.4133986928104575,0.08187702265372168,Module 0,['HPA:0270351']
1054,HPA,HPA:0461471,skin 1; lymphocytes[≥Low],7.837272042794648e-11,True,skin 1; lymphocytes[≥Low],712,69,25,11019,0.36231884057971014,0.0351123595505618,Module 5,['HPA:0460000']
1055,HP,HP:0002242,Abnormal intestine morphology,8.034368787138396e-11,True,An abnormality of the intestine. The closely related term enteropathy is used to refer to any disease of the intestine.,775,44,29,4958,0.6590909090909091,0.03741935483870968,Module 3,['HP:0012718']
1056,HPA,HPA:0250132,hippocampus; neuronal cells[≥Medium],8.153745056109037e-11,True,hippocampus; neuronal cells[≥Medium],4230,79,62,11019,0.7848101265822784,0.014657210401891253,Module 3,['HPA:0250131']
1057,GO:CC,GO:0070062,extracellular exosome,8.174924926035524e-11,True,"""A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm."" [GOC:BHF, GOC:mah, GOC:vesicles, PMID:15908444, PMID:17641064, PMID:19442504, PMID:19498381, PMID:22418571, PMID:24009894]",2109,177,51,22097,0.288135593220339,0.02418207681365576,Module Singleton,"['GO:0005615', 'GO:1903561']"
1058,TF,TF:M02069_1,Factor: Erm; motif: ACCGGAAGTN; match class: 1,8.808311163463981e-11,True,Factor: Erm; motif: ACCGGAAGTN; match class: 1,2008,826,153,20045,0.18523002421307505,0.07619521912350598,Module 0,['TF:M02069']
1059,GO:CC,GO:0005775,vacuolar lumen,8.811860588594623e-11,True,"""The volume enclosed within the vacuolar membrane."" [ISBN:0198506732]",178,221,18,22097,0.08144796380090498,0.10112359550561797,Module 2,"['GO:0005773', 'GO:0070013']"
1060,GO:CC,GO:0012505,endomembrane system,8.869273578906929e-11,True,"""A collection of membranous structures involved in transport within the cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles."" [GOC:lh]",4777,221,96,22097,0.4343891402714932,0.02009629474565627,Module 2,['GO:0110165']
1061,GO:BP,GO:0050776,regulation of immune response,8.977127743834366e-11,True,"""Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus."" [GOC:ai]",881,215,38,21031,0.17674418604651163,0.043132803632236094,Module 2,"['GO:0002682', 'GO:0006955', 'GO:0048583']"
1062,GO:BP,GO:0034470,ncRNA processing,9.504444604405885e-11,True,"""Any process that results in the conversion of one or more primary non-coding RNA (ncRNA) transcripts into one or more mature ncRNA molecules."" [GOC:mah, PMID:27573892]",438,105,20,21031,0.19047619047619047,0.045662100456621,Module 3,"['GO:0006396', 'GO:0034660']"
1063,HPA,HPA:0060103,bronchus; respiratory epithelial cells[High],9.62121451790911e-11,True,bronchus; respiratory epithelial cells[High],1845,612,172,11019,0.28104575163398693,0.09322493224932249,Module 0,['HPA:0060102']
1064,GO:BP,GO:0050863,regulation of T cell activation,9.801562915129032e-11,True,"""Any process that modulates the frequency, rate or extent of T cell activation."" [GOC:ai]",374,226,26,21031,0.11504424778761062,0.06951871657754011,Module 1,"['GO:0042110', 'GO:0051249']"
1065,HPA,HPA:0090163,cerebellum; Purkinje cells[High],9.812696930615815e-11,True,cerebellum; Purkinje cells[High],1552,79,38,11019,0.4810126582278481,0.024484536082474227,Module 3,['HPA:0090162']
1066,HPA,HPA:0530722,spleen; cells in white pulp[≥Medium],9.839833189932145e-11,True,spleen; cells in white pulp[≥Medium],2720,185,91,11019,0.4918918918918919,0.033455882352941176,Module 1,['HPA:0530721']
1067,GO:CC,GO:0005768,endosome,1.00013007220266e-10,True,"""A vacuole to which materials ingested by endocytosis are delivered."" [ISBN:0198506732, PMID:19696797]",1060,17,12,22097,0.7058823529411765,0.011320754716981131,Module 6,"['GO:0012505', 'GO:0031410']"
1068,TF,TF:M00333_1,Factor: ZF5; motif: NRNGNGCGCGCWN; match class: 1,1.0283733915683582e-10,True,Factor: ZF5; motif: NRNGNGCGCGCWN; match class: 1,12784,826,626,20045,0.7578692493946732,0.048967459324155194,Module 0,['TF:M00333']
1069,HPA,HPA:0461471,skin 1; lymphocytes[≥Low],1.0871666799585967e-10,True,skin 1; lymphocytes[≥Low],712,185,42,11019,0.22702702702702704,0.05898876404494382,Module 1,['HPA:0460000']
1070,CORUM,CORUM:178,"Respiratory chain complex I (holoenzyme), mitochondrial",1.1407270958248629e-10,True,"Respiratory chain complex I (holoenzyme), mitochondrial",44,331,23,3383,0.06948640483383686,0.5227272727272727,Module 0,['CORUM:0000000']
1071,GO:BP,GO:0006915,apoptotic process,1.161321285856531e-10,True,"""A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died."" [GOC:cjm, GOC:dhl, GOC:ecd, GOC:go_curators, GOC:mtg_apoptosis, GOC:tb, ISBN:0198506732, PMID:18846107, PMID:21494263]",1913,226,59,21031,0.2610619469026549,0.030841610036591742,Module 1,['GO:0012501']
1072,HPA,HPA:0040082,bone marrow; hematopoietic cells[≥Medium],1.1618274376895602e-10,True,bone marrow; hematopoietic cells[≥Medium],4256,69,56,11019,0.8115942028985508,0.013157894736842105,Module 5,['HPA:0040081']
1073,HP,HP:0004377,Hematological neoplasm,1.1726025400250702e-10,True,Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue).,296,44,20,4958,0.45454545454545453,0.06756756756756757,Module 3,"['HP:0001871', 'HP:0011793']"
1074,GO:CC,GO:1903561,extracellular vesicle,1.2647350746929187e-10,True,"""Any vesicle that is part of the extracellular region."" [GO_REF:0000064, GOC:pm, GOC:TermGenie, PMID:24769233]",2133,177,51,22097,0.288135593220339,0.02390998593530239,Module Singleton,"['GO:0031982', 'GO:0065010']"
1075,GO:CC,GO:0030666,endocytic vesicle membrane,1.2820858469481525e-10,True,"""The lipid bilayer surrounding an endocytic vesicle."" [GOC:mah]",200,17,8,22097,0.47058823529411764,0.04,Module 6,"['GO:0030139', 'GO:0030659', 'GO:0098588']"
1076,GO:CC,GO:0065010,extracellular membrane-bounded organelle,1.2877507379640568e-10,True,"""Organized structure of distinctive morphology and function, bounded by a lipid bilayer membrane and occurring outside the cell."" [GOC:isa_complete]",2134,177,51,22097,0.288135593220339,0.023898781630740395,Module Singleton,"['GO:0043227', 'GO:0043230']"
1077,GO:CC,GO:0043230,extracellular organelle,1.2877507379640568e-10,True,"""Organized structure of distinctive morphology and function, occurring outside the cell. Includes, for example, extracellular membrane vesicles (EMVs) and the cellulosomes of anaerobic bacteria and fungi."" [GOC:jl, PMID:9914479]",2134,177,51,22097,0.288135593220339,0.023898781630740395,Module Singleton,"['GO:0005576', 'GO:0043226']"
1078,HP,HP:0032309,Abnormal granulocyte count,1.288576405135233e-10,True,Any deviation from the normal cell count per volume of granulocytes in the blood circulation.,258,44,19,4958,0.4318181818181818,0.07364341085271318,Module 3,"['HP:0001911', 'HP:0011893']"
1079,TF,TF:M11601_1,Factor: TCF-1; motif: ACATCGRGRCGCTGW; match class: 1,1.2978157478157562e-10,True,Factor: TCF-1; motif: ACATCGRGRCGCTGW; match class: 1,11404,826,573,20045,0.6937046004842615,0.05024552788495265,Module 0,['TF:M11601']
1080,HPA,HPA:0080122,caudate; glial cells[≥Medium],1.3618729604620286e-10,True,caudate; glial cells[≥Medium],2317,612,203,11019,0.33169934640522875,0.08761329305135952,Module 0,['HPA:0080121']
1081,TF,TF:M00426_1,Factor: E2F; motif: TTTSGCGS; match class: 1,1.4454711677492125e-10,True,Factor: E2F; motif: TTTSGCGS; match class: 1,6004,826,347,20045,0.42009685230024213,0.05779480346435709,Module 0,['TF:M00426']
1082,GO:CC,GO:0034663,endoplasmic reticulum chaperone complex,1.4471593619873572e-10,True,"""A protein complex that is located in the endoplasmic reticulum and is composed of chaperone proteins, including BiP, GRP94; CaBP1, protein disulfide isomerase (PDI), ERdj3, cyclophilin B, ERp72, GRP170, UDP-glucosyltransferase, and SDF2-L1."" [PMID:12475965]",11,73,6,22097,0.0821917808219178,0.5454545454545454,Module 4,['GO:0140534']
1083,GO:BP,GO:0006955,immune response,1.4741372009585295e-10,True,"""Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat."" [GO_REF:0000022, GOC:add]",1988,34,21,21031,0.6176470588235294,0.01056338028169014,Module 7,"['GO:0002376', 'GO:0050896']"
1084,KEGG,KEGG:05166,Human T-cell leukemia virus 1 infection,1.4752115485515478e-10,True,Human T-cell leukemia virus 1 infection,218,13,9,8484,0.6923076923076923,0.04128440366972477,Module 6,['KEGG:00000']
1085,HPA,HPA:0471441,skin 2; fibrohistiocytic cells[≥Low],1.478973876984749e-10,True,skin 2; fibrohistiocytic cells[≥Low],1021,140,43,11019,0.30714285714285716,0.04211557296767875,Module Singleton,['HPA:0470000']
1086,HP,HP:0011873,Abnormal platelet count,1.6167251589620913e-10,True,"Abnormal number of platelets per volume of blood. In a healthy adult, a normal platelet count is between 150,000 and 450,000 per microliter of blood.",438,44,23,4958,0.5227272727272727,0.05251141552511415,Module 3,['HP:0011875']
1087,TF,TF:M11603,Factor: TCF-1; motif: ACATCGRGRCGCTGW,1.6580856817607384e-10,True,Factor: TCF-1; motif: ACATCGRGRCGCTGW,16683,826,760,20045,0.9200968523002422,0.045555355751363664,Module 0,['TF:M00000']
1088,GO:BP,GO:0050792,regulation of viral process,1.8327894914758292e-10,True,"""Any process that modulates the rate or extent of the viral life cycle, the set of processes by which a virus reproduces and spreads among hosts."" [GOC:go_curators, GOC:tb]",169,34,10,21031,0.29411764705882354,0.05917159763313609,Module 7,"['GO:0016032', 'GO:0050789']"
1089,GO:BP,GO:0042981,regulation of apoptotic process,1.834392419810339e-10,True,"""Any process that modulates the occurrence or rate of cell death by apoptotic process."" [GOC:jl, GOC:mtg_apoptosis]",1463,215,49,21031,0.22790697674418606,0.03349282296650718,Module 2,"['GO:0006915', 'GO:0043067']"
1090,REAC,REAC:R-HSA-2132295,MHC class II antigen presentation,1.9092404158477668e-10,True,MHC class II antigen presentation,123,14,8,10842,0.5714285714285714,0.06504065040650407,Module 6,['REAC:R-HSA-1280218']
1091,TF,TF:M03970_1,Factor: ELK1; motif: ACCGGAAGTN; match class: 1,1.9372179104723967e-10,True,Factor: ELK1; motif: ACCGGAAGTN; match class: 1,1133,826,102,20045,0.1234866828087167,0.09002647837599294,Module 0,['TF:M03970']
1092,HP,HP:0011875,Abnormal platelet morphology,1.9683279719638138e-10,True,"An anomaly in platelet form, ultrastructure, or intracellular organelles.",442,44,23,4958,0.5227272727272727,0.05203619909502263,Module 3,['HP:0001872']
1093,HPA,HPA:0250133,hippocampus; neuronal cells[High],2.077336827581324e-10,True,hippocampus; neuronal cells[High],1258,79,34,11019,0.43037974683544306,0.02702702702702703,Module 3,['HPA:0250132']
1094,GO:BP,GO:0031347,regulation of defense response,2.1036231525761962e-10,True,"""Any process that modulates the frequency, rate or extent of a defense response."" [GOC:mah]",768,215,35,21031,0.16279069767441862,0.045572916666666664,Module 2,"['GO:0006952', 'GO:0080134']"
1095,KEGG,KEGG:05140,Leishmaniasis,2.1094357234891736e-10,True,Leishmaniasis,72,13,7,8484,0.5384615384615384,0.09722222222222222,Module 6,['KEGG:00000']
1096,HPA,HPA:0530000,spleen,2.116144846265539e-10,True,spleen,5893,140,115,11019,0.8214285714285714,0.01951467843203801,Module Singleton,['HPA:0000000']
1097,TF,TF:M07370,Factor: YY1; motif: NNNNAARATGGNNNN,2.1274170938046723e-10,True,Factor: YY1; motif: NNNNAARATGGNNNN,5864,826,340,20045,0.4116222760290557,0.05798090040927694,Module 0,['TF:M00000']
1098,HP,HP:0000518,Cataract,2.1506674287038232e-10,True,A cataract is an opacity or clouding that develops in the crystalline lens of the eye or in its capsule.,804,44,29,4958,0.6590909090909091,0.036069651741293535,Module 3,['HP:0000517']
1099,HP,HP:0008678,Renal hypoplasia/aplasia,2.1946404217406548e-10,True,Absence or underdevelopment of the kidney.,349,44,21,4958,0.4772727272727273,0.06017191977077364,Module 3,['HP:0012210']
1100,HP,HP:0012210,Abnormal renal morphology,2.2259613592362303e-10,True,Any structural anomaly of the kidney.,1116,44,33,4958,0.75,0.02956989247311828,Module 3,['HP:0000077']
1101,TF,TF:M00793,Factor: YY1; motif: GCCATNTTN,2.3036680866105381e-10,True,Factor: YY1; motif: GCCATNTTN,4587,826,281,20045,0.34019370460048426,0.06126008284281666,Module 0,['TF:M00000']
1102,HP,HP:0410240,Abnormal circulating IgA level,2.355892419153059e-10,True,An abnormal deviation from normal levels of IgA immunoglobulin in blood.,96,71,16,4958,0.22535211267605634,0.16666666666666666,Module 1,['HP:0010701']
1103,GO:BP,GO:0034654,nucleobase-containing compound biosynthetic process,2.428858542507571e-10,True,"""The chemical reactions and pathways resulting in the formation of nucleobases, nucleosides, nucleotides and nucleic acids."" [GOC:mah]",4027,787,235,21031,0.29860228716645487,0.05835609634963993,Module 0,"['GO:0006139', 'GO:0018130', 'GO:0019438', 'GO:0044271', 'GO:1901362']"
1104,TF,TF:M07250,Factor: E2F-1; motif: NNNSSCGCSAANN,2.4345512439381615e-10,True,Factor: E2F-1; motif: NNNSSCGCSAANN,11049,826,558,20045,0.6755447941888619,0.050502307901167526,Module 0,['TF:M00000']
1105,GO:CC,GO:0005654,nucleoplasm,2.4609393994412695e-10,True,"""That part of the nuclear content other than the chromosomes or the nucleolus."" [GOC:ma, ISBN:0124325653]",4220,80,44,22097,0.55,0.01042654028436019,Module 5,"['GO:0031981', 'GO:0110165']"
1106,HP,HP:0001881,Abnormal leukocyte morphology,2.489548217773793e-10,True,An abnormality of leukocytes.,615,71,34,4958,0.4788732394366197,0.055284552845528454,Module 1,"['HP:0001871', 'HP:0010987']"
1107,HP,HP:0010987,Abnormal cellular immune system morphology,2.489548217773793e-10,True,An abnormality of the morphology or counts of the cells that make up the immune system.,615,71,34,4958,0.4788732394366197,0.055284552845528454,Module 1,['HP:0032251']
1108,HP,HP:0002843,Abnormal T cell morphology,2.4914649714364074e-10,True,An abnormality of T cells.,114,71,17,4958,0.23943661971830985,0.14912280701754385,Module 1,['HP:0004332']
1109,TF,TF:M10104,Factor: YY1; motif: CAARATGGCGGC,2.494696892147712e-10,True,Factor: YY1; motif: CAARATGGCGGC,6115,826,351,20045,0.42493946731234866,0.05739983646770237,Module 0,['TF:M00000']
1110,GO:BP,GO:0050727,regulation of inflammatory response,2.5332669775406554e-10,True,"""Any process that modulates the frequency, rate or extent of the inflammatory response, the immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents."" [GOC:ai]",375,215,25,21031,0.11627906976744186,0.06666666666666667,Module 2,"['GO:0006954', 'GO:0031347', 'GO:0032101']"
1111,GO:CC,GO:0031984,organelle subcompartment,2.7027103823851834e-10,True,"""A compartment that consists of a lumen and an enclosing membrane, and is part of an organelle."" [GOC:mah, GOC:pz]",1521,73,26,22097,0.3561643835616438,0.017094017094017096,Module 4,"['GO:0043227', 'GO:0043229', 'GO:0110165']"
1112,GO:CC,GO:0010008,endosome membrane,2.7353615142902154e-10,True,"""The lipid bilayer surrounding an endosome."" [GOC:mah]",567,17,10,22097,0.5882352941176471,0.01763668430335097,Module 6,"['GO:0005768', 'GO:0030659', 'GO:0098588']"
1113,REAC,REAC:R-HSA-3371556,Cellular response to heat stress,2.7375078934570377e-10,True,Cellular response to heat stress,87,19,8,10842,0.42105263157894735,0.09195402298850575,Module 9,['REAC:R-HSA-2262752']
1114,HP,HP:0001172,Abnormal thumb morphology,2.831579679413473e-10,True,An abnormal structure of the first digit of the hand.,400,44,22,4958,0.5,0.055,Module 3,['HP:0001167']
1115,HPA,HPA:0461491,skin 1; vascular mural cells[≥Low],2.8731136257977085e-10,True,skin 1; vascular mural cells[≥Low],242,69,16,11019,0.2318840579710145,0.06611570247933884,Module 5,['HPA:0460000']
1116,HP,HP:0010720,Abnormal hair pattern,2.9149871722952223e-10,True,An abnormality of the distribution of hair growth.,354,44,21,4958,0.4772727272727273,0.059322033898305086,Module 3,['HP:0001595']
1117,GO:BP,GO:0006952,defense response,3.0323817041052875e-10,True,"""Reactions, triggered in response to the presence of a foreign body or the occurrence of an injury, which result in restriction of damage to the organism attacked or prevention/recovery from the infection caused by the attack."" [GOC:go_curators]",1791,34,20,21031,0.5882352941176471,0.011166945840312675,Module 7,['GO:0006950']
1118,GO:BP,GO:0009150,purine ribonucleotide metabolic process,3.0542575953086734e-10,True,"""The chemical reactions and pathways involving a purine ribonucleotide, a compound consisting of ribonucleoside (a purine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:go_curators, ISBN:0198506732]",450,787,53,21031,0.06734434561626429,0.11777777777777777,Module 0,"['GO:0006163', 'GO:0009259']"
1119,HP,HP:0006265,Aplasia/Hypoplasia of fingers,3.0835916455624755e-10,True,Small/hypoplastic or absent/aplastic fingers.,355,44,21,4958,0.4772727272727273,0.059154929577464786,Module 3,"['HP:0001167', 'HP:0005927']"
1120,TF,TF:M08222,Factor: Elk-1:HOXB13; motif: ACCGGAAGTNGTAAAN,3.132090866839578e-10,True,Factor: Elk-1:HOXB13; motif: ACCGGAAGTNGTAAAN,7770,826,423,20045,0.5121065375302664,0.05444015444015444,Module 0,['TF:M00000']
1121,HP,HP:0009381,Short finger,3.216289670817476e-10,True,Abnormally short finger associated with developmental hypoplasia.,312,44,20,4958,0.45454545454545453,0.0641025641025641,Module 3,"['HP:0006265', 'HP:0011927']"
1122,HP,HP:0001427,Mitochondrial inheritance,3.34018587995539e-10,True,"A mode of inheritance that is observed for traits related to a gene encoded on the mitochondrial genome. Because the mitochondrial genome is essentially always maternally inherited, a mitochondrial condition can only be transmitted by females, although the condition can affect both sexes. The proportion of mutant mitochondria can vary (heteroplasmy).",16,44,8,4958,0.18181818181818182,0.5,Module 3,['HP:0034345']
1123,GO:BP,GO:0002449,lymphocyte mediated immunity,3.384215950617816e-10,True,"""Any process involved in the carrying out of an immune response by a lymphocyte."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",361,226,25,21031,0.11061946902654868,0.06925207756232687,Module 1,['GO:0002443']
1124,TF,TF:M07052,Factor: NRF-1; motif: GCGCMTGCGCN,3.527676654654824e-10,True,Factor: NRF-1; motif: GCGCMTGCGCN,2172,826,160,20045,0.1937046004842615,0.07366482504604052,Module 0,['TF:M00000']
1125,HP,HP:0008972,Decreased activity of mitochondrial respiratory chain,3.611995111966616e-10,True,Decreased activity of the mitochondrial respiratory chain.,136,228,30,4958,0.13157894736842105,0.22058823529411764,Module 0,['HP:0011922']
1126,GO:BP,GO:0009059,macromolecule biosynthetic process,3.7283341886595883e-10,True,"""The chemical reactions and pathways resulting in the formation of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass."" [GOC:mah]",9691,105,85,21031,0.8095238095238095,0.00877102466205758,Module 3,"['GO:0043170', 'GO:0044249', 'GO:1901576']"
1127,GO:MF,GO:0042277,peptide binding,3.728420072065758e-10,True,"""Binding to a peptide, an organic compound comprising two or more amino acids linked by peptide bonds."" [GOC:jl]",327,17,9,20212,0.5294117647058824,0.027522935779816515,Module 6,['GO:0033218']
1128,TF,TF:M08231,Factor: Elk-1:T-bet; motif: TCACACCGGAAGNN,3.7562117605471836e-10,True,Factor: Elk-1:T-bet; motif: TCACACCGGAAGNN,6763,826,379,20045,0.45883777239709445,0.05604021883779388,Module 0,['TF:M00000']
1129,TF,TF:M09613,Factor: Fli-1; motif: RCMGGAAGYGNNN,3.902548175540796e-10,True,Factor: Fli-1; motif: RCMGGAAGYGNNN,5273,826,312,20045,0.37772397094430993,0.059169353309311584,Module 0,['TF:M00000']
1130,HP,HP:0000517,Abnormal lens morphology,4.0114104557184994e-10,True,An abnormality of the lens.,823,44,29,4958,0.6590909090909091,0.03523693803159174,Module 3,['HP:0004328']
1131,HP,HP:0025015,Abnormal vascular morphology,4.0270980839402453e-10,True,Abnormal vascular morphology,1138,44,33,4958,0.75,0.02899824253075571,Module 3,"['HP:0002597', 'HP:0030680']"
1132,TF,TF:M04696_1,Factor: YY1; motif: GCCGCCATNTTGNNNNNGGNCN; match class: 1,4.1357642359616286e-10,True,Factor: YY1; motif: GCCGCCATNTTGNNNNNGGNCN; match class: 1,1972,826,149,20045,0.18038740920096852,0.0755578093306288,Module 0,['TF:M04696']
1133,HPA,HPA:0530721,spleen; cells in white pulp[≥Low],4.2160372064256693e-10,True,spleen; cells in white pulp[≥Low],4339,185,120,11019,0.6486486486486487,0.027656141968195436,Module 1,['HPA:0530000']
1134,GO:BP,GO:0051641,cellular localization,4.2949283536598073e-10,True,"""A cellular localization process whereby a substance or cellular entity, such as a protein complex or organelle, is transported to, and/or maintained in, a specific location within a cell including the localization of substances or cellular entities to the cell membrane."" [GOC:tb, GOC:vw]",3621,787,216,21031,0.2744599745870394,0.05965202982601491,Module 0,"['GO:0009987', 'GO:0051179']"
1135,KEGG,KEGG:03050,Proteasome,4.356187459860592e-10,True,Proteasome,46,439,18,8484,0.04100227790432802,0.391304347826087,Module 0,['KEGG:00000']
1136,HPA,HPA:0461442,skin 1; fibrohistiocytic cells[≥Medium],4.4094574641190686e-10,True,skin 1; fibrohistiocytic cells[≥Medium],699,69,24,11019,0.34782608695652173,0.034334763948497854,Module 5,['HPA:0461441']
1137,HPA,HPA:0471491,skin 2; vascular mural cells[≥Low],4.477861814891421e-10,True,skin 2; vascular mural cells[≥Low],240,612,44,11019,0.0718954248366013,0.18333333333333332,Module 0,['HPA:0470000']
1138,HPA,HPA:0461473,skin 1; lymphocytes[High],4.507337114217535e-10,True,skin 1; lymphocytes[High],394,69,19,11019,0.2753623188405797,0.048223350253807105,Module 5,['HPA:0461472']
1139,GO:BP,GO:0009605,response to external stimulus,4.5537559047275774e-10,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an external stimulus."" [GOC:hb]",2723,34,23,21031,0.6764705882352942,0.008446566287183254,Module 7,['GO:0050896']
1140,REAC,REAC:R-HSA-351202,Metabolism of polyamines,4.659107896179162e-10,True,Metabolism of polyamines,58,586,21,10842,0.03583617747440273,0.3620689655172414,Module 0,['REAC:R-HSA-71291']
1141,GO:CC,GO:1905369,endopeptidase complex,4.678970266051117e-10,True,"""A protein complex which is capable of endopeptidase activity."" [GO_REF:0000088, GOC:bhm, GOC:TermGenie, PMID:1689240]",91,813,22,22097,0.02706027060270603,0.24175824175824176,Module 0,['GO:1905368']
1142,HPA,HPA:0170053,endometrium 2; glandular cells[High],4.72658711166173e-10,True,endometrium 2; glandular cells[High],1333,612,134,11019,0.21895424836601307,0.1005251312828207,Module 0,['HPA:0170052']
1143,HPA,HPA:0530712,spleen; cells in red pulp[≥Medium],4.749484745853821e-10,True,spleen; cells in red pulp[≥Medium],3143,185,98,11019,0.5297297297297298,0.031180400890868598,Module 1,['HPA:0530711']
1144,HP,HP:0002733,Abnormal lymph node morphology,4.75279056987397e-10,True,A structural lymph node abnormality.,257,71,23,4958,0.323943661971831,0.08949416342412451,Module 1,['HP:0100763']
1145,HPA,HPA:0310431,lymph node; germinal center cells[≥Low],4.891349422293748e-10,True,lymph node; germinal center cells[≥Low],5061,140,105,11019,0.75,0.02074688796680498,Module Singleton,['HPA:0310000']
1146,HPA,HPA:0471393,skin 2; cells in basal layer[High],5.01507546018881e-10,True,skin 2; cells in basal layer[High],296,69,17,11019,0.2463768115942029,0.057432432432432436,Module 5,['HPA:0471392']
1147,TF,TF:M11882,Factor: pax-6; motif: NYACGCNYSANYGMNCN,5.040356436340183e-10,True,Factor: pax-6; motif: NYACGCNYSANYGMNCN,15852,826,732,20045,0.8861985472154964,0.04617713853141559,Module 0,['TF:M00000']
1148,HPA,HPA:0310432,lymph node; germinal center cells[≥Medium],5.066903889506242e-10,True,lymph node; germinal center cells[≥Medium],3302,69,49,11019,0.7101449275362319,0.014839491217443974,Module 5,['HPA:0310431']
1149,HPA,HPA:0470202,skin 2; endothelial cells[≥Medium],5.22453458627857e-10,True,skin 2; endothelial cells[≥Medium],637,69,23,11019,0.3333333333333333,0.03610675039246468,Module 5,['HPA:0470201']
1150,GO:CC,GO:0043229,intracellular organelle,5.383201717471877e-10,True,"""Organized structure of distinctive morphology and function, occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane."" [GOC:go_curators]",16018,105,103,22097,0.9809523809523809,0.006430265950805344,Module 3,"['GO:0005622', 'GO:0043226']"
1151,HPA,HPA:0640412,endometrium; macrophages[≥Medium],5.408401737992681e-10,True,endometrium; macrophages[≥Medium],26,166,10,11019,0.060240963855421686,0.38461538461538464,Module 2,['HPA:0640411']
1152,HPA,HPA:0640411,endometrium; macrophages[≥Low],5.408401737992681e-10,True,endometrium; macrophages[≥Low],26,166,10,11019,0.060240963855421686,0.38461538461538464,Module 2,['HPA:0640000']
1153,GO:CC,GO:0005576,extracellular region,5.434456045504158e-10,True,"""The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite."" [GOC:go_curators]",4213,238,92,22097,0.3865546218487395,0.021837170662235936,Module 1,['GO:0110165']
1154,HPA,HPA:0461472,skin 1; lymphocytes[≥Medium],5.515871691212655e-10,True,skin 1; lymphocytes[≥Medium],574,69,22,11019,0.3188405797101449,0.03832752613240418,Module 5,['HPA:0461471']
1155,REAC,REAC:R-HSA-1280215,Cytokine Signaling in Immune system,5.581926056827271e-10,True,Cytokine Signaling in Immune system,719,28,16,10842,0.5714285714285714,0.022253129346314324,Module 7,['REAC:R-HSA-168256']
1156,GO:BP,GO:0002237,response to molecule of bacterial origin,5.617692239200425e-10,True,"""Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin."" [GOC:rl, GOC:sm]",354,215,24,21031,0.11162790697674418,0.06779661016949153,Module 2,"['GO:0009617', 'GO:0010033', 'GO:0043207']"
1157,GO:BP,GO:0018130,heterocycle biosynthetic process,5.888082618574681e-10,True,"""The chemical reactions and pathways resulting in the formation of heterocyclic compounds, those with a cyclic molecular structure and at least two different atoms in the ring (or rings)."" [ISBN:0198547684]",4105,787,237,21031,0.301143583227446,0.05773447015834348,Module 0,"['GO:0044249', 'GO:0046483']"
1158,HPA,HPA:0471473,skin 2; lymphocytes[High],6.01633899971656e-10,True,skin 2; lymphocytes[High],456,69,20,11019,0.2898550724637681,0.043859649122807015,Module 5,['HPA:0471472']
1159,HPA,HPA:0461443,skin 1; fibrohistiocytic cells[High],6.041786969501384e-10,True,skin 1; fibrohistiocytic cells[High],408,166,29,11019,0.1746987951807229,0.07107843137254902,Module 2,['HPA:0461442']
1160,HPA,HPA:0460673,skin 1; melanocytes[High],6.04454471733051e-10,True,skin 1; melanocytes[High],986,612,108,11019,0.17647058823529413,0.10953346855983773,Module 0,['HPA:0460672']
1161,HPA,HPA:0310441,lymph node; non-germinal center cells[≥Low],6.258430598803269e-10,True,lymph node; non-germinal center cells[≥Low],6061,140,116,11019,0.8285714285714286,0.019138755980861243,Module Singleton,['HPA:0310000']
1162,REAC,REAC:R-HSA-202433,Generation of second messenger molecules,6.556448374794242e-10,True,Generation of second messenger molecules,35,14,6,10842,0.42857142857142855,0.17142857142857143,Module 6,['REAC:R-HSA-202403']
1163,GO:MF,GO:0005515,protein binding,6.562139145349196e-10,True,"""Binding to a protein."" [GOC:go_curators]",14838,218,201,20212,0.9220183486238532,0.013546300040436717,Module 2,['GO:0005488']
1164,TF,TF:M00740_1,Factor: Rb:E2F-1:DP-1; motif: TTTSGCGC; match class: 1,6.574911383321637e-10,True,Factor: Rb:E2F-1:DP-1; motif: TTTSGCGC; match class: 1,4732,826,286,20045,0.34624697336561744,0.06043956043956044,Module 0,['TF:M00740']
1165,HPA,HPA:0100122,cerebral cortex; glial cells[≥Medium],6.59787293217057e-10,True,cerebral cortex; glial cells[≥Medium],2681,612,224,11019,0.3660130718954248,0.0835509138381201,Module 0,['HPA:0100121']
1166,HPA,HPA:0530000,spleen,6.61993838133777e-10,True,spleen,5893,79,71,11019,0.8987341772151899,0.012048192771084338,Module 3,['HPA:0000000']
1167,TF,TF:M11662_1,Factor: HSF2; motif: RGAANGTTCYRGAAN; match class: 1,6.680591741029176e-10,True,Factor: HSF2; motif: RGAANGTTCYRGAAN; match class: 1,11,21,5,20045,0.23809523809523808,0.45454545454545453,Module 9,['TF:M11662']
1168,KEGG,KEGG:05340,Primary immunodeficiency,6.730645601979715e-10,True,Primary immunodeficiency,37,136,11,8484,0.08088235294117647,0.2972972972972973,Module 1,['KEGG:00000']
1169,TF,TF:M04826,Factor: p300; motif: ACNTCCG,6.829328718246803e-10,True,Factor: p300; motif: ACNTCCG,18156,826,801,20045,0.9697336561743342,0.04411764705882353,Module 0,['TF:M00000']
1170,GO:BP,GO:0046651,lymphocyte proliferation,6.946638170431384e-10,True,"""The expansion of a lymphocyte population by cell division."" [GOC:ai]",308,226,23,21031,0.10176991150442478,0.07467532467532467,Module 1,"['GO:0032943', 'GO:0046649']"
1171,GO:BP,GO:0030217,T cell differentiation,6.946638170431384e-10,True,"""The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex."" [GO_REF:0000022, GOC:jid, GOC:mah]",308,226,23,21031,0.10176991150442478,0.07467532467532467,Module 1,"['GO:0030098', 'GO:0042110']"
1172,HP,HP:0001872,Abnormality of thrombocytes,7.063888331879209e-10,True,An abnormality of platelets.,469,44,23,4958,0.5227272727272727,0.04904051172707889,Module 3,['HP:0001871']
1173,HP,HP:0100037,Abnormality of the scalp hair,7.399961455916722e-10,True,An abnormality of the hair of head.,419,44,22,4958,0.5,0.05250596658711217,Module 3,"['HP:0001595', 'HP:0001965']"
1174,KEGG,KEGG:05150,Staphylococcus aureus infection,7.627317196302406e-10,True,Staphylococcus aureus infection,86,13,7,8484,0.5384615384615384,0.08139534883720931,Module 6,['KEGG:00000']
1175,HPA,HPA:0420052,salivary gland; glandular cells[≥Medium],7.639664525550079e-10,True,salivary gland; glandular cells[≥Medium],4872,79,65,11019,0.8227848101265823,0.013341543513957306,Module 3,['HPA:0420051']
1176,TF,TF:M01208,Factor: FLI-1; motif: CMGGAWGTSAN,7.680660496672053e-10,True,Factor: FLI-1; motif: CMGGAWGTSAN,6363,826,360,20045,0.4358353510895884,0.056577086280056574,Module 0,['TF:M00000']
1177,HPA,HPA:0471461,skin 2; langerhans cells[≥Low],7.769109263430175e-10,True,skin 2; langerhans cells[≥Low],789,69,25,11019,0.36231884057971014,0.031685678073510776,Module 5,['HPA:0470000']
1178,TF,TF:M03924,Factor: YY1; motif: NNCGCCATTNN,8.098842059647706e-10,True,Factor: YY1; motif: NNCGCCATTNN,10299,826,526,20045,0.6368038740920097,0.05107291970094184,Module 0,['TF:M00000']
1179,GO:CC,GO:0071944,cell periphery,8.144577198511562e-10,True,"""The broad region around and including the plasma membrane of a cell, encompassing the cell cortex (inside the cell), the plasma membrane, and any external encapsulating structures."" [GOC:pdt]",6228,238,118,22097,0.4957983193277311,0.01894669235709698,Module 1,['GO:0110165']
1180,HP,HP:0011922,Abnormal activity of mitochondrial respiratory chain,8.162850147218129e-10,True,An increased or decreased activity of the mitochondrial respiratory chain.,140,228,30,4958,0.13157894736842105,0.21428571428571427,Module 0,['HP:0003287']
1181,TF,TF:M08457_1,Factor: ER71:SREBP-2; motif: NTSACGTGACGGAARY; match class: 1,8.221869875118195e-10,True,Factor: ER71:SREBP-2; motif: NTSACGTGACGGAARY; match class: 1,5719,826,331,20045,0.400726392251816,0.05787725126770414,Module 0,['TF:M08457']
1182,HP,HP:0032251,Abnormal immune system morphology,8.529843900477084e-10,True,Abnormal immune system morphology,641,71,34,4958,0.4788732394366197,0.0530421216848674,Module 1,['HP:0002715']
1183,GO:MF,GO:1990948,ubiquitin ligase inhibitor activity,8.817073090725776e-10,True,"""Binds to and stops, prevents or reduces the activity of a ubiquitin ligase."" [GOC:dph, GOC:vw, PMID:21389117]",9,105,6,20212,0.05714285714285714,0.6666666666666666,Module 3,['GO:0055105']
1184,KEGG,KEGG:05323,Rheumatoid arthritis,9.000290559891988e-10,True,Rheumatoid arthritis,88,13,7,8484,0.5384615384615384,0.07954545454545454,Module 6,['KEGG:00000']
1185,REAC,REAC:R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,9.261125093351227e-10,True,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,66,586,22,10842,0.03754266211604096,0.3333333333333333,Module 0,['REAC:R-HSA-1234174']
1186,TF,TF:M07380,Factor: E2F-4; motif: NTTTCSCGCC,9.395994440569153e-10,True,Factor: E2F-4; motif: NTTTCSCGCC,13369,826,644,20045,0.7796610169491526,0.04817114219462937,Module 0,['TF:M00000']
1187,KEGG,KEGG:04658,Th1 and Th2 cell differentiation,9.762511249520253e-10,True,Th1 and Th2 cell differentiation,89,13,7,8484,0.5384615384615384,0.07865168539325842,Module 6,['KEGG:00000']
1188,TF,TF:M07100_1,Factor: HSF1; motif: NTTCTRGAANNTTCY; match class: 1,1.0125029122957969e-09,True,Factor: HSF1; motif: NTTCTRGAANNTTCY; match class: 1,495,21,11,20045,0.5238095238095238,0.022222222222222223,Module 9,['TF:M07100']
1189,HPA,HPA:0030073,appendix; lymphoid tissue[High],1.0227540166755397e-09,True,appendix; lymphoid tissue[High],763,612,90,11019,0.14705882352941177,0.11795543905635648,Module 0,['HPA:0030072']
1190,GO:BP,GO:0043067,regulation of programmed cell death,1.0419072997819557e-09,True,"""Any process that modulates the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes."" [GOC:jl]",1506,226,50,21031,0.22123893805309736,0.033200531208499334,Module 1,"['GO:0012501', 'GO:0050794']"
1191,HPA,HPA:0030432,appendix; germinal center cells[≥Medium],1.064590346312886e-09,True,appendix; germinal center cells[≥Medium],227,185,23,11019,0.12432432432432433,0.1013215859030837,Module 1,['HPA:0030431']
1192,HP,HP:0003287,Abnormality of mitochondrial metabolism,1.068402664926867e-09,True,A functional anomaly of mitochondria.,191,228,35,4958,0.15350877192982457,0.18324607329842932,Module 0,['HP:0012103']
1193,HPA,HPA:0461421,skin 1; eccrine glands[≥Low],1.08045172486811e-09,True,skin 1; eccrine glands[≥Low],246,612,44,11019,0.0718954248366013,0.17886178861788618,Module 0,['HPA:0460000']
1194,GO:BP,GO:0002684,positive regulation of immune system process,1.095186906365646e-09,True,"""Any process that activates or increases the frequency, rate, or extent of an immune system process."" [GOC:add]",1054,215,40,21031,0.18604651162790697,0.03795066413662239,Module 2,"['GO:0002376', 'GO:0002682', 'GO:0048518']"
1195,HP,HP:0011893,Abnormal leukocyte count,1.1103545933223105e-09,True,Number of leukocytes per volume of blood beyond normal limits.,479,44,23,4958,0.5227272727272727,0.04801670146137787,Module 3,['HP:0001881']
1196,GO:BP,GO:0032943,mononuclear cell proliferation,1.1119201619788982e-09,True,"""The expansion of a mononuclear cell population by cell division. A mononuclear cell is a leukocyte with a single non-segmented nucleus in the mature form."" [GOC:add]",315,226,23,21031,0.10176991150442478,0.07301587301587302,Module 1,['GO:0070661']
1197,GO:BP,GO:0007005,mitochondrion organization,1.159686638716854e-09,True,"""A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a mitochondrion; includes mitochondrial morphogenesis and distribution, and replication of the mitochondrial genome as well as synthesis of new mitochondrial components."" [GOC:dph, GOC:jl, GOC:mah, GOC:sgd_curators, PMID:9786946]",495,787,55,21031,0.0698856416772554,0.1111111111111111,Module 0,['GO:0006996']
1198,GO:BP,GO:0006996,organelle organization,1.170227119097683e-09,True,"""A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an organelle within a cell. An organelle is an organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane."" [GOC:mah]",3613,77,41,21031,0.5324675324675324,0.011347910323830611,Module 5,['GO:0016043']
1199,GO:CC,GO:0030133,transport vesicle,1.1747190235407371e-09,True,"""Any of the vesicles of the constitutive secretory pathway, which carry cargo from the endoplasmic reticulum to the Golgi, between Golgi cisternae, from the Golgi to the ER (retrograde transport) or to destinations within or outside the cell."" [GOC:mah, PMID:22160157]",432,17,9,22097,0.5294117647058824,0.020833333333333332,Module 6,"['GO:0012505', 'GO:0031410']"
1200,HP,HP:0004332,Abnormal lymphocyte morphology,1.1908254732254897e-09,True,An abnormality of lymphocytes.,241,71,22,4958,0.30985915492957744,0.0912863070539419,Module 1,['HP:0001881']
1201,HPA,HPA:0241102,heart muscle; cardiomyocytes[≥Medium],1.2316831776170347e-09,True,heart muscle; cardiomyocytes[≥Medium],4376,612,325,11019,0.5310457516339869,0.07426873857404022,Module 0,['HPA:0241101']
1202,GO:BP,GO:0050853,B cell receptor signaling pathway,1.258806057002352e-09,True,"""The series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell."" [GOC:add]",71,226,13,21031,0.05752212389380531,0.18309859154929578,Module 1,['GO:0050851']
1203,GO:BP,GO:0042255,ribosome assembly,1.2735392400346507e-09,True,"""The aggregation, arrangement and bonding together of the mature ribosome and of its subunits."" [GOC:ma, PMID:30467428]",63,105,10,21031,0.09523809523809523,0.15873015873015872,Module 3,"['GO:0042254', 'GO:0140694']"
1204,HPA,HPA:0640413,endometrium; macrophages[High],1.2802992885517674e-09,True,endometrium; macrophages[High],20,166,9,11019,0.05421686746987952,0.45,Module 2,['HPA:0640412']
1205,MIRNA,MIRNA:hsa-miR-744-5p,hsa-miR-744-5p,1.3123929321399058e-09,True,hsa-miR-744-5p,434,104,21,14819,0.20192307692307693,0.04838709677419355,Module 3,['MIRNA:000000']
1206,HP,HP:0001965,Abnormal scalp morphology,1.3239223799449619e-09,True,"Any anomaly of the scalp, the skin an subcutaneous tissue of the head on which head hair grows.",431,44,22,4958,0.5,0.05104408352668213,Module 3,['HP:0000234']
1207,GO:CC,GO:1905368,peptidase complex,1.3387489844869804e-09,True,"""A protein complex which is capable of peptidase activity."" [GO_REF:0000088, GOC:bhm, GOC:TermGenie, PMID:1689240]",125,813,25,22097,0.03075030750307503,0.2,Module 0,['GO:1902494']
1208,WP,WP:WP2446,Retinoblastoma gene in cancer,1.3978594706619801e-09,True,Retinoblastoma gene in cancer,89,55,11,8286,0.2,0.12359550561797752,Module 5,['WP:000000']
1209,HPA,HPA:0471492,skin 2; vascular mural cells[≥Medium],1.4185211435834034e-09,True,skin 2; vascular mural cells[≥Medium],192,612,38,11019,0.06209150326797386,0.19791666666666666,Module 0,['HPA:0471491']
1210,GO:BP,GO:0019438,aromatic compound biosynthetic process,1.4437510203840255e-09,True,"""The chemical reactions and pathways resulting in the formation of aromatic compounds, any substance containing an aromatic carbon ring."" [GOC:ai]",4116,787,236,21031,0.29987293519695046,0.057337220602526724,Module 0,"['GO:0006725', 'GO:0044249']"
1211,HPA,HPA:0461451,skin 1; hair follicles[≥Low],1.4543036863760088e-09,True,skin 1; hair follicles[≥Low],367,69,18,11019,0.2608695652173913,0.04904632152588556,Module 5,['HPA:0460000']
1212,HPA,HPA:0470201,skin 2; endothelial cells[≥Low],1.4842510504557708e-09,True,skin 2; endothelial cells[≥Low],888,69,26,11019,0.37681159420289856,0.02927927927927928,Module 5,['HPA:0470000']
1213,GO:BP,GO:0032496,response to lipopolysaccharide,1.485453213291179e-09,True,"""Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria."" [GOC:add, ISBN:0721601464]",336,215,23,21031,0.10697674418604651,0.06845238095238096,Module 2,"['GO:0002237', 'GO:0033993', 'GO:1901700']"
1214,HP,HP:0034058,Abnormal fetal morphology,1.4878240308378865e-09,True,Any structural anomaly of the fetus.,295,44,19,4958,0.4318181818181818,0.06440677966101695,Module 3,['HP:0034057']
1215,HPA,HPA:0460203,skin 1; endothelial cells[High],1.5079323537994431e-09,True,skin 1; endothelial cells[High],317,69,17,11019,0.2463768115942029,0.05362776025236593,Module 5,['HPA:0460202']
1216,REAC,REAC:R-HSA-9824446,Viral Infection Pathways,1.5096808630377013e-09,True,Viral Infection Pathways,809,586,92,10842,0.15699658703071673,0.11372064276885044,Module 0,['REAC:R-HSA-5663205']
1217,TF,TF:M08231_1,Factor: Elk-1:T-bet; motif: TCACACCGGAAGNN; match class: 1,1.5220325671933586e-09,True,Factor: Elk-1:T-bet; motif: TCACACCGGAAGNN; match class: 1,1622,826,128,20045,0.1549636803874092,0.07891491985203453,Module 0,['TF:M08231']
1218,GO:CC,GO:0030669,clathrin-coated endocytic vesicle membrane,1.5418406348363048e-09,True,"""The lipid bilayer surrounding a clathrin-coated endocytic vesicle."" [GOC:mah]",71,17,6,22097,0.35294117647058826,0.08450704225352113,Module 6,"['GO:0030665', 'GO:0030666', 'GO:0045334']"
1219,GO:CC,GO:0016469,proton-transporting two-sector ATPase complex,1.6054655850710487e-09,True,"""A large protein complex that catalyzes the synthesis or hydrolysis of ATP by a rotational mechanism, coupled to the transport of protons across a membrane. The complex comprises a membrane sector (F0, V0, or A0) that carries out proton transport and a cytoplasmic compartment sector (F1, V1, or A1) that catalyzes ATP synthesis or hydrolysis. Two major types have been characterized: V-type ATPases couple ATP hydrolysis to the transport of protons across a concentration gradient, whereas F-type ATPases, also known as ATP synthases, normally run in the reverse direction to utilize energy from a proton concentration or electrochemical gradient to synthesize ATP. A third type, A-type ATPases have been found in archaea, and are closely related to eukaryotic V-type ATPases but are reversible."" [GOC:mah, ISBN:0716743663, PMID:16691483]",54,813,17,22097,0.020910209102091022,0.3148148148148148,Module 0,"['GO:0098796', 'GO:1904949']"
1220,HPA,HPA:0290402,liver; hepatocytes[≥Medium],1.6058379107004374e-09,True,liver; hepatocytes[≥Medium],3750,612,288,11019,0.47058823529411764,0.0768,Module 0,['HPA:0290401']
1221,HP,HP:0012103,Abnormality of the mitochondrion,1.6226458777380622e-09,True,"An anomaly of the mitochondrion, the membranous cytoplasmic organelle the interior of which is subdivided by cristae. The mitochondrion is a self replicating organelle that is the site of tissue respiration.",215,228,37,4958,0.16228070175438597,0.17209302325581396,Module 0,['HP:0011017']
1222,TF,TF:M08526,Factor: E2F-3:HES-7; motif: NNNSGCGCSNNNNNCRCGYGNN,1.6270785998233997e-09,True,Factor: E2F-3:HES-7; motif: NNNSGCGCSNNNNNCRCGYGNN,17226,826,774,20045,0.937046004842615,0.04493207941483804,Module 0,['TF:M00000']
1223,HPA,HPA:0400000,rectum,1.6625975545013203e-09,True,rectum,7973,79,79,11019,1.0,0.009908440988335633,Module 3,['HPA:0000000']
1224,TF,TF:M01240_1,Factor: BEN; motif: CAGCGRNV; match class: 1,1.6749027199559723e-09,True,Factor: BEN; motif: CAGCGRNV; match class: 1,13586,826,651,20045,0.788135593220339,0.04791697335492419,Module 0,['TF:M01240']
1225,TF,TF:M11436,Factor: SAP-1; motif: NRNCGGAWRYN,1.6868588309752018e-09,True,Factor: SAP-1; motif: NRNCGGAWRYN,1465,826,119,20045,0.1440677966101695,0.08122866894197953,Module 0,['TF:M00000']
1226,HP,HP:0040088,Abnormal lymphocyte count,1.706898683580099e-09,True,Any abnormality in the total number of lymphocytes in the blood.,219,71,21,4958,0.29577464788732394,0.0958904109589041,Module 1,"['HP:0004332', 'HP:0011893']"
1227,TF,TF:M09913,Factor: ER81; motif: NNCCGGAAGYG,1.7677373982969103e-09,True,Factor: ER81; motif: NNCCGGAAGYG,2950,826,198,20045,0.2397094430992736,0.0671186440677966,Module 0,['TF:M00000']
1228,HPA,HPA:0530721,spleen; cells in white pulp[≥Low],1.7951294399409145e-09,True,spleen; cells in white pulp[≥Low],4339,140,95,11019,0.6785714285714286,0.02189444572482139,Module Singleton,['HPA:0530000']
1229,HP,HP:0000470,Short neck,1.7953855286259555e-09,True,Diminished length of the neck.,388,44,21,4958,0.4772727272727273,0.05412371134020619,Module 3,"['HP:0003319', 'HP:0025668']"
1230,GO:CC,GO:0101002,ficolin-1-rich granule,1.8052524942273339e-09,True,"""Highly exocytosable gelatinase-poor granules found in neutrophils and rich in ficolin-1. Ficolin-1 is released from neutrophil granules by stimulation with fMLP or PMA, and the majority becomes associated with the surface membrane of the cells and can be detected by flow cytometry."" [GOC:mec, PMID:19741154]",184,221,17,22097,0.07692307692307693,0.09239130434782608,Module 2,['GO:0030141']
1231,GO:BP,GO:0140546,defense response to symbiont,1.8077639097074661e-09,True,"""Reactions triggered in response to the presence of a symbiont that act to protect or prevent damage to the host."" [GOC:pg]",1113,226,42,21031,0.18584070796460178,0.03773584905660377,Module 1,['GO:0098542']
1232,HPA,HPA:0310443,lymph node; non-germinal center cells[High],1.8126724881842197e-09,True,lymph node; non-germinal center cells[High],1209,185,54,11019,0.2918918918918919,0.04466501240694789,Module 1,['HPA:0310442']
1233,TF,TF:M11018_1,Factor: IRX-1; motif: NACRYNNNNNNNNRYGNN; match class: 1,1.9563676788441106e-09,True,Factor: IRX-1; motif: NACRYNNNNNNNNRYGNN; match class: 1,16304,826,745,20045,0.9019370460048426,0.045694308145240434,Module 0,['TF:M11018']
1234,HPA,HPA:0620221,vagina; squamous epithelial cells[≥Low],2.0327026936877714e-09,True,vagina; squamous epithelial cells[≥Low],6000,79,71,11019,0.8987341772151899,0.011833333333333333,Module 3,['HPA:0620000']
1235,HPA,HPA:0620000,vagina,2.0327026936877714e-09,True,vagina,6000,79,71,11019,0.8987341772151899,0.011833333333333333,Module 3,['HPA:0000000']
1236,GO:BP,GO:0032103,positive regulation of response to external stimulus,2.075410867624776e-09,True,"""Any process that activates, maintains or increases the rate of a response to an external stimulus."" [GOC:mah]",609,215,30,21031,0.13953488372093023,0.04926108374384237,Module 2,"['GO:0009605', 'GO:0032101', 'GO:0048584']"
1237,GO:BP,GO:1901701,cellular response to oxygen-containing compound,2.099268294442658e-09,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an oxygen-containing compound stimulus."" [GOC:pr, GOC:TermGenie]",1179,215,42,21031,0.19534883720930232,0.035623409669211195,Module 2,"['GO:0070887', 'GO:1901700']"
1238,REAC,REAC:R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,2.107551247532575e-09,True,Regulation of activated PAK-2p34 by proteasome mediated degradation,50,586,19,10842,0.032423208191126277,0.38,Module 0,['REAC:R-HSA-169911']
1239,GO:MF,GO:0033218,amide binding,2.1729782727994844e-09,True,"""Binding to an amide, any derivative of an oxoacid in which an acidic hydroxy group has been replaced by an amino or substituted amino group."" [GOC:mah]",398,17,9,20212,0.5294117647058824,0.022613065326633167,Module 6,['GO:0005488']
1240,GO:CC,GO:0005615,extracellular space,2.1745884334689484e-09,True,"""That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid."" [ISBN:0198547684]",3303,813,194,22097,0.23862238622386223,0.058734483802603696,Module 0,"['GO:0005576', 'GO:0110165']"
1241,REAC,REAC:R-HSA-5362768,Hh mutants are degraded by ERAD,2.206702771090528e-09,True,Hh mutants are degraded by ERAD,56,586,20,10842,0.034129692832764506,0.35714285714285715,Module 0,['REAC:R-HSA-5387390']
1242,TF,TF:M04710,Factor: CHD2; motif: TCTCGCGAG,2.220857432080697e-09,True,Factor: CHD2; motif: TCTCGCGAG,14402,826,680,20045,0.8232445520581114,0.04721566449104291,Module 0,['TF:M00000']
1243,WP,WP:WP619,Type II interferon signaling,2.226668378249409e-09,True,Type II interferon signaling,37,27,7,8286,0.25925925925925924,0.1891891891891892,Module 7,['WP:000000']
1244,HPA,HPA:0600442,tonsil; non-germinal center cells[≥Medium],2.25075104325151e-09,True,tonsil; non-germinal center cells[≥Medium],4200,140,93,11019,0.6642857142857143,0.02214285714285714,Module Singleton,['HPA:0600441']
1245,WP,WP:WP4324,Mitochondrial complex I assembly model OXPHOS system,2.2829005958068906e-09,True,Mitochondrial complex I assembly model OXPHOS system,56,472,20,8286,0.0423728813559322,0.35714285714285715,Module 0,['WP:000000']
1246,HPA,HPA:0471492,skin 2; vascular mural cells[≥Medium],2.3409992159915377e-09,True,skin 2; vascular mural cells[≥Medium],192,69,14,11019,0.2028985507246377,0.07291666666666667,Module 5,['HPA:0471491']
1247,TF,TF:M11389,Factor: elf5; motif: GAMCCGGAAGTN,2.3720888055858107e-09,True,Factor: elf5; motif: GAMCCGGAAGTN,1333,826,111,20045,0.1343825665859564,0.08327081770442611,Module 0,['TF:M00000']
1248,GO:MF,GO:0016651,"oxidoreductase activity, acting on NAD(P)H",2.439372427326789e-09,True,"""Catalysis of an oxidation-reduction (redox) reaction in which NADH or NADPH acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor."" [GOC:ai]",88,808,22,20212,0.027227722772277228,0.25,Module 0,['GO:0016491']
1249,HP,HP:0000431,Wide nasal bridge,2.440844772948893e-09,True,"Increased breadth of the nasal bridge (and with it, the nasal root).",497,44,23,4958,0.5227272727272727,0.04627766599597585,Module 3,['HP:0000422']
1250,HPA,HPA:0471452,skin 2; hair follicles[≥Medium],2.4504466383713594e-09,True,skin 2; hair follicles[≥Medium],160,612,34,11019,0.05555555555555555,0.2125,Module 0,['HPA:0471451']
1251,TF,TF:M00736,Factor: E2F-1:DP-1; motif: TTTCSCGC,2.536235557312561e-09,True,Factor: E2F-1:DP-1; motif: TTTCSCGC,10653,826,538,20045,0.6513317191283293,0.0505022059513752,Module 0,['TF:M00000']
1252,GO:CC,GO:0070062,extracellular exosome,2.577914267259647e-09,True,"""A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm."" [GOC:BHF, GOC:mah, GOC:vesicles, PMID:15908444, PMID:17641064, PMID:19442504, PMID:19498381, PMID:22418571, PMID:24009894]",2109,21,15,22097,0.7142857142857143,0.007112375533428165,Module 9,"['GO:0005615', 'GO:1903561']"
1253,HPA,HPA:0540000,stomach 1,2.590611659068222e-09,True,stomach 1,7664,79,78,11019,0.9873417721518988,0.010177453027139875,Module 3,['HPA:0000000']
1254,HPA,HPA:0540051,stomach 1; glandular cells[≥Low],2.590611659068222e-09,True,stomach 1; glandular cells[≥Low],7664,79,78,11019,0.9873417721518988,0.010177453027139875,Module 3,['HPA:0540000']
1255,TF,TF:M11422_1,Factor: Erm; motif: NRCMGGAAGTN; match class: 1,2.612822133412962e-09,True,Factor: Erm; motif: NRCMGGAAGTN; match class: 1,950,826,88,20045,0.10653753026634383,0.09263157894736843,Module 0,['TF:M11422']
1256,TF,TF:M10436_1,Factor: YY1; motif: CAANATGGCGGC; match class: 1,2.643537730647301e-09,True,Factor: YY1; motif: CAANATGGCGGC; match class: 1,2339,826,166,20045,0.2009685230024213,0.07097050021376657,Module 0,['TF:M10436']
1257,HP,HP:0001595,Abnormal hair morphology,2.6617353332046967e-09,True,An abnormality of the hair.,1304,44,34,4958,0.7727272727272727,0.02607361963190184,Module 3,['HP:0011138']
1258,HPA,HPA:0600432,tonsil; germinal center cells[≥Medium],2.743581736587446e-09,True,tonsil; germinal center cells[≥Medium],4100,79,59,11019,0.7468354430379747,0.014390243902439025,Module 3,['HPA:0600431']
1259,GO:BP,GO:0050870,positive regulation of T cell activation,2.767694285056585e-09,True,"""Any process that activates or increases the frequency, rate or extent of T cell activation."" [GOC:ai]",247,15,8,21031,0.5333333333333333,0.032388663967611336,Module 6,"['GO:0042110', 'GO:0050863', 'GO:0051251', 'GO:1903039']"
1260,HPA,HPA:0461441,skin 1; fibrohistiocytic cells[≥Low],2.8132080917746867e-09,True,skin 1; fibrohistiocytic cells[≥Low],885,140,38,11019,0.2714285714285714,0.04293785310734463,Module Singleton,['HPA:0460000']
1261,GO:CC,GO:0098797,plasma membrane protein complex,2.8208223408259178e-09,True,"""Any protein complex that is part of the plasma membrane."" [GOC:dos]",718,17,10,22097,0.5882352941176471,0.013927576601671309,Module 6,"['GO:0005886', 'GO:0098796']"
1262,HPA,HPA:0250131,hippocampus; neuronal cells[≥Low],2.847274144322015e-09,True,hippocampus; neuronal cells[≥Low],6228,79,72,11019,0.9113924050632911,0.011560693641618497,Module 3,['HPA:0250000']
1263,GO:BP,GO:0071216,cellular response to biotic stimulus,2.9021940726205607e-09,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a biotic stimulus, a stimulus caused or produced by a living organism."" [GOC:mah]",250,215,20,21031,0.09302325581395349,0.08,Module 2,"['GO:0009607', 'GO:0051716']"
1264,GO:CC,GO:0098552,side of membrane,2.939084572509639e-09,True,"""A cellular component consisting of one leaflet of a membrane bilayer and any proteins embedded or anchored in it or attached to its surface."" [GOC:dos]",721,17,10,22097,0.5882352941176471,0.013869625520110958,Module 6,"['GO:0016020', 'GO:0110165']"
1265,GO:BP,GO:0006413,translational initiation,2.953852060554297e-09,True,"""The process preceding formation of the peptide bond between the first two amino acids of a protein. This includes the formation of a complex of the ribosome, mRNA or circRNA, and an initiation complex that contains the first aminoacyl-tRNA."" [ISBN:019879276X]",128,787,26,21031,0.03303684879288437,0.203125,Module 0,"['GO:0006412', 'GO:0044237']"
1266,GO:MF,GO:0055131,C3HC4-type RING finger domain binding,3.0351436950326103e-09,True,"""Binding to a C3HC4-type zinc finger domain of a protein. The C3HC4-type zinc finger is a variant of RING finger, is a cysteine-rich domain of 40 to 60 residues that coordinates two zinc ions, and has the consensus sequence: C-X2-C-X(9-39)-C-X(1-3)-H-X(2-3)-C-X2-C-X(4-48)-C-X2-C, where X is any amino acid. Many proteins containing a C3HC4-type RING finger play a key role in the ubiquitination pathway."" [GOC:amm, InterPro:IPR001841, InterPro:IPR018957]",6,20,4,20212,0.2,0.6666666666666666,Module 9,['GO:0019904']
1267,GO:CC,GO:1903561,extracellular vesicle,3.036107640053775e-09,True,"""Any vesicle that is part of the extracellular region."" [GO_REF:0000064, GOC:pm, GOC:TermGenie, PMID:24769233]",2133,21,15,22097,0.7142857142857143,0.007032348804500703,Module 9,"['GO:0031982', 'GO:0065010']"
1268,TF,TF:M11656,Factor: HSF1; motif: RGAANRTTCYRGAAN,3.051781165882251e-09,True,Factor: HSF1; motif: RGAANRTTCYRGAAN,2043,21,16,20045,0.7619047619047619,0.00783162016642193,Module 9,['TF:M00000']
1269,GO:CC,GO:0043230,extracellular organelle,3.0567457063172384e-09,True,"""Organized structure of distinctive morphology and function, occurring outside the cell. Includes, for example, extracellular membrane vesicles (EMVs) and the cellulosomes of anaerobic bacteria and fungi."" [GOC:jl, PMID:9914479]",2134,21,15,22097,0.7142857142857143,0.007029053420805998,Module 9,"['GO:0005576', 'GO:0043226']"
1270,GO:CC,GO:0065010,extracellular membrane-bounded organelle,3.0567457063172384e-09,True,"""Organized structure of distinctive morphology and function, bounded by a lipid bilayer membrane and occurring outside the cell."" [GOC:isa_complete]",2134,21,15,22097,0.7142857142857143,0.007029053420805998,Module 9,"['GO:0043227', 'GO:0043230']"
1271,GO:BP,GO:0030183,B cell differentiation,3.089530714448256e-09,True,"""The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity."" [GO_REF:0000022, GOC:mah]",159,226,17,21031,0.0752212389380531,0.1069182389937107,Module 1,"['GO:0030098', 'GO:0042113']"
1272,HPA,HPA:0210053,fallopian tube; glandular cells[High],3.1032221554906924e-09,True,fallopian tube; glandular cells[High],1668,612,155,11019,0.25326797385620914,0.09292565947242207,Module 0,['HPA:0210052']
1273,GO:BP,GO:0016032,viral process,3.1311528199167294e-09,True,"""A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle."" [GOC:bf, GOC:jl, GOC:mah]",429,34,12,21031,0.35294117647058826,0.027972027972027972,Module 7,['GO:0008150']
1274,REAC,REAC:R-HSA-350562,Regulation of ornithine decarboxylase (ODC),3.1920189620730046e-09,True,Regulation of ornithine decarboxylase (ODC),51,586,19,10842,0.032423208191126277,0.37254901960784315,Module 0,['REAC:R-HSA-351202']
1275,KEGG,KEGG:04659,Th17 cell differentiation,3.1927854999238133e-09,True,Th17 cell differentiation,105,13,7,8484,0.5384615384615384,0.06666666666666667,Module 6,['KEGG:00000']
1276,TF,TF:M00427_1,Factor: E2F; motif: TTTSGCGS; match class: 1,3.224229051884475e-09,True,Factor: E2F; motif: TTTSGCGS; match class: 1,3946,826,246,20045,0.29782082324455206,0.06234161175874303,Module 0,['TF:M00427']
1277,TF,TF:M12554,Factor: YY2; motif: NNATGGCGGCN,3.316658449105179e-09,True,Factor: YY2; motif: NNATGGCGGCN,2713,826,185,20045,0.22397094430992737,0.0681901953556948,Module 0,['TF:M00000']
1278,GO:BP,GO:0001775,cell activation,3.3543942287740133e-09,True,"""A multicellular organismal process by which exposure to an activating factor such as a cellular or soluble ligand results in a change in the morphology or behavior of a cell."" [GOC:mgi_curators]",1092,215,40,21031,0.18604651162790697,0.03663003663003663,Module 2,"['GO:0009987', 'GO:0032501']"
1279,HP,HP:0001888,Lymphopenia,3.366934791845681e-09,True,A reduced number of lymphocytes in the blood.,177,71,19,4958,0.2676056338028169,0.10734463276836158,Module 1,['HP:0040088']
1280,REAC,REAC:R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,3.3803274131700554e-09,True,Diseases of signal transduction by growth factor receptors and second messengers,417,586,59,10842,0.10068259385665529,0.14148681055155876,Module 0,['REAC:R-HSA-1643685']
1281,HP,HP:0004315,Decreased circulating IgG level,3.4254782654708557e-09,True,An abnormally decreased level of immunoglobulin G (IgG) in blood.,95,71,15,4958,0.2112676056338028,0.15789473684210525,Module 1,"['HP:0004313', 'HP:0410242']"
1282,TF,TF:M02053_1,Factor: ELF1; motif: NCCGGAARTN; match class: 1,3.447170347469242e-09,True,Factor: ELF1; motif: NCCGGAARTN; match class: 1,1587,826,125,20045,0.1513317191283293,0.07876496534341525,Module 0,['TF:M02053']
1283,HPA,HPA:0471491,skin 2; vascular mural cells[≥Low],3.5926690869849755e-09,True,skin 2; vascular mural cells[≥Low],240,69,15,11019,0.21739130434782608,0.0625,Module 5,['HPA:0470000']
1284,HPA,HPA:0090162,cerebellum; Purkinje cells[≥Medium],3.71314123533045e-09,True,cerebellum; Purkinje cells[≥Medium],4126,79,59,11019,0.7468354430379747,0.014299563742123121,Module 3,['HPA:0090161']
1285,TF,TF:M00425_1,Factor: E2F; motif: TTTCGCGC; match class: 1,3.739425816457843e-09,True,Factor: E2F; motif: TTTCGCGC; match class: 1,5516,826,319,20045,0.38619854721549635,0.05783176214648296,Module 0,['TF:M00425']
1286,HPA,HPA:0020053,adrenal gland; glandular cells[High],3.743238185679702e-09,True,adrenal gland; glandular cells[High],2287,612,196,11019,0.3202614379084967,0.08570179274158286,Module 0,['HPA:0020052']
1287,GO:BP,GO:0071219,cellular response to molecule of bacterial origin,3.826950994713124e-09,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin."" [GOC:mah]",224,215,19,21031,0.08837209302325581,0.08482142857142858,Module 2,"['GO:0002237', 'GO:0071216']"
1288,GO:BP,GO:0008283,cell population proliferation,3.898908057400422e-09,True,"""The multiplication or reproduction of cells, resulting in the expansion of a cell population."" [GOC:mah, GOC:mb]",2006,215,56,21031,0.26046511627906976,0.027916251246261216,Module 2,['GO:0009987']
1289,KEGG,KEGG:05145,Toxoplasmosis,3.904017534968734e-09,True,Toxoplasmosis,108,13,7,8484,0.5384615384615384,0.06481481481481481,Module 6,['KEGG:00000']
1290,HPA,HPA:0430053,seminal vesicle; glandular cells[High],3.914260254705635e-09,True,seminal vesicle; glandular cells[High],1471,612,141,11019,0.23039215686274508,0.09585316111488783,Module 0,['HPA:0430052']
1291,TF,TF:M09607_1,Factor: SAP-1; motif: ACCGGAAGTNN; match class: 1,3.944562121673219e-09,True,Factor: SAP-1; motif: ACCGGAAGTNN; match class: 1,1006,826,91,20045,0.11016949152542373,0.09045725646123261,Module 0,['TF:M09607']
1292,HP,HP:0001713,Abnormal cardiac ventricle morphology,4.061010817225538e-09,True,An abnormality of a cardiac ventricle.,689,44,26,4958,0.5909090909090909,0.03773584905660377,Module 3,['HP:0001627']
1293,HP,HP:0034930,Digestive system neoplasm,4.331696151901856e-09,True,A tumor (abnormal growth of tissue) of the digestive system.,313,44,19,4958,0.4318181818181818,0.06070287539936102,Module 3,['HP:0025031']
1294,HP,HP:0007378,Neoplasm of the gastrointestinal tract,4.331696151901856e-09,True,A tumor (abnormal growth of tissue) of the gastrointestinal tract.,313,44,19,4958,0.4318181818181818,0.06070287539936102,Module 3,"['HP:0011024', 'HP:0034930']"
1295,GO:BP,GO:0032501,multicellular organismal process,4.3653059965645e-09,True,"""Any biological process, occurring at the level of a multicellular organism, pertinent to its function."" [GOC:curators, GOC:dph, GOC:isa_complete, GOC:tb]",7669,226,134,21031,0.5929203539823009,0.01747294301734255,Module 1,['GO:0008150']
1296,TF,TF:M07380_1,Factor: E2F-4; motif: NTTTCSCGCC; match class: 1,4.500190911771108e-09,True,Factor: E2F-4; motif: NTTTCSCGCC; match class: 1,8243,826,438,20045,0.5302663438256658,0.05313599417687735,Module 0,['TF:M07380']
1297,TF,TF:M11654,Factor: HSF1; motif: RGAANRTTCYRGAAN,4.5440808013377696e-09,True,Factor: HSF1; motif: RGAANRTTCYRGAAN,1335,21,14,20045,0.6666666666666666,0.010486891385767791,Module 9,['TF:M00000']
1298,TF,TF:M13119_1,Factor: ZBTB11; motif: RCTTCCGGNNSNNNN; match class: 1,4.552210241558259e-09,True,Factor: ZBTB11; motif: RCTTCCGGNNSNNNN; match class: 1,1469,826,118,20045,0.14285714285714285,0.08032675289312458,Module 0,['TF:M13119']
1299,GO:CC,GO:0031902,late endosome membrane,4.553586385960558e-09,True,"""The lipid bilayer surrounding a late endosome."" [GOC:pz]",175,17,7,22097,0.4117647058823529,0.04,Module 6,"['GO:0005770', 'GO:0010008']"
1300,HP,HP:0011792,Neoplasm by histology,4.589162238219005e-09,True,Neoplasm categorized according to type of histological abnormality.,359,44,20,4958,0.45454545454545453,0.055710306406685235,Module 3,['HP:0002664']
1301,HP,HP:0001873,Thrombocytopenia,4.592389417666072e-09,True,A reduction in the number of circulating thrombocytes.,407,44,21,4958,0.4772727272727273,0.051597051597051594,Module 3,['HP:0011873']
1302,HPA,HPA:0471493,skin 2; vascular mural cells[High],4.6829702420107175e-09,True,skin 2; vascular mural cells[High],129,69,12,11019,0.17391304347826086,0.09302325581395349,Module 5,['HPA:0471492']
1303,GO:CC,GO:0005886,plasma membrane,4.773239503718764e-09,True,"""The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins."" [ISBN:0716731363]",5742,238,110,22097,0.46218487394957986,0.019157088122605363,Module 1,"['GO:0016020', 'GO:0071944']"
1304,REAC,REAC:R-HSA-9762114,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,4.7799513681087875e-09,True,GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2,52,586,19,10842,0.032423208191126277,0.36538461538461536,Module 0,['REAC:R-HSA-9759194']
1305,GO:BP,GO:0051604,protein maturation,4.8593473687289785e-09,True,"""Any process leading to the attainment of the full functional capacity of a protein."" [GOC:ai]",540,72,17,21031,0.2361111111111111,0.03148148148148148,Module 4,"['GO:0010467', 'GO:0019538']"
1306,HPA,HPA:0460181,skin 1; cells in granular layer[≥Low],4.989880319350997e-09,True,skin 1; cells in granular layer[≥Low],711,69,23,11019,0.3333333333333333,0.03234880450070324,Module 5,['HPA:0460000']
1307,HPA,HPA:0600432,tonsil; germinal center cells[≥Medium],5.010061611857072e-09,True,tonsil; germinal center cells[≥Medium],4100,140,91,11019,0.65,0.02219512195121951,Module Singleton,['HPA:0600431']
1308,HPA,HPA:0570000,testis,5.030444346064886e-09,True,testis,9036,612,559,11019,0.9133986928104575,0.06186365648517043,Module 0,['HPA:0000000']
1309,HPA,HPA:0130242,colon; peripheral nerve/ganglion[≥Medium],5.095585044575769e-09,True,colon; peripheral nerve/ganglion[≥Medium],3432,612,267,11019,0.4362745098039216,0.0777972027972028,Module 0,['HPA:0130241']
1310,TF,TF:M11662,Factor: HSF2; motif: RGAANGTTCYRGAAN,5.122926770802652e-09,True,Factor: HSF2; motif: RGAANGTTCYRGAAN,264,21,9,20045,0.42857142857142855,0.03409090909090909,Module 9,['TF:M00000']
1311,GO:CC,GO:0034774,secretory granule lumen,5.129146813843161e-09,True,"""The volume enclosed by the membrane of a secretory granule."" [GOC:rph]",320,813,40,22097,0.04920049200492005,0.125,Module 0,"['GO:0030141', 'GO:0060205']"
1312,GO:BP,GO:0001906,cell killing,5.2859777751479885e-09,True,"""Any process in an organism that results in the killing of its own cells or those of another organism, including in some cases the death of the other organism. Killing here refers to the induction of death in one cell by another cell, not cell-autonomous death due to internal or other environmental conditions."" [GOC:add]",217,226,19,21031,0.084070796460177,0.08755760368663594,Module 1,['GO:0009987']
1313,HP,HP:0000047,Hypospadias,5.36475144637517e-09,True,"Abnormal position of urethral meatus on the ventral penile shaft (underside) characterized by displacement of the urethral meatus from the tip of the glans penis to the ventral surface of the penis, scrotum, or perineum.",362,44,20,4958,0.45454545454545453,0.055248618784530384,Module 3,['HP:0100627']
1314,HPA,HPA:0461462,skin 1; langerhans cells[≥Medium],5.4642686879078435e-09,True,skin 1; langerhans cells[≥Medium],578,69,21,11019,0.30434782608695654,0.03633217993079585,Module 5,['HPA:0461461']
1315,HPA,HPA:0471471,skin 2; lymphocytes[≥Low],5.466884837256423e-09,True,skin 2; lymphocytes[≥Low],802,185,42,11019,0.22702702702702704,0.05236907730673317,Module 1,['HPA:0470000']
1316,HPA,HPA:0100131,cerebral cortex; neuronal cells[≥Low],5.5137331785742775e-09,True,cerebral cortex; neuronal cells[≥Low],6712,79,74,11019,0.9367088607594937,0.01102502979737783,Module 3,['HPA:0100000']
1317,GO:BP,GO:0045071,negative regulation of viral genome replication,5.514198116357829e-09,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of viral genome replication."" [GOC:go_curators]",55,34,7,21031,0.20588235294117646,0.12727272727272726,Module 7,"['GO:0019079', 'GO:0045069', 'GO:0048525']"
1318,GO:BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,5.659049722230882e-09,True,"""Any process that activates or increases the frequency, rate or extent of leukocyte cell-cell adhesion."" [GO_REF:0000058, GOC:BHF, GOC:rl, GOC:TermGenie, PMID:21106532]",270,15,8,21031,0.5333333333333333,0.02962962962962963,Module 6,"['GO:0007159', 'GO:0022409', 'GO:1903037']"
1319,HPA,HPA:0461472,skin 1; lymphocytes[≥Medium],5.6664384716716325e-09,True,skin 1; lymphocytes[≥Medium],574,185,35,11019,0.1891891891891892,0.06097560975609756,Module 1,['HPA:0461471']
1320,HPA,HPA:0350471,pancreas; exocrine glandular cells[≥Low],5.6889541354856595e-09,True,pancreas; exocrine glandular cells[≥Low],6942,79,75,11019,0.9493670886075949,0.010803802938634399,Module 3,['HPA:0350000']
1321,GO:CC,GO:0045334,clathrin-coated endocytic vesicle,5.79194167932199e-09,True,"""A clathrin-coated, membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance."" [GOC:go_curators]",88,17,6,22097,0.35294117647058826,0.06818181818181818,Module 6,"['GO:0030136', 'GO:0030139']"
1322,REAC,REAC:R-HSA-5358346,Hedgehog ligand biogenesis,5.920700196095098e-09,True,Hedgehog ligand biogenesis,65,586,21,10842,0.03583617747440273,0.3230769230769231,Module 0,['REAC:R-HSA-5358351']
1323,HP,HP:0000576,Centrocecal scotoma,6.034529467464764e-09,True,A scotoma (area of diminished vision within the visual field) located between the central point of fixation and the blind spot with a roughly horizontal oval shape.,13,44,7,4958,0.1590909090909091,0.5384615384615384,Module 3,['HP:0000575']
1324,GO:MF,GO:0032395,MHC class II receptor activity,6.039326824891195e-09,True,"""Combining with an MHC class II protein complex and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity."" [GOC:add, GOC:signaling, ISBN:0781735149]",8,17,4,20212,0.23529411764705882,0.5,Module 6,"['GO:0004888', 'GO:0140375']"
1325,WP,WP:WP5218,Extrafollicular and follicular B cell activation by SARS CoV 2,6.097619958348831e-09,True,Extrafollicular and follicular B cell activation by SARS CoV 2,74,148,14,8286,0.0945945945945946,0.1891891891891892,Module 1,['WP:000000']
1326,GO:BP,GO:1901362,organic cyclic compound biosynthetic process,6.14457311185453e-09,True,"""The chemical reactions and pathways resulting in the formation of organic cyclic compound."" [GOC:TermGenie]",4264,787,240,21031,0.30495552731893266,0.05628517823639775,Module 0,"['GO:1901360', 'GO:1901576']"
1327,HPA,HPA:0090191,cerebellum; cells in molecular layer[≥Low],6.1854041077648025e-09,True,cerebellum; cells in molecular layer[≥Low],4460,612,327,11019,0.5343137254901961,0.07331838565022422,Module 0,['HPA:0090000']
1328,WP,WP:WP4197,Immune response to tuberculosis,6.54793542110264e-09,True,Immune response to tuberculosis,22,27,6,8286,0.2222222222222222,0.2727272727272727,Module 7,['WP:000000']
1329,HP,HP:0002665,Lymphoma,6.54996856825541e-09,True,A cancer originating in lymphocytes and presenting as a solid tumor of lymhpoid cells.,118,71,16,4958,0.22535211267605634,0.13559322033898305,Module 1,['HP:0004377']
1330,HPA,HPA:0471441,skin 2; fibrohistiocytic cells[≥Low],6.588078815988931e-09,True,skin 2; fibrohistiocytic cells[≥Low],1021,185,48,11019,0.2594594594594595,0.04701273261508325,Module 1,['HPA:0470000']
1331,TF,TF:M08313_1,Factor: GCMa:PEA3; motif: ATRCGGGCGGAAGTR; match class: 1,6.715323421460053e-09,True,Factor: GCMa:PEA3; motif: ATRCGGGCGGAAGTR; match class: 1,9904,826,506,20045,0.612590799031477,0.05109046849757674,Module 0,['TF:M08313']
1332,REAC,REAC:R-HSA-5387390,Hh mutants abrogate ligand secretion,6.735749776491006e-09,True,Hh mutants abrogate ligand secretion,59,586,20,10842,0.034129692832764506,0.3389830508474576,Module 0,['REAC:R-HSA-5663202']
1333,GO:CC,GO:0060205,cytoplasmic vesicle lumen,6.875836672004058e-09,True,"""The volume enclosed by a cytoplasmic vesicle."" [GOC:dph, GOC:vesicles]",323,813,40,22097,0.04920049200492005,0.1238390092879257,Module 0,"['GO:0031410', 'GO:0031983', 'GO:0070013']"
1334,GO:BP,GO:0001817,regulation of cytokine production,6.879746911405403e-09,True,"""Any process that modulates the frequency, rate, or extent of production of a cytokine."" [GOC:add, ISBN:0781735149]",773,215,33,21031,0.15348837209302327,0.042690815006468305,Module 2,"['GO:0001816', 'GO:0010468', 'GO:0051239']"
1335,HPA,HPA:0380512,placenta; decidual cells[≥Medium],6.971908509192381e-09,True,placenta; decidual cells[≥Medium],3591,612,276,11019,0.45098039215686275,0.07685881370091896,Module 0,['HPA:0380511']
1336,REAC,REAC:R-HSA-9604323,Negative regulation of NOTCH4 signaling,7.080934073552148e-09,True,Negative regulation of NOTCH4 signaling,53,586,19,10842,0.032423208191126277,0.3584905660377358,Module 0,['REAC:R-HSA-9013694']
1337,REAC,REAC:R-HSA-169911,Regulation of Apoptosis,7.080934073552148e-09,True,Regulation of Apoptosis,53,586,19,10842,0.032423208191126277,0.3584905660377358,Module 0,['REAC:R-HSA-109581']
1338,KEGG,KEGG:04141,Protein processing in endoplasmic reticulum,7.2641463384066105e-09,True,Protein processing in endoplasmic reticulum,168,15,8,8484,0.5333333333333333,0.047619047619047616,Module 9,['KEGG:00000']
1339,GO:BP,GO:0045087,innate immune response,7.351043840905934e-09,True,"""Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens."" [GO_REF:0000022, GOC:add, GOC:ebc, GOC:mtg_sensu]",965,226,38,21031,0.168141592920354,0.039378238341968914,Module 1,"['GO:0006955', 'GO:0140546']"
1340,REAC,REAC:R-HSA-913531,Interferon Signaling,7.379598473674961e-09,True,Interferon Signaling,193,14,8,10842,0.5714285714285714,0.04145077720207254,Module 6,['REAC:R-HSA-1280215']
1341,GO:BP,GO:0050778,positive regulation of immune response,7.433536316592506e-09,True,"""Any process that activates or increases the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus."" [GOC:ai]",718,15,10,21031,0.6666666666666666,0.013927576601671309,Module 6,"['GO:0002684', 'GO:0006955', 'GO:0048584', 'GO:0050776']"
1342,REAC,REAC:R-HSA-9711123,Cellular response to chemical stress,7.471823509954272e-09,True,Cellular response to chemical stress,195,586,37,10842,0.06313993174061433,0.18974358974358974,Module 0,['REAC:R-HSA-2262752']
1343,HPA,HPA:0620222,vagina; squamous epithelial cells[≥Medium],7.560264981944725e-09,True,vagina; squamous epithelial cells[≥Medium],4050,79,58,11019,0.7341772151898734,0.014320987654320988,Module 3,['HPA:0620221']
1344,GO:CC,GO:0031983,vesicle lumen,7.574807443831222e-09,True,"""The volume enclosed by the membrane or protein that forms a vesicle."" [GOC:mah, GOC:vesicles]",324,813,40,22097,0.04920049200492005,0.12345679012345678,Module 0,"['GO:0031982', 'GO:0043233']"
1345,TF,TF:M01163_1,Factor: Elk-1; motif: AACCGGAAGTR; match class: 1,7.634295800536326e-09,True,Factor: Elk-1; motif: AACCGGAAGTR; match class: 1,1101,826,96,20045,0.1162227602905569,0.08719346049046321,Module 0,['TF:M01163']
1346,TF,TF:M11418,Factor: ER81; motif: NRCMGGAWGNN,7.683852554639128e-09,True,Factor: ER81; motif: NRCMGGAWGNN,4040,826,249,20045,0.30145278450363194,0.06163366336633663,Module 0,['TF:M00000']
1347,GO:BP,GO:0042273,ribosomal large subunit biogenesis,7.861674095960538e-09,True,"""A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a large ribosomal subunit; includes transport to the sites of protein synthesis."" [GOC:jl]",75,105,10,21031,0.09523809523809523,0.13333333333333333,Module 3,"['GO:0022613', 'GO:0042254']"
1348,HPA,HPA:0461493,skin 1; vascular mural cells[High],8.042145432909346e-09,True,skin 1; vascular mural cells[High],135,69,12,11019,0.17391304347826086,0.08888888888888889,Module 5,['HPA:0461492']
1349,HPA,HPA:0471391,skin 2; cells in basal layer[≥Low],8.076771073354145e-09,True,skin 2; cells in basal layer[≥Low],962,140,39,11019,0.2785714285714286,0.04054054054054054,Module Singleton,['HPA:0470000']
1350,HPA,HPA:0310442,lymph node; non-germinal center cells[≥Medium],8.120301917520203e-09,True,lymph node; non-germinal center cells[≥Medium],3989,69,52,11019,0.7536231884057971,0.013035848583604914,Module 5,['HPA:0310441']
1351,GO:CC,GO:0043202,lysosomal lumen,8.123527435193965e-09,True,"""The volume enclosed within the lysosomal membrane."" [GOC:jl, PMID:15213228]",100,221,13,22097,0.058823529411764705,0.13,Module 2,"['GO:0005764', 'GO:0005775']"
1352,GO:MF,GO:0031072,heat shock protein binding,8.131006934291115e-09,True,"""Binding to a heat shock protein, a protein synthesized or activated in response to heat shock."" [GOC:mah, GOC:vw]",130,20,7,20212,0.35,0.05384615384615385,Module 9,['GO:0005515']
1353,GO:CC,GO:0005774,vacuolar membrane,8.178992666029735e-09,True,"""The lipid bilayer surrounding the vacuole and separating its contents from the cytoplasm of the cell."" [GOC:ai]",489,813,51,22097,0.06273062730627306,0.10429447852760736,Module 0,"['GO:0005773', 'GO:0098588']"
1354,TF,TF:M10119,Factor: REX-1; motif: GGCMGCCATTTT,8.362204724248225e-09,True,Factor: REX-1; motif: GGCMGCCATTTT,1918,826,142,20045,0.17191283292978207,0.0740354535974974,Module 0,['TF:M00000']
1355,GO:BP,GO:1903513,endoplasmic reticulum to cytosol transport,8.45954450096814e-09,True,"""The directed movement of substances from endoplasmic reticulum to cytosol."" [GO_REF:0000076, GOC:BHF, GOC:mtg_cardiac_conduct_nov11, GOC:rl, GOC:TermGenie, PMID:16402920]",28,72,7,21031,0.09722222222222222,0.25,Module 4,['GO:0046907']
1356,GO:BP,GO:0030970,"retrograde protein transport, ER to cytosol",8.45954450096814e-09,True,"""The directed movement of unfolded or misfolded proteins from the endoplasmic reticulum to the cytosol through the translocon."" [PMID:11994744]",28,72,7,21031,0.09722222222222222,0.25,Module 4,"['GO:0032527', 'GO:0036503', 'GO:1903513']"
1357,GO:BP,GO:0001816,cytokine production,8.474169316451272e-09,True,"""The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels."" [GOC:add, ISBN:0781735149]",779,215,33,21031,0.15348837209302327,0.04236200256739409,Module 2,"['GO:0010467', 'GO:0032501']"
1358,GO:BP,GO:0009057,macromolecule catabolic process,8.537962957697088e-09,True,"""The chemical reactions and pathways resulting in the breakdown of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass."" [GOC:mah]",1338,787,102,21031,0.12960609911054638,0.07623318385650224,Module 0,"['GO:0043170', 'GO:1901575']"
1359,GO:BP,GO:0080134,regulation of response to stress,8.599109901427499e-09,True,"""Any process that modulates the frequency, rate or extent of a response to stress. Response to stress is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis, usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation)."" [GOC:dhl]",1340,215,44,21031,0.20465116279069767,0.03283582089552239,Module 2,"['GO:0006950', 'GO:0048583']"
1360,GO:BP,GO:0048856,anatomical structure development,8.742610997855823e-09,True,"""The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome."" [GO_REF:0000021]",5899,215,108,21031,0.5023255813953489,0.0183081878284455,Module 2,['GO:0032502']
1361,GO:BP,GO:0002376,immune system process,8.844403088941671e-09,True,"""Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats."" [GO_REF:0000022, GOC:add]",2776,34,22,21031,0.6470588235294118,0.00792507204610951,Module 7,['GO:0008150']
1362,HPA,HPA:0471472,skin 2; lymphocytes[≥Medium],8.950499475809284e-09,True,skin 2; lymphocytes[≥Medium],647,185,37,11019,0.2,0.0571870170015456,Module 1,['HPA:0471471']
1363,GO:CC,GO:0016020,membrane,9.371553143833915e-09,True,"""A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it."" [GOC:dos, GOC:mah, ISBN:0815316194]",9864,813,455,22097,0.5596555965559655,0.04612733171127332,Module 0,['GO:0110165']
1364,HPA,HPA:0310000,lymph node,9.409937593420461e-09,True,lymph node,6530,69,65,11019,0.9420289855072463,0.009954058192955589,Module 5,['HPA:0000000']
1365,TF,TF:M11601,Factor: TCF-1; motif: ACATCGRGRCGCTGW,9.4366760198586e-09,True,Factor: TCF-1; motif: ACATCGRGRCGCTGW,15178,826,705,20045,0.8535108958837773,0.04644880748451707,Module 0,['TF:M00000']
1366,HPA,HPA:0471442,skin 2; fibrohistiocytic cells[≥Medium],9.532801957488324e-09,True,skin 2; fibrohistiocytic cells[≥Medium],833,140,36,11019,0.2571428571428571,0.04321728691476591,Module Singleton,['HPA:0471441']
1367,GO:CC,GO:1904813,ficolin-1-rich granule lumen,9.558328560025009e-09,True,"""Any membrane-enclosed lumen that is part of a ficolin-1-rich granule."" [GO_REF:0000064, GOC:TermGenie, PMID:23650620]",124,221,14,22097,0.06334841628959276,0.11290322580645161,Module 2,"['GO:0070013', 'GO:0101002']"
1368,GO:MF,GO:0055105,ubiquitin-protein transferase inhibitor activity,9.577121487196584e-09,True,"""Binds to and stops, prevents or reduces the activity of a ubiquitin-protein transferase."" [GOC:BHF, GOC:rl]",12,105,6,20212,0.05714285714285714,0.5,Module 3,"['GO:0004857', 'GO:0055106']"
1369,REAC,REAC:R-HSA-5610783,Degradation of GLI2 by the proteasome,9.601197879464807e-09,True,Degradation of GLI2 by the proteasome,60,586,20,10842,0.034129692832764506,0.3333333333333333,Module 0,['REAC:R-HSA-5610787']
1370,REAC,REAC:R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,9.601197879464807e-09,True,GLI3 is processed to GLI3R by the proteasome,60,586,20,10842,0.034129692832764506,0.3333333333333333,Module 0,['REAC:R-HSA-5610787']
1371,GO:BP,GO:0002250,adaptive immune response,9.88877326216817e-09,True,"""An immune response mediated by cells expressing specific receptors for antigens produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory)."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",739,15,10,21031,0.6666666666666666,0.013531799729364006,Module 6,['GO:0006955']
1372,GO:CC,GO:0030139,endocytic vesicle,1.035785038449037e-08,True,"""A membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance. Endocytic vesicles fuse with early endosomes to deliver the cargo for further sorting."" [GOC:go_curators, PMID:19696797]",346,17,8,22097,0.47058823529411764,0.023121387283236993,Module 6,['GO:0031410']
1373,GO:BP,GO:0097529,myeloid leukocyte migration,1.0401759148252064e-08,True,"""The movement of a myeloid leukocyte within or between different tissues and organs of the body."" [GOC:cvs, PMID:22342843, PMID:24157461]",237,215,19,21031,0.08837209302325581,0.08016877637130802,Module 2,['GO:0050900']
1374,GO:BP,GO:0070661,leukocyte proliferation,1.0417859368519528e-08,True,"""The expansion of a leukocyte population by cell division."" [GOC:add]",351,226,23,21031,0.10176991150442478,0.06552706552706553,Module 1,['GO:0008283']
1375,HPA,HPA:0080131,caudate; neuronal cells[≥Low],1.0678043411157912e-08,True,caudate; neuronal cells[≥Low],6163,79,71,11019,0.8987341772151899,0.011520363459354211,Module 3,['HPA:0080000']
1376,HPA,HPA:0310432,lymph node; germinal center cells[≥Medium],1.1247546372796091e-08,True,lymph node; germinal center cells[≥Medium],3302,185,98,11019,0.5297297297297298,0.029678982434887948,Module 1,['HPA:0310431']
1377,GO:BP,GO:0034097,response to cytokine,1.1450727387222664e-08,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus."" [GOC:sl]",932,215,36,21031,0.16744186046511628,0.03862660944206009,Module 2,['GO:0010033']
1378,GO:BP,GO:0034097,response to cytokine,1.162258378142096e-08,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus."" [GOC:sl]",932,226,37,21031,0.16371681415929204,0.03969957081545064,Module 1,['GO:0010033']
1379,GO:BP,GO:0071396,cellular response to lipid,1.1776180326152053e-08,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus."" [GOC:mah]",609,215,29,21031,0.13488372093023257,0.047619047619047616,Module 2,"['GO:0033993', 'GO:0071310']"
1380,TF,TF:M10018_1,Factor: NRF-1; motif: CNSTGCGCATGCGCNNS; match class: 1,1.1817781440379588e-08,True,Factor: NRF-1; motif: CNSTGCGCATGCGCNNS; match class: 1,863,826,81,20045,0.09806295399515738,0.09385863267670916,Module 0,['TF:M10018']
1381,GO:BP,GO:0071345,cellular response to cytokine stimulus,1.1822226101420703e-08,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus."" [GOC:mah]",839,226,35,21031,0.15486725663716813,0.041716328963051254,Module 1,"['GO:0034097', 'GO:0071310']"
1382,GO:BP,GO:0034660,ncRNA metabolic process,1.1925374528843387e-08,True,"""The chemical reactions and pathways involving non-coding RNA transcripts (ncRNAs)."" [GOC:mah]",640,105,21,21031,0.2,0.0328125,Module 3,['GO:0016070']
1383,GO:BP,GO:0006950,response to stress,1.2004536493905216e-08,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis, usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation)."" [GOC:mah]",3855,226,85,21031,0.37610619469026546,0.02204928664072633,Module 1,['GO:0050896']
1384,HP,HP:0002716,Lymphadenopathy,1.2146844337821864e-08,True,Enlargment (swelling) of a lymph node.,242,71,21,4958,0.29577464788732394,0.08677685950413223,Module 1,['HP:0002733']
1385,HP,HP:0000286,Epicanthus,1.221257250906739e-08,True,"A fold of skin starting above the medial aspect of the upper eyelid and arching downward to cover, pass in front of and lateral to the medial canthus.",595,44,24,4958,0.5454545454545454,0.040336134453781515,Module 3,['HP:0000492']
1386,GO:BP,GO:0002696,positive regulation of leukocyte activation,1.2397405175420654e-08,True,"""Any process that activates or increases the frequency, rate, or extent of leukocyte activation."" [GOC:add]",354,226,23,21031,0.10176991150442478,0.06497175141242938,Module 1,"['GO:0002684', 'GO:0002694', 'GO:0045321', 'GO:0050867']"
1387,TF,TF:M08222_1,Factor: Elk-1:HOXB13; motif: ACCGGAAGTNGTAAAN; match class: 1,1.2534495658262052e-08,True,Factor: Elk-1:HOXB13; motif: ACCGGAAGTNGTAAAN; match class: 1,2097,826,151,20045,0.18280871670702178,0.07200762994754412,Module 0,['TF:M08222']
1388,GO:BP,GO:0051179,localization,1.2752246862340214e-08,True,"""Any process in which a cell, a substance, or a cellular entity, such as a protein complex or organelle, is transported, tethered to or otherwise maintained in a specific location. In the case of substances, localization may also be achieved via selective degradation."" [GOC:ai, GOC:dos]",5520,787,292,21031,0.3710292249047014,0.05289855072463768,Module 0,['GO:0008150']
1389,GO:BP,GO:0010033,response to organic substance,1.2794826397686861e-08,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus."" [GOC:sm, PMID:23356676]",2637,226,67,21031,0.29646017699115046,0.02540766021994691,Module 1,['GO:0042221']
1390,HP,HP:0003319,Abnormality of the cervical spine,1.2826819952837939e-08,True,Any abnormality of the cervical vertebral column.,429,44,21,4958,0.4772727272727273,0.04895104895104895,Module 3,['HP:0000925']
1391,TF,TF:M03990_1,Factor: GABPA; motif: ACCGGAAGTN; match class: 1,1.2865710757630015e-08,True,Factor: GABPA; motif: ACCGGAAGTN; match class: 1,1230,826,103,20045,0.12469733656174334,0.08373983739837398,Module 0,['TF:M03990']
1392,HPA,HPA:0030000,appendix,1.3366209529196995e-08,True,appendix,7831,79,78,11019,0.9873417721518988,0.009960413740263057,Module 3,['HPA:0000000']
1393,REAC,REAC:R-HSA-5678895,Defective CFTR causes cystic fibrosis,1.3574407676278075e-08,True,Defective CFTR causes cystic fibrosis,61,586,20,10842,0.034129692832764506,0.32786885245901637,Module 0,['REAC:R-HSA-5619084']
1394,TF,TF:M11450_1,Factor: Elf-1; motif: NANSCGGAAGTR; match class: 1,1.3634261057598309e-08,True,Factor: Elf-1; motif: NANSCGGAAGTR; match class: 1,1335,826,109,20045,0.13196125907990314,0.08164794007490636,Module 0,['TF:M11450']
1395,HPA,HPA:0470201,skin 2; endothelial cells[≥Low],1.368844156150444e-08,True,skin 2; endothelial cells[≥Low],888,140,37,11019,0.2642857142857143,0.041666666666666664,Module Singleton,['HPA:0470000']
1396,HP,HP:0002720,Decreased circulating IgA level,1.3748202058236142e-08,True,Decreased levels of immunoglobulin A (IgA).,70,71,13,4958,0.18309859154929578,0.18571428571428572,Module 1,"['HP:0004313', 'HP:0410240']"
1397,HPA,HPA:0500652,soft tissue 1; fibroblasts[≥Medium],1.3920997095994146e-08,True,soft tissue 1; fibroblasts[≥Medium],2728,612,222,11019,0.3627450980392157,0.0813782991202346,Module 0,['HPA:0500651']
1398,HP,HP:0100627,Displacement of the urethral meatus,1.3956275956719703e-08,True,"A displacement of the external urethral orifice from its normal position (in males normally placed at the tip of glans penis, in females normally placed about 2.5 cm behind the glans clitoridis and immediately in front of that of the vagina).",381,44,20,4958,0.45454545454545453,0.05249343832020997,Module 3,"['HP:0000795', 'HP:0032076']"
1399,HPA,HPA:0470000,skin 2,1.4336201262070902e-08,True,skin 2,7036,79,75,11019,0.9493670886075949,0.010659465605457646,Module 3,['HPA:0000000']
1400,GO:BP,GO:0051251,positive regulation of lymphocyte activation,1.4508006950240178e-08,True,"""Any process that activates or increases the frequency, rate or extent of lymphocyte activation."" [GOC:ai]",323,226,22,21031,0.09734513274336283,0.06811145510835913,Module 1,"['GO:0002696', 'GO:0046649', 'GO:0051249']"
1401,HPA,HPA:0471471,skin 2; lymphocytes[≥Low],1.4648731105758358e-08,True,skin 2; lymphocytes[≥Low],802,140,35,11019,0.25,0.043640897755610975,Module Singleton,['HPA:0470000']
1402,GO:BP,GO:0042100,B cell proliferation,1.4737086408060247e-08,True,"""The expansion of a B cell population by cell division. Follows B cell activation."" [GOC:jl]",105,226,14,21031,0.061946902654867256,0.13333333333333333,Module 1,"['GO:0042113', 'GO:0046651']"
1403,TF,TF:M00327_1,Factor: Pax-3; motif: NNNNNNCGTCACGSTYNNNNN; match class: 1,1.4968746583804434e-08,True,Factor: Pax-3; motif: NNNNNNCGTCACGSTYNNNNN; match class: 1,7016,826,383,20045,0.463680387409201,0.05458950969213227,Module 0,['TF:M00327']
1404,TF,TF:M11375,Factor: Spi-B; motif: NAWGCGGAAGTN,1.4988272567411445e-08,True,Factor: Spi-B; motif: NAWGCGGAAGTN,2641,826,179,20045,0.21670702179176757,0.06777735706171904,Module 0,['TF:M00000']
1405,REAC,REAC:R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,1.507374950647516e-08,True,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,55,586,19,10842,0.032423208191126277,0.34545454545454546,Module 0,['REAC:R-HSA-69275']
1406,HPA,HPA:0471393,skin 2; cells in basal layer[High],1.5174020969917e-08,True,skin 2; cells in basal layer[High],296,612,47,11019,0.07679738562091504,0.15878378378378377,Module 0,['HPA:0471392']
1407,HP,HP:0032076,Abnormal male urethral meatus morphology,1.5385216161643057e-08,True,Abnormal male urethral meatus morphology,383,44,20,4958,0.45454545454545453,0.05221932114882506,Module 3,['HP:0000036']
1408,HPA,HPA:0160051,endometrium 1; glandular cells[≥Low],1.56888778526267e-08,True,endometrium 1; glandular cells[≥Low],6818,79,74,11019,0.9367088607594937,0.010853622763273688,Module 3,['HPA:0160000']
1409,HP,HP:0004313,Decreased circulating antibody level,1.6099462231889827e-08,True,An abnormally decreased level of immunoglobulin in blood.,193,71,19,4958,0.2676056338028169,0.09844559585492228,Module 1,['HP:0010701']
1410,TF,TF:M08207,Factor: E2F-3:TBR2; motif: ANGTGYKANGGCGCSTTNNCRNNT,1.6179323027406342e-08,True,Factor: E2F-3:TBR2; motif: ANGTGYKANGGCGCSTTNNCRNNT,17410,826,777,20045,0.940677966101695,0.04462952326249282,Module 0,['TF:M00000']
1411,KEGG,KEGG:05322,Systemic lupus erythematosus,1.6254511241189623e-08,True,Systemic lupus erythematosus,132,13,7,8484,0.5384615384615384,0.05303030303030303,Module 6,['KEGG:00000']
1412,HP,HP:0000508,Ptosis,1.6408004386668345e-08,True,"The upper eyelid margin is positioned 3 mm or more lower than usual and covers the superior portion of the iris (objective); or, the upper lid margin obscures at least part of the pupil (subjective).",731,44,26,4958,0.5909090909090909,0.03556771545827633,Module 3,['HP:0012373']
1413,TF,TF:M00007,Factor: Elk-1; motif: NAAACMGGAAGTNCVH,1.6547371781560402e-08,True,Factor: Elk-1; motif: NAAACMGGAAGTNCVH,5911,826,334,20045,0.4043583535108959,0.05650482151920149,Module 0,['TF:M00000']
1414,REAC,REAC:R-HSA-1234174,Cellular response to hypoxia,1.6572448296278892e-08,True,Cellular response to hypoxia,75,586,22,10842,0.03754266211604096,0.29333333333333333,Module 0,['REAC:R-HSA-2262752']
1415,HPA,HPA:0160000,endometrium 1,1.7248140805427392e-08,True,endometrium 1,7055,79,75,11019,0.9493670886075949,0.010630758327427357,Module 3,['HPA:0000000']
1416,GO:BP,GO:0071222,cellular response to lipopolysaccharide,1.7278803522445408e-08,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria."" [GOC:mah]",214,215,18,21031,0.08372093023255814,0.08411214953271028,Module 2,"['GO:0032496', 'GO:0071219', 'GO:0071396', 'GO:1901701']"
1417,GO:BP,GO:0045321,leukocyte activation,1.753571351752074e-08,True,"""A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor."" [GOC:add]",946,215,36,21031,0.16744186046511628,0.03805496828752643,Module 2,"['GO:0001775', 'GO:0002376']"
1418,HPA,HPA:0250122,hippocampus; glial cells[≥Medium],1.8035026052837277e-08,True,hippocampus; glial cells[≥Medium],2004,612,175,11019,0.28594771241830064,0.08732534930139721,Module 0,['HPA:0250121']
1419,HPA,HPA:0600000,tonsil,1.8124890088564875e-08,True,tonsil,7788,140,130,11019,0.9285714285714286,0.016692347200821776,Module Singleton,['HPA:0000000']
1420,GO:BP,GO:0051171,regulation of nitrogen compound metabolic process,1.8266687923945276e-08,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving nitrogen or nitrogenous compounds."" [GOC:ai, GOC:tb]",5440,787,288,21031,0.36594663278271916,0.052941176470588235,Module 0,"['GO:0006807', 'GO:0019222']"
1421,HPA,HPA:0530713,spleen; cells in red pulp[High],1.869289686807238e-08,True,spleen; cells in red pulp[High],817,612,91,11019,0.14869281045751634,0.11138310893512852,Module 0,['HPA:0530712']
1422,HPA,HPA:0190223,esophagus; squamous epithelial cells[High],1.887085684609072e-08,True,esophagus; squamous epithelial cells[High],1652,79,36,11019,0.45569620253164556,0.021791767554479417,Module 3,['HPA:0190222']
1423,HPA,HPA:0630222,cervix; squamous epithelial cells[≥Medium],1.8982074615167688e-08,True,cervix; squamous epithelial cells[≥Medium],3730,79,55,11019,0.6962025316455697,0.014745308310991957,Module 3,['HPA:0630221']
1424,HPA,HPA:0461463,skin 1; langerhans cells[High],1.8983162940881522e-08,True,skin 1; langerhans cells[High],218,612,39,11019,0.06372549019607843,0.17889908256880735,Module 0,['HPA:0461462']
1425,GO:CC,GO:0032588,trans-Golgi network membrane,1.9158642782678773e-08,True,"""The lipid bilayer surrounding any of the compartments that make up the trans-Golgi network."" [GOC:mah]",107,17,6,22097,0.35294117647058826,0.056074766355140186,Module 6,"['GO:0005802', 'GO:0031090']"
1426,GO:CC,GO:0030659,cytoplasmic vesicle membrane,1.9276501272342067e-08,True,"""The lipid bilayer surrounding a cytoplasmic vesicle."" [GOC:mah]",1226,17,11,22097,0.6470588235294118,0.00897226753670473,Module 6,"['GO:0012506', 'GO:0031410']"
1427,GO:BP,GO:0006807,nitrogen compound metabolic process,1.9289149533093274e-08,True,"""The chemical reactions and pathways involving organic or inorganic compounds that contain nitrogen."" [GOC:jl, ISBN:0198506732]",11995,105,92,21031,0.8761904761904762,0.007669862442684452,Module 3,['GO:0008152']
1428,GO:CC,GO:0062023,collagen-containing extracellular matrix,1.9806786505897417e-08,True,"""An extracellular matrix consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that provides not only essential physical scaffolding for the cellular constituents but can also initiate crucial biochemical and biomechanical cues required for tissue morphogenesis, differentiation and homeostasis. The components are secreted by cells in the vicinity and form a sheet underlying or overlying cells such as endothelial and epithelial cells."" [GOC:BHF, GOC:rph, PMID:21123617]",425,221,23,22097,0.10407239819004525,0.05411764705882353,Module 2,['GO:0031012']
1429,GO:CC,GO:0070062,extracellular exosome,1.993078114882494e-08,True,"""A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm."" [GOC:BHF, GOC:mah, GOC:vesicles, PMID:15908444, PMID:17641064, PMID:19442504, PMID:19498381, PMID:22418571, PMID:24009894]",2109,238,57,22097,0.23949579831932774,0.02702702702702703,Module 1,"['GO:0005615', 'GO:1903561']"
1430,HP,HP:0000969,Edema,2.0471261017196796e-08,True,"An abnormal accumulation of fluid beneath the skin, or in one or more cavities of the body.",672,44,25,4958,0.5681818181818182,0.03720238095238095,Module 3,['HP:0011032']
1431,GO:BP,GO:0051276,chromosome organization,2.0487501914328588e-08,True,"""A process that is carried out at the cellular level that results in the assembly, arrangement of constituent parts, or disassembly of chromosomes, structures composed of a very long molecule of DNA and associated proteins that carries hereditary information. This term covers covalent modifications at the molecular level as well as spatial relationships among the major components of a chromosome."" [GOC:ai, GOC:dph, GOC:jl, GOC:mah]",635,77,18,21031,0.23376623376623376,0.028346456692913385,Module 5,['GO:0006996']
1432,HPA,HPA:0030443,appendix; non-germinal center cells[High],2.0558418824959803e-08,True,appendix; non-germinal center cells[High],105,612,26,11019,0.042483660130718956,0.24761904761904763,Module 0,['HPA:0030442']
1433,GO:BP,GO:0022409,positive regulation of cell-cell adhesion,2.0985863154205253e-08,True,"""Any process that activates or increases the rate or extent of cell adhesion to another cell."" [GOC:isa_complete]",318,15,8,21031,0.5333333333333333,0.025157232704402517,Module 6,"['GO:0022407', 'GO:0045785', 'GO:0098609']"
1434,HPA,HPA:0310433,lymph node; germinal center cells[High],2.0988945568226056e-08,True,lymph node; germinal center cells[High],944,185,45,11019,0.24324324324324326,0.04766949152542373,Module 1,['HPA:0310432']
1435,HPA,HPA:0030431,appendix; germinal center cells[≥Low],2.1105091568269562e-08,True,appendix; germinal center cells[≥Low],287,185,24,11019,0.12972972972972974,0.08362369337979095,Module 1,['HPA:0030000']
1436,GO:CC,GO:0005694,chromosome,2.115554140026347e-08,True,"""A structure composed of a very long molecule of DNA and associated proteins (e.g. histones) that carries hereditary information."" [ISBN:0198547684]",1949,80,28,22097,0.35,0.014366341713699333,Module 5,['GO:0043232']
1437,REAC,REAC:R-HSA-195253,Degradation of beta-catenin by the destruction complex,2.1430004044897658e-08,True,Degradation of beta-catenin by the destruction complex,83,586,23,10842,0.03924914675767918,0.27710843373493976,Module 0,['REAC:R-HSA-195721']
1438,GO:CC,GO:0012506,vesicle membrane,2.177212423875436e-08,True,"""The lipid bilayer surrounding any membrane-bounded vesicle in the cell."" [GOC:mah, GOC:vesicle]",1240,17,11,22097,0.6470588235294118,0.008870967741935484,Module 6,"['GO:0031090', 'GO:0031982']"
1439,HPA,HPA:0460201,skin 1; endothelial cells[≥Low],2.2050198752242545e-08,True,skin 1; endothelial cells[≥Low],841,69,24,11019,0.34782608695652173,0.028537455410225922,Module 5,['HPA:0460000']
1440,GO:BP,GO:0009056,catabolic process,2.21878542333995e-08,True,"""The chemical reactions and pathways resulting in the breakdown of substances, including the breakdown of carbon compounds with the liberation of energy for use by the cell or organism."" [ISBN:0198547684]",2556,787,161,21031,0.204574332909784,0.06298904538341157,Module 0,['GO:0008152']
1441,TF,TF:M08266,Factor: ER71:Pax-5; motif: ACCGGAACYACGCWTSANTG,2.2199862925703878e-08,True,Factor: ER71:Pax-5; motif: ACCGGAACYACGCWTSANTG,14675,826,686,20045,0.8305084745762712,0.04674616695059625,Module 0,['TF:M00000']
1442,GO:CC,GO:0016604,nuclear body,2.2285031410153292e-08,True,"""Extra-nucleolar nuclear domains usually visualized by confocal microscopy and fluorescent antibodies to specific proteins."" [GOC:ma, PMID:10330182]",895,813,74,22097,0.0910209102091021,0.08268156424581005,Module 0,"['GO:0005654', 'GO:0110165']"
1443,TF,TF:M11658_1,Factor: HSF4; motif: RGAANNTTCYRGAAN; match class: 1,2.228510412577067e-08,True,Factor: HSF4; motif: RGAANNTTCYRGAAN; match class: 1,20,21,5,20045,0.23809523809523808,0.25,Module 9,['TF:M11658']
1444,HP,HP:0001744,Splenomegaly,2.304710897898655e-08,True,Abnormal increased size of the spleen.,477,71,28,4958,0.39436619718309857,0.05870020964360587,Module 1,"['HP:0003271', 'HP:0025408']"
1445,GO:BP,GO:0051716,cellular response to stimulus,2.3409760717048325e-08,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus by a cell and ends with a change in state or activity or the cell."" [GOC:bf, GOC:jl]",7394,215,124,21031,0.5767441860465117,0.016770354341357856,Module 2,"['GO:0009987', 'GO:0050896']"
1446,GO:BP,GO:0051251,positive regulation of lymphocyte activation,2.3772818959802926e-08,True,"""Any process that activates or increases the frequency, rate or extent of lymphocyte activation."" [GOC:ai]",323,15,8,21031,0.5333333333333333,0.02476780185758514,Module 6,"['GO:0002696', 'GO:0046649', 'GO:0051249']"
1447,GO:BP,GO:0016477,cell migration,2.4266149837461437e-08,True,"""The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues."" [GOC:cjm, GOC:dph, GOC:ems, GOC:pf, Wikipedia:Cell_migration]",1496,215,46,21031,0.21395348837209302,0.03074866310160428,Module 2,['GO:0048870']
1448,HP,HP:0001871,Abnormality of blood and blood-forming tissues,2.4327094753753315e-08,True,An abnormality of the hematopoietic system.,1442,71,48,4958,0.676056338028169,0.033287101248266296,Module 1,['HP:0000118']
1449,HP,HP:0010987,Abnormal cellular immune system morphology,2.5126080302096155e-08,True,An abnormality of the morphology or counts of the cells that make up the immune system.,615,44,24,4958,0.5454545454545454,0.03902439024390244,Module 3,['HP:0032251']
1450,HP,HP:0001881,Abnormal leukocyte morphology,2.5126080302096155e-08,True,An abnormality of leukocytes.,615,44,24,4958,0.5454545454545454,0.03902439024390244,Module 3,"['HP:0001871', 'HP:0010987']"
1451,HP,HP:0034057,Fetal anomaly,2.513620558269618e-08,True,Structural or functional abnormalities of the fetus. Note that this section comprises terms that describe abnormalities that are specific to the fetus or differ from the corresponding general terms. A term from anywhere in the Human Phenotype Ontology can be applied to a fetus if appropriate.,555,44,23,4958,0.5227272727272727,0.04144144144144144,Module 3,['HP:0001197']
1452,HPA,HPA:0180051,epididymis; glandular cells[≥Low],2.5170992749366996e-08,True,epididymis; glandular cells[≥Low],7337,79,76,11019,0.9620253164556962,0.010358457135068829,Module 3,['HPA:0180000']
1453,HPA,HPA:0180000,epididymis,2.5170992749366996e-08,True,epididymis,7337,79,76,11019,0.9620253164556962,0.010358457135068829,Module 3,['HPA:0000000']
1454,TF,TF:M10849_1,Factor: Cdx-2; motif: NRTCGTAANNNN; match class: 1,2.5266586233206244e-08,True,Factor: Cdx-2; motif: NRTCGTAANNNN; match class: 1,4594,826,273,20045,0.3305084745762712,0.059425337396604265,Module 0,['TF:M10849']
1455,GO:BP,GO:0022407,regulation of cell-cell adhesion,2.5458628593298686e-08,True,"""Any process that modulates the frequency, rate or extent of attachment of a cell to another cell."" [GOC:isa_complete]",477,226,26,21031,0.11504424778761062,0.05450733752620545,Module 1,"['GO:0030155', 'GO:0098609']"
1456,GO:MF,GO:0003723,RNA binding,2.558808301255833e-08,True,"""Binding to an RNA molecule or a portion thereof."" [GOC:jl, GOC:mah]",3123,808,195,20212,0.24133663366336633,0.06243996157540826,Module 0,['GO:0003676']
1457,GO:BP,GO:1903241,U2-type prespliceosome assembly,2.586056561049934e-08,True,"""The aggregation, arrangement and bonding together of a set of components to form an U2-type prespliceosome."" [GO_REF:0000079, GOC:TermGenie, PMID:12374752]",24,787,12,21031,0.015247776365946633,0.5,Module 0,['GO:0000245']
1458,HP,HP:0033353,Abnormal blood vessel morphology,2.644032762944964e-08,True,"Any structural anomaly of a blood vessel (artery, arteriole, capillary, venule, or vein).",965,44,29,4958,0.6590909090909091,0.03005181347150259,Module 3,['HP:0025015']
1459,GO:BP,GO:0050789,regulation of biological process,2.6835204766031803e-08,True,"""Any process that modulates the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule."" [GOC:ai, GOC:go_curators]",12287,215,172,21031,0.8,0.013998535037031008,Module 2,"['GO:0008150', 'GO:0065007']"
1460,HPA,HPA:0100133,cerebral cortex; neuronal cells[High],2.6978585202442644e-08,True,cerebral cortex; neuronal cells[High],1848,612,164,11019,0.2679738562091503,0.08874458874458875,Module 0,['HPA:0100132']
1461,HP,HP:0001679,Abnormal aortic morphology,2.7285404278546463e-08,True,An abnormality of the aorta.,395,44,20,4958,0.45454545454545453,0.05063291139240506,Module 3,"['HP:0011004', 'HP:0030962']"
1462,TF,TF:M12186,Factor: BTEB4; motif: NCCACGCCCM,2.732722200556669e-08,True,Factor: BTEB4; motif: NCCACGCCCM,9361,826,481,20045,0.5823244552058111,0.05138339920948617,Module 0,['TF:M00000']
1463,TF,TF:M11387,Factor: elf5; motif: NNNNMGGAAGTN,2.7497268592878138e-08,True,Factor: elf5; motif: NNNNMGGAAGTN,2640,826,178,20045,0.21549636803874092,0.06742424242424243,Module 0,['TF:M00000']
1464,HPA,HPA:0550000,stomach 2,2.7981566941738393e-08,True,stomach 2,7612,79,77,11019,0.9746835443037974,0.010115606936416185,Module 3,['HPA:0000000']
1465,HPA,HPA:0550051,stomach 2; glandular cells[≥Low],2.7981566941738393e-08,True,stomach 2; glandular cells[≥Low],7612,79,77,11019,0.9746835443037974,0.010115606936416185,Module 3,['HPA:0550000']
1466,GO:BP,GO:0035456,response to interferon-beta,2.8052386069436597e-08,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-beta stimulus. Interferon-beta is a type I interferon."" [GOC:sl, PMID:9561374]",34,34,6,21031,0.17647058823529413,0.17647058823529413,Module 7,['GO:0034097']
1467,TF,TF:M00427,Factor: E2F; motif: TTTSGCGS,2.865728077721887e-08,True,Factor: E2F; motif: TTTSGCGS,9803,826,499,20045,0.6041162227602905,0.05090278486177701,Module 0,['TF:M00000']
1468,HPA,HPA:0461492,skin 1; vascular mural cells[≥Medium],2.9098246193880673e-08,True,skin 1; vascular mural cells[≥Medium],189,69,13,11019,0.18840579710144928,0.06878306878306878,Module 5,['HPA:0461491']
1469,GO:BP,GO:0036503,ERAD pathway,2.9162541658681907e-08,True,"""The protein catabolic pathway which targets endoplasmic reticulum (ER)-resident proteins for degradation by the cytoplasmic proteasome. It begins with recognition of the ER-resident protein, includes retrotranslocation (dislocation) of the protein from the ER to the cytosol, protein modifications necessary for correct substrate transfer (e.g. ubiquitination), transport of the protein to the proteasome, and ends with degradation of the protein by the cytoplasmic proteasome."" [GOC:bf, GOC:PARL, PMID:20940304, PMID:21969857]",56,72,8,21031,0.1111111111111111,0.14285714285714285,Module 4,"['GO:0010243', 'GO:0010498', 'GO:0034976']"
1470,HPA,HPA:0461481,skin 1; sebaceous glands[≥Low],2.9447920943481797e-08,True,skin 1; sebaceous glands[≥Low],202,612,37,11019,0.06045751633986928,0.18316831683168316,Module 0,['HPA:0460000']
1471,GO:BP,GO:0001909,leukocyte mediated cytotoxicity,3.0467664760857043e-08,True,"""The directed killing of a target cell by a leukocyte."" [GO_REF:0000022, GOC:add, ISBN:0781735149, PMID:11911826]",133,226,15,21031,0.06637168141592921,0.11278195488721804,Module 1,"['GO:0001906', 'GO:0002443']"
1472,HP,HP:0100763,Abnormality of the lymphatic system,3.0517576592918106e-08,True,"An anomaly of the lymphatic system, a network of lymphatic vessels that carry a clear fluid called lymph unidirectionally towards either the right lymphatic duct or the thoracic duct, which in turn drain into the right and left subclavian veins respectively.",769,71,35,4958,0.49295774647887325,0.045513654096228866,Module 1,"['HP:0002597', 'HP:0002715']"
1473,HPA,HPA:0190222,esophagus; squamous epithelial cells[≥Medium],3.0713923422325894e-08,True,esophagus; squamous epithelial cells[≥Medium],5058,79,64,11019,0.810126582278481,0.01265322261763543,Module 3,['HPA:0190221']
1474,TF,TF:M00938,Factor: E2F-1; motif: TTGGCGCGRAANNGNM,3.082529346006822e-08,True,Factor: E2F-1; motif: TTGGCGCGRAANNGNM,7512,826,403,20045,0.48789346246973364,0.053647497337593185,Module 0,['TF:M00000']
1475,GO:BP,GO:0051131,chaperone-mediated protein complex assembly,3.08648131226955e-08,True,"""The aggregation, arrangement and bonding together of a set of components to form a protein complex, mediated by chaperone molecules that do not form part of the finished complex."" [GOC:ai]",23,21,5,21031,0.23809523809523808,0.21739130434782608,Module 9,['GO:0065003']
1476,GO:BP,GO:1903047,mitotic cell cycle process,3.088201267280995e-08,True,"""A process that is part of the mitotic cell cycle."" [GO_REF:0000060, GOC:mtg_cell_cycle, GOC:TermGenie]",745,77,19,21031,0.24675324675324675,0.025503355704697986,Module 5,"['GO:0000278', 'GO:0022402']"
1477,REAC,REAC:R-HSA-4641258,Degradation of DVL,3.09065086190343e-08,True,Degradation of DVL,57,586,19,10842,0.032423208191126277,0.3333333333333333,Module 0,['REAC:R-HSA-201681']
1478,REAC,REAC:R-HSA-69541,Stabilization of p53,3.09065086190343e-08,True,Stabilization of p53,57,586,19,10842,0.032423208191126277,0.3333333333333333,Module 0,['REAC:R-HSA-69563']
1479,GO:CC,GO:1903561,extracellular vesicle,3.0984274553627156e-08,True,"""Any vesicle that is part of the extracellular region."" [GO_REF:0000064, GOC:pm, GOC:TermGenie, PMID:24769233]",2133,238,57,22097,0.23949579831932774,0.026722925457102673,Module 1,"['GO:0031982', 'GO:0065010']"
1480,HP,HP:0011839,Abnormal T cell count,3.1025039775052356e-08,True,A deviation from the normal count of T cells.,110,71,15,4958,0.2112676056338028,0.13636363636363635,Module 1,"['HP:0002843', 'HP:0040088']"
1481,HPA,HPA:0530723,spleen; cells in white pulp[High],3.106289859938252e-08,True,spleen; cells in white pulp[High],847,185,42,11019,0.22702702702702704,0.049586776859504134,Module 1,['HPA:0530722']
1482,GO:BP,GO:0042127,regulation of cell population proliferation,3.1342486784769104e-08,True,"""Any process that modulates the frequency, rate or extent of cell proliferation."" [GOC:jl]",1683,215,49,21031,0.22790697674418606,0.029114676173499703,Module 2,"['GO:0008283', 'GO:0050794']"
1483,GO:CC,GO:0043230,extracellular organelle,3.1553895050678744e-08,True,"""Organized structure of distinctive morphology and function, occurring outside the cell. Includes, for example, extracellular membrane vesicles (EMVs) and the cellulosomes of anaerobic bacteria and fungi."" [GOC:jl, PMID:9914479]",2134,238,57,22097,0.23949579831932774,0.026710402999062792,Module 1,"['GO:0005576', 'GO:0043226']"
1484,GO:CC,GO:0065010,extracellular membrane-bounded organelle,3.1553895050678744e-08,True,"""Organized structure of distinctive morphology and function, bounded by a lipid bilayer membrane and occurring outside the cell."" [GOC:isa_complete]",2134,238,57,22097,0.23949579831932774,0.026710402999062792,Module 1,"['GO:0043227', 'GO:0043230']"
1485,HP,HP:0000077,Abnormality of the kidney,3.155825357469567e-08,True,An abnormality of the kidney.,1413,44,34,4958,0.7727272727272727,0.024062278839348902,Module 3,['HP:0010935']
1486,TF,TF:M03924_1,Factor: YY1; motif: NNCGCCATTNN; match class: 1,3.182052433543054e-08,True,Factor: YY1; motif: NNCGCCATTNN; match class: 1,3779,826,234,20045,0.28329297820823246,0.061921143159566025,Module 0,['TF:M03924']
1487,GO:BP,GO:0050867,positive regulation of cell activation,3.216420608626774e-08,True,"""Any process that activates or increases the frequency, rate or extent of activation."" [GOC:ai]",371,226,23,21031,0.10176991150442478,0.06199460916442048,Module 1,"['GO:0001775', 'GO:0048522', 'GO:0050865', 'GO:0051240']"
1488,MIRNA,MIRNA:hsa-miR-484,hsa-miR-484,3.220947761160455e-08,True,hsa-miR-484,891,753,92,14819,0.12217795484727756,0.10325476992143659,Module 0,['MIRNA:000000']
1489,HP,HP:0000795,Abnormality of the urethra,3.237423421813578e-08,True,"An abnormality of the urethra, i.e., of the tube which connects the urinary bladder to the outside of the body.",450,44,21,4958,0.4772727272727273,0.04666666666666667,Module 3,['HP:0010936']
1490,HPA,HPA:0190221,esophagus; squamous epithelial cells[≥Low],3.2864417282747366e-08,True,esophagus; squamous epithelial cells[≥Low],6679,79,73,11019,0.9240506329113924,0.010929779907171732,Module 3,['HPA:0190000']
1491,HPA,HPA:0190000,esophagus,3.2864417282747366e-08,True,esophagus,6679,79,73,11019,0.9240506329113924,0.010929779907171732,Module 3,['HPA:0000000']
1492,GO:BP,GO:0030155,regulation of cell adhesion,3.2973943408195156e-08,True,"""Any process that modulates the frequency, rate or extent of attachment of a cell to another cell or to the extracellular matrix."" [GOC:mah]",778,226,33,21031,0.14601769911504425,0.042416452442159386,Module 1,"['GO:0007155', 'GO:0050794']"
1493,HPA,HPA:0461393,skin 1; cells in basal layer[High],3.3197375513317735e-08,True,skin 1; cells in basal layer[High],191,69,13,11019,0.18840579710144928,0.06806282722513089,Module 5,['HPA:0461392']
1494,HP,HP:0011024,Abnormality of the gastrointestinal tract,3.356338528475147e-08,True,An abnormality of the gastrointestinal tract.,1738,44,37,4958,0.8409090909090909,0.021288837744533946,Module 3,['HP:0025031']
1495,HP,HP:0008316,Abnormal mitochondria in muscle tissue,3.477418240146459e-08,True,An abnormality of the mitochondria in muscle tissue.,39,44,9,4958,0.20454545454545456,0.23076923076923078,Module 3,"['HP:0003287', 'HP:0011805']"
1496,GO:CC,GO:0005689,U12-type spliceosomal complex,3.486879275570795e-08,True,"""Any spliceosomal complex that forms during the splicing of a messenger RNA primary transcript to excise an intron; the series of U12-type spliceosomal complexes is involved in the splicing of the majority of introns that contain atypical AT-AC terminal dinucleotides, as well as other non-canonical introns. The entire splice site signal, not just the terminal dinucleotides, is involved in determining which spliceosome utilizes the site."" [GOC:krc, GOC:mah, PMID:11574683, PMID:11971955]",28,813,12,22097,0.014760147601476014,0.42857142857142855,Module 0,['GO:0005681']
1497,HPA,HPA:0461442,skin 1; fibrohistiocytic cells[≥Medium],3.516854249759726e-08,True,skin 1; fibrohistiocytic cells[≥Medium],699,140,32,11019,0.22857142857142856,0.045779685264663805,Module Singleton,['HPA:0461441']
1498,HPA,HPA:0550052,stomach 2; glandular cells[≥Medium],3.52185717046497e-08,True,stomach 2; glandular cells[≥Medium],6284,79,71,11019,0.8987341772151899,0.011298535964353915,Module 3,['HPA:0550051']
1499,GO:CC,GO:0005765,lysosomal membrane,3.5540891843751736e-08,True,"""The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm."" [GOC:ai]",446,813,47,22097,0.05781057810578106,0.10538116591928251,Module 0,"['GO:0005764', 'GO:0098852']"
1500,GO:CC,GO:0098852,lytic vacuole membrane,3.5540891843751736e-08,True,"""The lipid bilayer surrounding a lytic vacuole and separating its contents from the cytoplasm of the cell."" [GOC:dos]",446,813,47,22097,0.05781057810578106,0.10538116591928251,Module 0,"['GO:0000323', 'GO:0005774']"
1501,HP,HP:0011017,Abnormal cellular physiology,3.563244168757308e-08,True,An abnormality in a cellular process.,602,71,31,4958,0.43661971830985913,0.05149501661129568,Module 1,"['HP:0001939', 'HP:0025354']"
1502,GO:BP,GO:0040011,locomotion,3.7028292792544694e-08,True,"""Self-propelled movement of a cell or organism from one location to another."" [GOC:dgh]",1234,215,41,21031,0.19069767441860466,0.03322528363047002,Module 2,['GO:0008150']
1503,HPA,HPA:0471471,skin 2; lymphocytes[≥Low],3.749686421962156e-08,True,skin 2; lymphocytes[≥Low],802,166,38,11019,0.2289156626506024,0.04738154613466334,Module 2,['HPA:0470000']
1504,TF,TF:M02056_1,Factor: ELF4; motif: NCCGGAARTN; match class: 1,3.7660873638143986e-08,True,Factor: ELF4; motif: NCCGGAARTN; match class: 1,1322,826,107,20045,0.12953995157384987,0.08093797276853253,Module 0,['TF:M02056']
1505,HP,HP:0012718,Abnormal gastrointestinal tract morphology,3.9440434596906984e-08,True,Abnormal structure of the gastrointestinal tract.,980,44,29,4958,0.6590909090909091,0.02959183673469388,Module 3,"['HP:0011024', 'HP:0025033']"
1506,REAC,REAC:R-HSA-388841,Costimulation by the CD28 family,3.949984461352621e-08,True,Costimulation by the CD28 family,67,14,6,10842,0.42857142857142855,0.08955223880597014,Module 6,['REAC:R-HSA-1280218']
1507,GO:BP,GO:0065007,biological regulation,4.107978509215408e-08,True,"""Any process that modulates a measurable attribute of any biological process, quality or function."" [GOC:dph, GOC:isa_complete, GOC:mah, GOC:pr, GOC:vw]",12680,215,175,21031,0.813953488372093,0.013801261829652996,Module 2,['GO:0008150']
1508,HPA,HPA:0600431,tonsil; germinal center cells[≥Low],4.147727797057082e-08,True,tonsil; germinal center cells[≥Low],5987,140,112,11019,0.8,0.018707198931017206,Module Singleton,['HPA:0600000']
1509,HPA,HPA:0471461,skin 2; langerhans cells[≥Low],4.158282176758344e-08,True,skin 2; langerhans cells[≥Low],789,140,34,11019,0.24285714285714285,0.043092522179974654,Module Singleton,['HPA:0470000']
1510,GO:BP,GO:0051240,positive regulation of multicellular organismal process,4.161245831059196e-08,True,"""Any process that activates or increases the frequency, rate or extent of an organismal process, any of the processes pertinent to the function of an organism above the cellular level; includes the integrated processes of tissues and organs."" [GOC:ai]",1637,215,48,21031,0.22325581395348837,0.029321930360415395,Module 2,"['GO:0032501', 'GO:0048518', 'GO:0051239']"
1511,HP,HP:0009127,Abnormality of the musculature of the limbs,4.240806012922479e-08,True,Abnormality of the musculature of the limbs,630,44,24,4958,0.5454545454545454,0.0380952380952381,Module 3,"['HP:0011805', 'HP:0040064']"
1512,TF,TF:M08225,Factor: Elk-1:Pax-5; motif: ACCGGAACYACGCWTSANYG,4.328021141316733e-08,True,Factor: Elk-1:Pax-5; motif: ACCGGAACYACGCWTSANYG,14315,826,672,20045,0.8135593220338984,0.0469437652811736,Module 0,['TF:M00000']
1513,MIRNA,MIRNA:hsa-miR-320a,hsa-miR-320a,4.334097308852372e-08,True,hsa-miR-320a,580,104,22,14819,0.21153846153846154,0.03793103448275862,Module 3,['MIRNA:000000']
1514,TF,TF:M00652,Factor: NRF-1; motif: CGCATGCGCR,4.43230817364961e-08,True,Factor: NRF-1; motif: CGCATGCGCR,1396,826,111,20045,0.1343825665859564,0.07951289398280802,Module 0,['TF:M00000']
1515,TF,TF:M08423,Factor: TEF-3:ER81; motif: ACCGGAAATRCC,4.498668719934906e-08,True,Factor: TEF-3:ER81; motif: ACCGGAAATRCC,3938,826,241,20045,0.2917675544794189,0.0611985779583545,Module 0,['TF:M00000']
1516,TF,TF:M11401,Factor: Fli-1; motif: NACCGGATATCCGGTN,4.5602554972997134e-08,True,Factor: Fli-1; motif: NACCGGATATCCGGTN,12200,826,593,20045,0.7179176755447942,0.04860655737704918,Module 0,['TF:M00000']
1517,GO:BP,GO:0034605,cellular response to heat,4.632554763775285e-08,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a heat stimulus, a temperature stimulus above the optimal temperature for that organism."" [GOC:mah]",63,21,6,21031,0.2857142857142857,0.09523809523809523,Module 9,"['GO:0009408', 'GO:0033554']"
1518,HPA,HPA:0461391,skin 1; cells in basal layer[≥Low],4.645873247281203e-08,True,skin 1; cells in basal layer[≥Low],881,140,36,11019,0.2571428571428571,0.04086265607264472,Module Singleton,['HPA:0460000']
1519,GO:CC,GO:0042571,"immunoglobulin complex, circulating",4.690323796166508e-08,True,"""An immunoglobulin complex that is secreted into extracellular space and found in mucosal areas or other tissues or circulating in the blood or lymph. In its canonical form, a circulating immunoglobulin complex is composed of two identical heavy chains and two identical light chains, held together by disulfide bonds. Some forms of are polymers of the basic structure and contain additional components such as J-chain and the secretory component."" [GOC:add, ISBN:0781735149]",11,73,5,22097,0.0684931506849315,0.45454545454545453,Module 4,"['GO:0005615', 'GO:0019814']"
1520,HPA,HPA:0160251,endometrium 1; cells in endometrial stroma[≥Low],4.753685126683303e-08,True,endometrium 1; cells in endometrial stroma[≥Low],4077,79,57,11019,0.7215189873417721,0.013980868285504048,Module 3,['HPA:0160000']
1521,REAC,REAC:R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,4.8490520719753885e-08,True,Ubiquitin-dependent degradation of Cyclin D,52,586,18,10842,0.030716723549488054,0.34615384615384615,Module 0,['REAC:R-HSA-69242']
1522,REAC,REAC:R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,4.8490520719753885e-08,True,Autodegradation of the E3 ubiquitin ligase COP1,52,586,18,10842,0.030716723549488054,0.34615384615384615,Module 0,['REAC:R-HSA-69541']
1523,REAC,REAC:R-HSA-180534,Vpu mediated degradation of CD4,4.8490520719753885e-08,True,Vpu mediated degradation of CD4,52,586,18,10842,0.030716723549488054,0.34615384615384615,Module 0,['REAC:R-HSA-162909']
1524,REAC,REAC:R-HSA-69610,p53-Independent DNA Damage Response,4.8490520719753885e-08,True,p53-Independent DNA Damage Response,52,586,18,10842,0.030716723549488054,0.34615384615384615,Module 0,['REAC:R-HSA-69613']
1525,REAC,REAC:R-HSA-69613,p53-Independent G1/S DNA damage checkpoint,4.8490520719753885e-08,True,p53-Independent G1/S DNA damage checkpoint,52,586,18,10842,0.030716723549488054,0.34615384615384615,Module 0,['REAC:R-HSA-69615']
1526,REAC,REAC:R-HSA-69601,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,4.8490520719753885e-08,True,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,52,586,18,10842,0.030716723549488054,0.34615384615384615,Module 0,['REAC:R-HSA-69610']
1527,GO:CC,GO:0098687,chromosomal region,4.893372608160385e-08,True,"""Any subdivision of a chromosome along its length."" [GOC:dos]",402,80,14,22097,0.175,0.03482587064676617,Module 5,"['GO:0005694', 'GO:0110165']"
1528,HPA,HPA:0090162,cerebellum; Purkinje cells[≥Medium],4.895446764345697e-08,True,cerebellum; Purkinje cells[≥Medium],4126,612,304,11019,0.49673202614379086,0.07367910809500727,Module 0,['HPA:0090161']
1529,HPA,HPA:0510652,soft tissue 2; fibroblasts[≥Medium],4.9352549029447e-08,True,soft tissue 2; fibroblasts[≥Medium],2619,612,213,11019,0.3480392156862745,0.08132875143184422,Module 0,['HPA:0510651']
1530,GO:BP,GO:0002696,positive regulation of leukocyte activation,4.940782571386532e-08,True,"""Any process that activates or increases the frequency, rate, or extent of leukocyte activation."" [GOC:add]",354,15,8,21031,0.5333333333333333,0.022598870056497175,Module 6,"['GO:0002684', 'GO:0002694', 'GO:0045321', 'GO:0050867']"
1531,HPA,HPA:0350000,pancreas,5.01374818412378e-08,True,pancreas,7409,79,76,11019,0.9620253164556962,0.010257794574166553,Module 3,['HPA:0000000']
1532,HPA,HPA:0150053,duodenum; glandular cells[High],5.0953560499800194e-08,True,duodenum; glandular cells[High],2604,612,212,11019,0.3464052287581699,0.08141321044546851,Module 0,['HPA:0150052']
1533,GO:BP,GO:0043068,positive regulation of programmed cell death,5.113320283243537e-08,True,"""Any process that activates or increases the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes."" [GOC:jl]",532,226,27,21031,0.11946902654867257,0.05075187969924812,Module 1,"['GO:0012501', 'GO:0043067', 'GO:0048522']"
1534,HPA,HPA:0461422,skin 1; eccrine glands[≥Medium],5.172119370746928e-08,True,skin 1; eccrine glands[≥Medium],187,612,35,11019,0.05718954248366013,0.18716577540106952,Module 0,['HPA:0461421']
1535,GO:CC,GO:0005622,intracellular anatomical structure,5.252580327151213e-08,True,"""A component of a cell contained within (but not including) the plasma membrane. In eukaryotes it includes the nucleus and cytoplasm."" [ISBN:0198506732]",17834,105,105,22097,1.0,0.00588763036895817,Module 3,['GO:0110165']
1536,HPA,HPA:0460201,skin 1; endothelial cells[≥Low],5.423538971404357e-08,True,skin 1; endothelial cells[≥Low],841,140,35,11019,0.25,0.041617122473246136,Module Singleton,['HPA:0460000']
1537,GO:CC,GO:0016020,membrane,5.4472697196934446e-08,True,"""A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it."" [GOC:dos, GOC:mah, ISBN:0815316194]",9864,105,79,22097,0.7523809523809524,0.008008921330089213,Module 3,['GO:0110165']
1538,GO:BP,GO:0006417,regulation of translation,5.564446085052157e-08,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA."" [GOC:isa_complete]",378,787,44,21031,0.05590851334180432,0.1164021164021164,Module 0,"['GO:0006412', 'GO:0010608', 'GO:0034248', 'GO:0051246']"
1539,GO:BP,GO:0048584,positive regulation of response to stimulus,5.5951061029220055e-08,True,"""Any process that activates, maintains or increases the rate of a response to a stimulus. Response to stimulus is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus."" [GOC:jid]",2274,215,58,21031,0.26976744186046514,0.025505716798592787,Module 2,"['GO:0048518', 'GO:0048583', 'GO:0050896']"
1540,GO:BP,GO:0050776,regulation of immune response,5.609917164669287e-08,True,"""Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus."" [GOC:ai]",881,15,10,21031,0.6666666666666666,0.011350737797956867,Module 6,"['GO:0002682', 'GO:0006955', 'GO:0048583']"
1541,HPA,HPA:0461471,skin 1; lymphocytes[≥Low],5.63652969479821e-08,True,skin 1; lymphocytes[≥Low],712,140,32,11019,0.22857142857142856,0.0449438202247191,Module Singleton,['HPA:0460000']
1542,HPA,HPA:0310000,lymph node,5.653750154079636e-08,True,lymph node,6530,79,72,11019,0.9113924050632911,0.011026033690658498,Module 3,['HPA:0000000']
1543,HPA,HPA:0030443,appendix; non-germinal center cells[High],5.682244788118355e-08,True,appendix; non-germinal center cells[High],105,185,15,11019,0.08108108108108109,0.14285714285714285,Module 1,['HPA:0030442']
1544,HPA,HPA:0471451,skin 2; hair follicles[≥Low],5.6935400059905044e-08,True,skin 2; hair follicles[≥Low],197,612,36,11019,0.058823529411764705,0.18274111675126903,Module 0,['HPA:0470000']
1545,GO:BP,GO:0050684,regulation of mRNA processing,5.6944197596755705e-08,True,"""Any process that modulates the frequency, rate or extent of mRNA processing, those processes involved in the conversion of a primary mRNA transcript into a mature mRNA prior to its translation into polypeptide."" [GOC:ai]",134,787,25,21031,0.03176620076238882,0.1865671641791045,Module 0,"['GO:0006397', 'GO:1903311']"
1546,TF,TF:M11530_1,Factor: E2F-2; motif: NWTTTGGCGCCAWWNN; match class: 1,5.7828129083546325e-08,True,Factor: E2F-2; motif: NWTTTGGCGCCAWWNN; match class: 1,13807,826,653,20045,0.7905569007263923,0.04729485043818353,Module 0,['TF:M11530']
1547,HP,HP:0001871,Abnormality of blood and blood-forming tissues,5.8675317044748386e-08,True,An abnormality of the hematopoietic system.,1442,44,34,4958,0.7727272727272727,0.023578363384188627,Module 3,['HP:0000118']
1548,HP,HP:0010935,Abnormality of the upper urinary tract,5.8675317044748386e-08,True,An abnormality of the upper urinary tract.,1442,44,34,4958,0.7727272727272727,0.023578363384188627,Module 3,['HP:0000079']
1549,GO:CC,GO:0000139,Golgi membrane,5.88256987249234e-08,True,"""The lipid bilayer surrounding any of the compartments of the Golgi apparatus."" [GOC:mah]",671,17,9,22097,0.5294117647058824,0.013412816691505217,Module 6,"['GO:0005794', 'GO:0098588']"
1550,GO:BP,GO:0097190,apoptotic signaling pathway,5.9441288037574066e-08,True,"""The series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered."" [GOC:mtg_apoptosis]",607,215,28,21031,0.13023255813953488,0.04612850082372323,Module 2,"['GO:0006915', 'GO:0007165']"
1551,GO:CC,GO:0043226,organelle,5.9544161750272624e-08,True,"""Organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton, and prokaryotic structures such as anammoxosomes and pirellulosomes. Excludes the plasma membrane."" [GOC:go_curators]",16808,105,103,22097,0.9809523809523809,0.006128034269395526,Module 3,['GO:0110165']
1552,GO:BP,GO:0048518,positive regulation of biological process,6.036686206782699e-08,True,"""Any process that activates or increases the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule."" [GOC:jid]",6250,787,319,21031,0.40533672172808133,0.05104,Module 0,"['GO:0008150', 'GO:0050789']"
1553,HPA,HPA:0461452,skin 1; hair follicles[≥Medium],6.067654273622635e-08,True,skin 1; hair follicles[≥Medium],293,69,15,11019,0.21739130434782608,0.051194539249146756,Module 5,['HPA:0461451']
1554,GO:BP,GO:1901137,carbohydrate derivative biosynthetic process,6.12708802254355e-08,True,"""The chemical reactions and pathways resulting in the formation of carbohydrate derivative."" [GOC:TermGenie]",661,787,62,21031,0.07878017789072427,0.09379727685325265,Module 0,"['GO:1901135', 'GO:1901576']"
1555,HP,HP:0032251,Abnormal immune system morphology,6.168502233563929e-08,True,Abnormal immune system morphology,641,44,24,4958,0.5454545454545454,0.0374414976599064,Module 3,['HP:0002715']
1556,GO:BP,GO:1903037,regulation of leukocyte cell-cell adhesion,6.305632245875886e-08,True,"""Any process that modulates the frequency, rate or extent of leukocyte cell-cell adhesion."" [GO_REF:0000058, GOC:BHF, GOC:rl, GOC:TermGenie, PMID:21106532]",365,15,8,21031,0.5333333333333333,0.021917808219178082,Module 6,"['GO:0007159', 'GO:0022407']"
1557,TF,TF:M09950,Factor: HSF1; motif: NRGAANNTTCYRGAA,6.344356718492257e-08,True,Factor: HSF1; motif: NRGAANNTTCYRGAA,2486,21,16,20045,0.7619047619047619,0.006436041834271922,Module 9,['TF:M00000']
1558,GO:BP,GO:0034248,regulation of amide metabolic process,6.40729540172679e-08,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving amides."" [GOC:mah]",439,787,48,21031,0.060991105463786534,0.10933940774487472,Module 0,"['GO:0043603', 'GO:0051171']"
1559,TF,TF:M11399,Factor: Fli-1; motif: NACCGGAWWTCCGGTY,6.455756353878436e-08,True,Factor: Fli-1; motif: NACCGGAWWTCCGGTY,13219,826,631,20045,0.7639225181598063,0.0477343218095166,Module 0,['TF:M00000']
1560,HPA,HPA:0461461,skin 1; langerhans cells[≥Low],6.502048617174237e-08,True,skin 1; langerhans cells[≥Low],716,140,32,11019,0.22857142857142856,0.0446927374301676,Module Singleton,['HPA:0460000']
1561,GO:BP,GO:0048518,positive regulation of biological process,6.507820971065933e-08,True,"""Any process that activates or increases the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule."" [GOC:jid]",6250,215,110,21031,0.5116279069767442,0.0176,Module 2,"['GO:0008150', 'GO:0050789']"
1562,TF,TF:M00050,Factor: E2F; motif: TTTSGCGC,6.663255458510506e-08,True,Factor: E2F; motif: TTTSGCGC,7247,826,390,20045,0.4721549636803874,0.05381537187801849,Module 0,['TF:M00000']
1563,HPA,HPA:0540052,stomach 1; glandular cells[≥Medium],6.727536273791734e-08,True,stomach 1; glandular cells[≥Medium],6351,79,71,11019,0.8987341772151899,0.011179341835931349,Module 3,['HPA:0540051']
1564,TF,TF:M11457,Factor: nerf; motif: NANGCGGAAGTR,6.80883261803432e-08,True,Factor: nerf; motif: NANGCGGAAGTR,1093,826,93,20045,0.11259079903147699,0.08508691674290943,Module 0,['TF:M00000']
1565,HPA,HPA:0040081,bone marrow; hematopoietic cells[≥Low],6.936385157757603e-08,True,bone marrow; hematopoietic cells[≥Low],6496,140,117,11019,0.8357142857142857,0.018011083743842363,Module Singleton,['HPA:0040000']
1566,HPA,HPA:0040000,bone marrow,6.936385157757603e-08,True,bone marrow,6496,140,117,11019,0.8357142857142857,0.018011083743842363,Module Singleton,['HPA:0000000']
1567,TF,TF:M08523,Factor: E2F-1:TBR2; motif: NGGTGNNANGGCGCNNTNNCRNNN,6.938712872424229e-08,True,Factor: E2F-1:TBR2; motif: NGGTGNNANGGCGCNNTNNCRNNN,12482,826,603,20045,0.7300242130750605,0.04830956577471559,Module 0,['TF:M00000']
1568,GO:BP,GO:0042981,regulation of apoptotic process,6.941176553354817e-08,True,"""Any process that modulates the occurrence or rate of cell death by apoptotic process."" [GOC:jl, GOC:mtg_apoptosis]",1463,226,46,21031,0.20353982300884957,0.03144224196855776,Module 1,"['GO:0006915', 'GO:0043067']"
1569,TF,TF:M00516_1,Factor: E2F-1; motif: TTTSGCGCGMNR; match class: 1,7.078036558701406e-08,True,Factor: E2F-1; motif: TTTSGCGCGMNR; match class: 1,2126,826,150,20045,0.18159806295399517,0.07055503292568203,Module 0,['TF:M00516']
1570,GO:BP,GO:0050867,positive regulation of cell activation,7.180272129904163e-08,True,"""Any process that activates or increases the frequency, rate or extent of activation."" [GOC:ai]",371,15,8,21031,0.5333333333333333,0.0215633423180593,Module 6,"['GO:0001775', 'GO:0048522', 'GO:0050865', 'GO:0051240']"
1571,GO:BP,GO:0006950,response to stress,7.204779011203969e-08,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis, usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation)."" [GOC:mah]",3855,34,24,21031,0.7058823529411765,0.0062256809338521405,Module 7,['GO:0050896']
1572,GO:BP,GO:0008152,metabolic process,7.455609444643773e-08,True,"""The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation."" [GOC:go_curators, ISBN:0198547684]",14261,105,99,21031,0.9428571428571428,0.006942009676740761,Module 3,['GO:0008150']
1573,GO:CC,GO:0030665,clathrin-coated vesicle membrane,7.5218811534822e-08,True,"""The lipid bilayer surrounding a clathrin-coated vesicle."" [GOC:mah]",134,17,6,22097,0.35294117647058826,0.04477611940298507,Module 6,"['GO:0030136', 'GO:0030662']"
1574,GO:BP,GO:0050863,regulation of T cell activation,7.65592570878342e-08,True,"""Any process that modulates the frequency, rate or extent of T cell activation."" [GOC:ai]",374,15,8,21031,0.5333333333333333,0.0213903743315508,Module 6,"['GO:0042110', 'GO:0051249']"
1575,TF,TF:M11401_1,Factor: Fli-1; motif: NACCGGATATCCGGTN; match class: 1,7.734702005824008e-08,True,Factor: Fli-1; motif: NACCGGATATCCGGTN; match class: 1,12045,826,586,20045,0.7094430992736077,0.048650892486508925,Module 0,['TF:M11401']
1576,GO:CC,GO:0098852,lytic vacuole membrane,7.751171744543024e-08,True,"""The lipid bilayer surrounding a lytic vacuole and separating its contents from the cytoplasm of the cell."" [GOC:dos]",446,17,8,22097,0.47058823529411764,0.017937219730941704,Module 6,"['GO:0000323', 'GO:0005774']"
1577,GO:CC,GO:0005765,lysosomal membrane,7.751171744543024e-08,True,"""The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm."" [GOC:ai]",446,17,8,22097,0.47058823529411764,0.017937219730941704,Module 6,"['GO:0005764', 'GO:0098852']"
1578,HPA,HPA:0471443,skin 2; fibrohistiocytic cells[High],7.75199804225923e-08,True,skin 2; fibrohistiocytic cells[High],467,69,18,11019,0.2608695652173913,0.03854389721627409,Module 5,['HPA:0471442']
1579,HPA,HPA:0310441,lymph node; non-germinal center cells[≥Low],7.958631965996536e-08,True,lymph node; non-germinal center cells[≥Low],6061,69,62,11019,0.8985507246376812,0.01022933509321894,Module 5,['HPA:0310000']
1580,HPA,HPA:0100132,cerebral cortex; neuronal cells[≥Medium],8.008750766098575e-08,True,cerebral cortex; neuronal cells[≥Medium],4996,79,63,11019,0.7974683544303798,0.012610088070456365,Module 3,['HPA:0100131']
1581,HP,HP:0000501,Glaucoma,8.086923419939245e-08,True,Glaucoma refers loss of retinal ganglion cells in a characteristic pattern of optic neuropathy usually associated with increased intraocular pressure.,369,44,19,4958,0.4318181818181818,0.051490514905149054,Module 3,['HP:0012373']
1582,HPA,HPA:0530711,spleen; cells in red pulp[≥Low],8.1549049276542e-08,True,spleen; cells in red pulp[≥Low],5333,140,104,11019,0.7428571428571429,0.019501218826176635,Module Singleton,['HPA:0530000']
1583,REAC,REAC:R-HSA-202403,TCR signaling,8.315988565115894e-08,True,TCR signaling,120,586,27,10842,0.04607508532423208,0.225,Module 0,['REAC:R-HSA-1280218']
1584,REAC,REAC:R-HSA-5610780,Degradation of GLI1 by the proteasome,8.515525084108693e-08,True,Degradation of GLI1 by the proteasome,60,586,19,10842,0.032423208191126277,0.31666666666666665,Module 0,['REAC:R-HSA-5610787']
1585,KEGG,KEGG:05164,Influenza A,8.537816569711664e-08,True,Influenza A,167,13,7,8484,0.5384615384615384,0.041916167664670656,Module 6,['KEGG:00000']
1586,GO:BP,GO:0032502,developmental process,8.917888735254604e-08,True,"""A biological process whose specific outcome is the progression of an integrated living unit: an anatomical structure (which may be a subcellular structure, cell, tissue, or organ), or organism over time from an initial condition to a later condition."" [GOC:isa_complete]",6453,215,112,21031,0.5209302325581395,0.01735626840229351,Module 2,['GO:0008150']
1587,GO:CC,GO:0005576,extracellular region,9.261228562057641e-08,True,"""The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite."" [GOC:go_curators]",4213,813,227,22097,0.27921279212792127,0.053880845003560406,Module 0,['GO:0110165']
1588,HP,HP:0011138,Abnormal skin adnexa morphology,9.300699856297228e-08,True,"An abnormality of the skin adnexa (skin appendages), which are specialized skin structures located within the dermis and focally within the subcutaneous fatty tissue, comprising three histologically distinct structures: (1) the pilosebaceous unit (hair follicle and sebaceous glands); (2) the eccrine sweat glands; and (3) the apocrine glands.",1464,44,34,4958,0.7727272727272727,0.023224043715846996,Module 3,['HP:0001574']
1589,GO:BP,GO:0030595,leukocyte chemotaxis,9.503570782658556e-08,True,"""The movement of a leukocyte in response to an external stimulus."" [GOC:add, GOC:jl]",237,215,18,21031,0.08372093023255814,0.0759493670886076,Module 2,"['GO:0050900', 'GO:0060326']"
1590,REAC,REAC:R-HSA-6798695,Neutrophil degranulation,9.700812991951935e-08,True,Neutrophil degranulation,476,586,61,10842,0.10409556313993173,0.12815126050420167,Module 0,['REAC:R-HSA-168249']
1591,HP,HP:0001112,Leber optic atrophy,9.749366055775387e-08,True,Degeneration of retinal ganglion cells and their axons.,10,44,6,4958,0.13636363636363635,0.6,Module 3,['HP:0000587']
1592,HP,HP:0007327,Mixed demyelinating and axonal polyneuropathy,9.749366055775387e-08,True,Mixed demyelinating and axonal polyneuropathy,10,44,6,4958,0.13636363636363635,0.6,Module 3,"['HP:0009830', 'HP:0012447']"
1593,HP,HP:0100611,Multiple glomerular cysts,9.749366055775387e-08,True,The presence of many cysts in the glomerulus of the kidney related to dilatation of the Bowman's capsule.,10,44,6,4958,0.13636363636363635,0.6,Module 3,['HP:0000095']
1594,REAC,REAC:R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,9.948923700830868e-08,True,AUF1 (hnRNP D0) binds and destabilizes mRNA,54,586,18,10842,0.030716723549488054,0.3333333333333333,Module 0,['REAC:R-HSA-450531']
1595,REAC,REAC:R-HSA-8941858,Regulation of RUNX3 expression and activity,9.948923700830868e-08,True,Regulation of RUNX3 expression and activity,54,586,18,10842,0.030716723549488054,0.3333333333333333,Module 0,['REAC:R-HSA-8878159']
1596,REAC,REAC:R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,1.0029305245340865e-07,True,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,181,164,18,10842,0.10975609756097561,0.09944751381215469,Module 1,['REAC:R-HSA-1280218']
1597,GO:CC,GO:0005615,extracellular space,1.0081207477763418e-07,True,"""That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid."" [ISBN:0198547684]",3303,21,16,22097,0.7619047619047619,0.004844081138359067,Module 9,"['GO:0005576', 'GO:0110165']"
1598,HP,HP:0004309,Ventricular preexcitation,1.0237606726599399e-07,True,An abnormality in which the cardiac ventricles depolarize too early as a result of an abnormality of cardiac conduction pathways such as an accessory pathway.,29,44,8,4958,0.18181818181818182,0.27586206896551724,Module 3,['HP:0004308']
1599,HPA,HPA:0630053,cervix; glandular cells[High],1.0292746403099957e-07,True,cervix; glandular cells[High],1182,612,116,11019,0.1895424836601307,0.09813874788494077,Module 0,['HPA:0630052']
1600,GO:CC,GO:0098800,inner mitochondrial membrane protein complex,1.0645797310332692e-07,True,"""Any protein complex that is part of the inner mitochondrial membrane."" [GOC:dos]",162,105,11,22097,0.10476190476190476,0.06790123456790123,Module 3,"['GO:0005743', 'GO:0098796', 'GO:0098798']"
1601,GO:BP,GO:0032879,regulation of localization,1.0775109259362794e-07,True,"""Any process that modulates the frequency, rate or extent of any process in which a cell, a substance, or a cellular entity is transported to, or maintained in, a specific location."" [GOC:mah]",2018,787,133,21031,0.16899618805590852,0.06590683845391476,Module 0,"['GO:0050789', 'GO:0051179']"
1602,TF,TF:M08525,Factor: E2F-1:HES-7; motif: GGCRCGTGSYNNWNGGCGCSM,1.0873433236616316e-07,True,Factor: E2F-1:HES-7; motif: GGCRCGTGSYNNWNGGCGCSM,17481,826,777,20045,0.940677966101695,0.044448258108803845,Module 0,['TF:M00000']
1603,GO:CC,GO:0031410,cytoplasmic vesicle,1.1426341709904363e-07,True,"""A vesicle found in the cytoplasm of a cell."" [GOC:ai, GOC:mah, GOC:vesicles]",2513,17,13,22097,0.7647058823529411,0.005173099880620772,Module 6,"['GO:0005737', 'GO:0097708']"
1604,GO:BP,GO:0006807,nitrogen compound metabolic process,1.1649697837128272e-07,True,"""The chemical reactions and pathways involving organic or inorganic compounds that contain nitrogen."" [GOC:jl, ISBN:0198506732]",11995,787,536,21031,0.6810673443456162,0.04468528553563985,Module 0,['GO:0008152']
1605,GO:CC,GO:0097708,intracellular vesicle,1.1715175224832599e-07,True,"""Any vesicle that is part of the intracellular region."" [GOC:vesicles]",2518,17,13,22097,0.7647058823529411,0.005162827640984908,Module 6,"['GO:0031982', 'GO:0043231']"
1606,KEGG,KEGG:05152,Tuberculosis,1.1856956825810427e-07,True,Tuberculosis,175,13,7,8484,0.5384615384615384,0.04,Module 6,['KEGG:00000']
1607,GO:CC,GO:0005791,rough endoplasmic reticulum,1.1911630646200604e-07,True,"""The rough (or granular) endoplasmic reticulum (ER) has ribosomes adhering to the outer surface; the ribosomes are the site of translation of the mRNA for those proteins which are either to be retained within the cisternae (ER-resident proteins), the proteins of the lysosomes, or the proteins destined for export from the cell. Glycoproteins undergo their initial glycosylation within the cisternae."" [ISBN:0198506732]",59,105,8,22097,0.0761904761904762,0.13559322033898305,Module 3,['GO:0005783']
1608,REAC,REAC:R-HSA-453279,Mitotic G1 phase and G1/S transition,1.204011663289351e-07,True,Mitotic G1 phase and G1/S transition,147,59,11,10842,0.1864406779661017,0.07482993197278912,Module 5,['REAC:R-HSA-69278']
1609,HPA,HPA:0461482,skin 1; sebaceous glands[≥Medium],1.2447326684803908e-07,True,skin 1; sebaceous glands[≥Medium],165,612,32,11019,0.05228758169934641,0.19393939393939394,Module 0,['HPA:0461481']
1610,GO:CC,GO:0016020,membrane,1.255441706978837e-07,True,"""A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it."" [GOC:dos, GOC:mah, ISBN:0815316194]",9864,238,154,22097,0.6470588235294118,0.015612327656123276,Module 1,['GO:0110165']
1611,GO:BP,GO:1903900,regulation of viral life cycle,1.2610826690375596e-07,True,"""Any process that modulates the frequency, rate or extent of viral life cycle."" [GO_REF:0000058, GOC:TermGenie, PMID:18005716]",145,34,8,21031,0.23529411764705882,0.05517241379310345,Module 7,"['GO:0019058', 'GO:0050792']"
1612,TF,TF:M10086,Factor: TAFII250; motif: RARRWGGCGGMGGNGR,1.290133959760489e-07,True,Factor: TAFII250; motif: RARRWGGCGGMGGNGR,9269,826,474,20045,0.5738498789346247,0.05113820261085338,Module 0,['TF:M00000']
1613,GO:BP,GO:0048522,positive regulation of cellular process,1.296240803234131e-07,True,"""Any process that activates or increases the frequency, rate or extent of a cellular process, any of those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level."" [GOC:jid]",5717,215,103,21031,0.4790697674418605,0.01801644218995977,Module 2,"['GO:0009987', 'GO:0048518', 'GO:0050794']"
1614,GO:BP,GO:0045069,regulation of viral genome replication,1.2966760890192648e-07,True,"""Any process that modulates the frequency, rate or extent of viral genome replication."" [GOC:ai]",85,34,7,21031,0.20588235294117646,0.08235294117647059,Module 7,"['GO:0019079', 'GO:1903900']"
1615,GO:CC,GO:0030055,cell-substrate junction,1.3034965262104922e-07,True,"""A cell junction that forms a connection between a cell and the extracellular matrix."" [GOC:aruk, GOC:bc, GOC:hb, GOC:mah, PMID:10419689, PMID:1643657, PMID:16805308, PMID:26923917, PMID:8314002]",432,813,45,22097,0.055350553505535055,0.10416666666666667,Module 0,['GO:0070161']
1616,HPA,HPA:0310432,lymph node; germinal center cells[≥Medium],1.3086761984844143e-07,True,lymph node; germinal center cells[≥Medium],3302,140,77,11019,0.55,0.023319200484554815,Module Singleton,['HPA:0310431']
1617,CORUM,CORUM:351,Spliceosome,1.3249835799702657e-07,True,Spliceosome,138,331,38,3383,0.1148036253776435,0.2753623188405797,Module 0,['CORUM:0000000']
1618,GO:CC,GO:0005788,endoplasmic reticulum lumen,1.3533685574175908e-07,True,"""The volume enclosed by the membranes of the endoplasmic reticulum."" [ISBN:0198547684]",313,73,12,22097,0.1643835616438356,0.038338658146964855,Module 4,"['GO:0005783', 'GO:0070013']"
1619,HPA,HPA:0430051,seminal vesicle; glandular cells[≥Low],1.3561730834600035e-07,True,seminal vesicle; glandular cells[≥Low],6828,79,73,11019,0.9240506329113924,0.010691271236086701,Module 3,['HPA:0430000']
1620,HPA,HPA:0430000,seminal vesicle,1.3561730834600035e-07,True,seminal vesicle,6828,79,73,11019,0.9240506329113924,0.010691271236086701,Module 3,['HPA:0000000']
1621,GO:BP,GO:0007159,leukocyte cell-cell adhesion,1.386919501227339e-07,True,"""The attachment of a leukocyte to another cell via adhesion molecules."" [GOC:go_curators]",403,15,8,21031,0.5333333333333333,0.019851116625310174,Module 6,['GO:0098609']
1622,REAC,REAC:R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,1.4055623092811988e-07,True,SCF-beta-TrCP mediated degradation of Emi1,55,586,18,10842,0.030716723549488054,0.32727272727272727,Module 0,['REAC:R-HSA-176408']
1623,REAC,REAC:R-HSA-4641257,Degradation of AXIN,1.4055623092811988e-07,True,Degradation of AXIN,55,586,18,10842,0.030716723549488054,0.32727272727272727,Module 0,['REAC:R-HSA-201681']
1624,HPA,HPA:0030442,appendix; non-germinal center cells[≥Medium],1.4107580107280937e-07,True,appendix; non-germinal center cells[≥Medium],263,612,42,11019,0.06862745098039216,0.1596958174904943,Module 0,['HPA:0030441']
1625,GO:CC,GO:0031974,membrane-enclosed lumen,1.433534983611877e-07,True,"""The enclosed volume within a sealed membrane or between two sealed membranes. Encompasses the volume enclosed by the membranes of a particular organelle, e.g. endoplasmic reticulum lumen, or the space between the two lipid bilayers of a double membrane surrounding an organelle, e.g. nuclear envelope lumen."" [GOC:add, GOC:mah]",6657,80,51,22097,0.6375,0.0076611086074808476,Module 5,['GO:0110165']
1626,GO:CC,GO:0043233,organelle lumen,1.433534983611877e-07,True,"""The internal volume enclosed by the membranes of a particular organelle; includes the volume enclosed by a single organelle membrane, e.g. endoplasmic reticulum lumen, or the volume enclosed by the innermost of the two lipid bilayers of an organelle envelope, e.g. nuclear lumen."" [GOC:jl, GOC:mah]",6657,80,51,22097,0.6375,0.0076611086074808476,Module 5,"['GO:0031974', 'GO:0043226']"
1627,GO:CC,GO:0070013,intracellular organelle lumen,1.433534983611877e-07,True,"""An organelle lumen that is part of an intracellular organelle."" [GOC:mah]",6657,80,51,22097,0.6375,0.0076611086074808476,Module 5,"['GO:0043229', 'GO:0043233']"
1628,HP,HP:0025354,Abnormal cellular phenotype,1.4495301412232557e-07,True,An anomaly of cellular morphology or physiology.,635,71,31,4958,0.43661971830985913,0.048818897637795275,Module 1,['HP:0000118']
1629,GO:CC,GO:0031981,nuclear lumen,1.4736602643069832e-07,True,"""The volume enclosed by the nuclear inner membrane."" [GOC:mah, GOC:pz]",5521,105,56,22097,0.5333333333333333,0.010143090019923928,Module 3,"['GO:0005634', 'GO:0070013']"
1630,HPA,HPA:0600000,tonsil,1.4822746693763206e-07,True,tonsil,7788,79,77,11019,0.9746835443037974,0.009887005649717515,Module 3,['HPA:0000000']
1631,GO:BP,GO:0032501,multicellular organismal process,1.4854035722366046e-07,True,"""Any biological process, occurring at the level of a multicellular organism, pertinent to its function."" [GOC:curators, GOC:dph, GOC:isa_complete, GOC:tb]",7669,215,125,21031,0.5813953488372093,0.016299387143043423,Module 2,['GO:0008150']
1632,GO:CC,GO:0042582,azurophil granule,1.499982269256045e-07,True,"""Primary lysosomal granule found in neutrophil granulocytes. Contains a wide range of hydrolytic enzymes and is released into the extracellular fluid."" [GOC:jl, PMID:17152095]",154,813,25,22097,0.03075030750307503,0.16233766233766234,Module 0,"['GO:0005766', 'GO:0030141']"
1633,GO:CC,GO:0005766,primary lysosome,1.499982269256045e-07,True,"""A lysosome before it has fused with a vesicle or vacuole."" [GOC:jl, ISBN:0815316194]",154,813,25,22097,0.03075030750307503,0.16233766233766234,Module 0,['GO:0005764']
1634,HPA,HPA:0310431,lymph node; germinal center cells[≥Low],1.5365592000478688e-07,True,lymph node; germinal center cells[≥Low],5061,79,63,11019,0.7974683544303798,0.012448132780082987,Module 3,['HPA:0310000']
1635,TF,TF:M00737,Factor: E2F-1:DP-2; motif: TTTSSCGC,1.5387064304532954e-07,True,Factor: E2F-1:DP-2; motif: TTTSSCGC,8964,826,461,20045,0.5581113801452785,0.05142793395805444,Module 0,['TF:M00000']
1636,TF,TF:M04869_1,Factor: Egr-1; motif: GCGCATGCG; match class: 1,1.5530398388850581e-07,True,Factor: Egr-1; motif: GCGCATGCG; match class: 1,10557,826,526,20045,0.6368038740920097,0.04982476082220328,Module 0,['TF:M04869']
1637,REAC,REAC:R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),1.5599744613325223e-07,True,Cross-presentation of soluble exogenous antigens (endosomes),49,586,17,10842,0.02901023890784983,0.3469387755102041,Module 0,['REAC:R-HSA-1236975']
1638,TF,TF:M11658,Factor: HSF4; motif: RGAANNTTCYRGAAN,1.564884356425532e-07,True,Factor: HSF4; motif: RGAANNTTCYRGAAN,387,21,9,20045,0.42857142857142855,0.023255813953488372,Module 9,['TF:M00000']
1639,GO:CC,GO:0016607,nuclear speck,1.5862801691585783e-07,True,"""A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy."" [http://www.cellnucleus.com/]",419,813,44,22097,0.05412054120541206,0.10501193317422435,Module 0,['GO:0016604']
1640,GO:CC,GO:0005774,vacuolar membrane,1.6021541839383582e-07,True,"""The lipid bilayer surrounding the vacuole and separating its contents from the cytoplasm of the cell."" [GOC:ai]",489,17,8,22097,0.47058823529411764,0.016359918200409,Module 6,"['GO:0005773', 'GO:0098588']"
1641,GO:CC,GO:0005737,cytoplasm,1.604580321155413e-07,True,"""The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures."" [ISBN:0198547684]",12345,238,179,22097,0.7521008403361344,0.014499797488861887,Module 1,"['GO:0005622', 'GO:0110165']"
1642,HP,HP:0011893,Abnormal leukocyte count,1.611578385316317e-07,True,Number of leukocytes per volume of blood beyond normal limits.,479,71,27,4958,0.38028169014084506,0.05636743215031315,Module 1,['HP:0001881']
1643,TF,TF:M09733,Factor: STAT2; motif: NRGAAANNGAAACTNA,1.61699960552845e-07,True,Factor: STAT2; motif: NRGAAANNGAAACTNA,2798,36,22,20045,0.6111111111111112,0.007862759113652609,Module 7,['TF:M00000']
1644,GO:CC,GO:0005787,signal peptidase complex,1.6464247205427844e-07,True,"""A protein complex that is located in the endoplasmic reticulum membrane and cleaves the signal sequence from precursor proteins following their transport out of the cytoplasmic space."" [GOC:sgd_curators, PMID:1846444, PMID:7615509]",5,73,4,22097,0.0547945205479452,0.8,Module 4,"['GO:0005789', 'GO:0098796', 'GO:0140534', 'GO:1905368']"
1645,GO:CC,GO:0031981,nuclear lumen,1.655015734641507e-07,True,"""The volume enclosed by the nuclear inner membrane."" [GOC:mah, GOC:pz]",5521,80,46,22097,0.575,0.00833182394493751,Module 5,"['GO:0005634', 'GO:0070013']"
1646,TF,TF:M12597,Factor: E2F1; motif: GSGCGGGAAN,1.659086324816031e-07,True,Factor: E2F1; motif: GSGCGGGAAN,14407,826,673,20045,0.8147699757869249,0.04671340320677449,Module 0,['TF:M00000']
1647,GO:BP,GO:0008104,protein localization,1.666564340360632e-07,True,"""Any process in which a protein is transported to, or maintained in, a specific location."" [GOC:ai]",2731,787,166,21031,0.21092757306226176,0.06078359575247162,Module 0,['GO:0070727']
1648,GO:BP,GO:0080090,regulation of primary metabolic process,1.6750101096268457e-07,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism involving those compounds formed as a part of the normal anabolic and catabolic processes. These processes take place in most, if not all, cells of the organism."" [PMID:19211694]",5591,787,290,21031,0.3684879288437103,0.051869075299588625,Module 0,"['GO:0019222', 'GO:0044238']"
1649,HPA,HPA:0330221,oral mucosa; squamous epithelial cells[≥Low],1.6789666109385961e-07,True,oral mucosa; squamous epithelial cells[≥Low],6257,79,70,11019,0.8860759493670886,0.01118747003356241,Module 3,['HPA:0330000']
1650,HPA,HPA:0330000,oral mucosa,1.6789666109385961e-07,True,oral mucosa,6257,79,70,11019,0.8860759493670886,0.01118747003356241,Module 3,['HPA:0000000']
1651,GO:BP,GO:0007159,leukocyte cell-cell adhesion,1.6892463868997363e-07,True,"""The attachment of a leukocyte to another cell via adhesion molecules."" [GOC:go_curators]",403,226,23,21031,0.10176991150442478,0.05707196029776675,Module 1,['GO:0098609']
1652,HP,HP:0011923,Decreased activity of mitochondrial complex I,1.7098555872472915e-07,True,"A reduction in the activity of the mitochondrial respiratory chain complex I, which is part of the electron transport chain in mitochondria.",93,228,22,4958,0.09649122807017543,0.23655913978494625,Module 0,['HP:0008972']
1653,GO:MF,GO:0005515,protein binding,1.7104906507829934e-07,True,"""Binding to a protein."" [GOC:go_curators]",14838,177,163,20212,0.9209039548022598,0.010985307992990969,Module Singleton,['GO:0005488']
1654,HP,HP:0001629,Ventricular septal defect,1.7915832608018293e-07,True,A hole between the two bottom chambers (ventricles) of the heart. The defect is centered around the most superior aspect of the ventricular septum.,492,44,21,4958,0.4772727272727273,0.042682926829268296,Module 3,['HP:0010438']
1655,GO:CC,GO:0005764,lysosome,1.8039570474821857e-07,True,"""A small lytic vacuole that has cell cycle-independent morphology found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions."" [GOC:mah, ISBN:0198506732]",762,17,9,22097,0.5294117647058824,0.011811023622047244,Module 6,['GO:0000323']
1656,GO:CC,GO:0000323,lytic vacuole,1.8039570474821857e-07,True,"""A vacuole that is maintained at an acidic pH and which contains degradative enzymes, including a wide variety of acid hydrolases."" [GOC:krc]",762,17,9,22097,0.5294117647058824,0.011811023622047244,Module 6,['GO:0005773']
1657,GO:BP,GO:0060341,regulation of cellular localization,1.8048992728554833e-07,True,"""Any process that modulates the frequency, rate or extent of a process in which a cell, a substance, or a cellular entity is transported to, or maintained in a specific location within or in the membrane of a cell."" [GOC:dph, GOC:tb]",995,787,80,21031,0.10165184243964422,0.08040201005025126,Module 0,"['GO:0032879', 'GO:0050794', 'GO:0051641']"
1658,HPA,HPA:0460182,skin 1; cells in granular layer[≥Medium],1.8340569101942142e-07,True,skin 1; cells in granular layer[≥Medium],558,69,19,11019,0.2753623188405797,0.034050179211469536,Module 5,['HPA:0460181']
1659,GO:BP,GO:0051649,establishment of localization in cell,1.8367759240906375e-07,True,"""Any process, occuring in a cell, that localizes a substance or cellular component. This may occur via movement, tethering or selective degradation."" [GOC:ai, GOC:dos, GOC:dph, GOC:tb]",1972,787,130,21031,0.16518424396442186,0.06592292089249494,Module 0,"['GO:0051234', 'GO:0051641']"
1660,HPA,HPA:0610000,urinary bladder,1.8368392093782076e-07,True,urinary bladder,7304,79,75,11019,0.9493670886075949,0.010268346111719605,Module 3,['HPA:0000000']
1661,HPA,HPA:0610831,urinary bladder; urothelial cells[≥Low],1.8368392093782076e-07,True,urinary bladder; urothelial cells[≥Low],7304,79,75,11019,0.9493670886075949,0.010268346111719605,Module 3,['HPA:0610000']
1662,KEGG,KEGG:04640,Hematopoietic cell lineage,1.8476092702909065e-07,True,Hematopoietic cell lineage,92,136,13,8484,0.09558823529411764,0.14130434782608695,Module 1,['KEGG:00000']
1663,GO:BP,GO:0033554,cellular response to stress,1.8508759044868502e-07,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation)."" [GOC:mah]",1770,215,49,21031,0.22790697674418606,0.02768361581920904,Module 2,"['GO:0006950', 'GO:0051716']"
1664,TF,TF:M08887_1,Factor: IRF; motif: NNGAAANTGAAANN; match class: 1,1.8629699060489495e-07,True,Factor: IRF; motif: NNGAAANTGAAANN; match class: 1,79,36,7,20045,0.19444444444444445,0.08860759493670886,Module 7,['TF:M08887']
1665,GO:CC,GO:0030054,cell junction,1.8850810339992286e-07,True,"""A cellular component that forms a specialized region of connection between two or more cells, or between a cell and the extracellular matrix, or between two membrane-bound components of a cell, such as flagella."" [GOC:aruk, GOC:bc, GOC:mah, http://www.vivo.colostate.edu/hbooks/cmb/cells/pmemb/junctions_a.html, ISBN:0198506732, PMID:26820516, PMID:28096264]",2230,813,138,22097,0.16974169741697417,0.06188340807174888,Module 0,['GO:0110165']
1666,GO:BP,GO:0048468,cell development,1.8865945973015645e-07,True,"""The cellular developmental process in which a specific cell progresses from an immature to a mature state. Cell development start once cell commitment has taken place."" [GOC:go_curators]",2819,215,65,21031,0.3023255813953488,0.02305782192266761,Module 2,"['GO:0030154', 'GO:0048856', 'GO:0048869']"
1667,MIRNA,MIRNA:hsa-miR-615-3p,hsa-miR-615-3p,1.892673737870245e-07,True,hsa-miR-615-3p,890,104,26,14819,0.25,0.029213483146067417,Module 3,['MIRNA:000000']
1668,HP,HP:0006496,Aplasia/hypoplasia involving bones of the upper limbs,1.8930519705122727e-07,True,Absence (due to failure to form) or underdevelopment of the bones of the upper limbs.,551,44,22,4958,0.5,0.039927404718693285,Module 3,"['HP:0002817', 'HP:0045060']"
1669,HPA,HPA:0471462,skin 2; langerhans cells[≥Medium],1.9154147529091046e-07,True,skin 2; langerhans cells[≥Medium],662,140,30,11019,0.21428571428571427,0.045317220543806644,Module Singleton,['HPA:0471461']
1670,TF,TF:M00431_1,Factor: E2F-1; motif: TTTSGCGS; match class: 1,1.9484312254287902e-07,True,Factor: E2F-1; motif: TTTSGCGS; match class: 1,2325,80,32,20045,0.4,0.013763440860215054,Module 5,['TF:M00431']
1671,REAC,REAC:R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,1.9851563835893494e-07,True,SRP-dependent cotranslational protein targeting to membrane,113,60,10,10842,0.16666666666666666,0.08849557522123894,Module 4,['REAC:R-HSA-72766']
1672,GO:CC,GO:0005925,focal adhesion,1.9891274746800345e-07,True,"""A cell-substrate junction that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments. In insects focal adhesion has also been referred to as hemi-adherens junction (HAJ)."" [GOC:aruk, GOC:bc, ISBN:0124325653, ISBN:0815316208, PMID:10419689, PMID:12191915, PMID:15246682, PMID:1643657, PMID:16805308, PMID:19197329, PMID:23033047, PMID:26923917, PMID:28796323, PMID:8314002]",422,813,44,22097,0.05412054120541206,0.10426540284360189,Module 0,['GO:0030055']
1673,TF,TF:M11664,Factor: IRF-2; motif: NGAAASYGAAAS,1.989835468360611e-07,True,Factor: IRF-2; motif: NGAAASYGAAAS,1694,36,18,20045,0.5,0.010625737898465172,Module 7,['TF:M00000']
1674,GO:CC,GO:0098803,respiratory chain complex,1.992660746200842e-07,True,"""Any protein complex that is part of a respiratory chain."" [GOC:dos]",93,105,9,22097,0.08571428571428572,0.0967741935483871,Module 3,"['GO:0070469', 'GO:0098796']"
1675,GO:BP,GO:0002366,leukocyte activation involved in immune response,2.0059080594982233e-07,True,"""A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response."" [GOC:add, ISBN:0781735149]",300,226,20,21031,0.08849557522123894,0.06666666666666667,Module 1,"['GO:0002263', 'GO:0045321']"
1676,TF,TF:M12557_1,Factor: ETV5; motif: NNACTTCCGNN; match class: 1,2.0114926807064413e-07,True,Factor: ETV5; motif: NNACTTCCGNN; match class: 1,880,826,79,20045,0.09564164648910412,0.08977272727272727,Module 0,['TF:M12557']
1677,GO:BP,GO:0000028,ribosomal small subunit assembly,2.0612253478177038e-07,True,"""The aggregation, arrangement and bonding together of constituent RNAs and proteins to form the small ribosomal subunit."" [GOC:jl, PMID:30467428]",16,105,6,21031,0.05714285714285714,0.375,Module 3,"['GO:0022618', 'GO:0042255', 'GO:0042274']"
1678,REAC,REAC:R-HSA-4086400,PCP/CE pathway,2.0740299529593092e-07,True,PCP/CE pathway,92,586,23,10842,0.03924914675767918,0.25,Module 0,['REAC:R-HSA-3858494']
1679,GO:BP,GO:0007155,cell adhesion,2.0844436126222803e-07,True,"""The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules."" [GOC:hb, GOC:pf]",1512,226,46,21031,0.20353982300884957,0.03042328042328042,Module 1,['GO:0009987']
1680,TF,TF:M04059_1,Factor: NRF-1; motif: YGCGCATGCGCN; match class: 1,2.136747158935152e-07,True,Factor: NRF-1; motif: YGCGCATGCGCN; match class: 1,1048,826,89,20045,0.10774818401937046,0.08492366412213741,Module 0,['TF:M04059']
1681,TF,TF:M11393,Factor: Erg; motif: NACCGGATATCCGGTN,2.2429176481436881e-07,True,Factor: Erg; motif: NACCGGATATCCGGTN,14394,826,672,20045,0.8135593220338984,0.04668611921634014,Module 0,['TF:M00000']
1682,HPA,HPA:0010012,adipose tissue; adipocytes[≥Medium],2.2786171031759576e-07,True,adipose tissue; adipocytes[≥Medium],2236,612,186,11019,0.30392156862745096,0.08318425760286226,Module 0,['HPA:0010011']
1683,GO:BP,GO:0070727,cellular macromolecule localization,2.2812023496400553e-07,True,"""Any process in which a macromolecule is transported to, and/or maintained in, a specific location at the level of a cell. Localization at the cellular level encompasses movement within the cell, from within the cell to the cell surface, or from one location to another at the surface of a cell."" [GOC:mah]",2742,787,166,21031,0.21092757306226176,0.060539752005835154,Module 0,"['GO:0033036', 'GO:0051641']"
1684,GO:BP,GO:0031349,positive regulation of defense response,2.3061709687600334e-07,True,"""Any process that activates or increases the frequency, rate or extent of a defense response."" [GOC:mah]",471,215,24,21031,0.11162790697674418,0.050955414012738856,Module 2,"['GO:0006952', 'GO:0031347', 'GO:0048584']"
1685,TF,TF:M00074,Factor: c-Ets-1(p54); motif: NNACMGGAWRTNN,2.317227074442746e-07,True,Factor: c-Ets-1(p54); motif: NNACMGGAWRTNN,3541,826,219,20045,0.2651331719128329,0.061846935893815305,Module 0,['TF:M00000']
1686,HP,HP:0025033,Abnormal digestive system morphology,2.3259924769504202e-07,True,A structural anomaly of the digestive system.,1050,44,29,4958,0.6590909090909091,0.02761904761904762,Module 3,['HP:0025031']
1687,TF,TF:M01240,Factor: BEN; motif: CAGCGRNV,2.3279374431963043e-07,True,Factor: BEN; motif: CAGCGRNV,16870,826,757,20045,0.9164648910411622,0.044872554831061055,Module 0,['TF:M00000']
1688,GO:CC,GO:1904813,ficolin-1-rich granule lumen,2.4475315115187355e-07,True,"""Any membrane-enclosed lumen that is part of a ficolin-1-rich granule."" [GO_REF:0000064, GOC:TermGenie, PMID:23650620]",124,21,6,22097,0.2857142857142857,0.04838709677419355,Module 9,"['GO:0070013', 'GO:0101002']"
1689,HP,HP:0001627,Abnormal heart morphology,2.4703914160350026e-07,True,Any structural anomaly of the heart.,1512,44,34,4958,0.7727272727272727,0.022486772486772486,Module 3,['HP:0030680']
1690,TF,TF:M01023,Factor: HSF1; motif: NTTCTRGAAVNTTCTYM,2.482099534930764e-07,True,Factor: HSF1; motif: NTTCTRGAAVNTTCTYM,2717,21,16,20045,0.7619047619047619,0.005888847994111152,Module 9,['TF:M00000']
1691,HPA,HPA:0471442,skin 2; fibrohistiocytic cells[≥Medium],2.486993025884689e-07,True,skin 2; fibrohistiocytic cells[≥Medium],833,185,40,11019,0.21621621621621623,0.04801920768307323,Module 1,['HPA:0471441']
1692,REAC,REAC:R-HSA-72766,Translation,2.489695124436061e-07,True,Translation,292,586,44,10842,0.07508532423208192,0.1506849315068493,Module 0,['REAC:R-HSA-392499']
1693,HPA,HPA:0471443,skin 2; fibrohistiocytic cells[High],2.499794270269068e-07,True,skin 2; fibrohistiocytic cells[High],467,185,29,11019,0.15675675675675677,0.06209850107066381,Module 1,['HPA:0471442']
1694,GO:BP,GO:0002263,cell activation involved in immune response,2.5394888127553377e-07,True,"""A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",304,226,20,21031,0.08849557522123894,0.06578947368421052,Module 1,"['GO:0001775', 'GO:0002252', 'GO:0006955']"
1695,TF,TF:M11882_1,Factor: pax-6; motif: NYACGCNYSANYGMNCN; match class: 1,2.559826300481692e-07,True,Factor: pax-6; motif: NYACGCNYSANYGMNCN; match class: 1,11746,826,572,20045,0.6924939467312349,0.048697428911970035,Module 0,['TF:M11882']
1696,GO:BP,GO:0051246,regulation of protein metabolic process,2.5908871546099876e-07,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a protein."" [GOC:ai]",2102,215,54,21031,0.25116279069767444,0.025689819219790674,Module 2,"['GO:0019538', 'GO:0051171', 'GO:0060255', 'GO:0080090']"
1697,HP,HP:0200125,Mitochondrial respiratory chain defects,2.603646523294723e-07,True,Mitochondrial respiratory chain defects,20,44,7,4958,0.1590909090909091,0.35,Module 3,['HP:0003287']
1698,GO:CC,GO:0005746,mitochondrial respirasome,2.654684640297802e-07,True,"""The protein complexes that form the mitochondrial electron transport system (the respiratory chain), associated with the inner mitochondrial membrane. The respiratory chain complexes transfer electrons from an electron donor to an electron acceptor and are associated with a proton pump to create a transmembrane electrochemical gradient."" [GOC:curators, GOC:ecd, ISBN:0198547684]",96,105,9,22097,0.08571428571428572,0.09375,Module 3,"['GO:0005743', 'GO:0070469']"
1699,GO:CC,GO:0005770,late endosome,2.722763238912401e-07,True,"""A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center."" [NIF_Subcellular:nlx_subcell_20090702, PMID:11964142, PMID:2557062]",314,17,7,22097,0.4117647058823529,0.022292993630573247,Module 6,['GO:0005768']
1700,TF,TF:M02089,Factor: E2F-3; motif: GGCGGGN,2.7245852354364214e-07,True,Factor: E2F-3; motif: GGCGGGN,13559,826,641,20045,0.7760290556900726,0.047274872778228484,Module 0,['TF:M00000']
1701,HP,HP:0010438,Abnormal ventricular septum morphology,2.727362383881122e-07,True,A structural abnormality of the interventricular septum.,503,44,21,4958,0.4772727272727273,0.041749502982107355,Module 3,"['HP:0001671', 'HP:0001713']"
1702,HPA,HPA:0300413,lung; macrophages[High],2.744353114294171e-07,True,lung; macrophages[High],1371,166,50,11019,0.30120481927710846,0.03646973012399708,Module 2,['HPA:0300412']
1703,REAC,REAC:R-HSA-9759194,Nuclear events mediated by NFE2L2,2.746430269823912e-07,True,Nuclear events mediated by NFE2L2,78,586,21,10842,0.03583617747440273,0.2692307692307692,Module 0,['REAC:R-HSA-9755511']
1704,HPA,HPA:0600431,tonsil; germinal center cells[≥Low],2.7526354191794027e-07,True,tonsil; germinal center cells[≥Low],5987,69,61,11019,0.8840579710144928,0.010188742274929012,Module 5,['HPA:0600000']
1705,KEGG,KEGG:05168,Herpes simplex virus 1 infection,2.7960969241951355e-07,True,Herpes simplex virus 1 infection,506,13,9,8484,0.6923076923076923,0.017786561264822136,Module 6,['KEGG:00000']
1706,GO:BP,GO:0050900,leukocyte migration,2.8241061827657316e-07,True,"""The movement of a leukocyte within or between different tissues and organs of the body."" [GOC:add, ISBN:0781735149, PMID:14680625, PMID:14708592, PMID:7507411, PMID:8600538]",396,215,22,21031,0.10232558139534884,0.05555555555555555,Module 2,"['GO:0002376', 'GO:0016477']"
1707,REAC,REAC:R-HSA-8939902,Regulation of RUNX2 expression and activity,2.945995244227776e-07,True,Regulation of RUNX2 expression and activity,71,586,20,10842,0.034129692832764506,0.28169014084507044,Module 0,['REAC:R-HSA-8878166']
1708,REAC,REAC:R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,2.962184267413422e-07,True,Autodegradation of Cdh1 by Cdh1:APC/C,64,586,19,10842,0.032423208191126277,0.296875,Module 0,['REAC:R-HSA-174143']
1709,TF,TF:M09892,Factor: E2F-1; motif: NNNNGGCGGGAARN,3.047416897256674e-07,True,Factor: E2F-1; motif: NNNNGGCGGGAARN,13916,826,654,20045,0.7917675544794189,0.04699626329405002,Module 0,['TF:M00000']
1710,GO:BP,GO:0002697,regulation of immune effector process,3.064553864939377e-07,True,"""Any process that modulates the frequency, rate, or extent of an immune effector process."" [GOC:add]",378,226,22,21031,0.09734513274336283,0.0582010582010582,Module 1,"['GO:0002252', 'GO:0002682']"
1711,GO:BP,GO:0002252,immune effector process,3.0714302696983367e-07,True,"""Any process of the immune system that executes a component of an immune response. An effector immune process takes place after its activation."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",698,215,29,21031,0.13488372093023257,0.04154727793696275,Module 2,['GO:0002376']
1712,TF,TF:M00431,Factor: E2F-1; motif: TTTSGCGS,3.0854024975417615e-07,True,Factor: E2F-1; motif: TTTSGCGS,7484,826,397,20045,0.48062953995157387,0.05304649919828969,Module 0,['TF:M00000']
1713,HPA,HPA:0170000,endometrium 2,3.09928187715343e-07,True,endometrium 2,6917,79,73,11019,0.9240506329113924,0.010553708255023855,Module 3,['HPA:0000000']
1714,GO:BP,GO:0048024,"regulation of mRNA splicing, via spliceosome",3.1070777522900937e-07,True,"""Any process that modulates the frequency, rate or extent of mRNA splicing via a spliceosomal mechanism."" [GOC:jid]",112,787,22,21031,0.02795425667090216,0.19642857142857142,Module 0,"['GO:0000398', 'GO:0043484', 'GO:0050684']"
1715,TF,TF:M11397,Factor: Erg; motif: NACCGGATATCCGGTN,3.1105743848891695e-07,True,Factor: Erg; motif: NACCGGATATCCGGTN,12272,826,592,20045,0.7167070217917676,0.048239895697522815,Module 0,['TF:M00000']
1716,HPA,HPA:0380202,placenta; endothelial cells[≥Medium],3.1473994314236573e-07,True,placenta; endothelial cells[≥Medium],334,612,48,11019,0.0784313725490196,0.1437125748502994,Module 0,['HPA:0380201']
1717,GO:BP,GO:0048519,negative regulation of biological process,3.155952376088774e-07,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule."" [GOC:jid]",5874,226,108,21031,0.4778761061946903,0.018386108273748723,Module 1,"['GO:0008150', 'GO:0050789']"
1718,HP,HP:0011450,Unusual CNS infection,3.1914030335477655e-07,True,A type of infection of the central nervous system that can be regarded as a sign of a pathological susceptibility to infection.,108,71,14,4958,0.19718309859154928,0.12962962962962962,Module 1,"['HP:0002011', 'HP:0032158']"
1719,GO:BP,GO:0006119,oxidative phosphorylation,3.266426575586085e-07,True,"""The phosphorylation of ADP to ATP that accompanies the oxidation of a metabolite through the operation of the respiratory chain. Oxidation of compounds establishes a proton gradient across the membrane, providing the energy for ATP synthesis."" [ISBN:0198506732, ISBN:0471331309]",145,105,11,21031,0.10476190476190476,0.07586206896551724,Module 3,['GO:0009060']
1720,GO:BP,GO:0002684,positive regulation of immune system process,3.268471619590011e-07,True,"""Any process that activates or increases the frequency, rate, or extent of an immune system process."" [GOC:add]",1054,15,10,21031,0.6666666666666666,0.009487666034155597,Module 6,"['GO:0002376', 'GO:0002682', 'GO:0048518']"
1721,TF,TF:M00428,Factor: E2F-1; motif: NKTSSCGC,3.268855463932157e-07,True,Factor: E2F-1; motif: NKTSSCGC,9220,826,470,20045,0.5690072639225182,0.0509761388286334,Module 0,['TF:M00000']
1722,HP,HP:0011032,Abnormality of fluid regulation,3.310016854859521e-07,True,An abnormality of the regulation of body fluids.,761,44,25,4958,0.5681818181818182,0.0328515111695138,Module 3,['HP:0012337']
1723,GO:BP,GO:0032502,developmental process,3.3138123748847324e-07,True,"""A biological process whose specific outcome is the progression of an integrated living unit: an anatomical structure (which may be a subcellular structure, cell, tissue, or organ), or organism over time from an initial condition to a later condition."" [GOC:isa_complete]",6453,226,115,21031,0.5088495575221239,0.017821168448783512,Module 1,['GO:0008150']
1724,REAC,REAC:R-HSA-168249,Innate Immune System,3.3407105142064183e-07,True,Innate Immune System,1101,586,107,10842,0.1825938566552901,0.0971843778383288,Module 0,['REAC:R-HSA-168256']
1725,HPA,HPA:0480000,small intestine,3.385108073678409e-07,True,small intestine,7877,79,77,11019,0.9746835443037974,0.009775295163133172,Module 3,['HPA:0000000']
1726,HPA,HPA:0080132,caudate; neuronal cells[≥Medium],3.385915995849163e-07,True,caudate; neuronal cells[≥Medium],4124,79,56,11019,0.7088607594936709,0.013579049466537343,Module 3,['HPA:0080131']
1727,REAC,REAC:R-HSA-1643685,Disease,3.392312932622262e-07,True,Disease,1767,586,152,10842,0.2593856655290102,0.08602150537634409,Module 0,['REAC:0000000']
1728,HPA,HPA:0480053,small intestine; glandular cells[High],3.471400923387296e-07,True,small intestine; glandular cells[High],2546,612,205,11019,0.3349673202614379,0.0805184603299293,Module 0,['HPA:0480052']
1729,GO:BP,GO:0006446,regulation of translational initiation,3.493823321312544e-07,True,"""Any process that modulates the frequency, rate or extent of translational initiation."" [GOC:go_curators]",83,787,19,21031,0.0241423125794155,0.2289156626506024,Module 0,"['GO:0006413', 'GO:0006417']"
1730,GO:BP,GO:0006457,protein folding,3.5307608797915926e-07,True,"""The process of assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure."" [GOC:go_curators, GOC:rb]",217,72,11,21031,0.1527777777777778,0.05069124423963134,Module 4,"['GO:0009987', 'GO:0051604']"
1731,HPA,HPA:0471461,skin 2; langerhans cells[≥Low],3.5949439817615015e-07,True,skin 2; langerhans cells[≥Low],789,166,36,11019,0.21686746987951808,0.045627376425855515,Module 2,['HPA:0470000']
1732,GO:BP,GO:0019538,protein metabolic process,3.6015048565400273e-07,True,"""The chemical reactions and pathways involving a protein. Includes protein modification."" [GOC:ma]",4912,72,42,21031,0.5833333333333334,0.008550488599348535,Module 4,"['GO:0043170', 'GO:0044238', 'GO:1901564']"
1733,HP,HP:0011017,Abnormal cellular physiology,3.6374858109704033e-07,True,An abnormality in a cellular process.,602,228,62,4958,0.2719298245614035,0.10299003322259136,Module 0,"['HP:0001939', 'HP:0025354']"
1734,TF,TF:M12310,Factor: ZNF597; motif: NGCCGCCATTTTGN,3.665008857913327e-07,True,Factor: ZNF597; motif: NGCCGCCATTTTGN,442,826,50,20045,0.06053268765133172,0.11312217194570136,Module 0,['TF:M00000']
1735,MIRNA,MIRNA:hsa-miR-615-3p,hsa-miR-615-3p,3.6835404266117776e-07,True,hsa-miR-615-3p,890,753,89,14819,0.11819389110225764,0.1,Module 0,['MIRNA:000000']
1736,GO:BP,GO:1901798,positive regulation of signal transduction by p53 class mediator,3.83525782133525e-07,True,"""Any process that activates or increases the frequency, rate or extent of signal transduction by p53 class mediator."" [GOC:TermGenie]",32,105,7,21031,0.06666666666666667,0.21875,Module 3,"['GO:0072331', 'GO:1901796', 'GO:1902533']"
1737,GO:BP,GO:0051241,negative regulation of multicellular organismal process,3.853395326726316e-07,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of an organismal process, the processes pertinent to the function of an organism above the cellular level; includes the integrated processes of tissues and organs."" [GOC:ai]",1110,215,37,21031,0.17209302325581396,0.03333333333333333,Module 2,"['GO:0032501', 'GO:0048519', 'GO:0051239']"
1738,GO:BP,GO:0007166,cell surface receptor signaling pathway,3.9948215135904503e-07,True,"""The series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription."" [GOC:bf, GOC:mah, GOC:pr, GOC:signaling]",2799,215,64,21031,0.29767441860465116,0.022865309038942478,Module 2,['GO:0007165']
1739,GO:MF,GO:0015078,proton transmembrane transporter activity,4.0422331409972146e-07,True,"""Enables the transfer of a proton from one side of a membrane to the other."" [GOC:ai]",144,808,25,20212,0.03094059405940594,0.1736111111111111,Module 0,"['GO:0008324', 'GO:0022890']"
1740,REAC,REAC:R-HSA-168249,Innate Immune System,4.080219963347098e-07,True,Innate Immune System,1101,164,44,10842,0.2682926829268293,0.03996366939146231,Module 1,['REAC:R-HSA-168256']
1741,REAC,REAC:R-HSA-202424,Downstream TCR signaling,4.084964583546267e-07,True,Downstream TCR signaling,98,14,6,10842,0.42857142857142855,0.061224489795918366,Module 6,['REAC:R-HSA-202403']
1742,TF,TF:M08213_1,Factor: Elk-1:TBR2; motif: TNRCACCGGAAGN; match class: 1,4.103912888508843e-07,True,Factor: Elk-1:TBR2; motif: TNRCACCGGAAGN; match class: 1,1448,826,111,20045,0.1343825665859564,0.07665745856353591,Module 0,['TF:M08213']
1743,HPA,HPA:0150000,duodenum,4.144395153400574e-07,True,duodenum,7899,79,77,11019,0.9746835443037974,0.009748069375870364,Module 3,['HPA:0000000']
1744,KEGG,KEGG:04142,Lysosome,4.1747076264063633e-07,True,Lysosome,131,143,15,8484,0.1048951048951049,0.11450381679389313,Module 2,['KEGG:00000']
1745,HP,HP:0012766,Widened cerebral subarachnoid space,4.2334663457834754e-07,True,An increase in size of the anatomic space between the arachnoid membrane and pia mater in the region surrounding the cerebrum.,12,44,6,4958,0.13636363636363635,0.5,Module 3,['HP:0012704']
1746,HP,HP:0000631,Retinal arterial tortuosity,4.2334663457834754e-07,True,The presence of an increased number of twists and turns of the retinal artery.,12,44,6,4958,0.13636363636363635,0.5,Module 3,"['HP:0000630', 'HP:0005116', 'HP:0012841']"
1747,HP,HP:0007768,Central retinal vessel vascular tortuosity,4.2334663457834754e-07,True,"The presence of an increased number of twists and turns of retinal blood vessels (arteries, arterioles, veins, venules).",12,44,6,4958,0.13636363636363635,0.5,Module 3,['HP:0000631']
1748,HPA,HPA:0461441,skin 1; fibrohistiocytic cells[≥Low],4.262293565458066e-07,True,skin 1; fibrohistiocytic cells[≥Low],885,185,41,11019,0.22162162162162163,0.04632768361581921,Module 1,['HPA:0460000']
1749,GO:BP,GO:0032527,protein exit from endoplasmic reticulum,4.2679619782377253e-07,True,"""The directed movement of proteins from the endoplasmic reticulum."" [GOC:rb]",47,72,7,21031,0.09722222222222222,0.14893617021276595,Module 4,['GO:0006886']
1750,GO:BP,GO:0050729,positive regulation of inflammatory response,4.2786861805397987e-07,True,"""Any process that activates or increases the frequency, rate or extent of the inflammatory response."" [GOC:ai]",141,215,14,21031,0.06511627906976744,0.09929078014184398,Module 2,"['GO:0006954', 'GO:0031349', 'GO:0032103', 'GO:0050727']"
1751,GO:BP,GO:0050865,regulation of cell activation,4.322877730792359e-07,True,"""Any process that modulates the frequency, rate or extent of cell activation, the change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand."" [GOC:ai]",616,215,27,21031,0.12558139534883722,0.04383116883116883,Module 2,"['GO:0001775', 'GO:0050794', 'GO:0051239']"
1752,TF,TF:M04869,Factor: Egr-1; motif: GCGCATGCG,4.323087501699256e-07,True,Factor: Egr-1; motif: GCGCATGCG,11569,826,564,20045,0.6828087167070218,0.0487509724263117,Module 0,['TF:M00000']
1753,TF,TF:M00940_1,Factor: E2F-1; motif: NTTTCGCGCS; match class: 1,4.3681203362333257e-07,True,Factor: E2F-1; motif: NTTTCGCGCS; match class: 1,2709,826,177,20045,0.21428571428571427,0.06533776301218161,Module 0,['TF:M00940']
1754,HPA,HPA:0470182,skin 2; cells in granular layer[≥Medium],4.495914995162517e-07,True,skin 2; cells in granular layer[≥Medium],562,140,27,11019,0.19285714285714287,0.04804270462633452,Module Singleton,['HPA:0470181']
1755,HP,HP:0001631,Atrial septal defect,4.7560761044455256e-07,True,Atrial septal defect (ASD) is a congenital abnormality of the interatrial septum that enables blood flow between the left and right atria via the interatrial septum.,518,44,21,4958,0.4772727272727273,0.04054054054054054,Module 3,"['HP:0005120', 'HP:0011994']"
1756,HP,HP:0005927,Aplasia/hypoplasia involving bones of the hand,4.7560761044455256e-07,True,Absence (due to failure to form) or underdevelopment of the bones of the hand.,518,44,21,4958,0.4772727272727273,0.04054054054054054,Module 3,"['HP:0005922', 'HP:0006496']"
1757,HPA,HPA:0080000,caudate,4.7666891480300145e-07,True,caudate,6964,79,73,11019,0.9240506329113924,0.01048248133256749,Module 3,['HPA:0000000']
1758,HPA,HPA:0471462,skin 2; langerhans cells[≥Medium],4.7680991958425814e-07,True,skin 2; langerhans cells[≥Medium],662,69,20,11019,0.2898550724637681,0.030211480362537766,Module 5,['HPA:0471461']
1759,WP,WP:WP2431,Spinal cord injury,4.775050792342852e-07,True,Spinal cord injury,115,154,15,8286,0.09740259740259741,0.13043478260869565,Module 2,['WP:000000']
1760,GO:BP,GO:0033365,protein localization to organelle,4.826475641989705e-07,True,"""A process in which a protein is transported to, or maintained in, a location within an organelle."" [GOC:mah]",1184,787,89,21031,0.11308767471410419,0.07516891891891891,Module 0,['GO:0008104']
1761,WP,WP:WP3613,Photodynamic therapy induced unfolded protein response,4.869336429653008e-07,True,Photodynamic therapy induced unfolded protein response,27,43,6,8286,0.13953488372093023,0.2222222222222222,Module 4,['WP:000000']
1762,GO:CC,GO:0071745,IgA immunoglobulin complex,4.926934064917393e-07,True,"""A protein complex composed of two identical immunoglobulin heavy chains of the IgA isotype and two identical immunoglobulin light chains, held together by disulfide bonds, and sometimes complexed with J chain or J chain and secretory component. An IgA immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph."" [GOC:add, ISBN:0781765196, PMID:16362985]",6,73,4,22097,0.0547945205479452,0.6666666666666666,Module 4,['GO:0019814']
1763,GO:CC,GO:0005773,vacuole,4.954468122148301e-07,True,"""A closed structure, found only in eukaryotic cells, that is completely surrounded by unit membrane and contains liquid material. Cells contain one or several vacuoles, that may have different functions from each other. Vacuoles have a diverse array of functions. They can act as a storage organelle for nutrients or waste products, as a degradative compartment, as a cost-effective way of increasing cell size, and as a homeostatic regulator controlling both turgor pressure and pH of the cytosol."" [GOC:mtg_sensu, ISBN:0198506732]",855,17,9,22097,0.5294117647058824,0.010526315789473684,Module 6,"['GO:0005737', 'GO:0043231']"
1764,HP,HP:0000202,Orofacial cleft,4.961869586121506e-07,True,"The presence of a cleft (gap, opening, or groove) in the oral cavity, including cleft of the upper lip and/or cleft of the palate. Cleft of the upper lip is visible as a groove or fissure in the lip, most frequently due to a congenital failure of the maxillary and median nasal processes to fuse. Cleft palate is characterized by a grooved depression or fissure in the roof of the mouth, most often resulting from a congenital failure of the palate to fuse properly. Clefts of the lip and palate can occur individually or together. It is preferable to code each defect separately.",641,44,23,4958,0.5227272727272727,0.0358814352574103,Module 3,"['HP:0000163', 'HP:5201015']"
1765,HPA,HPA:0471472,skin 2; lymphocytes[≥Medium],5.017726475395152e-07,True,skin 2; lymphocytes[≥Medium],647,140,29,11019,0.20714285714285716,0.04482225656877898,Module Singleton,['HPA:0471471']
1766,HPA,HPA:0310431,lymph node; germinal center cells[≥Low],5.056110179807648e-07,True,lymph node; germinal center cells[≥Low],5061,185,125,11019,0.6756756756756757,0.024698676150958308,Module 1,['HPA:0310000']
1767,GO:MF,GO:0019904,protein domain specific binding,5.067314884085993e-07,True,"""Binding to a specific domain of a protein."" [GOC:go_curators]",653,808,61,20212,0.07549504950495049,0.09341500765696784,Module 0,['GO:0005515']
1768,HPA,HPA:0460202,skin 1; endothelial cells[≥Medium],5.067922652203906e-07,True,skin 1; endothelial cells[≥Medium],593,69,19,11019,0.2753623188405797,0.03204047217537943,Module 5,['HPA:0460201']
1769,REAC,REAC:R-HSA-5676590,NIK-->noncanonical NF-kB signaling,5.154342522805365e-07,True,NIK-->noncanonical NF-kB signaling,59,586,18,10842,0.030716723549488054,0.3050847457627119,Module 0,['REAC:R-HSA-5668541']
1770,MIRNA,MIRNA:hsa-miR-193b-3p,hsa-miR-193b-3p,5.218550142768635e-07,True,hsa-miR-193b-3p,848,76,21,14819,0.27631578947368424,0.024764150943396228,Module 5,['MIRNA:000000']
1771,GO:BP,GO:0022407,regulation of cell-cell adhesion,5.282227048572997e-07,True,"""Any process that modulates the frequency, rate or extent of attachment of a cell to another cell."" [GOC:isa_complete]",477,15,8,21031,0.5333333333333333,0.016771488469601678,Module 6,"['GO:0030155', 'GO:0098609']"
1772,GO:BP,GO:0045785,positive regulation of cell adhesion,5.282227048572997e-07,True,"""Any process that activates or increases the frequency, rate or extent of cell adhesion."" [GOC:go_curators]",477,15,8,21031,0.5333333333333333,0.016771488469601678,Module 6,"['GO:0007155', 'GO:0030155', 'GO:0048522']"
1773,HP,HP:0011994,Abnormal atrial septum morphology,5.303573323697724e-07,True,An abnormality of the interatrial septum.,521,44,21,4958,0.4772727272727273,0.04030710172744722,Module 3,['HP:0001671']
1774,REAC,REAC:R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,5.308780387302766e-07,True,p53-Dependent G1/S DNA damage checkpoint,66,586,19,10842,0.032423208191126277,0.2878787878787879,Module 0,['REAC:R-HSA-69615']
1775,REAC,REAC:R-HSA-69563,p53-Dependent G1 DNA Damage Response,5.308780387302766e-07,True,p53-Dependent G1 DNA Damage Response,66,586,19,10842,0.032423208191126277,0.2878787878787879,Module 0,['REAC:R-HSA-69580']
1776,HPA,HPA:0301373,lung; alveolar cells type II[High],5.325796306350684e-07,True,lung; alveolar cells type II[High],662,612,75,11019,0.12254901960784313,0.11329305135951662,Module 0,['HPA:0301372']
1777,HPA,HPA:0220051,gallbladder; glandular cells[≥Low],5.384822819953314e-07,True,gallbladder; glandular cells[≥Low],7664,79,76,11019,0.9620253164556962,0.009916492693110648,Module 3,['HPA:0220000']
1778,HPA,HPA:0220000,gallbladder,5.384822819953314e-07,True,gallbladder,7664,79,76,11019,0.9620253164556962,0.009916492693110648,Module 3,['HPA:0000000']
1779,TF,TF:M00341_1,Factor: GABP; motif: VCCGGAAGNGCR; match class: 1,5.412851434136611e-07,True,Factor: GABP; motif: VCCGGAAGNGCR; match class: 1,2380,826,160,20045,0.1937046004842615,0.06722689075630252,Module 0,['TF:M00341']
1780,GO:CC,GO:0070469,respirasome,5.451826324368652e-07,True,"""The protein complexes that form the electron transport system (the respiratory chain), associated with a cell membrane, usually the plasma membrane (in prokaryotes) or the inner mitochondrial membrane (on eukaryotes). The respiratory chain complexes transfer electrons from an electron donor to an electron acceptor and are associated with a proton pump to create a transmembrane electrochemical gradient."" [GOC:ecd, GOC:mah, ISBN:0198547684, Wikipedia:Respirasome]",104,105,9,22097,0.08571428571428572,0.08653846153846154,Module 3,"['GO:0016020', 'GO:0110165']"
1781,GO:BP,GO:0071310,cellular response to organic substance,5.459255320293726e-07,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus."" [GOC:mah]",1971,226,53,21031,0.2345132743362832,0.026889903602232368,Module 1,"['GO:0010033', 'GO:0070887']"
1782,MIRNA,MIRNA:hsa-miR-1180-3p,hsa-miR-1180-3p,5.470581291743384e-07,True,hsa-miR-1180-3p,67,104,9,14819,0.08653846153846154,0.13432835820895522,Module 3,['MIRNA:000000']
1783,HPA,HPA:0170251,endometrium 2; cells in endometrial stroma[≥Low],5.493147880928567e-07,True,endometrium 2; cells in endometrial stroma[≥Low],3517,79,51,11019,0.6455696202531646,0.014500995166334945,Module 3,['HPA:0170000']
1784,GO:CC,GO:0005615,extracellular space,5.510047544261358e-07,True,"""That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid."" [ISBN:0198547684]",3303,238,72,22097,0.3025210084033613,0.021798365122615803,Module 1,"['GO:0005576', 'GO:0110165']"
1785,HP,HP:0002572,Episodic vomiting,5.55431057535183e-07,True,"Paroxysmal, recurrent episodes of vomiting.",52,44,9,4958,0.20454545454545456,0.17307692307692307,Module 3,['HP:0002013']
1786,GO:MF,GO:0140375,immune receptor activity,5.593060555462962e-07,True,"""Receiving a signal and transmitting it in a cell to initiate an immune response."" [PMID:31415752, Wikipedia:Immune_receptor]",145,232,14,20212,0.0603448275862069,0.09655172413793103,Module 1,['GO:0038023']
1787,GO:BP,GO:0030154,cell differentiation,5.634303604637369e-07,True,"""The cellular developmental process in which a relatively unspecialized cell, e.g. embryonic or regenerative cell, acquires specialized structural and/or functional features that characterize a specific cell. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state."" [ISBN:0198506732]",4366,226,88,21031,0.3893805309734513,0.02015574896930829,Module 1,['GO:0048869']
1788,GO:CC,GO:0005615,extracellular space,5.70261369532934e-07,True,"""That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid."" [ISBN:0198547684]",3303,177,58,22097,0.327683615819209,0.01755979412655162,Module Singleton,"['GO:0005576', 'GO:0110165']"
1789,GO:BP,GO:0048869,cellular developmental process,5.703642591719947e-07,True,"""A biological process whose specific outcome is the progression of a cell over time from an initial condition to a later condition."" [GOC:isa_complete]",4367,226,88,21031,0.3893805309734513,0.020151133501259445,Module 1,"['GO:0009987', 'GO:0032502']"
1790,HPA,HPA:0330223,oral mucosa; squamous epithelial cells[High],5.733074017525314e-07,True,oral mucosa; squamous epithelial cells[High],1152,79,28,11019,0.35443037974683544,0.024305555555555556,Module 3,['HPA:0330222']
1791,HPA,HPA:0461473,skin 1; lymphocytes[High],5.733464748896334e-07,True,skin 1; lymphocytes[High],394,185,26,11019,0.14054054054054055,0.06598984771573604,Module 1,['HPA:0461472']
1792,REAC,REAC:R-HSA-381119,Unfolded Protein Response (UPR),5.797847701021892e-07,True,Unfolded Protein Response (UPR),91,60,9,10842,0.15,0.0989010989010989,Module 4,['REAC:R-HSA-2262752']
1793,HP,HP:5201015,Craniofacial cleft,5.81550178518508e-07,True,"Congenital abnormality with cleft (gap or opening) in the craniofacial bones. Craniofacial cleft includes facial cleft, orofacial clef, and cleft of the jaw.",646,44,23,4958,0.5227272727272727,0.03560371517027864,Module 3,['HP:0000234']
1794,HPA,HPA:0500703,soft tissue 1; peripheral nerve[High],5.862981443765408e-07,True,soft tissue 1; peripheral nerve[High],241,69,13,11019,0.18840579710144928,0.05394190871369295,Module 5,['HPA:0500702']
1795,TF,TF:M02068_1,Factor: etv3; motif: ACCGGAAGYN; match class: 1,5.896875571642257e-07,True,Factor: etv3; motif: ACCGGAAGYN; match class: 1,627,826,62,20045,0.07506053268765134,0.09888357256778309,Module 0,['TF:M02068']
1796,GO:BP,GO:0050794,regulation of cellular process,6.03597463427656e-07,True,"""Any process that modulates the frequency, rate or extent of a cellular process, any of those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level."" [GOC:go_curators]",11738,215,164,21031,0.7627906976744186,0.013971715794854319,Module 2,"['GO:0009987', 'GO:0050789']"
1797,GO:BP,GO:0048870,cell motility,6.153628011743184e-07,True,"""Any process involved in the controlled self-propelled movement of a cell that results in translocation of the cell from one place to another."" [GOC:dgh, GOC:dph, GOC:isa_complete, GOC:mlg]",1709,215,47,21031,0.2186046511627907,0.027501462843768285,Module 2,['GO:0009987']
1798,KEGG,KEGG:03060,Protein export,6.166325029622026e-07,True,Protein export,31,43,6,8484,0.13953488372093023,0.1935483870967742,Module 4,['KEGG:00000']
1799,HPA,HPA:0300411,lung; macrophages[≥Low],6.213735975598068e-07,True,lung; macrophages[≥Low],6787,79,72,11019,0.9113924050632911,0.010608516281125682,Module 3,['HPA:0300000']
1800,GO:MF,GO:0050839,cell adhesion molecule binding,6.36255687041095e-07,True,"""Binding to a cell adhesion molecule."" [GOC:ai]",561,808,55,20212,0.06806930693069307,0.09803921568627451,Module 0,['GO:0005515']
1801,REAC,REAC:R-HSA-69206,G1/S Transition,6.365003973633185e-07,True,G1/S Transition,130,59,10,10842,0.1694915254237288,0.07692307692307693,Module 5,['REAC:R-HSA-453279']
1802,GO:CC,GO:0005838,proteasome regulatory particle,6.466715138637743e-07,True,"""A multisubunit complex, which caps one or both ends of the proteasome core complex. This complex recognizes and unfolds ubiquitinated proteins, and translocates them to the proteasome core complex."" [GOC:mtg_sensu, GOC:rb]",22,813,10,22097,0.012300123001230012,0.45454545454545453,Module 0,"['GO:0022624', 'GO:0032991']"
1803,GO:CC,GO:0005753,mitochondrial proton-transporting ATP synthase complex,6.466715138637743e-07,True,"""A proton-transporting ATP synthase complex found in the mitochondrial membrane."" [GOC:mah, GOC:mtg_sensu]",22,813,10,22097,0.012300123001230012,0.45454545454545453,Module 0,"['GO:0045259', 'GO:0098800']"
1804,HPA,HPA:0471473,skin 2; lymphocytes[High],6.510214618528843e-07,True,skin 2; lymphocytes[High],456,185,28,11019,0.15135135135135136,0.06140350877192982,Module 1,['HPA:0471472']
1805,TF,TF:M04744,Factor: ATF-3; motif: GGCGCSSNSNGRTSACGTSA,6.572463173966075e-07,True,Factor: ATF-3; motif: GGCGCSSNSNGRTSACGTSA,10285,826,512,20045,0.6198547215496368,0.04978123480797277,Module 0,['TF:M00000']
1806,GO:BP,GO:0045184,establishment of protein localization,6.63793977242551e-07,True,"""The directed movement of a protein to a specific location."" [GOC:bf]",1924,72,26,21031,0.3611111111111111,0.013513513513513514,Module 4,"['GO:0008104', 'GO:0051234']"
1807,HP,HP:0032158,Unusual infection by anatomical site,6.685383172934944e-07,True,An unusual infection classified by the affected body part.,114,71,14,4958,0.19718309859154928,0.12280701754385964,Module 1,['HP:0032101']
1808,GO:BP,GO:0070887,cellular response to chemical stimulus,6.687088557352621e-07,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemical stimulus."" [GOC:mah]",2683,226,64,21031,0.2831858407079646,0.023853894893775623,Module 1,"['GO:0042221', 'GO:0051716']"
1809,HP,HP:0002846,Abnormal B cell morphology,6.692429905368341e-07,True,A structural abnormality of B cells.,94,71,13,4958,0.18309859154929578,0.13829787234042554,Module 1,['HP:0004332']
1810,GO:BP,GO:0048523,negative regulation of cellular process,6.695025233085481e-07,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of a cellular process, any of those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level."" [GOC:jid]",5541,226,103,21031,0.4557522123893805,0.018588702400288756,Module 1,"['GO:0009987', 'GO:0048519', 'GO:0050794']"
1811,HPA,HPA:0040083,bone marrow; hematopoietic cells[High],6.700424287277501e-07,True,bone marrow; hematopoietic cells[High],1453,166,51,11019,0.3072289156626506,0.03509979353062629,Module 2,['HPA:0040082']
1812,HP,HP:0004322,Short stature,6.794961385898959e-07,True,"A height below that which is expected according to age and gender norms. Although there is no universally accepted definition of short stature, many refer to \""short stature\"" as height more than 2 standard deviations below the mean for age and gender (or below the 3rd percentile for age and gender dependent norms).",1364,44,32,4958,0.7272727272727273,0.02346041055718475,Module 3,"['HP:0000002', 'HP:0001510']"
1813,HPA,HPA:0401333,rectum; mucosal lymphoid cells[High],6.813686724772835e-07,True,rectum; mucosal lymphoid cells[High],176,612,32,11019,0.05228758169934641,0.18181818181818182,Module 0,['HPA:0401332']
1814,GO:CC,GO:1904949,ATPase complex,6.834378065267781e-07,True,"""A protein complex which is capable of ATPase activity."" [GO_REF:0000088, GOC:bhm, GOC:TermGenie, PMID:9606181]",153,813,24,22097,0.02952029520295203,0.1568627450980392,Module 0,['GO:1902494']
1815,TF,TF:M04691,Factor: Kaiso; motif: TCTCGCGAG,6.886622042977269e-07,True,Factor: Kaiso; motif: TCTCGCGAG,15460,826,708,20045,0.8571428571428571,0.045795601552393275,Module 0,['TF:M00000']
1816,GO:BP,GO:0030163,protein catabolic process,6.888388706099187e-07,True,"""The chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds."" [GOC:mah]",968,787,77,21031,0.09783989834815757,0.07954545454545454,Module 0,"['GO:0009057', 'GO:0019538', 'GO:1901565']"
1817,GO:BP,GO:0007165,signal transduction,6.951165519551428e-07,True,"""The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell."" [GOC:go_curators, GOC:mtg_signaling_feb11]",5959,215,104,21031,0.48372093023255813,0.017452592716898807,Module 2,"['GO:0007154', 'GO:0009987', 'GO:0023052', 'GO:0050794', 'GO:0051716']"
1818,GO:BP,GO:0090407,organophosphate biosynthetic process,6.95951113926013e-07,True,"""The chemical reactions and pathways resulting in the biosynthesis of deoxyribose phosphate, the phosphorylated sugar 2-deoxy-erythro-pentose."" [GOC:chem_mtg]",600,787,56,21031,0.07115628970775095,0.09333333333333334,Module 0,"['GO:0019637', 'GO:1901576']"
1819,TF,TF:M03979,Factor: ETV1; motif: ACCGGAAGTN,6.987137944469813e-07,True,Factor: ETV1; motif: ACCGGAAGTN,1038,826,87,20045,0.1053268765133172,0.0838150289017341,Module 0,['TF:M00000']
1820,REAC,REAC:R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,6.99839538611734e-07,True,SCF(Skp2)-mediated degradation of p27/p21,60,586,18,10842,0.030716723549488054,0.3,Module 0,"['REAC:R-HSA-69202', 'REAC:R-HSA-69656']"
1821,REAC,REAC:R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,6.99839538611734e-07,True,Dectin-1 mediated noncanonical NF-kB signaling,60,586,18,10842,0.030716723549488054,0.3,Module 0,['REAC:R-HSA-5607764']
1822,TF,TF:M10436,Factor: YY1; motif: CAANATGGCGGC,7.036201583574355e-07,True,Factor: YY1; motif: CAANATGGCGGC,8349,826,432,20045,0.5230024213075061,0.05174272367948257,Module 0,['TF:M00000']
1823,REAC,REAC:R-HSA-5658442,Regulation of RAS by GAPs,7.042413436495328e-07,True,Regulation of RAS by GAPs,67,586,19,10842,0.032423208191126277,0.2835820895522388,Module 0,['REAC:R-HSA-5673001']
1824,HPA,HPA:0570732,testis; Leydig cells[≥Medium],7.169555230999582e-07,True,testis; Leydig cells[≥Medium],5378,79,64,11019,0.810126582278481,0.01190033469691335,Module 3,['HPA:0570731']
1825,GO:BP,GO:0043484,regulation of RNA splicing,7.2273804158099e-07,True,"""Any process that modulates the frequency, rate or extent of RNA splicing, the process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA."" [GOC:jl]",186,787,28,21031,0.035578144853875476,0.15053763440860216,Module 0,"['GO:0008380', 'GO:0010468', 'GO:0051252']"
1826,GO:BP,GO:0051249,regulation of lymphocyte activation,7.310340510640503e-07,True,"""Any process that modulates the frequency, rate or extent of lymphocyte activation."" [GOC:ai]",497,15,8,21031,0.5333333333333333,0.01609657947686117,Module 6,"['GO:0002694', 'GO:0046649']"
1827,TF,TF:M01876,Factor: GABP-beta; motif: ASMGGAAGKGN,7.393679069979203e-07,True,Factor: GABP-beta; motif: ASMGGAAGKGN,2195,826,150,20045,0.18159806295399517,0.0683371298405467,Module 0,['TF:M00000']
1828,TF,TF:M11393_1,Factor: Erg; motif: NACCGGATATCCGGTN; match class: 1,7.451329052884407e-07,True,Factor: Erg; motif: NACCGGATATCCGGTN; match class: 1,13934,826,653,20045,0.7905569007263923,0.04686378642170231,Module 0,['TF:M11393']
1829,HP,HP:0025408,Abnormal spleen morphology,7.471096944975963e-07,True,Any anomaly of the structure of the spleen.,592,71,29,4958,0.4084507042253521,0.048986486486486486,Module 1,['HP:0001743']
1830,GO:BP,GO:0031647,regulation of protein stability,7.775237195909436e-07,True,"""Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation."" [GOC:dph, GOC:mah, GOC:tb]",324,21,8,21031,0.38095238095238093,0.024691358024691357,Module 9,['GO:0065008']
1831,HP,HP:0007067,Distal peripheral sensory neuropathy,7.810427246733873e-07,True,Peripheral sensory neuropathy affecting primarily distal sensation.,13,44,6,4958,0.13636363636363635,0.46153846153846156,Module 3,['HP:0000763']
1832,HP,HP:0005157,Concentric hypertrophic cardiomyopathy,7.810427246733873e-07,True,Hypertrophic cardiomyopathy with an symmetrical and concentric pattern of hypertrophy.,13,44,6,4958,0.13636363636363635,0.46153846153846156,Module 3,['HP:0001639']
1833,GO:CC,GO:0012505,endomembrane system,7.83477575257385e-07,True,"""A collection of membranous structures involved in transport within the cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles."" [GOC:lh]",4777,73,39,22097,0.5342465753424658,0.00816411974042286,Module 4,['GO:0110165']
1834,GO:CC,GO:0012506,vesicle membrane,7.855340051312813e-07,True,"""The lipid bilayer surrounding any membrane-bounded vesicle in the cell."" [GOC:mah, GOC:vesicle]",1240,221,37,22097,0.167420814479638,0.029838709677419355,Module 2,"['GO:0031090', 'GO:0031982']"
1835,GO:BP,GO:0016192,vesicle-mediated transport,7.895874567802245e-07,True,"""A cellular transport process in which transported substances are moved in membrane-bounded vesicles; transported substances are enclosed in the vesicle lumen or located in the vesicle membrane. The process begins with a step that directs a substance to the forming vesicle, and includes vesicle budding and coating. Vesicles are then targeted to, and fuse with, an acceptor membrane."" [GOC:ai, GOC:mah, ISBN:08789310662000]",1547,787,107,21031,0.13595933926302414,0.0691661279896574,Module 0,"['GO:0006810', 'GO:0009987']"
1836,HP,HP:0003200,Ragged-red muscle fibers,7.926107741922608e-07,True,"An abnormal appearance of muscle fibers observed on muscle biopsy. Ragged red fibers can be visualized with Gomori trichrome staining as irregular and intensely red subsarcolemmal zones, whereas the normal myofibrils are green. The margins of affect fibers appear red and ragged. The ragged-red is due to the accumulation of abnormal mitochondria below the plasma membrane of the muscle fiber, leading to the appearance of a red rim and speckled sarcoplasm.",54,44,9,4958,0.20454545454545456,0.16666666666666666,Module 3,['HP:0004303']
1837,HP,HP:0003737,Mitochondrial myopathy,7.926107741922608e-07,True,A type of myopathy associated with mitochondrial disease and characterized by findings on biopsy such as ragged red muscle fibers.,54,44,9,4958,0.20454545454545456,0.16666666666666666,Module 3,['HP:0003800']
1838,GO:CC,GO:0098556,cytoplasmic side of rough endoplasmic reticulum membrane,7.939927214756632e-07,True,"""The side (leaflet) of the rough endoplasmic reticulum membrane that faces the cytoplasm."" [GOC:ab, GOC:dos]",5,105,4,22097,0.0380952380952381,0.8,Module 3,"['GO:0030867', 'GO:0098554']"
1839,GO:CC,GO:0009986,cell surface,7.988098648554736e-07,True,"""The external part of the cell wall and/or plasma membrane."" [GOC:jl, GOC:mtg_sensu, GOC:sm]",903,17,9,22097,0.5294117647058824,0.009966777408637873,Module 6,['GO:0110165']
1840,HPA,HPA:0270363,kidney; cells in tubules[High],8.048373350287323e-07,True,kidney; cells in tubules[High],2161,612,179,11019,0.29248366013071897,0.08283202221193892,Module 0,['HPA:0270362']
1841,GO:BP,GO:0048522,positive regulation of cellular process,8.144192622581454e-07,True,"""Any process that activates or increases the frequency, rate or extent of a cellular process, any of those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level."" [GOC:jid]",5717,787,292,21031,0.3710292249047014,0.05107573902396362,Module 0,"['GO:0009987', 'GO:0048518', 'GO:0050794']"
1842,REAC,REAC:R-HSA-5357801,Programmed Cell Death,8.208141604918522e-07,True,Programmed Cell Death,208,586,35,10842,0.059726962457337884,0.16826923076923078,Module 0,['REAC:0000000']
1843,GO:MF,GO:0051087,protein-folding chaperone binding,8.283679487159194e-07,True,"""Binding to a chaperone protein, a class of proteins that bind to nascent or unfolded polypeptides and ensure correct folding or transport."" [PMID:10585443]",135,20,6,20212,0.3,0.044444444444444446,Module 9,['GO:0005515']
1844,KEGG,KEGG:04650,Natural killer cell mediated cytotoxicity,8.599464186551752e-07,True,Natural killer cell mediated cytotoxicity,124,136,14,8484,0.10294117647058823,0.11290322580645161,Module 1,['KEGG:00000']
1845,KEGG,KEGG:04723,Retrograde endocannabinoid signaling,8.651096166298851e-07,True,Retrograde endocannabinoid signaling,148,439,27,8484,0.06150341685649203,0.18243243243243243,Module 0,['KEGG:00000']
1846,GO:MF,GO:0034987,immunoglobulin receptor binding,8.658584736139276e-07,True,"""Binding to one or more specific sites on an immunoglobulin receptor molecule."" [GOC:BHF, GOC:vk]",15,72,5,20212,0.06944444444444445,0.3333333333333333,Module 4,['GO:0005102']
1847,HP,HP:0000175,Cleft palate,8.879676817161144e-07,True,Cleft palate is a developmental defect of the palate resulting from a failure of fusion of the palatine processes and manifesting as a separation of the roof of the mouth (soft and hard palate).,596,44,22,4958,0.5,0.03691275167785235,Module 3,"['HP:0000174', 'HP:0000202']"
1848,TF,TF:M00740_1,Factor: Rb:E2F-1:DP-1; motif: TTTSGCGC; match class: 1,8.924785308440817e-07,True,Factor: Rb:E2F-1:DP-1; motif: TTTSGCGC; match class: 1,4732,80,45,20045,0.5625,0.009509721048182587,Module 5,['TF:M00740']
1849,HPA,HPA:0461413,skin 1; cells in spinous layer[High],8.949631375558775e-07,True,skin 1; cells in spinous layer[High],207,612,35,11019,0.05718954248366013,0.16908212560386474,Module 0,['HPA:0461412']
1850,TF,TF:M03987,Factor: FEV; motif: ACCGGAAGTN,8.96853142789962e-07,True,Factor: FEV; motif: ACCGGAAGTN,1341,826,104,20045,0.12590799031476999,0.07755406413124534,Module 0,['TF:M00000']
1851,HPA,HPA:0180053,epididymis; glandular cells[High],9.017194186530774e-07,True,epididymis; glandular cells[High],1842,612,158,11019,0.2581699346405229,0.08577633007600434,Module 0,['HPA:0180052']
1852,TF,TF:M04823,Factor: E2F-4; motif: NNTTCCCGCCNN,9.043006389209987e-07,True,Factor: E2F-4; motif: NNTTCCCGCCNN,13114,826,622,20045,0.7530266343825666,0.04743022723806619,Module 0,['TF:M00000']
1853,GO:BP,GO:2000026,regulation of multicellular organismal development,9.13507549830983e-07,True,"""Any process that modulates the frequency, rate or extent of multicellular organismal development."" [GOC:obol]",1411,226,43,21031,0.1902654867256637,0.03047484053862509,Module 1,"['GO:0007275', 'GO:0050793', 'GO:0051239']"
1854,HPA,HPA:0250000,hippocampus,9.162992314428959e-07,True,hippocampus,6830,79,72,11019,0.9113924050632911,0.010541727672035138,Module 3,['HPA:0000000']
1855,MIRNA,MIRNA:hsa-miR-186-5p,hsa-miR-186-5p,9.283465430457268e-07,True,hsa-miR-186-5p,748,104,23,14819,0.22115384615384615,0.03074866310160428,Module 3,['MIRNA:000000']
1856,REAC,REAC:R-HSA-69615,G1/S DNA Damage Checkpoints,9.288152445222135e-07,True,G1/S DNA Damage Checkpoints,68,586,19,10842,0.032423208191126277,0.27941176470588236,Module 0,['REAC:R-HSA-69620']
1857,REAC,REAC:R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,9.288152445222135e-07,True,APC/C:Cdc20 mediated degradation of Securin,68,586,19,10842,0.032423208191126277,0.27941176470588236,Module 0,['REAC:R-HSA-176409']
1858,TF,TF:M11005_1,Factor: LHX4; motif: NNCRTTAN; match class: 1,9.474029574534485e-07,True,Factor: LHX4; motif: NNCRTTAN; match class: 1,4292,826,252,20045,0.3050847457627119,0.05871388630009319,Module 0,['TF:M11005']
1859,HP,HP:0001287,Meningitis,9.474308169788006e-07,True,Inflammation of the meninges.,78,71,12,4958,0.16901408450704225,0.15384615384615385,Module 1,['HP:0011450']
1860,HPA,HPA:0470183,skin 2; cells in granular layer[High],9.485038418604082e-07,True,skin 2; cells in granular layer[High],248,612,39,11019,0.06372549019607843,0.15725806451612903,Module 0,['HPA:0470182']
1861,HPA,HPA:0490692,smooth muscle; smooth muscle cells[≥Medium],9.487732748275237e-07,True,smooth muscle; smooth muscle cells[≥Medium],3126,612,239,11019,0.39052287581699346,0.0764555342290467,Module 0,['HPA:0490691']
1862,GO:BP,GO:0051234,establishment of localization,9.519182542770253e-07,True,"""Any process that localizes a substance or cellular component. This may occur via movement, tethering or selective degradation."" [GOC:ai, GOC:dos]",4881,787,257,21031,0.32655654383735705,0.05265314484736734,Module 0,['GO:0051179']
1863,GO:BP,GO:0006465,signal peptide processing,9.525800887354685e-07,True,"""The proteolytic removal of a signal peptide from a protein during or after transport to a specific location in the cell."" [GOC:mah, ISBN:0815316194]",13,72,5,21031,0.06944444444444445,0.38461538461538464,Module 4,"['GO:0006518', 'GO:0016485']"
1864,HP,HP:0002415,Leukodystrophy,9.536897571730576e-07,True,Leukodystrophy refers to deterioration of white matter of the brain resulting from degeneration of myelin sheaths in the CNS. Their basic defect is directly related to the synthesis and maintenance of myelin membranes. Symmetric white matter involvement at MRI is a typical finding in patients with leukodystrophies.,101,228,22,4958,0.09649122807017543,0.21782178217821782,Module 0,['HP:0011400']
1865,GO:BP,GO:0048856,anatomical structure development,9.862622030299039e-07,True,"""The biological process whose specific outcome is the progression of an anatomical structure from an initial condition to its mature state. This process begins with the formation of the structure and ends with the mature structure, whatever form that may be including its natural destruction. An anatomical structure is any biological entity that occupies space and is distinguished from its surroundings. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome."" [GO_REF:0000021]",5899,226,107,21031,0.47345132743362833,0.018138667570774706,Module 1,['GO:0032502']
1866,HPA,HPA:0300000,lung,9.862867885673426e-07,True,lung,7379,166,144,11019,0.8674698795180723,0.019514839409134028,Module 2,['HPA:0000000']
1867,GO:BP,GO:0046649,lymphocyte activation,9.999804103560321e-07,True,"""A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor."" [GOC:mgi_curators, ISBN:0781735149]",783,215,30,21031,0.13953488372093023,0.038314176245210725,Module 2,['GO:0045321']
1868,REAC,REAC:R-HSA-68882,Mitotic Anaphase,1.0085271685433458e-06,True,Mitotic Anaphase,228,59,12,10842,0.2033898305084746,0.05263157894736842,Module 5,['REAC:R-HSA-2555396']
1869,GO:BP,GO:1903037,regulation of leukocyte cell-cell adhesion,1.0100604404253684e-06,True,"""Any process that modulates the frequency, rate or extent of leukocyte cell-cell adhesion."" [GO_REF:0000058, GOC:BHF, GOC:rl, GOC:TermGenie, PMID:21106532]",365,226,21,21031,0.09292035398230089,0.057534246575342465,Module 1,"['GO:0007159', 'GO:0022407']"
1870,TF,TF:M02061_1,Factor: ERF; motif: ACCGGAARYN; match class: 1,1.010070794319569e-06,True,Factor: ERF; motif: ACCGGAARYN; match class: 1,370,826,44,20045,0.053268765133171914,0.11891891891891893,Module 0,['TF:M02061']
1871,HPA,HPA:0600222,tonsil; squamous epithelial cells[≥Medium],1.0113653872458245e-06,True,tonsil; squamous epithelial cells[≥Medium],4949,79,61,11019,0.7721518987341772,0.012325722368155182,Module 3,['HPA:0600221']
1872,GO:BP,GO:0008283,cell population proliferation,1.0305116200400335e-06,True,"""The multiplication or reproduction of cells, resulting in the expansion of a cell population."" [GOC:mah, GOC:mb]",2006,226,53,21031,0.2345132743362832,0.02642073778664008,Module 1,['GO:0009987']
1873,HPA,HPA:0351183,pancreas; pancreatic endocrine cells[High],1.0360116835898892e-06,True,pancreas; pancreatic endocrine cells[High],802,612,85,11019,0.1388888888888889,0.1059850374064838,Module 0,['HPA:0351182']
1874,REAC,REAC:R-HSA-68886,M Phase,1.048122674619803e-06,True,M Phase,406,59,15,10842,0.2542372881355932,0.03694581280788178,Module 5,['REAC:R-HSA-69278']
1875,REAC,REAC:R-HSA-2555396,Mitotic Metaphase and Anaphase,1.0599788110426412e-06,True,Mitotic Metaphase and Anaphase,229,59,12,10842,0.2033898305084746,0.05240174672489083,Module 5,['REAC:R-HSA-68886']
1876,HPA,HPA:0050052,breast; glandular cells[≥Medium],1.0902523025756293e-06,True,breast; glandular cells[≥Medium],5109,79,62,11019,0.7848101265822784,0.012135447249951067,Module 3,['HPA:0050051']
1877,TF,TF:M11454,Factor: ELFR; motif: NANGMGGAAGTN,1.0947963129296255e-06,True,Factor: ELFR; motif: NANGMGGAAGTN,1099,826,90,20045,0.1089588377723971,0.0818926296633303,Module 0,['TF:M00000']
1878,GO:CC,GO:0098791,Golgi apparatus subcompartment,1.096473114075251e-06,True,"""A compartment that consists of a lumen and an enclosing membrane, and is part of the Golgi apparatus."" [GOC:dos]",384,17,7,22097,0.4117647058823529,0.018229166666666668,Module 6,"['GO:0005794', 'GO:0031984']"
1879,GO:MF,GO:0044877,protein-containing complex binding,1.0998462789675458e-06,True,"""Binding to a macromolecular complex."" [GOC:jl]",1752,808,121,20212,0.14975247524752475,0.06906392694063927,Module 0,['GO:0005488']
1880,GO:BP,GO:0022402,cell cycle process,1.10118352463807e-06,True,"""The cellular process that ensures successive accurate and complete genome replication and chromosome segregation."" [GOC:isa_complete, GOC:mtg_cell_cycle]",1276,77,22,21031,0.2857142857142857,0.017241379310344827,Module 5,"['GO:0007049', 'GO:0009987']"
1881,HPA,HPA:0190223,esophagus; squamous epithelial cells[High],1.1172908376533061e-06,True,esophagus; squamous epithelial cells[High],1652,612,145,11019,0.2369281045751634,0.08777239709443099,Module 0,['HPA:0190222']
1882,TF,TF:M11005,Factor: LHX4; motif: NNCRTTAN,1.127964135085989e-06,True,Factor: LHX4; motif: NNCRTTAN,10812,826,532,20045,0.6440677966101694,0.049204587495375506,Module 0,['TF:M00000']
1883,GO:MF,GO:0015453,oxidoreduction-driven active transmembrane transporter activity,1.1322339582348912e-06,True,"""Primary active transport of a solute across a membrane, driven by exothermic flow of electrons from a reduced substrate to an oxidized substrate. Primary active transport is catalysis of the transport of a solute across a membrane, up the solute's concentration gradient, by binding the solute and undergoing a series of conformational changes. Transport works equally well in either direction and is driven by a primary energy source."" [GOC:mtg_transport, ISBN:0815340729, TC:3.D.-.-.-]",66,105,8,20212,0.0761904761904762,0.12121212121212122,Module 3,['GO:0015399']
1884,HPA,HPA:0080133,caudate; neuronal cells[High],1.1361791225474606e-06,True,caudate; neuronal cells[High],1103,612,107,11019,0.17483660130718953,0.09700815956482321,Module 0,['HPA:0080132']
1885,TF,TF:M11665,Factor: IRF-2; motif: NGAAASYGAAAS,1.1476753890672307e-06,True,Factor: IRF-2; motif: NGAAASYGAAAS,2449,36,20,20045,0.5555555555555556,0.008166598611678236,Module 7,['TF:M00000']
1886,TF,TF:M03819_1,Factor: Elk-1; motif: GGAAGN; match class: 1,1.15330835430031e-06,True,Factor: Elk-1; motif: GGAAGN; match class: 1,7574,826,398,20045,0.48184019370460046,0.052548191180353844,Module 0,['TF:M03819']
1887,WP,WP:WP183,Proteasome degradation,1.1696202202353427e-06,True,Proteasome degradation,62,472,18,8286,0.038135593220338986,0.2903225806451613,Module 0,['WP:000000']
1888,REAC,REAC:R-HSA-1280218,Adaptive Immune System,1.1894555021567737e-06,True,Adaptive Immune System,809,14,10,10842,0.7142857142857143,0.012360939431396786,Module 6,['REAC:R-HSA-168256']
1889,HPA,HPA:0040000,bone marrow,1.1967344486845059e-06,True,bone marrow,6496,166,133,11019,0.8012048192771084,0.020474137931034482,Module 2,['HPA:0000000']
1890,HPA,HPA:0040081,bone marrow; hematopoietic cells[≥Low],1.1967344486845059e-06,True,bone marrow; hematopoietic cells[≥Low],6496,166,133,11019,0.8012048192771084,0.020474137931034482,Module 2,['HPA:0040000']
1891,TF,TF:M11686,Factor: IRF-4; motif: NYGAAASYGAAACYN,1.2052410933673158e-06,True,Factor: IRF-4; motif: NYGAAASYGAAACYN,3447,36,23,20045,0.6388888888888888,0.006672468813460981,Module 7,['TF:M00000']
1892,GO:CC,GO:0034709,methylosome,1.2312277757474628e-06,True,"""A large (20 S) protein complex that possesses protein arginine methyltransferase activity and modifies specific arginines to dimethylarginines in the arginine- and glycine-rich domains of several spliceosomal Sm proteins, thereby targeting these proteins to the survival of motor neurons (SMN) complex for assembly into small nuclear ribonucleoprotein (snRNP) core particles. Proteins found in the methylosome include the methyltransferase JBP1 (PRMT5), pICln (CLNS1A), MEP50 (WDR77), and unmethylated forms of SM proteins that have RG domains."" [PMID:11713266, PMID:11756452]",13,813,8,22097,0.00984009840098401,0.6153846153846154,Module 0,"['GO:0005737', 'GO:0034708']"
1893,GO:BP,GO:0007154,cell communication,1.254098744487584e-06,True,"""Any process that mediates interactions between a cell and its surroundings. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment."" [GOC:mah]",6537,215,110,21031,0.5116279069767442,0.016827290806180204,Module 2,['GO:0009987']
1894,HPA,HPA:0590053,thyroid gland; glandular cells[High],1.267395610643477e-06,True,thyroid gland; glandular cells[High],1881,612,160,11019,0.26143790849673204,0.08506113769271664,Module 0,['HPA:0590052']
1895,GO:BP,GO:0052547,regulation of peptidase activity,1.2778931639724933e-06,True,"""Any process that modulates the frequency, rate or extent of peptidase activity, the hydrolysis of peptide bonds within proteins."" [GOC:ai]",244,215,17,21031,0.07906976744186046,0.06967213114754098,Module 2,"['GO:0030162', 'GO:0051336']"
1896,TF,TF:M00516,Factor: E2F-1; motif: TTTSGCGCGMNR,1.2870234934123243e-06,True,Factor: E2F-1; motif: TTTSGCGCGMNR,7115,826,378,20045,0.4576271186440678,0.053127196064652146,Module 0,['TF:M00000']
1897,GO:CC,GO:0030136,clathrin-coated vesicle,1.2940952278885742e-06,True,"""A vesicle with a coat formed of clathrin connected to the membrane via one of the clathrin adaptor complexes."" [GOC:mah, PMID:11252894]",215,17,6,22097,0.35294117647058826,0.027906976744186046,Module 6,['GO:0030135']
1898,GO:CC,GO:0042470,melanosome,1.298777526940333e-06,True,"""A tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. Melanosomes are synthesized in melanocyte cells."" [GOC:jl, PMID:11584301]",111,813,20,22097,0.024600246002460024,0.18018018018018017,Module 0,['GO:0048770']
1899,GO:CC,GO:0048770,pigment granule,1.298777526940333e-06,True,"""A small, subcellular membrane-bounded vesicle containing pigment and/or pigment precursor molecules. Pigment granule biogenesis is poorly understood, as pigment granules are derived from multiple sources including the endoplasmic reticulum, coated vesicles, lysosomes, and endosomes."" [GOC:jid, GOC:mh]",111,813,20,22097,0.024600246002460024,0.18018018018018017,Module 0,['GO:0031410']
1900,GO:BP,GO:0009611,response to wounding,1.3099638341019068e-06,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to the organism."" [GOC:go_curators]",557,215,25,21031,0.11627906976744186,0.04488330341113106,Module 2,['GO:0006950']
1901,GO:BP,GO:0033036,macromolecule localization,1.32628917158874e-06,True,"""Any process in which a macromolecule is transported to, or maintained in, a specific location."" [GOC:mah]",3210,72,33,21031,0.4583333333333333,0.010280373831775701,Module 4,['GO:0051179']
1902,KEGG,KEGG:05131,Shigellosis,1.341683821362346e-06,True,Shigellosis,246,439,36,8484,0.08200455580865604,0.14634146341463414,Module 0,['KEGG:00000']
1903,TF,TF:M08875_1,Factor: E2F; motif: NNTTTCGCGCN; match class: 1,1.3532351581616298e-06,True,Factor: E2F; motif: NNTTTCGCGCN; match class: 1,1784,80,27,20045,0.3375,0.015134529147982063,Module 5,['TF:M08875']
1904,HP,HP:0007159,Fluctuations in consciousness,1.3578321908830008e-06,True,Changes in one's level of awareness and responsiveness to their environment.,14,44,6,4958,0.13636363636363635,0.42857142857142855,Module 3,['HP:0004372']
1905,HPA,HPA:0390051,prostate; glandular cells[≥Low],1.372596636686506e-06,True,prostate; glandular cells[≥Low],6677,79,71,11019,0.8987341772151899,0.010633518047027108,Module 3,['HPA:0390000']
1906,HPA,HPA:0390000,prostate,1.372596636686506e-06,True,prostate,6677,79,71,11019,0.8987341772151899,0.010633518047027108,Module 3,['HPA:0000000']
1907,HP,HP:0012748,Focal T2 hyperintense brainstem lesion,1.3730955170013906e-06,True,A lighter than expected T2 signal on magnetic resonance imaging (MRI) of the brainstem. This term refers to a localized hyperintensity affecting a particular region of the brainstem.,33,228,13,4958,0.05701754385964912,0.3939393939393939,Module 0,['HP:0012747']
1908,REAC,REAC:R-HSA-202403,TCR signaling,1.3978049453456646e-06,True,TCR signaling,120,14,6,10842,0.42857142857142855,0.05,Module 6,['REAC:R-HSA-1280218']
1909,GO:BP,GO:0051336,regulation of hydrolase activity,1.4115188004993733e-06,True,"""Any process that modulates the frequency, rate or extent of hydrolase activity, the catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3."" [GOC:ai]",604,215,26,21031,0.12093023255813953,0.04304635761589404,Module 2,['GO:0050790']
1910,TF,TF:M00940,Factor: E2F-1; motif: NTTTCGCGCS,1.455396268900821e-06,True,Factor: E2F-1; motif: NTTTCGCGCS,8032,826,417,20045,0.5048426150121066,0.05191733067729084,Module 0,['TF:M00000']
1911,TF,TF:M11682,Factor: IRF-8; motif: NYGAAASYGAAACYN,1.5219685874193985e-06,True,Factor: IRF-8; motif: NYGAAASYGAAACYN,3860,36,24,20045,0.6666666666666666,0.0062176165803108805,Module 7,['TF:M00000']
1912,HPA,HPA:0610832,urinary bladder; urothelial cells[≥Medium],1.5240122754000728e-06,True,urinary bladder; urothelial cells[≥Medium],5958,79,67,11019,0.8481012658227848,0.011245384357166835,Module 3,['HPA:0610831']
1913,REAC,REAC:R-HSA-5632684,Hedgehog 'on' state,1.5269250408336906e-06,True,Hedgehog 'on' state,85,586,21,10842,0.03583617747440273,0.24705882352941178,Module 0,['REAC:R-HSA-5358351']
1914,TF,TF:M02074_1,Factor: GABPalpha; motif: RCCGGAWRYN; match class: 1,1.5291481616597368e-06,True,Factor: GABPalpha; motif: RCCGGAWRYN; match class: 1,1020,826,85,20045,0.10290556900726393,0.08333333333333333,Module 0,['TF:M02074']
1915,HPA,HPA:0630221,cervix; squamous epithelial cells[≥Low],1.5365494299596395e-06,True,cervix; squamous epithelial cells[≥Low],5460,79,64,11019,0.810126582278481,0.011721611721611722,Module 3,['HPA:0630000']
1916,HPA,HPA:0040083,bone marrow; hematopoietic cells[High],1.5514237942950275e-06,True,bone marrow; hematopoietic cells[High],1453,612,131,11019,0.21405228758169934,0.09015829318651067,Module 0,['HPA:0040082']
1917,HPA,HPA:0390053,prostate; glandular cells[High],1.5686127738297621e-06,True,prostate; glandular cells[High],1337,612,123,11019,0.20098039215686275,0.09199700822737472,Module 0,['HPA:0390052']
1918,HPA,HPA:0350472,pancreas; exocrine glandular cells[≥Medium],1.577878072274179e-06,True,pancreas; exocrine glandular cells[≥Medium],5304,79,63,11019,0.7974683544303798,0.011877828054298642,Module 3,['HPA:0350471']
1919,TF,TF:M11399_1,Factor: Fli-1; motif: NACCGGAWWTCCGGTY; match class: 1,1.6043263736607351e-06,True,Factor: Fli-1; motif: NACCGGAWWTCCGGTY; match class: 1,11767,826,569,20045,0.6888619854721549,0.04835557066372057,Module 0,['TF:M11399']
1920,HPA,HPA:0380511,placenta; decidual cells[≥Low],1.6315615389373421e-06,True,placenta; decidual cells[≥Low],4850,79,60,11019,0.759493670886076,0.012371134020618556,Module 3,['HPA:0380000']
1921,TF,TF:M07206_1,Factor: E2F-1; motif: NGGGCGGGARV; match class: 1,1.634336502889359e-06,True,Factor: E2F-1; motif: NGGGCGGGARV; match class: 1,11184,826,546,20045,0.6610169491525424,0.04881974248927039,Module 0,['TF:M07206']
1922,REAC,REAC:R-HSA-2467813,Separation of Sister Chromatids,1.6587506467835074e-06,True,Separation of Sister Chromatids,188,59,11,10842,0.1864406779661017,0.05851063829787234,Module 5,['REAC:R-HSA-68882']
1923,HP,HP:0001138,Optic neuropathy,1.6631949153338863e-06,True,Optic neuropathy,61,228,17,4958,0.07456140350877193,0.2786885245901639,Module 0,['HP:0000587']
1924,GO:BP,GO:0019646,aerobic electron transport chain,1.6752760321291219e-06,True,"""A process in which a series of electron carriers operate together to transfer electrons from donors such as NADH and FADH2 to oxygen to generate a transmembrane electrochemical gradient."" [GOC:ai, GOC:mtg_electron_transport]",92,105,9,21031,0.08571428571428572,0.09782608695652174,Module 3,"['GO:0006119', 'GO:0009060', 'GO:0022904']"
1925,HP,HP:0410243,Abnormal circulating IgM level,1.6779820088179185e-06,True,An abnormal deviation from normal levels of IgM immunoglobulin in blood.,101,71,13,4958,0.18309859154929578,0.12871287128712872,Module 1,['HP:0010701']
1926,TF,TF:M04008_1,Factor: HSF1; motif: TTCTAGAAYNTTC; match class: 1,1.7016238111588244e-06,True,Factor: HSF1; motif: TTCTAGAAYNTTC; match class: 1,14,21,4,20045,0.19047619047619047,0.2857142857142857,Module 9,['TF:M04008']
1927,TF,TF:M11659_1,Factor: HSF4; motif: NGAANRTTCTAGAAN; match class: 1,1.7016238111588244e-06,True,Factor: HSF4; motif: NGAANRTTCTAGAAN; match class: 1,14,21,4,20045,0.19047619047619047,0.2857142857142857,Module 9,['TF:M11659']
1928,GO:BP,GO:0050821,protein stabilization,1.7026493535923208e-06,True,"""Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation."" [GOC:ai]",215,21,7,21031,0.3333333333333333,0.03255813953488372,Module 9,['GO:0031647']
1929,GO:CC,GO:0044194,cytolytic granule,1.7065372516814325e-06,True,"""A specialized secretory lysosome that is present in cells with cytolytic capability such as cytotoxic T lymphocytes and natural killer cells. Cytolytic granules mediate the storage and regulated excretion of lytic molecules for killing of target cells."" [GOC:jl, PMID:11052265, PMID:12766758]",14,238,6,22097,0.025210084033613446,0.42857142857142855,Module 1,['GO:0005764']
1930,HPA,HPA:0471412,skin 2; cells in spinous layer[≥Medium],1.723123640390457e-06,True,skin 2; cells in spinous layer[≥Medium],683,140,29,11019,0.20714285714285716,0.0424597364568082,Module Singleton,['HPA:0471411']
1931,HPA,HPA:0540053,stomach 1; glandular cells[High],1.7265420506514467e-06,True,stomach 1; glandular cells[High],2453,79,41,11019,0.5189873417721519,0.016714227476559314,Module 3,['HPA:0540052']
1932,GO:MF,GO:0048027,mRNA 5'-UTR binding,1.7379381631141368e-06,True,"""Binding to an mRNA molecule at its 5' untranslated region."" [GOC:jid]",25,105,6,20212,0.05714285714285714,0.24,Module 3,['GO:0003729']
1933,GO:BP,GO:0042110,T cell activation,1.7474387069796946e-06,True,"""The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific."" [GOC:mgi_curators, ISBN:0781735149]",555,15,8,21031,0.5333333333333333,0.014414414414414415,Module 6,['GO:0046649']
1934,GO:BP,GO:0034097,response to cytokine,1.7560727039681546e-06,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus."" [GOC:sl]",932,34,13,21031,0.38235294117647056,0.013948497854077254,Module 7,['GO:0010033']
1935,GO:BP,GO:0050670,regulation of lymphocyte proliferation,1.7629931596627238e-06,True,"""Any process that modulates the frequency, rate or extent of lymphocyte proliferation."" [GOC:ai]",237,226,17,21031,0.0752212389380531,0.07172995780590717,Module 1,"['GO:0032944', 'GO:0046651', 'GO:0051249']"
1936,GO:BP,GO:0002683,negative regulation of immune system process,1.7634103699312004e-06,True,"""Any process that stops, prevents, or reduces the frequency, rate, or extent of an immune system process."" [GOC:add]",495,226,24,21031,0.10619469026548672,0.048484848484848485,Module 1,"['GO:0002376', 'GO:0002682', 'GO:0048519']"
1937,GO:MF,GO:0019899,enzyme binding,1.802135460491132e-06,True,"""Binding to an enzyme, a protein with catalytic activity."" [GOC:jl]",2103,20,13,20212,0.65,0.006181645268663814,Module 9,['GO:0005515']
1938,REAC,REAC:R-HSA-5619084,ABC transporter disorders,1.8119099442081383e-06,True,ABC transporter disorders,78,586,20,10842,0.034129692832764506,0.2564102564102564,Module 0,['REAC:R-HSA-5619115']
1939,GO:BP,GO:0007275,multicellular organism development,1.8338023189026854e-06,True,"""The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult)."" [GOC:dph, GOC:ems, GOC:isa_complete, GOC:tb]",4643,215,87,21031,0.4046511627906977,0.01873788498815421,Module 2,"['GO:0032501', 'GO:0048856']"
1940,GO:CC,GO:0045259,proton-transporting ATP synthase complex,1.8342218966691918e-06,True,"""A proton-transporting two-sector ATPase complex that catalyzes the phosphorylation of ADP to ATP during oxidative phosphorylation. The complex comprises a membrane sector (F0) that carries out proton transport and a cytoplasmic compartment sector (F1) that catalyzes ATP synthesis by a rotational mechanism; the extramembrane sector (containing 3 a and 3 b subunits) is connected via the d-subunit to the membrane sector by several smaller subunits. Within this complex, the g and e subunits and the 9-12 c subunits rotate by consecutive 120 degree angles and perform parts of ATP synthesis. This movement is driven by the hydrogen ion electrochemical potential gradient."" [ISBN:0198547684, ISBN:0716743663]",24,813,10,22097,0.012300123001230012,0.4166666666666667,Module 0,['GO:0016469']
1941,GO:CC,GO:0031982,vesicle,1.8496352483181399e-06,True,"""Any small, fluid-filled, spherical organelle enclosed by membrane."" [GOC:mah, GOC:pz, GOC:vesicles]",4004,21,16,22097,0.7619047619047619,0.003996003996003996,Module 9,['GO:0043227']
1942,GO:CC,GO:0042582,azurophil granule,1.859075391164126e-06,True,"""Primary lysosomal granule found in neutrophil granulocytes. Contains a wide range of hydrolytic enzymes and is released into the extracellular fluid."" [GOC:jl, PMID:17152095]",154,221,13,22097,0.058823529411764705,0.08441558441558442,Module 2,"['GO:0005766', 'GO:0030141']"
1943,GO:CC,GO:0005766,primary lysosome,1.859075391164126e-06,True,"""A lysosome before it has fused with a vesicle or vacuole."" [GOC:jl, ISBN:0815316194]",154,221,13,22097,0.058823529411764705,0.08441558441558442,Module 2,['GO:0005764']
1944,HP,HP:0012747,Abnormal brainstem MRI signal intensity,1.8859706665652695e-06,True,A deviation from normal signal on magnetic resonance imaging (MRI) of the brainstem.,40,228,14,4958,0.06140350877192982,0.35,Module 0,['HP:0002363']
1945,GO:BP,GO:1903311,regulation of mRNA metabolic process,1.8908505257509826e-06,True,"""Any process that modulates the frequency, rate or extent of mRNA metabolic process."" [GO_REF:0000058, GOC:TermGenie, GOC:vw]",302,787,36,21031,0.045743329097839895,0.11920529801324503,Module 0,"['GO:0016071', 'GO:0051252']"
1946,GO:CC,GO:0098796,membrane protein complex,1.8956069535096835e-06,True,"""Any protein complex that is part of a membrane."" [GOC:dos]",1401,17,10,22097,0.5882352941176471,0.007137758743754461,Module 6,"['GO:0016020', 'GO:0032991']"
1947,GO:BP,GO:0002694,regulation of leukocyte activation,1.9019942120984347e-06,True,"""Any process that modulates the frequency, rate, or extent of leukocyte activation."" [GOC:add]",561,15,8,21031,0.5333333333333333,0.0142602495543672,Module 6,"['GO:0002682', 'GO:0045321', 'GO:0050865']"
1948,HPA,HPA:0470181,skin 2; cells in granular layer[≥Low],1.972402390742519e-06,True,skin 2; cells in granular layer[≥Low],719,69,20,11019,0.2898550724637681,0.027816411682892908,Module 5,['HPA:0470000']
1949,GO:CC,GO:0031410,cytoplasmic vesicle,1.983669116150415e-06,True,"""A vesicle found in the cytoplasm of a cell."" [GOC:ai, GOC:mah, GOC:vesicles]",2513,238,59,22097,0.24789915966386555,0.02347791484281735,Module 1,"['GO:0005737', 'GO:0097708']"
1950,HPA,HPA:0131333,colon; mucosal lymphoid cells[High],1.984261961480841e-06,True,colon; mucosal lymphoid cells[High],155,612,29,11019,0.04738562091503268,0.1870967741935484,Module 0,['HPA:0131332']
1951,HPA,HPA:0471472,skin 2; lymphocytes[≥Medium],1.996249479151011e-06,True,skin 2; lymphocytes[≥Medium],647,166,31,11019,0.18674698795180722,0.04791344667697063,Module 2,['HPA:0471471']
1952,GO:BP,GO:0044238,primary metabolic process,1.9970534173267644e-06,True,"""The chemical reactions and pathways involving those compounds which are formed as a part of the normal anabolic and catabolic processes. These processes take place in most, if not all, cells of the organism."" [GOC:go_curators, http://www.metacyc.org]",12505,105,91,21031,0.8666666666666667,0.007277089164334266,Module 3,['GO:0008152']
1953,GO:CC,GO:0070062,extracellular exosome,2.0138624613408312e-06,True,"""A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm."" [GOC:BHF, GOC:mah, GOC:vesicles, PMID:15908444, PMID:17641064, PMID:19442504, PMID:19498381, PMID:22418571, PMID:24009894]",2109,73,25,22097,0.3424657534246575,0.011853959222380275,Module 4,"['GO:0005615', 'GO:1903561']"
1954,GO:CC,GO:0030659,cytoplasmic vesicle membrane,2.0343847688130794e-06,True,"""The lipid bilayer surrounding a cytoplasmic vesicle."" [GOC:mah]",1226,221,36,22097,0.16289592760180996,0.02936378466557912,Module 2,"['GO:0012506', 'GO:0031410']"
1955,TF,TF:M11406,Factor: Pet-1; motif: NACCGGAAGTN,2.0534706852259115e-06,True,Factor: Pet-1; motif: NACCGGAAGTN,1325,826,102,20045,0.1234866828087167,0.07698113207547169,Module 0,['TF:M00000']
1956,REAC,REAC:R-HSA-68949,Orc1 removal from chromatin,2.0619930591674836e-06,True,Orc1 removal from chromatin,71,586,19,10842,0.032423208191126277,0.2676056338028169,Module 0,['REAC:R-HSA-69052']
1957,HPA,HPA:0170051,endometrium 2; glandular cells[≥Low],2.06445023694248e-06,True,endometrium 2; glandular cells[≥Low],6723,79,71,11019,0.8987341772151899,0.01056076156477763,Module 3,['HPA:0170000']
1958,TF,TF:M01167,Factor: SAP-1a; motif: NACCGGAAGTV,2.064710059370246e-06,True,Factor: SAP-1a; motif: NACCGGAAGTV,2014,826,139,20045,0.1682808716707022,0.06901688182720954,Module 0,['TF:M00000']
1959,TF,TF:M08226,Factor: Elk-1:Pax-9; motif: ACCGGAACYACGCWYSANTG,2.0652293150380503e-06,True,Factor: Elk-1:Pax-9; motif: ACCGGAACYACGCWYSANTG,12295,826,589,20045,0.7130750605326877,0.04790565270435136,Module 0,['TF:M00000']
1960,TF,TF:M08874,Factor: E2F1; motif: NNNNNGCGSSAAAN,2.080621844868e-06,True,Factor: E2F1; motif: NNNNNGCGSSAAAN,7418,826,390,20045,0.4721549636803874,0.05257481801024535,Module 0,['TF:M00000']
1961,HP,HP:0001945,Fever,2.0829002145777643e-06,True,Body temperature elevated above the normal range.,421,71,24,4958,0.3380281690140845,0.057007125890736345,Module 1,['HP:0004370']
1962,GO:CC,GO:0000228,nuclear chromosome,2.117894917801095e-06,True,"""A chromosome that encodes the nuclear genome and is found in the nucleus of a eukaryotic cell during the cell cycle phases when the nucleus is intact."" [GOC:dph, GOC:mah]",222,80,10,22097,0.125,0.04504504504504504,Module 5,"['GO:0005694', 'GO:0031981']"
1963,GO:CC,GO:0097708,intracellular vesicle,2.1361736085419596e-06,True,"""Any vesicle that is part of the intracellular region."" [GOC:vesicles]",2518,238,59,22097,0.24789915966386555,0.023431294678316124,Module 1,"['GO:0031982', 'GO:0043231']"
1964,HPA,HPA:0131332,colon; mucosal lymphoid cells[≥Medium],2.1371399544210623e-06,True,colon; mucosal lymphoid cells[≥Medium],365,612,49,11019,0.08006535947712418,0.13424657534246576,Module 0,['HPA:0131331']
1965,HPA,HPA:0471411,skin 2; cells in spinous layer[≥Low],2.1753303544379084e-06,True,skin 2; cells in spinous layer[≥Low],871,140,33,11019,0.2357142857142857,0.03788748564867968,Module Singleton,['HPA:0470000']
1966,GO:BP,GO:0010243,response to organonitrogen compound,2.185057437367061e-06,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organonitrogen stimulus. An organonitrogen compound is formally a compound containing at least one carbon-nitrogen bond."" [PMID:9869419]",964,215,33,21031,0.15348837209302327,0.03423236514522822,Module 2,"['GO:0010033', 'GO:1901698']"
1967,HP,HP:0001743,Abnormality of the spleen,2.1875732549311677e-06,True,An abnormality of the spleen.,619,71,29,4958,0.4084507042253521,0.046849757673667204,Module 1,"['HP:0002012', 'HP:0100763']"
1968,REAC,REAC:R-HSA-4608870,Asymmetric localization of PCP proteins,2.2236339122398373e-06,True,Asymmetric localization of PCP proteins,64,586,18,10842,0.030716723549488054,0.28125,Module 0,['REAC:R-HSA-4086400']
1969,HPA,HPA:0630000,cervix,2.2303217624885885e-06,True,cervix,6930,79,72,11019,0.9113924050632911,0.01038961038961039,Module 3,['HPA:0000000']
1970,GO:BP,GO:0030097,hemopoiesis,2.2427251798867453e-06,True,"""The process whose specific outcome is the progression of the myeloid and lymphoid derived organ/tissue systems of the blood and other parts of the body over time, from formation to the mature structure. The site of hemopoiesis is variable during development, but occurs primarily in bone marrow or kidney in many adult vertebrates."" [GOC:dgh, ISBN:0198506732]",965,215,33,21031,0.15348837209302327,0.03419689119170984,Module 2,['GO:0048468']
1971,HP,HP:0000816,Abnormality of Krebs cycle metabolism,2.248164079078387e-06,True,An abnormality of the tricarboxylic acid cycle.,15,44,6,4958,0.13636363636363635,0.4,Module 3,['HP:0012379']
1972,HP,HP:0003572,Low plasma citrulline,2.248164079078387e-06,True,A decreased concentration of citrulline in the blood.,15,44,6,4958,0.13636363636363635,0.4,Module 3,['HP:0011965']
1973,HPA,HPA:0050012,breast; adipocytes[≥Medium],2.256920287753294e-06,True,breast; adipocytes[≥Medium],1491,612,133,11019,0.2173202614379085,0.0892018779342723,Module 0,['HPA:0050011']
1974,GO:BP,GO:0032944,regulation of mononuclear cell proliferation,2.278856381300275e-06,True,"""Any process that modulates the frequency, rate or extent of mononuclear cell proliferation."" [GOC:add]",241,226,17,21031,0.0752212389380531,0.07053941908713693,Module 1,"['GO:0032943', 'GO:0070663']"
1975,TF,TF:M11657_1,Factor: HSF1; motif: NGAANRTTCKAGAAN; match class: 1,2.3188212561155956e-06,True,Factor: HSF1; motif: NGAANRTTCKAGAAN; match class: 1,15,21,4,20045,0.19047619047619047,0.26666666666666666,Module 9,['TF:M11657']
1976,HPA,HPA:0530712,spleen; cells in red pulp[≥Medium],2.3567496566904068e-06,True,spleen; cells in red pulp[≥Medium],3143,166,82,11019,0.4939759036144578,0.026089723194400255,Module 2,['HPA:0530711']
1977,GO:BP,GO:0019079,viral genome replication,2.365772284963294e-06,True,"""Any process involved directly in viral genome replication, including viral nucleotide metabolism."" [ISBN:0781702534]",128,34,7,21031,0.20588235294117646,0.0546875,Module 7,"['GO:0016032', 'GO:0019058']"
1978,GO:BP,GO:0006959,humoral immune response,2.3662969289264728e-06,True,"""An immune response mediated through a body fluid."" [GOC:hb, ISBN:0198506732]",254,215,17,21031,0.07906976744186046,0.06692913385826772,Module 2,['GO:0006955']
1979,CORUM,CORUM:2914,Respiratory chain complex I (beta subunit) mitochondrial,2.459150782898557e-06,True,Respiratory chain complex I (beta subunit) mitochondrial,16,331,11,3383,0.03323262839879154,0.6875,Module 0,['CORUM:0000000']
1980,HPA,HPA:0440342,skeletal muscle; myocytes[≥Medium],2.484729273314719e-06,True,skeletal muscle; myocytes[≥Medium],3794,612,277,11019,0.4526143790849673,0.07301001581444386,Module 0,['HPA:0440341']
1981,HPA,HPA:0350473,pancreas; exocrine glandular cells[High],2.509618414080732e-06,True,pancreas; exocrine glandular cells[High],1960,612,164,11019,0.2679738562091503,0.0836734693877551,Module 0,['HPA:0350472']
1982,GO:BP,GO:0002483,antigen processing and presentation of endogenous peptide antigen,2.5215246881696193e-06,True,"""The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger endogenous protein which has been degraded within the cell."" [GOC:add, ISBN:0781735149]",24,15,4,21031,0.26666666666666666,0.16666666666666666,Module 6,"['GO:0019883', 'GO:0048002']"
1983,GO:CC,GO:1903561,extracellular vesicle,2.533928561359191e-06,True,"""Any vesicle that is part of the extracellular region."" [GO_REF:0000064, GOC:pm, GOC:TermGenie, PMID:24769233]",2133,73,25,22097,0.3424657534246575,0.011720581340834505,Module 4,"['GO:0031982', 'GO:0065010']"
1984,GO:CC,GO:0065010,extracellular membrane-bounded organelle,2.558116478175054e-06,True,"""Organized structure of distinctive morphology and function, bounded by a lipid bilayer membrane and occurring outside the cell."" [GOC:isa_complete]",2134,73,25,22097,0.3424657534246575,0.011715089034676664,Module 4,"['GO:0043227', 'GO:0043230']"
1985,GO:CC,GO:0043230,extracellular organelle,2.558116478175054e-06,True,"""Organized structure of distinctive morphology and function, occurring outside the cell. Includes, for example, extracellular membrane vesicles (EMVs) and the cellulosomes of anaerobic bacteria and fungi."" [GOC:jl, PMID:9914479]",2134,73,25,22097,0.3424657534246575,0.011715089034676664,Module 4,"['GO:0005576', 'GO:0043226']"
1986,GO:BP,GO:0051172,negative regulation of nitrogen compound metabolic process,2.5723076590223365e-06,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving nitrogen or nitrogenous compounds."" [GOC:ai, GOC:tb]",2202,787,137,21031,0.17407878017789072,0.062216167120799276,Module 0,"['GO:0006807', 'GO:0009892', 'GO:0051171']"
1987,HP,HP:0011805,Abnormal skeletal muscle morphology,2.5735253473050023e-06,True,A structural abnormality of a skeletal muscle.,1859,44,36,4958,0.8181818181818182,0.019365250134480903,Module 3,['HP:0003011']
1988,GO:CC,GO:0043233,organelle lumen,2.58408455903093e-06,True,"""The internal volume enclosed by the membranes of a particular organelle; includes the volume enclosed by a single organelle membrane, e.g. endoplasmic reticulum lumen, or the volume enclosed by the innermost of the two lipid bilayers of an organelle envelope, e.g. nuclear lumen."" [GOC:jl, GOC:mah]",6657,105,60,22097,0.5714285714285714,0.009013068949977467,Module 3,"['GO:0031974', 'GO:0043226']"
1989,GO:CC,GO:0070013,intracellular organelle lumen,2.58408455903093e-06,True,"""An organelle lumen that is part of an intracellular organelle."" [GOC:mah]",6657,105,60,22097,0.5714285714285714,0.009013068949977467,Module 3,"['GO:0043229', 'GO:0043233']"
1990,GO:CC,GO:0031974,membrane-enclosed lumen,2.58408455903093e-06,True,"""The enclosed volume within a sealed membrane or between two sealed membranes. Encompasses the volume enclosed by the membranes of a particular organelle, e.g. endoplasmic reticulum lumen, or the space between the two lipid bilayers of a double membrane surrounding an organelle, e.g. nuclear envelope lumen."" [GOC:add, GOC:mah]",6657,105,60,22097,0.5714285714285714,0.009013068949977467,Module 3,['GO:0110165']
1991,GO:BP,GO:0019637,organophosphate metabolic process,2.598388673665497e-06,True,"""The chemical reactions and pathways involving organophosphates, any phosphate-containing organic compound."" [ISBN:0198506732]",1034,787,79,21031,0.10038119440914867,0.07640232108317214,Module 0,"['GO:0006793', 'GO:0071704']"
1992,GO:CC,GO:0101002,ficolin-1-rich granule,2.6268842233941857e-06,True,"""Highly exocytosable gelatinase-poor granules found in neutrophils and rich in ficolin-1. Ficolin-1 is released from neutrophil granules by stimulation with fMLP or PMA, and the majority becomes associated with the surface membrane of the cells and can be detected by flow cytometry."" [GOC:mec, PMID:19741154]",184,21,6,22097,0.2857142857142857,0.03260869565217391,Module 9,['GO:0030141']
1993,TF,TF:M10849,Factor: Cdx-2; motif: NRTCGTAANNNN,2.6698663642132524e-06,True,Factor: Cdx-2; motif: NRTCGTAANNNN,11312,826,550,20045,0.6658595641646489,0.04862093352192362,Module 0,['TF:M00000']
1994,HPA,HPA:0570731,testis; Leydig cells[≥Low],2.6754666910282194e-06,True,testis; Leydig cells[≥Low],7157,79,73,11019,0.9240506329113924,0.01019980438731312,Module 3,['HPA:0570000']
1995,HPA,HPA:0100000,cerebral cortex,2.6901816996437674e-06,True,cerebral cortex,8106,79,77,11019,0.9746835443037974,0.009499136442141624,Module 3,['HPA:0000000']
1996,GO:MF,GO:0060090,molecular adaptor activity,2.7648504072721324e-06,True,"""The binding activity of a molecule that brings together two or more molecules through a selective, non-covalent, often stoichiometric interaction, permitting those molecules to function in a coordinated way."" [GOC:mtg_MIT_16mar07, GOC:vw]",1136,808,87,20212,0.10767326732673267,0.07658450704225352,Module 0,['GO:0003674']
1997,HP,HP:0001438,Abnormal abdomen morphology,2.7843359086156434e-06,True,"A structural abnormality of the abdomen ('belly'), that is, the part of the body between the pelvis and the thorax.",804,71,33,4958,0.4647887323943662,0.041044776119402986,Module 1,['HP:0025031']
1998,GO:BP,GO:0016043,cellular component organization,2.785420272034395e-06,True,"""A process that results in the assembly, arrangement of constituent parts, or disassembly of a cellular component."" [GOC:ai, GOC:jl, GOC:mah]",8151,77,56,21031,0.7272727272727273,0.006870322659796344,Module 5,['GO:0071840']
1999,GO:BP,GO:0019058,viral life cycle,2.821273190170318e-06,True,"""A set of processes which all viruses follow to ensure survival; includes attachment and entry of the virus particle, decoding of genome information, translation of viral mRNA by host ribosomes, genome replication, and assembly and release of viral particles containing the genome."" [ISBN:1555811272]",320,34,9,21031,0.2647058823529412,0.028125,Module 7,['GO:0016032']
2000,GO:BP,GO:0070727,cellular macromolecule localization,2.8235264205560096e-06,True,"""Any process in which a macromolecule is transported to, and/or maintained in, a specific location at the level of a cell. Localization at the cellular level encompasses movement within the cell, from within the cell to the cell surface, or from one location to another at the surface of a cell."" [GOC:mah]",2742,72,30,21031,0.4166666666666667,0.010940919037199124,Module 4,"['GO:0033036', 'GO:0051641']"
2001,GO:BP,GO:0001819,positive regulation of cytokine production,2.8352167034803957e-06,True,"""Any process that activates or increases the frequency, rate or extent of production of a cytokine."" [GOC:add, ISBN:0781735149]",490,215,23,21031,0.10697674418604651,0.04693877551020408,Module 2,"['GO:0001816', 'GO:0001817', 'GO:0010628', 'GO:0051240']"
2002,HP,HP:0007763,Retinal telangiectasia,2.8485758982486585e-06,True,Dilatation of small blood vessels of the retina.,27,44,7,4958,0.1590909090909091,0.25925925925925924,Module 3,"['HP:0001009', 'HP:0008046']"
2003,TF,TF:M03976,Factor: ERG; motif: ACCGGAWATCCGGT,2.8957476220990603e-06,True,Factor: ERG; motif: ACCGGAWATCCGGT,13044,826,617,20045,0.7469733656174334,0.0473014412756823,Module 0,['TF:M00000']
2004,GO:BP,GO:0030154,cell differentiation,2.9124590692560137e-06,True,"""The cellular developmental process in which a relatively unspecialized cell, e.g. embryonic or regenerative cell, acquires specialized structural and/or functional features that characterize a specific cell. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state."" [ISBN:0198506732]",4366,215,83,21031,0.386046511627907,0.0190105359596885,Module 2,['GO:0048869']
2005,GO:BP,GO:0048869,cellular developmental process,2.945940600572026e-06,True,"""A biological process whose specific outcome is the progression of a cell over time from an initial condition to a later condition."" [GOC:isa_complete]",4367,215,83,21031,0.386046511627907,0.01900618273414243,Module 2,"['GO:0009987', 'GO:0032502']"
2006,HPA,HPA:0130202,colon; endothelial cells[≥Medium],2.9529312365726467e-06,True,colon; endothelial cells[≥Medium],3715,612,272,11019,0.4444444444444444,0.07321668909825034,Module 0,['HPA:0130201']
2007,GO:CC,GO:0022624,proteasome accessory complex,2.95635566733159e-06,True,"""A protein complex, that caps one or both ends of the proteasome core complex and regulates entry into, or exit from, the proteasome core complex."" [GOC:mtg_sensu]",25,813,10,22097,0.012300123001230012,0.4,Module 0,"['GO:0000502', 'GO:0005622', 'GO:0032991']"
2008,GO:BP,GO:0009966,regulation of signal transduction,2.98985386442821e-06,True,"""Any process that modulates the frequency, rate or extent of signal transduction."" [GOC:sm]",3010,215,65,21031,0.3023255813953488,0.02159468438538206,Module 2,"['GO:0007165', 'GO:0010646', 'GO:0023051', 'GO:0048583']"
2009,HPA,HPA:0530722,spleen; cells in white pulp[≥Medium],3.058644394819265e-06,True,spleen; cells in white pulp[≥Medium],2720,79,43,11019,0.5443037974683544,0.015808823529411764,Module 3,['HPA:0530721']
2010,GO:CC,GO:0043227,membrane-bounded organelle,3.162754249378274e-06,True,"""Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane."" [GOC:go_curators]",15671,177,157,22097,0.8870056497175142,0.010018505519749856,Module Singleton,['GO:0043226']
2011,GO:BP,GO:0022613,ribonucleoprotein complex biogenesis,3.1662001246067613e-06,True,"""A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a complex containing RNA and proteins. Includes the biosynthesis of the constituent RNA and protein molecules, and those macromolecular modifications that are involved in synthesis or assembly of the ribonucleoprotein complex."" [GOC:isa_complete, GOC:mah]",1892,105,31,21031,0.29523809523809524,0.01638477801268499,Module 3,['GO:0044085']
2012,HPA,HPA:0460183,skin 1; cells in granular layer[High],3.170581270291159e-06,True,skin 1; cells in granular layer[High],248,612,38,11019,0.06209150326797386,0.1532258064516129,Module 0,['HPA:0460182']
2013,HP,HP:0009815,Aplasia/hypoplasia of the extremities,3.2228165383575846e-06,True,Absence (due to failure to form) or underdevelopment of the extremities.,703,44,23,4958,0.5227272727272727,0.032716927453769556,Module 3,"['HP:0009115', 'HP:0040064']"
2014,GO:BP,GO:0043067,regulation of programmed cell death,3.253907101669025e-06,True,"""Any process that modulates the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes."" [GOC:jl]",1506,787,103,21031,0.13087674714104194,0.06839309428950863,Module 0,"['GO:0012501', 'GO:0050794']"
2015,HPA,HPA:0530713,spleen; cells in red pulp[High],3.2978182568569366e-06,True,spleen; cells in red pulp[High],817,166,35,11019,0.21084337349397592,0.042839657282741736,Module 2,['HPA:0530712']
2016,HP,HP:0025354,Abnormal cellular phenotype,3.3891118403282956e-06,True,An anomaly of cellular morphology or physiology.,635,228,62,4958,0.2719298245614035,0.09763779527559055,Module 0,['HP:0000118']
2017,HPA,HPA:0380201,placenta; endothelial cells[≥Low],3.40077600068271e-06,True,placenta; endothelial cells[≥Low],405,612,52,11019,0.08496732026143791,0.12839506172839507,Module 0,['HPA:0380000']
2018,GO:CC,GO:0031012,extracellular matrix,3.4030360521873004e-06,True,"""A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues."" [GOC:BHF, GOC:mah, GOC:rph, NIF_Subcellular:nlx_subcell_20090513, PMID:21123617, PMID:28089324]",555,221,23,22097,0.10407239819004525,0.04144144144144144,Module 2,['GO:0030312']
2019,HPA,HPA:0050000,breast,3.4169972671770604e-06,True,breast,7185,79,73,11019,0.9240506329113924,0.010160055671537925,Module 3,['HPA:0000000']
2020,REAC,REAC:R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,3.4204207344291907e-06,True,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,73,586,19,10842,0.032423208191126277,0.2602739726027397,Module 0,['REAC:R-HSA-179419']
2021,REAC,REAC:R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,3.4204207344291907e-06,True,CDK-mediated phosphorylation and removal of Cdc6,73,586,19,10842,0.032423208191126277,0.2602739726027397,Module 0,['REAC:R-HSA-69052']
2022,GO:BP,GO:1901564,organonitrogen compound metabolic process,3.45068539293415e-06,True,"""The chemical reactions and pathways involving organonitrogen compound."" [GOC:pr, GOC:TermGenie]",5986,72,45,21031,0.625,0.007517540928833946,Module 4,"['GO:0006807', 'GO:0071704']"
2023,HPA,HPA:0471473,skin 2; lymphocytes[High],3.476235487750601e-06,True,skin 2; lymphocytes[High],456,140,23,11019,0.16428571428571428,0.05043859649122807,Module Singleton,['HPA:0471472']
2024,HP,HP:0002841,Recurrent fungal infections,3.484926774233291e-06,True,"Increased susceptibility to fungal infections, as manifested by multiple episodes of fungal infection.",107,71,13,4958,0.18309859154929578,0.12149532710280374,Module 1,"['HP:0002719', 'HP:0020100']"
2025,TF,TF:M00025_1,Factor: Elk-1; motif: NNNNCCGGAARTNN; match class: 1,3.5112694769211254e-06,True,Factor: Elk-1; motif: NNNNCCGGAARTNN; match class: 1,4534,105,52,20045,0.49523809523809526,0.011468901632112925,Module 3,['TF:M00025']
2026,GO:MF,GO:0051015,actin filament binding,3.514249032891343e-06,True,"""Binding to an actin filament, also known as F-actin, a helical filamentous polymer of globular G-actin subunits."" [ISBN:0198506732]",208,808,29,20212,0.03589108910891089,0.13942307692307693,Module 0,"['GO:0003779', 'GO:0044877']"
2027,GO:CC,GO:0030312,external encapsulating structure,3.5189615829692804e-06,True,"""A structure that lies outside the plasma membrane and surrounds the entire cell or cells. This does not include the periplasmic space."" [GOC:go_curators]",556,221,23,22097,0.10407239819004525,0.04136690647482014,Module 2,"['GO:0071944', 'GO:0110165']"
2028,HPA,HPA:0330222,oral mucosa; squamous epithelial cells[≥Medium],3.529674622258884e-06,True,oral mucosa; squamous epithelial cells[≥Medium],4358,79,56,11019,0.7088607594936709,0.012849931161083065,Module 3,['HPA:0330221']
2029,HP,HP:0004325,Decreased body weight,3.5467222994363795e-06,True,Abnormally low body weight.,1548,44,33,4958,0.75,0.02131782945736434,Module 3,['HP:0004323']
2030,GO:BP,GO:0042775,mitochondrial ATP synthesis coupled electron transport,3.5493054977449837e-06,True,"""The transfer of electrons through a series of electron donors and acceptors, generating energy that is ultimately used for synthesis of ATP, as it occurs in the mitochondrial inner membrane or chloroplast thylakoid membrane."" [GOC:mtg_sensu, ISBN:0716731363]",100,105,9,21031,0.08571428571428572,0.09,Module 3,['GO:0042773']
2031,GO:BP,GO:0042773,ATP synthesis coupled electron transport,3.5493054977449837e-06,True,"""The transfer of electrons through a series of electron donors and acceptors, generating energy that is ultimately used for synthesis of ATP."" [ISBN:0716731363]",100,105,9,21031,0.08571428571428572,0.09,Module 3,"['GO:0006119', 'GO:0022904']"
2032,HPA,HPA:0430052,seminal vesicle; glandular cells[≥Medium],3.5960437766716047e-06,True,seminal vesicle; glandular cells[≥Medium],5238,79,62,11019,0.7848101265822784,0.011836578846888126,Module 3,['HPA:0430051']
2033,TF,TF:M11396,Factor: Erg; motif: NACCGGAARTN,3.6555022060682714e-06,True,Factor: Erg; motif: NACCGGAARTN,11019,105,87,20045,0.8285714285714286,0.007895453307922679,Module 3,['TF:M00000']
2034,TF,TF:M00516,Factor: E2F-1; motif: TTTSGCGCGMNR,3.6852830196822194e-06,True,Factor: E2F-1; motif: TTTSGCGCGMNR,7115,80,55,20045,0.6875,0.007730147575544624,Module 5,['TF:M00000']
2035,REAC,REAC:R-HSA-9013694,Signaling by NOTCH4,3.6866880317450524e-06,True,Signaling by NOTCH4,81,586,20,10842,0.034129692832764506,0.24691358024691357,Module 0,['REAC:R-HSA-157118']
2036,GO:CC,GO:0070820,tertiary granule,3.7024765720321257e-06,True,"""A secretory granule that contains cathepsin and gelatinase and is readily exocytosed upon cell activation; found primarily in mature neutrophil cells."" [GOC:BHF, GOC:mah, GOC:rl, PMID:12070036]",163,221,13,22097,0.058823529411764705,0.07975460122699386,Module 2,['GO:0030141']
2037,HPA,HPA:0600431,tonsil; germinal center cells[≥Low],3.706670122286894e-06,True,tonsil; germinal center cells[≥Low],5987,60,53,11019,0.8833333333333333,0.008852513779856356,Module 4,['HPA:0600000']
2038,REAC,REAC:R-HSA-5687128,MAPK6/MAPK4 signaling,3.73322896483848e-06,True,MAPK6/MAPK4 signaling,89,586,21,10842,0.03583617747440273,0.23595505617977527,Module 0,['REAC:R-HSA-5683057']
2039,HPA,HPA:0320000,nasopharynx,3.760243628665451e-06,True,nasopharynx,7196,79,73,11019,0.9240506329113924,0.010144524735964425,Module 3,['HPA:0000000']
2040,GO:BP,GO:0022409,positive regulation of cell-cell adhesion,3.7699682834556814e-06,True,"""Any process that activates or increases the rate or extent of cell adhesion to another cell."" [GOC:isa_complete]",318,226,19,21031,0.084070796460177,0.059748427672955975,Module 1,"['GO:0022407', 'GO:0045785', 'GO:0098609']"
2041,HP,HP:0001045,Vitiligo,3.7732286210149875e-06,True,Vitiligo,28,44,7,4958,0.1590909090909091,0.25,Module 3,['HP:0001000']
2042,GO:BP,GO:0046907,intracellular transport,3.8084144173297698e-06,True,"""The directed movement of substances within a cell."" [GOC:ai]",1371,787,96,21031,0.12198221092757307,0.0700218818380744,Module 0,"['GO:0006810', 'GO:0051641', 'GO:0051649']"
2043,HPA,HPA:0600000,tonsil,3.8087723861706833e-06,True,tonsil,7788,69,67,11019,0.9710144927536232,0.008602978941961993,Module 5,['HPA:0000000']
2044,HP,HP:0025668,Abnormal neck morphology,3.874569469370574e-06,True,Any structural anomaly of the neck region.,643,44,22,4958,0.5,0.03421461897356143,Module 3,['HP:0000464']
2045,TF,TF:M11530,Factor: E2F-2; motif: NWTTTGGCGCCAWWNN,3.90092505382391e-06,True,Factor: E2F-2; motif: NWTTTGGCGCCAWWNN,14980,826,688,20045,0.8329297820823245,0.04592790387182911,Module 0,['TF:M00000']
2046,HPA,HPA:0500701,soft tissue 1; peripheral nerve[≥Low],3.942015393871208e-06,True,soft tissue 1; peripheral nerve[≥Low],2795,612,216,11019,0.35294117647058826,0.07728085867620751,Module 0,['HPA:0500000']
2047,GO:BP,GO:0048519,negative regulation of biological process,3.9620403055276765e-06,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule."" [GOC:jid]",5874,215,101,21031,0.4697674418604651,0.017194416070820565,Module 2,"['GO:0008150', 'GO:0050789']"
2048,GO:CC,GO:0005576,extracellular region,3.962262993095439e-06,True,"""The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite."" [GOC:go_curators]",4213,21,16,22097,0.7619047619047619,0.0037977688108236413,Module 9,['GO:0110165']
2049,TF,TF:M11397_1,Factor: Erg; motif: NACCGGATATCCGGTN; match class: 1,3.965644195132406e-06,True,Factor: Erg; motif: NACCGGATATCCGGTN; match class: 1,11996,826,576,20045,0.6973365617433414,0.0480160053351117,Module 0,['TF:M11397']
2050,GO:BP,GO:0050865,regulation of cell activation,3.970723764064027e-06,True,"""Any process that modulates the frequency, rate or extent of cell activation, the change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand."" [GOC:ai]",616,15,8,21031,0.5333333333333333,0.012987012987012988,Module 6,"['GO:0001775', 'GO:0050794', 'GO:0051239']"
2051,TF,TF:M13031_1,Factor: ETV4; motif: ACCGGAAGTN; match class: 1,3.9755489619203576e-06,True,Factor: ETV4; motif: ACCGGAAGTN; match class: 1,5008,105,55,20045,0.5238095238095238,0.010982428115015975,Module 3,['TF:M13031']
2052,HPA,HPA:0471392,skin 2; cells in basal layer[≥Medium],4.015765748062667e-06,True,skin 2; cells in basal layer[≥Medium],754,140,30,11019,0.21428571428571427,0.03978779840848806,Module Singleton,['HPA:0471391']
2053,GO:BP,GO:0035966,response to topologically incorrect protein,4.032809424103119e-06,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a protein that is not folded in its correct three-dimensional structure."" [GOC:bf]",150,72,9,21031,0.125,0.06,Module 4,"['GO:0006950', 'GO:0010033']"
2054,HP,HP:0007364,Aplasia/Hypoplasia of the cerebrum,4.034620171106851e-06,True,Aplasia/Hypoplasia of the cerebrum,1555,44,33,4958,0.75,0.02122186495176849,Module 3,"['HP:0002060', 'HP:0002977']"
2055,GO:CC,GO:0005615,extracellular space,4.041942540932642e-06,True,"""That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid."" [ISBN:0198547684]",3303,73,31,22097,0.4246575342465753,0.009385407205570693,Module 4,"['GO:0005576', 'GO:0110165']"
2056,REAC,REAC:R-HSA-9755511,KEAP1-NFE2L2 pathway,4.054853885765877e-06,True,KEAP1-NFE2L2 pathway,106,586,23,10842,0.03924914675767918,0.2169811320754717,Module 0,['REAC:R-HSA-9711123']
2057,HPA,HPA:0340451,ovary; follicle cells[≥Low],4.106190746524632e-06,True,ovary; follicle cells[≥Low],3306,612,247,11019,0.4035947712418301,0.07471264367816093,Module 0,['HPA:0340000']
2058,TF,TF:M03972,Factor: ELK3; motif: ACCGGAAGTN,4.238337411324123e-06,True,Factor: ELK3; motif: ACCGGAAGTN,1235,826,96,20045,0.1162227602905569,0.07773279352226721,Module 0,['TF:M00000']
2059,HPA,HPA:0460181,skin 1; cells in granular layer[≥Low],4.239443083310836e-06,True,skin 1; cells in granular layer[≥Low],711,140,29,11019,0.20714285714285716,0.040787623066104076,Module Singleton,['HPA:0460000']
2060,TF,TF:M02090,Factor: E2F-4; motif: GCGGGAAANA,4.255231695255827e-06,True,Factor: E2F-4; motif: GCGGGAAANA,12283,826,587,20045,0.7106537530266344,0.04778962794105675,Module 0,['TF:M00000']
2061,GO:CC,GO:0070069,cytochrome complex,4.262177972204324e-06,True,"""A protein complex in which at least one of the proteins is a cytochrome, i.e. a heme-containing protein involved in catalysis of redox reactions."" [GOC:mah]",40,813,12,22097,0.014760147601476014,0.3,Module 0,['GO:1902494']
2062,GO:BP,GO:0065009,regulation of molecular function,4.26885055101702e-06,True,"""Any process that modulates the frequency, rate or extent of a molecular function, an elemental biological activity occurring at the molecular level, such as catalysis or binding."" [GOC:isa_complete]",1799,787,117,21031,0.14866581956797967,0.06503613118399111,Module 0,['GO:0065007']
2063,GO:BP,GO:0030888,regulation of B cell proliferation,4.372048584408888e-06,True,"""Any process that modulates the frequency, rate or extent of B cell proliferation."" [GOC:mah]",66,226,10,21031,0.04424778761061947,0.15151515151515152,Module 1,"['GO:0042100', 'GO:0050670', 'GO:0050864']"
2064,REAC,REAC:R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,4.373757737572123e-06,True,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,74,586,19,10842,0.032423208191126277,0.25675675675675674,Module 0,['REAC:R-HSA-176409']
2065,REAC,REAC:R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,4.373757737572123e-06,True,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,74,586,19,10842,0.032423208191126277,0.25675675675675674,Module 0,['REAC:R-HSA-174143']
2066,GO:CC,GO:0005802,trans-Golgi network,4.400698903426529e-06,True,"""The network of interconnected tubular and cisternal structures located within the Golgi apparatus on the side distal to the endoplasmic reticulum, from which secretory vesicles emerge. The trans-Golgi network is important in the later stages of protein secretion where it is thought to play a key role in the sorting and targeting of secreted proteins to the correct destination."" [GOC:vw, ISBN:0815316194]",264,17,6,22097,0.35294117647058826,0.022727272727272728,Module 6,['GO:0098791']
2067,REAC,REAC:R-HSA-202424,Downstream TCR signaling,4.412276216976388e-06,True,Downstream TCR signaling,98,586,22,10842,0.03754266211604096,0.22448979591836735,Module 0,['REAC:R-HSA-202403']
2068,GO:BP,GO:0045785,positive regulation of cell adhesion,4.498810775000993e-06,True,"""Any process that activates or increases the frequency, rate or extent of cell adhesion."" [GOC:go_curators]",477,226,23,21031,0.10176991150442478,0.04821802935010482,Module 1,"['GO:0007155', 'GO:0030155', 'GO:0048522']"
2069,GO:BP,GO:0002831,regulation of response to biotic stimulus,4.501406405669705e-06,True,"""Any process that modulates the frequency, rate, or extent of a response to biotic stimulus."" [GOC:add]",502,215,23,21031,0.10697674418604651,0.045816733067729085,Module 2,"['GO:0009607', 'GO:0048583']"
2070,TF,TF:M11687,Factor: IRF-4; motif: NCGAAACCGAAACYN,4.5314891639537e-06,True,Factor: IRF-4; motif: NCGAAACCGAAACYN,3678,36,23,20045,0.6388888888888888,0.006253398586188146,Module 7,['TF:M00000']
2071,HPA,HPA:0090163,cerebellum; Purkinje cells[High],4.531836527750246e-06,True,cerebellum; Purkinje cells[High],1552,612,136,11019,0.2222222222222222,0.08762886597938144,Module 0,['HPA:0090162']
2072,GO:BP,GO:0071346,cellular response to type II interferon,4.547454206836822e-06,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far."" [GOC:mah]",124,5,4,21031,0.8,0.03225806451612903,Module 12,"['GO:0034341', 'GO:0071345']"
2073,GO:MF,GO:0055106,ubiquitin-protein transferase regulator activity,4.583778880709936e-06,True,"""Binds to and modulates the activity of a ubiquitin-protein transferase, an enzyme that catalyzes the covalent attachment of ubiquitin to lysine in a substrate protein."" [GOC:BHF, GOC:rl]",29,105,6,20212,0.05714285714285714,0.20689655172413793,Module 3,['GO:0030234']
2074,HPA,HPA:0530711,spleen; cells in red pulp[≥Low],4.629250943565783e-06,True,spleen; cells in red pulp[≥Low],5333,60,50,11019,0.8333333333333334,0.009375585974123383,Module 4,['HPA:0530000']
2075,TF,TF:M08982,Factor: YY1; motif: NAANATGGCGNNN,4.6491204828934254e-06,True,Factor: YY1; motif: NAANATGGCGNNN,7209,105,68,20045,0.6476190476190476,0.009432653627410182,Module 3,['TF:M00000']
2076,HPA,HPA:0471481,skin 2; sebaceous glands[≥Low],4.7176203337985415e-06,True,skin 2; sebaceous glands[≥Low],133,612,26,11019,0.042483660130718956,0.19548872180451127,Module 0,['HPA:0470000']
2077,GO:CC,GO:0043227,membrane-bounded organelle,4.718511273381569e-06,True,"""Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane."" [GOC:go_curators]",15671,221,192,22097,0.8687782805429864,0.01225193031714632,Module 2,['GO:0043226']
2078,TF,TF:M11427,Factor: PEA3; motif: NACCGGAAGTN,4.746381202157404e-06,True,Factor: PEA3; motif: NACCGGAAGTN,10834,105,86,20045,0.819047619047619,0.007937973047812442,Module 3,['TF:M00000']
2079,GO:BP,GO:0009893,positive regulation of metabolic process,4.754155180372109e-06,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism."" [GOC:go_curators]",3711,215,74,21031,0.34418604651162793,0.019940716787927783,Module 2,"['GO:0008152', 'GO:0019222', 'GO:0048518']"
2080,GO:BP,GO:0070663,regulation of leukocyte proliferation,4.7764108709583496e-06,True,"""Any process that modulates the frequency, rate or extent of leukocyte proliferation."" [GOC:add, GOC:mah]",266,215,17,21031,0.07906976744186046,0.06390977443609022,Module 2,"['GO:0042127', 'GO:0070661']"
2081,GO:MF,GO:0140545,ATP-dependent protein disaggregase activity,4.807751300295203e-06,True,"""An ATP-dependent molecular chaperone activity that mediates the solubilization of ordered protein aggregates."" [PMID:26312418]",6,20,3,20212,0.15,0.5,Module 9,"['GO:0140657', 'GO:0140776']"
2082,HPA,HPA:0461411,skin 1; cells in spinous layer[≥Low],4.811153040915515e-06,True,skin 1; cells in spinous layer[≥Low],760,140,30,11019,0.21428571428571427,0.039473684210526314,Module Singleton,['HPA:0460000']
2083,GO:CC,GO:0072562,blood microparticle,4.83903915859225e-06,True,"""A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids."" [GOC:BHF, GOC:mah, PMID:16373184]",136,73,8,22097,0.1095890410958904,0.058823529411764705,Module 4,"['GO:0005615', 'GO:0110165']"
2084,HP,HP:0030962,Abnormal morphology of the great vessels,4.919802293611289e-06,True,"A structural anomaly affecting a blood vessel involved in the circulation of the heart, i.e., the superior or inferior vena cava, the pulmonary arteries, the pulmonary veins, and the aorta.",718,44,23,4958,0.5227272727272727,0.03203342618384401,Module 3,['HP:0033353']
2085,HP,HP:0020100,Unusual fungal infection,4.934311276965797e-06,True,An unusual fungal infection that is regarded as a sign of a pathological susceptibility to infection by a fungal agent.,110,71,13,4958,0.18309859154929578,0.11818181818181818,Module 1,['HP:0032101']
2086,GO:BP,GO:0032103,positive regulation of response to external stimulus,4.945095872767943e-06,True,"""Any process that activates, maintains or increases the rate of a response to an external stimulus."" [GOC:mah]",609,226,26,21031,0.11504424778761062,0.042692939244663386,Module 1,"['GO:0009605', 'GO:0032101', 'GO:0048584']"
2087,REAC,REAC:R-HSA-1169091,Activation of NF-kappaB in B cells,4.964424058267737e-06,True,Activation of NF-kappaB in B cells,67,586,18,10842,0.030716723549488054,0.26865671641791045,Module 0,['REAC:R-HSA-1168372']
2088,HPA,HPA:0550053,stomach 2; glandular cells[High],4.996556642039458e-06,True,stomach 2; glandular cells[High],2431,79,40,11019,0.5063291139240507,0.016454134101192924,Module 3,['HPA:0550052']
2089,REAC,REAC:R-HSA-3858494,Beta-catenin independent WNT signaling,5.035782832743284e-06,True,Beta-catenin independent WNT signaling,143,586,27,10842,0.04607508532423208,0.1888111888111888,Module 0,['REAC:R-HSA-195721']
2090,GO:BP,GO:0006935,chemotaxis,5.281695018232161e-06,True,"""The directed movement of a motile cell or organism, or the directed growth of a cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis)."" [ISBN:0198506732]",463,215,22,21031,0.10232558139534884,0.047516198704103674,Module 2,"['GO:0042221', 'GO:0042330']"
2091,HPA,HPA:0570813,testis; spermatogonia cells[High],5.3061790847469535e-06,True,testis; spermatogonia cells[High],1467,612,130,11019,0.21241830065359477,0.08861622358554874,Module 0,['HPA:0570812']
2092,REAC,REAC:R-HSA-69242,S Phase,5.406732424516658e-06,True,S Phase,162,59,10,10842,0.1694915254237288,0.06172839506172839,Module 5,['REAC:R-HSA-69278']
2093,HPA,HPA:0470181,skin 2; cells in granular layer[≥Low],5.434575236833756e-06,True,skin 2; cells in granular layer[≥Low],719,140,29,11019,0.20714285714285716,0.04033379694019471,Module Singleton,['HPA:0470000']
2094,HP,HP:0025268,Stuttering,5.4861820646255375e-06,True,"Disruptions in the production of speech sounds, with involuntary repetitions of words or parts of words, prolongations of speech sounds, or complete blockage of speech production for several seconds.",17,44,6,4958,0.13636363636363635,0.35294117647058826,Module 3,['HP:0002167']
2095,HP,HP:0012429,Aplasia/Hypoplasia of the cerebral white matter,5.4861820646255375e-06,True,Absence or underdevelopment of the cerebral white matter.,17,44,6,4958,0.13636363636363635,0.35294117647058826,Module 3,['HP:0002500']
2096,HP,HP:0004885,Episodic respiratory distress,5.4861820646255375e-06,True,Episodic respiratory distress,17,44,6,4958,0.13636363636363635,0.35294117647058826,Module 3,['HP:0002098']
2097,KEGG,KEGG:04612,Antigen processing and presentation,5.495462816060674e-06,True,Antigen processing and presentation,69,15,5,8484,0.3333333333333333,0.07246376811594203,Module 9,['KEGG:00000']
2098,GO:BP,GO:2001233,regulation of apoptotic signaling pathway,5.650315424695732e-06,True,"""Any process that modulates the frequency, rate or extent of apoptotic signaling pathway."" [GOC:mtg_apoptosis]",382,215,20,21031,0.09302325581395349,0.05235602094240838,Module 2,"['GO:0009966', 'GO:0042981', 'GO:0097190']"
2099,HP,HP:0100533,Inflammatory abnormality of the eye,5.651965139378598e-06,True,"Inflammation of the eye, parts of the eye or the periorbital region.",211,71,17,4958,0.23943661971830985,0.08056872037914692,Module 1,"['HP:0012373', 'HP:0012649']"
2100,GO:BP,GO:0042330,taxis,5.716958770868278e-06,True,"""The directed movement of a motile cell or organism in response to an external stimulus."" [GOC:jl, ISBN:0192801023]",465,215,22,21031,0.10232558139534884,0.047311827956989246,Module 2,"['GO:0009605', 'GO:0040011']"
2101,TF,TF:M11392_1,Factor: Erg; motif: NACCGGAARYN; match class: 1,5.7271582053130895e-06,True,Factor: Erg; motif: NACCGGAARYN; match class: 1,3307,105,43,20045,0.4095238095238095,0.013002721499848805,Module 3,['TF:M11392']
2102,GO:CC,GO:0005683,U7 snRNP,5.73715686649936e-06,True,"""A ribonucleoprotein complex that contains the U7 snRNA and is required for the 3'-end processing of replication-dependent histone pre-mRNAs."" [PMID:12872004]",7,813,6,22097,0.007380073800738007,0.8571428571428571,Module 0,['GO:0030532']
2103,GO:CC,GO:0005665,"RNA polymerase II, core complex",5.764566000228939e-06,True,"""RNA polymerase II, one of three nuclear DNA-directed RNA polymerases found in all eukaryotes, is a multisubunit complex; typically it produces mRNAs, snoRNAs, and some of the snRNAs. Two large subunits comprise the most conserved portion including the catalytic site and share similarity with other eukaryotic and bacterial multisubunit RNA polymerases. The largest subunit of RNA polymerase II contains an essential carboxyl-terminal domain (CTD) composed of a variable number of heptapeptide repeats (YSPTSPS). The remainder of the complex is composed of smaller subunits (generally ten or more), some of which are also found in RNA polymerases I and III. Although the core is competent to mediate ribonucleic acid synthesis, it requires additional factors to select the appropriate template."" [GOC:krc, GOC:mtg_sensu]",15,813,8,22097,0.00984009840098401,0.5333333333333333,Module 0,"['GO:0016591', 'GO:0055029']"
2104,HPA,HPA:0460000,skin 1,5.794126744670053e-06,True,skin 1,7246,79,73,11019,0.9240506329113924,0.010074523875241513,Module 3,['HPA:0000000']
2105,HPA,HPA:0461461,skin 1; langerhans cells[≥Low],5.8373469899400635e-06,True,skin 1; langerhans cells[≥Low],716,166,32,11019,0.1927710843373494,0.0446927374301676,Module 2,['HPA:0460000']
2106,HP,HP:0045060,Aplasia/hypoplasia involving bones of the extremities,5.862025123078064e-06,True,Aplasia/hypoplasia involving bones of the extremities,657,44,22,4958,0.5,0.0334855403348554,Module 3,"['HP:0002813', 'HP:0009815']"
2107,TF,TF:M12666,Factor: SP1; motif: GGCCCCGCCCCCN,5.867234067692385e-06,True,Factor: SP1; motif: GGCCCCGCCCCCN,8941,826,452,20045,0.5472154963680388,0.05055362934794766,Module 0,['TF:M00000']
2108,GO:CC,GO:0005829,cytosol,5.869600257283171e-06,True,"""The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes."" [GOC:hjd, GOC:jl]",5487,34,24,22097,0.7058823529411765,0.004373974849644614,Module 7,"['GO:0005737', 'GO:0110165']"
2109,HPA,HPA:0600221,tonsil; squamous epithelial cells[≥Low],5.895091698497889e-06,True,tonsil; squamous epithelial cells[≥Low],6652,79,70,11019,0.8860759493670886,0.010523150932050512,Module 3,['HPA:0600000']
2110,HP,HP:0005120,Abnormal cardiac atrium morphology,5.9215595023879725e-06,True,Any structural abnormality of a cardiac atrium.,593,44,21,4958,0.4772727272727273,0.03541315345699832,Module 3,['HP:0001627']
2111,GO:BP,GO:0051241,negative regulation of multicellular organismal process,5.976226195243102e-06,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of an organismal process, the processes pertinent to the function of an organism above the cellular level; includes the integrated processes of tissues and organs."" [GOC:ai]",1110,226,36,21031,0.1592920353982301,0.032432432432432434,Module 1,"['GO:0032501', 'GO:0048519', 'GO:0051239']"
2112,GO:BP,GO:0042981,regulation of apoptotic process,6.004864236362889e-06,True,"""Any process that modulates the occurrence or rate of cell death by apoptotic process."" [GOC:jl, GOC:mtg_apoptosis]",1463,787,100,21031,0.12706480304955528,0.0683526999316473,Module 0,"['GO:0006915', 'GO:0043067']"
2113,GO:CC,GO:0005634,nucleus,6.006635393378181e-06,True,"""A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent."" [GOC:go_curators]",10074,80,61,22097,0.7625,0.006055191582291047,Module 5,['GO:0043231']
2114,TF,TF:M07250_1,Factor: E2F-1; motif: NNNSSCGCSAANN; match class: 1,6.0365386668343436e-06,True,Factor: E2F-1; motif: NNNSSCGCSAANN; match class: 1,5691,826,312,20045,0.37772397094430993,0.05482340537691091,Module 0,['TF:M07250']
2115,HP,HP:0007141,Sensorimotor neuropathy,6.0478587589724834e-06,True,Sensorimotor neuropathy,92,44,10,4958,0.22727272727272727,0.10869565217391304,Module 3,['HP:0009830']
2116,TF,TF:M11449_1,Factor: Elf-1; motif: NANCCGGAAGTN; match class: 1,6.066237168808634e-06,True,Factor: Elf-1; motif: NANCCGGAAGTN; match class: 1,713,826,65,20045,0.07869249394673124,0.091164095371669,Module 0,['TF:M11449']
2117,TF,TF:M09641_1,Factor: NRF-1; motif: SYGCGCMTGCGCRNNGSN; match class: 1,6.127496340544413e-06,True,Factor: NRF-1; motif: SYGCGCMTGCGCRNNGSN; match class: 1,1015,826,83,20045,0.10048426150121065,0.08177339901477833,Module 0,['TF:M09641']
2118,GO:BP,GO:0042110,T cell activation,6.148834947986035e-06,True,"""The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific."" [GOC:mgi_curators, ISBN:0781735149]",555,215,24,21031,0.11162790697674418,0.043243243243243246,Module 2,['GO:0046649']
2119,GO:BP,GO:0030162,regulation of proteolysis,6.148834947986035e-06,True,"""Any process that modulates the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein."" [GOC:mah]",555,215,24,21031,0.11162790697674418,0.043243243243243246,Module 2,"['GO:0006508', 'GO:0051246']"
2120,GO:BP,GO:0009967,positive regulation of signal transduction,6.196800192560739e-06,True,"""Any process that activates or increases the frequency, rate or extent of signal transduction."" [GOC:sm]",1561,226,44,21031,0.19469026548672566,0.028187059577194105,Module 1,"['GO:0007165', 'GO:0009966', 'GO:0010647', 'GO:0023056', 'GO:0048584']"
2121,GO:BP,GO:0046907,intracellular transport,6.203027867608957e-06,True,"""The directed movement of substances within a cell."" [GOC:ai]",1371,72,21,21031,0.2916666666666667,0.015317286652078774,Module 4,"['GO:0006810', 'GO:0051641', 'GO:0051649']"
2122,TF,TF:M11430,Factor: PEA3; motif: NACCGGAAGTN,6.2090555298078114e-06,True,Factor: PEA3; motif: NACCGGAAGTN,11108,105,87,20045,0.8285714285714286,0.007832193014043932,Module 3,['TF:M00000']
2123,HPA,HPA:0600441,tonsil; non-germinal center cells[≥Low],6.215240439669172e-06,True,tonsil; non-germinal center cells[≥Low],6117,79,67,11019,0.8481012658227848,0.010953081575935917,Module 3,['HPA:0600000']
2124,GO:BP,GO:1901698,response to nitrogen compound,6.236919866032411e-06,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nitrogen compound stimulus."" [GOC:pr, GOC:TermGenie]",1060,215,34,21031,0.15813953488372093,0.03207547169811321,Module 2,['GO:0042221']
2125,HPA,HPA:0630223,cervix; squamous epithelial cells[High],6.286968188548051e-06,True,cervix; squamous epithelial cells[High],1034,79,25,11019,0.31645569620253167,0.024177949709864602,Module 3,['HPA:0630222']
2126,HP,HP:0005280,Depressed nasal bridge,6.300137125527093e-06,True,Posterior positioning of the nasal root in relation to the overall facial profile for age.,595,44,21,4958,0.4772727272727273,0.03529411764705882,Module 3,['HP:0000422']
2127,HPA,HPA:0470671,skin 2; melanocytes[≥Low],6.334893883741643e-06,True,skin 2; melanocytes[≥Low],724,140,29,11019,0.20714285714285716,0.04005524861878453,Module Singleton,['HPA:0470000']
2128,HPA,HPA:0460671,skin 1; melanocytes[≥Low],6.390701220191924e-06,True,skin 1; melanocytes[≥Low],5302,79,62,11019,0.7848101265822784,0.011693700490380989,Module 3,['HPA:0460000']
2129,GO:CC,GO:0101002,ficolin-1-rich granule,6.4245476564201835e-06,True,"""Highly exocytosable gelatinase-poor granules found in neutrophils and rich in ficolin-1. Ficolin-1 is released from neutrophil granules by stimulation with fMLP or PMA, and the majority becomes associated with the surface membrane of the cells and can be detected by flow cytometry."" [GOC:mec, PMID:19741154]",184,813,25,22097,0.03075030750307503,0.1358695652173913,Module 0,['GO:0030141']
2130,HP,HP:0000002,Abnormality of body height,6.425031016850199e-06,True,Deviation from the norm of height with respect to that which is expected according to age and gender norms.,1479,44,32,4958,0.7272727272727273,0.021636240703177823,Module 3,['HP:0001507']
2131,GO:BP,GO:0048585,negative regulation of response to stimulus,6.438897199284841e-06,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of a response to a stimulus. Response to stimulus is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus."" [GOC:jid]",1648,215,44,21031,0.20465116279069767,0.02669902912621359,Module 2,"['GO:0048519', 'GO:0048583', 'GO:0050896']"
2132,HPA,HPA:0030431,appendix; germinal center cells[≥Low],6.52330473484588e-06,True,appendix; germinal center cells[≥Low],287,612,41,11019,0.06699346405228758,0.14285714285714285,Module 0,['HPA:0030000']
2133,HPA,HPA:0461493,skin 1; vascular mural cells[High],6.524825655453149e-06,True,skin 1; vascular mural cells[High],135,612,26,11019,0.042483660130718956,0.1925925925925926,Module 0,['HPA:0461492']
2134,HPA,HPA:0600441,tonsil; non-germinal center cells[≥Low],6.610268505778396e-06,True,tonsil; non-germinal center cells[≥Low],6117,140,109,11019,0.7785714285714286,0.01781919241458231,Module Singleton,['HPA:0600000']
2135,HPA,HPA:0600442,tonsil; non-germinal center cells[≥Medium],6.617782488287603e-06,True,tonsil; non-germinal center cells[≥Medium],4200,69,49,11019,0.7101449275362319,0.011666666666666667,Module 5,['HPA:0600441']
2136,GO:BP,GO:0042127,regulation of cell population proliferation,6.630912768904683e-06,True,"""Any process that modulates the frequency, rate or extent of cell proliferation."" [GOC:jl]",1683,226,46,21031,0.20353982300884957,0.027332144979203804,Module 1,"['GO:0008283', 'GO:0050794']"
2137,REAC,REAC:R-HSA-168256,Immune System,6.63370637162163e-06,True,Immune System,2052,28,19,10842,0.6785714285714286,0.009259259259259259,Module 7,['REAC:0000000']
2138,GO:BP,GO:0023052,signaling,6.68599336233813e-06,True,"""The entirety of a process in which information is transmitted within a biological system. This process begins with an active signal and ends when a cellular response has been triggered."" [GOC:mtg_signal, GOC:mtg_signaling_feb11, GOC:signaling]",6447,215,107,21031,0.49767441860465117,0.01659686675973321,Module 2,['GO:0050789']
2139,HPA,HPA:0160052,endometrium 1; glandular cells[≥Medium],6.784408337060526e-06,True,endometrium 1; glandular cells[≥Medium],5155,79,61,11019,0.7721518987341772,0.011833171677982542,Module 3,['HPA:0160051']
2140,GO:BP,GO:0050852,T cell receptor signaling pathway,6.787809274185382e-06,True,"""The series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell."" [GOC:add]",138,226,13,21031,0.05752212389380531,0.09420289855072464,Module 1,['GO:0050851']
2141,HPA,HPA:0570812,testis; spermatogonia cells[≥Medium],6.801468587445387e-06,True,testis; spermatogonia cells[≥Medium],2570,612,201,11019,0.3284313725490196,0.07821011673151751,Module 0,['HPA:0570811']
2142,GO:CC,GO:0070161,anchoring junction,6.859195530597665e-06,True,"""A cell junction that mechanically attaches a cell (and its cytoskeleton) to neighboring cells or to the extracellular matrix."" [ISBN:0815332181]",905,813,68,22097,0.08364083640836409,0.07513812154696133,Module 0,['GO:0030054']
2143,HP,HP:0003271,Visceromegaly,6.964847346372492e-06,True,Abnormal increased size of the viscera of the abdomen.,739,71,31,4958,0.43661971830985913,0.04194857916102842,Module 1,['HP:0001438']
2144,TF,TF:M07100,Factor: HSF1; motif: NTTCTRGAANNTTCY,6.965469219377361e-06,True,Factor: HSF1; motif: NTTCTRGAANNTTCY,3383,21,16,20045,0.7619047619047619,0.004729530002955957,Module 9,['TF:M00000']
2145,GO:CC,GO:0043231,intracellular membrane-bounded organelle,6.966036622554572e-06,True,"""Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane."" [GOC:go_curators]",14605,221,183,22097,0.8280542986425339,0.012529955494693597,Module 2,"['GO:0043227', 'GO:0043229']"
2146,MIRNA,MIRNA:hsa-miR-16-5p,hsa-miR-16-5p,6.971930036368893e-06,True,hsa-miR-16-5p,1553,104,32,14819,0.3076923076923077,0.0206052801030264,Module 3,['MIRNA:000000']
2147,GO:BP,GO:0051641,cellular localization,7.02605708808482e-06,True,"""A cellular localization process whereby a substance or cellular entity, such as a protein complex or organelle, is transported to, and/or maintained in, a specific location within a cell including the localization of substances or cellular entities to the cell membrane."" [GOC:tb, GOC:vw]",3621,72,34,21031,0.4722222222222222,0.009389671361502348,Module 4,"['GO:0009987', 'GO:0051179']"
2148,REAC,REAC:R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,7.054802317966524e-06,True,APC/C:Cdc20 mediated degradation of mitotic proteins,76,586,19,10842,0.032423208191126277,0.25,Module 0,['REAC:R-HSA-176814']
2149,GO:BP,GO:0032880,regulation of protein localization,7.09342174650279e-06,True,"""Any process that modulates the frequency, rate or extent of any process in which a protein is transported to, or maintained in, a specific location."" [GOC:dph, GOC:mah, GOC:tb]",889,787,70,21031,0.08894536213468869,0.07874015748031496,Module 0,"['GO:0008104', 'GO:0060341']"
2150,HPA,HPA:0300411,lung; macrophages[≥Low],7.099477043217749e-06,True,lung; macrophages[≥Low],6787,166,135,11019,0.8132530120481928,0.019890968027110652,Module 2,['HPA:0300000']
2151,GO:BP,GO:0006955,immune response,7.141396700412745e-06,True,"""Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat."" [GO_REF:0000022, GOC:add]",1988,15,11,21031,0.7333333333333333,0.005533199195171026,Module 6,"['GO:0002376', 'GO:0050896']"
2152,REAC,REAC:R-HSA-163200,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",7.159677708378476e-06,True,"Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.",127,97,11,10842,0.1134020618556701,0.08661417322834646,Module 3,['REAC:R-HSA-1428517']
2153,HP,HP:0005918,Abnormal finger phalanx morphology,7.181827709698975e-06,True,Abnormalities affecting the phalanx of finger.,664,44,22,4958,0.5,0.03313253012048193,Module 3,['HP:0001167']
2154,HPA,HPA:0470672,skin 2; melanocytes[≥Medium],7.227025184151147e-06,True,skin 2; melanocytes[≥Medium],640,140,27,11019,0.19285714285714287,0.0421875,Module Singleton,['HPA:0470671']
2155,TF,TF:M08341_1,Factor: HOXB2:Elk-1; motif: TAATKRCCGGAAGTN; match class: 1,7.2333963272511884e-06,True,Factor: HOXB2:Elk-1; motif: TAATKRCCGGAAGTN; match class: 1,1338,826,101,20045,0.12227602905569007,0.07548579970104634,Module 0,['TF:M08341']
2156,GO:CC,GO:0005737,cytoplasm,7.3131329569281965e-06,True,"""The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures."" [ISBN:0198547684]",12345,73,63,22097,0.863013698630137,0.005103280680437424,Module 4,"['GO:0005622', 'GO:0110165']"
2157,GO:BP,GO:0019883,antigen processing and presentation of endogenous antigen,7.444712646760547e-06,True,"""The process in which an antigen-presenting cell expresses antigen (peptide or lipid) of endogenous origin on its cell surface in association with an MHC protein complex."" [GOC:add, ISBN:0781735149, PMID:15771591, PMID:15928678]",31,15,4,21031,0.26666666666666666,0.12903225806451613,Module 6,['GO:0019882']
2158,WP,WP:WP111,Electron transport chain OXPHOS system in mitochondria,7.509715464813282e-06,True,Electron transport chain OXPHOS system in mitochondria,104,101,11,8286,0.10891089108910891,0.10576923076923077,Module 3,['WP:000000']
2159,GO:BP,GO:0002694,regulation of leukocyte activation,7.58666706046063e-06,True,"""Any process that modulates the frequency, rate, or extent of leukocyte activation."" [GOC:add]",561,215,24,21031,0.11162790697674418,0.0427807486631016,Module 2,"['GO:0002682', 'GO:0045321', 'GO:0050865']"
2160,HPA,HPA:0040081,bone marrow; hematopoietic cells[≥Low],7.594948682531551e-06,True,bone marrow; hematopoietic cells[≥Low],6496,79,69,11019,0.8734177215189873,0.010621921182266009,Module 3,['HPA:0040000']
2161,HPA,HPA:0040000,bone marrow,7.594948682531551e-06,True,bone marrow,6496,79,69,11019,0.8734177215189873,0.010621921182266009,Module 3,['HPA:0000000']
2162,GO:BP,GO:0071840,cellular component organization or biogenesis,7.793192839054876e-06,True,"""A process that results in the biosynthesis of constituent macromolecules, assembly, arrangement of constituent parts, or disassembly of a cellular component."" [GOC:mah]",8361,787,392,21031,0.49809402795425667,0.04688434397799306,Module 0,['GO:0009987']
2163,HPA,HPA:0241103,heart muscle; cardiomyocytes[High],7.816202318656609e-06,True,heart muscle; cardiomyocytes[High],1171,612,109,11019,0.1781045751633987,0.09308283518360376,Module 0,['HPA:0241102']
2164,GO:BP,GO:0009060,aerobic respiration,8.08012245487594e-06,True,"""The enzymatic release of energy from inorganic and organic compounds (especially carbohydrates and fats) which requires oxygen as the terminal electron acceptor."" [GOC:das, GOC:jl, ISBN:0140513590]",196,105,11,21031,0.10476190476190476,0.05612244897959184,Module 3,['GO:0045333']
2165,TF,TF:M09632_1,Factor: Kaiso; motif: GNTCTCGCGAGRNNNNGGN; match class: 1,8.12801862987756e-06,True,Factor: Kaiso; motif: GNTCTCGCGAGRNNNNGGN; match class: 1,702,826,64,20045,0.0774818401937046,0.09116809116809117,Module 0,['TF:M09632']
2166,HP,HP:0011895,Anemia due to reduced life span of red cells,8.164205576430555e-06,True,"A type of anemia related to a reduction in the average life span of red blood cells in the peripheral circulation, which is normally around 120 days.",162,71,15,4958,0.2112676056338028,0.09259259259259259,Module 1,['HP:0001903']
2167,HP,HP:0003481,Segmental peripheral demyelination/remyelination,8.175123362816138e-06,True,A segmental pattern of demyelination and regeneration (remyelination) affecting peripheral nerves.,18,44,6,4958,0.13636363636363635,0.3333333333333333,Module 3,['HP:0011096']
2168,HPA,HPA:0461451,skin 1; hair follicles[≥Low],8.193339618638384e-06,True,skin 1; hair follicles[≥Low],367,166,22,11019,0.13253012048192772,0.05994550408719346,Module 2,['HPA:0460000']
2169,GO:CC,GO:0098798,mitochondrial protein-containing complex,8.221054870311626e-06,True,"""A protein complex that is part of a mitochondrion."" [GOC:dos]",306,105,12,22097,0.11428571428571428,0.0392156862745098,Module 3,"['GO:0005739', 'GO:0032991']"
2170,REAC,REAC:R-HSA-8948751,Regulation of PTEN stability and activity,8.252212908725049e-06,True,Regulation of PTEN stability and activity,69,586,18,10842,0.030716723549488054,0.2608695652173913,Module 0,['REAC:R-HSA-6807070']
2171,GO:CC,GO:0098588,bounding membrane of organelle,8.254495900924355e-06,True,"""The lipid bilayer that forms the outer-most layer of an organelle."" [GOC:dos]",2203,221,50,22097,0.22624434389140272,0.022696323195642305,Module 2,['GO:0031090']
2172,GO:BP,GO:0002831,regulation of response to biotic stimulus,8.280981806733134e-06,True,"""Any process that modulates the frequency, rate, or extent of a response to biotic stimulus."" [GOC:add]",502,34,10,21031,0.29411764705882354,0.0199203187250996,Module 7,"['GO:0009607', 'GO:0048583']"
2173,GO:BP,GO:0044248,cellular catabolic process,8.324313306392818e-06,True,"""The chemical reactions and pathways resulting in the breakdown of substances, carried out by individual cells."" [GOC:jl]",1600,215,43,21031,0.2,0.026875,Module 2,"['GO:0009056', 'GO:0044237']"
2174,GO:BP,GO:0071840,cellular component organization or biogenesis,8.336281061216147e-06,True,"""A process that results in the biosynthesis of constituent macromolecules, assembly, arrangement of constituent parts, or disassembly of a cellular component."" [GOC:mah]",8361,77,56,21031,0.7272727272727273,0.00669776342542758,Module 5,['GO:0009987']
2175,HPA,HPA:0530000,spleen,8.36469991774384e-06,True,spleen,5893,166,123,11019,0.7409638554216867,0.020872221279484134,Module 2,['HPA:0000000']
2176,GO:BP,GO:0006122,"mitochondrial electron transport, ubiquinol to cytochrome c",8.426808985166686e-06,True,"""The transfer of electrons from ubiquinol to cytochrome c that occurs during oxidative phosphorylation, mediated by the multisubunit enzyme known as complex III."" [ISBN:0716731363]",13,787,8,21031,0.010165184243964422,0.6153846153846154,Module 0,"['GO:0019646', 'GO:0042775']"
2177,GO:MF,GO:0003729,mRNA binding,8.441452198688944e-06,True,"""Binding to messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns."" [GOC:kmv, GOC:pr, SO:0000234]",369,808,40,20212,0.04950495049504951,0.10840108401084012,Module 0,['GO:0003723']
2178,HP,HP:0004328,Abnormal anterior eye segment morphology,8.49706686643325e-06,True,"An abnormality of the anterior segment of the eyeball (which comprises the structures in front of the vitreous humour: the cornea, iris, ciliary body, and lens).",1302,44,30,4958,0.6818181818181818,0.02304147465437788,Module 3,['HP:0012372']
2179,HPA,HPA:0381202,placenta; hofbauer cells[≥Medium],8.745112633553714e-06,True,placenta; hofbauer cells[≥Medium],381,612,49,11019,0.08006535947712418,0.12860892388451445,Module 0,['HPA:0381201']
2180,WP,WP:WP4884,Pathogenesis of SARS CoV 2 mediated by nsp9 nsp10 complex,8.78773407071466e-06,True,Pathogenesis of SARS CoV 2 mediated by nsp9 nsp10 complex,21,148,7,8286,0.0472972972972973,0.3333333333333333,Module 1,['WP:000000']
2181,GO:BP,GO:0034341,response to type II interferon,8.797320023130775e-06,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon-gamma is also known as type II interferon."" [GOC:add, ISBN:0126896631, PMID:15546383]",146,5,4,21031,0.8,0.0273972602739726,Module 12,"['GO:0034097', 'GO:0045087']"
2182,HPA,HPA:0600431,tonsil; germinal center cells[≥Low],8.865486899516959e-06,True,tonsil; germinal center cells[≥Low],5987,79,66,11019,0.8354430379746836,0.011023885084349424,Module 3,['HPA:0600000']
2183,REAC,REAC:R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,8.901426528058348e-06,True,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,77,586,19,10842,0.032423208191126277,0.24675324675324675,Module 0,['REAC:R-HSA-174143']
2184,GO:BP,GO:0031347,regulation of defense response,8.991484193517416e-06,True,"""Any process that modulates the frequency, rate or extent of a defense response."" [GOC:mah]",768,226,29,21031,0.12831858407079647,0.037760416666666664,Module 1,"['GO:0006952', 'GO:0080134']"
2185,GO:CC,GO:0005789,endoplasmic reticulum membrane,9.029306241356373e-06,True,"""The lipid bilayer surrounding the endoplasmic reticulum."" [GOC:mah]",1194,17,9,22097,0.5294117647058824,0.007537688442211055,Module 6,"['GO:0031090', 'GO:0042175', 'GO:0098827']"
2186,GO:BP,GO:0050793,regulation of developmental process,9.035825456309504e-06,True,"""Any process that modulates the frequency, rate or extent of development, the biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote, or a young adult) to a later condition (e.g. a multicellular animal or an aged adult)."" [GOC:go_curators]",2455,215,56,21031,0.26046511627906976,0.022810590631364563,Module 2,"['GO:0032502', 'GO:0050789']"
2187,HP,HP:0002597,Abnormality of the vasculature,9.13269274171487e-06,True,An abnormality of the vasculature.,1935,44,36,4958,0.8181818181818182,0.018604651162790697,Module 3,['HP:0001626']
2188,HPA,HPA:0380000,placenta,9.31441211945674e-06,True,placenta,7517,79,74,11019,0.9367088607594937,0.009844352800319277,Module 3,['HPA:0000000']
2189,TF,TF:M10956_1,Factor: isx; motif: NTCRTTAA; match class: 1,9.356307516364081e-06,True,Factor: isx; motif: NTCRTTAA; match class: 1,3414,826,206,20045,0.24939467312348668,0.06033977738722906,Module 0,['TF:M10956']
2190,HPA,HPA:0620000,vagina,9.393265836749928e-06,True,vagina,6000,69,59,11019,0.855072463768116,0.009833333333333333,Module 5,['HPA:0000000']
2191,HPA,HPA:0620221,vagina; squamous epithelial cells[≥Low],9.393265836749928e-06,True,vagina; squamous epithelial cells[≥Low],6000,69,59,11019,0.855072463768116,0.009833333333333333,Module 5,['HPA:0620000']
2192,GO:CC,GO:0098827,endoplasmic reticulum subcompartment,9.428077651139445e-06,True,"""A distinct region of the endoplasmic reticulum."" [GOC:dos]",1200,17,9,22097,0.5294117647058824,0.0075,Module 6,"['GO:0005783', 'GO:0031984']"
2193,TF,TF:M07395,Factor: Sp1; motif: NGGGGCGGGGN,9.542354992369775e-06,True,Factor: Sp1; motif: NGGGGCGGGGN,10981,826,534,20045,0.6464891041162227,0.048629450869684,Module 0,['TF:M00000']
2194,GO:CC,GO:0098588,bounding membrane of organelle,9.551532584541366e-06,True,"""The lipid bilayer that forms the outer-most layer of an organelle."" [GOC:dos]",2203,17,11,22097,0.6470588235294118,0.004993191103041307,Module 6,['GO:0031090']
2195,HPA,HPA:0630223,cervix; squamous epithelial cells[High],9.662939383350875e-06,True,cervix; squamous epithelial cells[High],1034,612,99,11019,0.16176470588235295,0.09574468085106383,Module 0,['HPA:0630222']
2196,GO:BP,GO:0032101,regulation of response to external stimulus,9.714856681191328e-06,True,"""Any process that modulates the frequency, rate or extent of a response to an external stimulus."" [GOC:mah]",1077,226,35,21031,0.15486725663716813,0.032497678737233054,Module 1,"['GO:0009605', 'GO:0048583']"
2197,HPA,HPA:0030441,appendix; non-germinal center cells[≥Low],9.753499158364115e-06,True,appendix; non-germinal center cells[≥Low],336,612,45,11019,0.07352941176470588,0.13392857142857142,Module 0,['HPA:0030000']
2198,TF,TF:M00940_1,Factor: E2F-1; motif: NTTTCGCGCS; match class: 1,9.757454076595663e-06,True,Factor: E2F-1; motif: NTTTCGCGCS; match class: 1,2709,80,32,20045,0.4,0.011812476928755998,Module 5,['TF:M00940']
2199,GO:BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,9.7766659699961e-06,True,"""An immune response mediated by lymphocytes expressing specific receptors for antigen produced through a somatic diversification process that includes somatic recombination of germline gene segments encoding immunoglobulin superfamily domains. Recombined receptors for antigen encoded by immunoglobulin superfamily domains include T cell receptors and immunoglobulins (antibodies) produced by B cells. The first encounter with antigen elicits a primary immune response that is slow and not of great magnitude. T and B cells selected by antigen become activated and undergo clonal expansion. A fraction of antigen-reactive T and B cells become memory cells, whereas others differentiate into effector cells. The memory cells generated during the primary response enable a much faster and stronger secondary immune response upon subsequent exposures to the same antigen (immunological memory). An example of this is the adaptive immune response found in Mus musculus."" [GOC:add, GOC:mtg_sensu, ISBN:0781735149, ISBN:1405196831]",375,226,20,21031,0.08849557522123894,0.05333333333333334,Module 1,['GO:0002250']
2200,HPA,HPA:0340452,ovary; follicle cells[≥Medium],1.007734662280286e-05,True,ovary; follicle cells[≥Medium],2248,612,180,11019,0.29411764705882354,0.0800711743772242,Module 0,['HPA:0340451']
2201,GO:BP,GO:0070663,regulation of leukocyte proliferation,1.0180039402203535e-05,True,"""Any process that modulates the frequency, rate or extent of leukocyte proliferation."" [GOC:add, GOC:mah]",266,226,17,21031,0.0752212389380531,0.06390977443609022,Module 1,"['GO:0042127', 'GO:0070661']"
2202,GO:BP,GO:0001817,regulation of cytokine production,1.0394686306960655e-05,True,"""Any process that modulates the frequency, rate, or extent of production of a cytokine."" [GOC:add, ISBN:0781735149]",773,226,29,21031,0.12831858407079647,0.037516170763260026,Module 1,"['GO:0001816', 'GO:0010468', 'GO:0051239']"
2203,GO:CC,GO:0071750,dimeric IgA immunoglobulin complex,1.0419206338822129e-05,True,"""A protein complex composed of two monomeric IgA immunoglobulin complexes linked through both direct disulfide bonds and through a disulfide binded monomer of J chain acting as a bridge. Each IgA monomer consists of two identical immunoglobulin heavy chains of an IgA isotype and two identical immunoglobulin light chains, held together by disulfide bonds. Dimeric IgA is sometimes complexed additionally with secretory component, and present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph."" [GOC:add, ISBN:0781765196, PMID:16362985]",3,73,3,22097,0.0410958904109589,1.0,Module 4,['GO:0071749']
2204,GO:CC,GO:0071752,secretory dimeric IgA immunoglobulin complex,1.0419206338822129e-05,True,"""A dimeric form of secretory IgA immunoglobulin complex."" [GOC:add, ISBN:0781765196, PMID:16362985]",3,73,3,22097,0.0410958904109589,1.0,Module 4,"['GO:0071750', 'GO:0071751']"
2205,GO:CC,GO:0101031,protein folding chaperone complex,1.042912756038017e-05,True,"""A protein complex required for the non-covalent folding or unfolding, maturation, stabilization or assembly or disassembly of macromolecular structures. Usually active during or immediately after completion of translation. Many chaperone complexes contain heat shock proteins."" [GOC:bhm, PMID:21855797]",41,21,4,22097,0.19047619047619047,0.0975609756097561,Module 9,['GO:0140535']
2206,GO:BP,GO:0042267,natural killer cell mediated cytotoxicity,1.0504580714975427e-05,True,"""The directed killing of a target cell by a natural killer cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors."" [GOC:add, GOC:pr]",72,226,10,21031,0.04424778761061947,0.1388888888888889,Module 1,"['GO:0001909', 'GO:0002228']"
2207,GO:BP,GO:0019221,cytokine-mediated signaling pathway,1.0568034699179598e-05,True,"""The series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription."" [GOC:mah, GOC:signaling, PMID:19295629]",499,226,23,21031,0.10176991150442478,0.04609218436873747,Module 1,"['GO:0007166', 'GO:0071345']"
2208,GO:CC,GO:0016020,membrane,1.0581200343312672e-05,True,"""A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it."" [GOC:dos, GOC:mah, ISBN:0815316194]",9864,177,115,22097,0.6497175141242938,0.011658556366585564,Module Singleton,['GO:0110165']
2209,GO:BP,GO:0034340,response to type I interferon,1.0627017564434489e-05,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a type I interferon stimulus. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families."" [GOC:add, ISBN:0126896631, PMID:15546383, PMID:16681834]",88,34,6,21031,0.17647058823529413,0.06818181818181818,Module 7,"['GO:0034097', 'GO:0045087']"
2210,GO:CC,GO:0042175,nuclear outer membrane-endoplasmic reticulum membrane network,1.0643126139480684e-05,True,"""The continuous network of membranes encompassing the nuclear outer membrane and the endoplasmic reticulum membrane."" [GOC:bf, GOC:jl, GOC:mah, GOC:mcc, GOC:pr, GOC:vw]",1217,17,9,22097,0.5294117647058824,0.007395234182415777,Module 6,"['GO:0012505', 'GO:0016020']"
2211,TF,TF:M03925_1,Factor: YY2; motif: NCCGCCATNTY; match class: 1,1.068722823428473e-05,True,Factor: YY2; motif: NCCGCCATNTY; match class: 1,789,826,69,20045,0.08353510895883777,0.08745247148288973,Module 0,['TF:M03925']
2212,GO:CC,GO:0005622,intracellular anatomical structure,1.0932937440220695e-05,True,"""A component of a cell contained within (but not including) the plasma membrane. In eukaryotes it includes the nucleus and cytoplasm."" [ISBN:0198506732]",17834,177,168,22097,0.9491525423728814,0.009420208590333072,Module Singleton,['GO:0110165']
2213,GO:BP,GO:0002682,regulation of immune system process,1.1007145931877066e-05,True,"""Any process that modulates the frequency, rate, or extent of an immune system process."" [GOC:add]",1512,15,10,21031,0.6666666666666666,0.006613756613756613,Module 6,"['GO:0002376', 'GO:0050789']"
2214,HPA,HPA:0100202,cerebral cortex; endothelial cells[≥Medium],1.1080796461058613e-05,True,cerebral cortex; endothelial cells[≥Medium],2489,612,195,11019,0.31862745098039214,0.07834471675371635,Module 0,['HPA:0100201']
2215,HPA,HPA:0500111,soft tissue 1; chondrocytes[≥Low],1.1118298518206662e-05,True,soft tissue 1; chondrocytes[≥Low],2188,612,176,11019,0.2875816993464052,0.08043875685557587,Module 0,['HPA:0500000']
2216,GO:BP,GO:0009719,response to endogenous stimulus,1.1130302984576888e-05,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus arising within the organism."" [GOC:sm]",1678,215,44,21031,0.20465116279069767,0.026221692491060787,Module 2,['GO:0050896']
2217,REAC,REAC:R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,1.1137127739410606e-05,True,Regulation of mRNA stability by proteins that bind AU-rich elements,86,586,20,10842,0.034129692832764506,0.23255813953488372,Module 0,['REAC:R-HSA-8953854']
2218,REAC,REAC:R-HSA-1280215,Cytokine Signaling in Immune system,1.1150620676888414e-05,True,Cytokine Signaling in Immune system,719,164,32,10842,0.1951219512195122,0.04450625869262865,Module 1,['REAC:R-HSA-168256']
2219,HP,HP:0000114,Proximal tubulopathy,1.1170388793523685e-05,True,"Dysfunction of the proximal tubule, which is the portion of the duct system of the nephron of the kidney which leads from Bowman's capsule to the loop of Henle.",50,44,8,4958,0.18181818181818182,0.16,Module 3,['HP:0000124']
2220,HPA,HPA:0470672,skin 2; melanocytes[≥Medium],1.1176161290431926e-05,True,skin 2; melanocytes[≥Medium],640,69,18,11019,0.2608695652173913,0.028125,Module 5,['HPA:0470671']
2221,GO:CC,GO:0019814,immunoglobulin complex,1.1554034814264334e-05,True,"""A protein complex that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains, held together by disulfide bonds and sometimes complexed with additional proteins. An immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph."" [GOC:add, GOC:jl, ISBN:0781765196]",152,73,8,22097,0.1095890410958904,0.05263157894736842,Module 4,['GO:0032991']
2222,GO:BP,GO:0031341,regulation of cell killing,1.161728114656081e-05,True,"""Any process that modulates the frequency, rate or extent of cell killing, the process in which a cell brings about the death of another cell, either in the same or a different organism."" [GOC:mah]",105,15,5,21031,0.3333333333333333,0.047619047619047616,Module 6,"['GO:0001906', 'GO:0050794']"
2223,TF,TF:M00425_1,Factor: E2F; motif: TTTCGCGC; match class: 1,1.1708502118107932e-05,True,Factor: E2F; motif: TTTCGCGC; match class: 1,5516,80,47,20045,0.5875,0.008520667150108775,Module 5,['TF:M00425']
2224,GO:BP,GO:0006260,DNA replication,1.1727868161770736e-05,True,"""The cellular metabolic process in which a cell duplicates one or more molecules of DNA. DNA replication begins when specific sequences, known as origins of replication, are recognized and bound by the origin recognition complex, and ends when the original DNA molecule has been completely duplicated and the copies topologically separated. The unit of replication usually corresponds to the genome of the cell, an organelle, or a virus. The template for replication can either be an existing DNA molecule or RNA."" [GOC:mah]",281,77,11,21031,0.14285714285714285,0.03914590747330961,Module 5,['GO:0006259']
2225,KEGG,KEGG:04064,NF-kappa B signaling pathway,1.1778738396676539e-05,True,NF-kappa B signaling pathway,102,143,12,8484,0.08391608391608392,0.11764705882352941,Module 2,['KEGG:00000']
2226,GO:MF,GO:0140657,ATP-dependent activity,1.183540246252912e-05,True,"""A molecular function characterized by the coupling of ATP hydrolysis to other steps of a reaction mechanism to make the reaction energetically favorable, for example to catalyze a reaction or drive transport against a concentration gradient."" [PMID:24878343, PMID:25750732, PMID:32933017, PMID:33818025, PMID:33873056, PMID:33988324]",580,20,8,20212,0.4,0.013793103448275862,Module 9,['GO:0003674']
2227,HP,HP:0100027,Recurrent pancreatitis,1.1869633241158404e-05,True,A recurrent form of pancreatitis.,19,44,6,4958,0.13636363636363635,0.3157894736842105,Module 3,['HP:0001733']
2228,HPA,HPA:0030000,appendix,1.1901529896915184e-05,True,appendix,7831,140,126,11019,0.9,0.01608989911888648,Module Singleton,['HPA:0000000']
2229,GO:BP,GO:0050778,positive regulation of immune response,1.192750109143474e-05,True,"""Any process that activates or increases the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus."" [GOC:ai]",718,215,27,21031,0.12558139534883722,0.037604456824512536,Module 2,"['GO:0002684', 'GO:0006955', 'GO:0048584', 'GO:0050776']"
2230,GO:BP,GO:0060326,cell chemotaxis,1.1970238362908803e-05,True,"""The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis)."" [GOC:dph]",320,215,18,21031,0.08372093023255814,0.05625,Module 2,"['GO:0006935', 'GO:0016477', 'GO:0070887']"
2231,HP,HP:0012337,Abnormal homeostasis,1.2017165260862333e-05,True,An anomaly in the processes involved in the maintenance of an internal equilibrium.,1723,44,34,4958,0.7727272727272727,0.019733023795705164,Module 3,['HP:0001939']
2232,HP,HP:0004360,Abnormality of acid-base homeostasis,1.2093197860950957e-05,True,"An abnormality of the balance or maintenance of the balance of acids and bases in bodily fluids, resulting in an abnormal pH.",427,228,47,4958,0.20614035087719298,0.11007025761124122,Module 0,['HP:0012337']
2233,TF,TF:M00695,Factor: ETF; motif: GVGGMGG,1.2157408568660741e-05,True,Factor: ETF; motif: GVGGMGG,10745,826,524,20045,0.6343825665859564,0.04876686831084225,Module 0,['TF:M00000']
2234,GO:BP,GO:0008104,protein localization,1.2252508749044646e-05,True,"""Any process in which a protein is transported to, or maintained in, a specific location."" [GOC:ai]",2731,72,29,21031,0.4027777777777778,0.010618820944708897,Module 4,['GO:0070727']
2235,GO:CC,GO:0001772,immunological synapse,1.230114972230478e-05,True,"""An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction."" [GOC:mgi_curators, PMID:11244041, PMID:11376300]",46,238,8,22097,0.03361344537815126,0.17391304347826086,Module 1,"['GO:0005886', 'GO:0110165']"
2236,GO:BP,GO:0001816,cytokine production,1.234986903365555e-05,True,"""The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels."" [GOC:add, ISBN:0781735149]",779,226,29,21031,0.12831858407079647,0.037227214377406934,Module 1,"['GO:0010467', 'GO:0032501']"
2237,REAC,REAC:R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,1.2380302840419839e-05,True,Antiviral mechanism by IFN-stimulated genes,78,28,6,10842,0.21428571428571427,0.07692307692307693,Module 7,['REAC:R-HSA-913531']
2238,TF,TF:M00427_1,Factor: E2F; motif: TTTSGCGS; match class: 1,1.2482478031294396e-05,True,Factor: E2F; motif: TTTSGCGS; match class: 1,3946,80,39,20045,0.4875,0.009883426254434871,Module 5,['TF:M00427']
2239,GO:CC,GO:0014069,postsynaptic density,1.2549353351064654e-05,True,"""An electron dense network of proteins within and adjacent to the postsynaptic membrane of an asymmetric, neuron-neuron synapse. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components."" [GOC:BHF, GOC:dos, GOC:ef, GOC:jid, GOC:pr, GOC:sjp, http://molneuro.kaist.ac.kr/psd, PMID:14532281, Wikipedia:Postsynaptic_density]",318,105,12,22097,0.11428571428571428,0.03773584905660377,Module 3,"['GO:0032279', 'GO:0099572']"
2240,GO:BP,GO:0006954,inflammatory response,1.258425155676879e-05,True,"""The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages."" [GO_REF:0000022, ISBN:0198506732]",829,226,30,21031,0.13274336283185842,0.03618817852834741,Module 1,['GO:0006952']
2241,HPA,HPA:0570811,testis; spermatogonia cells[≥Low],1.2623203412258182e-05,True,testis; spermatogonia cells[≥Low],3062,612,230,11019,0.3758169934640523,0.07511430437622468,Module 0,['HPA:0570000']
2242,GO:BP,GO:0031663,lipopolysaccharide-mediated signaling pathway,1.2636661807181664e-05,True,"""The series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system."" [GOC:mah, GOC:signaling, PMID:15379975]",57,215,9,21031,0.04186046511627907,0.15789473684210525,Module 2,"['GO:0007166', 'GO:0071222']"
2243,GO:BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,1.2733113266265062e-05,True,"""Any process that activates or increases the frequency, rate or extent of leukocyte cell-cell adhesion."" [GO_REF:0000058, GOC:BHF, GOC:rl, GOC:TermGenie, PMID:21106532]",270,226,17,21031,0.0752212389380531,0.06296296296296296,Module 1,"['GO:0007159', 'GO:0022409', 'GO:1903037']"
2244,GO:MF,GO:0005488,binding,1.2765674650256137e-05,True,"""The selective, non-covalent, often stoichiometric, interaction of a molecule with one or more specific sites on another molecule."" [GOC:ceb, GOC:mah, ISBN:0198506732]",18370,808,775,20212,0.9591584158415841,0.042188350571584106,Module 0,['GO:0003674']
2245,TF,TF:M02065_1,Factor: ER81; motif: RCCGGAARYN; match class: 1,1.2901284725036878e-05,True,Factor: ER81; motif: RCCGGAARYN; match class: 1,7184,105,67,20045,0.638095238095238,0.009326280623608019,Module 3,['TF:M02065']
2246,TF,TF:M00453,Factor: IRF-7; motif: TNSGAAWNCGAAANTNNN,1.291010246782226e-05,True,Factor: IRF-7; motif: TNSGAAWNCGAAANTNNN,3142,36,21,20045,0.5833333333333334,0.00668364099299809,Module 7,['TF:M00000']
2247,GO:BP,GO:0002253,activation of immune response,1.3012535013928397e-05,True,"""Any process that initiates an immune response."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",531,215,23,21031,0.10697674418604651,0.04331450094161959,Module 2,"['GO:0002376', 'GO:0050778']"
2248,GO:BP,GO:0010035,response to inorganic substance,1.3012535013928397e-05,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an inorganic substance stimulus."" [GOC:sm]",531,215,23,21031,0.10697674418604651,0.04331450094161959,Module 2,['GO:0042221']
2249,HPA,HPA:0470671,skin 2; melanocytes[≥Low],1.307874578935996e-05,True,skin 2; melanocytes[≥Low],724,69,19,11019,0.2753623188405797,0.026243093922651933,Module 5,['HPA:0470000']
2250,TF,TF:M08982_1,Factor: YY1; motif: NAANATGGCGNNN; match class: 1,1.3085994988374028e-05,True,Factor: YY1; motif: NAANATGGCGNNN; match class: 1,1670,105,29,20045,0.2761904761904762,0.017365269461077845,Module 3,['TF:M08982']
2251,GO:BP,GO:1901135,carbohydrate derivative metabolic process,1.3092182633772161e-05,True,"""The chemical reactions and pathways involving carbohydrate derivative."" [GOC:TermGenie]",1091,787,80,21031,0.10165184243964422,0.07332722273143905,Module 0,['GO:0071704']
2252,GO:BP,GO:0033036,macromolecule localization,1.3355124650050839e-05,True,"""Any process in which a macromolecule is transported to, or maintained in, a specific location."" [GOC:mah]",3210,787,180,21031,0.22871664548919948,0.056074766355140186,Module 0,['GO:0051179']
2253,HP,HP:0004366,Abnormality of glycolysis,1.3397929996370889e-05,True,An abnormality of glycolysis.,53,228,15,4958,0.06578947368421052,0.2830188679245283,Module 0,['HP:0011013']
2254,HP,HP:0003542,Increased serum pyruvate,1.3397929996370889e-05,True,An increased concentration of pyruvate in the blood.,53,228,15,4958,0.06578947368421052,0.2830188679245283,Module 0,['HP:0004366']
2255,TF,TF:M00453_1,Factor: IRF-7; motif: TNSGAAWNCGAAANTNNN; match class: 1,1.3583899408465316e-05,True,Factor: IRF-7; motif: TNSGAAWNCGAAANTNNN; match class: 1,338,36,9,20045,0.25,0.026627218934911243,Module 7,['TF:M00453']
2256,TF,TF:M12173,Factor: GKLF; motif: NNCCMCRCCCN,1.4049008410368495e-05,True,Factor: GKLF; motif: NNCCMCRCCCN,10282,826,505,20045,0.6113801452784504,0.04911495817934254,Module 0,['TF:M00000']
2257,GO:MF,GO:0003697,single-stranded DNA binding,1.4201441873376202e-05,True,"""Binding to single-stranded DNA."" [GOC:elh, GOC:vw, PMID:22976174]",121,80,8,20212,0.1,0.06611570247933884,Module 5,['GO:0003677']
2258,TF,TF:M00931,Factor: Sp1; motif: GGGGCGGGGC,1.4290035318891697e-05,True,Factor: Sp1; motif: GGGGCGGGGC,10605,826,518,20045,0.6271186440677966,0.04884488448844884,Module 0,['TF:M00000']
2259,GO:BP,GO:0009056,catabolic process,1.430361111470786e-05,True,"""The chemical reactions and pathways resulting in the breakdown of substances, including the breakdown of carbon compounds with the liberation of energy for use by the cell or organism."" [ISBN:0198547684]",2556,215,57,21031,0.2651162790697674,0.022300469483568074,Module 2,['GO:0008152']
2260,GO:BP,GO:0044238,primary metabolic process,1.4304349513731498e-05,True,"""The chemical reactions and pathways involving those compounds which are formed as a part of the normal anabolic and catabolic processes. These processes take place in most, if not all, cells of the organism."" [GOC:go_curators, http://www.metacyc.org]",12505,787,544,21031,0.6912325285895807,0.043502598960415834,Module 0,['GO:0008152']
2261,TF,TF:M08224,Factor: Elk-1:Pax-1; motif: ACCGGAACTACGCWTSANTG,1.4426983554460804e-05,True,Factor: Elk-1:Pax-1; motif: ACCGGAACTACGCWTSANTG,9088,826,456,20045,0.5520581113801453,0.05017605633802817,Module 0,['TF:M00000']
2262,HP,HP:0000464,Abnormality of the neck,1.4934183208908088e-05,True,An abnormality of the neck.,690,44,22,4958,0.5,0.03188405797101449,Module 3,['HP:0000152']
2263,GO:BP,GO:0048245,eosinophil chemotaxis,1.4950128785107393e-05,True,"""The movement of an eosinophil in response to an external stimulus."" [GOC:jid, PMID:11292027, PMID:12391252]",27,5,3,21031,0.6,0.1111111111111111,Module 12,"['GO:0071621', 'GO:0072677']"
2264,TF,TF:M13031,Factor: ETV4; motif: ACCGGAAGTN,1.5021369387436433e-05,True,Factor: ETV4; motif: ACCGGAAGTN,11030,105,86,20045,0.819047619047619,0.007796917497733454,Module 3,['TF:M00000']
2265,GO:MF,GO:0022804,active transmembrane transporter activity,1.5161810865729599e-05,True,"""Enables the transfer of a specific substance or related group of substances from one side of a membrane to the other, up the solute's concentration gradient. The transporter binds the solute and undergoes a series of conformational changes. Transport works equally well in either direction."" [GOC:mtg_transport, ISBN:0815340729]",453,808,45,20212,0.055693069306930694,0.09933774834437085,Module 0,['GO:0022857']
2266,REAC,REAC:R-HSA-9613829,Chaperone Mediated Autophagy,1.5188765966613047e-05,True,Chaperone Mediated Autophagy,22,19,4,10842,0.21052631578947367,0.18181818181818182,Module 9,['REAC:R-HSA-9612973']
2267,GO:BP,GO:0006810,transport,1.5196680011559777e-05,True,"""The directed movement of substances (such as macromolecules, small molecules, ions) or cellular components (such as complexes and organelles) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or a transporter complex, a pore or a motor protein."" [GOC:dos, GOC:dph, GOC:jl, GOC:mah]",4350,787,229,21031,0.2909783989834816,0.05264367816091954,Module 0,['GO:0051234']
2268,GO:BP,GO:0000380,"alternative mRNA splicing, via spliceosome",1.5360567944763625e-05,True,"""The process of generating multiple mRNA molecules from a given set of exons by differential use of exons from the primary transcript(s) to form multiple mature mRNAs that vary in their exon composition."" [GOC:krc, PMID:12110900]",72,787,16,21031,0.020330368487928845,0.2222222222222222,Module 0,['GO:0000398']
2269,HPA,HPA:0250133,hippocampus; neuronal cells[High],1.5400007231711345e-05,True,hippocampus; neuronal cells[High],1258,612,114,11019,0.18627450980392157,0.09062003179650238,Module 0,['HPA:0250132']
2270,GO:MF,GO:0045182,translation regulator activity,1.5426157985329328e-05,True,"""Any molecular function involved in the initiation, activation, perpetuation, repression or termination of polypeptide synthesis at the ribosome."" [GOC:ai]",147,808,23,20212,0.028465346534653466,0.1564625850340136,Module 0,['GO:0003674']
2271,GO:BP,GO:0043066,negative regulation of apoptotic process,1.545843796299046e-05,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process."" [GOC:jl, GOC:mtg_apoptosis]",881,215,30,21031,0.13953488372093023,0.0340522133938706,Module 2,"['GO:0006915', 'GO:0042981', 'GO:0043069']"
2272,HPA,HPA:0030432,appendix; germinal center cells[≥Medium],1.5480243686697544e-05,True,appendix; germinal center cells[≥Medium],227,79,12,11019,0.1518987341772152,0.05286343612334802,Module 3,['HPA:0030431']
2273,TF,TF:M03985,Factor: ETV6; motif: NSCGGAAGTR,1.553918618822131e-05,True,Factor: ETV6; motif: NSCGGAAGTR,1159,826,90,20045,0.1089588377723971,0.07765314926660914,Module 0,['TF:M00000']
2274,HPA,HPA:0160252,endometrium 1; cells in endometrial stroma[≥Medium],1.557206160455611e-05,True,endometrium 1; cells in endometrial stroma[≥Medium],2234,69,34,11019,0.4927536231884058,0.01521933751119069,Module 5,['HPA:0160251']
2275,GO:BP,GO:0140507,granzyme-mediated programmed cell death signaling pathway,1.558083463477497e-05,True,"""The series of molecular signals induced by granzymes which triggers the cell death of a cell. The pathway starts with reception of a granzyme signal, and ends when the execution phase of cell death is triggered. Granzymes are serine proteases that are secreted by cytotoxic T cells and natural killer cells to induce cell death in target cells."" [PMID:32299851]",8,226,5,21031,0.022123893805309734,0.625,Module 1,"['GO:0007165', 'GO:0012501']"
2276,GO:BP,GO:0002228,natural killer cell mediated immunity,1.5789300009130485e-05,True,"""The promotion of an immune response by natural killer cells through direct recognition of target cells or through the release of cytokines."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",75,226,10,21031,0.04424778761061947,0.13333333333333333,Module 1,"['GO:0002449', 'GO:0045087']"
2277,HPA,HPA:0381201,placenta; hofbauer cells[≥Low],1.5866051975451256e-05,True,placenta; hofbauer cells[≥Low],436,612,53,11019,0.08660130718954248,0.12155963302752294,Module 0,['HPA:0380000']
2278,HPA,HPA:0461462,skin 1; langerhans cells[≥Medium],1.5900278563216344e-05,True,skin 1; langerhans cells[≥Medium],578,140,25,11019,0.17857142857142858,0.04325259515570934,Module Singleton,['HPA:0461461']
2279,GO:BP,GO:0007155,cell adhesion,1.5999630976987446e-05,True,"""The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules."" [GOC:hb, GOC:pf]",1512,215,41,21031,0.19069767441860466,0.027116402116402115,Module 2,['GO:0009987']
2280,MIRNA,MIRNA:hsa-miR-296-3p,hsa-miR-296-3p,1.6061338259744346e-05,True,hsa-miR-296-3p,255,104,13,14819,0.125,0.050980392156862744,Module 3,['MIRNA:000000']
2281,HP,HP:0005339,Abnormality of complement system,1.6098065611680884e-05,True,An abnormality of the complement system.,59,74,10,4958,0.13513513513513514,0.1694915254237288,Module 2,['HP:0005368']
2282,GO:BP,GO:0006796,phosphate-containing compound metabolic process,1.625952151544273e-05,True,"""The chemical reactions and pathways involving the phosphate group, the anion or salt of any phosphoric acid."" [GOC:ai]",2571,787,151,21031,0.19186785260482847,0.058732010890704005,Module 0,['GO:0006793']
2283,HP,HP:0007924,Slow decrease in visual acuity,1.648060911188027e-05,True,Slow decrease in visual acuity,34,44,7,4958,0.1590909090909091,0.20588235294117646,Module 3,['HP:0000529']
2284,GO:BP,GO:0006886,intracellular protein transport,1.64838213947145e-05,True,"""The directed movement of proteins in a cell, including the movement of proteins between specific compartments or structures within a cell, such as organelles of a eukaryotic cell."" [GOC:mah]",686,72,15,21031,0.20833333333333334,0.021865889212827987,Module 4,"['GO:0008104', 'GO:0015031', 'GO:0046907']"
2285,GO:BP,GO:0097530,granulocyte migration,1.6626171954912596e-05,True,"""The movement of a granulocyte within or between different tissues and organs of the body."" [GOC:cvs, PMID:24163421, PMID:24193336]",156,215,13,21031,0.06046511627906977,0.08333333333333333,Module 2,['GO:0097529']
2286,GO:BP,GO:0023051,regulation of signaling,1.6697057121185402e-05,True,"""Any process that modulates the frequency, rate or extent of a signaling process."" [GOC:mtg_signal]",3437,215,69,21031,0.3209302325581395,0.02007564736688973,Module 2,"['GO:0023052', 'GO:0050789']"
2287,HP,HP:0011965,Abnormal circulating citrulline concentration,1.6845034064942292e-05,True,Any deviation from the normal concentration of citrulline in the blood circulation.,20,44,6,4958,0.13636363636363635,0.3,Module 3,['HP:0033109']
2288,GO:CC,GO:1990351,transporter complex,1.7348417405793154e-05,True,"""A protein complex facilitating transport of molecules (proteins, small molecules, nucleic acids) into, out of or within a cell, or between cells."" [GOC:bhm, PMID:15449578]",472,813,43,22097,0.05289052890528905,0.09110169491525423,Module 0,['GO:0032991']
2289,GO:BP,GO:0001916,positive regulation of T cell mediated cytotoxicity,1.74137145200086e-05,True,"""Any process that activates or increases the frequency, rate or extent of T cell mediated cytotoxicity."" [GOC:add, ISBN:0781735149]",38,15,4,21031,0.26666666666666666,0.10526315789473684,Module 6,"['GO:0001912', 'GO:0001913', 'GO:0001914', 'GO:0002711']"
2290,GO:BP,GO:0006793,phosphorus metabolic process,1.7585124116170546e-05,True,"""The chemical reactions and pathways involving the nonmetallic element phosphorus or compounds that contain phosphorus, usually in the form of a phosphate group (PO4)."" [GOC:ai]",2596,787,152,21031,0.193138500635324,0.05855161787365177,Module 0,['GO:0044237']
2291,GO:BP,GO:0010033,response to organic substance,1.7614464996092298e-05,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus."" [GOC:sm, PMID:23356676]",2637,21,14,21031,0.6666666666666666,0.005309063329541145,Module 9,['GO:0042221']
2292,GO:CC,GO:0043227,membrane-bounded organelle,1.7643851096787034e-05,True,"""Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane."" [GOC:go_curators]",15671,73,70,22097,0.958904109589041,0.0044668495947929295,Module 4,['GO:0043226']
2293,TF,TF:M00147,Factor: HSF2; motif: NGAANNWTCK,1.7711821482160623e-05,True,Factor: HSF2; motif: NGAANNWTCK,5920,21,19,20045,0.9047619047619048,0.0032094594594594596,Module 9,['TF:M00000']
2294,GO:BP,GO:0002683,negative regulation of immune system process,1.78507676150899e-05,True,"""Any process that stops, prevents, or reduces the frequency, rate, or extent of an immune system process."" [GOC:add]",495,215,22,21031,0.10232558139534884,0.044444444444444446,Module 2,"['GO:0002376', 'GO:0002682', 'GO:0048519']"
2295,HPA,HPA:0300000,lung,1.790784110271361e-05,True,lung,7379,79,73,11019,0.9240506329113924,0.009892939422686,Module 3,['HPA:0000000']
2296,HPA,HPA:0050053,breast; glandular cells[High],1.791850225989471e-05,True,breast; glandular cells[High],1349,612,120,11019,0.19607843137254902,0.08895478131949593,Module 0,['HPA:0050052']
2297,GO:BP,GO:0010646,regulation of cell communication,1.7960133542169995e-05,True,"""Any process that modulates the frequency, rate or extent of cell communication. Cell communication is the process that mediates interactions between a cell and its surroundings. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment."" [GOC:dph, GOC:tb]",3443,215,69,21031,0.3209302325581395,0.020040662213186174,Module 2,"['GO:0007154', 'GO:0050794']"
2298,WP,WP:WP4585,Cancer immunotherapy by PD 1 blockade,1.7980477091533127e-05,True,Cancer immunotherapy by PD 1 blockade,23,148,7,8286,0.0472972972972973,0.30434782608695654,Module 1,['WP:000000']
2299,HPA,HPA:0040000,bone marrow,1.8055847061372202e-05,True,bone marrow,6496,69,61,11019,0.8840579710144928,0.009390394088669951,Module 5,['HPA:0000000']
2300,HPA,HPA:0040081,bone marrow; hematopoietic cells[≥Low],1.8055847061372202e-05,True,bone marrow; hematopoietic cells[≥Low],6496,69,61,11019,0.8840579710144928,0.009390394088669951,Module 5,['HPA:0040000']
2301,HPA,HPA:0040082,bone marrow; hematopoietic cells[≥Medium],1.8240957806088096e-05,True,bone marrow; hematopoietic cells[≥Medium],4256,166,98,11019,0.5903614457831325,0.023026315789473683,Module 2,['HPA:0040081']
2302,GO:MF,GO:0008135,"translation factor activity, RNA binding",1.82489170174243e-05,True,"""Functions during translation by binding to RNA during polypeptide synthesis at the ribosome."" [GOC:ai, GOC:vw]",93,808,18,20212,0.022277227722772276,0.1935483870967742,Module 0,['GO:0090079']
2303,GO:BP,GO:0071621,granulocyte chemotaxis,1.829066882319357e-05,True,"""The movement of a granulocyte in response to an external stimulus."" [GOC:rph]",129,215,12,21031,0.05581395348837209,0.09302325581395349,Module 2,"['GO:0030595', 'GO:0097530']"
2304,GO:CC,GO:0005829,cytosol,1.837830199975271e-05,True,"""The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes."" [GOC:hjd, GOC:jl]",5487,21,17,22097,0.8095238095238095,0.0030982321851649353,Module 9,"['GO:0005737', 'GO:0110165']"
2305,GO:MF,GO:0005125,cytokine activity,1.8725928513020737e-05,True,"""The activity of a soluble extracellular gene product that interacts with a receptor to effect a change in the activity of the receptor to control the survival, growth, differentiation and effector function of tissues and cells."" [ISBN:0198599471, PMID:11530802]",238,5,4,20212,0.8,0.01680672268907563,Module 12,['GO:0048018']
2306,TF,TF:M11683,Factor: IRF-8; motif: NCGAAACCGAAACYN,1.8763361144599458e-05,True,Factor: IRF-8; motif: NCGAAACCGAAACYN,4769,36,25,20045,0.6944444444444444,0.005242189138184106,Module 7,['TF:M00000']
2307,GO:BP,GO:0098609,cell-cell adhesion,1.8786879330612793e-05,True,"""The attachment of one cell to another cell via adhesion molecules."" [GOC:dos]",946,226,32,21031,0.1415929203539823,0.03382663847780127,Module 1,['GO:0007155']
2308,REAC,REAC:R-HSA-5607764,CLEC7A (Dectin-1) signaling,1.9031344328697094e-05,True,CLEC7A (Dectin-1) signaling,97,586,21,10842,0.03583617747440273,0.21649484536082475,Module 0,['REAC:R-HSA-5621481']
2309,TF,TF:M00024,Factor: E2F-1; motif: TWSGCGCGAAAAYKR,1.9108773031096973e-05,True,Factor: E2F-1; motif: TWSGCGCGAAAAYKR,9080,826,455,20045,0.5508474576271186,0.05011013215859031,Module 0,['TF:M00000']
2310,HPA,HPA:0460000,skin 1,1.9138481438831694e-05,True,skin 1,7246,140,120,11019,0.8571428571428571,0.016560861164780567,Module Singleton,['HPA:0000000']
2311,HPA,HPA:0290401,liver; hepatocytes[≥Low],1.94869917070458e-05,True,liver; hepatocytes[≥Low],5748,79,64,11019,0.810126582278481,0.011134307585247043,Module 3,['HPA:0290000']
2312,TF,TF:M05444,Factor: CPBP; motif: NGGGCGG,1.9605498567053913e-05,True,Factor: CPBP; motif: NGGGCGG,8793,826,443,20045,0.5363196125907991,0.050380984874331854,Module 0,['TF:M00000']
2313,TF,TF:M05332,Factor: Sp2; motif: WGGGCGG,1.9605498567053913e-05,True,Factor: Sp2; motif: WGGGCGG,8793,826,443,20045,0.5363196125907991,0.050380984874331854,Module 0,['TF:M00000']
2314,TF,TF:M05361,Factor: Sp6; motif: WGGGCGG,1.9605498567053913e-05,True,Factor: Sp6; motif: WGGGCGG,8793,826,443,20045,0.5363196125907991,0.050380984874331854,Module 0,['TF:M00000']
2315,GO:BP,GO:0033365,protein localization to organelle,1.979167884077532e-05,True,"""A process in which a protein is transported to, or maintained in, a location within an organelle."" [GOC:mah]",1184,72,19,21031,0.2638888888888889,0.016047297297297296,Module 4,['GO:0008104']
2316,GO:BP,GO:1901564,organonitrogen compound metabolic process,1.9886371235150584e-05,True,"""The chemical reactions and pathways involving organonitrogen compound."" [GOC:pr, GOC:TermGenie]",5986,172,84,21031,0.4883720930232558,0.014032743067156699,Module Singleton,"['GO:0006807', 'GO:0071704']"
2317,GO:BP,GO:0002285,lymphocyte activation involved in immune response,2.016298849638547e-05,True,"""A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response."" [GOC:add, ISBN:0781735149]",211,226,15,21031,0.06637168141592921,0.07109004739336493,Module 1,"['GO:0002366', 'GO:0046649']"
2318,GO:BP,GO:0071345,cellular response to cytokine stimulus,2.0332786942993525e-05,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus."" [GOC:mah]",839,215,29,21031,0.13488372093023257,0.03456495828367104,Module 2,"['GO:0034097', 'GO:0071310']"
2319,TF,TF:M10849,Factor: Cdx-2; motif: NRTCGTAANNNN,2.0347704211238256e-05,True,Factor: Cdx-2; motif: NRTCGTAANNNN,11312,105,87,20045,0.8285714285714286,0.007690947666195191,Module 3,['TF:M00000']
2320,GO:CC,GO:0000793,condensed chromosome,2.0352311671955982e-05,True,"""A highly compacted molecule of DNA and associated proteins resulting in a cytologically distinct structure."" [GOC:elh]",282,80,10,22097,0.125,0.03546099290780142,Module 5,['GO:0005694']
2321,GO:MF,GO:0042608,T cell receptor binding,2.0505947601641012e-05,True,"""Binding to a T cell receptor, the antigen-recognizing receptor on the surface of T cells."" [GOC:jl]",11,17,3,20212,0.17647058823529413,0.2727272727272727,Module 6,"['GO:0005102', 'GO:0044877']"
2322,GO:BP,GO:0033554,cellular response to stress,2.0729557905629397e-05,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation)."" [GOC:mah]",1770,72,23,21031,0.3194444444444444,0.012994350282485875,Module 4,"['GO:0006950', 'GO:0051716']"
2323,GO:BP,GO:0022904,respiratory electron transport chain,2.0785940124002194e-05,True,"""A process in which a series of electron carriers operate together to transfer electrons from donors such as NADH and FADH2 to any of several different terminal electron acceptors to generate a transmembrane electrochemical gradient."" [GOC:mtg_electron_transport, ISBN:0716720094]",122,105,9,21031,0.08571428571428572,0.07377049180327869,Module 3,"['GO:0022900', 'GO:0045333']"
2324,GO:BP,GO:0051248,negative regulation of protein metabolic process,2.1098378750394593e-05,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of chemical reactions and pathways involving a protein."" [GOC:ai]",766,787,62,21031,0.07878017789072427,0.08093994778067885,Module 0,"['GO:0010605', 'GO:0019538', 'GO:0051172', 'GO:0051246']"
2325,GO:CC,GO:0032279,asymmetric synapse,2.1462099901076095e-05,True,"""A type of synapse occurring between an axon and a dendritic spine or dendritic shaft. Asymmetric synapses, the most abundant synapse type in the central nervous system, involve axons that contain predominantly spherical vesicles and contain a thickened postsynaptic density. Most or all synapses of this type are excitatory."" [GOC:dgh, GOC:ef]",334,105,12,22097,0.11428571428571428,0.03592814371257485,Module 3,['GO:0098984']
2326,REAC,REAC:R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,2.1662064516016536e-05,True,Regulation of APC/C activators between G1/S and early anaphase,81,586,19,10842,0.032423208191126277,0.2345679012345679,Module 0,['REAC:R-HSA-174143']
2327,GO:BP,GO:0031664,regulation of lipopolysaccharide-mediated signaling pathway,2.1753942556662437e-05,True,"""Any process that modulates the frequency, rate or extent of signaling in response to detection of lipopolysaccharide."" [GOC:mah]",28,215,7,21031,0.03255813953488372,0.25,Module 2,"['GO:0002831', 'GO:0009966', 'GO:0031663', 'GO:0032101']"
2328,GO:MF,GO:0016887,ATP hydrolysis activity,2.1789371812507135e-05,True,"""Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient."" [RHEA:13065]",404,20,7,20212,0.35,0.017326732673267328,Module 9,"['GO:0017111', 'GO:0140657']"
2329,TF,TF:M11535,Factor: E2F-4; motif: TTTTGGCGCCAWWN,2.2041462064731544e-05,True,Factor: E2F-4; motif: TTTTGGCGCCAWWN,11180,826,540,20045,0.6537530266343826,0.04830053667262969,Module 0,['TF:M00000']
2330,TF,TF:M08226_1,Factor: Elk-1:Pax-9; motif: ACCGGAACYACGCWYSANTG; match class: 1,2.2068092255446635e-05,True,Factor: Elk-1:Pax-9; motif: ACCGGAACYACGCWYSANTG; match class: 1,5756,826,312,20045,0.37772397094430993,0.054204308547602505,Module 0,['TF:M08226']
2331,HPA,HPA:0461463,skin 1; langerhans cells[High],2.2310461973693422e-05,True,skin 1; langerhans cells[High],218,69,11,11019,0.15942028985507245,0.05045871559633028,Module 5,['HPA:0461462']
2332,WP,WP:WP5095,Overview of proinflammatory and profibrotic mediators,2.2465256594344553e-05,True,Overview of proinflammatory and profibrotic mediators,127,5,4,8286,0.8,0.031496062992125984,Module 12,['WP:000000']
2333,HPA,HPA:0471461,skin 2; langerhans cells[≥Low],2.2515803110113047e-05,True,skin 2; langerhans cells[≥Low],789,79,21,11019,0.26582278481012656,0.026615969581749048,Module 3,['HPA:0470000']
2334,HP,HP:0002719,Recurrent infections,2.2773725557156413e-05,True,Increased susceptibility to infections.,971,71,35,4958,0.49295774647887325,0.03604531410916581,Module 1,['HP:0032101']
2335,HPA,HPA:0090000,cerebellum,2.2793629709307854e-05,True,cerebellum,7202,79,72,11019,0.9113924050632911,0.009997222993612885,Module 3,['HPA:0000000']
2336,GO:BP,GO:0045619,regulation of lymphocyte differentiation,2.290445377471707e-05,True,"""Any process that modulates the frequency, rate or extent of lymphocyte differentiation."" [GOC:go_curators]",213,226,15,21031,0.06637168141592921,0.07042253521126761,Module 1,"['GO:0030098', 'GO:0051249', 'GO:1902105']"
2337,HPA,HPA:0050051,breast; glandular cells[≥Low],2.293349915796535e-05,True,breast; glandular cells[≥Low],6813,79,70,11019,0.8860759493670886,0.010274475267870248,Module 3,['HPA:0050000']
2338,GO:BP,GO:0072677,eosinophil migration,2.296808204590594e-05,True,"""The movement of an eosinophil within or between different tissues and organs of the body."" [CL:0000771, GOC:BHF, GOC:mah]",31,5,3,21031,0.6,0.0967741935483871,Module 12,['GO:0097530']
2339,GO:CC,GO:0071007,U2-type catalytic step 2 spliceosome,2.29871735007839e-05,True,"""A spliceosomal complex that contains the U2, U5 and U6 snRNPs bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the U2, U5 and U6 snRNPs."" [GOC:ab, GOC:krc, GOC:mah, ISBN:0879695897, ISBN:0879697393, PMID:18322460, PMID:19239890]",30,813,10,22097,0.012300123001230012,0.3333333333333333,Module 0,"['GO:0005684', 'GO:0071013']"
2340,TF,TF:M02065,Factor: ER81; motif: RCCGGAARYN,2.3024517847260016e-05,True,Factor: ER81; motif: RCCGGAARYN,13076,183,154,20045,0.8415300546448088,0.011777301927194861,Module Singleton,['TF:M00000']
2341,GO:BP,GO:0140694,non-membrane-bounded organelle assembly,2.3070638259572958e-05,True,"""The aggregation, arrangement and bonding together of a set of components to form a non-membrane-bounded organelle."" [PMID:28225081]",409,787,41,21031,0.052096569250317665,0.10024449877750612,Module 0,['GO:0070925']
2342,GO:BP,GO:0050793,regulation of developmental process,2.3319493265423195e-05,True,"""Any process that modulates the frequency, rate or extent of development, the biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote, or a young adult) to a later condition (e.g. a multicellular animal or an aged adult)."" [GOC:go_curators]",2455,226,57,21031,0.252212389380531,0.023217922606924644,Module 1,"['GO:0032502', 'GO:0050789']"
2343,HP,HP:0002401,Stroke-like episode,2.3427851409762216e-05,True,"No consensus exists on what a stroke-like episode is, but these episodes can be functionally defined as a new neurological deficit, occurring with or without the context of seizures, which last longer than 24 hours.",21,44,6,4958,0.13636363636363635,0.2857142857142857,Module 3,['HP:0001297']
2344,HP,HP:0010974,Abnormal myeloid leukocyte morphology,2.36694751425419e-05,True,An abnormality of myeloid leukocytes.,328,71,20,4958,0.28169014084507044,0.06097560975609756,Module 1,['HP:0001881']
2345,GO:BP,GO:2000026,regulation of multicellular organismal development,2.3677702304407064e-05,True,"""Any process that modulates the frequency, rate or extent of multicellular organismal development."" [GOC:obol]",1411,215,39,21031,0.1813953488372093,0.027639971651311126,Module 2,"['GO:0007275', 'GO:0050793', 'GO:0051239']"
2346,GO:BP,GO:0019941,modification-dependent protein catabolic process,2.3708558077400414e-05,True,"""The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent modification of the target protein."" [GOC:go_curators]",609,787,53,21031,0.06734434561626429,0.08702791461412152,Module 0,"['GO:0043632', 'GO:0051603']"
2347,GO:BP,GO:0050870,positive regulation of T cell activation,2.4163044087977707e-05,True,"""Any process that activates or increases the frequency, rate or extent of T cell activation."" [GOC:ai]",247,226,16,21031,0.07079646017699115,0.06477732793522267,Module 1,"['GO:0042110', 'GO:0050863', 'GO:0051251', 'GO:1903039']"
2348,HPA,HPA:0020051,adrenal gland; glandular cells[≥Low],2.4174239187772252e-05,True,adrenal gland; glandular cells[≥Low],7415,79,73,11019,0.9240506329113924,0.009844908968307484,Module 3,['HPA:0020000']
2349,TF,TF:M03969_1,Factor: ELF5; motif: ANSMGGAAGTN; match class: 1,2.4346993625426336e-05,True,Factor: ELF5; motif: ANSMGGAAGTN; match class: 1,454,826,47,20045,0.05690072639225181,0.10352422907488987,Module 0,['TF:M03969']
2350,GO:BP,GO:0030155,regulation of cell adhesion,2.4705901378783342e-05,True,"""Any process that modulates the frequency, rate or extent of attachment of a cell to another cell or to the extracellular matrix."" [GOC:mah]",778,15,8,21031,0.5333333333333333,0.010282776349614395,Module 6,"['GO:0007155', 'GO:0050794']"
2351,HPA,HPA:0090192,cerebellum; cells in molecular layer[≥Medium],2.4751186860822162e-05,True,cerebellum; cells in molecular layer[≥Medium],2792,79,42,11019,0.5316455696202531,0.01504297994269341,Module 3,['HPA:0090191']
2352,GO:BP,GO:0051301,cell division,2.483462131783863e-05,True,"""The process resulting in division and partitioning of components of a cell to form more cells; may or may not be accompanied by the physical separation of a cell into distinct, individually membrane-bounded daughter cells."" [GOC:di, GOC:go_curators, GOC:pr]",656,77,15,21031,0.19480519480519481,0.022865853658536585,Module 5,['GO:0009987']
2353,GO:CC,GO:0042470,melanosome,2.4898889244593557e-05,True,"""A tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. Melanosomes are synthesized in melanocyte cells."" [GOC:jl, PMID:11584301]",111,73,7,22097,0.0958904109589041,0.06306306306306306,Module 4,['GO:0048770']
2354,GO:CC,GO:0048770,pigment granule,2.4898889244593557e-05,True,"""A small, subcellular membrane-bounded vesicle containing pigment and/or pigment precursor molecules. Pigment granule biogenesis is poorly understood, as pigment granules are derived from multiple sources including the endoplasmic reticulum, coated vesicles, lysosomes, and endosomes."" [GOC:jid, GOC:mh]",111,73,7,22097,0.0958904109589041,0.06306306306306306,Module 4,['GO:0031410']
2355,GO:BP,GO:0071704,organic substance metabolic process,2.503690109341924e-05,True,"""The chemical reactions and pathways involving an organic substance, any molecular entity containing carbon."" [GOC:mah]",13768,105,94,21031,0.8952380952380953,0.006827425915165601,Module 3,['GO:0008152']
2356,GO:CC,GO:1904724,tertiary granule lumen,2.5064773325845583e-05,True,"""Any membrane-enclosed lumen that is part of a tertiary granule."" [GO_REF:0000064, GOC:TermGenie, PMID:23650620]",55,221,8,22097,0.03619909502262444,0.14545454545454545,Module 2,"['GO:0070013', 'GO:0070820']"
2357,TF,TF:M01244_1,Factor: HSF2; motif: GAANRTTCTAGAA; match class: 1,2.520763780179712e-05,True,Factor: HSF2; motif: GAANRTTCTAGAA; match class: 1,26,21,4,20045,0.19047619047619047,0.15384615384615385,Module 9,['TF:M01244']
2358,TF,TF:M02065,Factor: ER81; motif: RCCGGAARYN,2.521777579312224e-05,True,Factor: ER81; motif: RCCGGAARYN,13076,105,94,20045,0.8952380952380953,0.007188742734781279,Module 3,['TF:M00000']
2359,HP,HP:0010702,Increased circulating antibody level,2.5227410394586005e-05,True,An increased level of gamma globulin (immunoglobulin) in the blood.,103,71,12,4958,0.16901408450704225,0.11650485436893204,Module 1,['HP:0010701']
2360,TF,TF:M12273_1,Factor: YY1; motif: GGCSGCCATTTTGN; match class: 1,2.5461228249422288e-05,True,Factor: YY1; motif: GGCSGCCATTTTGN; match class: 1,1261,826,95,20045,0.11501210653753027,0.0753370340999207,Module 0,['TF:M12273']
2361,HPA,HPA:0030431,appendix; germinal center cells[≥Low],2.5618028131459338e-05,True,appendix; germinal center cells[≥Low],287,79,13,11019,0.16455696202531644,0.04529616724738676,Module 3,['HPA:0030000']
2362,HPA,HPA:0020000,adrenal gland,2.5619803448077075e-05,True,adrenal gland,7422,79,73,11019,0.9240506329113924,0.009835623821072488,Module 3,['HPA:0000000']
2363,GO:BP,GO:0046649,lymphocyte activation,2.5971423670067862e-05,True,"""A change in morphology and behavior of a lymphocyte resulting from exposure to a specific antigen, mitogen, cytokine, chemokine, cellular ligand, or soluble factor."" [GOC:mgi_curators, ISBN:0781735149]",783,15,8,21031,0.5333333333333333,0.010217113665389528,Module 6,['GO:0045321']
2364,GO:CC,GO:1902495,transmembrane transporter complex,2.6137348154615865e-05,True,"""A transmembrane protein complex which enables the transfer of a substance from one side of a membrane to the other."" [GOC:bhm, GOC:TermGenie, PMID:18024586]",445,813,41,22097,0.05043050430504305,0.09213483146067415,Module 0,"['GO:0098796', 'GO:1990351']"
2365,REAC,REAC:R-HSA-3371453,Regulation of HSF1-mediated heat shock response,2.648123251058156e-05,True,Regulation of HSF1-mediated heat shock response,67,19,5,10842,0.2631578947368421,0.07462686567164178,Module 9,['REAC:R-HSA-3371556']
2366,WP,WP:WP5092,Interactions of natural killer cells in pancreatic cancer,2.6533923250039603e-05,True,Interactions of natural killer cells in pancreatic cancer,27,5,3,8286,0.6,0.1111111111111111,Module 12,['WP:000000']
2367,GO:BP,GO:1905323,telomerase holoenzyme complex assembly,2.676075602842276e-05,True,"""The aggregation, arrangement and bonding together of a set of components to form a telomerase holoenzyme complex."" [GO_REF:0000079, GOC:TermGenie, PMID:26305931]",6,21,3,21031,0.14285714285714285,0.5,Module 9,['GO:0022618']
2368,HPA,HPA:0620222,vagina; squamous epithelial cells[≥Medium],2.682474151149319e-05,True,vagina; squamous epithelial cells[≥Medium],4050,69,47,11019,0.6811594202898551,0.011604938271604939,Module 5,['HPA:0620221']
2369,GO:CC,GO:0036464,cytoplasmic ribonucleoprotein granule,2.7045117909750522e-05,True,"""A ribonucleoprotein granule located in the cytoplasm."" [GOC:bf, GOC:PARL, PMID:15121898]",255,813,29,22097,0.03567035670356704,0.11372549019607843,Module 0,"['GO:0005737', 'GO:0035770']"
2370,GO:BP,GO:0045088,regulation of innate immune response,2.711425280499246e-05,True,"""Any process that modulates the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection."" [GOC:ebc]",415,34,9,21031,0.2647058823529412,0.021686746987951807,Module 7,"['GO:0002831', 'GO:0031347', 'GO:0032101', 'GO:0045087', 'GO:0050776']"
2371,HPA,HPA:0351181,pancreas; pancreatic endocrine cells[≥Low],2.7490313282797324e-05,True,pancreas; pancreatic endocrine cells[≥Low],5628,79,63,11019,0.7974683544303798,0.011194029850746268,Module 3,['HPA:0350000']
2372,KEGG,KEGG:00190,Oxidative phosphorylation,2.762063591316573e-05,True,Oxidative phosphorylation,134,97,11,8484,0.1134020618556701,0.08208955223880597,Module 3,['KEGG:00000']
2373,GO:MF,GO:0090079,"translation regulator activity, nucleic acid binding",2.805539472767289e-05,True,"""Any selective and non-covalent interaction with a nucleic acid involved in the initiation, activation, perpetuation, repression or termination of polypeptide synthesis at the ribosome."" [GOC:dph, GOC:tb, GOC:vw]",117,808,20,20212,0.024752475247524754,0.17094017094017094,Module 0,"['GO:0003676', 'GO:0045182']"
2374,GO:CC,GO:0010008,endosome membrane,2.8082318786574344e-05,True,"""The lipid bilayer surrounding an endosome."" [GOC:mah]",567,813,48,22097,0.05904059040590406,0.08465608465608465,Module 0,"['GO:0005768', 'GO:0030659', 'GO:0098588']"
2375,GO:BP,GO:0032680,regulation of tumor necrosis factor production,2.8263569886763638e-05,True,"""Any process that modulates the frequency, rate or extent of tumor necrosis factor production."" [GOC:mah, PMID:10891884, PMID:15560120]",163,215,13,21031,0.06046511627906977,0.07975460122699386,Module 2,"['GO:0032640', 'GO:1903555']"
2376,GO:BP,GO:0032640,tumor necrosis factor production,2.8263569886763638e-05,True,"""The appearance of tumor necrosis factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Tumor necrosis factor is an inflammatory cytokine produced by macrophages/monocytes during acute inflammation and which is responsible for a diverse range of signaling events within cells, leading to necrosis or apoptosis."" [GOC:mah, PMID:10891884, PMID:15560120]",163,215,13,21031,0.06046511627906977,0.07975460122699386,Module 2,['GO:0071706']
2377,TF,TF:M00430,Factor: E2F-1; motif: NTTSGCGG,2.8402199217080763e-05,True,Factor: E2F-1; motif: NTTSGCGG,8242,826,419,20045,0.5072639225181598,0.050837175442853676,Module 0,['TF:M00000']
2378,GO:MF,GO:0008009,chemokine activity,2.8618437584006864e-05,True,"""The function of a family of small chemotactic cytokines; their name is derived from their ability to induce directed chemotaxis in nearby responsive cells. All chemokines possess a number of conserved cysteine residues involved in intramolecular disulfide bond formation. Some chemokines are considered pro-inflammatory and can be induced during an immune response to recruit cells of the immune system to a site of infection, while others are considered homeostatic and are involved in controlling the migration of cells during normal processes of tissue maintenance or development. Chemokines are found in all vertebrates, some viruses and some bacteria."" [GOC:BHF, GOC:rl, PMID:12183377, Wikipedia:Chemokine]",50,5,3,20212,0.6,0.06,Module 12,"['GO:0005125', 'GO:0042379']"
2379,GO:CC,GO:0031090,organelle membrane,2.8666674912742006e-05,True,"""A membrane that is one of the two lipid bilayers of an organelle envelope or the outermost membrane of single membrane bound organelle."" [GOC:dos, GOC:mah]",3770,177,59,22097,0.3333333333333333,0.015649867374005304,Module Singleton,"['GO:0016020', 'GO:0043227']"
2380,KEGG,KEGG:04714,Thermogenesis,2.8750017339086077e-05,True,Thermogenesis,232,97,14,8484,0.14432989690721648,0.0603448275862069,Module 3,['KEGG:00000']
2381,HPA,HPA:0100133,cerebral cortex; neuronal cells[High],2.9188289564097874e-05,True,cerebral cortex; neuronal cells[High],1848,79,33,11019,0.4177215189873418,0.017857142857142856,Module 3,['HPA:0100132']
2382,HPA,HPA:0530722,spleen; cells in white pulp[≥Medium],2.9268747370334648e-05,True,spleen; cells in white pulp[≥Medium],2720,140,63,11019,0.45,0.023161764705882354,Module Singleton,['HPA:0530721']
2383,GO:BP,GO:0043069,negative regulation of programmed cell death,2.98385052221703e-05,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes."" [GOC:jl]",907,215,30,21031,0.13953488372093023,0.03307607497243661,Module 2,"['GO:0012501', 'GO:0043067', 'GO:0048523']"
2384,HPA,HPA:0080123,caudate; glial cells[High],2.9999727919636082e-05,True,caudate; glial cells[High],683,69,18,11019,0.2608695652173913,0.02635431918008785,Module 5,['HPA:0080122']
2385,GO:CC,GO:0005737,cytoplasm,3.0236725723293587e-05,True,"""The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures."" [ISBN:0198547684]",12345,80,67,22097,0.8375,0.005427298501417578,Module 5,"['GO:0005622', 'GO:0110165']"
2386,GO:BP,GO:1902105,regulation of leukocyte differentiation,3.0280895293099552e-05,True,"""Any process that modulates the frequency, rate or extent of leukocyte differentiation."" [GOC:add, GOC:TermGenie]",323,226,18,21031,0.07964601769911504,0.05572755417956656,Module 1,"['GO:0002521', 'GO:1903706']"
2387,GO:MF,GO:0048020,CCR chemokine receptor binding,3.0404829306625303e-05,True,"""Binding to a CCR chemokine receptor."" [GOC:ai]",51,5,3,20212,0.6,0.058823529411764705,Module 12,['GO:0042379']
2388,TF,TF:M11052,Factor: Hey2; motif: NNCACGYGNN,3.0413428542983904e-05,True,Factor: Hey2; motif: NNCACGYGNN,12783,826,602,20045,0.7288135593220338,0.04709379644840804,Module 0,['TF:M00000']
2389,GO:BP,GO:0008284,positive regulation of cell population proliferation,3.0455856171085257e-05,True,"""Any process that activates or increases the rate or extent of cell proliferation."" [GOC:go_curators]",962,215,31,21031,0.14418604651162792,0.032224532224532226,Module 2,"['GO:0008283', 'GO:0042127', 'GO:0048522']"
2390,TF,TF:M03973,Factor: ELK4; motif: ACCGGAARTN,3.096537007029935e-05,True,Factor: ELK4; motif: ACCGGAARTN,710,826,63,20045,0.07627118644067797,0.08873239436619719,Module 0,['TF:M00000']
2391,GO:CC,GO:0099572,postsynaptic specialization,3.149679641185792e-05,True,"""A network of proteins within and adjacent to the postsynaptic membrane. Its major components include neurotransmitter receptors and the proteins that spatially and functionally organize them such as anchoring and scaffolding molecules, signaling enzymes and cytoskeletal components."" [PMID:22046028]",346,105,12,22097,0.11428571428571428,0.03468208092485549,Module 3,"['GO:0043226', 'GO:0098794']"
2392,GO:BP,GO:1901652,response to peptide,3.162703634662256e-05,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide stimulus."" [GOC:pr, GOC:TermGenie]",511,215,22,21031,0.10232558139534884,0.043052837573385516,Module 2,"['GO:0010243', 'GO:1901700']"
2393,GO:CC,GO:0005681,spliceosomal complex,3.174382788552391e-05,True,"""Any of a series of ribonucleoprotein complexes that contain snRNA(s) and small nuclear ribonucleoproteins (snRNPs), and are formed sequentially during the spliceosomal splicing of one or more substrate RNAs, and which also contain the RNA substrate(s) from the initial target RNAs of splicing, the splicing intermediate RNA(s), to the final RNA products. During cis-splicing, the initial target RNA is a single, contiguous RNA transcript, whether mRNA, snoRNA, etc., and the released products are a spliced RNA and an excised intron, generally as a lariat structure. During trans-splicing, there are two initial substrate RNAs, the spliced leader RNA and a pre-mRNA."" [GOC:editors, GOC:mah, ISBN:0198547684, PMID:19239890]",206,177,12,22097,0.06779661016949153,0.05825242718446602,Module Singleton,"['GO:0140513', 'GO:1990904']"
2394,GO:CC,GO:0071944,cell periphery,3.180925341963969e-05,True,"""The broad region around and including the plasma membrane of a cell, encompassing the cell cortex (inside the cell), the plasma membrane, and any external encapsulating structures."" [GOC:pdt]",6228,221,99,22097,0.4479638009049774,0.015895953757225433,Module 2,['GO:0110165']
2395,GO:BP,GO:0051649,establishment of localization in cell,3.194557291776322e-05,True,"""Any process, occuring in a cell, that localizes a substance or cellular component. This may occur via movement, tethering or selective degradation."" [GOC:ai, GOC:dos, GOC:dph, GOC:tb]",1972,72,24,21031,0.3333333333333333,0.012170385395537525,Module 4,"['GO:0051234', 'GO:0051641']"
2396,HP,HP:0001345,Psychotic mentation,3.2001297652644164e-05,True,"A pattern of thinking and perceiving characterized by a loss of contact with reality, leading to significant changes in thoughts, perceptions, and behaviors.",22,44,6,4958,0.13636363636363635,0.2727272727272727,Module 3,['HP:5200430']
2397,GO:CC,GO:0035770,ribonucleoprotein granule,3.21519667849546e-05,True,"""A non-membranous macromolecular complex containing proteins and translationally silenced mRNAs. RNA granules contain proteins that control the localization, stability, and translation of their RNA cargo. Different types of RNA granules (RGs) exist, depending on the cell type and cellular conditions."" [GOC:go_curators, GOC:sp, PMID:16520386, PMID:20368989, PMID:21436445]",272,813,30,22097,0.03690036900369004,0.11029411764705882,Module 0,"['GO:0043232', 'GO:0099080']"
2398,TF,TF:M11018,Factor: IRX-1; motif: NACRYNNNNNNNNRYGNN,3.2281974667407795e-05,True,Factor: IRX-1; motif: NACRYNNNNNNNNRYGNN,17328,826,765,20045,0.9261501210653753,0.04414819944598338,Module 0,['TF:M00000']
2399,GO:CC,GO:0005768,endosome,3.2379099979255265e-05,True,"""A vacuole to which materials ingested by endocytosis are delivered."" [ISBN:0198506732, PMID:19696797]",1060,813,74,22097,0.0910209102091021,0.06981132075471698,Module 0,"['GO:0012505', 'GO:0031410']"
2400,GO:BP,GO:0140888,interferon-mediated signaling pathway,3.277021707174535e-05,True,"""The series of molecular signals initiated by type II interferon binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. Type II interferon is also known as interferon-gamma."" [GOC:add, GOC:dph, GOC:signaling, PMID:32464097]",106,34,6,21031,0.17647058823529413,0.05660377358490566,Module 7,['GO:0019221']
2401,KEGG,KEGG:05130,Pathogenic Escherichia coli infection,3.296828647189383e-05,True,Pathogenic Escherichia coli infection,197,439,29,8484,0.06605922551252848,0.14720812182741116,Module 0,['KEGG:00000']
2402,GO:MF,GO:0023023,MHC protein complex binding,3.3108442706003227e-05,True,"""Binding to a major histocompatibility complex."" [GOC:mtg_signal, GOC:vw]",33,232,7,20212,0.03017241379310345,0.21212121212121213,Module 1,['GO:0044877']
2403,WP,WP:WP4494,Selective expression of chemokine receptors during T cell polarization,3.313496410970452e-05,True,Selective expression of chemokine receptors during T cell polarization,29,5,3,8286,0.6,0.10344827586206896,Module 12,['WP:000000']
2404,TF,TF:M10880_1,Factor: Alx-4; motif: NNCRTTAN; match class: 1,3.331098519864744e-05,True,Factor: Alx-4; motif: NNCRTTAN; match class: 1,2742,826,171,20045,0.20702179176755447,0.06236323851203501,Module 0,['TF:M10880']
2405,GO:BP,GO:0007015,actin filament organization,3.348170276218183e-05,True,"""A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments. Includes processes that control the spatial distribution of actin filaments, such as organizing filaments into meshworks, bundles, or other structures, as by cross-linking."" [GOC:mah]",463,787,44,21031,0.05590851334180432,0.09503239740820735,Module 0,"['GO:0030036', 'GO:0097435']"
2406,GO:BP,GO:0033043,regulation of organelle organization,3.358829148267463e-05,True,"""Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of an organelle."" [GOC:mah]",1173,787,83,21031,0.10546378653113088,0.07075873827791987,Module 0,"['GO:0006996', 'GO:0051128']"
2407,GO:BP,GO:0010604,positive regulation of macromolecule metabolic process,3.3637549653997606e-05,True,"""Any process that increases the frequency, rate or extent of the chemical reactions and pathways involving macromolecules, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass."" [GOC:dph, GOC:tb]",3420,215,68,21031,0.31627906976744186,0.019883040935672516,Module 2,"['GO:0009893', 'GO:0043170', 'GO:0060255']"
2408,HPA,HPA:0460182,skin 1; cells in granular layer[≥Medium],3.3803161259594045e-05,True,skin 1; cells in granular layer[≥Medium],558,140,24,11019,0.17142857142857143,0.043010752688172046,Module Singleton,['HPA:0460181']
2409,HPA,HPA:0030432,appendix; germinal center cells[≥Medium],3.398080150512402e-05,True,appendix; germinal center cells[≥Medium],227,612,34,11019,0.05555555555555555,0.14977973568281938,Module 0,['HPA:0030431']
2410,REAC,REAC:R-HSA-109581,Apoptosis,3.420385886707591e-05,True,Apoptosis,176,586,29,10842,0.04948805460750853,0.16477272727272727,Module 0,['REAC:R-HSA-5357801']
2411,KEGG,KEGG:04657,IL-17 signaling pathway,3.4249495140112854e-05,True,IL-17 signaling pathway,92,143,11,8484,0.07692307692307693,0.11956521739130435,Module 2,['KEGG:00000']
2412,HPA,HPA:0090181,cerebellum; cells in granular layer[≥Low],3.4619291657767804e-05,True,cerebellum; cells in granular layer[≥Low],4549,612,315,11019,0.5147058823529411,0.06924598812925918,Module 0,['HPA:0090000']
2413,TF,TF:M00147_1,Factor: HSF2; motif: NGAANNWTCK; match class: 1,3.489714331738545e-05,True,Factor: HSF2; motif: NGAANNWTCK; match class: 1,4457,21,17,20045,0.8095238095238095,0.003814224814897913,Module 9,['TF:M00147']
2414,GO:MF,GO:0005126,cytokine receptor binding,3.4930904315084986e-05,True,"""Binding to a cytokine receptor."" [GOC:mah, GOC:vw]",278,5,4,20212,0.8,0.014388489208633094,Module 12,['GO:0005102']
2415,TF,TF:M08441,Factor: AP-2gamma:Elk-1; motif: NGCCKNRGGSGRCGGAAGTG,3.502712554141486e-05,True,Factor: AP-2gamma:Elk-1; motif: NGCCKNRGGSGRCGGAAGTG,16725,826,745,20045,0.9019370460048426,0.044544095665171896,Module 0,['TF:M00000']
2416,HPA,HPA:0401332,rectum; mucosal lymphoid cells[≥Medium],3.504840997303107e-05,True,rectum; mucosal lymphoid cells[≥Medium],398,612,49,11019,0.08006535947712418,0.12311557788944724,Module 0,['HPA:0401331']
2417,GO:BP,GO:0051247,positive regulation of protein metabolic process,3.5238389908092775e-05,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein."" [GOC:ai]",1253,787,87,21031,0.11054637865311309,0.06943335993615324,Module 0,"['GO:0010604', 'GO:0019538', 'GO:0051173', 'GO:0051246']"
2418,HPA,HPA:0381203,placenta; hofbauer cells[High],3.53387131136717e-05,True,placenta; hofbauer cells[High],282,612,39,11019,0.06372549019607843,0.13829787234042554,Module 0,['HPA:0381202']
2419,HP,HP:0002783,Recurrent lower respiratory tract infections,3.539353277739955e-05,True,An increased susceptibility to lower respiratory tract infections as manifested by a history of recurrent lower respiratory tract infections.,238,71,17,4958,0.23943661971830985,0.07142857142857142,Module 1,['HP:0002205']
2420,GO:CC,GO:0034719,SMN-Sm protein complex,3.552267535114055e-05,True,"""A protein complex formed by the association of several methylated Sm proteins with the SMN complex; the latter contains the survival motor neuron (SMN) protein and at least eight additional integral components, including the Gemin2-8 and unrip proteins; additional proteins, including galectin-1 and galectin-3, are also found in the SMN-SM complex. The SMN-Sm complex is involved in spliceosomal snRNP assembly in the cytoplasm."" [GOC:vw, PMID:11522829, PMID:17401408]",18,813,8,22097,0.00984009840098401,0.4444444444444444,Module 0,"['GO:0005737', 'GO:0120114']"
2421,GO:BP,GO:0006511,ubiquitin-dependent protein catabolic process,3.55249663908173e-05,True,"""The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the protein."" [GOC:go_curators]",599,787,52,21031,0.06607369758576874,0.08681135225375626,Module 0,['GO:0019941']
2422,HP,HP:0032101,Unusual infection,3.6479136581613757e-05,True,"A type of infection that is regarded as a sign of a pathological susceptibility to infection. There are five general subtypes. (i) Opportunistic infection, meaning infection by a pathogen that is not normally able to cause infection in a healthy host (e.g., pneumonia by Pneumocystis jirovecii or CMV); (ii) Unusual location (focus) of an infection (e.g., an aspergillus brain abscess); (iii) a protracted course or lack of adequate response to treatment (e.g., chronic rhinosinusitis); (iv) Unusual severity or intensity of an infection; and (v) unusual recurrence of infections.",1040,71,36,4958,0.5070422535211268,0.03461538461538462,Module 1,['HP:0010978']
2423,HPA,HPA:0420053,salivary gland; glandular cells[High],3.668731614319616e-05,True,salivary gland; glandular cells[High],1483,79,29,11019,0.3670886075949367,0.019554956169925825,Module 3,['HPA:0420052']
2424,TF,TF:M04010,Factor: HSF4; motif: TTCTAGAANNTTC,3.675418812372903e-05,True,Factor: HSF4; motif: TTCTAGAANNTTC,174,21,6,20045,0.2857142857142857,0.034482758620689655,Module 9,['TF:M00000']
2425,HPA,HPA:0500653,soft tissue 1; fibroblasts[High],3.679756876296137e-05,True,soft tissue 1; fibroblasts[High],541,69,16,11019,0.2318840579710145,0.029574861367837338,Module 5,['HPA:0500652']
2426,TF,TF:M08441_1,Factor: AP-2gamma:Elk-1; motif: NGCCKNRGGSGRCGGAAGTG; match class: 1,3.682992366545435e-05,True,Factor: AP-2gamma:Elk-1; motif: NGCCKNRGGSGRCGGAAGTG; match class: 1,13081,826,613,20045,0.7421307506053268,0.04686186071401269,Module 0,['TF:M08441']
2427,GO:CC,GO:0031982,vesicle,3.6901451715643885e-05,True,"""Any small, fluid-filled, spherical organelle enclosed by membrane."" [GOC:mah, GOC:pz, GOC:vesicles]",4004,17,13,22097,0.7647058823529411,0.003246753246753247,Module 6,['GO:0043227']
2428,TF,TF:M10591_1,Factor: BSX; motif: NNCGTTAN; match class: 1,3.700528744696673e-05,True,Factor: BSX; motif: NNCGTTAN; match class: 1,2303,826,149,20045,0.18038740920096852,0.06469821971341728,Module 0,['TF:M10591']
2429,HPA,HPA:0600442,tonsil; non-germinal center cells[≥Medium],3.702430120909078e-05,True,tonsil; non-germinal center cells[≥Medium],4200,79,53,11019,0.6708860759493671,0.012619047619047618,Module 3,['HPA:0600441']
2430,GO:BP,GO:0031341,regulation of cell killing,3.703406139966961e-05,True,"""Any process that modulates the frequency, rate or extent of cell killing, the process in which a cell brings about the death of another cell, either in the same or a different organism."" [GOC:mah]",105,226,11,21031,0.048672566371681415,0.10476190476190476,Module 1,"['GO:0001906', 'GO:0050794']"
2431,GO:BP,GO:0009617,response to bacterium,3.719486056357779e-05,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a bacterium."" [GOC:hb]",720,226,27,21031,0.11946902654867257,0.0375,Module 1,['GO:0051707']
2432,TF,TF:M00008,Factor: Sp1; motif: GGGGCGGGGT,3.736032057799985e-05,True,Factor: Sp1; motif: GGGGCGGGGT,10364,826,506,20045,0.612590799031477,0.04882284832111154,Module 0,['TF:M00000']
2433,REAC,REAC:R-HSA-69052,Switching of origins to a post-replicative state,3.745190790571171e-05,True,Switching of origins to a post-replicative state,92,586,20,10842,0.034129692832764506,0.21739130434782608,Module 0,['REAC:R-HSA-69239']
2434,TF,TF:M02052,Factor: EHF; motif: CSCGGAARTN,3.746397970169223e-05,True,Factor: EHF; motif: CSCGGAARTN,10305,105,82,20045,0.780952380952381,0.007957302280446386,Module 3,['TF:M00000']
2435,HPA,HPA:0470000,skin 2,3.747214241572431e-05,True,skin 2,7036,69,63,11019,0.9130434782608695,0.008953951108584423,Module 5,['HPA:0000000']
2436,TF,TF:M11394,Factor: Erg; motif: NACMGGAARTN,3.7492849725241483e-05,True,Factor: Erg; motif: NACMGGAARTN,4088,826,235,20045,0.2845036319612591,0.0574853228962818,Module 0,['TF:M00000']
2437,GO:CC,GO:0019773,"proteasome core complex, alpha-subunit complex",3.7618324854549766e-05,True,"""The proteasome core subcomplex that constitutes the two outer rings of the proteasome core complex. An example of this component is found in Mus musculus."" [GOC:jl, GOC:mtg_sensu, GOC:rb, PMID:10854779]",10,2,2,22097,1.0,0.2,Module 41,"['GO:0005622', 'GO:0005839', 'GO:0032991']"
2438,TF,TF:M11382_1,Factor: ESE-1; motif: NWTRCGGAWGCN; match class: 1,3.794735461756768e-05,True,Factor: ESE-1; motif: NWTRCGGAWGCN; match class: 1,4233,105,48,20045,0.45714285714285713,0.011339475549255847,Module 3,['TF:M11382']
2439,GO:MF,GO:0003729,mRNA binding,3.8915026244577776e-05,True,"""Binding to messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns."" [GOC:kmv, GOC:pr, SO:0000234]",369,105,13,20212,0.12380952380952381,0.03523035230352303,Module 3,['GO:0003723']
2440,HPA,HPA:0401331,rectum; mucosal lymphoid cells[≥Low],3.9276719290228e-05,True,rectum; mucosal lymphoid cells[≥Low],543,166,26,11019,0.1566265060240964,0.04788213627992634,Module 2,['HPA:0400000']
2441,TF,TF:M01078,Factor: c-Ets-1; motif: NNNRCCGGAWRYNNNN,3.933220619504743e-05,True,Factor: c-Ets-1; motif: NNNRCCGGAWRYNNNN,7725,105,69,20045,0.6571428571428571,0.008932038834951457,Module 3,['TF:M00000']
2442,GO:MF,GO:0030527,structural constituent of chromatin,3.943497783493987e-05,True,"""The action of a molecule that contributes to the structural integrity of chromatin."" [GOC:ai]",100,3,3,20212,1.0,0.03,Module 27,['GO:0005198']
2443,GO:MF,GO:0000166,nucleotide binding,3.981143948381185e-05,True,"""Binding to a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose."" [GOC:mah, ISBN:0198547684]",2187,20,12,20212,0.6,0.0054869684499314125,Module 9,"['GO:1901265', 'GO:1901363']"
2444,REAC,REAC:R-HSA-1280215,Cytokine Signaling in Immune system,3.9855752219114366e-05,True,Cytokine Signaling in Immune system,719,173,32,10842,0.18497109826589594,0.04450625869262865,Module 2,['REAC:R-HSA-168256']
2445,HPA,HPA:0471482,skin 2; sebaceous glands[≥Medium],3.996578577079122e-05,True,skin 2; sebaceous glands[≥Medium],110,612,22,11019,0.03594771241830065,0.2,Module 0,['HPA:0471481']
2446,GO:MF,GO:1901265,nucleoside phosphate binding,4.001482491298619e-05,True,"""Binding to nucleoside phosphate."" [GOC:TermGenie]",2188,20,12,20212,0.6,0.005484460694698354,Module 9,['GO:0097159']
2447,HPA,HPA:0381192,placenta; cytotrophoblasts[≥Medium],4.0365869361740925e-05,True,placenta; cytotrophoblasts[≥Medium],424,612,51,11019,0.08333333333333333,0.12028301886792453,Module 0,['HPA:0381191']
2448,GO:BP,GO:0071706,tumor necrosis factor superfamily cytokine production,4.063284506276098e-05,True,"""The appearance of any member of the TNF superfamily due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels."" [GOC:add]",168,215,13,21031,0.06046511627906977,0.07738095238095238,Module 2,['GO:0001816']
2449,GO:BP,GO:1903555,regulation of tumor necrosis factor superfamily cytokine production,4.063284506276098e-05,True,"""Any process that modulates the frequency, rate or extent of tumor necrosis factor superfamily cytokine production."" [GO_REF:0000058, GOC:TermGenie, PMID:24187568]",168,215,13,21031,0.06046511627906977,0.07738095238095238,Module 2,"['GO:0001817', 'GO:0071706']"
2450,HP,HP:0003800,Muscle abnormality related to mitochondrial dysfunction,4.065664628052749e-05,True,Muscle abnormality related to mitochondrial dysfunction,83,44,9,4958,0.20454545454545456,0.10843373493975904,Module 3,['HP:0011804']
2451,HPA,HPA:0130053,colon; glandular cells[High],4.067425435224957e-05,True,colon; glandular cells[High],2418,612,188,11019,0.30718954248366015,0.07775020678246485,Module 0,['HPA:0130052']
2452,GO:MF,GO:0005515,protein binding,4.0903808915989745e-05,True,"""Binding to a protein."" [GOC:go_curators]",14838,80,77,20212,0.9625,0.0051893786224558565,Module 5,['GO:0005488']
2453,GO:CC,GO:0000786,nucleosome,4.0996834556741285e-05,True,"""A complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA into higher order structures."" [GOC:elh]",135,3,3,22097,1.0,0.022222222222222223,Module 27,"['GO:0000785', 'GO:0032993']"
2454,HPA,HPA:0430051,seminal vesicle; glandular cells[≥Low],4.1164298807033215e-05,True,seminal vesicle; glandular cells[≥Low],6828,60,55,11019,0.9166666666666666,0.008055067369654365,Module 4,['HPA:0430000']
2455,HPA,HPA:0430000,seminal vesicle,4.1164298807033215e-05,True,seminal vesicle,6828,60,55,11019,0.9166666666666666,0.008055067369654365,Module 4,['HPA:0000000']
2456,GO:BP,GO:0006986,response to unfolded protein,4.1192227648051636e-05,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus."" [GOC:jl]",137,72,8,21031,0.1111111111111111,0.058394160583941604,Module 4,['GO:0035966']
2457,HPA,HPA:0270351,kidney; cells in glomeruli[≥Low],4.120587610475609e-05,True,kidney; cells in glomeruli[≥Low],5168,140,96,11019,0.6857142857142857,0.018575851393188854,Module Singleton,['HPA:0270000']
2458,GO:CC,GO:0071748,monomeric IgA immunoglobulin complex,4.157779243543918e-05,True,"""A protein complex composed of two identical immunoglobulin heavy chains of an IgA isotype and two identical immunoglobulin light chains, held together by disulfide bonds, and present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph."" [GOC:add, ISBN:0781765196, PMID:16362985]",4,73,3,22097,0.0410958904109589,0.75,Module 4,['GO:0071746']
2459,HPA,HPA:0381193,placenta; cytotrophoblasts[High],4.1683420405018076e-05,True,placenta; cytotrophoblasts[High],295,612,40,11019,0.06535947712418301,0.13559322033898305,Module 0,['HPA:0381192']
2460,GO:BP,GO:0001914,regulation of T cell mediated cytotoxicity,4.1919771554481346e-05,True,"""Any process that modulates the frequency, rate, or extent of T cell mediated cytotoxicity."" [GOC:add, ISBN:0781735149]",47,15,4,21031,0.26666666666666666,0.0851063829787234,Module 6,"['GO:0001910', 'GO:0001913', 'GO:0002709']"
2461,TF,TF:M03975_1,Factor: ERG; motif: ACCGGAARTN; match class: 1,4.24893322802307e-05,True,Factor: ERG; motif: ACCGGAARTN; match class: 1,4100,105,47,20045,0.44761904761904764,0.011463414634146341,Module 3,['TF:M03975']
2462,TF,TF:M11382,Factor: ESE-1; motif: NWTRCGGAWGCN,4.27824388778205e-05,True,Factor: ESE-1; motif: NWTRCGGAWGCN,10545,105,83,20045,0.7904761904761904,0.007871028923660503,Module 3,['TF:M00000']
2463,GO:BP,GO:0043632,modification-dependent macromolecule catabolic process,4.323790980666785e-05,True,"""The chemical reactions and pathways resulting in the breakdown of a macromolecule, initiated by covalent modification of the target molecule."" [GOC:jl]",620,787,53,21031,0.06734434561626429,0.08548387096774193,Module 0,['GO:0009057']
2464,HPA,HPA:0090192,cerebellum; cells in molecular layer[≥Medium],4.3399383680278564e-05,True,cerebellum; cells in molecular layer[≥Medium],2792,612,211,11019,0.34477124183006536,0.0755730659025788,Module 0,['HPA:0090191']
2465,GO:CC,GO:0031967,organelle envelope,4.3401798986524694e-05,True,"""A double membrane structure enclosing an organelle, including two lipid bilayers and the region between them. In some cases, an organelle envelope may have more than two membranes."" [GOC:mah, GOC:pz]",1299,177,30,22097,0.1694915254237288,0.023094688221709007,Module Singleton,"['GO:0031975', 'GO:0043227', 'GO:0043229']"
2466,GO:CC,GO:0031975,envelope,4.3401798986524694e-05,True,"""A multilayered structure surrounding all or part of a cell; encompasses one or more lipid bilayers, and may include a cell wall layer; also includes the space between layers."" [GOC:mah, GOC:pz]",1299,177,30,22097,0.1694915254237288,0.023094688221709007,Module Singleton,['GO:0110165']
2467,HPA,HPA:0131331,colon; mucosal lymphoid cells[≥Low],4.340233260550759e-05,True,colon; mucosal lymphoid cells[≥Low],509,166,25,11019,0.15060240963855423,0.04911591355599214,Module 2,['HPA:0130000']
2468,HP,HP:0000036,Abnormal penis morphology,4.3907767013256306e-05,True,Abnormality of the male external sex organ.,662,44,21,4958,0.4772727272727273,0.03172205438066465,Module 3,['HP:0000032']
2469,TF,TF:M11438,Factor: SAP-1; motif: NTCGTAAATGCN,4.4315515605811144e-05,True,Factor: SAP-1; motif: NTCGTAAATGCN,5986,105,59,20045,0.5619047619047619,0.00985633144002673,Module 3,['TF:M00000']
2470,HPA,HPA:0600433,tonsil; germinal center cells[High],4.470545079374064e-05,True,tonsil; germinal center cells[High],1228,79,26,11019,0.3291139240506329,0.021172638436482084,Module 3,['HPA:0600432']
2471,GO:BP,GO:0019222,regulation of metabolic process,4.502284999208085e-05,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism."" [GOC:go_curators]",7158,787,341,21031,0.4332909783989835,0.04763900530874546,Module 0,"['GO:0008152', 'GO:0050789']"
2472,TF,TF:M00738_1,Factor: E2F-4:DP-1; motif: TTTSGCGC; match class: 1,4.5386676670581725e-05,True,Factor: E2F-4:DP-1; motif: TTTSGCGC; match class: 1,4124,80,39,20045,0.4875,0.009456838021338506,Module 5,['TF:M00738']
2473,HPA,HPA:0471462,skin 2; langerhans cells[≥Medium],4.595059549086665e-05,True,skin 2; langerhans cells[≥Medium],662,166,29,11019,0.1746987951807229,0.04380664652567976,Module 2,['HPA:0471461']
2474,GO:BP,GO:0051973,positive regulation of telomerase activity,4.608559484375029e-05,True,"""Any process that activates or increases the frequency, rate or extent of telomerase activity, the catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1)."" [GOC:ai]",33,21,4,21031,0.19047619047619047,0.12121212121212122,Module 9,"['GO:0051347', 'GO:0051972', 'GO:2000573']"
2475,HP,HP:0011927,Short digit,4.740294247736381e-05,True,"One or more digit that appears disproportionately short compared to the hand/foot, whereby either the entire digit or a specific phalanx is shortened.",599,44,20,4958,0.45454545454545453,0.0333889816360601,Module 3,['HP:0011297']
2476,GO:CC,GO:1904813,ficolin-1-rich granule lumen,4.782430998532726e-05,True,"""Any membrane-enclosed lumen that is part of a ficolin-1-rich granule."" [GO_REF:0000064, GOC:TermGenie, PMID:23650620]",124,813,19,22097,0.023370233702337023,0.1532258064516129,Module 0,"['GO:0070013', 'GO:0101002']"
2477,TF,TF:M12591_1,Factor: CREB1; motif: NNNNSSGGCGCSSNNNNRTGACGTCAC; match class: 1,4.920826970411324e-05,True,Factor: CREB1; motif: NNNNSSGGCGCSSNNNNRTGACGTCAC; match class: 1,9547,826,472,20045,0.5714285714285714,0.04943961453859851,Module 0,['TF:M12591']
2478,GO:CC,GO:0016020,membrane,4.932755317658737e-05,True,"""A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it."" [GOC:dos, GOC:mah, ISBN:0815316194]",9864,221,137,22097,0.6199095022624435,0.013888888888888888,Module 2,['GO:0110165']
2479,HP,HP:0002490,Increased CSF lactate,4.9710835301960253e-05,True,Increased concentration of lactate in the cerebrospinal fluid.,103,228,20,4958,0.08771929824561403,0.1941747572815534,Module 0,['HP:0030085']
2480,HP,HP:0030085,Abnormal CSF lactate concentration,4.9710835301960253e-05,True,Abnormal concentration of lactate in the cerebrospinal fluid.,103,228,20,4958,0.08771929824561403,0.1941747572815534,Module 0,['HP:0025454']
2481,TF,TF:M08982_1,Factor: YY1; motif: NAANATGGCGNNN; match class: 1,4.978321836731047e-05,True,Factor: YY1; motif: NAANATGGCGNNN; match class: 1,1670,826,116,20045,0.14043583535108958,0.06946107784431138,Module 0,['TF:M08982']
2482,GO:BP,GO:0070661,leukocyte proliferation,5.0027477719981406e-05,True,"""The expansion of a leukocyte population by cell division."" [GOC:add]",351,215,18,21031,0.08372093023255814,0.05128205128205128,Module 2,['GO:0008283']
2483,TF,TF:M11883,Factor: pax-6; motif: NYACGCNTSRNYGCNYN,5.0032734886243165e-05,True,Factor: pax-6; motif: NYACGCNTSRNYGCNYN,13758,826,638,20045,0.7723970944309927,0.046373019334205554,Module 0,['TF:M00000']
2484,TF,TF:M00918,Factor: E2F; motif: TTTSGCGSG,5.084536255539462e-05,True,Factor: E2F; motif: TTTSGCGSG,5754,80,47,20045,0.5875,0.008168230795968023,Module 5,['TF:M00000']
2485,GO:BP,GO:1903311,regulation of mRNA metabolic process,5.106655408435843e-05,True,"""Any process that modulates the frequency, rate or extent of mRNA metabolic process."" [GO_REF:0000058, GOC:TermGenie, GOC:vw]",302,172,15,21031,0.0872093023255814,0.04966887417218543,Module Singleton,"['GO:0016071', 'GO:0051252']"
2486,TF,TF:M08020,Factor: YY2; motif: NNCCGCCATTW,5.119804255775929e-05,True,Factor: YY2; motif: NNCCGCCATTW,1595,826,112,20045,0.13559322033898305,0.07021943573667712,Module 0,['TF:M00000']
2487,HP,HP:0030680,Abnormal cardiovascular system morphology,5.1667706191203705e-05,True,Any structural anomaly of the heart and great vessels.,1926,44,35,4958,0.7954545454545454,0.018172377985462097,Module 3,['HP:0001626']
2488,HP,HP:0000708,Atypical behavior,5.190682975005266e-05,True,"Atypical behavior is an abnormality in a person's actions, which can be controlled or modulated by the will of the individual. While abnormal behaviors can be difficult to control, they are distinct from other abnormal actions that cannot be affected by the individual's will.",1812,44,34,4958,0.7727272727272727,0.018763796909492272,Module 3,['HP:0011446']
2489,HP,HP:0002837,Recurrent bronchitis,5.288672343242664e-05,True,An increased susceptibility to bronchitis as manifested by a history of recurrent bronchitis.,37,71,8,4958,0.11267605633802817,0.21621621621621623,Module 1,"['HP:0002783', 'HP:0012387', 'HP:0025426']"
2490,TF,TF:M07234_1,Factor: YY1; motif: CAARATGGCNGC; match class: 1,5.295470803079606e-05,True,Factor: YY1; motif: CAARATGGCNGC; match class: 1,1171,826,89,20045,0.10774818401937046,0.07600341588385995,Module 0,['TF:M07234']
2491,TF,TF:M11659,Factor: HSF4; motif: NGAANRTTCTAGAAN,5.299251057813741e-05,True,Factor: HSF4; motif: NGAANRTTCTAGAAN,327,21,7,20045,0.3333333333333333,0.021406727828746176,Module 9,['TF:M00000']
2492,HPA,HPA:0530711,spleen; cells in red pulp[≥Low],5.305307467597397e-05,True,spleen; cells in red pulp[≥Low],5333,166,113,11019,0.6807228915662651,0.021188824301518847,Module 2,['HPA:0530000']
2493,HP,HP:0000388,Otitis media,5.340291263643582e-05,True,Inflammation or infection of the middle ear.,344,71,20,4958,0.28169014084507044,0.05813953488372093,Module 1,"['HP:0000370', 'HP:0012649']"
2494,HPA,HPA:0471411,skin 2; cells in spinous layer[≥Low],5.3484731910269924e-05,True,skin 2; cells in spinous layer[≥Low],871,166,34,11019,0.20481927710843373,0.03903559127439724,Module 2,['HPA:0470000']
2495,HPA,HPA:0300203,lung; endothelial cells[High],5.381427100776092e-05,True,lung; endothelial cells[High],293,69,12,11019,0.17391304347826086,0.040955631399317405,Module 5,['HPA:0300202']
2496,TF,TF:M11448,Factor: Elf-1; motif: NANGCGGAAGTN,5.402633748990228e-05,True,Factor: Elf-1; motif: NANGCGGAAGTN,7777,105,69,20045,0.6571428571428571,0.008872315803008872,Module 3,['TF:M00000']
2497,HP,HP:0001878,Hemolytic anemia,5.474256792180644e-05,True,A type of anemia caused by premature destruction of red blood cells (hemolysis).,159,71,14,4958,0.19718309859154928,0.0880503144654088,Module 1,['HP:0011895']
2498,REAC,REAC:R-HSA-8878159,Transcriptional regulation by RUNX3,5.47433103582612e-05,True,Transcriptional regulation by RUNX3,94,586,20,10842,0.034129692832764506,0.2127659574468085,Module 0,['REAC:R-HSA-212436']
2499,HPA,HPA:0380512,placenta; decidual cells[≥Medium],5.4913839290136394e-05,True,placenta; decidual cells[≥Medium],3591,79,48,11019,0.6075949367088608,0.013366750208855471,Module 3,['HPA:0380511']
2500,GO:BP,GO:1901575,organic substance catabolic process,5.562293710249159e-05,True,"""The chemical reactions and pathways resulting in the breakdown of an organic substance, any molecular entity containing carbon."" [GOC:pr, GOC:TermGenie]",2074,787,126,21031,0.16010165184243966,0.06075216972034716,Module 0,"['GO:0009056', 'GO:0071704']"
2501,REAC,REAC:R-HSA-2262752,Cellular responses to stress,5.611296574095354e-05,True,Cellular responses to stress,780,19,10,10842,0.5263157894736842,0.01282051282051282,Module 9,['REAC:R-HSA-8953897']
2502,HPA,HPA:0530000,spleen,5.6239352531444115e-05,True,spleen,5893,60,51,11019,0.85,0.008654335652469031,Module 4,['HPA:0000000']
2503,MIRNA,MIRNA:hsa-miR-324-3p,hsa-miR-324-3p,5.641356349113003e-05,True,hsa-miR-324-3p,336,104,14,14819,0.1346153846153846,0.041666666666666664,Module 3,['MIRNA:000000']
2504,HP,HP:0001716,Wolff-Parkinson-White syndrome,5.697046968342152e-05,True,A disorder of the cardiac conduction system of the heart characterized by ventricular preexcitation due to the presence of an abnormal accessory atrioventricular electrical conduction pathway.,24,44,6,4958,0.13636363636363635,0.25,Module 3,['HP:0004309']
2505,HPA,HPA:0461472,skin 1; lymphocytes[≥Medium],5.7071402016967346e-05,True,skin 1; lymphocytes[≥Medium],574,140,24,11019,0.17142857142857143,0.041811846689895474,Module Singleton,['HPA:0461471']
2506,REAC,REAC:R-HSA-382556,ABC-family proteins mediated transport,5.724394867751456e-05,True,ABC-family proteins mediated transport,103,586,21,10842,0.03583617747440273,0.20388349514563106,Module 0,['REAC:R-HSA-382551']
2507,HPA,HPA:0170252,endometrium 2; cells in endometrial stroma[≥Medium],5.746691138254424e-05,True,endometrium 2; cells in endometrial stroma[≥Medium],1801,79,32,11019,0.4050632911392405,0.01776790671848973,Module 3,['HPA:0170251']
2508,GO:BP,GO:0030334,regulation of cell migration,5.748919048063876e-05,True,"""Any process that modulates the frequency, rate or extent of cell migration."" [GOC:go_curators]",934,215,30,21031,0.13953488372093023,0.032119914346895075,Module 2,"['GO:0016477', 'GO:2000145']"
2509,GO:CC,GO:0098984,neuron to neuron synapse,5.7774286362083825e-05,True,"""A synapse in which pre and post-synaptic cells are neurons."" [GOC:dos]",366,105,12,22097,0.11428571428571428,0.03278688524590164,Module 3,['GO:0045202']
2510,GO:BP,GO:0050790,regulation of catalytic activity,5.796508200231685e-05,True,"""Any process that modulates the activity of an enzyme."" [GOC:ai, GOC:ebc, GOC:vw]",1227,787,85,21031,0.10800508259212198,0.06927465362673187,Module 0,['GO:0065009']
2511,TF,TF:M09957,Factor: IRF-2; motif: NAAANNGAAAGTGAAASTRN,5.815367227738926e-05,True,Factor: IRF-2; motif: NAAANNGAAAGTGAAASTRN,278,36,8,20045,0.2222222222222222,0.02877697841726619,Module 7,['TF:M00000']
2512,HP,HP:0025454,Abnormal CSF metabolite concentration,5.905529064004316e-05,True,Any deviation from the normal range of concentration of a metabolite in the cerebrospinal fluid.,146,228,24,4958,0.10526315789473684,0.1643835616438356,Module 0,"['HP:0001939', 'HP:0002921']"
2513,TF,TF:M04694_1,Factor: NRF-1; motif: CNCTGCGCATGCGC; match class: 1,5.914311984944978e-05,True,Factor: NRF-1; motif: CNCTGCGCATGCGC; match class: 1,467,826,47,20045,0.05690072639225181,0.1006423982869379,Module 0,['TF:M04694']
2514,GO:BP,GO:1903131,mononuclear cell differentiation,5.995511901221457e-05,True,"""The process in which a relatively unspecialized cell acquires the specialized features of a mononuclear cell."" [CL:0000842, GO_REF:0000086, GOC:TermGenie, PMID:24759906]",484,215,21,21031,0.09767441860465116,0.04338842975206612,Module 2,['GO:0002521']
2515,TF,TF:M11657,Factor: HSF1; motif: NGAANRTTCKAGAAN,6.00326809056485e-05,True,Factor: HSF1; motif: NGAANRTTCKAGAAN,333,21,7,20045,0.3333333333333333,0.021021021021021023,Module 9,['TF:M00000']
2516,TF,TF:M11435,Factor: Elk-1; motif: NNCCGGAAGTN,6.056831921050357e-05,True,Factor: Elk-1; motif: NNCCGGAAGTN,11976,105,89,20045,0.8476190476190476,0.007431529726118905,Module 3,['TF:M00000']
2517,HP,HP:0002205,Recurrent respiratory infections,6.068348471997409e-05,True,An increased susceptibility to respiratory infections as manifested by a history of recurrent respiratory infections.,624,71,27,4958,0.38028169014084506,0.04326923076923077,Module 1,"['HP:0002719', 'HP:0011947']"
2518,HPA,HPA:0570761,testis; pachytene spermatocytes[≥Low],6.087522969261598e-05,True,testis; pachytene spermatocytes[≥Low],2367,612,184,11019,0.3006535947712418,0.0777355302070131,Module 0,['HPA:0570000']
2519,HPA,HPA:0040082,bone marrow; hematopoietic cells[≥Medium],6.105332757440784e-05,True,bone marrow; hematopoietic cells[≥Medium],4256,79,53,11019,0.6708860759493671,0.012453007518796992,Module 3,['HPA:0040081']
2520,TF,TF:M03974,Factor: ERF; motif: ACCGGAAGTR,6.116971131574262e-05,True,Factor: ERF; motif: ACCGGAAGTR,979,826,78,20045,0.09443099273607748,0.07967313585291114,Module 0,['TF:M00000']
2521,GO:CC,GO:0044391,ribosomal subunit,6.135292904869711e-05,True,"""Either of the two subunits of a ribosome: the ribosomal large subunit or the ribosomal small subunit."" [GOC:jl]",192,813,24,22097,0.02952029520295203,0.125,Module 0,"['GO:0005840', 'GO:1990904']"
2522,HPA,HPA:0470182,skin 2; cells in granular layer[≥Medium],6.18201849613505e-05,True,skin 2; cells in granular layer[≥Medium],562,69,16,11019,0.2318840579710145,0.028469750889679714,Module 5,['HPA:0470181']
2523,TF,TF:M03819,Factor: Elk-1; motif: GGAAGN,6.230342870391909e-05,True,Factor: Elk-1; motif: GGAAGN,14441,826,663,20045,0.8026634382566586,0.04591094799529118,Module 0,['TF:M00000']
2524,GO:BP,GO:0006508,proteolysis,6.266453623045812e-05,True,"""The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds."" [GOC:bf, GOC:mah]",1573,787,102,21031,0.12960609911054638,0.06484424666242848,Module 0,['GO:0019538']
2525,TF,TF:M00981,"Factor: CREB,; motif: NTGACGTNA",6.274604046587306e-05,True,"Factor: CREB,; motif: NTGACGTNA",8502,826,428,20045,0.5181598062953995,0.050341096212655846,Module 0,['TF:M00000']
2526,TF,TF:M09611,Factor: ER81; motif: NNNGRCMGGAAGYRNNNNNNNS,6.301022894715272e-05,True,Factor: ER81; motif: NNNGRCMGGAAGYRNNNNNNNS,2746,826,170,20045,0.20581113801452786,0.061908230152949745,Module 0,['TF:M00000']
2527,KEGG,KEGG:05417,Lipid and atherosclerosis,6.307163612850237e-05,True,Lipid and atherosclerosis,214,15,6,8484,0.4,0.028037383177570093,Module 9,['KEGG:00000']
2528,HPA,HPA:0461471,skin 1; lymphocytes[≥Low],6.339716746424203e-05,True,skin 1; lymphocytes[≥Low],712,166,30,11019,0.18072289156626506,0.042134831460674156,Module 2,['HPA:0460000']
2529,GO:BP,GO:0008152,metabolic process,6.413111137417837e-05,True,"""The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation."" [GOC:go_curators, ISBN:0198547684]",14261,787,602,21031,0.7649301143583227,0.042213028539373115,Module 0,['GO:0008150']
2530,GO:BP,GO:0002521,leukocyte differentiation,6.413454624514454e-05,True,"""The process in which a relatively unspecialized hemopoietic precursor cell acquires the specialized features of a leukocyte. A leukocyte is an achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue."" [CL:0000738, GOC:add, PMID:16551264]",627,215,24,21031,0.11162790697674418,0.03827751196172249,Module 2,"['GO:0030097', 'GO:0030154']"
2531,HPA,HPA:0590000,thyroid gland,6.4354305076943e-05,True,thyroid gland,7131,79,71,11019,0.8987341772151899,0.009956527836208106,Module 3,['HPA:0000000']
2532,HPA,HPA:0590051,thyroid gland; glandular cells[≥Low],6.4354305076943e-05,True,thyroid gland; glandular cells[≥Low],7131,79,71,11019,0.8987341772151899,0.009956527836208106,Module 3,['HPA:0590000']
2533,HPA,HPA:0640000,endometrium,6.473497094786004e-05,True,endometrium,120,166,12,11019,0.07228915662650602,0.1,Module 2,['HPA:0000000']
2534,GO:BP,GO:0043068,positive regulation of programmed cell death,6.476165506280918e-05,True,"""Any process that activates or increases the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes."" [GOC:jl]",532,215,22,21031,0.10232558139534884,0.041353383458646614,Module 2,"['GO:0012501', 'GO:0043067', 'GO:0048522']"
2535,TF,TF:M09632,Factor: Kaiso; motif: GNTCTCGCGAGRNNNNGGN,6.521566052125491e-05,True,Factor: Kaiso; motif: GNTCTCGCGAGRNNNNGGN,3056,826,185,20045,0.22397094430992737,0.060536649214659684,Module 0,['TF:M00000']
2536,GO:BP,GO:0030036,actin cytoskeleton organization,6.565839576938071e-05,True,"""A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures comprising actin filaments and their associated proteins."" [GOC:dph, GOC:jl, GOC:mah]",717,787,58,21031,0.07369758576874205,0.08089260808926081,Module 0,"['GO:0007010', 'GO:0030029']"
2537,REAC,REAC:R-HSA-9010553,Regulation of expression of SLITs and ROBOs,6.622967791654093e-05,True,Regulation of expression of SLITs and ROBOs,171,586,28,10842,0.04778156996587031,0.16374269005847952,Module 0,['REAC:R-HSA-376176']
2538,REAC,REAC:R-HSA-8953897,Cellular responses to stimuli,6.635569735906344e-05,True,Cellular responses to stimuli,794,19,10,10842,0.5263157894736842,0.012594458438287154,Module 9,['REAC:0000000']
2539,GO:CC,GO:0035578,azurophil granule lumen,6.674862650694352e-05,True,"""The volume enclosed by the membrane of an azurophil granule, a primary lysosomal granule found in neutrophil granulocytes that contains a wide range of hydrolytic enzymes and is released into the extracellular fluid."" [GOC:bf, PMID:17152095]",91,813,16,22097,0.01968019680196802,0.17582417582417584,Module 0,"['GO:0005775', 'GO:0034774', 'GO:0042582']"
2540,REAC,REAC:R-HSA-446652,Interleukin-1 family signaling,6.689141167948592e-05,True,Interleukin-1 family signaling,151,586,26,10842,0.04436860068259386,0.17218543046357615,Module 0,['REAC:R-HSA-449147']
2541,HPA,HPA:0461393,skin 1; cells in basal layer[High],6.697475236420334e-05,True,skin 1; cells in basal layer[High],191,612,30,11019,0.049019607843137254,0.15706806282722513,Module 0,['HPA:0461392']
2542,GO:CC,GO:0043229,intracellular organelle,6.716051893437828e-05,True,"""Organized structure of distinctive morphology and function, occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane."" [GOC:go_curators]",16018,80,76,22097,0.95,0.004744662254963166,Module 5,"['GO:0005622', 'GO:0043226']"
2543,REAC,REAC:R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,6.721939895003889e-05,True,DNA Damage/Telomere Stress Induced Senescence,79,3,3,10842,1.0,0.0379746835443038,Module 27,['REAC:R-HSA-2559583']
2544,HPA,HPA:0090161,cerebellum; Purkinje cells[≥Low],6.790486476114051e-05,True,cerebellum; Purkinje cells[≥Low],5579,79,62,11019,0.7848101265822784,0.01111310270657824,Module 3,['HPA:0090000']
2545,GO:BP,GO:0006281,DNA repair,6.826207508279193e-05,True,"""The process of restoring DNA after damage. Genomes are subject to damage by chemical and physical agents in the environment (e.g. UV and ionizing radiations, chemical mutagens, fungal and bacterial toxins, etc.) and by free radicals or alkylating agents endogenously generated in metabolism. DNA is also damaged because of errors during its replication. A variety of different DNA repair pathways have been reported that include direct reversal, base excision repair, nucleotide excision repair, photoreactivation, bypass, double-strand break repair pathway, and mismatch repair pathway."" [PMID:11563486]",604,77,14,21031,0.18181818181818182,0.023178807947019868,Module 5,"['GO:0006259', 'GO:0006974']"
2546,HPA,HPA:0330221,oral mucosa; squamous epithelial cells[≥Low],6.826493105457801e-05,True,oral mucosa; squamous epithelial cells[≥Low],6257,69,59,11019,0.855072463768116,0.009429439028288317,Module 5,['HPA:0330000']
2547,HPA,HPA:0330000,oral mucosa,6.826493105457801e-05,True,oral mucosa,6257,69,59,11019,0.855072463768116,0.009429439028288317,Module 5,['HPA:0000000']
2548,GO:BP,GO:0015031,protein transport,6.926112764490563e-05,True,"""The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore."" [GOC:ai]",1424,72,20,21031,0.2777777777777778,0.014044943820224719,Module 4,"['GO:0045184', 'GO:0071702', 'GO:0071705']"
2549,GO:BP,GO:0050790,regulation of catalytic activity,6.958652657599142e-05,True,"""Any process that modulates the activity of an enzyme."" [GOC:ai, GOC:ebc, GOC:vw]",1227,215,35,21031,0.16279069767441862,0.02852485737571312,Module 2,['GO:0065009']
2550,GO:CC,GO:0005759,mitochondrial matrix,6.977210247579724e-05,True,"""The gel-like material, with considerable fine structure, that lies in the matrix space, or lumen, of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and, in some organisms, the enzymes concerned with fatty acid oxidation."" [GOC:as, ISBN:0198506732]",496,813,43,22097,0.05289052890528905,0.08669354838709678,Module 0,"['GO:0005739', 'GO:0070013']"
2551,TF,TF:M12597_1,Factor: E2F1; motif: GSGCGGGAAN; match class: 1,7.032472420992441e-05,True,Factor: E2F1; motif: GSGCGGGAAN; match class: 1,10180,826,497,20045,0.6016949152542372,0.04882121807465619,Module 0,['TF:M12597']
2552,HP,HP:0000951,Abnormality of the skin,7.143721759822236e-05,True,An abnormality of the skin.,2067,44,36,4958,0.8181818181818182,0.01741654571843251,Module 3,['HP:0001574']
2553,GO:CC,GO:0031984,organelle subcompartment,7.175175713617212e-05,True,"""A compartment that consists of a lumen and an enclosing membrane, and is part of an organelle."" [GOC:mah, GOC:pz]",1521,17,9,22097,0.5294117647058824,0.005917159763313609,Module 6,"['GO:0043227', 'GO:0043229', 'GO:0110165']"
2554,TF,TF:M09966_1,Factor: Kaiso; motif: SARNYCTCGCGAGAN; match class: 1,7.216421268973645e-05,True,Factor: Kaiso; motif: SARNYCTCGCGAGAN; match class: 1,470,826,47,20045,0.05690072639225181,0.1,Module 0,['TF:M09966']
2555,HPA,HPA:0190000,esophagus,7.227014468361619e-05,True,esophagus,6679,69,61,11019,0.8840579710144928,0.009133103758047613,Module 5,['HPA:0000000']
2556,HPA,HPA:0190221,esophagus; squamous epithelial cells[≥Low],7.227014468361619e-05,True,esophagus; squamous epithelial cells[≥Low],6679,69,61,11019,0.8840579710144928,0.009133103758047613,Module 5,['HPA:0190000']
2557,KEGG,KEGG:04060,Cytokine-cytokine receptor interaction,7.286285471283058e-05,True,Cytokine-cytokine receptor interaction,291,4,4,8484,1.0,0.013745704467353952,Module 12,['KEGG:00000']
2558,TF,TF:M08313,Factor: GCMa:PEA3; motif: ATRCGGGCGGAAGTR,7.34556449487068e-05,True,Factor: GCMa:PEA3; motif: ATRCGGGCGGAAGTR,15692,826,708,20045,0.8571428571428571,0.045118531735916394,Module 0,['TF:M00000']
2559,WP,WP:WP5098,T cell activation SARS CoV 2,7.415220011020265e-05,True,T cell activation SARS CoV 2,88,148,11,8286,0.07432432432432433,0.125,Module 1,['WP:000000']
2560,HPA,HPA:0300411,lung; macrophages[≥Low],7.429976393885166e-05,True,lung; macrophages[≥Low],6787,140,114,11019,0.8142857142857143,0.01679681744511566,Module Singleton,['HPA:0300000']
2561,HP,HP:0002331,Recurrent paroxysmal headache,7.4467768188064e-05,True,"Repeated episodes of headache with rapid onset, reaching a peak within minutes and of short duration (less than one hour) with pain that is throbbing, pulsating, or bursting in quality.",25,44,6,4958,0.13636363636363635,0.24,Module 3,['HP:0002315']
2562,HPA,HPA:0050053,breast; glandular cells[High],7.474150836100014e-05,True,breast; glandular cells[High],1349,79,27,11019,0.34177215189873417,0.02001482579688658,Module 3,['HPA:0050052']
2563,GO:CC,GO:0005938,cell cortex,7.555188604465775e-05,True,"""The region of a cell that lies just beneath the plasma membrane and often, but not always, contains a network of actin filaments and associated proteins."" [GOC:mah, ISBN:0815316194]",314,813,32,22097,0.03936039360393604,0.10191082802547771,Module 0,"['GO:0005737', 'GO:0071944']"
2564,KEGG,KEGG:04060,Cytokine-cytokine receptor interaction,7.556917996853563e-05,True,Cytokine-cytokine receptor interaction,291,136,18,8484,0.1323529411764706,0.061855670103092786,Module 1,['KEGG:00000']
2565,GO:BP,GO:0034975,protein folding in endoplasmic reticulum,7.576501392452675e-05,True,"""A protein folding process that takes place in the endoplasmic reticulum (ER). Secreted, plasma membrane and organelle proteins are folded in the ER, assisted by chaperones and foldases (protein disulphide isomerases), and additional factors required for optimal folding (ATP, Ca2+ and an oxidizing environment to allow disulfide bond formation)."" [GOC:mah, GOC:vw]",11,72,4,21031,0.05555555555555555,0.36363636363636365,Module 4,['GO:0006457']
2566,GO:BP,GO:0098609,cell-cell adhesion,7.62945024756355e-05,True,"""The attachment of one cell to another cell via adhesion molecules."" [GOC:dos]",946,215,30,21031,0.13953488372093023,0.03171247357293869,Module 2,['GO:0007155']
2567,HPA,HPA:0160252,endometrium 1; cells in endometrial stroma[≥Medium],7.721875664156276e-05,True,endometrium 1; cells in endometrial stroma[≥Medium],2234,79,36,11019,0.45569620253164556,0.01611459265890779,Module 3,['HPA:0160251']
2568,GO:BP,GO:0042776,proton motive force-driven mitochondrial ATP synthesis,7.723788987707295e-05,True,"""The transport of protons across a mitochondrial membrane to generate an electrochemical gradient (proton-motive force) that powers ATP synthesis."" [GOC:mtg_sensu, ISBN:0716731363]",66,105,7,21031,0.06666666666666667,0.10606060606060606,Module 3,"['GO:0006119', 'GO:0015986']"
2569,HPA,HPA:0460673,skin 1; melanocytes[High],7.755121848124068e-05,True,skin 1; melanocytes[High],986,69,21,11019,0.30434782608695654,0.02129817444219067,Module 5,['HPA:0460672']
2570,MIRNA,MIRNA:hsa-miR-6822-3p,hsa-miR-6822-3p,7.756385715867018e-05,True,hsa-miR-6822-3p,89,3,3,14819,1.0,0.033707865168539325,Module 27,['MIRNA:000000']
2571,GO:CC,GO:0110165,cellular anatomical entity,7.796447173055596e-05,True,"""A part of a cellular organism that is either an immaterial entity or a material entity with granularity above the level of a protein complex but below that of an anatomical system. Or, a substance produced by a cellular organism with granularity above the level of a protein complex."" [GOC:kmv]",21548,813,811,22097,0.997539975399754,0.03763690365695192,Module 0,['GO:0005575']
2572,TF,TF:M00327,Factor: Pax-3; motif: NNNNNNCGTCACGSTYNNNNN,7.802415559571517e-05,True,Factor: Pax-3; motif: NNNNNNCGTCACGSTYNNNNN,13598,826,631,20045,0.7639225181598063,0.0464038829239594,Module 0,['TF:M00000']
2573,GO:BP,GO:0045333,cellular respiration,7.81270808949264e-05,True,"""The enzymatic release of energy from inorganic and organic compounds (especially carbohydrates and fats) which either requires oxygen (aerobic respiration) or does not (anaerobic respiration)."" [GOC:das, ISBN:0140513590, ISBN:0198506732]",244,105,11,21031,0.10476190476190476,0.045081967213114756,Module 3,['GO:0015980']
2574,HPA,HPA:0470181,skin 2; cells in granular layer[≥Low],7.828981724766496e-05,True,skin 2; cells in granular layer[≥Low],719,166,30,11019,0.18072289156626506,0.04172461752433936,Module 2,['HPA:0470000']
2575,TF,TF:M04014,Factor: IRF3; motif: NNRRAANGGAAACCGAAACYR,7.854370506310361e-05,True,Factor: IRF3; motif: NNRRAANGGAAACCGAAACYR,289,36,8,20045,0.2222222222222222,0.02768166089965398,Module 7,['TF:M00000']
2576,GO:MF,GO:1901363,heterocyclic compound binding,7.859517771156122e-05,True,"""Binding to heterocyclic compound."" [GOC:TermGenie]",2325,20,12,20212,0.6,0.005161290322580645,Module 9,['GO:0036094']
2577,REAC,REAC:R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,7.936019826153081e-05,True,The role of GTSE1 in G2/M progression after G2 checkpoint,79,586,18,10842,0.030716723549488054,0.22784810126582278,Module 0,['REAC:R-HSA-69275']
2578,GO:BP,GO:0001913,T cell mediated cytotoxicity,7.988731721761821e-05,True,"""The directed killing of a target cell by a T cell through the release of granules containing cytotoxic mediators or through the engagement of death receptors."" [GOC:add, GOC:pr, ISBN:0781735149, PMID:11911826]",55,15,4,21031,0.26666666666666666,0.07272727272727272,Module 6,"['GO:0001909', 'GO:0002456']"
2579,HP,HP:0001581,Recurrent skin infections,8.045983214966997e-05,True,Infections of the skin that happen multiple times.,138,71,13,4958,0.18309859154929578,0.09420289855072464,Module 1,['HP:0011123']
2580,TF,TF:M11452,Factor: Elf-1; motif: NANGCGGAAGTR,8.046861166825862e-05,True,Factor: Elf-1; motif: NANGCGGAAGTR,6415,105,61,20045,0.580952380952381,0.009508963367108339,Module 3,['TF:M00000']
2581,HP,HP:0001510,Growth delay,8.069082771234403e-05,True,A deficiency or slowing down of growth pre- and postnatally.,1840,44,34,4958,0.7727272727272727,0.01847826086956522,Module 3,['HP:0001507']
2582,GO:BP,GO:0035710,"CD4-positive, alpha-beta T cell activation",8.253220251012056e-05,True,"""The change in morphology and behavior of a CD4-positive, alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific."" [CL:0000624, GOC:BHF]",119,215,11,21031,0.05116279069767442,0.09243697478991597,Module 2,['GO:0046631']
2583,GO:BP,GO:0032102,negative regulation of response to external stimulus,8.334488618712526e-05,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of a response to an external stimulus."" [GOC:mah]",405,215,19,21031,0.08837209302325581,0.04691358024691358,Module 2,"['GO:0009605', 'GO:0032101', 'GO:0048585']"
2584,GO:MF,GO:0035639,purine ribonucleoside triphosphate binding,8.347231888684285e-05,True,"""Binding to a purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:BHF, GOC:ebc, ISBN:0198506732]",1853,20,11,20212,0.55,0.0059363194819212085,Module 9,"['GO:0043168', 'GO:1901265', 'GO:1901363']"
2585,GO:BP,GO:0010033,response to organic substance,8.35132625147526e-05,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus."" [GOC:sm, PMID:23356676]",2637,172,48,21031,0.27906976744186046,0.01820250284414107,Module Singleton,['GO:0042221']
2586,GO:BP,GO:0050896,response to stimulus,8.375058430476698e-05,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus and ends with a change in state or activity or the cell or organism."" [GOC:ai, GOC:bf]",8976,34,30,21031,0.8823529411764706,0.0033422459893048127,Module 7,['GO:0008150']
2587,GO:BP,GO:0048468,cell development,8.384613909062111e-05,True,"""The cellular developmental process in which a specific cell progresses from an immature to a mature state. Cell development start once cell commitment has taken place."" [GOC:go_curators]",2819,226,61,21031,0.26991150442477874,0.021638879035118838,Module 1,"['GO:0030154', 'GO:0048856', 'GO:0048869']"
2588,GO:CC,GO:0045275,respiratory chain complex III,8.455248779724242e-05,True,"""A protein complex that transfers electrons from ubiquinol to cytochrome c and translocates two protons across a membrane. The complex contains a core structure of three catalytic subunits: cytochrome b, the Rieske iron sulfur protein (ISP), and cytochrome c1, which are arranged in an integral membrane-bound dimeric complex; additional subunits are present, and vary among different species."" [PMID:16228398, PMID:16352458, PMID:17200733]",14,813,7,22097,0.008610086100861008,0.5,Module 0,"['GO:0070069', 'GO:0098803', 'GO:1902495', 'GO:1990204']"
2589,GO:CC,GO:0005750,mitochondrial respiratory chain complex III,8.455248779724242e-05,True,"""A protein complex located in the mitochondrial inner membrane that forms part of the mitochondrial respiratory chain. Contains about 10 polypeptide subunits including four redox centers: cytochrome b/b6, cytochrome c1 and an 2Fe-2S cluster. Catalyzes the oxidation of ubiquinol by oxidized cytochrome c1."" [GOC:mtg_sensu, ISBN:0198547684]",14,813,7,22097,0.008610086100861008,0.5,Module 0,"['GO:0005746', 'GO:0045275', 'GO:0098800']"
2590,GO:BP,GO:0034641,cellular nitrogen compound metabolic process,8.494781476058239e-05,True,"""The chemical reactions and pathways involving various organic and inorganic nitrogenous compounds, as carried out by individual cells."" [GOC:mah]",8692,787,399,21031,0.5069885641677255,0.045904279797514956,Module 0,"['GO:0006807', 'GO:0044237']"
2591,HPA,HPA:0350472,pancreas; exocrine glandular cells[≥Medium],8.530127867720909e-05,True,pancreas; exocrine glandular cells[≥Medium],5304,60,48,11019,0.8,0.00904977375565611,Module 4,['HPA:0350471']
2592,GO:BP,GO:0031295,T cell costimulation,8.531608264386862e-05,True,"""The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the T cell receptor to augment T cell activation."" [ISBN:0781735149]",48,226,8,21031,0.035398230088495575,0.16666666666666666,Module 1,"['GO:0031294', 'GO:0050870']"
2593,HPA,HPA:0300000,lung,8.621350883273349e-05,True,lung,7379,140,120,11019,0.8571428571428571,0.016262366174278356,Module Singleton,['HPA:0000000']
2594,TF,TF:M01660,Factor: GABP-alpha; motif: CTTCCK,8.641395706602107e-05,True,Factor: GABP-alpha; motif: CTTCCK,11340,105,86,20045,0.819047619047619,0.007583774250440917,Module 3,['TF:M00000']
2595,GO:BP,GO:0071705,nitrogen compound transport,8.686504159523216e-05,True,"""The directed movement of nitrogen-containing compounds into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore."" [GOC:mah]",1911,72,23,21031,0.3194444444444444,0.012035583464154892,Module 4,['GO:0006810']
2596,TF,TF:M08775_1,Factor: IRF-2; motif: NAANYGAAASYR; match class: 1,8.703870122779041e-05,True,Factor: IRF-2; motif: NAANYGAAASYR; match class: 1,2790,36,19,20045,0.5277777777777778,0.006810035842293907,Module 7,['TF:M08775']
2597,HPA,HPA:0530713,spleen; cells in red pulp[High],8.723255426733433e-05,True,spleen; cells in red pulp[High],817,69,19,11019,0.2753623188405797,0.023255813953488372,Module 5,['HPA:0530712']
2598,GO:BP,GO:0065009,regulation of molecular function,8.758245642043617e-05,True,"""Any process that modulates the frequency, rate or extent of a molecular function, an elemental biological activity occurring at the molecular level, such as catalysis or binding."" [GOC:isa_complete]",1799,215,44,21031,0.20465116279069767,0.024458032240133407,Module 2,['GO:0065007']
2599,GO:BP,GO:0006754,ATP biosynthetic process,8.76805073177269e-05,True,"""The chemical reactions and pathways resulting in the formation of ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator."" [GOC:go_curators, ISBN:0198506732]",102,105,8,21031,0.0761904761904762,0.0784313725490196,Module 3,"['GO:0009152', 'GO:0009206', 'GO:0046034']"
2600,TF,TF:M00920,Factor: E2F; motif: NKCGCGCSAAAN,8.909191175948377e-05,True,Factor: E2F; motif: NKCGCGCSAAAN,5849,80,47,20045,0.5875,0.00803556163446743,Module 5,['TF:M00000']
2601,REAC,REAC:R-HSA-453276,Regulation of mitotic cell cycle,8.930595658566329e-05,True,Regulation of mitotic cell cycle,88,586,19,10842,0.032423208191126277,0.2159090909090909,Module 0,['REAC:R-HSA-69278']
2602,REAC,REAC:R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,8.930595658566329e-05,True,APC/C-mediated degradation of cell cycle proteins,88,586,19,10842,0.032423208191126277,0.2159090909090909,Module 0,['REAC:R-HSA-453276']
2603,TF,TF:M04008,Factor: HSF1; motif: TTCTAGAAYNTTC,8.951567490409241e-05,True,Factor: HSF1; motif: TTCTAGAAYNTTC,353,21,7,20045,0.3333333333333333,0.019830028328611898,Module 9,['TF:M00000']
2604,GO:BP,GO:0012501,programmed cell death,8.953881215968734e-05,True,"""A process which begins when a cell receives an internal or external signal and activates a series of biochemical events (signaling pathway). The process ends with the death of the cell."" [GOC:lr, GOC:mtg_apoptosis]",1984,787,121,21031,0.15374841168996187,0.06098790322580645,Module 0,['GO:0008219']
2605,GO:BP,GO:0019538,protein metabolic process,8.962045847927195e-05,True,"""The chemical reactions and pathways involving a protein. Includes protein modification."" [GOC:ma]",4912,172,72,21031,0.4186046511627907,0.014657980456026058,Module Singleton,"['GO:0043170', 'GO:0044238', 'GO:1901564']"
2606,GO:BP,GO:0031349,positive regulation of defense response,8.978886852317652e-05,True,"""Any process that activates or increases the frequency, rate or extent of a defense response."" [GOC:mah]",471,226,21,21031,0.09292035398230089,0.044585987261146494,Module 1,"['GO:0006952', 'GO:0031347', 'GO:0048584']"
2607,HPA,HPA:0220052,gallbladder; glandular cells[≥Medium],8.988370853321625e-05,True,gallbladder; glandular cells[≥Medium],6615,79,68,11019,0.8607594936708861,0.010279667422524565,Module 3,['HPA:0220051']
2608,GO:CC,GO:0031090,organelle membrane,9.055920438421754e-05,True,"""A membrane that is one of the two lipid bilayers of an organelle envelope or the outermost membrane of single membrane bound organelle."" [GOC:dos, GOC:mah]",3770,73,31,22097,0.4246575342465753,0.008222811671087533,Module 4,"['GO:0016020', 'GO:0043227']"
2609,GO:CC,GO:0005829,cytosol,9.056731114417788e-05,True,"""The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes."" [GOC:hjd, GOC:jl]",5487,80,41,22097,0.5125,0.00747220703480955,Module 5,"['GO:0005737', 'GO:0110165']"
2610,HP,HP:0011947,Respiratory tract infection,9.086356453932261e-05,True,An infection of the upper or lower respiratory tract.,773,71,30,4958,0.4225352112676056,0.03880983182406209,Module 1,['HP:0002088']
2611,HP,HP:0004370,Abnormality of temperature regulation,9.152522529382158e-05,True,An abnormality of temperature homeostasis.,550,71,25,4958,0.352112676056338,0.045454545454545456,Module 1,['HP:0012337']
2612,GO:BP,GO:0016043,cellular component organization,9.222386818120896e-05,True,"""A process that results in the assembly, arrangement of constituent parts, or disassembly of a cellular component."" [GOC:ai, GOC:jl, GOC:mah]",8151,787,378,21031,0.48030495552731894,0.04637467795362532,Module 0,['GO:0071840']
2613,GO:BP,GO:0051249,regulation of lymphocyte activation,9.421130994254783e-05,True,"""Any process that modulates the frequency, rate or extent of lymphocyte activation."" [GOC:ai]",497,215,21,21031,0.09767441860465116,0.04225352112676056,Module 2,"['GO:0002694', 'GO:0046649']"
2614,GO:MF,GO:0009055,electron transfer activity,9.457375929205206e-05,True,"""A molecular function representing the directed movement of electrons from one molecular entity to another, typically mediated by electron carriers or acceptors, resulting in the transfer of energy and/or the reduction-oxidation (redox) transformation of chemical species. This activity is fundamental to various biological processes, including cellular respiration and photosynthesis, as well as numerous enzymatic reactions involved in metabolic pathways."" [Wikipedia:Electron_transfer]",115,105,8,20212,0.0761904761904762,0.06956521739130435,Module 3,['GO:0003674']
2615,HP,HP:0011013,Abnormal circulating carbohydrate concentration,9.519396067999943e-05,True,A deviation from the normal concentration of a carbohydrate in the blood circulation.,69,228,16,4958,0.07017543859649122,0.2318840579710145,Module 0,['HP:0032180']
2616,HP,HP:0003648,Lacticaciduria,9.617090932434547e-05,True,An increased concentration of lactic acid in the urine.,26,44,6,4958,0.13636363636363635,0.23076923076923078,Module 3,['HP:0012072']
2617,TF,TF:M12275_1,Factor: YY1; motif: NGCCGCCATYTTGN; match class: 1,9.698851289813813e-05,True,Factor: YY1; motif: NGCCGCCATYTTGN; match class: 1,1595,826,111,20045,0.1343825665859564,0.06959247648902821,Module 0,['TF:M12275']
2618,REAC,REAC:R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),9.733539893030489e-05,True,Downstream signaling events of B Cell Receptor (BCR),80,586,18,10842,0.030716723549488054,0.225,Module 0,['REAC:R-HSA-983705']
2619,HP,HP:0002977,Aplasia/Hypoplasia involving the central nervous system,9.873844959475088e-05,True,Absence or underdevelopment of tissue in the central nervous system.,1853,44,34,4958,0.7727272727272727,0.01834862385321101,Module 3,['HP:0002011']
2620,HPA,HPA:0050012,breast; adipocytes[≥Medium],9.935786301665923e-05,True,breast; adipocytes[≥Medium],1491,69,26,11019,0.37681159420289856,0.017437961099932932,Module 5,['HPA:0050011']
2621,HPA,HPA:0471421,skin 2; eccrine glands[≥Low],9.938324998961235e-05,True,skin 2; eccrine glands[≥Low],89,612,19,11019,0.03104575163398693,0.21348314606741572,Module 0,['HPA:0470000']
2622,GO:BP,GO:0009894,regulation of catabolic process,9.943335908379737e-05,True,"""Any process that modulates the frequency, rate, or extent of the chemical reactions and pathways resulting in the breakdown of substances."" [GOC:go_curators]",1026,787,74,21031,0.0940279542566709,0.07212475633528265,Module 0,"['GO:0009056', 'GO:0019222']"
2623,TF,TF:M09918,Factor: Pet-1; motif: GCNGGAAGYG,9.953980815998743e-05,True,Factor: Pet-1; motif: GCNGGAAGYG,13904,826,642,20045,0.7772397094430993,0.04617376294591485,Module 0,['TF:M00000']
2624,GO:BP,GO:0008219,cell death,0.00010012924518998109,True,"""Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538)."" [GOC:mah, GOC:mtg_apoptosis, PMID:25236395]",1988,787,121,21031,0.15374841168996187,0.06086519114688129,Module 0,['GO:0009987']
2625,HPA,HPA:0461481,skin 1; sebaceous glands[≥Low],0.00010118125042531661,True,skin 1; sebaceous glands[≥Low],202,166,15,11019,0.09036144578313253,0.07425742574257425,Module 2,['HPA:0460000']
2626,GO:BP,GO:0010647,positive regulation of cell communication,0.00010123586943192144,True,"""Any process that increases the frequency, rate or extent of cell communication. Cell communication is the process that mediates interactions between a cell and its surroundings. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment."" [GOC:dph, GOC:tb]",1777,226,45,21031,0.19911504424778761,0.025323579065841307,Module 1,"['GO:0007154', 'GO:0010646', 'GO:0048522']"
2627,HP,HP:0002960,Autoimmunity,0.00010158773277014834,True,The occurrence of an immune reaction against the organism's own cells or tissues.,288,71,18,4958,0.2535211267605634,0.0625,Module 1,['HP:0010978']
2628,GO:BP,GO:0023056,positive regulation of signaling,0.00010292273880572553,True,"""Any process that activates, maintains or increases the frequency, rate or extent of a signaling process."" [GOC:mtg_signal]",1778,226,45,21031,0.19911504424778761,0.02530933633295838,Module 1,"['GO:0023051', 'GO:0023052', 'GO:0048518']"
2629,REAC,REAC:R-HSA-376176,Signaling by ROBO receptors,0.00010365344959122553,True,Signaling by ROBO receptors,217,586,32,10842,0.05460750853242321,0.14746543778801843,Module 0,['REAC:R-HSA-422475']
2630,GO:CC,GO:0071751,secretory IgA immunoglobulin complex,0.00010369751738051634,True,"""A polymeric IgA immunoglobulin complex that is complexed with one chain of secretory component (SC). Polymeric IgA is present in mucosal areas, having been transported via a transcytosis mechanism in mucosal epithelial cells relying on the polymeric Ig receptor, a portion of which then remains bound to the polymeric IgA as secretory component."" [GOC:add, ISBN:0781765196, PMID:16362985]",5,73,3,22097,0.0410958904109589,0.6,Module 4,['GO:0071749']
2631,GO:CC,GO:0071749,polymeric IgA immunoglobulin complex,0.00010369751738051634,True,"""A protein complex composed of two, three, or four monomeric IgA immunoglobulin complexes linked through both direct disulfide bonds and through disulfide binded monomers of J chain acting as a bridge. Each IgA monomer consists of two identical immunoglobulin heavy chains of an IgA isotype and two identical immunoglobulin light chains, held together by disulfide bonds. Dimeric IgA is sometimes complexed additionally with secretory component, and present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph."" [GOC:add, ISBN:0781765196, PMID:16362985]",5,73,3,22097,0.0410958904109589,0.6,Module 4,['GO:0071746']
2632,GO:CC,GO:0071746,"IgA immunoglobulin complex, circulating",0.00010369751738051634,True,"""A protein complex composed of two identical immunoglobulin heavy chains of an IgA isotype and two identical immunoglobulin light chains, held together by disulfide bonds, sometimes complexed with J chain or J chain and secretory component, and present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph."" [GOC:add, ISBN:0781765196, PMID:16362985]",5,73,3,22097,0.0410958904109589,0.6,Module 4,"['GO:0042571', 'GO:0071745']"
2633,REAC,REAC:R-HSA-381070,IRE1alpha activates chaperones,0.0001042444608952539,True,IRE1alpha activates chaperones,49,60,6,10842,0.1,0.12244897959183673,Module 4,['REAC:R-HSA-381119']
2634,TF,TF:M02102_1,Factor: NRF-1; motif: YGCGCMTGCGC; match class: 1,0.00010455808632204973,True,Factor: NRF-1; motif: YGCGCMTGCGC; match class: 1,667,826,59,20045,0.07142857142857142,0.08845577211394302,Module 0,['TF:M02102']
2635,HPA,HPA:0600441,tonsil; non-germinal center cells[≥Low],0.00010506419112726497,True,tonsil; non-germinal center cells[≥Low],6117,69,58,11019,0.8405797101449275,0.00948177211051169,Module 5,['HPA:0600000']
2636,HP,HP:0003128,Lactic acidosis,0.00010523169139911318,True,"An abnormal buildup of lactic acid in the body, leading to acidification of the blood and other bodily fluids.",185,228,27,4958,0.11842105263157894,0.14594594594594595,Module 0,['HP:0001941']
2637,GO:MF,GO:0005102,signaling receptor binding,0.00010536859844436698,True,"""Binding to one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function."" [GOC:bf, GOC:ceb, ISBN:0198506732]",1501,218,39,20212,0.17889908256880735,0.02598267821452365,Module 2,['GO:0005515']
2638,HPA,HPA:0310433,lymph node; germinal center cells[High],0.00010539256243349147,True,lymph node; germinal center cells[High],944,79,22,11019,0.27848101265822783,0.023305084745762712,Module 3,['HPA:0310432']
2639,GO:BP,GO:0001910,regulation of leukocyte mediated cytotoxicity,0.00010539450834061167,True,"""Any process that modulates the frequency, rate, or extent of leukocyte mediated cytotoxicity."" [GOC:add, ISBN:0781735149, PMID:11911826]",91,226,10,21031,0.04424778761061947,0.10989010989010989,Module 1,"['GO:0001909', 'GO:0002703', 'GO:0031341']"
2640,HP,HP:0025540,Abnormal T cell subset distribution,0.00010589777369005407,True,Any abnormality in the proportion T cells subsets relative to the total number of T cells.,74,71,10,4958,0.14084507042253522,0.13513513513513514,Module 1,['HP:0011839']
2641,GO:BP,GO:0006228,UTP biosynthetic process,0.00010598443395596115,True,"""The chemical reactions and pathways resulting in the formation of UTP, uridine (5'-)triphosphate."" [ISBN:0198506732]",10,2,2,21031,1.0,0.2,Module 39,"['GO:0009209', 'GO:0009220', 'GO:0046051']"
2642,TF,TF:M00738,Factor: E2F-4:DP-1; motif: TTTSGCGC,0.00010615580963453044,True,Factor: E2F-4:DP-1; motif: TTTSGCGC,10100,80,64,20045,0.8,0.006336633663366337,Module 5,['TF:M00000']
2643,HP,HP:0011400,Abnormal CNS myelination,0.00010653745793047993,True,An abnormality of myelination of nerves in the central nervous system.,398,228,43,4958,0.18859649122807018,0.10804020100502512,Module 0,"['HP:0002011', 'HP:0012447']"
2644,GO:MF,GO:0042379,chemokine receptor binding,0.00010659380939121802,True,"""Binding to a chemokine receptor."" [GOC:ai]",77,5,3,20212,0.6,0.03896103896103896,Module 12,"['GO:0001664', 'GO:0005126']"
2645,CORUM,CORUM:193,PA700-20S-PA28 complex,0.00010766516886687505,True,PA700-20S-PA28 complex,33,331,14,3383,0.04229607250755287,0.42424242424242425,Module 0,['CORUM:0000000']
2646,GO:BP,GO:0035967,cellular response to topologically incorrect protein,0.000107975650888954,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a protein that is not folded in its correct three-dimensional structure."" [GOC:bf]",102,72,7,21031,0.09722222222222222,0.06862745098039216,Module 4,"['GO:0033554', 'GO:0035966', 'GO:0071310']"
2647,GO:MF,GO:0140776,protein-containing complex destabilizing activity,0.00010875686138226926,True,"""A molecular function that involves direct binding to one of the subunits of a protein-containing complex and promoting the dissociation of one or many subunits. This often happens by changing the conformation of the protein being bound, which decreases its affinity for the rest of the complex."" [PMID:23727094, PMID:29779865, PMID:34836783]",15,20,3,20212,0.15,0.2,Module 9,['GO:0003674']
2648,TF,TF:M01244,Factor: HSF2; motif: GAANRTTCTAGAA,0.00010883562919754171,True,Factor: HSF2; motif: GAANRTTCTAGAA,566,21,8,20045,0.38095238095238093,0.014134275618374558,Module 9,['TF:M00000']
2649,HP,HP:0000622,Blurred vision,0.00010992500961451067,True,Lack of sharpness of vision resulting in the inability to see fine detail.,44,44,7,4958,0.1590909090909091,0.1590909090909091,Module 3,['HP:0000504']
2650,GO:CC,GO:0043235,receptor complex,0.00011064712655432045,True,"""Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function."" [GOC:go_curators]",523,238,21,22097,0.08823529411764706,0.040152963671128104,Module 1,['GO:0032991']
2651,TF,TF:M11881_1,Factor: pax-6; motif: NYACGCNTSANYGCNYN; match class: 1,0.00011091858001914367,True,Factor: pax-6; motif: NYACGCNTSANYGCNYN; match class: 1,7333,826,377,20045,0.45641646489104115,0.05141142779217237,Module 0,['TF:M11881']
2652,GO:BP,GO:0048523,negative regulation of cellular process,0.00011133952233321879,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of a cellular process, any of those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level."" [GOC:jid]",5541,215,93,21031,0.4325581395348837,0.016783974011911208,Module 2,"['GO:0009987', 'GO:0048519', 'GO:0050794']"
2653,GO:CC,GO:0098588,bounding membrane of organelle,0.00011208007387732866,True,"""The lipid bilayer that forms the outer-most layer of an organelle."" [GOC:dos]",2203,813,126,22097,0.15498154981549817,0.05719473445301861,Module 0,['GO:0031090']
2654,GO:BP,GO:0098609,cell-cell adhesion,0.00011286125659499824,True,"""The attachment of one cell to another cell via adhesion molecules."" [GOC:dos]",946,15,8,21031,0.5333333333333333,0.008456659619450317,Module 6,['GO:0007155']
2655,GO:BP,GO:0045321,leukocyte activation,0.00011286125659499824,True,"""A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor."" [GOC:add]",946,15,8,21031,0.5333333333333333,0.008456659619450317,Module 6,"['GO:0001775', 'GO:0002376']"
2656,TF,TF:M02064,Factor: c-ets-2; motif: ACCGGAWRTN,0.00011329870598187559,True,Factor: c-ets-2; motif: ACCGGAWRTN,11163,105,85,20045,0.8095238095238095,0.007614440562572785,Module 3,['TF:M00000']
2657,REAC,REAC:R-HSA-69205,G1/S-Specific Transcription,0.00011373154481793167,True,G1/S-Specific Transcription,27,59,5,10842,0.0847457627118644,0.18518518518518517,Module 5,['REAC:R-HSA-69206']
2658,TF,TF:M11447,Factor: Elf-1; motif: NAMCCGGAAGTN,0.00011414438244679839,True,Factor: Elf-1; motif: NAMCCGGAAGTN,7902,105,69,20045,0.6571428571428571,0.008731966590736523,Module 3,['TF:M00000']
2659,GO:MF,GO:0003823,antigen binding,0.00011443059229536462,True,"""Binding to an antigen, any substance which is capable of inducing a specific immune response and of reacting with the products of that response, the specific antibody or specifically sensitized T-lymphocytes, or both. Binding may counteract the biological activity of the antigen. Antigen binding by an MHC protein complex allows the antigen to be displayed to a T cell or NK cell."" [GOC:jl, ISBN:0198506732, ISBN:0721662544]",174,72,8,20212,0.1111111111111111,0.04597701149425287,Module 4,['GO:0005488']
2660,GO:BP,GO:0010628,positive regulation of gene expression,0.00011590614313958631,True,"""Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA)."" [GOC:txnOH-2018]",1189,226,35,21031,0.15486725663716813,0.02943650126156434,Module 1,"['GO:0010467', 'GO:0010468', 'GO:0010557']"
2661,HP,HP:0007704,Paroxysmal involuntary eye movements,0.00011626135311724518,True,"Sudden-onset episode of abnormal, involuntary eye movements.",38,228,12,4958,0.05263157894736842,0.3157894736842105,Module 0,['HP:0012547']
2662,TF,TF:M10591,Factor: BSX; motif: NNCGTTAN,0.00011635263294606747,True,Factor: BSX; motif: NNCGTTAN,7922,826,402,20045,0.48668280871670705,0.05074476142388286,Module 0,['TF:M00000']
2663,GO:BP,GO:0051247,positive regulation of protein metabolic process,0.0001166224883562804,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein."" [GOC:ai]",1253,215,35,21031,0.16279069767441862,0.027932960893854747,Module 2,"['GO:0010604', 'GO:0019538', 'GO:0051173', 'GO:0051246']"
2664,TF,TF:M11684,Factor: IRF-8; motif: NYGAAACYGAAACTN,0.00011716570874397267,True,Factor: IRF-8; motif: NYGAAACYGAAACTN,4748,36,24,20045,0.6666666666666666,0.005054759898904802,Module 7,['TF:M00000']
2665,HPA,HPA:0461483,skin 1; sebaceous glands[High],0.0001183970603976231,True,skin 1; sebaceous glands[High],83,166,10,11019,0.060240963855421686,0.12048192771084337,Module 2,['HPA:0461482']
2666,MIRNA,MIRNA:hsa-miR-16-5p,hsa-miR-16-5p,0.00011859164399228642,True,hsa-miR-16-5p,1553,18,11,14819,0.6111111111111112,0.0070830650354153256,Module 9,['MIRNA:000000']
2667,HPA,HPA:0600223,tonsil; squamous epithelial cells[High],0.00011870681309642793,True,tonsil; squamous epithelial cells[High],1472,79,28,11019,0.35443037974683544,0.019021739130434784,Module 3,['HPA:0600222']
2668,GO:BP,GO:0031294,lymphocyte costimulation,0.0001191642342579956,True,"""The process of providing, via surface-bound receptor-ligand pairs, a second, antigen-independent, signal in addition to that provided by the B- or T cell receptor to augment B- or T cell activation."" [ISBN:0781735149]",50,226,8,21031,0.035398230088495575,0.16,Module 1,"['GO:0002376', 'GO:0051251']"
2669,GO:MF,GO:0032555,purine ribonucleotide binding,0.00011925081227444151,True,"""Binding to a purine ribonucleotide, any compound consisting of a purine ribonucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose moiety."" [GOC:mah]",1919,20,11,20212,0.55,0.005732152162584679,Module 9,"['GO:0017076', 'GO:0032553']"
2670,HPA,HPA:0310432,lymph node; germinal center cells[≥Medium],0.00012009692644892091,True,lymph node; germinal center cells[≥Medium],3302,79,45,11019,0.569620253164557,0.013628104179285281,Module 3,['HPA:0310431']
2671,TF,TF:M11460,Factor: nerf; motif: NANSCGGAAGTN,0.00012068073638269536,True,Factor: nerf; motif: NANSCGGAAGTN,753,826,64,20045,0.0774818401937046,0.0849933598937583,Module 0,['TF:M00000']
2672,TF,TF:M03832,Factor: Net; motif: CACTTCCKGK,0.00012082889864891421,True,Factor: Net; motif: CACTTCCKGK,942,826,75,20045,0.09079903147699758,0.07961783439490445,Module 0,['TF:M00000']
2673,TF,TF:M08377_1,Factor: meis1:Elf-1; motif: NTGCCGGAAGTN; match class: 1,0.00012159165097694101,True,Factor: meis1:Elf-1; motif: NTGCCGGAAGTN; match class: 1,5157,105,53,20045,0.5047619047619047,0.010277292999806089,Module 3,['TF:M08377']
2674,HP,HP:0005116,Arterial tortuosity,0.00012283443316037332,True,"Abnormal tortuous (i.e., twisted) form of arteries.",27,44,6,4958,0.13636363636363635,0.2222222222222222,Module 3,"['HP:0004948', 'HP:0011004']"
2675,GO:CC,GO:0031090,organelle membrane,0.00012321778495486457,True,"""A membrane that is one of the two lipid bilayers of an organelle envelope or the outermost membrane of single membrane bound organelle."" [GOC:dos, GOC:mah]",3770,221,68,22097,0.3076923076923077,0.01803713527851459,Module 2,"['GO:0016020', 'GO:0043227']"
2676,GO:BP,GO:0009893,positive regulation of metabolic process,0.0001244421615471119,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism."" [GOC:go_curators]",3711,226,73,21031,0.3230088495575221,0.019671247642144975,Module 1,"['GO:0008152', 'GO:0019222', 'GO:0048518']"
2677,HPA,HPA:0050093,breast; myoepithelial cells[High],0.00012662229217475673,True,breast; myoepithelial cells[High],837,69,19,11019,0.2753623188405797,0.022700119474313024,Module 5,['HPA:0050092']
2678,GO:BP,GO:0010604,positive regulation of macromolecule metabolic process,0.0001270220478185949,True,"""Any process that increases the frequency, rate or extent of the chemical reactions and pathways involving macromolecules, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass."" [GOC:dph, GOC:tb]",3420,226,69,21031,0.3053097345132743,0.02017543859649123,Module 1,"['GO:0009893', 'GO:0043170', 'GO:0060255']"
2679,GO:CC,GO:0005794,Golgi apparatus,0.00012835010759916236,True,"""A membrane-bound cytoplasmic organelle of the endomembrane system that further processes the core oligosaccharides (e.g. N-glycans) added to proteins in the endoplasmic reticulum and packages them into membrane-bound vesicles. The Golgi apparatus operates at the intersection of the secretory, lysosomal, and endocytic pathways."" [ISBN:0198506732]",1629,17,9,22097,0.5294117647058824,0.0055248618784530384,Module 6,"['GO:0005737', 'GO:0012505', 'GO:0043231']"
2680,HPA,HPA:0340462,ovary; ovarian stroma cells[≥Medium],0.00012874271580044108,True,ovary; ovarian stroma cells[≥Medium],2067,69,31,11019,0.4492753623188406,0.014997581035316884,Module 5,['HPA:0340461']
2681,GO:BP,GO:1901564,organonitrogen compound metabolic process,0.00012936616630492776,True,"""The chemical reactions and pathways involving organonitrogen compound."" [GOC:pr, GOC:TermGenie]",5986,215,98,21031,0.4558139534883721,0.016371533578349484,Module 2,"['GO:0006807', 'GO:0071704']"
2682,GO:BP,GO:0006183,GTP biosynthetic process,0.0001295365303906186,True,"""The chemical reactions and pathways resulting in the formation of GTP, guanosine triphosphate."" [ISBN:0198506732]",11,2,2,21031,1.0,0.18181818181818182,Module 39,"['GO:0009152', 'GO:0009206', 'GO:0046039']"
2683,REAC,REAC:R-HSA-1236974,ER-Phagosome pathway,0.00013002705310829224,True,ER-Phagosome pathway,90,586,19,10842,0.032423208191126277,0.2111111111111111,Module 0,['REAC:R-HSA-1236975']
2684,GO:MF,GO:0032553,ribonucleotide binding,0.00013044345710265257,True,"""Binding to a ribonucleotide, any compound consisting of a ribonucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose moiety."" [GOC:mah]",1936,20,11,20212,0.55,0.005681818181818182,Module 9,"['GO:0000166', 'GO:0097367']"
2685,GO:BP,GO:0048871,multicellular organismal-level homeostasis,0.0001308705374983505,True,"""Any process involved in the maintenance of an internal steady state at the level of the multicellular organism."" [GOC:isa_complete]",806,215,27,21031,0.12558139534883722,0.033498759305210915,Module 2,"['GO:0032501', 'GO:0042592']"
2686,KEGG,KEGG:04658,Th1 and Th2 cell differentiation,0.000130973033683233,True,Th1 and Th2 cell differentiation,89,136,10,8484,0.07352941176470588,0.11235955056179775,Module 1,['KEGG:00000']
2687,GO:MF,GO:0005524,ATP binding,0.0001324813713771595,True,"""Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator."" [ISBN:0198506732]",1500,20,10,20212,0.5,0.006666666666666667,Module 9,"['GO:0032559', 'GO:0035639']"
2688,HPA,HPA:0461413,skin 1; cells in spinous layer[High],0.00013516800638378807,True,skin 1; cells in spinous layer[High],207,69,10,11019,0.14492753623188406,0.04830917874396135,Module 5,['HPA:0461412']
2689,REAC,REAC:R-HSA-2262752,Cellular responses to stress,0.00013597318626358665,True,Cellular responses to stress,780,586,76,10842,0.1296928327645051,0.09743589743589744,Module 0,['REAC:R-HSA-8953897']
2690,TF,TF:M11392,Factor: Erg; motif: NACCGGAARYN,0.00013657393079083758,True,Factor: Erg; motif: NACCGGAARYN,8890,105,74,20045,0.7047619047619048,0.008323959505061868,Module 3,['TF:M00000']
2691,HPA,HPA:0050091,breast; myoepithelial cells[≥Low],0.0001369622331904647,True,breast; myoepithelial cells[≥Low],5666,79,62,11019,0.7848101265822784,0.010942463819272856,Module 3,['HPA:0050000']
2692,HPA,HPA:0271123,kidney; collecting ducts[High],0.0001381017969328334,True,kidney; collecting ducts[High],274,612,37,11019,0.06045751633986928,0.13503649635036497,Module 0,['HPA:0271122']
2693,GO:MF,GO:0003743,translation initiation factor activity,0.00013827520141998877,True,"""Functions in the initiation of ribosome-mediated translation of mRNA into a polypeptide."" [ISBN:0198506732]",55,808,13,20212,0.01608910891089109,0.23636363636363636,Module 0,['GO:0008135']
2694,TF,TF:M01035_1,Factor: YY1; motif: NYNKCCATNTT; match class: 1,0.00013842863422421726,True,Factor: YY1; motif: NYNKCCATNTT; match class: 1,1105,826,84,20045,0.1016949152542373,0.0760180995475113,Module 0,['TF:M01035']
2695,GO:BP,GO:0140014,mitotic nuclear division,0.00013864008343638694,True,"""A mitotic cell cycle process comprising the steps by which the nucleus of a eukaryotic cell divides; the process involves condensation of chromosomal DNA into a highly compacted form. Canonically, mitosis produces two daughter nuclei whose chromosome complement is identical to that of the mother cell."" [ISBN:0198547684]",279,77,10,21031,0.12987012987012986,0.035842293906810034,Module 5,"['GO:0000280', 'GO:1903047']"
2696,KEGG,KEGG:05134,Legionellosis,0.00013970787150501405,True,Legionellosis,56,15,4,8484,0.26666666666666666,0.07142857142857142,Module 9,['KEGG:00000']
2697,HPA,HPA:0471471,skin 2; lymphocytes[≥Low],0.0001397594616626707,True,skin 2; lymphocytes[≥Low],802,79,20,11019,0.25316455696202533,0.02493765586034913,Module 3,['HPA:0470000']
2698,HPA,HPA:0040081,bone marrow; hematopoietic cells[≥Low],0.00013999437145205385,True,bone marrow; hematopoietic cells[≥Low],6496,60,53,11019,0.8833333333333333,0.008158866995073892,Module 4,['HPA:0040000']
2699,HPA,HPA:0040000,bone marrow,0.00013999437145205385,True,bone marrow,6496,60,53,11019,0.8833333333333333,0.008158866995073892,Module 4,['HPA:0000000']
2700,TF,TF:M08913_1,Factor: FLI-1; motif: NAYTTCCGGT; match class: 1,0.00014012190614248393,True,Factor: FLI-1; motif: NAYTTCCGGT; match class: 1,3115,105,39,20045,0.37142857142857144,0.012520064205457464,Module 3,['TF:M08913']
2701,HPA,HPA:0471392,skin 2; cells in basal layer[≥Medium],0.00014031293039700176,True,skin 2; cells in basal layer[≥Medium],754,18,9,11019,0.5,0.011936339522546418,Module 9,['HPA:0471391']
2702,HPA,HPA:0060000,bronchus,0.00014176098796452315,True,bronchus,7428,79,72,11019,0.9113924050632911,0.009693053311793215,Module 3,['HPA:0000000']
2703,TF,TF:M09966,Factor: Kaiso; motif: SARNYCTCGCGAGAN,0.00014209933982208984,True,Factor: Kaiso; motif: SARNYCTCGCGAGAN,2452,826,154,20045,0.1864406779661017,0.06280587275693311,Module 0,['TF:M00000']
2704,GO:BP,GO:0141124,intracellular signaling cassette,0.00014289633247689893,True,"""An intracellular signaling module that is part of larger signaling pathways that can be initiated either intracellularly or by cell surface receptors. Intracellular signaling cassettes are discrete signaling units that are often shared by multiple signaling pathways."" [GOC:ha, GOC:pg]",1861,226,46,21031,0.20353982300884957,0.024717893605588393,Module 1,['GO:0035556']
2705,TF,TF:M07209,Factor: ELK4; motif: NCRCTTCCGGN,0.00014360146423253857,True,Factor: ELK4; motif: NCRCTTCCGGN,1142,826,86,20045,0.10411622276029056,0.07530647985989491,Module 0,['TF:M00000']
2706,HPA,HPA:0380513,placenta; decidual cells[High],0.0001445215543527249,True,placenta; decidual cells[High],1209,612,107,11019,0.17483660130718953,0.08850289495450786,Module 0,['HPA:0380512']
2707,REAC,REAC:R-HSA-69202,Cyclin E associated events during G1/S transition ,0.00014487600945878797,True,Cyclin E associated events during G1/S transition ,82,586,18,10842,0.030716723549488054,0.21951219512195122,Module 0,['REAC:R-HSA-69206']
2708,GO:BP,GO:0006950,response to stress,0.00014499461506867572,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis, usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation)."" [GOC:mah]",3855,72,33,21031,0.4583333333333333,0.008560311284046693,Module 4,['GO:0050896']
2709,REAC,REAC:R-HSA-611105,Respiratory electron transport,0.00014515062796433372,True,Respiratory electron transport,103,97,9,10842,0.09278350515463918,0.08737864077669903,Module 3,['REAC:R-HSA-163200']
2710,GO:BP,GO:0036261,7-methylguanosine cap hypermethylation,0.0001474084328717774,True,"""Hypermethylation of the 7-(mono)methylguanosine (m(7)G) cap structure at the 2' position of the guanosine residue to convert a mono-methylated cap to a 2,2,7-trimethylguanosine cap structure. This type of cap modification occurs on small nuclear RNAs (snRNAs) and small nucleolar RNAs (snoRNAs) and is dependent on prior guanine-N7 methylation."" [GOC:bf, GOC:BHF, GOC:krc, GOC:mah, GOC:rl, PMID:11983179, PMID:18775984]",8,787,6,21031,0.007623888182973317,0.75,Module 0,"['GO:0001510', 'GO:0036260']"
2711,TF,TF:M00196,Factor: Sp1; motif: NGGGGGCGGGGYN,0.00014749373002095274,True,Factor: Sp1; motif: NGGGGGCGGGGYN,10571,826,511,20045,0.6186440677966102,0.04833979755936051,Module 0,['TF:M00000']
2712,GO:MF,GO:0031726,CCR1 chemokine receptor binding,0.0001480030137755087,True,"""Binding to a CCR1 chemokine receptor."" [GOC:mah, GOC:nln]",6,5,2,20212,0.4,0.3333333333333333,Module 12,['GO:0048020']
2713,HP,HP:0003737,Mitochondrial myopathy,0.00014810994187129667,True,A type of myopathy associated with mitochondrial disease and characterized by findings on biopsy such as ragged red muscle fibers.,54,228,14,4958,0.06140350877192982,0.25925925925925924,Module 0,['HP:0003800']
2714,GO:BP,GO:0000280,nuclear division,0.00014865626634165378,True,"""The division of a cell nucleus into two nuclei, with DNA and other nuclear contents distributed between the daughter nuclei."" [GOC:mah]",447,77,12,21031,0.15584415584415584,0.026845637583892617,Module 5,['GO:0048285']
2715,GO:BP,GO:0050776,regulation of immune response,0.00014873130659446575,True,"""Any process that modulates the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus."" [GOC:ai]",881,34,11,21031,0.3235294117647059,0.012485811577752554,Module 7,"['GO:0002682', 'GO:0006955', 'GO:0048583']"
2716,TF,TF:M00933,Factor: Sp1; motif: CCCCGCCCCN,0.000149290369342686,True,Factor: Sp1; motif: CCCCGCCCCN,10005,826,488,20045,0.5907990314769975,0.04877561219390305,Module 0,['TF:M00000']
2717,GO:BP,GO:0009893,positive regulation of metabolic process,0.00015004349506543744,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism."" [GOC:go_curators]",3711,787,197,21031,0.2503176620076239,0.05308542171921315,Module 0,"['GO:0008152', 'GO:0019222', 'GO:0048518']"
2718,REAC,REAC:R-HSA-8878166,Transcriptional regulation by RUNX2,0.00015033493898007193,True,Transcriptional regulation by RUNX2,118,586,22,10842,0.03754266211604096,0.1864406779661017,Module 0,['REAC:R-HSA-212436']
2719,GO:CC,GO:0033177,"proton-transporting two-sector ATPase complex, proton-transporting domain",0.00015102556632154565,True,"""A protein complex that forms part of a proton-transporting two-sector ATPase complex and carries out proton transport across a membrane. The proton-transporting domain (F0, V0, or A0) includes integral and peripheral membrane proteins."" [GOC:mah, PMID:10838056]",28,813,9,22097,0.01107011070110701,0.32142857142857145,Module 0,"['GO:0016469', 'GO:0098796']"
2720,GO:BP,GO:0045595,regulation of cell differentiation,0.00015371121502729025,True,"""Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features."" [GOC:go_curators]",1576,215,40,21031,0.18604651162790697,0.025380710659898477,Module 2,"['GO:0030154', 'GO:0050793', 'GO:0050794']"
2721,HP,HP:0004377,Hematological neoplasm,0.0001550323879749985,True,Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue).,296,71,18,4958,0.2535211267605634,0.060810810810810814,Module 1,"['HP:0001871', 'HP:0011793']"
2722,HP,HP:0010794,Impaired visuospatial constructive cognition,0.0001553056707620165,True,"Reduced ability affecting mainly visuospatial cognition which may be tested using pattern construction (for example by Differential Ability Scales, which test a person's strengths and weaknesses across a range of intellectual abilities).",28,44,6,4958,0.13636363636363635,0.21428571428571427,Module 3,['HP:0001328']
2723,GO:BP,GO:0046051,UTP metabolic process,0.00015544383646874294,True,"""The chemical reactions and pathways involving UTP, uridine (5'-)triphosphate."" [GOC:go_curators]",12,2,2,21031,1.0,0.16666666666666666,Module 39,"['GO:0009208', 'GO:0009218']"
2724,GO:BP,GO:0043065,positive regulation of apoptotic process,0.0001557763121074136,True,"""Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process."" [GOC:jl, GOC:mtg_apoptosis]",512,215,21,21031,0.09767441860465116,0.041015625,Module 2,"['GO:0006915', 'GO:0042981', 'GO:0043068']"
2725,GO:BP,GO:0010638,positive regulation of organelle organization,0.00015599634758423262,True,"""Any process that increases the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of an organelle."" [GOC:dph, GOC:tb]",505,787,45,21031,0.05717916137229987,0.0891089108910891,Module 0,"['GO:0006996', 'GO:0033043', 'GO:0051130']"
2726,TF,TF:M08222,Factor: Elk-1:HOXB13; motif: ACCGGAAGTNGTAAAN,0.0001564939120282127,True,Factor: Elk-1:HOXB13; motif: ACCGGAAGTNGTAAAN,7770,105,68,20045,0.6476190476190476,0.008751608751608752,Module 3,['TF:M00000']
2727,GO:CC,GO:1902494,catalytic complex,0.0001567546053683363,True,"""A protein complex which is capable of catalytic activity."" [GOC:bhm, GOC:TermGenie, PMID:8077207]",1776,177,35,22097,0.1977401129943503,0.019707207207207207,Module Singleton,['GO:0032991']
2728,HPA,HPA:0030441,appendix; non-germinal center cells[≥Low],0.00015684746844966643,True,appendix; non-germinal center cells[≥Low],336,79,13,11019,0.16455696202531644,0.03869047619047619,Module 3,['HPA:0030000']
2729,TF,TF:M08775,Factor: IRF-2; motif: NAANYGAAASYR,0.0001571442855385757,True,Factor: IRF-2; motif: NAANYGAAASYR,8493,36,31,20045,0.8611111111111112,0.00365006475921347,Module 7,['TF:M00000']
2730,GO:CC,GO:0030141,secretory granule,0.000157393490893256,True,"""A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules."" [GOC:mah, ISBN:0198506732]",896,21,8,22097,0.38095238095238093,0.008928571428571428,Module 9,"['GO:0012505', 'GO:0099503']"
2731,HPA,HPA:0271133,kidney; distal tubules[High],0.00015809274346140778,True,kidney; distal tubules[High],310,612,40,11019,0.06535947712418301,0.12903225806451613,Module 0,['HPA:0271132']
2732,HP,HP:0000988,Skin rash,0.0001597568718051172,True,A red eruption of the skin.,166,74,14,4958,0.1891891891891892,0.08433734939759036,Module 2,['HP:0011123']
2733,HP,HP:0008316,Abnormal mitochondria in muscle tissue,0.0001611778256857445,True,An abnormality of the mitochondria in muscle tissue.,39,228,12,4958,0.05263157894736842,0.3076923076923077,Module 0,"['HP:0003287', 'HP:0011805']"
2734,TF,TF:M10948,Factor: rax; motif: NNCRTTAN,0.00016147384540541622,True,Factor: rax; motif: NNCRTTAN,12008,826,568,20045,0.6876513317191283,0.04730179880079947,Module 0,['TF:M00000']
2735,GO:MF,GO:0003779,actin binding,0.00016398583592403372,True,"""Binding to monomeric or multimeric forms of actin, including actin filaments."" [GOC:clt]",443,808,42,20212,0.05198019801980198,0.09480812641083522,Module 0,['GO:0008092']
2736,KEGG,KEGG:04915,Estrogen signaling pathway,0.0001647034409110878,True,Estrogen signaling pathway,136,15,5,8484,0.3333333333333333,0.03676470588235294,Module 9,['KEGG:00000']
2737,WP,WP:WP3286,Copper homeostasis,0.00016475702087095188,True,Copper homeostasis,52,14,4,8286,0.2857142857142857,0.07692307692307693,Module 10,['WP:000000']
2738,TF,TF:M00939,Factor: E2F; motif: TTTSGCGSG,0.00016703777191775227,True,Factor: E2F; motif: TTTSGCGSG,6627,80,50,20045,0.625,0.007544892108042855,Module 5,['TF:M00000']
2739,HPA,HPA:0471462,skin 2; langerhans cells[≥Medium],0.00016711280737868522,True,skin 2; langerhans cells[≥Medium],662,79,18,11019,0.22784810126582278,0.027190332326283987,Module 3,['HPA:0471461']
2740,GO:BP,GO:0002711,positive regulation of T cell mediated immunity,0.00016804197313906197,True,"""Any process that activates or increases the frequency, rate, or extent of T cell mediated immunity."" [GOC:add]",66,15,4,21031,0.26666666666666666,0.06060606060606061,Module 6,"['GO:0002456', 'GO:0002708', 'GO:0002709', 'GO:0002824']"
2741,GO:BP,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,0.00016804197313906197,True,"""Any process that activates or increases the frequency, rate or extent of leukocyte mediated cytotoxicity."" [GOC:add, ISBN:0781735149, PMID:11911826]",66,15,4,21031,0.26666666666666666,0.06060606060606061,Module 6,"['GO:0001909', 'GO:0001910', 'GO:0002705', 'GO:0031343']"
2742,HPA,HPA:0630051,cervix; glandular cells[≥Low],0.00016829430872122018,True,cervix; glandular cells[≥Low],5692,79,62,11019,0.7848101265822784,0.01089248067463106,Module 3,['HPA:0630000']
2743,MIRNA,MIRNA:hsa-miR-146a-3p,hsa-miR-146a-3p,0.00016863534352225612,True,hsa-miR-146a-3p,115,3,3,14819,1.0,0.02608695652173913,Module 27,['MIRNA:000000']
2744,REAC,REAC:R-HSA-1280218,Adaptive Immune System,0.00016914352263136065,True,Adaptive Immune System,809,164,32,10842,0.1951219512195122,0.03955500618046971,Module 1,['REAC:R-HSA-168256']
2745,TF,TF:M08875,Factor: E2F; motif: NNTTTCGCGCN,0.00016919340673170782,True,Factor: E2F; motif: NNTTTCGCGCN,6410,826,336,20045,0.4067796610169492,0.052418096723868955,Module 0,['TF:M00000']
2746,TF,TF:M11685_1,Factor: IRF-8; motif: NCGAAACYGAAACYN; match class: 1,0.00017195952612863175,True,Factor: IRF-8; motif: NCGAAACYGAAACYN; match class: 1,123,36,6,20045,0.16666666666666666,0.04878048780487805,Module 7,['TF:M11685']
2747,TF,TF:M00050_1,Factor: E2F; motif: TTTSGCGC; match class: 1,0.00017270253434728333,True,Factor: E2F; motif: TTTSGCGC; match class: 1,1933,80,25,20045,0.3125,0.012933264355923435,Module 5,['TF:M00050']
2748,GO:BP,GO:0042592,homeostatic process,0.00017500739874941147,True,"""Any biological process involved in the maintenance of an internal steady state."" [GOC:jl, ISBN:0395825172]",1712,215,42,21031,0.19534883720930232,0.02453271028037383,Module 2,['GO:0008150']
2749,GO:BP,GO:1903829,positive regulation of protein localization,0.0001750898372586382,True,"""Any process that activates or increases the frequency, rate or extent of a protein localization."" [GO_REF:0000058, GOC:TermGenie, GOC:vw]",490,787,44,21031,0.05590851334180432,0.08979591836734693,Module 0,"['GO:0008104', 'GO:0032880', 'GO:0048522']"
2750,GO:CC,GO:0032993,protein-DNA complex,0.0001751791395179052,True,"""A macromolecular complex containing both protein and DNA molecules."" [GOC:mah]",1436,80,19,22097,0.2375,0.013231197771587743,Module 5,['GO:0032991']
2751,GO:BP,GO:0001819,positive regulation of cytokine production,0.00017524655901827592,True,"""Any process that activates or increases the frequency, rate or extent of production of a cytokine."" [GOC:add, ISBN:0781735149]",490,226,21,21031,0.09292035398230089,0.04285714285714286,Module 1,"['GO:0001816', 'GO:0001817', 'GO:0010628', 'GO:0051240']"
2752,TF,TF:M03920,Factor: SP1; motif: RCCMCRCCCMC,0.00017550200533214032,True,Factor: SP1; motif: RCCMCRCCCMC,7500,826,383,20045,0.463680387409201,0.05106666666666667,Module 0,['TF:M00000']
2753,HP,HP:0000079,Abnormality of the urinary system,0.0001755390064224202,True,An abnormality of the urinary system.,2007,44,35,4958,0.7954545454545454,0.017438963627304436,Module 3,['HP:0000119']
2754,HPA,HPA:0310000,lymph node,0.00017578131108769184,True,lymph node,6530,60,53,11019,0.8833333333333333,0.008116385911179172,Module 4,['HPA:0000000']
2755,GO:BP,GO:0045580,regulation of T cell differentiation,0.00017718001154044295,True,"""Any process that modulates the frequency, rate or extent of T cell differentiation."" [GOC:go_curators]",181,226,13,21031,0.05752212389380531,0.0718232044198895,Module 1,"['GO:0030217', 'GO:0045619', 'GO:0050863']"
2756,HPA,HPA:0310442,lymph node; non-germinal center cells[≥Medium],0.0001776083127194463,True,lymph node; non-germinal center cells[≥Medium],3989,166,91,11019,0.5481927710843374,0.022812735021308598,Module 2,['HPA:0310441']
2757,GO:BP,GO:0042060,wound healing,0.0001776809510175962,True,"""The series of events that restore integrity to a damaged tissue, following an injury."" [GOC:bf, PMID:15269788]",425,215,19,21031,0.08837209302325581,0.04470588235294118,Module 2,['GO:0009611']
2758,HP,HP:0031381,Decreased lymphocyte proliferation in response to mitogen,0.00017914815776102935,True,"A decreased proliferative response of lymphocytes in vitro or in vivo, when stimulated with mitogens, such as phytohemagglutinin (PHA).",29,71,7,4958,0.09859154929577464,0.2413793103448276,Module 1,['HP:0031378']
2759,HPA,HPA:0530713,spleen; cells in red pulp[High],0.00017999140662521964,True,spleen; cells in red pulp[High],817,185,34,11019,0.1837837837837838,0.0416156670746634,Module 1,['HPA:0530712']
2760,HP,HP:0000369,Low-set ears,0.00018011008785808066,True,Upper insertion of the ear to the scalp below an imaginary horizontal line drawn between the inner canthi of the eye and extending posteriorly to the ear.,863,44,23,4958,0.5227272727272727,0.026651216685979143,Module 3,['HP:0000357']
2761,KEGG,KEGG:05166,Human T-cell leukemia virus 1 infection,0.00018027232397541194,True,Human T-cell leukemia virus 1 infection,218,136,15,8484,0.11029411764705882,0.06880733944954129,Module 1,['KEGG:00000']
2762,REAC,REAC:R-HSA-449147,Signaling by Interleukins,0.00018123155534125664,True,Signaling by Interleukins,471,173,24,10842,0.13872832369942195,0.050955414012738856,Module 2,['REAC:R-HSA-1280215']
2763,GO:BP,GO:0051248,negative regulation of protein metabolic process,0.00018135892763294985,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of chemical reactions and pathways involving a protein."" [GOC:ai]",766,215,26,21031,0.12093023255813953,0.033942558746736295,Module 2,"['GO:0010605', 'GO:0019538', 'GO:0051172', 'GO:0051246']"
2764,GO:BP,GO:0034612,response to tumor necrosis factor,0.00018264298695365414,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus."" [GOC:mah]",249,226,15,21031,0.06637168141592921,0.060240963855421686,Module 1,['GO:0034097']
2765,HPA,HPA:0471493,skin 2; vascular mural cells[High],0.00018288328458081405,True,skin 2; vascular mural cells[High],129,612,23,11019,0.03758169934640523,0.17829457364341086,Module 0,['HPA:0471492']
2766,HPA,HPA:0130000,colon,0.0001830073967550465,True,colon,8342,79,76,11019,0.9620253164556962,0.009110525053943897,Module 3,['HPA:0000000']
2767,GO:BP,GO:0009725,response to hormone,0.000184873649164472,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus."" [GOC:jl]",874,215,28,21031,0.13023255813953488,0.032036613272311214,Module 2,"['GO:0009719', 'GO:0010033']"
2768,TF,TF:M00699,Factor: ICSBP; motif: RAARTGAAACTG,0.00018571903641673976,True,Factor: ICSBP; motif: RAARTGAAACTG,1213,36,13,20045,0.3611111111111111,0.010717230008244023,Module 7,['TF:M00000']
2769,TF,TF:M04698_1,Factor: GABP-alpha; motif: CACTTCCGG; match class: 1,0.00018639386590953256,True,Factor: GABP-alpha; motif: CACTTCCGG; match class: 1,596,826,54,20045,0.06537530266343826,0.09060402684563758,Module 0,['TF:M04698']
2770,HPA,HPA:0350472,pancreas; exocrine glandular cells[≥Medium],0.0001865156452554671,True,pancreas; exocrine glandular cells[≥Medium],5304,140,96,11019,0.6857142857142857,0.01809954751131222,Module Singleton,['HPA:0350471']
2771,GO:CC,GO:0042105,alpha-beta T cell receptor complex,0.00018657930180197428,True,"""A T cell receptor complex in which the TCR heterodimer comprises alpha and beta chains, associated with the CD3 complex; recognizes a complex consisting of an antigen-derived peptide bound to a class I or class II MHC protein."" [GOC:mah, ISBN:0781735149]",7,238,4,22097,0.01680672268907563,0.5714285714285714,Module 1,['GO:0042101']
2772,TF,TF:M11455,Factor: ELFR; motif: NANSCGGAAGTN,0.00018670587638518917,True,Factor: ELFR; motif: NANSCGGAAGTN,645,826,57,20045,0.06900726392251816,0.08837209302325581,Module 0,['TF:M00000']
2773,GO:CC,GO:0005739,mitochondrion,0.00018674171510136143,True,"""A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration."" [GOC:giardia, ISBN:0198506732]",1689,21,10,22097,0.47619047619047616,0.005920663114268798,Module 9,"['GO:0005737', 'GO:0043231']"
2774,GO:BP,GO:0035458,cellular response to interferon-beta,0.0001870923139512604,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-beta stimulus. Interferon-beta is a type I interferon."" [GOC:sl]",27,34,4,21031,0.11764705882352941,0.14814814814814814,Module 7,"['GO:0035456', 'GO:0071345']"
2775,TF,TF:M09918_1,Factor: Pet-1; motif: GCNGGAAGYG; match class: 1,0.00018847471928582022,True,Factor: Pet-1; motif: GCNGGAAGYG; match class: 1,7364,826,377,20045,0.45641646489104115,0.05119500271591526,Module 0,['TF:M09918']
2776,TF,TF:M09956,Factor: IRF-1; motif: NAAANNGAAASTGAAASNRN,0.00018960694735427672,True,Factor: IRF-1; motif: NAAANNGAAASTGAAASNRN,324,36,8,20045,0.2222222222222222,0.024691358024691357,Module 7,['TF:M00000']
2777,REAC,REAC:R-HSA-5689603,UCH proteinases,0.00018966268652954318,True,UCH proteinases,101,586,20,10842,0.034129692832764506,0.19801980198019803,Module 0,['REAC:R-HSA-5688426']
2778,HPA,HPA:0091071,cerebellum; white matter cells - cytoplasm/membrane[≥Low],0.00019054580922160468,True,cerebellum; white matter cells - cytoplasm/membrane[≥Low],289,612,38,11019,0.06209150326797386,0.1314878892733564,Module 0,['HPA:0090000']
2779,GO:MF,GO:0032559,adenyl ribonucleotide binding,0.00019075647091367293,True,"""Binding to an adenyl ribonucleotide, any compound consisting of adenosine esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose moiety."" [GOC:mah]",1560,20,10,20212,0.5,0.00641025641025641,Module 9,"['GO:0030554', 'GO:0032555']"
2780,HPA,HPA:0210000,fallopian tube,0.00019101645979756576,True,fallopian tube,7466,79,72,11019,0.9113924050632911,0.00964371818912403,Module 3,['HPA:0000000']
2781,REAC,REAC:R-HSA-72766,Translation,0.00019136039517603234,True,Translation,292,60,11,10842,0.18333333333333332,0.03767123287671233,Module 4,['REAC:R-HSA-392499']
2782,HPA,HPA:0131331,colon; mucosal lymphoid cells[≥Low],0.0001923033078376073,True,colon; mucosal lymphoid cells[≥Low],509,612,56,11019,0.0915032679738562,0.1100196463654224,Module 0,['HPA:0130000']
2783,HPA,HPA:0160000,endometrium 1,0.00019235625118234085,True,endometrium 1,7055,60,55,11019,0.9166666666666666,0.007795889440113395,Module 4,['HPA:0000000']
2784,TF,TF:M04714,Factor: Elf-1; motif: ACTTCCGGG,0.0001930740925322218,True,Factor: Elf-1; motif: ACTTCCGGG,7992,105,69,20045,0.6571428571428571,0.008633633633633633,Module 3,['TF:M00000']
2785,HPA,HPA:0030072,appendix; lymphoid tissue[≥Medium],0.0001934581640577403,True,appendix; lymphoid tissue[≥Medium],2987,69,38,11019,0.5507246376811594,0.012721794442584533,Module 5,['HPA:0030071']
2786,HP,HP:0004389,Intestinal pseudo-obstruction,0.00019453117778840887,True,"A functional rather than mechanical obstruction of the intestines, associated with manifestations that resemble those caused by an intestinal obstruction, including distension, abdominal pain, nausea, vomiting, constipation or diarrhea, in an individual in whom a mechanical blockage has been excluded.",29,44,6,4958,0.13636363636363635,0.20689655172413793,Module 3,"['HP:0002242', 'HP:0002579']"
2787,HP,HP:0007183,Focal T2 hyperintense basal ganglia lesion,0.00019453117778840887,True,A lighter than expected T2 signal on magnetic resonance imaging (MRI) of the basal ganglia. This term refers to a localized hyperintensity affecting a particular region of the basal ganglia.,29,44,6,4958,0.13636363636363635,0.20689655172413793,Module 3,['HP:0012751']
2788,REAC,REAC:R-HSA-5358351,Signaling by Hedgehog,0.0001950840803404643,True,Signaling by Hedgehog,149,586,25,10842,0.042662116040955635,0.16778523489932887,Module 0,['REAC:R-HSA-162582']
2789,GO:BP,GO:0009206,purine ribonucleoside triphosphate biosynthetic process,0.00019556604219117272,True,"""The chemical reactions and pathways resulting in the formation of purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",113,105,8,21031,0.0761904761904762,0.07079646017699115,Module 3,"['GO:0009145', 'GO:0009201', 'GO:0009205']"
2790,TF,TF:M11396_1,Factor: Erg; motif: NACCGGAARTN; match class: 1,0.00019656992835404054,True,Factor: Erg; motif: NACCGGAARTN; match class: 1,5068,105,52,20045,0.49523809523809526,0.010260457774269928,Module 3,['TF:M11396']
2791,HPA,HPA:0600443,tonsil; non-germinal center cells[High],0.00019670943242198574,True,tonsil; non-germinal center cells[High],1321,140,38,11019,0.2714285714285714,0.028766086298258896,Module Singleton,['HPA:0600442']
2792,GO:BP,GO:0051972,regulation of telomerase activity,0.0001990690011214258,True,"""Any process that modulates the frequency, rate or extent of telomerase activity, the catalysis of the reaction: deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1). Telomerases catalyze extension of the 3'- end of a DNA strand by one deoxynucleotide at a time using an internal RNA template that encodes the telomeric repeat sequence."" [EC:2.-.-.-, GOC:ai]",47,21,4,21031,0.19047619047619047,0.0851063829787234,Module 9,"['GO:0051338', 'GO:2000278']"
2793,TF,TF:M11400_1,Factor: Fli-1; motif: NACCGGAARTN; match class: 1,0.00019908769636521923,True,Factor: Fli-1; motif: NACCGGAARTN; match class: 1,4300,105,47,20045,0.44761904761904764,0.010930232558139534,Module 3,['TF:M11400']
2794,HP,HP:0045080,Decreased proportion of CD3-positive T cells,0.00020086357143184698,True,Any abnormality in the proportion of CD3-positive T cells relative to the total number of T cells.,10,71,5,4958,0.07042253521126761,0.5,Module 1,['HP:0025540']
2795,CORUM,CORUM:2755,17S U2 snRNP,0.0002013509055985618,True,17S U2 snRNP,30,331,13,3383,0.03927492447129909,0.43333333333333335,Module 0,['CORUM:0000000']
2796,GO:MF,GO:0017076,purine nucleotide binding,0.0002017254576933064,True,"""Binding to a purine nucleotide, a compound consisting of a purine nucleoside esterified with (ortho)phosphate."" [GOC:ai]",2021,20,11,20212,0.55,0.0054428500742206825,Module 9,['GO:0000166']
2797,HPA,HPA:0461453,skin 1; hair follicles[High],0.00020201630690609948,True,skin 1; hair follicles[High],122,69,8,11019,0.11594202898550725,0.06557377049180328,Module 5,['HPA:0461452']
2798,GO:BP,GO:0048247,lymphocyte chemotaxis,0.0002024477871513017,True,"""The directed movement of a lymphocyte in response to an external stimulus."" [GOC:hjd, GOC:jid, PMID:12391252]",63,5,3,21031,0.6,0.047619047619047616,Module 12,"['GO:0030595', 'GO:0072676']"
2799,WP,WP:WP4921,Mitochondrial complex III assembly,0.00020290298738871466,True,Mitochondrial complex III assembly,16,472,8,8286,0.01694915254237288,0.5,Module 0,['WP:000000']
2800,TF,TF:M11450,Factor: Elf-1; motif: NANSCGGAAGTR,0.00020291780384492505,True,Factor: Elf-1; motif: NANSCGGAAGTR,5718,105,56,20045,0.5333333333333333,0.009793634137810424,Module 3,['TF:M00000']
2801,TF,TF:M11400,Factor: Fli-1; motif: NACCGGAARTN,0.00020462550494406383,True,Factor: Fli-1; motif: NACCGGAARTN,10184,105,80,20045,0.7619047619047619,0.007855459544383346,Module 3,['TF:M00000']
2802,HPA,HPA:0471461,skin 2; langerhans cells[≥Low],0.00020583334497659283,True,skin 2; langerhans cells[≥Low],789,18,9,11019,0.5,0.011406844106463879,Module 9,['HPA:0470000']
2803,GO:CC,GO:0005634,nucleus,0.00020700210415196003,True,"""A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent."" [GOC:go_curators]",10074,813,439,22097,0.5399753997539976,0.04357752630534048,Module 0,['GO:0043231']
2804,GO:MF,GO:0031730,CCR5 chemokine receptor binding,0.00020718371213835978,True,"""Binding to a CCR5 chemokine receptor."" [GOC:mah, GOC:nln]",7,5,2,20212,0.4,0.2857142857142857,Module 12,['GO:0048020']
2805,TF,TF:M07379,Factor: c-Ets-2; motif: NNCTTCCTNNN,0.00020818567999392212,True,Factor: c-Ets-2; motif: NNCTTCCTNNN,3504,826,204,20045,0.2469733656174334,0.05821917808219178,Module 0,['TF:M00000']
2806,GO:BP,GO:0009145,purine nucleoside triphosphate biosynthetic process,0.00020946412040502726,True,"""The chemical reactions and pathways resulting in the formation of purine nucleoside triphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",114,105,8,21031,0.0761904761904762,0.07017543859649122,Module 3,"['GO:0009142', 'GO:0009144']"
2807,HPA,HPA:0400000,rectum,0.000210696351255876,True,rectum,7973,140,125,11019,0.8928571428571429,0.015677912956227266,Module Singleton,['HPA:0000000']
2808,HP,HP:0001911,Abnormal granulocyte morphology,0.00021090252370117607,True,Any structural abnormality or abnormal count of granulocytes.,302,71,18,4958,0.2535211267605634,0.059602649006622516,Module 1,['HP:0010974']
2809,GO:CC,GO:0043232,intracellular non-membrane-bounded organelle,0.00021106044978951073,True,"""Organized structure of distinctive morphology and function, not bounded by a lipid bilayer membrane and occurring within the cell. Includes ribosomes, the cytoskeleton and chromosomes."" [GOC:go_curators]",6591,80,45,22097,0.5625,0.006827492034592627,Module 5,"['GO:0043228', 'GO:0043229']"
2810,GO:CC,GO:0005839,proteasome core complex,0.00021149858196002389,True,"""A multisubunit barrel shaped endoprotease complex, which is the core of the proteasome complex."" [GOC:rb, PMID:10806206]",23,2,2,22097,1.0,0.08695652173913043,Module 41,"['GO:0000502', 'GO:0140535', 'GO:1902494']"
2811,GO:CC,GO:0043228,non-membrane-bounded organelle,0.00021205203296602337,True,"""Organized structure of distinctive morphology and function, not bounded by a lipid bilayer membrane. Includes ribosomes, the cytoskeleton and chromosomes."" [GOC:go_curators]",6592,80,45,22097,0.5625,0.006826456310679611,Module 5,['GO:0043226']
2812,REAC,REAC:R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,0.0002127425731724022,True,Cyclin A:Cdk2-associated events at S phase entry,84,586,18,10842,0.030716723549488054,0.21428571428571427,Module 0,['REAC:R-HSA-69242']
2813,GO:BP,GO:0006241,CTP biosynthetic process,0.000214324077555388,True,"""The chemical reactions and pathways resulting in the formation of CTP, cytidine 5'-triphosphate."" [ISBN:0198506732]",14,2,2,21031,1.0,0.14285714285714285,Module 39,"['GO:0009209', 'GO:0009220', 'GO:0046036']"
2814,TF,TF:M00430_1,Factor: E2F-1; motif: NTTSGCGG; match class: 1,0.0002152223836355315,True,Factor: E2F-1; motif: NTTSGCGG; match class: 1,2574,80,29,20045,0.3625,0.011266511266511266,Module 5,['TF:M00430']
2815,GO:BP,GO:0032481,positive regulation of type I interferon production,0.00021688897557634536,True,"""Any process that activates or increases the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families."" [GOC:add, GOC:mah]",73,34,5,21031,0.14705882352941177,0.0684931506849315,Module 7,"['GO:0001819', 'GO:0032479', 'GO:0032606']"
2816,REAC,REAC:R-HSA-1428517,The citric acid (TCA) cycle and respiratory electron transport,0.00021740052853759043,True,The citric acid (TCA) cycle and respiratory electron transport,177,97,11,10842,0.1134020618556701,0.062146892655367235,Module 3,['REAC:R-HSA-1430728']
2817,GO:BP,GO:0048731,system development,0.00021844117335412618,True,"""The process whose specific outcome is the progression of an organismal system over time, from its formation to the mature structure. A system is a regularly interacting or interdependent group of organs or tissues that work together to carry out a given biological process."" [GOC:dph, GOC:jid]",3973,215,73,21031,0.3395348837209302,0.018374024666498866,Module 2,"['GO:0007275', 'GO:0048856']"
2818,GO:BP,GO:0042063,gliogenesis,0.00022080589992685913,True,"""The process that results in the generation of glial cells. This includes the production of glial progenitors and their differentiation into mature glia."" [GOC:dgh, GOC:jid]",345,215,17,21031,0.07906976744186046,0.04927536231884058,Module 2,['GO:0022008']
2819,GO:BP,GO:0034341,response to type II interferon,0.00022245207439753755,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon-gamma is also known as type II interferon."" [GOC:add, ISBN:0126896631, PMID:15546383]",146,34,6,21031,0.17647058823529413,0.0410958904109589,Module 7,"['GO:0034097', 'GO:0045087']"
2820,GO:BP,GO:0002253,activation of immune response,0.000223970650456606,True,"""Any process that initiates an immune response."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",531,34,9,21031,0.2647058823529412,0.01694915254237288,Module 7,"['GO:0002376', 'GO:0050778']"
2821,TF,TF:M04018,Factor: IRF7; motif: NCGAAARYGAAANT,0.00022453931321269116,True,Factor: IRF7; motif: NCGAAARYGAAANT,628,36,10,20045,0.2777777777777778,0.01592356687898089,Module 7,['TF:M00000']
2822,TF,TF:M00069_1,Factor: YY1; motif: NNNCGGCCATCTTGNCTSNW; match class: 1,0.00022599377136638788,True,Factor: YY1; motif: NNNCGGCCATCTTGNCTSNW; match class: 1,2228,826,142,20045,0.17191283292978207,0.06373429084380611,Module 0,['TF:M00069']
2823,TF,TF:M06748,Factor: ZN337; motif: KGKTAAGTCMGA,0.00022649099394651823,True,Factor: ZN337; motif: KGKTAAGTCMGA,14,2,2,20045,1.0,0.14285714285714285,Module 41,['TF:M00000']
2824,GO:BP,GO:0015986,proton motive force-driven ATP synthesis,0.0002280326103514639,True,"""The transport of protons across a membrane to generate an electrochemical gradient (proton-motive force) that powers ATP synthesis."" [ISBN:0716731363]",77,105,7,21031,0.06666666666666667,0.09090909090909091,Module 3,['GO:0006754']
2825,HPA,HPA:0080123,caudate; glial cells[High],0.00022853805989556895,True,caudate; glial cells[High],683,612,69,11019,0.11274509803921569,0.10102489019033675,Module 0,['HPA:0080122']
2826,TF,TF:M10625_1,Factor: Nkx3-2; motif: NTCGTTAN; match class: 1,0.00022868955402189427,True,Factor: Nkx3-2; motif: NTCGTTAN; match class: 1,1338,826,96,20045,0.1162227602905569,0.07174887892376682,Module 0,['TF:M10625']
2827,REAC,REAC:R-HSA-1280215,Cytokine Signaling in Immune system,0.00023322691120643694,True,Cytokine Signaling in Immune system,719,14,8,10842,0.5714285714285714,0.011126564673157162,Module 6,['REAC:R-HSA-168256']
2828,WP,WP:WP5078,T cell modulation in pancreatic cancer,0.00023323073509168396,True,T cell modulation in pancreatic cancer,46,148,8,8286,0.05405405405405406,0.17391304347826086,Module 1,['WP:000000']
2829,HPA,HPA:0290402,liver; hepatocytes[≥Medium],0.0002338720585906652,True,liver; hepatocytes[≥Medium],3750,79,48,11019,0.6075949367088608,0.0128,Module 3,['HPA:0290401']
2830,REAC,REAC:R-HSA-5661231,Metallothioneins bind metals,0.00023467951841263566,True,Metallothioneins bind metals,11,19,3,10842,0.15789473684210525,0.2727272727272727,Module 10,['REAC:R-HSA-5660526']
2831,GO:BP,GO:2000145,regulation of cell motility,0.00023537106949326074,True,"""Any process that modulates the frequency, rate or extent of cell motility."" [GOC:mah]",996,215,30,21031,0.13953488372093023,0.030120481927710843,Module 2,"['GO:0040012', 'GO:0048870', 'GO:0050794']"
2832,REAC,REAC:R-HSA-400511,"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",0.00023538522494879064,True,"Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)",13,60,4,10842,0.06666666666666667,0.3076923076923077,Module 4,['REAC:R-HSA-400508']
2833,GO:BP,GO:0006974,DNA damage response,0.0002362204233468031,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating damage to its DNA from environmental insults or errors during metabolism."" [GOC:go_curators]",896,77,16,21031,0.2077922077922078,0.017857142857142856,Module 5,['GO:0033554']
2834,GO:MF,GO:0023024,MHC class I protein complex binding,0.00024010570941114903,True,"""Binding to a class I major histocompatibility complex."" [GOC:mtg_signal, GOC:vw]",7,232,4,20212,0.017241379310344827,0.5714285714285714,Module 1,['GO:0023023']
2835,HPA,HPA:0210053,fallopian tube; glandular cells[High],0.00024094372697121107,True,fallopian tube; glandular cells[High],1668,69,27,11019,0.391304347826087,0.01618705035971223,Module 5,['HPA:0210052']
2836,GO:CC,GO:0120281,autolysosome membrane,0.00024140178944426964,True,"""A lipid bilayer that surrounds an autolysosome, a single-membrane-bounded vesicle in which endogenous cellular material is degraded."" [GOC:krc, GOC:nhn, PMID:17182262, PMID:24657946, PMID:26382870, PMID:32047650]",3,17,2,22097,0.11764705882352941,0.6666666666666666,Module 6,"['GO:0000421', 'GO:0005765', 'GO:0044754']"
2837,HP,HP:0000590,Progressive external ophthalmoplegia,0.0002415632557210247,True,Initial bilateral ptosis followed by limitation of eye movements in all directions and slowing of saccades.,30,44,6,4958,0.13636363636363635,0.2,Module 3,['HP:0000544']
2838,HP,HP:0033109,Abnormal circulating non-proteinogenic amino acid concentration,0.0002415632557210247,True,Any deviation from the normal concentration in the blood circulation of an alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.,30,44,6,4958,0.13636363636363635,0.2,Module 3,['HP:0003112']
2839,GO:CC,GO:0005770,late endosome,0.00024219040705342586,True,"""A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center."" [NIF_Subcellular:nlx_subcell_20090702, PMID:11964142, PMID:2557062]",314,221,15,22097,0.06787330316742081,0.04777070063694268,Module 2,['GO:0005768']
2840,GO:BP,GO:0050778,positive regulation of immune response,0.00024247372378079492,True,"""Any process that activates or increases the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus."" [GOC:ai]",718,34,10,21031,0.29411764705882354,0.013927576601671309,Module 7,"['GO:0002684', 'GO:0006955', 'GO:0048584', 'GO:0050776']"
2841,GO:BP,GO:0006915,apoptotic process,0.0002430639893701156,True,"""A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died."" [GOC:cjm, GOC:dhl, GOC:ecd, GOC:go_curators, GOC:mtg_apoptosis, GOC:tb, ISBN:0198506732, PMID:18846107, PMID:21494263]",1913,787,116,21031,0.1473951715374841,0.060637741766858336,Module 0,['GO:0012501']
2842,GO:BP,GO:0002376,immune system process,0.00024312371553843808,True,"""Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats."" [GO_REF:0000022, GOC:add]",2776,15,11,21031,0.7333333333333333,0.003962536023054755,Module 6,['GO:0008150']
2843,GO:BP,GO:0002695,negative regulation of leukocyte activation,0.00024380227924851593,True,"""Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte activation."" [GOC:add]",186,226,13,21031,0.05752212389380531,0.06989247311827956,Module 1,"['GO:0002683', 'GO:0002694', 'GO:0045321', 'GO:0050866']"
2844,GO:CC,GO:0043231,intracellular membrane-bounded organelle,0.0002443465314844734,True,"""Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane."" [GOC:go_curators]",14605,177,146,22097,0.8248587570621468,0.00999657651489216,Module Singleton,"['GO:0043227', 'GO:0043229']"
2845,MIRNA,MIRNA:hsa-miR-4766-5p,hsa-miR-4766-5p,0.00024434896214544933,True,hsa-miR-4766-5p,130,3,3,14819,1.0,0.023076923076923078,Module 27,['MIRNA:000000']
2846,TF,TF:M04020,Factor: IRF8; motif: NCGAAACCGAAACT,0.00024447377345038115,True,Factor: IRF8; motif: NCGAAACCGAAACT,1019,36,12,20045,0.3333333333333333,0.011776251226692836,Module 7,['TF:M00000']
2847,TF,TF:M11679,Factor: IRF-7; motif: NCGAAANCGAAANYN,0.00024532486161181065,True,Factor: IRF-7; motif: NCGAAANCGAAANYN,634,36,10,20045,0.2777777777777778,0.015772870662460567,Module 7,['TF:M00000']
2848,GO:BP,GO:0009209,pyrimidine ribonucleoside triphosphate biosynthetic process,0.0002472970125639094,True,"""The chemical reactions and pathways resulting in the formation of pyrimidine ribonucleoside triphosphate, a compound consisting of a pyrimidine base linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",15,2,2,21031,1.0,0.13333333333333333,Module 39,"['GO:0009148', 'GO:0009201', 'GO:0009208']"
2849,GO:BP,GO:0012501,programmed cell death,0.0002488072699664329,True,"""A process which begins when a cell receives an internal or external signal and activates a series of biochemical events (signaling pathway). The process ends with the death of the cell."" [GOC:lr, GOC:mtg_apoptosis]",1984,34,15,21031,0.4411764705882353,0.007560483870967742,Module 7,['GO:0008219']
2850,HPA,HPA:0540051,stomach 1; glandular cells[≥Low],0.00024888195930403996,True,stomach 1; glandular cells[≥Low],7664,60,57,11019,0.95,0.007437369519832986,Module 4,['HPA:0540000']
2851,HPA,HPA:0540000,stomach 1,0.00024888195930403996,True,stomach 1,7664,60,57,11019,0.95,0.007437369519832986,Module 4,['HPA:0000000']
2852,GO:BP,GO:0050728,negative regulation of inflammatory response,0.0002502658997047782,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response."" [GOC:ai]",163,215,12,21031,0.05581395348837209,0.0736196319018405,Module 2,"['GO:0006954', 'GO:0031348', 'GO:0032102', 'GO:0050727']"
2853,KEGG,KEGG:04210,Apoptosis,0.000250716232334048,True,Apoptosis,135,143,12,8484,0.08391608391608392,0.08888888888888889,Module 2,['KEGG:00000']
2854,TF,TF:M02062,Factor: Erg; motif: ACCGGAAGTN,0.0002511222909209301,True,Factor: Erg; motif: ACCGGAAGTN,8226,105,70,20045,0.6666666666666666,0.008509603695599319,Module 3,['TF:M00000']
2855,TF,TF:M11430,Factor: PEA3; motif: NACCGGAAGTN,0.00025285668201886763,True,Factor: PEA3; motif: NACCGGAAGTN,11108,183,136,20045,0.7431693989071039,0.012243428159884768,Module Singleton,['TF:M00000']
2856,GO:BP,GO:0031343,positive regulation of cell killing,0.0002530330851449353,True,"""Any process that activates or increases the frequency, rate or extent of cell killing."" [GOC:mah]",73,15,4,21031,0.26666666666666666,0.0547945205479452,Module 6,"['GO:0001906', 'GO:0031341', 'GO:0048522']"
2857,HP,HP:0003800,Muscle abnormality related to mitochondrial dysfunction,0.0002546774400596638,True,Muscle abnormality related to mitochondrial dysfunction,83,228,17,4958,0.07456140350877193,0.20481927710843373,Module 0,['HP:0011804']
2858,GO:BP,GO:0002548,monocyte chemotaxis,0.0002554014664758796,True,"""The movement of a monocyte in response to an external stimulus."" [GOC:add, PMID:11696603, PMID:15173832]",68,5,3,21031,0.6,0.04411764705882353,Module 12,"['GO:0030595', 'GO:0071674', 'GO:0097529']"
2859,GO:BP,GO:0008219,cell death,0.00025552202992711547,True,"""Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538)."" [GOC:mah, GOC:mtg_apoptosis, PMID:25236395]",1988,34,15,21031,0.4411764705882353,0.007545271629778672,Module 7,['GO:0009987']
2860,HPA,HPA:0570782,testis; preleptotene spermatocytes[≥Medium],0.0002586165783264811,True,testis; preleptotene spermatocytes[≥Medium],1492,612,125,11019,0.2042483660130719,0.08378016085790885,Module 0,['HPA:0570781']
2861,GO:BP,GO:0070106,interleukin-27-mediated signaling pathway,0.0002586830758801966,True,"""The series of molecular signals initiated by interleukin-27 binding to a receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription."" [GOC:add, GOC:BHF, GOC:mah, GOC:signaling]",7,34,3,21031,0.08823529411764706,0.42857142857142855,Module 7,['GO:0019221']
2862,HPA,HPA:0600441,tonsil; non-germinal center cells[≥Low],0.00025919022266099594,True,tonsil; non-germinal center cells[≥Low],6117,60,51,11019,0.85,0.008337420304070623,Module 4,['HPA:0600000']
2863,GO:CC,GO:0005783,endoplasmic reticulum,0.0002597863188763557,True,"""The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached)."" [ISBN:0198506732]",2055,105,27,22097,0.2571428571428571,0.013138686131386862,Module 3,"['GO:0005737', 'GO:0012505', 'GO:0043231']"
2864,HPA,HPA:0210052,fallopian tube; glandular cells[≥Medium],0.00025981993643790373,True,fallopian tube; glandular cells[≥Medium],4704,79,55,11019,0.6962025316455697,0.0116921768707483,Module 3,['HPA:0210051']
2865,HP,HP:0002718,Recurrent bacterial infections,0.00025993952624659653,True,"Increased susceptibility to bacterial infections, as manifested by recurrent episodes of bacterial infection.",209,71,15,4958,0.2112676056338028,0.07177033492822966,Module 1,['HP:0002719']
2866,GO:BP,GO:0140694,non-membrane-bounded organelle assembly,0.0002604045158192883,True,"""The aggregation, arrangement and bonding together of a set of components to form a non-membrane-bounded organelle."" [PMID:28225081]",409,105,13,21031,0.12380952380952381,0.03178484107579462,Module 3,['GO:0070925']
2867,KEGG,KEGG:05164,Influenza A,0.00026132445163359923,True,Influenza A,167,23,6,8484,0.2608695652173913,0.03592814371257485,Module 7,['KEGG:00000']
2868,HPA,HPA:0461443,skin 1; fibrohistiocytic cells[High],0.00026163185782334514,True,skin 1; fibrohistiocytic cells[High],408,12,6,11019,0.5,0.014705882352941176,Module 6,['HPA:0461442']
2869,GO:CC,GO:0030667,secretory granule membrane,0.00026232100298314827,True,"""The lipid bilayer surrounding a secretory granule."" [GOC:mah]",316,221,15,22097,0.06787330316742081,0.04746835443037975,Module 2,"['GO:0030141', 'GO:0030659', 'GO:0098588']"
2870,TF,TF:M03977_1,Factor: ETS1; motif: ACCGGAARYN; match class: 1,0.00026388979617173656,True,Factor: ETS1; motif: ACCGGAARYN; match class: 1,4797,105,50,20045,0.47619047619047616,0.010423181154888472,Module 3,['TF:M03977']
2871,GO:CC,GO:0071004,U2-type prespliceosome,0.00026419712014659014,True,"""A spliceosomal complex that is formed by association of the 5' splice site with the U1 snRNP, while the branch point sequence is recognized by the U2 snRNP. The prespliceosome includes many proteins in addition to those found in the U1 and U2 snRNPs. Commitment to a given pair of 5' and 3' splice sites occurs at the time of prespliceosome formation."" [GOC:ab, GOC:krc, GOC:mah, PMID:17332742, PMID:19239890]",16,813,7,22097,0.008610086100861008,0.4375,Module 0,"['GO:0005684', 'GO:0071010']"
2872,GO:CC,GO:0071010,prespliceosome,0.00026419712014659014,True,"""A spliceosomal complex that is formed by association of the 5' splice site and the branch point sequence with specific snRNPs. The prespliceosome includes many proteins in addition to those found in the bound snRNPs. Commitment to a given pair of 5' and 3' splice sites occurs at the time of prespliceosome formation. Prespliceosome complexes are not active for splicing, but are instead an early step in the assembly of a spliceosomal complex."" [GOC:ab, GOC:krc, GOC:mah, PMID:17332742, PMID:19239890]",16,813,7,22097,0.008610086100861008,0.4375,Module 0,['GO:0005681']
2873,HP,HP:0001941,Acidosis,0.00026647070635702294,True,Abnormal acid accumulation or depletion of base.,396,228,42,4958,0.18421052631578946,0.10606060606060606,Module 0,['HP:0004360']
2874,HPA,HPA:0600432,tonsil; germinal center cells[≥Medium],0.0002666544466955313,True,tonsil; germinal center cells[≥Medium],4100,185,101,11019,0.5459459459459459,0.024634146341463416,Module 1,['HPA:0600431']
2875,GO:BP,GO:0051173,positive regulation of nitrogen compound metabolic process,0.00026748535077499995,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving nitrogen or nitrogenous compounds."" [GOC:ai, GOC:tb]",3001,787,165,21031,0.2096569250317662,0.05498167277574142,Module 0,"['GO:0006807', 'GO:0009893', 'GO:0051171']"
2876,GO:BP,GO:0070665,positive regulation of leukocyte proliferation,0.00026762190491682204,True,"""Any process that activates or increases the frequency, rate or extent of leukocyte proliferation."" [GOC:add, GOC:mah]",164,215,12,21031,0.05581395348837209,0.07317073170731707,Module 2,"['GO:0008284', 'GO:0070661', 'GO:0070663']"
2877,HPA,HPA:0050093,breast; myoepithelial cells[High],0.00026873870464218935,True,breast; myoepithelial cells[High],837,612,80,11019,0.13071895424836602,0.0955794504181601,Module 0,['HPA:0050092']
2878,HPA,HPA:0300203,lung; endothelial cells[High],0.00026977737898398164,True,lung; endothelial cells[High],293,612,38,11019,0.06209150326797386,0.1296928327645051,Module 0,['HPA:0300202']
2879,HPA,HPA:0381191,placenta; cytotrophoblasts[≥Low],0.0002703877108658797,True,placenta; cytotrophoblasts[≥Low],476,612,53,11019,0.08660130718954248,0.11134453781512606,Module 0,['HPA:0380000']
2880,HPA,HPA:0600433,tonsil; germinal center cells[High],0.00027045728218951475,True,tonsil; germinal center cells[High],1228,140,36,11019,0.2571428571428571,0.029315960912052116,Module Singleton,['HPA:0600432']
2881,KEGG,KEGG:04660,T cell receptor signaling pathway,0.00027165477351940854,True,T cell receptor signaling pathway,119,136,11,8484,0.08088235294117647,0.09243697478991597,Module 1,['KEGG:00000']
2882,HP,HP:0030085,Abnormal CSF lactate concentration,0.0002728741469779384,True,Abnormal concentration of lactate in the cerebrospinal fluid.,103,44,9,4958,0.20454545454545456,0.08737864077669903,Module 3,['HP:0025454']
2883,HP,HP:0002490,Increased CSF lactate,0.0002728741469779384,True,Increased concentration of lactate in the cerebrospinal fluid.,103,44,9,4958,0.20454545454545456,0.08737864077669903,Module 3,['HP:0030085']
2884,TF,TF:M11677,Factor: IRF-3; motif: NGGAAACNGAAACCGAAACN,0.0002766982189728091,True,Factor: IRF-3; motif: NGGAAACNGAAACCGAAACN,480,36,9,20045,0.25,0.01875,Module 7,['TF:M00000']
2885,REAC,REAC:R-HSA-8953897,Cellular responses to stimuli,0.00027703274445711333,True,Cellular responses to stimuli,794,586,76,10842,0.1296928327645051,0.09571788413098237,Module 0,['REAC:0000000']
2886,REAC,REAC:R-HSA-1169408,ISG15 antiviral mechanism,0.0002777514259033679,True,ISG15 antiviral mechanism,70,28,5,10842,0.17857142857142858,0.07142857142857142,Module 7,['REAC:R-HSA-1169410']
2887,GO:BP,GO:0046036,CTP metabolic process,0.00028262515721589655,True,"""The chemical reactions and pathways involving CTP, cytidine triphosphate."" [GOC:go_curators]",16,2,2,21031,1.0,0.125,Module 39,"['GO:0009208', 'GO:0009218']"
2888,HPA,HPA:0620223,vagina; squamous epithelial cells[High],0.00028553344906995703,True,vagina; squamous epithelial cells[High],1138,612,101,11019,0.1650326797385621,0.08875219683655536,Module 0,['HPA:0620222']
2889,HPA,HPA:0530721,spleen; cells in white pulp[≥Low],0.00028555241536460166,True,spleen; cells in white pulp[≥Low],4339,69,47,11019,0.6811594202898551,0.010831988937543212,Module 5,['HPA:0530000']
2890,GO:BP,GO:0030593,neutrophil chemotaxis,0.0002855604308027999,True,"""The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding."" [GOC:jl, ISBN:0198506732]",106,215,10,21031,0.046511627906976744,0.09433962264150944,Module 2,"['GO:0071621', 'GO:1990266']"
2891,GO:BP,GO:0051603,proteolysis involved in protein catabolic process,0.000287281223700813,True,"""The hydrolysis of a peptide bond or bonds within a protein as part of the chemical reactions and pathways resulting in the breakdown of a protein by individual cells."" [GOC:ai, GOC:dph, GOC:tb]",730,787,57,21031,0.0724269377382465,0.07808219178082192,Module 0,"['GO:0006508', 'GO:0030163']"
2892,REAC,REAC:R-HSA-114608,Platelet degranulation ,0.0002882505056202587,True,Platelet degranulation ,125,173,12,10842,0.06936416184971098,0.096,Module 2,['REAC:R-HSA-76005']
2893,TF,TF:M11428,Factor: PEA3; motif: NACCGGAAGTN,0.00028932519905454466,True,Factor: PEA3; motif: NACCGGAAGTN,7327,105,65,20045,0.6190476190476191,0.008871297939129249,Module 3,['TF:M00000']
2894,GO:BP,GO:0009201,ribonucleoside triphosphate biosynthetic process,0.000292426694155141,True,"""The chemical reactions and pathways resulting in the formation of a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",119,105,8,21031,0.0761904761904762,0.06722689075630252,Module 3,"['GO:0009142', 'GO:0009199']"
2895,TF,TF:M02059,Factor: ELK-1; motif: ACCGGAAGTN,0.00029255893956283595,True,Factor: ELK-1; motif: ACCGGAAGTN,9628,105,77,20045,0.7333333333333333,0.007997507270461154,Module 3,['TF:M00000']
2896,GO:BP,GO:0090084,negative regulation of inclusion body assembly,0.00029323625586132377,True,"""Any process that decreases the rate, frequency, or extent of inclusion body assembly. Inclusion body assembly is the aggregation, arrangement and bonding together of a set of components to form an inclusion body."" [GOC:BHF, GOC:dph, GOC:tb]",12,21,3,21031,0.14285714285714285,0.25,Module 9,"['GO:0051129', 'GO:0070841', 'GO:0090083']"
2897,TF,TF:M11880_1,Factor: pax-6; motif: NYACGCWTSANYGMNCN; match class: 1,0.00029454817105710446,True,Factor: pax-6; motif: NYACGCWTSANYGMNCN; match class: 1,7204,826,369,20045,0.4467312348668281,0.05122154358689617,Module 0,['TF:M11880']
2898,REAC,REAC:R-HSA-5610787,Hedgehog 'off' state,0.00029623411559148315,True,Hedgehog 'off' state,113,586,21,10842,0.03583617747440273,0.18584070796460178,Module 0,['REAC:R-HSA-5358351']
2899,HP,HP:0012707,Elevated brain lactate level by MRS,0.00029756654981773125,True,An increase in the level of lactate in the brain identified by magnetic resonance spectroscopy (MRS).,31,44,6,4958,0.13636363636363635,0.1935483870967742,Module 3,['HP:0025045']
2900,HP,HP:0004948,Vascular tortuosity,0.00029756654981773125,True,Abnormal twisting of arteries or veins.,31,44,6,4958,0.13636363636363635,0.1935483870967742,Module 3,['HP:0033353']
2901,TF,TF:M10625,Factor: Nkx3-2; motif: NTCGTTAN,0.00029815265403429714,True,Factor: Nkx3-2; motif: NTCGTTAN,6168,826,324,20045,0.3922518159806295,0.05252918287937743,Module 0,['TF:M00000']
2902,HP,HP:0002090,Pneumonia,0.00029912990494543416,True,Inflammation of any part of the lung parenchyma.,309,71,18,4958,0.2535211267605634,0.05825242718446602,Module 1,"['HP:0011947', 'HP:0012649']"
2903,HPA,HPA:0461423,skin 1; eccrine glands[High],0.0003008114516216219,True,skin 1; eccrine glands[High],89,69,7,11019,0.10144927536231885,0.07865168539325842,Module 5,['HPA:0461422']
2904,HPA,HPA:0050092,breast; myoepithelial cells[≥Medium],0.0003012763044847569,True,breast; myoepithelial cells[≥Medium],3779,79,48,11019,0.6075949367088608,0.012701772955808415,Module 3,['HPA:0050091']
2905,GO:MF,GO:0042802,identical protein binding,0.0003015350273632811,True,"""Binding to an identical protein or proteins."" [GOC:jl]",2162,808,132,20212,0.16336633663366337,0.06105457909343201,Module 0,['GO:0005515']
2906,GO:BP,GO:1903706,regulation of hemopoiesis,0.0003017216680059253,True,"""Any process that modulates the frequency, rate or extent of hemopoiesis."" [GO_REF:0000058, GOC:pad, GOC:PARL, GOC:TermGenie, PMID:20080761]",418,226,19,21031,0.084070796460177,0.045454545454545456,Module 1,"['GO:0002682', 'GO:0030097', 'GO:0060284', 'GO:2000026']"
2907,GO:CC,GO:0030659,cytoplasmic vesicle membrane,0.0003017826175901902,True,"""The lipid bilayer surrounding a cytoplasmic vesicle."" [GOC:mah]",1226,813,79,22097,0.0971709717097171,0.06443719412724307,Module 0,"['GO:0012506', 'GO:0031410']"
2908,TF,TF:M00025,Factor: Elk-1; motif: NNNNCCGGAARTNN,0.0003018392207956245,True,Factor: Elk-1; motif: NNNNCCGGAARTNN,10256,105,80,20045,0.7619047619047619,0.0078003120124804995,Module 3,['TF:M00000']
2909,TF,TF:M00939,Factor: E2F; motif: TTTSGCGSG,0.00030289845470445265,True,Factor: E2F; motif: TTTSGCGSG,6627,826,344,20045,0.41646489104116224,0.051908857703334844,Module 0,['TF:M00000']
2910,GO:MF,GO:0016491,oxidoreductase activity,0.000303558483905009,True,"""Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced."" [GOC:go_curators]",742,808,59,20212,0.07301980198019802,0.07951482479784366,Module 0,['GO:0003824']
2911,TF,TF:M04515,Factor: E2F-1; motif: WWTGGCGCCAAA,0.00030399161041468834,True,Factor: E2F-1; motif: WWTGGCGCCAAA,13705,826,632,20045,0.7651331719128329,0.04611455673112003,Module 0,['TF:M00000']
2912,GO:CC,GO:0030666,endocytic vesicle membrane,0.0003048884076724917,True,"""The lipid bilayer surrounding an endocytic vesicle."" [GOC:mah]",200,221,12,22097,0.05429864253393665,0.06,Module 2,"['GO:0030139', 'GO:0030659', 'GO:0098588']"
2913,HP,HP:0011121,Abnormal skin morphology,0.0003053302209373122,True,Any morphological abnormality of the skin.,1928,44,34,4958,0.7727272727272727,0.017634854771784232,Module 3,['HP:0000951']
2914,GO:BP,GO:0050821,protein stabilization,0.00030744634626817,True,"""Any process involved in maintaining the structure and integrity of a protein and preventing it from degradation or aggregation."" [GOC:ai]",215,787,26,21031,0.03303684879288437,0.12093023255813953,Module 0,['GO:0031647']
2915,GO:BP,GO:0009265,2'-deoxyribonucleotide biosynthetic process,0.0003109121018960049,True,"""The chemical reactions and pathways resulting in the formation of a 2'-deoxyribonucleotide, a compound consisting of 2'-deoxyribonucleoside (a base linked to a 2'-deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:mah]",14,77,4,21031,0.05194805194805195,0.2857142857142857,Module 5,"['GO:0009263', 'GO:0009394', 'GO:0046385']"
2916,GO:BP,GO:0046385,deoxyribose phosphate biosynthetic process,0.0003109121018960049,True,"""The chemical reactions and pathways resulting in the formation of deoxyribose phosphate, the phosphorylated sugar 2-deoxy-erythro-pentose."" [ISBN:0198506732]",14,77,4,21031,0.05194805194805195,0.2857142857142857,Module 5,"['GO:0019692', 'GO:0090407', 'GO:1901137']"
2917,GO:BP,GO:0009263,deoxyribonucleotide biosynthetic process,0.0003109121018960049,True,"""The chemical reactions and pathways resulting in the formation of a deoxyribonucleotide, a compound consisting of deoxyribonucleoside (a base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:go_curators, ISBN:0198506732]",14,77,4,21031,0.05194805194805195,0.2857142857142857,Module 5,"['GO:0009165', 'GO:0009262', 'GO:1901137']"
2918,GO:CC,GO:0005768,endosome,0.00031106520510964765,True,"""A vacuole to which materials ingested by endocytosis are delivered."" [ISBN:0198506732, PMID:19696797]",1060,221,29,22097,0.13122171945701358,0.027358490566037737,Module 2,"['GO:0012505', 'GO:0031410']"
2919,REAC,REAC:R-HSA-3371511,HSF1 activation,0.000312559602774169,True,HSF1 activation,12,19,3,10842,0.15789473684210525,0.25,Module 9,['REAC:R-HSA-3371556']
2920,GO:CC,GO:0012505,endomembrane system,0.00031339990478685526,True,"""A collection of membranous structures involved in transport within the cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles."" [GOC:lh]",4777,17,13,22097,0.7647058823529411,0.00272137324680762,Module 6,['GO:0110165']
2921,TF,TF:M11066,Factor: HES-7; motif: GNCACGYGNN,0.0003147065794279966,True,Factor: HES-7; motif: GNCACGYGNN,11745,826,556,20045,0.6731234866828087,0.04733929331630481,Module 0,['TF:M00000']
2922,GO:MF,GO:0070182,DNA polymerase binding,0.00031670320341664355,True,"""Binding to a DNA polymerase."" [GOC:BHF, GOC:mah]",21,20,3,20212,0.15,0.14285714285714285,Module 9,['GO:0019899']
2923,HP,HP:0000603,Central scotoma,0.0003171595343532112,True,An area of depressed vision located at the point of fixation and that interferes with central vision.,51,44,7,4958,0.1590909090909091,0.13725490196078433,Module 3,['HP:0000575']
2924,HP,HP:0002922,Increased CSF protein concentration,0.0003171595343532112,True,Increased concentration of protein in the cerebrospinal fluid.,51,44,7,4958,0.1590909090909091,0.13725490196078433,Module 3,['HP:0025456']
2925,KEGG,KEGG:04061,Viral protein interaction with cytokine and cytokine receptor,0.0003184468703404803,True,Viral protein interaction with cytokine and cytokine receptor,98,4,3,8484,0.75,0.030612244897959183,Module 12,['KEGG:00000']
2926,GO:MF,GO:0097100,supercoiled DNA binding,0.000319190424514541,True,"""Binding to supercoiled DNA. For example, during replication and transcription, template DNA is negatively supercoiled in the receding downstream DNA and positively supercoiled in the approaching downstream DNA."" [GOC:pr, GOC:rph, PMID:20723754, PMID:21345933, Wikipedia:DNA_supercoil]",5,80,3,20212,0.0375,0.6,Module 5,['GO:0003690']
2927,HPA,HPA:0610000,urinary bladder,0.00032096590927476425,True,urinary bladder,7304,140,118,11019,0.8428571428571429,0.01615553121577218,Module Singleton,['HPA:0000000']
2928,HPA,HPA:0610831,urinary bladder; urothelial cells[≥Low],0.00032096590927476425,True,urinary bladder; urothelial cells[≥Low],7304,140,118,11019,0.8428571428571429,0.01615553121577218,Module Singleton,['HPA:0610000']
2929,HPA,HPA:0351183,pancreas; pancreatic endocrine cells[High],0.0003217516266223738,True,pancreas; pancreatic endocrine cells[High],802,69,18,11019,0.2608695652173913,0.022443890274314215,Module 5,['HPA:0351182']
2930,HPA,HPA:0461482,skin 1; sebaceous glands[≥Medium],0.00032186853313702135,True,skin 1; sebaceous glands[≥Medium],165,166,13,11019,0.0783132530120482,0.07878787878787878,Module 2,['HPA:0461481']
2931,HPA,HPA:0040000,bone marrow,0.0003221154867147762,True,bone marrow,6496,185,140,11019,0.7567567567567568,0.021551724137931036,Module 1,['HPA:0000000']
2932,HPA,HPA:0040081,bone marrow; hematopoietic cells[≥Low],0.0003221154867147762,True,bone marrow; hematopoietic cells[≥Low],6496,185,140,11019,0.7567567567567568,0.021551724137931036,Module 1,['HPA:0040000']
2933,TF,TF:M00258,Factor: ISGF-3; motif: CAGTTTCWCTTTYCC,0.00032344338486774404,True,Factor: ISGF-3; motif: CAGTTTCWCTTTYCC,839,36,11,20045,0.3055555555555556,0.013110846245530394,Module 7,['TF:M00000']
2934,GO:BP,GO:0070198,"protein localization to chromosome, telomeric region",0.00032349248818831934,True,"""Any process in which a protein is transported to, or maintained at, the telomeric region of a chromosome."" [GOC:BHF, GOC:mah]",32,787,10,21031,0.012706480304955527,0.3125,Module 0,['GO:0034502']
2935,GO:BP,GO:0043161,proteasome-mediated ubiquitin-dependent protein catabolic process,0.00032359409893226653,True,"""The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of ubiquitin, and mediated by the proteasome."" [GOC:go_curators]",400,787,38,21031,0.048284625158831,0.095,Module 0,"['GO:0006511', 'GO:0010498']"
2936,GO:CC,GO:0005576,extracellular region,0.000325507730043214,True,"""The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite."" [GOC:go_curators]",4213,73,32,22097,0.4383561643835616,0.0075955376216472826,Module 4,['GO:0110165']
2937,GO:BP,GO:0045184,establishment of protein localization,0.00032838148610582946,True,"""The directed movement of a protein to a specific location."" [GOC:bf]",1924,787,116,21031,0.1473951715374841,0.060291060291060294,Module 0,"['GO:0008104', 'GO:0051234']"
2938,GO:BP,GO:1901565,organonitrogen compound catabolic process,0.00033141405710006945,True,"""The chemical reactions and pathways resulting in the breakdown of organonitrogen compound."" [GOC:pr, GOC:TermGenie]",1399,787,91,21031,0.1156289707750953,0.06504646175839886,Module 0,"['GO:1901564', 'GO:1901575']"
2939,HPA,HPA:0600221,tonsil; squamous epithelial cells[≥Low],0.00033753409831574634,True,tonsil; squamous epithelial cells[≥Low],6652,140,111,11019,0.7928571428571428,0.016686710763680095,Module Singleton,['HPA:0600000']
2940,GO:CC,GO:0005839,proteasome core complex,0.0003378749071528401,True,"""A multisubunit barrel shaped endoprotease complex, which is the core of the proteasome complex."" [GOC:rb, PMID:10806206]",23,813,8,22097,0.00984009840098401,0.34782608695652173,Module 0,"['GO:0000502', 'GO:0140535', 'GO:1902494']"
2941,TF,TF:M01752_1,Factor: ERG; motif: ACCGGAART; match class: 1,0.00034045891531273275,True,Factor: ERG; motif: ACCGGAART; match class: 1,3782,105,43,20045,0.4095238095238095,0.011369645690111053,Module 3,['TF:M01752']
2942,GO:MF,GO:0030554,adenyl nucleotide binding,0.00034084616322811604,True,"""Binding to an adenyl nucleotide, an adenosine esterified with (ortho)phosphate."" [ISBN:0198506732]",1661,20,10,20212,0.5,0.006020469596628537,Module 9,['GO:0017076']
2943,GO:BP,GO:0001775,cell activation,0.0003414966803216604,True,"""A multicellular organismal process by which exposure to an activating factor such as a cellular or soluble ligand results in a change in the morphology or behavior of a cell."" [GOC:mgi_curators]",1092,15,8,21031,0.5333333333333333,0.007326007326007326,Module 6,"['GO:0009987', 'GO:0032501']"
2944,GO:BP,GO:0050670,regulation of lymphocyte proliferation,0.00034243713382537186,True,"""Any process that modulates the frequency, rate or extent of lymphocyte proliferation."" [GOC:ai]",237,215,14,21031,0.06511627906976744,0.05907172995780591,Module 2,"['GO:0032944', 'GO:0046651', 'GO:0051249']"
2945,TF,TF:M12600,Factor: ELF1; motif: NNNASCCGGAAGTGGNNNN,0.0003434772914951286,True,Factor: ELF1; motif: NNNASCCGGAAGTGGNNNN,8859,105,73,20045,0.6952380952380952,0.008240207698385823,Module 3,['TF:M00000']
2946,HPA,HPA:0090191,cerebellum; cells in molecular layer[≥Low],0.00034496870210273,True,cerebellum; cells in molecular layer[≥Low],4460,79,53,11019,0.6708860759493671,0.01188340807174888,Module 3,['HPA:0090000']
2947,MIRNA,MIRNA:hsa-miR-4477a,hsa-miR-4477a,0.00034554860047507726,True,hsa-miR-4477a,139,104,9,14819,0.08653846153846154,0.06474820143884892,Module 3,['MIRNA:000000']
2948,GO:MF,GO:0003682,chromatin binding,0.0003467165515162114,True,"""Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase."" [GOC:jl, ISBN:0198506732, PMID:20404130]",602,80,13,20212,0.1625,0.02159468438538206,Module 5,['GO:0044877']
2949,GO:CC,GO:0043227,membrane-bounded organelle,0.00034739236534071105,True,"""Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane."" [GOC:go_curators]",15671,105,95,22097,0.9047619047619048,0.00606215302150469,Module 3,['GO:0043226']
2950,KEGG,KEGG:05017,Spinocerebellar ataxia,0.00034828985656697317,True,Spinocerebellar ataxia,141,439,22,8484,0.05011389521640091,0.15602836879432624,Module 0,['KEGG:00000']
2951,GO:BP,GO:0051250,negative regulation of lymphocyte activation,0.00035105434899838445,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of lymphocyte activation."" [GOC:ai]",160,226,12,21031,0.05309734513274336,0.075,Module 1,"['GO:0002695', 'GO:0046649', 'GO:0051249']"
2952,HP,HP:0006532,Recurrent pneumonia,0.00035132310881914576,True,An increased susceptibility to pneumonia as manifested by a history of recurrent episodes of pneumonia.,130,71,12,4958,0.16901408450704225,0.09230769230769231,Module 1,"['HP:0002090', 'HP:0002783']"
2953,TF,TF:M00731_1,Factor: Osf2; motif: ACCACANM; match class: 1,0.0003572941766335146,True,Factor: Osf2; motif: ACCACANM; match class: 1,68,5,3,20045,0.6,0.04411764705882353,Module 12,['TF:M00731']
2954,TF,TF:M10080,Factor: STAT2; motif: RRGRAANNGAAACTGAAAN,0.0003577733007478785,True,Factor: STAT2; motif: RRGRAANNGAAACTGAAAN,352,36,8,20045,0.2222222222222222,0.022727272727272728,Module 7,['TF:M00000']
2955,HPA,HPA:0170052,endometrium 2; glandular cells[≥Medium],0.0003596378639618883,True,endometrium 2; glandular cells[≥Medium],4887,79,56,11019,0.7088607594936709,0.011458972784939635,Module 3,['HPA:0170051']
2956,GO:BP,GO:0009208,pyrimidine ribonucleoside triphosphate metabolic process,0.00036034707545026774,True,"""The chemical reactions and pathways involving pyrimidine ribonucleoside triphosphate, a compound consisting of a pyrimidine base linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",18,2,2,21031,1.0,0.1111111111111111,Module 39,"['GO:0009147', 'GO:0009199']"
2957,GO:BP,GO:0002347,response to tumor cell,0.0003606852511161852,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a tumor cell."" [GOC:add, ISBN:0781735149, PMID:16730260]",39,226,7,21031,0.030973451327433628,0.1794871794871795,Module 1,['GO:0009607']
2958,HP,HP:0410042,Abnormal liver morphology,0.00036098773581077093,True,"Any structural anomaly of the bile-secreting organ that is important for detoxification, for fat, carbohydrate, and protein metabolism, and for glycogen storage.",870,71,31,4958,0.43661971830985913,0.035632183908045977,Module 1,['HP:0001392']
2959,GO:CC,GO:0098554,cytoplasmic side of endoplasmic reticulum membrane,0.00036169538163564896,True,"""The side (leaflet) of the plasma membrane that faces the cytoplasm."" [GOC:ab, GOC:dos]",17,105,4,22097,0.0380952380952381,0.23529411764705882,Module 3,"['GO:0005789', 'GO:0098562']"
2960,TF,TF:M04823_1,Factor: E2F-4; motif: NNTTCCCGCCNN; match class: 1,0.00036172609750715603,True,Factor: E2F-4; motif: NNTTCCCGCCNN; match class: 1,8085,826,406,20045,0.4915254237288136,0.050216450216450215,Module 0,['TF:M04823']
2961,HP,HP:0025045,Abnormal brain lactate level by MRS,0.0003638247132344081,True,A deviation from normal of the level of lactate in the brain identified by magnetic resonance spectroscopy (MRS).,32,44,6,4958,0.13636363636363635,0.1875,Module 3,['HP:0012705']
2962,GO:BP,GO:0043065,positive regulation of apoptotic process,0.00036483941767317566,True,"""Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process."" [GOC:jl, GOC:mtg_apoptosis]",512,226,21,21031,0.09292035398230089,0.041015625,Module 1,"['GO:0006915', 'GO:0042981', 'GO:0043068']"
2963,WP,WP:WP4868,Type I interferon induction and signaling during SARS CoV 2 infection,0.00036494841553821205,True,Type I interferon induction and signaling during SARS CoV 2 infection,31,27,4,8286,0.14814814814814814,0.12903225806451613,Module 7,['WP:000000']
2964,REAC,REAC:R-HSA-1236975,Antigen processing-Cross presentation,0.0003653698958306277,True,Antigen processing-Cross presentation,105,586,20,10842,0.034129692832764506,0.19047619047619047,Module 0,['REAC:R-HSA-983169']
2965,GO:BP,GO:0060337,type I interferon-mediated signaling pathway,0.00036657792511755785,True,"""The series of molecular signals initiated by type I interferon binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families."" [GOC:add, GOC:dph, GOC:signaling, PMID:32464097]",81,34,5,21031,0.14705882352941177,0.06172839506172839,Module 7,"['GO:0071357', 'GO:0140888']"
2966,HPA,HPA:0600431,tonsil; germinal center cells[≥Low],0.0003685854987035295,True,tonsil; germinal center cells[≥Low],5987,185,132,11019,0.7135135135135136,0.022047770168698848,Module 1,['HPA:0600000']
2967,HP,HP:0000347,Micrognathia,0.00036996749842615876,True,Developmental hypoplasia of the mandible.,820,44,22,4958,0.5,0.026829268292682926,Module 3,['HP:0009118']
2968,GO:BP,GO:0060284,regulation of cell development,0.00037161011616791283,True,"""Any process that modulates the rate, frequency or extent of the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate."" [GOC:dph, GOC:tb]",849,215,27,21031,0.12558139534883722,0.03180212014134275,Module 2,"['GO:0045595', 'GO:0048468']"
2969,TF,TF:M00431,Factor: E2F-1; motif: TTTSGCGS,0.0003752561157889162,True,Factor: E2F-1; motif: TTTSGCGS,7484,80,53,20045,0.6625,0.007081774452164618,Module 5,['TF:M00000']
2970,HP,HP:0002664,Neoplasm,0.00037559766405430783,True,An organ or organ-system abnormality that consists of uncontrolled autonomous cell-proliferation which can occur in any part of the body as a benign or malignant neoplasm (tumor).,897,44,23,4958,0.5227272727272727,0.02564102564102564,Module 3,['HP:0000118']
2971,HPA,HPA:0080133,caudate; neuronal cells[High],0.0003801307033079382,True,caudate; neuronal cells[High],1103,79,23,11019,0.2911392405063291,0.02085222121486854,Module 3,['HPA:0080132']
2972,HPA,HPA:0610832,urinary bladder; urothelial cells[≥Medium],0.0003818604711231478,True,urinary bladder; urothelial cells[≥Medium],5958,140,103,11019,0.7357142857142858,0.017287680429674386,Module Singleton,['HPA:0610831']
2973,CORUM,CORUM:181,26S proteasome,0.0003820837833634411,True,26S proteasome,19,331,10,3383,0.030211480362537766,0.5263157894736842,Module 0,['CORUM:0000000']
2974,TF,TF:M08457,Factor: ER71:SREBP-2; motif: NTSACGTGACGGAARY,0.0003851842503612788,True,Factor: ER71:SREBP-2; motif: NTSACGTGACGGAARY,12343,826,579,20045,0.7009685230024213,0.04690917929190634,Module 0,['TF:M00000']
2975,HP,HP:0009118,Aplasia/Hypoplasia of the mandible,0.00038671766056669695,True,Absence or underdevelopment of the mandible.,822,44,22,4958,0.5,0.0267639902676399,Module 3,"['HP:0000277', 'HP:0009116']"
2976,REAC,REAC:R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,0.00038986036983109496,True,Binding and Uptake of Ligands by Scavenger Receptors,97,60,7,10842,0.11666666666666667,0.07216494845360824,Module 4,['REAC:R-HSA-5653656']
2977,GO:BP,GO:0071357,cellular response to type I interferon,0.0003899327389954532,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a type I interferon stimulus. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families."" [GOC:mah]",82,34,5,21031,0.14705882352941177,0.06097560975609756,Module 7,"['GO:0034340', 'GO:0071345']"
2978,WP,WP:WP545,Complement activation,0.00039093477272348476,True,Complement activation,22,154,6,8286,0.03896103896103896,0.2727272727272727,Module 2,['WP:000000']
2979,GO:BP,GO:0006810,transport,0.00039287129759994625,True,"""The directed movement of substances (such as macromolecules, small molecules, ions) or cellular components (such as complexes and organelles) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or a transporter complex, a pore or a motor protein."" [GOC:dos, GOC:dph, GOC:jl, GOC:mah]",4350,215,77,21031,0.3581395348837209,0.017701149425287357,Module 2,['GO:0051234']
2980,GO:BP,GO:0071356,cellular response to tumor necrosis factor,0.00039310765361391534,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus."" [GOC:mah]",228,226,14,21031,0.061946902654867256,0.06140350877192982,Module 1,"['GO:0034612', 'GO:0071345']"
2981,GO:CC,GO:1990234,transferase complex,0.0004014067344994609,True,"""A protein complex capable of catalyzing the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor)."" [GOC:bhm, PMID:16540464]",890,813,62,22097,0.07626076260762607,0.0696629213483146,Module 0,['GO:1902494']
2982,GO:BP,GO:0009148,pyrimidine nucleoside triphosphate biosynthetic process,0.0004027408490326525,True,"""The chemical reactions and pathways resulting in the formation of pyrimidine nucleoside triphosphate, a compound consisting of a pyrimidine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",19,2,2,21031,1.0,0.10526315789473684,Module 39,"['GO:0009142', 'GO:0009147']"
2983,KEGG,KEGG:04620,Toll-like receptor signaling pathway,0.0004036328313876775,True,Toll-like receptor signaling pathway,106,4,3,8484,0.75,0.02830188679245283,Module 12,['KEGG:00000']
2984,TF,TF:M00919,Factor: E2F; motif: NCSCGCSAAAN,0.0004051264331884475,True,Factor: E2F; motif: NCSCGCSAAAN,6340,80,48,20045,0.6,0.007570977917981073,Module 5,['TF:M00000']
2985,GO:MF,GO:0048018,receptor ligand activity,0.00040524522388144625,True,"""The activity of a gene product that interacts with a receptor to effect a change in the activity of the receptor. Ligands may be produced by the same, or different, cell that expresses the receptor. Ligands may diffuse extracellularly from their point of origin to the receiving cell, or remain attached to an adjacent cell surface (e.g. Notch ligands)."" [GOC:kv, GOC:molecular_function_refactoring, GOC:pdt]",513,5,4,20212,0.8,0.007797270955165692,Module 12,"['GO:0005102', 'GO:0030546']"
2986,TF,TF:M08759,Factor: c-Ets-2; motif: NCCGGAAGTG,0.0004056995138257906,True,Factor: c-Ets-2; motif: NCCGGAAGTG,8502,105,71,20045,0.6761904761904762,0.008350976240884498,Module 3,['TF:M00000']
2987,GO:MF,GO:0051787,misfolded protein binding,0.000408783303735479,True,"""Binding to a misfolded protein."" [GOC:ai]",20,72,4,20212,0.05555555555555555,0.2,Module 4,['GO:0005515']
2988,HP,HP:0001019,Erythroderma,0.0004104054080809407,True,"An inflammatory exfoliative dermatosis involving nearly all of the surface of the skin. Erythroderma develops suddenly. A patchy erythema may generalize and spread to affect most of the skin. Scaling may appear in 2-6 days and be accompanied by hot, red, dry skin, malaise, and fever.",65,71,9,4958,0.1267605633802817,0.13846153846153847,Module 1,['HP:0011123']
2989,HPA,HPA:0510703,soft tissue 2; peripheral nerve[High],0.000412955598371644,True,soft tissue 2; peripheral nerve[High],292,69,11,11019,0.15942028985507245,0.03767123287671233,Module 5,['HPA:0510702']
2990,HP,HP:0025456,Abnormal CSF protein concentration,0.00041674465351154813,True,Any deviation from the normal range of a protein concentration in the cerebrospinal fluid.,53,44,7,4958,0.1590909090909091,0.1320754716981132,Module 3,"['HP:0001939', 'HP:0002921']"
2991,HP,HP:0001671,Abnormal cardiac septum morphology,0.0004196436157612403,True,An anomaly of the intra-atrial or intraventricular septum.,752,44,21,4958,0.4772727272727273,0.027925531914893616,Module 3,['HP:0001627']
2992,GO:BP,GO:0032944,regulation of mononuclear cell proliferation,0.0004203859239932864,True,"""Any process that modulates the frequency, rate or extent of mononuclear cell proliferation."" [GOC:add]",241,215,14,21031,0.06511627906976744,0.058091286307053944,Module 2,"['GO:0032943', 'GO:0070663']"
2993,HP,HP:0001197,Abnormality of prenatal development or birth,0.0004219497456785245,True,"An abnormality of the fetus or the birth of the fetus, excluding structural abnormalities.",982,44,24,4958,0.5454545454545454,0.024439918533604887,Module 3,['HP:0000118']
2994,HPA,HPA:0300412,lung; macrophages[≥Medium],0.0004222428938884976,True,lung; macrophages[≥Medium],4898,140,90,11019,0.6428571428571429,0.01837484687627603,Module Singleton,['HPA:0300411']
2995,HP,HP:0000114,Proximal tubulopathy,0.0004222974622308268,True,"Dysfunction of the proximal tubule, which is the portion of the duct system of the nephron of the kidney which leads from Bowman's capsule to the loop of Henle.",50,228,13,4958,0.05701754385964912,0.26,Module 0,['HP:0000124']
2996,GO:MF,GO:0004550,nucleoside diphosphate kinase activity,0.0004228280829982475,True,"""Catalysis of the reaction: ATP + nucleoside diphosphate = ADP + nucleoside triphosphate."" [EC:2.7.4.6]",19,2,2,20212,1.0,0.10526315789473684,Module 39,"['GO:0016776', 'GO:0019205']"
2997,HPA,HPA:0290000,liver,0.00042297796045051935,True,liver,6298,79,65,11019,0.8227848101265823,0.010320736741822802,Module 3,['HPA:0000000']
2998,GO:MF,GO:0030546,signaling receptor activator activity,0.00042449401655873234,True,"""The function of interacting (directly or indirectly) with receptors such that the proportion of receptors in the active form is increased."" [GOC:ceb]",519,5,4,20212,0.8,0.007707129094412331,Module 12,"['GO:0030545', 'GO:0140677']"
2999,GO:BP,GO:0065009,regulation of molecular function,0.0004278888910673599,True,"""Any process that modulates the frequency, rate or extent of a molecular function, an elemental biological activity occurring at the molecular level, such as catalysis or binding."" [GOC:isa_complete]",1799,21,11,21031,0.5238095238095238,0.006114508060033352,Module 9,['GO:0065007']
3000,KEGG,KEGG:04621,NOD-like receptor signaling pathway,0.0004297961138104573,True,NOD-like receptor signaling pathway,182,23,6,8484,0.2608695652173913,0.03296703296703297,Module 7,['KEGG:00000']
3001,GO:BP,GO:0006325,chromatin organization,0.00043017173719447004,True,"""The assembly or remodeling of chromatin composed of DNA complexed with histones, other associated proteins, and sometimes RNA."" [PMID:20404130]",816,77,15,21031,0.19480519480519481,0.01838235294117647,Module 5,['GO:0071824']
3002,REAC,REAC:R-HSA-68877,Mitotic Prometaphase,0.00043138625669599803,True,Mitotic Prometaphase,199,59,9,10842,0.15254237288135594,0.04522613065326633,Module 5,['REAC:R-HSA-68886']
3003,GO:BP,GO:0031647,regulation of protein stability,0.0004323794748283437,True,"""Any process that affects the structure and integrity of a protein, altering the likelihood of its degradation or aggregation."" [GOC:dph, GOC:mah, GOC:tb]",324,787,33,21031,0.04193138500635324,0.10185185185185185,Module 0,['GO:0065008']
3004,GO:BP,GO:0045862,positive regulation of proteolysis,0.0004350301137011124,True,"""Any process that activates or increases the frequency, rate or extent of the hydrolysis of a peptide bond or bonds within a protein."" [GOC:go_curators]",320,215,16,21031,0.07441860465116279,0.05,Module 2,"['GO:0006508', 'GO:0030162', 'GO:0051247']"
3005,HPA,HPA:0570803,testis; sertoli cells[High],0.00043553066789473675,True,testis; sertoli cells[High],601,612,62,11019,0.10130718954248366,0.10316139767054909,Module 0,['HPA:0570802']
3006,TF,TF:M02063,Factor: c-ets-1; motif: ACCGGAWGTN,0.0004365215232334648,True,Factor: c-ets-1; motif: ACCGGAWGTN,7763,105,67,20045,0.638095238095238,0.008630684013912147,Module 3,['TF:M00000']
3007,HPA,HPA:0470673,skin 2; melanocytes[High],0.00043963293580922625,True,skin 2; melanocytes[High],357,69,12,11019,0.17391304347826086,0.03361344537815126,Module 5,['HPA:0470672']
3008,REAC,REAC:R-HSA-76005,Response to elevated platelet cytosolic Ca2+,0.00044012995038959156,True,Response to elevated platelet cytosolic Ca2+,130,173,12,10842,0.06936416184971098,0.09230769230769231,Module 2,['REAC:R-HSA-76002']
3009,GO:BP,GO:0001906,cell killing,0.00044045160338292307,True,"""Any process in an organism that results in the killing of its own cells or those of another organism, including in some cases the death of the other organism. Killing here refers to the induction of death in one cell by another cell, not cell-autonomous death due to internal or other environmental conditions."" [GOC:add]",217,15,5,21031,0.3333333333333333,0.02304147465437788,Module 6,['GO:0009987']
3010,TF,TF:M00793_1,Factor: YY1; motif: GCCATNTTN; match class: 1,0.00044341775506097884,True,Factor: YY1; motif: GCCATNTTN; match class: 1,645,826,56,20045,0.06779661016949153,0.08682170542635659,Module 0,['TF:M00793']
3011,GO:MF,GO:0019899,enzyme binding,0.0004437566124112704,True,"""Binding to an enzyme, a protein with catalytic activity."" [GOC:jl]",2103,232,49,20212,0.21120689655172414,0.02330004755111745,Module 1,['GO:0005515']
3012,GO:BP,GO:0010557,positive regulation of macromolecule biosynthetic process,0.00044591359531621563,True,"""Any process that increases the rate, frequency or extent of the chemical reactions and pathways resulting in the formation of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass."" [GOC:dph, GOC:tb]",2603,226,56,21031,0.24778761061946902,0.021513638109873223,Module 1,"['GO:0009059', 'GO:0010556', 'GO:0010604', 'GO:0031328']"
3013,GO:BP,GO:0048285,organelle fission,0.00044646581319177607,True,"""The creation of two or more organelles by division of one organelle."" [GOC:jid]",495,77,12,21031,0.15584415584415584,0.024242424242424242,Module 5,['GO:0006996']
3014,KEGG,KEGG:05133,Pertussis,0.0004496420991871531,True,Pertussis,76,143,9,8484,0.06293706293706294,0.11842105263157894,Module 2,['KEGG:00000']
3015,GO:BP,GO:0031347,regulation of defense response,0.00045257505484512067,True,"""Any process that modulates the frequency, rate or extent of a defense response."" [GOC:mah]",768,34,10,21031,0.29411764705882354,0.013020833333333334,Module 7,"['GO:0006952', 'GO:0080134']"
3016,GO:BP,GO:0030490,maturation of SSU-rRNA,0.0004531012204497534,True,"""Any process involved in the maturation of a precursor Small SubUnit (SSU) ribosomal RNA (rRNA) molecule into a mature SSU-rRNA molecule."" [GOC:curators]",52,105,6,21031,0.05714285714285714,0.11538461538461539,Module 3,"['GO:0006364', 'GO:0042274']"
3017,GO:BP,GO:0048872,homeostasis of number of cells,0.00045376078548291357,True,"""Any biological process involved in the maintenance of the steady-state number of cells within a population of cells."" [GOC:isa_complete]",321,215,16,21031,0.07441860465116279,0.04984423676012461,Module 2,['GO:0048871']
3018,MIRNA,MIRNA:hsa-miR-1276,hsa-miR-1276,0.0004575532667723605,True,hsa-miR-1276,160,3,3,14819,1.0,0.01875,Module 27,['MIRNA:000000']
3019,MIRNA,MIRNA:hsa-miR-8057,hsa-miR-8057,0.0004575532667723605,True,hsa-miR-8057,160,3,3,14819,1.0,0.01875,Module 27,['MIRNA:000000']
3020,HP,HP:0002240,Hepatomegaly,0.00045804724570202464,True,Abnormally increased size of the liver.,641,71,26,4958,0.36619718309859156,0.0405616224648986,Module 1,"['HP:0003271', 'HP:0410042']"
3021,TF,TF:M11877_1,Factor: pax-2; motif: NCGTCACGCNYSRNYGCNYN; match class: 1,0.00046153739282150724,True,Factor: pax-2; motif: NCGTCACGCNYSRNYGCNYN; match class: 1,5401,826,289,20045,0.3498789346246973,0.05350860951675616,Module 0,['TF:M11877']
3022,GO:CC,GO:0015934,large ribosomal subunit,0.0004649132446446271,True,"""The larger of the two subunits of a ribosome. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site)."" [ISBN:0198506732]",117,813,17,22097,0.020910209102091022,0.1452991452991453,Module 0,['GO:0044391']
3023,TF,TF:M11881,Factor: pax-6; motif: NYACGCNTSANYGCNYN,0.00046494760368476814,True,Factor: pax-6; motif: NYACGCNTSANYGCNYN,13468,826,622,20045,0.7530266343825666,0.046183546183546184,Module 0,['TF:M00000']
3024,GO:BP,GO:0019221,cytokine-mediated signaling pathway,0.0004676605304489116,True,"""The series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription."" [GOC:mah, GOC:signaling, PMID:19295629]",499,215,20,21031,0.09302325581395349,0.04008016032064128,Module 2,"['GO:0007166', 'GO:0071345']"
3025,GO:CC,GO:0012506,vesicle membrane,0.0004679584332821033,True,"""The lipid bilayer surrounding any membrane-bounded vesicle in the cell."" [GOC:mah, GOC:vesicle]",1240,813,79,22097,0.0971709717097171,0.06370967741935483,Module 0,"['GO:0031090', 'GO:0031982']"
3026,GO:BP,GO:0006897,endocytosis,0.00047084514321323756,True,"""A vesicle-mediated transport process in which cells take up external materials or membrane constituents by the invagination of a part of the plasma membrane to form a new membrane-bounded vesicle."" [GOC:mah, ISBN:0198506732, ISBN:0716731363, Wikipedia:Endocytosis]",704,787,55,21031,0.0698856416772554,0.078125,Module 0,"['GO:0016192', 'GO:0098657']"
3027,HP,HP:0009116,Aplasia/Hypoplasia involving bones of the skull,0.00047118785785975386,True,Aplasia/Hypoplasia involving bones of the skull,831,44,22,4958,0.5,0.026474127557160047,Module 3,"['HP:0000929', 'HP:0009122']"
3028,GO:BP,GO:0022900,electron transport chain,0.0004715203414287485,True,"""A process in which a series of electron carriers operate together to transfer electrons from donors to any of several different terminal electron acceptors."" [GOC:mtg_electron_transport]",175,105,9,21031,0.08571428571428572,0.05142857142857143,Module 3,['GO:0006091']
3029,GO:BP,GO:0030968,endoplasmic reticulum unfolded protein response,0.0004718075186510892,True,"""The series of molecular signals generated as a consequence of the presence of unfolded proteins in the endoplasmic reticulum (ER) or other ER-related stress; results in changes in the regulation of transcription and translation."" [GOC:mah, PMID:12042763]",77,72,6,21031,0.08333333333333333,0.07792207792207792,Module 4,"['GO:0007165', 'GO:0034620', 'GO:0034976']"
3030,HPA,HPA:0471411,skin 2; cells in spinous layer[≥Low],0.0004720108072173629,True,skin 2; cells in spinous layer[≥Low],871,18,9,11019,0.5,0.010332950631458095,Module 9,['HPA:0470000']
3031,HPA,HPA:0500000,soft tissue 1,0.0004722104481847095,True,soft tissue 1,5363,79,59,11019,0.7468354430379747,0.011001305239604698,Module 3,['HPA:0000000']
3032,HPA,HPA:0190222,esophagus; squamous epithelial cells[≥Medium],0.00047675771331467167,True,esophagus; squamous epithelial cells[≥Medium],5058,69,51,11019,0.7391304347826086,0.010083036773428233,Module 5,['HPA:0190221']
3033,GO:CC,GO:0070013,intracellular organelle lumen,0.0004779937432436431,True,"""An organelle lumen that is part of an intracellular organelle."" [GOC:mah]",6657,221,100,22097,0.45248868778280543,0.01502178158329578,Module 2,"['GO:0043229', 'GO:0043233']"
3034,GO:CC,GO:0031974,membrane-enclosed lumen,0.0004779937432436431,True,"""The enclosed volume within a sealed membrane or between two sealed membranes. Encompasses the volume enclosed by the membranes of a particular organelle, e.g. endoplasmic reticulum lumen, or the space between the two lipid bilayers of a double membrane surrounding an organelle, e.g. nuclear envelope lumen."" [GOC:add, GOC:mah]",6657,221,100,22097,0.45248868778280543,0.01502178158329578,Module 2,['GO:0110165']
3035,GO:CC,GO:0043233,organelle lumen,0.0004779937432436431,True,"""The internal volume enclosed by the membranes of a particular organelle; includes the volume enclosed by a single organelle membrane, e.g. endoplasmic reticulum lumen, or the volume enclosed by the innermost of the two lipid bilayers of an organelle envelope, e.g. nuclear lumen."" [GOC:jl, GOC:mah]",6657,221,100,22097,0.45248868778280543,0.01502178158329578,Module 2,"['GO:0031974', 'GO:0043226']"
3036,GO:BP,GO:0001817,regulation of cytokine production,0.0004805341127801323,True,"""Any process that modulates the frequency, rate, or extent of production of a cytokine."" [GOC:add, ISBN:0781735149]",773,34,10,21031,0.29411764705882354,0.0129366106080207,Module 7,"['GO:0001816', 'GO:0010468', 'GO:0051239']"
3037,TF,TF:M08220,Factor: Elk-1:HOXA3; motif: ACCGGWAATKRNNTNWCNNATTAN,0.00048063924506371194,True,Factor: Elk-1:HOXA3; motif: ACCGGWAATKRNNTNWCNNATTAN,12357,826,579,20045,0.7009685230024213,0.046856033017722745,Module 0,['TF:M00000']
3038,GO:MF,GO:0023026,MHC class II protein complex binding,0.00048104876767930525,True,"""Binding to a class II major histocompatibility complex."" [GOC:mtg_signal, GOC:vw]",24,20,3,20212,0.15,0.125,Module 9,['GO:0023023']
3039,WP,WP:WP4884,Pathogenesis of SARS CoV 2 mediated by nsp9 nsp10 complex,0.0004826745373317392,True,Pathogenesis of SARS CoV 2 mediated by nsp9 nsp10 complex,21,13,3,8286,0.23076923076923078,0.14285714285714285,Module 6,['WP:000000']
3040,GO:BP,GO:0009142,nucleoside triphosphate biosynthetic process,0.0004836398502266294,True,"""The chemical reactions and pathways resulting in the formation of a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",127,105,8,21031,0.0761904761904762,0.06299212598425197,Module 3,"['GO:0009141', 'GO:1901293']"
3041,HPA,HPA:0461442,skin 1; fibrohistiocytic cells[≥Medium],0.0004878233972853299,True,skin 1; fibrohistiocytic cells[≥Medium],699,185,30,11019,0.16216216216216217,0.04291845493562232,Module 1,['HPA:0461441']
3042,HP,HP:0000357,Abnormal location of ears,0.0004928027600936676,True,Abnormal location of the ear.,910,44,23,4958,0.5227272727272727,0.025274725274725275,Module 3,['HP:0000377']
3043,KEGG,KEGG:04662,B cell receptor signaling pathway,0.0004947370995181014,True,B cell receptor signaling pathway,81,136,9,8484,0.0661764705882353,0.1111111111111111,Module 1,['KEGG:00000']
3044,REAC,REAC:R-HSA-5621481,C-type lectin receptors (CLRs),0.0004952455265238186,True,C-type lectin receptors (CLRs),136,586,23,10842,0.03924914675767918,0.16911764705882354,Module 0,['REAC:R-HSA-168249']
3045,HPA,HPA:0360051,parathyroid gland; glandular cells[≥Low],0.0004962324191066799,True,parathyroid gland; glandular cells[≥Low],5898,140,102,11019,0.7285714285714285,0.017293997965412006,Module Singleton,['HPA:0360000']
3046,HPA,HPA:0360000,parathyroid gland,0.0004962324191066799,True,parathyroid gland,5898,140,102,11019,0.7285714285714285,0.017293997965412006,Module Singleton,['HPA:0000000']
3047,TF,TF:M10436,Factor: YY1; motif: CAANATGGCGGC,0.0005002845296715556,True,Factor: YY1; motif: CAANATGGCGGC,8349,105,70,20045,0.6666666666666666,0.00838423763324949,Module 3,['TF:M00000']
3048,GO:BP,GO:0044237,cellular metabolic process,0.0005009941750944251,True,"""The chemical reactions and pathways by which individual cells transform chemical substances."" [GOC:go_curators]",12881,787,549,21031,0.6975857687420585,0.042620914525269775,Module 0,"['GO:0008152', 'GO:0009987']"
3049,TF,TF:M11451,Factor: Elf-1; motif: NANCCGGAAGTN,0.0005014494671882843,True,Factor: Elf-1; motif: NANCCGGAAGTN,7063,105,63,20045,0.6,0.008919722497522299,Module 3,['TF:M00000']
3050,HPA,HPA:0480000,small intestine,0.0005018019961016404,True,small intestine,7877,69,65,11019,0.9420289855072463,0.008251872540307223,Module 5,['HPA:0000000']
3051,TF,TF:M04106,Factor: RUNX2; motif: NRACCGCAAACCGCAN,0.0005032599515306861,True,Factor: RUNX2; motif: NRACCGCAAACCGCAN,14133,826,647,20045,0.7832929782082324,0.04577938158918842,Module 0,['TF:M00000']
3052,HPA,HPA:0350471,pancreas; exocrine glandular cells[≥Low],0.0005072606676340683,True,pancreas; exocrine glandular cells[≥Low],6942,60,54,11019,0.9,0.007778738115816767,Module 4,['HPA:0350000']
3053,GO:MF,GO:0061134,peptidase regulator activity,0.0005098508810282546,True,"""Binds to and modulates the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds."" [GOC:dph, GOC:tb]",227,218,13,20212,0.05963302752293578,0.05726872246696035,Module 2,['GO:0030234']
3054,GO:CC,GO:0071755,IgM B cell receptor complex,0.0005141443664124532,True,"""An IgM immunoglobulin complex that is present in the plasma membrane of B cells and is composed of two identical immunoglobulin heavy chains of the IgM isotype and two identical immunoglobulin light chains and a signaling subunit, a heterodimer of the Ig-alpha and Ig-beta proteins."" [GOC:add, ISBN:0781765196, PMID:20176268]",3,238,3,22097,0.012605042016806723,1.0,Module 1,"['GO:0019815', 'GO:0071753']"
3055,GO:CC,GO:0042106,gamma-delta T cell receptor complex,0.0005141443664124532,True,"""A T cell receptor complex in which the TCR heterodimer comprises gamma and delta chains, associated with the CD3 complex; recognizes antigen directly, without a requirement for processing and presentation by an MHC protein."" [GOC:mah, ISBN:0781735149]",3,238,3,22097,0.012605042016806723,1.0,Module 1,['GO:0042101']
3056,REAC,REAC:R-HSA-5660526,Response to metal ions,0.0005159996325475014,True,Response to metal ions,14,19,3,10842,0.15789473684210525,0.21428571428571427,Module 10,['REAC:R-HSA-8953897']
3057,GO:BP,GO:0001816,cytokine production,0.0005160853858082442,True,"""The appearance of a cytokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels."" [GOC:add, ISBN:0781735149]",779,34,10,21031,0.29411764705882354,0.012836970474967908,Module 7,"['GO:0010467', 'GO:0032501']"
3058,HP,HP:0004323,Abnormality of body weight,0.0005173313915517242,True,An abnormal increase or decrease of weight or an abnormal distribution of mass in the body.,1851,44,33,4958,0.75,0.017828200972447326,Module 3,['HP:0001507']
3059,HPA,HPA:0461391,skin 1; cells in basal layer[≥Low],0.0005192309190119868,True,skin 1; cells in basal layer[≥Low],881,18,9,11019,0.5,0.01021566401816118,Module 9,['HPA:0460000']
3060,TF,TF:M00932,Factor: Sp1; motif: NNGGGGCGGGGNN,0.0005211835443536312,True,Factor: Sp1; motif: NNGGGGCGGGGNN,10750,826,515,20045,0.6234866828087167,0.04790697674418604,Module 0,['TF:M00000']
3061,HPA,HPA:0570762,testis; pachytene spermatocytes[≥Medium],0.0005222138444698351,True,testis; pachytene spermatocytes[≥Medium],1898,612,150,11019,0.24509803921568626,0.07903055848261328,Module 0,['HPA:0570761']
3062,TF,TF:M02071_1,Factor: ETV7; motif: NCCGGAANNN; match class: 1,0.0005231855043108163,True,Factor: ETV7; motif: NCCGGAANNN; match class: 1,4586,105,48,20045,0.45714285714285713,0.010466637592673354,Module 3,['TF:M02071']
3063,GO:BP,GO:0031328,positive regulation of cellular biosynthetic process,0.0005240200676618638,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of substances, carried out by individual cells."" [GOC:mah]",2685,226,57,21031,0.252212389380531,0.021229050279329607,Module 1,"['GO:0009891', 'GO:0031325', 'GO:0031326', 'GO:0044249']"
3064,MIRNA,MIRNA:hsa-miR-92a-3p,hsa-miR-92a-3p,0.0005242654434082739,True,hsa-miR-92a-3p,1401,104,27,14819,0.25961538461538464,0.019271948608137045,Module 3,['MIRNA:000000']
3065,HPA,HPA:0471391,skin 2; cells in basal layer[≥Low],0.0005323373361649495,True,skin 2; cells in basal layer[≥Low],962,166,34,11019,0.20481927710843373,0.035343035343035345,Module 2,['HPA:0470000']
3066,KEGG,KEGG:04514,Cell adhesion molecules,0.0005349987656056779,True,Cell adhesion molecules,153,136,12,8484,0.08823529411764706,0.0784313725490196,Module 1,['KEGG:00000']
3067,HPA,HPA:0310443,lymph node; non-germinal center cells[High],0.000536501806108386,True,lymph node; non-germinal center cells[High],1209,140,35,11019,0.25,0.028949545078577336,Module Singleton,['HPA:0310442']
3068,HPA,HPA:0461422,skin 1; eccrine glands[≥Medium],0.000537992117490212,True,skin 1; eccrine glands[≥Medium],187,69,9,11019,0.13043478260869565,0.0481283422459893,Module 5,['HPA:0461421']
3069,GO:BP,GO:2000503,positive regulation of natural killer cell chemotaxis,0.0005381288580401923,True,"""Any process that activates or increases the frequency, rate or extent of natural killer cell chemotaxis."" [GOC:BHF]",6,5,2,21031,0.4,0.3333333333333333,Module 12,"['GO:0035747', 'GO:0140131', 'GO:2000501']"
3070,HPA,HPA:0530712,spleen; cells in red pulp[≥Medium],0.0005384925600718449,True,spleen; cells in red pulp[≥Medium],3143,140,66,11019,0.4714285714285714,0.020999045497931912,Module Singleton,['HPA:0530711']
3071,HP,HP:0002728,Chronic mucocutaneous candidiasis,0.0005388433787657907,True,"Recurrent or persistent superficial Candida infections of the skin, mucous membranes, and nails.",49,71,8,4958,0.11267605633802817,0.16326530612244897,Module 1,['HP:0011370']
3072,TF,TF:M11670,Factor: IRF-5; motif: NYGAAACCGAAACY,0.0005405425238969966,True,Factor: IRF-5; motif: NYGAAACCGAAACY,883,36,11,20045,0.3055555555555556,0.01245753114382786,Module 7,['TF:M00000']
3073,GO:CC,GO:0032991,protein-containing complex,0.0005433911927226714,True,"""A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together."" [GOC:dos, GOC:mah]",8588,80,52,22097,0.65,0.006054960409874243,Module 5,['GO:0005575']
3074,GO:BP,GO:0048584,positive regulation of response to stimulus,0.0005504854422995196,True,"""Any process that activates, maintains or increases the rate of a response to a stimulus. Response to stimulus is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus."" [GOC:jid]",2274,15,10,21031,0.6666666666666666,0.0043975373790677225,Module 6,"['GO:0048518', 'GO:0048583', 'GO:0050896']"
3075,TF,TF:M10849_1,Factor: Cdx-2; motif: NRTCGTAANNNN; match class: 1,0.0005531325262281134,True,Factor: Cdx-2; motif: NRTCGTAANNNN; match class: 1,4594,105,48,20045,0.45714285714285713,0.01044841097083152,Module 3,['TF:M10849']
3076,GO:CC,GO:0098802,plasma membrane signaling receptor complex,0.0005534951748415437,True,"""Any protein complex that is part of the plasma membrane and which functions as a signaling receptor."" [GOC:dos]",307,238,15,22097,0.06302521008403361,0.048859934853420196,Module 1,"['GO:0043235', 'GO:0098797']"
3077,GO:MF,GO:0030545,signaling receptor regulator activity,0.0005547136832492349,True,"""Binds to and modulates the activity of a receptor."" [GOC:ceb]",555,5,4,20212,0.8,0.007207207207207207,Module 12,['GO:0098772']
3078,GO:MF,GO:0019904,protein domain specific binding,0.0005554361580979327,True,"""Binding to a specific domain of a protein."" [GOC:go_curators]",653,20,7,20212,0.35,0.010719754977029096,Module 9,['GO:0005515']
3079,GO:BP,GO:0002682,regulation of immune system process,0.0005558472733677119,True,"""Any process that modulates the frequency, rate, or extent of an immune system process."" [GOC:add]",1512,34,13,21031,0.38235294117647056,0.008597883597883597,Module 7,"['GO:0002376', 'GO:0050789']"
3080,GO:BP,GO:0051094,positive regulation of developmental process,0.0005565630835646055,True,"""Any process that activates or increases the rate or extent of development, the biological process whose specific outcome is the progression of an organism over time from an initial condition (e.g. a zygote, or a young adult) to a later condition (e.g. a multicellular animal or an aged adult)."" [GOC:ai]",1328,226,36,21031,0.1592920353982301,0.02710843373493976,Module 1,"['GO:0032502', 'GO:0048518', 'GO:0050793']"
3081,HP,HP:0000549,Abnormal conjugate eye movement,0.0005580654561761415,True,Any deviation from the normal motor coordination of the eyes that allows for bilateral fixation on a single object.,1165,44,26,4958,0.5909090909090909,0.022317596566523604,Module 3,['HP:0000496']
3082,TF,TF:M10785,Factor: hoxa9; motif: RTCGTWANNN,0.0005589275289461433,True,Factor: hoxa9; motif: RTCGTWANNN,5711,105,55,20045,0.5238095238095238,0.00963053755909648,Module 3,['TF:M00000']
3083,HPA,HPA:0131333,colon; mucosal lymphoid cells[High],0.0005601733667938733,True,colon; mucosal lymphoid cells[High],155,185,13,11019,0.07027027027027027,0.08387096774193549,Module 1,['HPA:0131332']
3084,HPA,HPA:0600000,tonsil,0.0005605128440303456,True,tonsil,7788,60,57,11019,0.95,0.007318952234206471,Module 4,['HPA:0000000']
3085,HPA,HPA:0380203,placenta; endothelial cells[High],0.000564464269159281,True,placenta; endothelial cells[High],244,612,33,11019,0.05392156862745098,0.13524590163934427,Module 0,['HPA:0380202']
3086,REAC,REAC:R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,0.0005671933407781392,True,Interleukin-4 and Interleukin-13 signaling,110,173,11,10842,0.06358381502890173,0.1,Module 2,['REAC:R-HSA-449147']
3087,GO:BP,GO:0031348,negative regulation of defense response,0.0005674768830333093,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of a defense response."" [GOC:mah]",247,215,14,21031,0.06511627906976744,0.05668016194331984,Module 2,"['GO:0006952', 'GO:0031347', 'GO:0048585']"
3088,HP,HP:0010975,Abnormal B cell count,0.0005676890627245751,True,"A deviation from the normal count of B cells, i.e., the cells that are formed in the bone marrow, migrate to the peripheral lymphatic system, and mature into plasma cells or memory cells.",88,71,10,4958,0.14084507042253522,0.11363636363636363,Module 1,"['HP:0002846', 'HP:0040088']"
3089,GO:BP,GO:1990173,protein localization to nucleoplasm,0.0005685228496805987,True,"""A process in which a protein is transported to, or maintained in, a location within the nucleoplasm."" [GOC:mah, PMID:22918952]",14,787,7,21031,0.008894536213468869,0.5,Module 0,['GO:0034504']
3090,GO:BP,GO:0040012,regulation of locomotion,0.000570430716369602,True,"""Any process that modulates the frequency, rate or extent of locomotion of a cell or organism."" [GOC:ems]",1038,215,30,21031,0.13953488372093023,0.028901734104046242,Module 2,"['GO:0040011', 'GO:0050789']"
3091,GO:BP,GO:0002833,positive regulation of response to biotic stimulus,0.0005734274864057702,True,"""Any process that activates or increases the frequency, rate, or extent of a response to biotic stimulus."" [GOC:add]",369,215,17,21031,0.07906976744186046,0.04607046070460705,Module 2,"['GO:0002831', 'GO:0009607', 'GO:0048584']"
3092,TF,TF:M11435_1,Factor: Elk-1; motif: NNCCGGAAGTN; match class: 1,0.0005741143228772442,True,Factor: Elk-1; motif: NNCCGGAAGTN; match class: 1,5881,105,56,20045,0.5333333333333333,0.009522190103723856,Module 3,['TF:M11435']
3093,HPA,HPA:0471443,skin 2; fibrohistiocytic cells[High],0.0005745506416771613,True,skin 2; fibrohistiocytic cells[High],467,12,6,11019,0.5,0.01284796573875803,Module 6,['HPA:0471442']
3094,TF,TF:M00063,Factor: IRF-2; motif: GAAAAGYGAAASY,0.0005746752375023796,True,Factor: IRF-2; motif: GAAAAGYGAAASY,695,36,10,20045,0.2777777777777778,0.014388489208633094,Module 7,['TF:M00000']
3095,GO:CC,GO:0005576,extracellular region,0.0005801619342600034,True,"""The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite."" [GOC:go_curators]",4213,177,60,22097,0.3389830508474576,0.014241633040588654,Module Singleton,['GO:0110165']
3096,HP,HP:0002014,Diarrhea,0.000580607366845583,True,Abnormally increased frequency (usually defined as three or more) loose or watery bowel movements a day.,397,71,20,4958,0.28169014084507044,0.05037783375314862,Module 1,['HP:0011458']
3097,HPA,HPA:0030442,appendix; non-germinal center cells[≥Medium],0.0005833979003113509,True,appendix; non-germinal center cells[≥Medium],263,79,11,11019,0.13924050632911392,0.04182509505703422,Module 3,['HPA:0030441']
3098,GO:BP,GO:0044092,negative regulation of molecular function,0.0005843229051690982,True,"""Any process that stops or reduces the rate or extent of a molecular function, an elemental biological activity occurring at the molecular level, such as catalysis or binding."" [GO:jl]",672,787,53,21031,0.06734434561626429,0.07886904761904762,Module 0,['GO:0065009']
3099,HPA,HPA:0461413,skin 1; cells in spinous layer[High],0.0005876371205116884,True,skin 1; cells in spinous layer[High],207,140,13,11019,0.09285714285714286,0.06280193236714976,Module Singleton,['HPA:0461412']
3100,GO:MF,GO:0098772,molecular function regulator activity,0.0005876696671716525,True,"""A molecular function regulator regulates the activity of its target via non-covalent binding that does not result in covalent modification to the target. Examples of molecular function regulators include regulatory subunits of multimeric enzymes and channels. Mechanisms of regulation include allosteric changes in the target and competitive inhibition."" [GOC:dos, GOC:pt]",2063,218,46,20212,0.21100917431192662,0.022297624818225885,Module 2,['GO:0003674']
3101,GO:MF,GO:0016504,peptidase activator activity,0.0005889306891414922,True,"""Binds to and increases the activity of a peptidase."" [GOC:ai]",52,218,7,20212,0.03211009174311927,0.1346153846153846,Module 2,"['GO:0008047', 'GO:0061134']"
3102,HPA,HPA:0461453,skin 1; hair follicles[High],0.0005897613578212813,True,skin 1; hair follicles[High],122,166,11,11019,0.06626506024096386,0.09016393442622951,Module 2,['HPA:0461452']
3103,GO:BP,GO:0006956,complement activation,0.0005907247610461837,True,"""Any process involved in the activation of any of the steps of the complement cascade, which allows for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes; the initial steps of complement activation involve one of three pathways, the classical pathway, the alternative pathway, and the lectin pathway, all of which lead to the terminal complement pathway."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",64,215,8,21031,0.037209302325581395,0.125,Module 2,"['GO:0002252', 'GO:0002253', 'GO:0006959']"
3104,GO:CC,GO:0099503,secretory vesicle,0.0005914294749972704,True,"""A cytoplasmic, membrane bound vesicle that is capable of fusing to the plasma membrane to release its contents into the extracellular space."" [GOC:dos]",1069,21,8,22097,0.38095238095238093,0.007483629560336763,Module 9,['GO:0031410']
3105,GO:BP,GO:0070098,chemokine-mediated signaling pathway,0.00059776107122048,True,"""The series of molecular signals initiated by a chemokine binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription."" [GOC:mah, GOC:signaling]",90,5,3,21031,0.6,0.03333333333333333,Module 12,"['GO:0007186', 'GO:0019221', 'GO:1990869']"
3106,HPA,HPA:0401332,rectum; mucosal lymphoid cells[≥Medium],0.000598174136214907,True,rectum; mucosal lymphoid cells[≥Medium],398,166,20,11019,0.12048192771084337,0.05025125628140704,Module 2,['HPA:0401331']
3107,TF,TF:M11058,Factor: Hey1; motif: NGCRCGYGYN,0.0006004637239617715,True,Factor: Hey1; motif: NGCRCGYGYN,13615,826,627,20045,0.7590799031476998,0.046052148365773045,Module 0,['TF:M00000']
3108,GO:MF,GO:0003729,mRNA binding,0.0006105360235145409,True,"""Binding to messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns."" [GOC:kmv, GOC:pr, SO:0000234]",369,177,15,20212,0.0847457627118644,0.04065040650406504,Module Singleton,['GO:0003723']
3109,GO:BP,GO:0065008,regulation of biological quality,0.0006134675997128566,True,"""Any process that modulates a qualitative or quantitative trait of a biological quality. A biological quality is a measurable attribute of an organism or part of an organism, such as size, mass, shape, color, etc."" [GOC:dph, GOC:isa_complete, GOC:mah, GOC:pr, GOC:vw]",2846,215,57,21031,0.2651162790697674,0.020028109627547436,Module 2,['GO:0065007']
3110,GO:BP,GO:0001910,regulation of leukocyte mediated cytotoxicity,0.0006166578123120767,True,"""Any process that modulates the frequency, rate, or extent of leukocyte mediated cytotoxicity."" [GOC:add, ISBN:0781735149, PMID:11911826]",91,15,4,21031,0.26666666666666666,0.04395604395604396,Module 6,"['GO:0001909', 'GO:0002703', 'GO:0031341']"
3111,HPA,HPA:0641511,endometrium; nonciliated glandular epithelial cells[≥Low],0.0006185648162120639,True,endometrium; nonciliated glandular epithelial cells[≥Low],58,166,8,11019,0.04819277108433735,0.13793103448275862,Module 2,['HPA:0640000']
3112,GO:BP,GO:0050867,positive regulation of cell activation,0.0006186999478263007,True,"""Any process that activates or increases the frequency, rate or extent of activation."" [GOC:ai]",371,215,17,21031,0.07906976744186046,0.04582210242587601,Module 2,"['GO:0001775', 'GO:0048522', 'GO:0050865', 'GO:0051240']"
3113,HP,HP:0000218,High palate,0.0006187028603638028,True,Height of the palate more than 2 SD above the mean (objective) or palatal height at the level of the first permanent molar more than twice the height of the teeth (subjective).,769,44,21,4958,0.4772727272727273,0.027308192457737322,Module 3,['HP:0000174']
3114,GO:MF,GO:0045182,translation regulator activity,0.0006213405450138025,True,"""Any molecular function involved in the initiation, activation, perpetuation, repression or termination of polypeptide synthesis at the ribosome."" [GOC:ai]",147,105,8,20212,0.0761904761904762,0.05442176870748299,Module 3,['GO:0003674']
3115,GO:MF,GO:0004911,interleukin-2 receptor activity,0.0006220899051063224,True,"""Combining with interleukin-2 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity."" [GOC:jl, GOC:signaling]",3,232,3,20212,0.01293103448275862,1.0,Module 1,['GO:0004896']
3116,GO:MF,GO:0019976,interleukin-2 binding,0.0006220899051063224,True,"""Binding to interleukin-2."" [GOC:jl]",3,232,3,20212,0.01293103448275862,1.0,Module 1,"['GO:0019838', 'GO:0019955']"
3117,TF,TF:M01744,Factor: REX1; motif: AANATGGCKGCN,0.0006227926629191447,True,Factor: REX1; motif: AANATGGCKGCN,635,826,55,20045,0.06658595641646489,0.08661417322834646,Module 0,['TF:M00000']
3118,GO:CC,GO:0030141,secretory granule,0.0006238302361282637,True,"""A small subcellular vesicle, surrounded by a membrane, that is formed from the Golgi apparatus and contains a highly concentrated protein destined for secretion. Secretory granules move towards the periphery of the cell and upon stimulation, their membranes fuse with the cell membrane, and their protein load is exteriorized. Processing of the contained protein may take place in secretory granules."" [GOC:mah, ISBN:0198506732]",896,238,27,22097,0.1134453781512605,0.030133928571428572,Module 1,"['GO:0012505', 'GO:0099503']"
3119,HPA,HPA:0530722,spleen; cells in white pulp[≥Medium],0.0006240048826489032,True,spleen; cells in white pulp[≥Medium],2720,69,35,11019,0.5072463768115942,0.012867647058823529,Module 5,['HPA:0530721']
3120,GO:CC,GO:0005829,cytosol,0.0006290029522765488,True,"""The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes."" [GOC:hjd, GOC:jl]",5487,238,92,22097,0.3865546218487395,0.016766903590304357,Module 1,"['GO:0005737', 'GO:0110165']"
3121,GO:MF,GO:0140677,molecular function activator activity,0.0006294499827801281,True,"""A molecular function regulator that activates or increases the activity of its target via non-covalent binding that does not result in covalent modification to the target."" [GOC:curators]",1124,218,31,20212,0.14220183486238533,0.027580071174377226,Module 2,['GO:0098772']
3122,HP,HP:0012115,Hepatitis,0.0006323342122341452,True,Inflammation of the liver.,89,71,10,4958,0.14084507042253522,0.11235955056179775,Module 1,"['HP:0012649', 'HP:0410042']"
3123,REAC,REAC:R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,0.0006337652459972341,True,AUF1 (hnRNP D0) binds and destabilizes mRNA,54,19,4,10842,0.21052631578947367,0.07407407407407407,Module 9,['REAC:R-HSA-450531']
3124,GO:BP,GO:0097435,supramolecular fiber organization,0.00063543802318605,True,"""A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a supramolecular fiber, a polymer consisting of an indefinite number of protein or protein complex subunits that have polymerised to form a fiber-shaped structure."" [GOC:pr]",842,787,62,21031,0.07878017789072427,0.07363420427553444,Module 0,['GO:0016043']
3125,HP,HP:0000422,Abnormal nasal bridge morphology,0.0006382981076329974,True,"Abnormality of the nasal bridge, which is the saddle-shaped area that includes the nasal root and the lateral aspects of the nose. It lies between the glabella and the inferior boundary of the nasal bone, and extends laterally to the inner canthi.",1003,44,24,4958,0.5454545454545454,0.023928215353938187,Module 3,['HP:0005105']
3126,HPA,HPA:0600223,tonsil; squamous epithelial cells[High],0.000638848913301196,True,tonsil; squamous epithelial cells[High],1472,612,122,11019,0.19934640522875818,0.08288043478260869,Module 0,['HPA:0600222']
3127,TF,TF:M12591,Factor: CREB1; motif: NNNNSSGGCGCSSNNNNRTGACGTCAC,0.0006418827291318456,True,Factor: CREB1; motif: NNNNSSGGCGCSSNNNNRTGACGTCAC,14201,826,649,20045,0.7857142857142857,0.045701006971340045,Module 0,['TF:M00000']
3128,REAC,REAC:R-HSA-6807070,PTEN Regulation,0.000644969702042333,True,PTEN Regulation,138,586,23,10842,0.03924914675767918,0.16666666666666666,Module 0,['REAC:R-HSA-1257604']
3129,HPA,HPA:0461421,skin 1; eccrine glands[≥Low],0.000649401522676102,True,skin 1; eccrine glands[≥Low],246,69,10,11019,0.14492753623188406,0.04065040650406504,Module 5,['HPA:0460000']
3130,GO:CC,GO:0043226,organelle,0.0006494667705463392,True,"""Organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton, and prokaryotic structures such as anammoxosomes and pirellulosomes. Excludes the plasma membrane."" [GOC:go_curators]",16808,177,159,22097,0.8983050847457628,0.009459781056639695,Module Singleton,['GO:0110165']
3131,GO:BP,GO:0009147,pyrimidine nucleoside triphosphate metabolic process,0.00065003786159656,True,"""The chemical reactions and pathways involving pyrimidine nucleoside triphosphate, a compound consisting of a pyrimidine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",24,2,2,21031,1.0,0.08333333333333333,Module 39,['GO:0009141']
3132,GO:BP,GO:0009220,pyrimidine ribonucleotide biosynthetic process,0.00065003786159656,True,"""The chemical reactions and pathways resulting in the formation of a pyrimidine ribonucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:go_curators, ISBN:0198506732]",24,2,2,21031,1.0,0.08333333333333333,Module 39,"['GO:0006221', 'GO:0009218', 'GO:0009260']"
3133,MIRNA,MIRNA:hsa-miR-760,hsa-miR-760,0.00065008523934368,True,hsa-miR-760,194,104,10,14819,0.09615384615384616,0.05154639175257732,Module 3,['MIRNA:000000']
3134,HPA,HPA:0620223,vagina; squamous epithelial cells[High],0.0006516111098775122,True,vagina; squamous epithelial cells[High],1138,79,23,11019,0.2911392405063291,0.020210896309314587,Module 3,['HPA:0620222']
3135,TF,TF:M00920,Factor: E2F; motif: NKCGCGCSAAAN,0.0006525585807503806,True,Factor: E2F; motif: NKCGCGCSAAAN,5849,826,308,20045,0.3728813559322034,0.05265857411523337,Module 0,['TF:M00000']
3136,HPA,HPA:0131332,colon; mucosal lymphoid cells[≥Medium],0.0006529139894319422,True,colon; mucosal lymphoid cells[≥Medium],365,166,19,11019,0.1144578313253012,0.052054794520547946,Module 2,['HPA:0131331']
3137,GO:BP,GO:0031325,positive regulation of cellular metabolic process,0.0006575148518069935,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform chemical substances."" [GOC:mah]",3346,226,66,21031,0.2920353982300885,0.01972504482964734,Module 1,"['GO:0009893', 'GO:0031323', 'GO:0044237', 'GO:0048522']"
3138,TF,TF:M01660_1,Factor: GABP-alpha; motif: CTTCCK; match class: 1,0.0006605002981960598,True,Factor: GABP-alpha; motif: CTTCCK; match class: 1,5249,105,52,20045,0.49523809523809526,0.009906648885502,Module 3,['TF:M01660']
3139,GO:BP,GO:0030029,actin filament-based process,0.0006607075794008481,True,"""Any cellular process that depends upon or alters the actin cytoskeleton, that part of the cytoskeleton comprising actin filaments and their associated proteins."" [GOC:mah]",805,787,60,21031,0.07623888182973317,0.07453416149068323,Module 0,['GO:0009987']
3140,GO:BP,GO:0002274,myeloid leukocyte activation,0.0006637956531987778,True,"""A change in the morphology or behavior of a myeloid leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand."" [GOC:add, ISBN:0781735149]",238,226,14,21031,0.061946902654867256,0.058823529411764705,Module 1,['GO:0045321']
3141,HPA,HPA:0471463,skin 2; langerhans cells[High],0.000664804719565422,True,skin 2; langerhans cells[High],266,185,17,11019,0.0918918918918919,0.06390977443609022,Module 1,['HPA:0471462']
3142,HPA,HPA:0380521,placenta; trophoblastic cells[≥Low],0.0006721147725386659,True,placenta; trophoblastic cells[≥Low],6360,79,65,11019,0.8227848101265823,0.010220125786163521,Module 3,['HPA:0380000']
3143,TF,TF:M03976_1,Factor: ERG; motif: ACCGGAWATCCGGT; match class: 1,0.0006758573444639631,True,Factor: ERG; motif: ACCGGAWATCCGGT; match class: 1,7982,826,400,20045,0.48426150121065376,0.05011275369581558,Module 0,['TF:M03976']
3144,GO:CC,GO:0012505,endomembrane system,0.0006762634683780929,True,"""A collection of membranous structures involved in transport within the cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles."" [GOC:lh]",4777,238,83,22097,0.3487394957983193,0.01737492149884865,Module 1,['GO:0110165']
3145,TF,TF:M00739_1,Factor: E2F-4:DP-2; motif: TTTCSCGC; match class: 1,0.0006770663552183142,True,Factor: E2F-4:DP-2; motif: TTTCSCGC; match class: 1,1229,80,19,20045,0.2375,0.015459723352318959,Module 5,['TF:M00739']
3146,TF,TF:M00986,Factor: Churchill; motif: CGGGNN,0.0006776857501593768,True,Factor: Churchill; motif: CGGGNN,14579,826,663,20045,0.8026634382566586,0.045476370121407504,Module 0,['TF:M00000']
3147,GO:BP,GO:0002469,myeloid dendritic cell antigen processing and presentation,0.0006783003773181503,True,"""The process in which a myeloid dendritic cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex."" [GOC:add, ISBN:0781735149, PMID:15771591]",2,15,2,21031,0.13333333333333333,1.0,Module 6,['GO:0002468']
3148,GO:BP,GO:0002491,antigen processing and presentation of endogenous peptide antigen via MHC class II,0.0006783003773181503,True,"""The process in which an antigen-presenting cell expresses a peptide antigen of endogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein."" [GOC:add, PMID:15531770, PMID:16181338]",2,15,2,21031,0.13333333333333333,1.0,Module 6,"['GO:0002483', 'GO:0002495']"
3149,GO:BP,GO:0009891,positive regulation of biosynthetic process,0.0006800561203042587,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of substances."" [GOC:go_curators]",2706,226,57,21031,0.252212389380531,0.02106430155210643,Module 1,"['GO:0009058', 'GO:0009889', 'GO:0009893']"
3150,GO:BP,GO:0050871,positive regulation of B cell activation,0.0006884319256218925,True,"""Any process that activates or increases the frequency, rate or extent of B cell activation."" [GOC:ai]",85,226,9,21031,0.03982300884955752,0.10588235294117647,Module 1,"['GO:0042113', 'GO:0050864', 'GO:0051251']"
3151,HPA,HPA:0460201,skin 1; endothelial cells[≥Low],0.0006947465606723752,True,skin 1; endothelial cells[≥Low],841,166,31,11019,0.18674698795180722,0.036860879904875146,Module 2,['HPA:0460000']
3152,REAC,REAC:R-HSA-168256,Immune System,0.0006952736944162924,True,Immune System,2052,14,11,10842,0.7857142857142857,0.005360623781676413,Module 6,['REAC:0000000']
3153,HP,HP:0012841,Retinal vascular tortuosity,0.000696223487982096,True,The presence of an increased number of twists and turns of the retinal blood vessels.,57,44,7,4958,0.1590909090909091,0.12280701754385964,Module 3,['HP:0008046']
3154,HPA,HPA:0030891,appendix; goblet cells[≥Low],0.0006978492053559351,True,appendix; goblet cells[≥Low],384,79,13,11019,0.16455696202531644,0.033854166666666664,Module 3,['HPA:0030000']
3155,HPA,HPA:0641521,endometrium; nonciliated luminal epithelial cells[≥Low],0.0007065082551968669,True,endometrium; nonciliated luminal epithelial cells[≥Low],59,166,8,11019,0.04819277108433735,0.13559322033898305,Module 2,['HPA:0640000']
3156,GO:BP,GO:0046039,GTP metabolic process,0.0007065628930397406,True,"""The chemical reactions and pathways involving GTP, guanosine triphosphate."" [GOC:go_curators]",25,2,2,21031,1.0,0.08,Module 39,"['GO:0009150', 'GO:0009205']"
3157,HPA,HPA:0030442,appendix; non-germinal center cells[≥Medium],0.000709253903956441,True,appendix; non-germinal center cells[≥Medium],263,12,5,11019,0.4166666666666667,0.019011406844106463,Module 6,['HPA:0030441']
3158,TF,TF:M02056_1,Factor: ELF4; motif: NCCGGAARTN; match class: 1,0.0007094490676453955,True,Factor: ELF4; motif: NCCGGAARTN; match class: 1,1322,105,23,20045,0.21904761904761905,0.01739788199697428,Module 3,['TF:M02056']
3159,GO:BP,GO:0019538,protein metabolic process,0.0007116443637951901,True,"""The chemical reactions and pathways involving a protein. Includes protein modification."" [GOC:ma]",4912,21,16,21031,0.7619047619047619,0.003257328990228013,Module 9,"['GO:0043170', 'GO:0044238', 'GO:1901564']"
3160,GO:BP,GO:0044093,positive regulation of molecular function,0.0007189509095579995,True,"""Any process that activates or increases the rate or extent of a molecular function, an elemental biological activity occurring at the molecular level, such as catalysis or binding."" [GO:jl]",1097,21,9,21031,0.42857142857142855,0.008204193254329991,Module 9,['GO:0065009']
3161,HPA,HPA:0470673,skin 2; melanocytes[High],0.0007189556308599774,True,skin 2; melanocytes[High],357,140,17,11019,0.12142857142857143,0.047619047619047616,Module Singleton,['HPA:0470672']
3162,GO:BP,GO:1901575,organic substance catabolic process,0.0007190703014611782,True,"""The chemical reactions and pathways resulting in the breakdown of an organic substance, any molecular entity containing carbon."" [GOC:pr, GOC:TermGenie]",2074,215,46,21031,0.21395348837209302,0.022179363548698167,Module 2,"['GO:0009056', 'GO:0071704']"
3163,GO:BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.0007191387829261365,True,"""An immune response mediated by lymphocytes expressing specific receptors for antigen produced through a somatic diversification process that includes somatic recombination of germline gene segments encoding immunoglobulin superfamily domains. Recombined receptors for antigen encoded by immunoglobulin superfamily domains include T cell receptors and immunoglobulins (antibodies) produced by B cells. The first encounter with antigen elicits a primary immune response that is slow and not of great magnitude. T and B cells selected by antigen become activated and undergo clonal expansion. A fraction of antigen-reactive T and B cells become memory cells, whereas others differentiate into effector cells. The memory cells generated during the primary response enable a much faster and stronger secondary immune response upon subsequent exposures to the same antigen (immunological memory). An example of this is the adaptive immune response found in Mus musculus."" [GOC:add, GOC:mtg_sensu, ISBN:0781735149, ISBN:1405196831]",375,215,17,21031,0.07906976744186046,0.04533333333333334,Module 2,['GO:0002250']
3164,REAC,REAC:R-HSA-73856,RNA Polymerase II Transcription Termination,0.0007292975744762797,True,RNA Polymerase II Transcription Termination,65,586,15,10842,0.025597269624573378,0.23076923076923078,Module 0,['REAC:R-HSA-73857']
3165,HPA,HPA:0190223,esophagus; squamous epithelial cells[High],0.0007297125349962632,True,esophagus; squamous epithelial cells[High],1652,69,26,11019,0.37681159420289856,0.015738498789346248,Module 5,['HPA:0190222']
3166,GO:BP,GO:0002709,regulation of T cell mediated immunity,0.0007332993361456696,True,"""Any process that modulates the frequency, rate, or extent of T cell mediated immunity."" [GOC:add]",95,15,4,21031,0.26666666666666666,0.042105263157894736,Module 6,"['GO:0002456', 'GO:0002706', 'GO:0002822']"
3167,HPA,HPA:0580063,thymus; medullary cells[High],0.000735313630022752,True,thymus; medullary cells[High],7,185,4,11019,0.021621621621621623,0.5714285714285714,Module 1,['HPA:0580062']
3168,GO:CC,GO:0043229,intracellular organelle,0.0007379105522357072,True,"""Organized structure of distinctive morphology and function, occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane."" [GOC:go_curators]",16018,177,154,22097,0.8700564971751412,0.00961418404295168,Module Singleton,"['GO:0005622', 'GO:0043226']"
3169,HPA,HPA:0030000,appendix,0.0007395742487129498,True,appendix,7831,60,57,11019,0.95,0.007278763887115311,Module 4,['HPA:0000000']
3170,HPA,HPA:0040082,bone marrow; hematopoietic cells[≥Medium],0.000743335086047451,True,bone marrow; hematopoietic cells[≥Medium],4256,140,81,11019,0.5785714285714286,0.019031954887218046,Module Singleton,['HPA:0040081']
3171,GO:MF,GO:0097367,carbohydrate derivative binding,0.0007534431689960934,True,"""Binding to a carbohydrate derivative."" [GOC:pr]",2304,20,11,20212,0.55,0.004774305555555556,Module 9,['GO:0005488']
3172,HP,HP:0007302,Bipolar affective disorder,0.0007616219379313306,True,"Bipolar disorder is an illness of mood characterized by alternating episodes of elevated and depressed moods, which are interspersed with euthymic periods.",36,44,6,4958,0.13636363636363635,0.16666666666666666,Module 3,['HP:5200275']
3173,GO:CC,GO:0045202,synapse,0.0007630377300956452,True,"""The junction between an axon of one neuron and a dendrite of another neuron, a muscle fiber or a glial cell. As the axon approaches the synapse it enlarges into a specialized structure, the presynaptic terminal bouton, which contains mitochondria and synaptic vesicles. At the tip of the terminal bouton is the presynaptic membrane; facing it, and separated from it by a minute cleft (the synaptic cleft) is a specialized area of membrane on the receiving cell, known as the postsynaptic membrane. In response to the arrival of nerve impulses, the presynaptic terminal bouton secretes molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane."" [GOC:aruk, ISBN:0198506732, PMID:24619342, PMID:29383328, PMID:31998110]",1468,813,89,22097,0.10947109471094711,0.060626702997275204,Module 0,['GO:0030054']
3174,HPA,HPA:0550052,stomach 2; glandular cells[≥Medium],0.0007656861718771052,True,stomach 2; glandular cells[≥Medium],6284,60,51,11019,0.85,0.008115849777211966,Module 4,['HPA:0550051']
3175,HP,HP:0000246,Sinusitis,0.0007713098977650756,True,"Inflammation of the paranasal sinuses owing to a viral, bacterial, or fungal infection, allergy, or an autoimmune reaction.",167,71,13,4958,0.18309859154929578,0.07784431137724551,Module 1,"['HP:0000245', 'HP:0012649']"
3176,HPA,HPA:0310441,lymph node; non-germinal center cells[≥Low],0.0007747932988926977,True,lymph node; non-germinal center cells[≥Low],6061,60,50,11019,0.8333333333333334,0.008249463784853984,Module 4,['HPA:0310000']
3177,GO:BP,GO:0010604,positive regulation of macromolecule metabolic process,0.000777800918078328,True,"""Any process that increases the frequency, rate or extent of the chemical reactions and pathways involving macromolecules, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass."" [GOC:dph, GOC:tb]",3420,787,181,21031,0.22998729351969505,0.05292397660818714,Module 0,"['GO:0009893', 'GO:0043170', 'GO:0060255']"
3178,GO:BP,GO:0042221,response to chemical,0.0007779590308374448,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemical stimulus."" [GOC:jl]",3957,226,74,21031,0.3274336283185841,0.018701036138488752,Module 1,['GO:0050896']
3179,HPA,HPA:0340000,ovary,0.0007791508974712755,True,ovary,5429,79,59,11019,0.7468354430379747,0.0108675630871247,Module 3,['HPA:0000000']
3180,TF,TF:M03971,Factor: ELK1; motif: NACTTCCGSCGGAAGYN,0.0007832401934354165,True,Factor: ELK1; motif: NACTTCCGSCGGAAGYN,11526,826,545,20045,0.6598062953995157,0.04728440048585806,Module 0,['TF:M00000']
3181,HPA,HPA:0390053,prostate; glandular cells[High],0.0007843409218287616,True,prostate; glandular cells[High],1337,69,23,11019,0.3333333333333333,0.01720269259536275,Module 5,['HPA:0390052']
3182,HP,HP:0000496,Abnormality of eye movement,0.0007868444901722756,True,An abnormality in voluntary or involuntary eye movements or their control.,1770,44,32,4958,0.7272727272727273,0.01807909604519774,Module 3,['HP:0012373']
3183,GO:CC,GO:0030667,secretory granule membrane,0.0007911590482591244,True,"""The lipid bilayer surrounding a secretory granule."" [GOC:mah]",316,813,30,22097,0.03690036900369004,0.0949367088607595,Module 0,"['GO:0030141', 'GO:0030659', 'GO:0098588']"
3184,HPA,HPA:0130203,colon; endothelial cells[High],0.0007912377052312576,True,colon; endothelial cells[High],854,69,18,11019,0.2608695652173913,0.02107728337236534,Module 5,['HPA:0130202']
3185,REAC,REAC:R-HSA-9679506,SARS-CoV Infections,0.0007923098033249667,True,SARS-CoV Infections,459,586,50,10842,0.08532423208191127,0.10893246187363835,Module 0,['REAC:R-HSA-9824446']
3186,HPA,HPA:0510653,soft tissue 2; fibroblasts[High],0.000795357744901675,True,soft tissue 2; fibroblasts[High],522,69,14,11019,0.2028985507246377,0.02681992337164751,Module 5,['HPA:0510652']
3187,GO:BP,GO:1990868,response to chemokine,0.0007975644177721975,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemokine stimulus."" [PMID:11113082]",99,5,3,21031,0.6,0.030303030303030304,Module 12,['GO:0034097']
3188,GO:BP,GO:1990869,cellular response to chemokine,0.0007975644177721975,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemokine stimulus."" [PMID:11113082]",99,5,3,21031,0.6,0.030303030303030304,Module 12,"['GO:0071345', 'GO:1990868']"
3189,GO:BP,GO:0002697,regulation of immune effector process,0.0008039611197429317,True,"""Any process that modulates the frequency, rate, or extent of an immune effector process."" [GOC:add]",378,215,17,21031,0.07906976744186046,0.04497354497354497,Module 2,"['GO:0002252', 'GO:0002682']"
3190,GO:CC,GO:0000781,"chromosome, telomeric region",0.0008064574792543451,True,"""The end of a linear chromosome, required for the integrity and maintenance of the end. A chromosome telomere usually includes a region of telomerase-encoded repeats the length of which rarely exceeds 20 bp each and that permits the formation of a telomeric loop (T-loop). The telomeric repeat region is usually preceded by a sub-telomeric region that is gene-poor but rich in repetitive elements. Some telomeres only consist of the latter part (for eg. D. melanogaster telomeres)."" [GOC:elh]",171,80,7,22097,0.0875,0.04093567251461988,Module 5,['GO:0098687']
3191,GO:CC,GO:0005774,vacuolar membrane,0.0008068027603505188,True,"""The lipid bilayer surrounding the vacuole and separating its contents from the cytoplasm of the cell."" [GOC:ai]",489,221,18,22097,0.08144796380090498,0.03680981595092025,Module 2,"['GO:0005773', 'GO:0098588']"
3192,GO:CC,GO:0030139,endocytic vesicle,0.0008092156683691569,True,"""A membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance. Endocytic vesicles fuse with early endosomes to deliver the cargo for further sorting."" [GOC:go_curators, PMID:19696797]",346,221,15,22097,0.06787330316742081,0.04335260115606936,Module 2,['GO:0031410']
3193,HPA,HPA:0250122,hippocampus; glial cells[≥Medium],0.0008112918674205275,True,hippocampus; glial cells[≥Medium],2004,69,29,11019,0.42028985507246375,0.014471057884231538,Module 5,['HPA:0250121']
3194,WP,WP:WP5063,FOXP3 in COVID 19,0.0008180193792144047,True,FOXP3 in COVID 19,15,148,5,8286,0.033783783783783786,0.3333333333333333,Module 1,['WP:000000']
3195,MIRNA,MIRNA:hsa-miR-760,hsa-miR-760,0.0008183286082871144,True,hsa-miR-760,194,3,3,14819,1.0,0.015463917525773196,Module 27,['MIRNA:000000']
3196,TF,TF:M11381_1,Factor: ESE-1; motif: SATKGCGGATGCN; match class: 1,0.0008219439882818948,True,Factor: ESE-1; motif: SATKGCGGATGCN; match class: 1,9991,826,483,20045,0.5847457627118644,0.04834350915824242,Module 0,['TF:M11381']
3197,REAC,REAC:R-HSA-877300,Interferon gamma signaling,0.0008227727451894588,True,Interferon gamma signaling,87,28,5,10842,0.17857142857142858,0.05747126436781609,Module 7,['REAC:R-HSA-913531']
3198,TF,TF:M05439,Factor: RREB-1; motif: GGGWCSA,0.0008234868722018016,True,Factor: RREB-1; motif: GGGWCSA,8852,826,436,20045,0.5278450363196125,0.04925440578400361,Module 0,['TF:M00000']
3199,TF,TF:M00341,Factor: GABP; motif: VCCGGAAGNGCR,0.0008260322707071111,True,Factor: GABP; motif: VCCGGAAGNGCR,8398,826,417,20045,0.5048426150121066,0.04965467968563944,Module 0,['TF:M00000']
3200,HPA,HPA:0460183,skin 1; cells in granular layer[High],0.0008288618808892797,True,skin 1; cells in granular layer[High],248,140,14,11019,0.1,0.056451612903225805,Module Singleton,['HPA:0460182']
3201,HPA,HPA:0310441,lymph node; non-germinal center cells[≥Low],0.000832383893141535,True,lymph node; non-germinal center cells[≥Low],6061,79,63,11019,0.7974683544303798,0.010394324368916021,Module 3,['HPA:0310000']
3202,GO:CC,GO:0031410,cytoplasmic vesicle,0.0008350181521529141,True,"""A vesicle found in the cytoplasm of a cell."" [GOC:ai, GOC:mah, GOC:vesicles]",2513,21,11,22097,0.5238095238095238,0.004377238360525269,Module 9,"['GO:0005737', 'GO:0097708']"
3203,HPA,HPA:0301363,lung; alveolar cells type I[High],0.0008394069137404813,True,lung; alveolar cells type I[High],507,612,54,11019,0.08823529411764706,0.10650887573964497,Module 0,['HPA:0301362']
3204,HPA,HPA:0301372,lung; alveolar cells type II[≥Medium],0.0008423104426186953,True,lung; alveolar cells type II[≥Medium],1233,140,35,11019,0.25,0.028386050283860504,Module Singleton,['HPA:0301371']
3205,GO:MF,GO:0070180,large ribosomal subunit rRNA binding,0.0008450503691381048,True,"""Binding to large ribosomal subunit RNA (LSU rRNA), a constituent of the large ribosomal subunit. In S. cerevisiae, this is the 25S rRNA."" [GOC:elh]",5,105,3,20212,0.02857142857142857,0.6,Module 3,['GO:0019843']
3206,HPA,HPA:0350473,pancreas; exocrine glandular cells[High],0.0008462168619018874,True,pancreas; exocrine glandular cells[High],1960,60,26,11019,0.43333333333333335,0.013265306122448979,Module 4,['HPA:0350472']
3207,HPA,HPA:0471412,skin 2; cells in spinous layer[≥Medium],0.0008463028156207695,True,skin 2; cells in spinous layer[≥Medium],683,18,8,11019,0.4444444444444444,0.01171303074670571,Module 9,['HPA:0471411']
3208,HP,HP:0003493,Antinuclear antibody positivity,0.0008509646533208376,True,The presence of autoantibodies in the serum that react against nuclei or nuclear components.,68,74,9,4958,0.12162162162162163,0.1323529411764706,Module 2,['HP:0030057']
3209,GO:CC,GO:0097708,intracellular vesicle,0.0008515558556383982,True,"""Any vesicle that is part of the intracellular region."" [GOC:vesicles]",2518,21,11,22097,0.5238095238095238,0.004368546465448769,Module 9,"['GO:0031982', 'GO:0043231']"
3210,GO:BP,GO:0002703,regulation of leukocyte mediated immunity,0.0008540334155271555,True,"""Any process that modulates the frequency, rate, or extent of leukocyte mediated immunity."" [GOC:add]",243,226,14,21031,0.061946902654867256,0.05761316872427984,Module 1,"['GO:0002443', 'GO:0002697']"
3211,GO:BP,GO:0043170,macromolecule metabolic process,0.0008608546423903372,True,"""The chemical reactions and pathways involving macromolecules, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass."" [GOC:mah]",12170,105,85,21031,0.8095238095238095,0.006984387838948234,Module 3,['GO:0071704']
3212,TF,TF:M13032,Factor: ETV5; motif: ACCGGAAGTN,0.0008637117057199791,True,Factor: ETV5; motif: ACCGGAAGTN,9651,183,122,20045,0.6666666666666666,0.012641177080095326,Module Singleton,['TF:M00000']
3213,GO:MF,GO:0005125,cytokine activity,0.0008642313304455595,True,"""The activity of a soluble extracellular gene product that interacts with a receptor to effect a change in the activity of the receptor to control the survival, growth, differentiation and effector function of tissues and cells."" [ISBN:0198599471, PMID:11530802]",238,218,13,20212,0.05963302752293578,0.0546218487394958,Module 2,['GO:0048018']
3214,GO:MF,GO:0097718,disordered domain specific binding,0.0008657186920281163,True,"""Binding to a disordered domain of a protein."" [GOC:gg, PMID:11746698]",29,20,3,20212,0.15,0.10344827586206896,Module 9,['GO:0019904']
3215,GO:MF,GO:0044877,protein-containing complex binding,0.0008735206035277574,True,"""Binding to a macromolecular complex."" [GOC:jl]",1752,17,9,20212,0.5294117647058824,0.005136986301369863,Module 6,['GO:0005488']
3216,TF,TF:M10948_1,Factor: rax; motif: NNCRTTAN; match class: 1,0.0008839170785731079,True,Factor: rax; motif: NNCRTTAN; match class: 1,5325,826,284,20045,0.34382566585956414,0.05333333333333334,Module 0,['TF:M10948']
3217,GO:BP,GO:0050866,negative regulation of cell activation,0.0008874715705352445,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of cell activation."" [GOC:ai]",208,226,13,21031,0.05752212389380531,0.0625,Module 1,"['GO:0001775', 'GO:0048523', 'GO:0050865', 'GO:0051241']"
3218,HP,HP:0011793,Neoplasm by anatomical site,0.0008928099627015362,True,Neoplasm categorized according to the anatomical site of origin of the neoplasm.,861,44,22,4958,0.5,0.025551684088269456,Module 3,['HP:0002664']
3219,HP,HP:0032169,Severe infection,0.0008930297068849208,True,A type of infection that is regarded as a sign of a pathological susceptibility to infection because of unusual severity or intensity of the infection.,71,71,9,4958,0.1267605633802817,0.1267605633802817,Module 1,['HP:0032101']
3220,TF,TF:M03982,Factor: ETV4; motif: ACCGGAAGTN,0.0008958347837026273,True,Factor: ETV4; motif: ACCGGAAGTN,6986,105,62,20045,0.5904761904761905,0.008874892642427712,Module 3,['TF:M00000']
3221,TF,TF:M00918,Factor: E2F; motif: TTTSGCGSG,0.0008966868707929742,True,Factor: E2F; motif: TTTSGCGSG,5754,826,303,20045,0.3668280871670702,0.05265901981230448,Module 0,['TF:M00000']
3222,HPA,HPA:0300412,lung; macrophages[≥Medium],0.0008983912307709634,True,lung; macrophages[≥Medium],4898,166,103,11019,0.6204819277108434,0.021028991425071458,Module 2,['HPA:0300411']
3223,GO:CC,GO:0005783,endoplasmic reticulum,0.0008987501457454524,True,"""The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached)."" [ISBN:0198506732]",2055,17,9,22097,0.5294117647058824,0.004379562043795621,Module 6,"['GO:0005737', 'GO:0012505', 'GO:0043231']"
3224,HP,HP:0002883,Hyperventilation,0.0009030472424608211,True,"Hyperventilation refers to an increased pulmonary ventilation rate that is faster than necessary for the exchange of gases. Hyperventilation can result from increased frequency of breathing, an increased tidal volume, or both, and leads to an excess intake of oxygen and the blowing off of carbon dioxide.",37,44,6,4958,0.13636363636363635,0.16216216216216217,Module 3,['HP:0002793']
3225,GO:BP,GO:0090083,regulation of inclusion body assembly,0.0009034610550865915,True,"""Any process that modulates the rate, frequency, or extent of inclusion body assembly. Inclusion body assembly is the aggregation, arrangement and bonding together of a set of components to form an inclusion body."" [GOC:BHF, GOC:dph, GOC:tb]",17,21,3,21031,0.14285714285714285,0.17647058823529413,Module 9,"['GO:0044087', 'GO:0051128', 'GO:0070841']"
3226,GO:BP,GO:0052548,regulation of endopeptidase activity,0.0009046130324698862,True,"""Any process that modulates the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins."" [GOC:ai, GOC:hjd]",219,215,13,21031,0.06046511627906977,0.0593607305936073,Module 2,['GO:0052547']
3227,GO:BP,GO:0009628,response to abiotic stimulus,0.0009094887673834391,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an abiotic (not derived from living organisms) stimulus."" [GOC:hb]",1128,21,9,21031,0.42857142857142855,0.007978723404255319,Module 9,['GO:0050896']
3228,TF,TF:M11671,Factor: IRF-5; motif: NCGAAACCGAAACY,0.0009105117480502958,True,Factor: IRF-5; motif: NCGAAACCGAAACY,398,36,8,20045,0.2222222222222222,0.020100502512562814,Module 7,['TF:M00000']
3229,HPA,HPA:0050053,breast; glandular cells[High],0.0009144897316494181,True,breast; glandular cells[High],1349,69,23,11019,0.3333333333333333,0.01704966641957005,Module 5,['HPA:0050052']
3230,HP,HP:0008866,Failure to thrive secondary to recurrent infections,0.0009146732741741765,True,"Insufficient weight gain or inappropriate weight loss for a child, that is attributed to an endogenous recurrent infections.",6,71,4,4958,0.056338028169014086,0.6666666666666666,Module 1,"['HP:0001508', 'HP:0002719', 'HP:0032169']"
3231,TF,TF:M08341,Factor: HOXB2:Elk-1; motif: TAATKRCCGGAAGTN,0.0009151788657431748,True,Factor: HOXB2:Elk-1; motif: TAATKRCCGGAAGTN,6256,826,325,20045,0.3934624697336562,0.05195012787723785,Module 0,['TF:M00000']
3232,HPA,HPA:0470671,skin 2; melanocytes[≥Low],0.0009248424212577549,True,skin 2; melanocytes[≥Low],724,166,28,11019,0.1686746987951807,0.03867403314917127,Module 2,['HPA:0470000']
3233,HPA,HPA:0300411,lung; macrophages[≥Low],0.0009272411402112037,True,lung; macrophages[≥Low],6787,60,53,11019,0.8833333333333333,0.007809046706939738,Module 4,['HPA:0300000']
3234,TF,TF:M12173,Factor: GKLF; motif: NNCCMCRCCCN,0.000927242521155092,True,Factor: GKLF; motif: NNCCMCRCCCN,10282,80,63,20045,0.7875,0.006127212604551644,Module 5,['TF:M00000']
3235,HPA,HPA:0030433,appendix; germinal center cells[High],0.0009330151153596805,True,appendix; germinal center cells[High],92,79,7,11019,0.08860759493670886,0.07608695652173914,Module 3,['HPA:0030432']
3236,TF,TF:M00144_1,Factor: Pax-5; motif: RRMSWGANWYCTNRAGCGKRACSRYNSM; match class: 1,0.0009358974446385698,True,Factor: Pax-5; motif: RRMSWGANWYCTNRAGCGKRACSRYNSM; match class: 1,7321,826,371,20045,0.4491525423728814,0.05067613713973501,Module 0,['TF:M00144']
3237,HPA,HPA:0040082,bone marrow; hematopoietic cells[≥Medium],0.0009367115280324548,True,bone marrow; hematopoietic cells[≥Medium],4256,185,102,11019,0.5513513513513514,0.023966165413533833,Module 1,['HPA:0040081']
3238,GO:BP,GO:0071702,organic substance transport,0.0009421228208274657,True,"""The directed movement of organic substances into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore. An organic substance is a molecular entity that contains carbon."" [GOC:mah]",2358,72,24,21031,0.3333333333333333,0.010178117048346057,Module 4,['GO:0006810']
3239,REAC,REAC:R-HSA-69239,Synthesis of DNA,0.0009533785657251238,True,Synthesis of DNA,121,586,21,10842,0.03583617747440273,0.17355371900826447,Module 0,"['REAC:R-HSA-69242', 'REAC:R-HSA-69306']"
3240,KEGG,KEGG:05014,Amyotrophic lateral sclerosis,0.0009739202767525305,True,Amyotrophic lateral sclerosis,363,53,11,8484,0.20754716981132076,0.030303030303030304,Module 5,['KEGG:00000']
3241,TF,TF:M01752,Factor: ERG; motif: ACCGGAART,0.0009751605912092168,True,Factor: ERG; motif: ACCGGAART,9651,105,76,20045,0.7238095238095238,0.00787483162366594,Module 3,['TF:M00000']
3242,TF,TF:M13032,Factor: ETV5; motif: ACCGGAAGTN,0.0009751605912092168,True,Factor: ETV5; motif: ACCGGAAGTN,9651,105,76,20045,0.7238095238095238,0.00787483162366594,Module 3,['TF:M00000']
3243,GO:CC,GO:0098852,lytic vacuole membrane,0.0009768232966756742,True,"""The lipid bilayer surrounding a lytic vacuole and separating its contents from the cytoplasm of the cell."" [GOC:dos]",446,221,17,22097,0.07692307692307693,0.03811659192825112,Module 2,"['GO:0000323', 'GO:0005774']"
3244,GO:CC,GO:0005765,lysosomal membrane,0.0009768232966756742,True,"""The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm."" [GOC:ai]",446,221,17,22097,0.07692307692307693,0.03811659192825112,Module 2,"['GO:0005764', 'GO:0098852']"
3245,GO:BP,GO:0030593,neutrophil chemotaxis,0.0009804911694286634,True,"""The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding."" [GOC:jl, ISBN:0198506732]",106,5,3,21031,0.6,0.02830188679245283,Module 12,"['GO:0071621', 'GO:1990266']"
3246,GO:BP,GO:0071347,cellular response to interleukin-1,0.0009804911694286634,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus."" [GOC:mah]",106,5,3,21031,0.6,0.02830188679245283,Module 12,"['GO:0070555', 'GO:0071345']"
3247,GO:MF,GO:0042802,identical protein binding,0.0009808909370576857,True,"""Binding to an identical protein or proteins."" [GOC:jl]",2162,232,49,20212,0.21120689655172414,0.022664199814986123,Module 1,['GO:0005515']
3248,REAC,REAC:R-HSA-422085,"Synthesis, secretion, and deacylation of Ghrelin",0.0009867556253472653,True,"Synthesis, secretion, and deacylation of Ghrelin",18,60,4,10842,0.06666666666666667,0.2222222222222222,Module 4,['REAC:R-HSA-2980736']
3249,TF,TF:M12349,Factor: zbtb2; motif: GTTTCCGGTAAY,0.0009951012083858307,True,Factor: zbtb2; motif: GTTTCCGGTAAY,16,3,2,20045,0.6666666666666666,0.125,Module 27,['TF:M00000']
3250,TF,TF:M08760,Factor: ETV7; motif: NNSCGGAAGTR,0.0009962440926302785,True,Factor: ETV7; motif: NNSCGGAAGTR,2410,105,32,20045,0.3047619047619048,0.013278008298755186,Module 3,['TF:M00000']
3251,HPA,HPA:0151351,duodenum; paneth cells[≥Low],0.000996801414169952,True,duodenum; paneth cells[≥Low],278,79,11,11019,0.13924050632911392,0.039568345323741004,Module 3,['HPA:0150000']
3252,REAC,REAC:R-HSA-163210,Formation of ATP by chemiosmotic coupling,0.0009977636271761524,True,Formation of ATP by chemiosmotic coupling,18,586,8,10842,0.013651877133105802,0.4444444444444444,Module 0,['REAC:R-HSA-163200']
3253,GO:BP,GO:2000501,regulation of natural killer cell chemotaxis,0.0010043161194743285,True,"""Any process that modulates the frequency, rate or extent of natural killer cell chemotaxis."" [GOC:BHF]",8,5,2,21031,0.4,0.25,Module 12,"['GO:0035747', 'GO:1901623']"
3254,HPA,HPA:0380523,placenta; trophoblastic cells[High],0.0010055747502939927,True,placenta; trophoblastic cells[High],1935,612,151,11019,0.24673202614379086,0.07803617571059432,Module 0,['HPA:0380522']
3255,GO:BP,GO:0042269,regulation of natural killer cell mediated cytotoxicity,0.0010074803044192676,True,"""Any process that modulates the frequency, rate, or extent of natural killer cell mediated cytotoxicity."" [GOC:add, ISBN:0781735149]",45,226,7,21031,0.030973451327433628,0.15555555555555556,Module 1,"['GO:0001910', 'GO:0002715', 'GO:0042267']"
3256,GO:BP,GO:2000573,positive regulation of DNA biosynthetic process,0.0010081996383319784,True,"""Any process that activates or increases the frequency, rate or extent of DNA biosynthetic process."" [GOC:obol]",70,21,4,21031,0.19047619047619047,0.05714285714285714,Module 9,"['GO:0010557', 'GO:0051054', 'GO:0071897', 'GO:2000278']"
3257,GO:BP,GO:0035556,intracellular signal transduction,0.0010093645826860275,True,"""The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell."" [GOC:bf, GOC:jl, GOC:signaling, ISBN:3527303782]",2668,215,54,21031,0.25116279069767444,0.020239880059970013,Module 2,['GO:0007165']
3258,HPA,HPA:0641522,endometrium; nonciliated luminal epithelial cells[≥Medium],0.0010163360976972186,True,endometrium; nonciliated luminal epithelial cells[≥Medium],44,166,7,11019,0.04216867469879518,0.1590909090909091,Module 2,['HPA:0641521']
3259,REAC,REAC:R-HSA-449147,Signaling by Interleukins,0.0010177842857792313,True,Signaling by Interleukins,471,164,22,10842,0.13414634146341464,0.04670912951167728,Module 1,['REAC:R-HSA-1280215']
3260,REAC,REAC:R-HSA-2559583,Cellular Senescence,0.001018456474355962,True,Cellular Senescence,194,3,3,10842,1.0,0.015463917525773196,Module 27,['REAC:R-HSA-2262752']
3261,GO:BP,GO:0071345,cellular response to cytokine stimulus,0.0010208389700571273,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus."" [GOC:mah]",839,34,10,21031,0.29411764705882354,0.011918951132300357,Module 7,"['GO:0034097', 'GO:0071310']"
3262,GO:MF,GO:0004896,cytokine receptor activity,0.0010310040812444746,True,"""Combining with a cytokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity."" [GOC:add, GOC:mah]",101,232,9,20212,0.03879310344827586,0.0891089108910891,Module 1,"['GO:0004888', 'GO:0140375']"
3263,GO:BP,GO:1904814,"regulation of protein localization to chromosome, telomeric region",0.0010314966681036505,True,"""Any process that modulates the frequency, rate or extent of protein localization to chromosome, telomeric region."" [GO_REF:0000058, GOC:BHF, GOC:BHF_telomere, GOC:nc, GOC:TermGenie, PMID:19487455]",15,787,7,21031,0.008894536213468869,0.4666666666666667,Module 0,"['GO:0032880', 'GO:0070198']"
3264,HP,HP:0012647,Abnormal inflammatory response,0.0010377281876823216,True,"Any anomaly of the inflammatory response, a response to injury or infection characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.",1234,71,37,4958,0.5211267605633803,0.029983792544570502,Module 1,['HP:0010978']
3265,HP,HP:0012649,Increased inflammatory response,0.0010377281876823216,True,A abnormal increase in the inflammatory response to injury or infection.,1234,71,37,4958,0.5211267605633803,0.029983792544570502,Module 1,['HP:0012647']
3266,HPA,HPA:0461463,skin 1; langerhans cells[High],0.0010431764268836114,True,skin 1; langerhans cells[High],218,140,13,11019,0.09285714285714286,0.05963302752293578,Module Singleton,['HPA:0461462']
3267,GO:BP,GO:0022407,regulation of cell-cell adhesion,0.0010450116122245937,True,"""Any process that modulates the frequency, rate or extent of attachment of a cell to another cell."" [GOC:isa_complete]",477,215,19,21031,0.08837209302325581,0.039832285115303984,Module 2,"['GO:0030155', 'GO:0098609']"
3268,HPA,HPA:0351182,pancreas; pancreatic endocrine cells[≥Medium],0.0010473577185376776,True,pancreas; pancreatic endocrine cells[≥Medium],3624,140,72,11019,0.5142857142857142,0.019867549668874173,Module Singleton,['HPA:0351181']
3269,TF,TF:M09905,Factor: SAP-1; motif: NNCCGGAAGTGN,0.0010487930905613268,True,Factor: SAP-1; motif: NNCCGGAAGTGN,8485,105,70,20045,0.6666666666666666,0.008249852681202121,Module 3,['TF:M00000']
3270,GO:BP,GO:0009628,response to abiotic stimulus,0.0010508685736370707,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an abiotic (not derived from living organisms) stimulus."" [GOC:hb]",1128,215,31,21031,0.14418604651162792,0.0274822695035461,Module 2,['GO:0050896']
3271,GO:BP,GO:0031325,positive regulation of cellular metabolic process,0.001059770627336387,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform chemical substances."" [GOC:mah]",3346,215,63,21031,0.2930232558139535,0.01882845188284519,Module 2,"['GO:0009893', 'GO:0031323', 'GO:0044237', 'GO:0048522']"
3272,HPA,HPA:0380000,placenta,0.0010647370246591513,True,placenta,7517,140,119,11019,0.85,0.015830783557270186,Module Singleton,['HPA:0000000']
3273,GO:BP,GO:0010628,positive regulation of gene expression,0.0010651061698666146,True,"""Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA)."" [GOC:txnOH-2018]",1189,215,32,21031,0.14883720930232558,0.02691337258200168,Module 2,"['GO:0010467', 'GO:0010468', 'GO:0010557']"
3274,GO:BP,GO:0007004,telomere maintenance via telomerase,0.0010676990714127454,True,"""The maintenance of proper telomeric length by the addition of telomeric repeats by telomerase."" [GOC:elh]",71,21,4,21031,0.19047619047619047,0.056338028169014086,Module 9,"['GO:0006278', 'GO:0010833']"
3275,HPA,HPA:0600442,tonsil; non-germinal center cells[≥Medium],0.0010677790634347516,True,tonsil; non-germinal center cells[≥Medium],4200,166,92,11019,0.5542168674698795,0.021904761904761906,Module 2,['HPA:0600441']
3276,HPA,HPA:0050011,breast; adipocytes[≥Low],0.001073378073281868,True,breast; adipocytes[≥Low],2781,69,35,11019,0.5072463768115942,0.012585400934915498,Module 5,['HPA:0050000']
3277,HPA,HPA:0471391,skin 2; cells in basal layer[≥Low],0.0010786630010751021,True,skin 2; cells in basal layer[≥Low],962,18,9,11019,0.5,0.009355509355509356,Module 9,['HPA:0470000']
3278,HP,HP:0005387,Combined immunodeficiency,0.0010789552323910542,True,"A group of phenotypically heterogeneous genetic disorders characterized by profound deficiencies of T- and B-cell function, which predispose the patients to both infectious and noninfectious complications.",37,71,7,4958,0.09859154929577464,0.1891891891891892,Module 1,['HP:0002721']
3279,TF,TF:M00428,Factor: E2F-1; motif: NKTSSCGC,0.0010813005673328722,True,Factor: E2F-1; motif: NKTSSCGC,9220,80,59,20045,0.7375,0.0063991323210412145,Module 5,['TF:M00000']
3280,KEGG,KEGG:05202,Transcriptional misregulation in cancer,0.001081875572997275,True,Transcriptional misregulation in cancer,192,136,13,8484,0.09558823529411764,0.06770833333333333,Module 1,['KEGG:00000']
3281,HPA,HPA:0170252,endometrium 2; cells in endometrial stroma[≥Medium],0.0010989272846182092,True,endometrium 2; cells in endometrial stroma[≥Medium],1801,69,27,11019,0.391304347826087,0.014991671293725709,Module 5,['HPA:0170251']
3282,GO:BP,GO:0050854,regulation of antigen receptor-mediated signaling pathway,0.0010999089347928925,True,"""Any process that modulates the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B- or T cell."" [GOC:ai]",66,226,8,21031,0.035398230088495575,0.12121212121212122,Module 1,"['GO:0009966', 'GO:0050776', 'GO:0050851']"
3283,GO:BP,GO:0034341,response to type II interferon,0.0011066282633913338,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon-gamma is also known as type II interferon."" [GOC:add, ISBN:0126896631, PMID:15546383]",146,226,11,21031,0.048672566371681415,0.07534246575342465,Module 1,"['GO:0034097', 'GO:0045087']"
3284,GO:BP,GO:0006886,intracellular protein transport,0.0011076463936272737,True,"""The directed movement of proteins in a cell, including the movement of proteins between specific compartments or structures within a cell, such as organelles of a eukaryotic cell."" [GOC:mah]",686,787,53,21031,0.06734434561626429,0.07725947521865889,Module 0,"['GO:0008104', 'GO:0015031', 'GO:0046907']"
3285,GO:BP,GO:0046631,alpha-beta T cell activation,0.0011126585691007514,True,"""The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific."" [GOC:add]",178,226,12,21031,0.05309734513274336,0.06741573033707865,Module 1,['GO:0042110']
3286,HPA,HPA:0301371,lung; alveolar cells type II[≥Low],0.001114898859027702,True,lung; alveolar cells type II[≥Low],1533,140,40,11019,0.2857142857142857,0.02609262883235486,Module Singleton,['HPA:0300000']
3287,HP,HP:0001138,Optic neuropathy,0.001118994714791521,True,Optic neuropathy,61,44,7,4958,0.1590909090909091,0.11475409836065574,Module 3,['HP:0000587']
3288,CORUM,CORUM:6591,Hsp90-p23 complex,0.001119748733261385,True,Hsp90-p23 complex,2,9,2,3383,0.2222222222222222,1.0,Module 9,['CORUM:0000000']
3289,HPA,HPA:0160053,endometrium 1; glandular cells[High],0.0011212692262425107,True,endometrium 1; glandular cells[High],1471,69,24,11019,0.34782608695652173,0.016315431679129844,Module 5,['HPA:0160052']
3290,HPA,HPA:0130000,colon,0.0011321325772821228,True,colon,8342,140,127,11019,0.9071428571428571,0.015224166866458883,Module Singleton,['HPA:0000000']
3291,GO:MF,GO:0050786,RAGE receptor binding,0.0011326070965233387,True,"""Binding to a RAGE receptor, the receptor for advanced glycation end-products."" [GOC:ai]",10,218,4,20212,0.01834862385321101,0.4,Module 2,['GO:0005102']
3292,GO:BP,GO:0002757,immune response-activating signaling pathway,0.001133221751513945,True,"""The series of molecular signals generated by a ligand binding to its receptor that lead to the activation or perpetuation of an immune response."" [GOC:add]",465,34,8,21031,0.23529411764705882,0.017204301075268817,Module 7,"['GO:0002253', 'GO:0002764']"
3293,TF,TF:M11430_1,Factor: PEA3; motif: NACCGGAAGTN; match class: 1,0.001140012538997199,True,Factor: PEA3; motif: NACCGGAAGTN; match class: 1,5014,105,50,20045,0.47619047619047616,0.00997207818109294,Module 3,['TF:M11430']
3294,HPA,HPA:0150000,duodenum,0.0011413502200971401,True,duodenum,7899,60,57,11019,0.95,0.0072161033042157235,Module 4,['HPA:0000000']
3295,KEGG,KEGG:05162,Measles,0.0011443931114437469,True,Measles,138,136,11,8484,0.08088235294117647,0.07971014492753623,Module 1,['KEGG:00000']
3296,CORUM,CORUM:6289,"prohibitin 2 complex, mitochondrial",0.001144929624744011,True,"prohibitin 2 complex, mitochondrial",5,331,5,3383,0.015105740181268883,1.0,Module 0,['CORUM:0000000']
3297,TF,TF:M08757,Factor: nerf; motif: AAMCCGGAAGTN,0.0011451719114026003,True,Factor: nerf; motif: AAMCCGGAAGTN,732,826,60,20045,0.07263922518159806,0.08196721311475409,Module 0,['TF:M00000']
3298,GO:BP,GO:0002831,regulation of response to biotic stimulus,0.0011466726337931432,True,"""Any process that modulates the frequency, rate, or extent of a response to biotic stimulus."" [GOC:add]",502,226,20,21031,0.08849557522123894,0.0398406374501992,Module 1,"['GO:0009607', 'GO:0048583']"
3299,TF,TF:M09636,Factor: MAZ; motif: GGGMGGGGSSGGGGGGGGGGGG,0.001151250732411454,True,Factor: MAZ; motif: GGGMGGGGSSGGGGGGGGGGGG,16635,826,736,20045,0.8910411622276029,0.04424406372107003,Module 0,['TF:M00000']
3300,TF,TF:M11425,Factor: PEA3; motif: NACCGGAAGTN,0.0011549469701202016,True,Factor: PEA3; motif: NACCGGAAGTN,7570,105,65,20045,0.6190476190476191,0.008586525759577279,Module 3,['TF:M00000']
3301,GO:CC,GO:0009897,external side of plasma membrane,0.0011624943574638973,True,"""The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface."" [GOC:dos, GOC:tb]",384,17,5,22097,0.29411764705882354,0.013020833333333334,Module 6,"['GO:0005886', 'GO:0009986', 'GO:0098552']"
3302,GO:MF,GO:0001055,RNA polymerase II activity,0.0011628828810515358,True,"""Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1). Utilizes a DNA template that contains an RNA polymerase II specific promoter to direct initiation and catalyses DNA-template-directed extension of the 3'-end of an RNA strand by one nucleotide at a time. Can initiate a chain 'de novo'."" [GOC:txnOH]",11,808,6,20212,0.007425742574257425,0.5454545454545454,Module 0,['GO:0003899']
3303,MIRNA,MIRNA:hsa-miR-100-5p,hsa-miR-100-5p,0.0011692234893173291,True,hsa-miR-100-5p,250,753,32,14819,0.04249667994687915,0.128,Module 0,['MIRNA:000000']
3304,GO:BP,GO:0032728,positive regulation of interferon-beta production,0.0011729714428433736,True,"""Any process that activates or increases the frequency, rate, or extent of interferon-beta production."" [GOC:mah, PMID:15546383]",42,34,4,21031,0.11764705882352941,0.09523809523809523,Module 7,"['GO:0032481', 'GO:0032608', 'GO:0032648']"
3305,KEGG,KEGG:00240,Pyrimidine metabolism,0.0011733321101037321,True,Pyrimidine metabolism,57,2,2,8484,1.0,0.03508771929824561,Module 39,['KEGG:00000']
3306,GO:BP,GO:0006915,apoptotic process,0.001176316345776947,True,"""A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died."" [GOC:cjm, GOC:dhl, GOC:ecd, GOC:go_curators, GOC:mtg_apoptosis, GOC:tb, ISBN:0198506732, PMID:18846107, PMID:21494263]",1913,34,14,21031,0.4117647058823529,0.007318348144276007,Module 7,['GO:0012501']
3307,GO:BP,GO:0032642,regulation of chemokine production,0.001180062993053885,True,"""Any process that modulates the frequency, rate, or extent of chemokine production."" [GOC:mah]",95,215,9,21031,0.04186046511627907,0.09473684210526316,Module 2,"['GO:0001817', 'GO:0032602']"
3308,GO:BP,GO:0032602,chemokine production,0.001180062993053885,True,"""The appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. All chemokines possess a number of conserved cysteine residues involved in intramolecular disulfide bond formation. Some chemokines are considered pro-inflammatory and can be induced during an immune response to recruit cells of the immune system to a site of infection, while others are considered homeostatic and are involved in controlling the migration of cells during normal processes of tissue maintenance or development. Chemokines are found in all vertebrates, some viruses and some bacteria."" [GOC:BHF, GOC:rl, ISBN:0198506732, PMID:12183377, Wikipedia:Chemokine]",95,215,9,21031,0.04186046511627907,0.09473684210526316,Module 2,['GO:0001816']
3309,GO:CC,GO:0032059,bleb,0.001180684777020814,True,"""A cell extension caused by localized decoupling of the cytoskeleton from the plasma membrane and characterized by rapid formation, rounded shape, and scarcity of organelles within the protrusion. Blebs are formed during apoptosis and other cellular processes, including cell locomotion, cell division, and as a result of physical or chemical stresses."" [GOC:mtg_apoptosis, PMID:12083798, PMID:16624291, Wikipedia:Bleb_(cell_biology)]",8,813,5,22097,0.006150061500615006,0.625,Module 0,['GO:0120025']
3310,HPA,HPA:0380000,placenta,0.0011814569733545688,True,placenta,7517,69,63,11019,0.9130434782608695,0.008381003059731275,Module 5,['HPA:0000000']
3311,HPA,HPA:0550051,stomach 2; glandular cells[≥Low],0.0011820576063377363,True,stomach 2; glandular cells[≥Low],7612,60,56,11019,0.9333333333333333,0.007356805044666317,Module 4,['HPA:0550000']
3312,HPA,HPA:0550000,stomach 2,0.0011820576063377363,True,stomach 2,7612,60,56,11019,0.9333333333333333,0.007356805044666317,Module 4,['HPA:0000000']
3313,HP,HP:0012447,Abnormal myelination,0.0011821075488535767,True,Any anomaly in the process by which myelin sheaths are formed and maintained around neurons.,606,228,54,4958,0.23684210526315788,0.0891089108910891,Module 0,['HP:0012639']
3314,GO:BP,GO:0006278,RNA-templated DNA biosynthetic process,0.0011944934459286007,True,"""A DNA biosynthetic process that uses RNA as a template for RNA-dependent DNA polymerases (e.g. reverse transcriptase) that synthesize the new strand."" [GOC:mah, ISBN:0198506732]",73,21,4,21031,0.19047619047619047,0.0547945205479452,Module 9,['GO:0071897']
3315,HP,HP:0000316,Hypertelorism,0.0011957702820241036,True,"Interpupillary distance more than 2 SD above the mean (alternatively, the appearance of an increased interpupillary distance or widely spaced eyes).",799,44,21,4958,0.4772727272727273,0.026282853566958697,Module 3,['HP:0100886']
3316,HPA,HPA:0320101,nasopharynx; respiratory epithelial cells[≥Low],0.0011989824360923629,True,nasopharynx; respiratory epithelial cells[≥Low],5794,79,61,11019,0.7721518987341772,0.01052813255091474,Module 3,['HPA:0320000']
3317,HPA,HPA:0461461,skin 1; langerhans cells[≥Low],0.0012026026916621211,True,skin 1; langerhans cells[≥Low],716,18,8,11019,0.4444444444444444,0.0111731843575419,Module 9,['HPA:0460000']
3318,GO:BP,GO:0002699,positive regulation of immune effector process,0.0012026747125933198,True,"""Any process that activates or increases the frequency, rate, or extent of an immune effector process."" [GOC:add]",250,226,14,21031,0.061946902654867256,0.056,Module 1,"['GO:0002252', 'GO:0002684', 'GO:0002697']"
3319,GO:BP,GO:0071216,cellular response to biotic stimulus,0.0012026747125933198,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a biotic stimulus, a stimulus caused or produced by a living organism."" [GOC:mah]",250,226,14,21031,0.061946902654867256,0.056,Module 1,"['GO:0009607', 'GO:0051716']"
3320,HPA,HPA:0461411,skin 1; cells in spinous layer[≥Low],0.0012027757003625554,True,skin 1; cells in spinous layer[≥Low],760,79,18,11019,0.22784810126582278,0.02368421052631579,Module 3,['HPA:0460000']
3321,HPA,HPA:0300413,lung; macrophages[High],0.0012058086961762775,True,lung; macrophages[High],1371,69,23,11019,0.3333333333333333,0.016776075857038657,Module 5,['HPA:0300412']
3322,GO:MF,GO:0017111,ribonucleoside triphosphate phosphatase activity,0.0012060769768772281,True,"""Catalysis of the reaction: a ribonucleoside triphosphate + H2O = a ribonucleoside diphosphate + H+ + phosphate."" [RHEA:23680]",734,20,7,20212,0.35,0.009536784741144414,Module 9,['GO:0016462']
3323,HPA,HPA:0461421,skin 1; eccrine glands[≥Low],0.001208891335705735,True,skin 1; eccrine glands[≥Low],246,166,15,11019,0.09036144578313253,0.06097560975609756,Module 2,['HPA:0460000']
3324,REAC,REAC:R-HSA-6798695,Neutrophil degranulation,0.0012097868864489,True,Neutrophil degranulation,476,164,22,10842,0.13414634146341464,0.046218487394957986,Module 1,['REAC:R-HSA-168249']
3325,TF,TF:M08913,Factor: FLI-1; motif: NAYTTCCGGT,0.0012115573102626613,True,Factor: FLI-1; motif: NAYTTCCGGT,8512,105,70,20045,0.6666666666666666,0.008223684210526315,Module 3,['TF:M00000']
3326,MIRNA,MIRNA:hsa-let-7a-5p,hsa-let-7a-5p,0.001217962237610162,True,hsa-let-7a-5p,637,104,17,14819,0.16346153846153846,0.026687598116169546,Module 3,['MIRNA:000000']
3327,GO:BP,GO:0019221,cytokine-mediated signaling pathway,0.0012195359067670043,True,"""The series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription."" [GOC:mah, GOC:signaling, PMID:19295629]",499,5,4,21031,0.8,0.008016032064128256,Module 12,"['GO:0007166', 'GO:0071345']"
3328,GO:BP,GO:0009653,anatomical structure morphogenesis,0.0012205423333975938,True,"""The process in which anatomical structures are generated and organized. Morphogenesis pertains to the creation of form."" [GOC:go_curators, ISBN:0521436125]",2684,215,54,21031,0.25116279069767444,0.020119225037257823,Module 2,"['GO:0032502', 'GO:0048856']"
3329,HP,HP:0001574,Abnormality of the integument,0.0012219577187234628,True,"An abnormality of the integument, which consists of the skin and the superficial fascia.",2535,44,38,4958,0.8636363636363636,0.014990138067061143,Module 3,['HP:0000118']
3330,REAC,REAC:R-HSA-9020702,Interleukin-1 signaling,0.0012226589502215954,True,Interleukin-1 signaling,113,586,20,10842,0.034129692832764506,0.17699115044247787,Module 0,['REAC:R-HSA-446652']
3331,GO:BP,GO:0071222,cellular response to lipopolysaccharide,0.0012271065207187977,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria."" [GOC:mah]",214,226,13,21031,0.05752212389380531,0.06074766355140187,Module 1,"['GO:0032496', 'GO:0071219', 'GO:0071396', 'GO:1901701']"
3332,GO:CC,GO:0033018,sarcoplasmic reticulum lumen,0.0012296630678718691,True,"""The volume enclosed by the membranes of the sarcoplasmic reticulum."" [GOC:rph]",10,73,3,22097,0.0410958904109589,0.3,Module 4,"['GO:0005788', 'GO:0016529']"
3333,TF,TF:M00050,Factor: E2F; motif: TTTSGCGC,0.0012304185036645786,True,Factor: E2F; motif: TTTSGCGC,7247,80,51,20045,0.6375,0.0070373947840485715,Module 5,['TF:M00000']
3334,WP,WP:WP69,T cell receptor signaling pathway,0.0012366600475938294,True,T cell receptor signaling pathway,75,148,9,8286,0.060810810810810814,0.12,Module 1,['WP:000000']
3335,HPA,HPA:0470181,skin 2; cells in granular layer[≥Low],0.0012405457260391871,True,skin 2; cells in granular layer[≥Low],719,18,8,11019,0.4444444444444444,0.011126564673157162,Module 9,['HPA:0470000']
3336,HP,HP:0002060,Abnormal cerebral morphology,0.0012410740440617796,True,"Any structural abnormality of the telencephalon, which is also known as the cerebrum.",2027,44,34,4958,0.7727272727272727,0.016773556980759743,Module 3,['HP:0100547']
3337,GO:CC,GO:0000775,"chromosome, centromeric region",0.0012427541742373364,True,"""The region of a chromosome that includes the centromeric DNA and associated proteins. In monocentric chromosomes, this region corresponds to a single area of the chromosome, whereas in holocentric chromosomes, it is evenly distributed along the chromosome."" [GOC:cjm, GOC:elh, GOC:kmv, GOC:pr]",259,80,8,22097,0.1,0.03088803088803089,Module 5,['GO:0098687']
3338,GO:BP,GO:0009218,pyrimidine ribonucleotide metabolic process,0.0012435506917499435,True,"""The chemical reactions and pathways involving a pyrimidine ribonucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:go_curators, ISBN:0198506732]",33,2,2,21031,1.0,0.06060606060606061,Module 39,"['GO:0006220', 'GO:0009259']"
3339,GO:BP,GO:0006221,pyrimidine nucleotide biosynthetic process,0.0012435506917499435,True,"""The chemical reactions and pathways resulting in the formation of a pyrimidine nucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:go_curators, ISBN:0198506732]",33,2,2,21031,1.0,0.06060606060606061,Module 39,"['GO:0006220', 'GO:0009165', 'GO:0072528']"
3340,HPA,HPA:0150891,duodenum; goblet cells[≥Low],0.0012505799735895936,True,duodenum; goblet cells[≥Low],405,79,13,11019,0.16455696202531644,0.03209876543209877,Module 3,['HPA:0150000']
3341,WP,WP:WP623,Oxidative phosphorylation,0.0012506453169047207,True,Oxidative phosphorylation,60,101,7,8286,0.06930693069306931,0.11666666666666667,Module 3,['WP:000000']
3342,HP,HP:0000829,Hypoparathyroidism,0.0012507095854655357,True,A condition caused by a deficiency of parathyroid hormone characterized by hypocalcemia and hyperphosphatemia.,39,44,6,4958,0.13636363636363635,0.15384615384615385,Module 3,['HP:0011767']
3343,HP,HP:0002483,Bulbar signs,0.0012507095854655357,True,Bulbar signs,39,44,6,4958,0.13636363636363635,0.15384615384615385,Module 3,['HP:0012638']
3344,HPA,HPA:0400892,rectum; goblet cells[≥Medium],0.0012515780886988034,True,rectum; goblet cells[≥Medium],343,79,12,11019,0.1518987341772152,0.03498542274052478,Module 3,['HPA:0400891']
3345,GO:BP,GO:0034620,cellular response to unfolded protein,0.0012773950087271808,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an unfolded protein stimulus."" [GOC:mah]",91,72,6,21031,0.08333333333333333,0.06593406593406594,Module 4,"['GO:0006986', 'GO:0035967']"
3346,WP,WP:WP5287,17q12 copy number variation syndrome,0.0012799502674369467,True,17q12 copy number variation syndrome,96,5,3,8286,0.6,0.03125,Module 12,['WP:000000']
3347,GO:CC,GO:0035578,azurophil granule lumen,0.0012852054729168738,True,"""The volume enclosed by the membrane of an azurophil granule, a primary lysosomal granule found in neutrophil granulocytes that contains a wide range of hydrolytic enzymes and is released into the extracellular fluid."" [GOC:bf, PMID:17152095]",91,221,8,22097,0.03619909502262444,0.08791208791208792,Module 2,"['GO:0005775', 'GO:0034774', 'GO:0042582']"
3348,HPA,HPA:0600433,tonsil; germinal center cells[High],0.0012877128416519386,True,tonsil; germinal center cells[High],1228,185,42,11019,0.22702702702702704,0.03420195439739414,Module 1,['HPA:0600432']
3349,WP,WP:WP5115,Network map of SARS CoV 2 signaling pathway,0.001287921798716878,True,Network map of SARS CoV 2 signaling pathway,217,148,15,8286,0.10135135135135136,0.06912442396313365,Module 1,['WP:000000']
3350,GO:MF,GO:0023023,MHC protein complex binding,0.0012893960921377158,True,"""Binding to a major histocompatibility complex."" [GOC:mtg_signal, GOC:vw]",33,20,3,20212,0.15,0.09090909090909091,Module 9,['GO:0044877']
3351,GO:CC,GO:0031252,cell leading edge,0.001294162256268328,True,"""The area of a motile cell closest to the direction of movement."" [GOC:pg]",427,813,36,22097,0.04428044280442804,0.08430913348946135,Module 0,['GO:0110165']
3352,HPA,HPA:0580061,thymus; medullary cells[≥Low],0.0012950824453967034,True,thymus; medullary cells[≥Low],27,185,6,11019,0.032432432432432434,0.2222222222222222,Module 1,['HPA:0580000']
3353,TF,TF:M10999,Factor: LIM-1; motif: NNCGTTAN,0.0013029058110849195,True,Factor: LIM-1; motif: NNCGTTAN,6003,826,313,20045,0.3789346246973366,0.05214059636848242,Module 0,['TF:M00000']
3354,HPA,HPA:0470671,skin 2; melanocytes[≥Low],0.0013060538734456027,True,skin 2; melanocytes[≥Low],724,18,8,11019,0.4444444444444444,0.011049723756906077,Module 9,['HPA:0470000']
3355,HPA,HPA:0461392,skin 1; cells in basal layer[≥Medium],0.0013094677425525962,True,skin 1; cells in basal layer[≥Medium],637,140,23,11019,0.16428571428571428,0.03610675039246468,Module Singleton,['HPA:0461391']
3356,KEGG,KEGG:05016,Huntington disease,0.001310484574669684,True,Huntington disease,305,53,10,8484,0.18867924528301888,0.03278688524590164,Module 5,['KEGG:00000']
3357,GO:CC,GO:0005751,mitochondrial respiratory chain complex IV,0.001316510616271753,True,"""A protein complex located in the mitochondrial inner membrane that forms part of the mitochondrial respiratory chain. Contains the 13 polypeptide subunits of cytochrome c oxidase, including cytochrome a and cytochrome a3. Catalyzes the oxidation of reduced cytochrome c by dioxygen (O2)."" [GOC:mtg_sensu, ISBN:0198547684]",23,105,4,22097,0.0380952380952381,0.17391304347826086,Module 3,"['GO:0005746', 'GO:0045277', 'GO:0098800']"
3358,TF,TF:M00427,Factor: E2F; motif: TTTSGCGS,0.0013167525258587014,True,Factor: E2F; motif: TTTSGCGS,9803,80,61,20045,0.7625,0.00622258492298276,Module 5,['TF:M00000']
3359,GO:CC,GO:0140534,endoplasmic reticulum protein-containing complex,0.001318555656304611,True,"""A protein complex that is part of an endoplasmic reticulum."" [GOC:pg]",126,813,17,22097,0.020910209102091022,0.1349206349206349,Module 0,"['GO:0005783', 'GO:0032991']"
3360,GO:BP,GO:0042273,ribosomal large subunit biogenesis,0.0013202892491236443,True,"""A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a large ribosomal subunit; includes transport to the sites of protein synthesis."" [GOC:jl]",75,787,14,21031,0.017789072426937738,0.18666666666666668,Module 0,"['GO:0022613', 'GO:0042254']"
3361,GO:BP,GO:0006809,nitric oxide biosynthetic process,0.0013355318662440657,True,"""The chemical reactions and pathways resulting in the formation of nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water."" [GOC:ai]",71,215,8,21031,0.037209302325581395,0.11267605633802817,Module 2,"['GO:0044271', 'GO:0046209']"
3362,MIRNA,MIRNA:hsa-miR-146a-5p,hsa-miR-146a-5p,0.0013377999151596139,True,hsa-miR-146a-5p,228,195,14,14819,0.07179487179487179,0.06140350877192982,Module 1,['MIRNA:000000']
3363,HP,HP:0000486,Strabismus,0.0013389770408235694,True,"A misalignment of the eyes so that the visual axes deviate from bifoveal fixation. The classification of strabismus may be based on a number of features including the relative position of the eyes, whether the deviation is latent or manifest, intermittent or constant, concomitant or otherwise and according to the age of onset and the relevance of any associated refractive error.",1127,44,25,4958,0.5681818181818182,0.022182786157941437,Module 3,['HP:0000549']
3364,HP,HP:0000252,Microcephaly,0.0013496202271970248,True,Head circumference below 2 standard deviations below the mean for age and gender.,1306,44,27,4958,0.6136363636363636,0.020673813169984685,Module 3,"['HP:0007364', 'HP:0040195']"
3365,GO:BP,GO:0019222,regulation of metabolic process,0.001353605678332597,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism."" [GOC:go_curators]",7158,215,108,21031,0.5023255813953489,0.015088013411567477,Module 2,"['GO:0008152', 'GO:0050789']"
3366,TF,TF:M07250_1,Factor: E2F-1; motif: NNNSSCGCSAANN; match class: 1,0.0013683424955115498,True,Factor: E2F-1; motif: NNNSSCGCSAANN; match class: 1,5691,80,44,20045,0.55,0.007731505886487436,Module 5,['TF:M07250']
3367,HPA,HPA:0461472,skin 1; lymphocytes[≥Medium],0.0013703637502737872,True,skin 1; lymphocytes[≥Medium],574,166,24,11019,0.14457831325301204,0.041811846689895474,Module 2,['HPA:0461471']
3368,GO:CC,GO:0005634,nucleus,0.0013713578677077784,True,"""A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent."" [GOC:go_curators]",10074,105,71,22097,0.6761904761904762,0.007047845940043677,Module 3,['GO:0043231']
3369,REAC,REAC:R-HSA-190840,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,0.001381078337983315,True,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,20,59,4,10842,0.06779661016949153,0.2,Module 5,['REAC:R-HSA-190872']
3370,GO:CC,GO:0043226,organelle,0.0013826436504921324,True,"""Organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton, and prokaryotic structures such as anammoxosomes and pirellulosomes. Excludes the plasma membrane."" [GOC:go_curators]",16808,73,70,22097,0.958904109589041,0.0041646834840552115,Module 4,['GO:0110165']
3371,GO:MF,GO:0008137,NADH dehydrogenase (ubiquinone) activity,0.0013874579525670215,True,"""Catalysis of the reaction: NADH + ubiquinone + 5 H+(in) = NAD+ + ubiquinol + 4 H+(out)."" [RHEA:29091]",41,105,5,20212,0.047619047619047616,0.12195121951219512,Module 3,"['GO:0009055', 'GO:0015453', 'GO:0050136']"
3372,GO:BP,GO:1901564,organonitrogen compound metabolic process,0.0013963579914823933,True,"""The chemical reactions and pathways involving organonitrogen compound."" [GOC:pr, GOC:TermGenie]",5986,21,17,21031,0.8095238095238095,0.0028399599064483794,Module 9,"['GO:0006807', 'GO:0071704']"
3373,GO:MF,GO:0043168,anion binding,0.0013993154435380792,True,"""Binding to an anion, a charged atom or group of atoms with a net negative charge."" [GOC:jl]",2452,20,11,20212,0.55,0.004486133768352365,Module 9,['GO:0043167']
3374,GO:BP,GO:0010273,detoxification of copper ion,0.0014106646913180248,True,"""Any process that reduces or removes the toxicity of copper ion. These include transport of copper away from sensitive areas and to compartments or complexes whose purpose is sequestration of copper ion."" [GOC:kmv, PMID:16367966]",14,28,3,21031,0.10714285714285714,0.21428571428571427,Module 10,"['GO:0061687', 'GO:1990169']"
3375,GO:BP,GO:1990169,stress response to copper ion,0.0014106646913180248,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis caused by a copper ion stimulus."" [GOC:kmv, PMID:23437011]",14,28,3,21031,0.10714285714285714,0.21428571428571427,Module 10,"['GO:0046688', 'GO:0097501']"
3376,TF,TF:M11058_1,Factor: Hey1; motif: NGCRCGYGYN; match class: 1,0.0014113607940045214,True,Factor: Hey1; motif: NGCRCGYGYN; match class: 1,11364,826,537,20045,0.6501210653753027,0.0472544878563886,Module 0,['TF:M11058']
3377,GO:MF,GO:0140375,immune receptor activity,0.0014202417839891484,True,"""Receiving a signal and transmitting it in a cell to initiate an immune response."" [PMID:31415752, Wikipedia:Immune_receptor]",145,17,4,20212,0.23529411764705882,0.027586206896551724,Module 6,['GO:0038023']
3378,REAC,REAC:R-HSA-9612973,Autophagy,0.0014349078827649378,True,Autophagy,149,19,5,10842,0.2631578947368421,0.03355704697986577,Module 9,['REAC:0000000']
3379,GO:BP,GO:0045597,positive regulation of cell differentiation,0.0014353924013001732,True,"""Any process that activates or increases the frequency, rate or extent of cell differentiation."" [GOC:go_curators]",864,226,27,21031,0.11946902654867257,0.03125,Module 1,"['GO:0030154', 'GO:0045595', 'GO:0048522', 'GO:0051094']"
3380,HPA,HPA:0500112,soft tissue 1; chondrocytes[≥Medium],0.0014413853052800713,True,soft tissue 1; chondrocytes[≥Medium],1450,612,119,11019,0.19444444444444445,0.08206896551724138,Module 0,['HPA:0500111']
3381,GO:BP,GO:0000381,"regulation of alternative mRNA splicing, via spliceosome",0.0014418254661785314,True,"""Any process that modulates the frequency, rate or extent of alternative splicing of nuclear mRNAs."" [GOC:krc]",55,787,12,21031,0.015247776365946633,0.21818181818181817,Module 0,"['GO:0000380', 'GO:0048024']"
3382,HP,HP:0025116,Fetal distress,0.001446594227647543,True,"An intrauterine state characterized by suboptimal values in the fetal heart rate, oxygenation of fetal blood, or other parameters indicative of compromise of the fetus. Signs of fetal distress include repetitive variable decelerations, fetal tachycardia or bradycardia, late decelerations, or low biophysical profile.",64,228,14,4958,0.06140350877192982,0.21875,Module 0,['HP:0034059']
3383,REAC,REAC:R-HSA-168256,Immune System,0.0014504267753573618,True,Immune System,2052,586,155,10842,0.2645051194539249,0.07553606237816764,Module 0,['REAC:0000000']
3384,TF,TF:M02017_1,Factor: HSF1; motif: GAANNTTCTRGNAN; match class: 1,0.0014616822818557373,True,Factor: HSF1; motif: GAANNTTCTRGNAN; match class: 1,533,21,7,20045,0.3333333333333333,0.013133208255159476,Module 9,['TF:M02017']
3385,HP,HP:0012704,Widened subarachnoid space,0.00146173377049326,True,An increase in size of the anatomic space between the arachnoid membrane and pia mater.,40,44,6,4958,0.13636363636363635,0.15,Module 3,['HP:0012703']
3386,HPA,HPA:0480891,small intestine; goblet cells[≥Low],0.001467369340306457,True,small intestine; goblet cells[≥Low],411,79,13,11019,0.16455696202531644,0.031630170316301706,Module 3,['HPA:0480000']
3387,REAC,REAC:R-HSA-69239,Synthesis of DNA,0.0014699074109380712,True,Synthesis of DNA,121,59,7,10842,0.11864406779661017,0.05785123966942149,Module 5,"['REAC:R-HSA-69242', 'REAC:R-HSA-69306']"
3388,GO:BP,GO:0046651,lymphocyte proliferation,0.001471067620208552,True,"""The expansion of a lymphocyte population by cell division."" [GOC:ai]",308,215,15,21031,0.06976744186046512,0.048701298701298704,Module 2,"['GO:0032943', 'GO:0046649']"
3389,HPA,HPA:0401331,rectum; mucosal lymphoid cells[≥Low],0.0014718821994771432,True,rectum; mucosal lymphoid cells[≥Low],543,612,56,11019,0.0915032679738562,0.10313075506445672,Module 0,['HPA:0400000']
3390,GO:BP,GO:1902949,positive regulation of tau-protein kinase activity,0.0014837820753834552,True,"""Any process that activates or increases the frequency, rate or extent of tau-protein kinase activity."" [GO_REF:0000059, GOC:sjp, GOC:TermGenie, PMID:15897157, PMID:22986780]",2,21,2,21031,0.09523809523809523,1.0,Module 9,"['GO:0045860', 'GO:1902947']"
3391,HPA,HPA:0630053,cervix; glandular cells[High],0.0014872060940581994,True,cervix; glandular cells[High],1182,69,21,11019,0.30434782608695654,0.017766497461928935,Module 5,['HPA:0630052']
3392,HPA,HPA:0640691,endometrium; smooth muscle cells[≥Low],0.0014894929694106596,True,endometrium; smooth muscle cells[≥Low],65,166,8,11019,0.04819277108433735,0.12307692307692308,Module 2,['HPA:0640000']
3393,TF,TF:M10072,Factor: sp4; motif: NNGNARGRGGCGGRGCNNRR,0.0014924397257845645,True,Factor: sp4; motif: NNGNARGRGGCGGRGCNNRR,10844,826,516,20045,0.6246973365617433,0.047583917373662854,Module 0,['TF:M00000']
3394,GO:MF,GO:0008092,cytoskeletal protein binding,0.001498685931139378,True,"""Binding to a protein component of a cytoskeleton (actin, microtubule, or intermediate filament cytoskeleton)."" [GOC:mah]",1002,808,71,20212,0.08787128712871287,0.07085828343313373,Module 0,['GO:0005515']
3395,GO:CC,GO:0043231,intracellular membrane-bounded organelle,0.0015049694040589552,True,"""Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane."" [GOC:go_curators]",14605,105,90,22097,0.8571428571428571,0.0061622731941116055,Module 3,"['GO:0043227', 'GO:0043229']"
3396,KEGG,KEGG:05169,Epstein-Barr virus infection,0.001506450322785339,True,Epstein-Barr virus infection,198,136,13,8484,0.09558823529411764,0.06565656565656566,Module 1,['KEGG:00000']
3397,TF,TF:M00339,Factor: c-Ets-1; motif: RCAGGAAGTGNNTNS,0.0015103366744077557,True,Factor: c-Ets-1; motif: RCAGGAAGTGNNTNS,6901,238,119,20045,0.5,0.01724387769888422,Module 1,['TF:M00000']
3398,HPA,HPA:0500651,soft tissue 1; fibroblasts[≥Low],0.0015108469820737565,True,soft tissue 1; fibroblasts[≥Low],4238,79,50,11019,0.6329113924050633,0.011798017932987258,Module 3,['HPA:0500000']
3399,GO:BP,GO:1902533,positive regulation of intracellular signal transduction,0.0015266214969098363,True,"""Any process that activates or increases the frequency, rate or extent of intracellular signal transduction."" [GOC:BHF, GOC:dph, GOC:signaling, GOC:tb, GOC:TermGenie]",1033,226,30,21031,0.13274336283185842,0.02904162633107454,Module 1,"['GO:0009967', 'GO:0035556', 'GO:1902531']"
3400,GO:BP,GO:0031323,regulation of cellular metabolic process,0.0015290869411314992,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform chemical substances."" [GOC:mah]",6673,787,313,21031,0.397712833545108,0.046905439832159446,Module 0,"['GO:0019222', 'GO:0044237', 'GO:0050794']"
3401,HPA,HPA:0300000,lung,0.0015342127181787386,True,lung,7379,60,55,11019,0.9166666666666666,0.007453584496544247,Module 4,['HPA:0000000']
3402,TF,TF:M02068,Factor: etv3; motif: ACCGGAAGYN,0.0015350898392323283,True,Factor: etv3; motif: ACCGGAAGYN,3547,105,40,20045,0.38095238095238093,0.01127713560755568,Module 3,['TF:M00000']
3403,KEGG,KEGG:05415,Diabetic cardiomyopathy,0.0015386594387876169,True,Diabetic cardiomyopathy,202,97,11,8484,0.1134020618556701,0.054455445544554455,Module 3,['KEGG:00000']
3404,GO:BP,GO:0007010,cytoskeleton organization,0.0015484969316502562,True,"""A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of cytoskeletal structures."" [GOC:dph, GOC:jl, GOC:mah]",1512,787,94,21031,0.11944091486658195,0.062169312169312166,Module 0,['GO:0006996']
3405,GO:MF,GO:0015399,primary active transmembrane transporter activity,0.001549583812606972,True,"""Enables the transfer of a solute from one side of a membrane to the other, up the solute's concentration gradient, by binding the solute and undergoing a series of conformational changes. Transport works equally well in either direction and is powered by a primary energy source. Primary energy sources known to be coupled to transport are chemical such as ATP hydrolysis, redox energy and photon energy."" [GOC:mtg_transport, PMID:31613498]",166,105,8,20212,0.0761904761904762,0.04819277108433735,Module 3,['GO:0022804']
3406,TF,TF:M09817,Factor: PAX5; motif: RNGCGTGACCNN,0.0015497211728007392,True,Factor: PAX5; motif: RNGCGTGACCNN,12766,826,592,20045,0.7167070217917676,0.04637317875607081,Module 0,['TF:M00000']
3407,GO:CC,GO:0043226,organelle,0.0015520332268626567,True,"""Organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton, and prokaryotic structures such as anammoxosomes and pirellulosomes. Excludes the plasma membrane."" [GOC:go_curators]",16808,80,76,22097,0.95,0.004521656354117087,Module 5,['GO:0110165']
3408,GO:MF,GO:0050136,NADH dehydrogenase (quinone) activity,0.0015684754465643234,True,"""Catalysis of the reaction: NADH + H+ + a quinone = NAD+ + a quinol."" [EC:1.6.5.11, GOC:mah]",42,105,5,20212,0.047619047619047616,0.11904761904761904,Module 3,"['GO:0003954', 'GO:0003955']"
3409,GO:BP,GO:0051172,negative regulation of nitrogen compound metabolic process,0.0015703123244125837,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving nitrogen or nitrogenous compounds."" [GOC:ai, GOC:tb]",2202,215,47,21031,0.2186046511627907,0.02134423251589464,Module 2,"['GO:0006807', 'GO:0009892', 'GO:0051171']"
3410,TF,TF:M02059_1,Factor: ELK-1; motif: ACCGGAAGTN; match class: 1,0.001570737995792147,True,Factor: ELK-1; motif: ACCGGAAGTN; match class: 1,3840,105,42,20045,0.4,0.0109375,Module 3,['TF:M02059']
3411,TF,TF:M11391_1,Factor: Erg; motif: NACCGGATATCCGGTN; match class: 1,0.0015731480611961303,True,Factor: Erg; motif: NACCGGATATCCGGTN; match class: 1,9304,826,453,20045,0.5484261501210653,0.04868873602751505,Module 0,['TF:M11391']
3412,GO:BP,GO:0072676,lymphocyte migration,0.0015741353732603978,True,"""The movement of a lymphocyte within or between different tissues and organs of the body."" [CL:0000542, GOC:BHF, GOC:mah]",124,5,3,21031,0.6,0.024193548387096774,Module 12,['GO:0071674']
3413,MIRNA,MIRNA:hsa-miR-1225-5p,hsa-miR-1225-5p,0.0015845917076748402,True,hsa-miR-1225-5p,31,15,3,14819,0.2,0.0967741935483871,Module 11,['MIRNA:000000']
3414,HPA,HPA:0060102,bronchus; respiratory epithelial cells[≥Medium],0.0015989461175284173,True,bronchus; respiratory epithelial cells[≥Medium],4938,79,55,11019,0.6962025316455697,0.01113811259619279,Module 3,['HPA:0060101']
3415,HP,HP:0002381,Aphasia,0.001600505724993481,True,An acquired language impairment of some or all of the abilities to produce or comprehend speech and to read or write.,93,44,8,4958,0.18181818181818182,0.08602150537634409,Module 3,['HP:0002167']
3416,HP,HP:0000758,Abnormal nonverbal communicative behavior,0.0016057326418383174,True,"Abnormalities in eye contact, communicative facial expressions, gesture use, or the use of others' bodies to communicate convey shared meanings within a culture that replace or supplement verbal communication.",115,228,19,4958,0.08333333333333333,0.16521739130434782,Module 0,['HP:0034434']
3417,HPA,HPA:0640692,endometrium; smooth muscle cells[≥Medium],0.0016058902493755233,True,endometrium; smooth muscle cells[≥Medium],47,166,7,11019,0.04216867469879518,0.14893617021276595,Module 2,['HPA:0640691']
3418,HPA,HPA:0310433,lymph node; germinal center cells[High],0.001607318488292699,True,lymph node; germinal center cells[High],944,140,29,11019,0.20714285714285716,0.03072033898305085,Module Singleton,['HPA:0310432']
3419,GO:BP,GO:0035747,natural killer cell chemotaxis,0.001613772425150851,True,"""The directed movement of a natural killer cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis)."" [CL:0000623, GOC:BHF]",10,5,2,21031,0.4,0.2,Module 12,['GO:0048247']
3420,GO:BP,GO:0010033,response to organic substance,0.001620941771802773,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus."" [GOC:sm, PMID:23356676]",2637,34,16,21031,0.47058823529411764,0.006067500948047023,Module 7,['GO:0042221']
3421,GO:MF,GO:0015026,coreceptor activity,0.001621569276301472,True,"""Combining with an extracellular or intracellular messenger, and in cooperation with a nearby primary receptor, initiating a change in cell activity."" [GOC:go_curators]",57,232,7,20212,0.03017241379310345,0.12280701754385964,Module 1,['GO:0038023']
3422,HPA,HPA:0641471,endometrium; lymphocytes[≥Low],0.001625431537170569,True,endometrium; lymphocytes[≥Low],28,185,6,11019,0.032432432432432434,0.21428571428571427,Module 1,['HPA:0640000']
3423,TF,TF:M02044_1,Factor: YY1; motif: GCCGCCATTTTG; match class: 1,0.0016265537453078868,True,Factor: YY1; motif: GCCGCCATTTTG; match class: 1,1245,826,88,20045,0.10653753026634383,0.07068273092369477,Module 0,['TF:M02044']
3424,TF,TF:M02057_1,Factor: Elf5; motif: CSMGGAARNN; match class: 1,0.0016278781365239847,True,Factor: Elf5; motif: CSMGGAARNN; match class: 1,3622,826,205,20045,0.24818401937046006,0.056598564329099946,Module 0,['TF:M02057']
3425,HPA,HPA:0050052,breast; glandular cells[≥Medium],0.001628084889399812,True,breast; glandular cells[≥Medium],5109,140,91,11019,0.65,0.017811704834605598,Module Singleton,['HPA:0050051']
3426,TF,TF:M00919_1,Factor: E2F; motif: NCSCGCSAAAN; match class: 1,0.0016312778413703631,True,Factor: E2F; motif: NCSCGCSAAAN; match class: 1,1576,80,21,20045,0.2625,0.0133248730964467,Module 5,['TF:M00919']
3427,GO:BP,GO:0032496,response to lipopolysaccharide,0.0016351296951052237,True,"""Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria."" [GOC:add, ISBN:0721601464]",336,226,16,21031,0.07079646017699115,0.047619047619047616,Module 1,"['GO:0002237', 'GO:0033993', 'GO:1901700']"
3428,REAC,REAC:R-HSA-2500257,Resolution of Sister Chromatid Cohesion,0.0016396048597282311,True,Resolution of Sister Chromatid Cohesion,123,59,7,10842,0.11864406779661017,0.056910569105691054,Module 5,['REAC:R-HSA-68877']
3429,HP,HP:0001392,Abnormality of the liver,0.0016412474547195712,True,An abnormality of the liver.,1088,71,34,4958,0.4788732394366197,0.03125,Module 1,['HP:0002012']
3430,REAC,REAC:R-HSA-8949613,Cristae formation,0.0016545497286808125,True,Cristae formation,31,586,10,10842,0.017064846416382253,0.3225806451612903,Module 0,['REAC:R-HSA-1592230']
3431,GO:BP,GO:0009966,regulation of signal transduction,0.00165937037412759,True,"""Any process that modulates the frequency, rate or extent of signal transduction."" [GOC:sm]",3010,34,17,21031,0.5,0.005647840531561462,Module 7,"['GO:0007165', 'GO:0010646', 'GO:0023051', 'GO:0048583']"
3432,GO:BP,GO:0006950,response to stress,0.0016608497564035121,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis, usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation)."" [GOC:mah]",3855,172,58,21031,0.3372093023255814,0.015045395590142672,Module Singleton,['GO:0050896']
3433,GO:BP,GO:0010498,proteasomal protein catabolic process,0.0016619741122168334,True,"""The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds that is mediated by the proteasome."" [GOC:tb]",496,787,42,21031,0.053367217280813214,0.0846774193548387,Module 0,"['GO:0030163', 'GO:0051603']"
3434,HP,HP:0040195,Decreased head circumference,0.0016698282566053489,True,An abnormally reduced head circumference in a growing child. Head circumference is measured with a nonelastic tape and comprises the distance from above the eyebrows and ears and around the back of the head. The measured HC is then plotted on an appropriate growth chart. Microcephaly is defined as a head circumference (HC) that is great than two standard deviations below the mean of age- and gender-matched population based samples. Severe microcephaly is defined with an HC that is three standard deviations below the mean.,1319,44,27,4958,0.6136363636363636,0.02047005307050796,Module 3,['HP:0000240']
3435,HPA,HPA:0340461,ovary; ovarian stroma cells[≥Low],0.001673007672989305,True,ovary; ovarian stroma cells[≥Low],3986,79,48,11019,0.6075949367088608,0.012042147516307075,Module 3,['HPA:0340000']
3436,GO:BP,GO:0002696,positive regulation of leukocyte activation,0.0016741448508176466,True,"""Any process that activates or increases the frequency, rate, or extent of leukocyte activation."" [GOC:add]",354,215,16,21031,0.07441860465116279,0.04519774011299435,Module 2,"['GO:0002684', 'GO:0002694', 'GO:0045321', 'GO:0050867']"
3437,HPA,HPA:0271111,kidney; bowman's capsule[≥Low],0.0016776539304691359,True,kidney; bowman's capsule[≥Low],268,612,34,11019,0.05555555555555555,0.12686567164179105,Module 0,['HPA:0270000']
3438,GO:BP,GO:0001819,positive regulation of cytokine production,0.0016807614328496973,True,"""Any process that activates or increases the frequency, rate or extent of production of a cytokine."" [GOC:add, ISBN:0781735149]",490,34,8,21031,0.23529411764705882,0.0163265306122449,Module 7,"['GO:0001816', 'GO:0001817', 'GO:0010628', 'GO:0051240']"
3439,GO:BP,GO:0032649,regulation of type II interferon production,0.0016919875156676276,True,"""Any process that modulates the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon."" [GOC:add, GOC:mah, PMID:15546383]",117,15,4,21031,0.26666666666666666,0.03418803418803419,Module 6,"['GO:0001817', 'GO:0032609']"
3440,TF,TF:M00972,Factor: IRF; motif: RAAANTGAAAN,0.0016934355560060726,True,Factor: IRF; motif: RAAANTGAAAN,2024,36,15,20045,0.4166666666666667,0.007411067193675889,Module 7,['TF:M00000']
3441,REAC,REAC:R-HSA-190872,Transport of connexons to the plasma membrane,0.0016991222708302059,True,Transport of connexons to the plasma membrane,21,59,4,10842,0.06779661016949153,0.19047619047619047,Module 5,['REAC:R-HSA-190861']
3442,HP,HP:0012751,Abnormal basal ganglia MRI signal intensity,0.0017010408112032417,True,A deviation from normal signal on magnetic resonance imaging (MRI) of the basal ganglia.,41,44,6,4958,0.13636363636363635,0.14634146341463414,Module 3,['HP:0002134']
3443,HPA,HPA:0050051,breast; glandular cells[≥Low],0.0017090019236950915,True,breast; glandular cells[≥Low],6813,140,111,11019,0.7928571428571428,0.016292382210479964,Module Singleton,['HPA:0050000']
3444,HPA,HPA:0310442,lymph node; non-germinal center cells[≥Medium],0.001713098997363161,True,lymph node; non-germinal center cells[≥Medium],3989,79,48,11019,0.6075949367088608,0.01203309100025069,Module 3,['HPA:0310441']
3445,GO:BP,GO:0044248,cellular catabolic process,0.0017140892053125283,True,"""The chemical reactions and pathways resulting in the breakdown of substances, carried out by individual cells."" [GOC:jl]",1600,787,98,21031,0.12452350698856417,0.06125,Module 0,"['GO:0009056', 'GO:0044237']"
3446,GO:BP,GO:0010498,proteasomal protein catabolic process,0.0017182728496919146,True,"""The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds that is mediated by the proteasome."" [GOC:tb]",496,72,11,21031,0.1527777777777778,0.02217741935483871,Module 4,"['GO:0030163', 'GO:0051603']"
3447,TF,TF:M01820,Factor: CREM; motif: TGACGTCASYN,0.0017282697332709337,True,Factor: CREM; motif: TGACGTCASYN,6432,826,331,20045,0.400726392251816,0.05146144278606965,Module 0,['TF:M00000']
3448,GO:BP,GO:0002764,immune response-regulating signaling pathway,0.001732972367178966,True,"""The cascade of processes by which a signal interacts with a receptor, causing a change in the level or activity of a second messenger or other downstream target, and ultimately leading to the activation, perpetuation, or inhibition of an immune response."" [GOC:add, ISBN:0781735149, PMID:15771571]",492,34,8,21031,0.23529411764705882,0.016260162601626018,Module 7,"['GO:0007165', 'GO:0050776']"
3449,GO:MF,GO:0016776,"phosphotransferase activity, phosphate group as acceptor",0.001738293230103905,True,"""Catalysis of the transfer of a phosphorus-containing group from one compound (donor) to a phosphate group (acceptor)."" [GOC:jl]",38,2,2,20212,1.0,0.05263157894736842,Module 39,['GO:0016772']
3450,GO:CC,GO:0030964,NADH dehydrogenase complex,0.001744567717504374,True,"""An integral membrane complex that possesses NADH oxidoreductase activity. The complex is one of the components of the electron transport chain. It catalyzes the transfer of a pair of electrons from NADH to a quinone."" [GOC:mah]",53,105,5,22097,0.047619047619047616,0.09433962264150944,Module 3,"['GO:0098796', 'GO:1990204']"
3451,GO:CC,GO:0005747,mitochondrial respiratory chain complex I,0.001744567717504374,True,"""A protein complex located in the mitochondrial inner membrane that forms part of the mitochondrial respiratory chain. It contains about 25 different polypeptide subunits, including NADH dehydrogenase (ubiquinone), flavin mononucleotide and several different iron-sulfur clusters containing non-heme iron. The iron undergoes oxidation-reduction between Fe(II) and Fe(III), and catalyzes proton translocation linked to the oxidation of NADH by ubiquinone."" [GOC:mtg_sensu, ISBN:0198547684]",53,105,5,22097,0.047619047619047616,0.09433962264150944,Module 3,"['GO:0005746', 'GO:0045271', 'GO:0098800']"
3452,GO:CC,GO:0045271,respiratory chain complex I,0.001744567717504374,True,"""Respiratory chain complex I is an enzyme of the respiratory chain. It consists of several polypeptide chains and is L-shaped, with a horizontal arm lying in the membrane and a vertical arm that projects into the matrix. The electrons of NADH enter the chain at this complex."" [GOC:imk, GOC:jid, ISBN:0716749556]",53,105,5,22097,0.047619047619047616,0.09433962264150944,Module 3,"['GO:0030964', 'GO:0098803', 'GO:1902495']"
3453,GO:BP,GO:0032609,type II interferon production,0.0017506207112498022,True,"""The appearance of interferon-gamma due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Interferon-gamma is also known as type II interferon."" [GOC:add, GOC:mah, PMID:15546383]",118,15,4,21031,0.26666666666666666,0.03389830508474576,Module 6,['GO:0001816']
3454,CORUM,CORUM:1183,CDC5L complex,0.0017577007248896844,True,CDC5L complex,26,331,11,3383,0.03323262839879154,0.4230769230769231,Module 0,['CORUM:0000000']
3455,GO:BP,GO:0071621,granulocyte chemotaxis,0.001773386144904271,True,"""The movement of a granulocyte in response to an external stimulus."" [GOC:rph]",129,5,3,21031,0.6,0.023255813953488372,Module 12,"['GO:0030595', 'GO:0097530']"
3456,GO:BP,GO:1990266,neutrophil migration,0.001773386144904271,True,"""The movement of a neutrophil within or between different tissues and organs of the body."" [PMID:1826836]",129,5,3,21031,0.6,0.023255813953488372,Module 12,['GO:0097530']
3457,GO:CC,GO:0000785,chromatin,0.001776777221323284,True,"""The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome."" [GOC:elh, PMID:20404130]",1368,80,17,22097,0.2125,0.012426900584795321,Module 5,"['GO:0005694', 'GO:0032993']"
3458,TF,TF:M10785_1,Factor: hoxa9; motif: RTCGTWANNN; match class: 1,0.0017780417157097909,True,Factor: hoxa9; motif: RTCGTWANNN; match class: 1,1173,826,84,20045,0.1016949152542373,0.07161125319693094,Module 0,['TF:M10785']
3459,GO:CC,GO:0005793,endoplasmic reticulum-Golgi intermediate compartment,0.0017785259368199296,True,"""A complex system of membrane-bounded compartments located between endoplasmic reticulum (ER) and the Golgi complex, with a distinctive membrane protein composition; involved in ER-to-Golgi and Golgi-to-ER transport."" [GOC:pr, PMID:16723730]",136,73,6,22097,0.0821917808219178,0.04411764705882353,Module 4,"['GO:0005737', 'GO:0043231']"
3460,REAC,REAC:R-HSA-9700206,Signaling by ALK in cancer,0.0017795236945556527,True,Signaling by ALK in cancer,53,586,13,10842,0.02218430034129693,0.24528301886792453,Module 0,['REAC:R-HSA-5663202']
3461,REAC,REAC:R-HSA-9725370,Signaling by ALK fusions and activated point mutants,0.0017795236945556527,True,Signaling by ALK fusions and activated point mutants,53,586,13,10842,0.02218430034129693,0.24528301886792453,Module 0,['REAC:R-HSA-9700206']
3462,TF,TF:M11374,Factor: Spi-B; motif: NAWGRGGAAGTR,0.0017839931476009581,True,Factor: Spi-B; motif: NAWGRGGAAGTR,2532,826,153,20045,0.18523002421307505,0.06042654028436019,Module 0,['TF:M00000']
3463,HPA,HPA:0340462,ovary; ovarian stroma cells[≥Medium],0.0017869543318176195,True,ovary; ovarian stroma cells[≥Medium],2067,18,12,11019,0.6666666666666666,0.005805515239477504,Module 9,['HPA:0340461']
3464,GO:BP,GO:1990266,neutrophil migration,0.0017977005159482465,True,"""The movement of a neutrophil within or between different tissues and organs of the body."" [PMID:1826836]",129,215,10,21031,0.046511627906976744,0.07751937984496124,Module 2,['GO:0097530']
3465,KEGG,KEGG:05162,Measles,0.0018090085572599738,True,Measles,138,23,5,8484,0.21739130434782608,0.036231884057971016,Module 7,['KEGG:00000']
3466,HPA,HPA:0530723,spleen; cells in white pulp[High],0.0018267189478742571,True,spleen; cells in white pulp[High],847,140,27,11019,0.19285714285714287,0.031877213695395513,Module Singleton,['HPA:0530722']
3467,GO:CC,GO:0031410,cytoplasmic vesicle,0.001827347002126855,True,"""A vesicle found in the cytoplasm of a cell."" [GOC:ai, GOC:mah, GOC:vesicles]",2513,177,41,22097,0.23163841807909605,0.01631516116195782,Module Singleton,"['GO:0005737', 'GO:0097708']"
3468,GO:BP,GO:0071824,protein-DNA complex organization,0.0018336958927880772,True,"""Any process in which macromolecules aggregate, disaggregate, or are modified, resulting in the formation, disassembly, or alteration of a protein-DNA complex."" [GOC:mah]",915,77,15,21031,0.19480519480519481,0.01639344262295082,Module 5,['GO:0043933']
3469,GO:BP,GO:0002715,regulation of natural killer cell mediated immunity,0.0018387992163466827,True,"""Any process that modulates the frequency, rate, or extent of natural killer cell mediated immunity."" [GOC:add]",49,226,7,21031,0.030973451327433628,0.14285714285714285,Module 1,"['GO:0002228', 'GO:0002706', 'GO:0045088']"
3470,HPA,HPA:0630000,cervix,0.0018409480168943872,True,cervix,6930,69,60,11019,0.8695652173913043,0.008658008658008658,Module 5,['HPA:0000000']
3471,GO:BP,GO:0050790,regulation of catalytic activity,0.0018434510907267365,True,"""Any process that modulates the activity of an enzyme."" [GOC:ai, GOC:ebc, GOC:vw]",1227,21,9,21031,0.42857142857142855,0.007334963325183374,Module 9,['GO:0065009']
3472,HPA,HPA:0350000,pancreas,0.0018460645024794416,True,pancreas,7409,60,55,11019,0.9166666666666666,0.007423403968146849,Module 4,['HPA:0000000']
3473,TF,TF:M09892_1,Factor: E2F-1; motif: NNNNGGCGGGAARN; match class: 1,0.0018466120059742186,True,Factor: E2F-1; motif: NNNNGGCGGGAARN; match class: 1,9460,826,459,20045,0.5556900726392252,0.04852008456659619,Module 0,['TF:M09892']
3474,TF,TF:M00939_1,Factor: E2F; motif: TTTSGCGSG; match class: 1,0.0018472097987232731,True,Factor: E2F; motif: TTTSGCGSG; match class: 1,1732,80,22,20045,0.275,0.012702078521939953,Module 5,['TF:M00939']
3475,GO:CC,GO:0000502,proteasome complex,0.0018483136945202031,True,"""A large multisubunit complex which catalyzes protein degradation, found in eukaryotes, archaea and some bacteria. In eukaryotes, this complex consists of the barrel shaped proteasome core complex and one or two associated proteins or complexes that act in regulating entry into or exit from the core."" [GOC:rb, Wikipedia:Proteasome]",67,2,2,22097,1.0,0.029850746268656716,Module 41,"['GO:0140535', 'GO:1905369']"
3476,WP,WP:WP3945,TYROBP causal network in microglia,0.0018516450782759743,True,TYROBP causal network in microglia,60,148,8,8286,0.05405405405405406,0.13333333333333333,Module 1,['WP:000000']
3477,GO:BP,GO:0015980,energy derivation by oxidation of organic compounds,0.0018680256347818867,True,"""The chemical reactions and pathways by which a cell derives energy from organic compounds; results in the oxidation of the compounds from which energy is released."" [GOC:mah]",335,105,11,21031,0.10476190476190476,0.03283582089552239,Module 3,['GO:0006091']
3478,HPA,HPA:0461411,skin 1; cells in spinous layer[≥Low],0.0018708803665775065,True,skin 1; cells in spinous layer[≥Low],760,18,8,11019,0.4444444444444444,0.010526315789473684,Module 9,['HPA:0460000']
3479,GO:BP,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.0018724056029783985,True,"""Any process that activates or increases the frequency, rate, or extent of an adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. An example of this process is found in the Gnathostomata."" [GOC:add, GOC:mtg_sensu]",120,15,4,21031,0.26666666666666666,0.03333333333333333,Module 6,"['GO:0002460', 'GO:0002821', 'GO:0002822']"
3480,WP,WP:WP179,Cell cycle,0.001886863477888301,True,Cell cycle,120,55,7,8286,0.12727272727272726,0.058333333333333334,Module 5,['WP:000000']
3481,HP,HP:0012539,Non-Hodgkin lymphoma,0.0018882945167992239,True,A type of lymphoma characterized microscopically by the absence of multinucleated Reed-Sternberg cells.,40,71,7,4958,0.09859154929577464,0.175,Module 1,['HP:0002665']
3482,HP,HP:0100547,Abnormal forebrain morphology,0.0018883999864864687,True,"An abnormality of the forebrain, which has as its parts the telencephalon, diencephalon, lateral ventricles and third ventricle.",2058,44,34,4958,0.7727272727272727,0.01652089407191448,Module 3,['HP:0012443']
3483,TF,TF:M10080_1,Factor: STAT2; motif: RRGRAANNGAAACTGAAAN; match class: 1,0.001889425956804209,True,Factor: STAT2; motif: RRGRAANNGAAACTGAAAN; match class: 1,11,36,3,20045,0.08333333333333333,0.2727272727272727,Module 7,['TF:M10080']
3484,TF,TF:M11880,Factor: pax-6; motif: NYACGCWTSANYGMNCN,0.0018908562734992669,True,Factor: pax-6; motif: NYACGCWTSANYGMNCN,13348,826,614,20045,0.7433414043583535,0.0459994006592748,Module 0,['TF:M00000']
3485,HPA,HPA:0471481,skin 2; sebaceous glands[≥Low],0.001896886594107355,True,skin 2; sebaceous glands[≥Low],133,140,10,11019,0.07142857142857142,0.07518796992481203,Module Singleton,['HPA:0470000']
3486,GO:BP,GO:0070555,response to interleukin-1,0.0019006193759397963,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus."" [GOC:BHF, GOC:mah]",132,5,3,21031,0.6,0.022727272727272728,Module 12,['GO:0034097']
3487,HP,HP:0011123,Inflammatory abnormality of the skin,0.00190585711154709,True,"The presence of inflammation of the skin. That is, an abnormality of the skin resulting from the local accumulation of fluid, plasma proteins, and leukocytes.",488,74,22,4958,0.2972972972972973,0.045081967213114756,Module 2,"['HP:0011122', 'HP:0012649']"
3488,REAC,REAC:R-HSA-381771,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",0.0019061781693797263,True,"Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)",21,60,4,10842,0.06666666666666667,0.19047619047619047,Module 4,['REAC:R-HSA-400508']
3489,GO:CC,GO:0005737,cytoplasm,0.0019161638990330858,True,"""The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures."" [ISBN:0198547684]",12345,34,31,22097,0.9117647058823529,0.002511138112596193,Module 7,"['GO:0005622', 'GO:0110165']"
3490,GO:CC,GO:0097708,intracellular vesicle,0.0019187316408625806,True,"""Any vesicle that is part of the intracellular region."" [GOC:vesicles]",2518,177,41,22097,0.23163841807909605,0.016282764098490866,Module Singleton,"['GO:0031982', 'GO:0043231']"
3491,HPA,HPA:0090183,cerebellum; cells in granular layer[High],0.0019261194898577425,True,cerebellum; cells in granular layer[High],753,612,71,11019,0.11601307189542484,0.09428950863213811,Module 0,['HPA:0090182']
3492,GO:CC,GO:0005743,mitochondrial inner membrane,0.0019290750635934748,True,"""The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae."" [GOC:ai]",512,105,12,22097,0.11428571428571428,0.0234375,Module 3,"['GO:0019866', 'GO:0031966']"
3493,GO:BP,GO:0000302,response to reactive oxygen species,0.0019301201231482802,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a reactive oxygen species stimulus. Reactive oxygen species include singlet oxygen, superoxide, and oxygen free radicals."" [GOC:krc]",197,215,12,21031,0.05581395348837209,0.06091370558375635,Module 2,"['GO:0006979', 'GO:1901700']"
3494,GO:MF,GO:0042826,histone deacetylase binding,0.0019366736658855085,True,"""Binding to histone deacetylase."" [GOC:jl]",127,20,4,20212,0.2,0.031496062992125984,Module 9,['GO:0019899']
3495,GO:CC,GO:0005622,intracellular anatomical structure,0.0019413185236240253,True,"""A component of a cell contained within (but not including) the plasma membrane. In eukaryotes it includes the nucleus and cytoplasm."" [ISBN:0198506732]",17834,80,78,22097,0.975,0.004373668274083212,Module 5,['GO:0110165']
3496,TF,TF:M06025,Factor: ZNF195; motif: NGWGKAAGCTGC,0.001941351376684442,True,Factor: ZNF195; motif: NGWGKAAGCTGC,40,2,2,20045,1.0,0.05,Module 41,['TF:M00000']
3497,HPA,HPA:0461482,skin 1; sebaceous glands[≥Medium],0.0019450952431929165,True,skin 1; sebaceous glands[≥Medium],165,69,8,11019,0.11594202898550725,0.048484848484848485,Module 5,['HPA:0461481']
3498,GO:BP,GO:0032943,mononuclear cell proliferation,0.0019505540926410148,True,"""The expansion of a mononuclear cell population by cell division. A mononuclear cell is a leukocyte with a single non-segmented nucleus in the mature form."" [GOC:add]",315,215,15,21031,0.06976744186046512,0.047619047619047616,Module 2,['GO:0070661']
3499,GO:BP,GO:0007159,leukocyte cell-cell adhesion,0.0019524306596397374,True,"""The attachment of a leukocyte to another cell via adhesion molecules."" [GOC:go_curators]",403,215,17,21031,0.07906976744186046,0.04218362282878412,Module 2,['GO:0098609']
3500,HPA,HPA:0031291,appendix; endocrine cells[≥Low],0.0019526309415905576,True,appendix; endocrine cells[≥Low],422,79,13,11019,0.16455696202531644,0.030805687203791468,Module 3,['HPA:0030000']
3501,GO:BP,GO:0023051,regulation of signaling,0.0019600135660882583,True,"""Any process that modulates the frequency, rate or extent of a signaling process."" [GOC:mtg_signal]",3437,34,18,21031,0.5294117647058824,0.00523712540005819,Module 7,"['GO:0023052', 'GO:0050789']"
3502,GO:MF,GO:0003723,RNA binding,0.0019620352206854968,True,"""Binding to an RNA molecule or a portion thereof."" [GOC:jl, GOC:mah]",3123,20,12,20212,0.6,0.0038424591738712775,Module 9,['GO:0003676']
3503,HPA,HPA:0461462,skin 1; langerhans cells[≥Medium],0.0019694324965727514,True,skin 1; langerhans cells[≥Medium],578,12,6,11019,0.5,0.010380622837370242,Module 6,['HPA:0461461']
3504,GO:MF,GO:0044877,protein-containing complex binding,0.0019706602270580915,True,"""Binding to a macromolecular complex."" [GOC:jl]",1752,177,35,20212,0.1977401129943503,0.01997716894977169,Module Singleton,['GO:0005488']
3505,GO:CC,GO:0008250,oligosaccharyltransferase complex,0.001971032620898881,True,"""A protein complex that is found in the endoplasmic reticulum membrane of eukaryotes and transfers lipid-linked oligosaccharide precursor to asparagine residues on nascent proteins. In yeast, the complex includes at least nine different subunits, whereas in mammalian cells at least three different forms of the complex have been detected."" [ISBN:0879695595, PMID:15835887]",14,813,6,22097,0.007380073800738007,0.42857142857142855,Module 0,"['GO:0005789', 'GO:0098796', 'GO:0140534', 'GO:1990234']"
3506,HP,HP:0000751,Personality changes,0.0019714786409356054,True,"An abnormal shift in patterns of thinking, acting, or feeling.",42,44,6,4958,0.13636363636363635,0.14285714285714285,Module 3,['HP:0031466']
3507,GO:CC,GO:0098796,membrane protein complex,0.0019772824935244556,True,"""Any protein complex that is part of a membrane."" [GOC:dos]",1401,177,28,22097,0.15819209039548024,0.01998572448251249,Module Singleton,"['GO:0016020', 'GO:0032991']"
3508,GO:MF,GO:0003954,NADH dehydrogenase activity,0.0019859656928589114,True,"""Catalysis of the reaction: NADH + H+ + acceptor = NAD+ + reduced acceptor."" [RHEA:11356]",44,105,5,20212,0.047619047619047616,0.11363636363636363,Module 3,['GO:0016651']
3509,TF,TF:M03975_1,Factor: ERG; motif: ACCGGAARTN; match class: 1,0.0019891198313900646,True,Factor: ERG; motif: ACCGGAARTN; match class: 1,4100,183,66,20045,0.36065573770491804,0.016097560975609757,Module Singleton,['TF:M03975']
3510,MIRNA,MIRNA:hsa-miR-34a-5p,hsa-miR-34a-5p,0.001990519194277604,True,hsa-miR-34a-5p,728,76,15,14819,0.19736842105263158,0.020604395604395604,Module 5,['MIRNA:000000']
3511,TF,TF:M11435_1,Factor: Elk-1; motif: NNCCGGAAGTN; match class: 1,0.0019927719653365867,True,Factor: Elk-1; motif: NNCCGGAAGTN; match class: 1,5881,183,85,20045,0.4644808743169399,0.014453324264580854,Module Singleton,['TF:M11435']
3512,GO:CC,GO:0048471,perinuclear region of cytoplasm,0.0020068017382270727,True,"""Cytoplasm situated near, or occurring around, the nucleus."" [GOC:jid]",736,813,52,22097,0.06396063960639606,0.07065217391304347,Module 0,"['GO:0005737', 'GO:0110165']"
3513,TF,TF:M10885,Factor: PRX-2; motif: NKCGTTAN,0.002007206745727014,True,Factor: PRX-2; motif: NKCGTTAN,5824,826,304,20045,0.36803874092009686,0.0521978021978022,Module 0,['TF:M00000']
3514,TF,TF:M10887,Factor: PRX-2; motif: NNCRTTAN,0.002007206745727014,True,Factor: PRX-2; motif: NNCRTTAN,5824,826,304,20045,0.36803874092009686,0.0521978021978022,Module 0,['TF:M00000']
3515,HPA,HPA:0030000,appendix,0.002016206322695959,True,appendix,7831,69,64,11019,0.927536231884058,0.008172647171497892,Module 5,['HPA:0000000']
3516,HPA,HPA:0580821,thymus; cortical cells[≥Low],0.0020210459831688813,True,thymus; cortical cells[≥Low],29,185,6,11019,0.032432432432432434,0.20689655172413793,Module 1,['HPA:0580000']
3517,GO:MF,GO:0016462,pyrophosphatase activity,0.00202359580165263,True,"""Catalysis of the hydrolysis of a pyrophosphate bond (diphosphate bond) between two phosphate groups."" [GOC:curators, https://en.wikipedia.org/wiki/Pyrophosphatase]",794,20,7,20212,0.35,0.008816120906801008,Module 9,['GO:0016818']
3518,GO:BP,GO:0031396,regulation of protein ubiquitination,0.0020276103741123735,True,"""Any process that modulates the frequency, rate or extent of the addition of ubiquitin groups to a protein."" [GOC:mah]",199,21,5,21031,0.23809523809523808,0.02512562814070352,Module 9,"['GO:0016567', 'GO:1903320']"
3519,GO:MF,GO:0016817,"hydrolase activity, acting on acid anhydrides",0.0020403905528972315,True,"""Catalysis of the hydrolysis of any acid anhydride."" [GOC:jl]",795,20,7,20212,0.35,0.00880503144654088,Module 9,['GO:0016787']
3520,GO:MF,GO:0016818,"hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides",0.0020403905528972315,True,"""Catalysis of the hydrolysis of any acid anhydride which contains phosphorus."" [GOC:jl]",795,20,7,20212,0.35,0.00880503144654088,Module 9,['GO:0016817']
3521,HP,HP:0002715,Abnormality of the immune system,0.0020461199276844734,True,An abnormality of the immune system.,2064,44,34,4958,0.7727272727272727,0.016472868217054265,Module 3,['HP:0000118']
3522,HPA,HPA:0471411,skin 2; cells in spinous layer[≥Low],0.0020545521382898833,True,skin 2; cells in spinous layer[≥Low],871,79,19,11019,0.24050632911392406,0.021814006888633754,Module 3,['HPA:0470000']
3523,GO:BP,GO:0071219,cellular response to molecule of bacterial origin,0.0020564120683615144,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin."" [GOC:mah]",224,226,13,21031,0.05752212389380531,0.05803571428571429,Module 1,"['GO:0002237', 'GO:0071216']"
3524,TF,TF:M08760_1,Factor: ETV7; motif: NNSCGGAAGTR; match class: 1,0.0020623718281733918,True,Factor: ETV7; motif: NNSCGGAAGTR; match class: 1,338,826,35,20045,0.0423728813559322,0.10355029585798817,Module 0,['TF:M08760']
3525,HPA,HPA:0130000,colon,0.0020628936841953797,True,colon,8342,69,66,11019,0.9565217391304348,0.007911771757372333,Module 5,['HPA:0000000']
3526,HP,HP:0011370,Recurrent cutaneous fungal infections,0.0020670466322615486,True,"Increased susceptibility to cutaneous fungal infections, as manifested by recurrent episodes of cutaneous fungal infections.",58,71,8,4958,0.11267605633802817,0.13793103448275862,Module 1,"['HP:0001581', 'HP:0002841']"
3527,HPA,HPA:0390000,prostate,0.002076555450000422,True,prostate,6677,60,52,11019,0.8666666666666667,0.007787928710498727,Module 4,['HPA:0000000']
3528,HPA,HPA:0390051,prostate; glandular cells[≥Low],0.002076555450000422,True,prostate; glandular cells[≥Low],6677,60,52,11019,0.8666666666666667,0.007787928710498727,Module 4,['HPA:0390000']
3529,GO:BP,GO:0065008,regulation of biological quality,0.002089696624322825,True,"""Any process that modulates a qualitative or quantitative trait of a biological quality. A biological quality is a measurable attribute of an organism or part of an organism, such as size, mass, shape, color, etc."" [GOC:dph, GOC:isa_complete, GOC:mah, GOC:pr, GOC:vw]",2846,787,154,21031,0.19567979669631513,0.054111033028812365,Module 0,['GO:0065007']
3530,HPA,HPA:0030000,appendix,0.002093784882092877,True,appendix,7831,185,157,11019,0.8486486486486486,0.020048525092580767,Module 1,['HPA:0000000']
3531,GO:MF,GO:0042802,identical protein binding,0.0020944325328752936,True,"""Binding to an identical protein or proteins."" [GOC:jl]",2162,218,46,20212,0.21100917431192662,0.02127659574468085,Module 2,['GO:0005515']
3532,HP,HP:0004431,Complement deficiency,0.0020952935494612758,True,An immunodeficiency defined by the absent or suboptimal functioning of one of the complement system proteins.,56,74,8,4958,0.10810810810810811,0.14285714285714285,Module 2,['HP:0005339']
3533,GO:BP,GO:0010833,telomere maintenance via telomere lengthening,0.00210249306294433,True,"""Any process that contributes to the maintenance of proper telomeric length and structure by affecting and monitoring the activity of telomeric proteins and lengthening the telomeric DNA."" [GOC:dph, GOC:tb]",84,21,4,21031,0.19047619047619047,0.047619047619047616,Module 9,['GO:0000723']
3534,GO:BP,GO:0051093,negative regulation of developmental process,0.0021062200907402944,True,"""Any process that stops, prevents or reduces the rate or extent of development, the biological process whose specific outcome is the progression of an organism over time from an initial condition (e.g. a zygote, or a young adult) to a later condition (e.g. a multicellular animal or an aged adult)."" [GOC:ai]",928,215,27,21031,0.12558139534883722,0.029094827586206896,Module 2,"['GO:0032502', 'GO:0048519', 'GO:0050793']"
3535,TF,TF:M01203,Factor: SPI1; motif: NNAAWGNGGAASTNNNN,0.0021087567166524924,True,Factor: SPI1; motif: NNAAWGNGGAASTNNNN,2663,826,159,20045,0.19249394673123488,0.05970709725873075,Module 0,['TF:M00000']
3536,TF,TF:M07216,Factor: IRF1; motif: NNNYASTTTCACTTTCNNTTT,0.002112008541962297,True,Factor: IRF1; motif: NNNYASTTTCACTTTCNNTTT,445,36,8,20045,0.2222222222222222,0.017977528089887642,Module 7,['TF:M00000']
3537,TF,TF:M08523_1,Factor: E2F-1:TBR2; motif: NGGTGNNANGGCGCNNTNNCRNNN; match class: 1,0.002113047206498776,True,Factor: E2F-1:TBR2; motif: NGGTGNNANGGCGCNNTNNCRNNN; match class: 1,7607,826,381,20045,0.4612590799031477,0.0500854476140397,Module 0,['TF:M08523']
3538,GO:MF,GO:0035662,Toll-like receptor 4 binding,0.002116895374299224,True,"""Binding to a Toll-like 4 protein, a pattern recognition receptor that binds bacterial lipopolysaccharide (LPS) to initiate an innate immune response."" [GOC:BHF, PMID:18304834]",4,218,3,20212,0.013761467889908258,0.75,Module 2,['GO:0035325']
3539,HPA,HPA:0470682,skin 2; epidermal cells[≥Medium],0.0021169638485059187,True,skin 2; epidermal cells[≥Medium],4016,79,48,11019,0.6075949367088608,0.01195219123505976,Module 3,['HPA:0470681']
3540,HPA,HPA:0470201,skin 2; endothelial cells[≥Low],0.0021249181401675294,True,skin 2; endothelial cells[≥Low],888,166,31,11019,0.18674698795180722,0.03490990990990991,Module 2,['HPA:0470000']
3541,GO:BP,GO:0045089,positive regulation of innate immune response,0.0021260899246058115,True,"""Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection."" [GOC:ebc]",345,34,7,21031,0.20588235294117646,0.020289855072463767,Module 7,"['GO:0002833', 'GO:0031349', 'GO:0032103', 'GO:0045087', 'GO:0045088', 'GO:0050778']"
3542,GO:BP,GO:0072528,pyrimidine-containing compound biosynthetic process,0.0021267543080496164,True,"""The chemical reactions and pathways resulting in the formation of a pyrimidine-containing compound, i.e. any compound that contains pyrimidine or a formal derivative thereof."" [GOC:mah]",43,2,2,21031,1.0,0.046511627906976744,Module 39,"['GO:0018130', 'GO:0044271', 'GO:0072527', 'GO:1901362', 'GO:1901566']"
3543,TF,TF:M03989,Factor: FLI1; motif: ACCGGAAATCCGGT,0.0021302835010789892,True,Factor: FLI1; motif: ACCGGAAATCCGGT,10645,826,507,20045,0.6138014527845036,0.04762799436355096,Module 0,['TF:M00000']
3544,GO:BP,GO:0002456,T cell mediated immunity,0.0021347488543284328,True,"""Any process involved in the carrying out of an immune response by a T cell."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",124,15,4,21031,0.26666666666666666,0.03225806451612903,Module 6,"['GO:0002449', 'GO:0002460']"
3545,GO:BP,GO:0002708,positive regulation of lymphocyte mediated immunity,0.0021347488543284328,True,"""Any process that activates or increases the frequency, rate, or extent of lymphocyte mediated immunity."" [GOC:add]",124,15,4,21031,0.26666666666666666,0.03225806451612903,Module 6,"['GO:0002449', 'GO:0002705', 'GO:0002706']"
3546,GO:BP,GO:0009968,negative regulation of signal transduction,0.002141679361932809,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of signal transduction."" [GOC:sm]",1290,215,33,21031,0.15348837209302327,0.02558139534883721,Module 2,"['GO:0007165', 'GO:0009966', 'GO:0010648', 'GO:0023057', 'GO:0048585']"
3547,TF,TF:M04515_1,Factor: E2F-1; motif: WWTGGCGCCAAA; match class: 1,0.00214457292052655,True,Factor: E2F-1; motif: WWTGGCGCCAAA; match class: 1,12531,826,582,20045,0.7046004842615012,0.04644481685420158,Module 0,['TF:M04515']
3548,TF,TF:M04744_1,Factor: ATF-3; motif: GGCGCSSNSNGRTSACGTSA; match class: 1,0.0021662502424557063,True,Factor: ATF-3; motif: GGCGCSSNSNGRTSACGTSA; match class: 1,4973,826,266,20045,0.3220338983050847,0.05348883973456666,Module 0,['TF:M04744']
3549,GO:BP,GO:0044087,regulation of cellular component biogenesis,0.002168598918262758,True,"""Any process that modulates the frequency, rate or extent of cellular component biogenesis, a process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a cellular component."" [GOC:jl]",971,787,67,21031,0.08513341804320203,0.0690010298661174,Module 0,"['GO:0044085', 'GO:0050794']"
3550,REAC,REAC:R-HSA-5602498,MyD88 deficiency (TLR2/4),0.002173103439240816,True,MyD88 deficiency (TLR2/4),17,173,5,10842,0.028901734104046242,0.29411764705882354,Module 2,['REAC:R-HSA-5602358']
3551,HPA,HPA:0090193,cerebellum; cells in molecular layer[High],0.0021799131636988027,True,cerebellum; cells in molecular layer[High],918,69,18,11019,0.2608695652173913,0.0196078431372549,Module 5,['HPA:0090192']
3552,GO:CC,GO:0030867,rough endoplasmic reticulum membrane,0.002198439021972754,True,"""The lipid bilayer surrounding the rough endoplasmic reticulum."" [GOC:mah]",26,105,4,22097,0.0380952380952381,0.15384615384615385,Module 3,"['GO:0005789', 'GO:0005791', 'GO:0098588']"
3553,GO:CC,GO:0045277,respiratory chain complex IV,0.002198439021972754,True,"""A part of the respiratory chain, containing the 13 polypeptide subunits of cytochrome c oxidase, including cytochrome a and cytochrome a3. Catalyzes the oxidation of reduced cytochrome c by dioxygen (O2)."" [ISBN:0198547684]",26,105,4,22097,0.0380952380952381,0.15384615384615385,Module 3,"['GO:0070069', 'GO:0098803']"
3554,GO:BP,GO:1904869,regulation of protein localization to Cajal body,0.002207656585437024,True,"""Any process that modulates the frequency, rate or extent of protein localization to Cajal body."" [GO_REF:0000058, GOC:BHF, GOC:BHF_telomere, GOC:nc, GOC:TermGenie, PMID:25467444]",11,787,6,21031,0.007623888182973317,0.5454545454545454,Module 0,"['GO:1900180', 'GO:1904867']"
3555,GO:BP,GO:1904871,positive regulation of protein localization to Cajal body,0.002207656585437024,True,"""Any process that activates or increases the frequency, rate or extent of protein localization to Cajal body."" [GO_REF:0000058, GOC:BHF, GOC:BHF_telomere, GOC:nc, GOC:TermGenie, PMID:25467444]",11,787,6,21031,0.007623888182973317,0.5454545454545454,Module 0,"['GO:1900182', 'GO:1904867', 'GO:1904869']"
3556,GO:BP,GO:0070203,regulation of establishment of protein localization to telomere,0.002207656585437024,True,"""Any process that modulates the frequency, rate or extent of the directed movement of a protein to a specific location in the telomeric region of a chromosome."" [GOC:BHF, GOC:mah]",11,787,6,21031,0.007623888182973317,0.5454545454545454,Module 0,"['GO:0070200', 'GO:0070202', 'GO:1904814']"
3557,GO:MF,GO:0003955,NAD(P)H dehydrogenase (quinone) activity,0.0022250256716709205,True,"""Catalysis of the reaction: NAD(P)H + H+ + a quinone = NAD(P)+ + a hydroquinone."" [EC:1.6.5.2]",45,105,5,20212,0.047619047619047616,0.1111111111111111,Module 3,['GO:0016655']
3558,HP,HP:0011122,Abnormality of skin physiology,0.0022368727803646652,True,Any abnormality of the physiological function of the skin.,558,71,23,4958,0.323943661971831,0.04121863799283154,Module 1,['HP:0000951']
3559,HPA,HPA:0550000,stomach 2,0.0022375501165729857,True,stomach 2,7612,69,63,11019,0.9130434782608695,0.008276405675249605,Module 5,['HPA:0000000']
3560,HPA,HPA:0550051,stomach 2; glandular cells[≥Low],0.0022375501165729857,True,stomach 2; glandular cells[≥Low],7612,69,63,11019,0.9130434782608695,0.008276405675249605,Module 5,['HPA:0550000']
3561,GO:CC,GO:0042612,MHC class I protein complex,0.002247989700265334,True,"""A transmembrane protein complex composed of a MHC class I alpha chain and an invariant beta2-microglobin chain, and with or without a bound peptide antigen. Class I here refers to classical class I molecules."" [GOC:add, GOC:jl, ISBN:0120781859, ISBN:0781735149]",8,17,2,22097,0.11764705882352941,0.25,Module 6,['GO:0042611']
3562,TF,TF:M10956,Factor: isx; motif: NTCRTTAA,0.002250693523548009,True,Factor: isx; motif: NTCRTTAA,9619,826,465,20045,0.562953995157385,0.04834182347437364,Module 0,['TF:M00000']
3563,HP,HP:0031378,Abnormal lymphocyte proliferation,0.002251314086631965,True,"Any abnormality in the multiplication or reproduction of lymphocytes, which results in the expansion of a cell population.",41,71,7,4958,0.09859154929577464,0.17073170731707318,Module 1,"['HP:0031377', 'HP:0031409']"
3564,HP,HP:0031377,Abnormal cell proliferation,0.002251314086631965,True,"Any abnormality in the multiplication or reproduction of cells, which may result in the expansion of a cell population.",41,71,7,4958,0.09859154929577464,0.17073170731707318,Module 1,['HP:0011017']
3565,REAC,REAC:R-HSA-111367,SLBP independent Processing of Histone Pre-mRNAs,0.0022530476867193266,True,SLBP independent Processing of Histone Pre-mRNAs,10,586,6,10842,0.010238907849829351,0.6,Module 0,['REAC:R-HSA-75067']
3566,TF,TF:M11457,Factor: nerf; motif: NANGCGGAAGTR,0.0022535270230948545,True,Factor: nerf; motif: NANGCGGAAGTR,1093,105,20,20045,0.19047619047619047,0.018298261665141813,Module 3,['TF:M00000']
3567,WP,WP:WP3888,VEGFA VEGFR2 signaling,0.0022588383795042713,True,VEGFA VEGFR2 signaling,430,472,47,8286,0.09957627118644068,0.10930232558139535,Module 0,['WP:000000']
3568,TF,TF:M00426_1,Factor: E2F; motif: TTTSGCGS; match class: 1,0.0022639332395365044,True,Factor: E2F; motif: TTTSGCGS; match class: 1,6004,80,45,20045,0.5625,0.007495003331112591,Module 5,['TF:M00426']
3569,WP,WP:WP453,Inflammatory response pathway,0.0022644874215430096,True,Inflammatory response pathway,30,148,6,8286,0.04054054054054054,0.2,Module 1,['WP:000000']
3570,KEGG,KEGG:00983,Drug metabolism - other enzymes,0.002265060295256639,True,Drug metabolism - other enzymes,79,2,2,8484,1.0,0.02531645569620253,Module 39,['KEGG:00000']
3571,GO:BP,GO:0046209,nitric oxide metabolic process,0.00226567552544047,True,"""The chemical reactions and pathways involving nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water."" [GOC:ai]",76,215,8,21031,0.037209302325581395,0.10526315789473684,Module 2,['GO:2001057']
3572,REAC,REAC:R-HSA-381038,XBP1(S) activates chaperone genes,0.0022670761137762066,True,XBP1(S) activates chaperone genes,47,60,5,10842,0.08333333333333333,0.10638297872340426,Module 4,['REAC:R-HSA-381070']
3573,GO:BP,GO:0002821,positive regulation of adaptive immune response,0.0022757135235835354,True,"""Any process that activates or increases the frequency, rate, or extent of an adaptive immune response."" [GOC:add]",126,15,4,21031,0.26666666666666666,0.031746031746031744,Module 6,"['GO:0002250', 'GO:0002819', 'GO:0050778']"
3574,GO:CC,GO:0031090,organelle membrane,0.002284898424981988,True,"""A membrane that is one of the two lipid bilayers of an organelle envelope or the outermost membrane of single membrane bound organelle."" [GOC:dos, GOC:mah]",3770,17,11,22097,0.6470588235294118,0.0029177718832891246,Module 6,"['GO:0016020', 'GO:0043227']"
3575,HPA,HPA:0401333,rectum; mucosal lymphoid cells[High],0.0022903984107561543,True,rectum; mucosal lymphoid cells[High],176,185,13,11019,0.07027027027027027,0.07386363636363637,Module 1,['HPA:0401332']
3576,GO:BP,GO:0048025,"negative regulation of mRNA splicing, via spliceosome",0.002299634531724171,True,"""Any process that stops, prevents or reduces the rate or extent of mRNA splicing via a spliceosomal mechanism."" [GOC:jid]",23,787,8,21031,0.010165184243964422,0.34782608695652173,Module 0,"['GO:0000398', 'GO:0033119', 'GO:0048024', 'GO:0050686']"
3577,HPA,HPA:0471391,skin 2; cells in basal layer[≥Low],0.002309768596758878,True,skin 2; cells in basal layer[≥Low],962,79,20,11019,0.25316455696202533,0.02079002079002079,Module 3,['HPA:0470000']
3578,HPA,HPA:0570781,testis; preleptotene spermatocytes[≥Low],0.0023210784745967194,True,testis; preleptotene spermatocytes[≥Low],1900,612,147,11019,0.24019607843137256,0.07736842105263157,Module 0,['HPA:0570000']
3579,GO:BP,GO:0035556,intracellular signal transduction,0.0023305247892989604,True,"""The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell."" [GOC:bf, GOC:jl, GOC:signaling, ISBN:3527303782]",2668,226,55,21031,0.24336283185840707,0.020614692653673165,Module 1,['GO:0007165']
3580,TF,TF:M11427,Factor: PEA3; motif: NACCGGAAGTN,0.0023332458409926057,True,Factor: PEA3; motif: NACCGGAAGTN,10834,183,131,20045,0.7158469945355191,0.012091563596086395,Module Singleton,['TF:M00000']
3581,KEGG,KEGG:04062,Chemokine signaling pathway,0.0023364861717121584,True,Chemokine signaling pathway,190,4,3,8484,0.75,0.015789473684210527,Module 12,['KEGG:00000']
3582,GO:MF,GO:0019205,nucleobase-containing compound kinase activity,0.002339154190154043,True,"""Catalysis of the transfer of a phosphate group, usually from ATP or GTP, to a nucleobase, nucleoside, nucleotide or polynucleotide substrate."" [GOC:jl]",44,2,2,20212,1.0,0.045454545454545456,Module 39,['GO:0016301']
3583,TF,TF:M11877,Factor: pax-2; motif: NCGTCACGCNYSRNYGCNYN,0.002339259680674692,True,Factor: pax-2; motif: NCGTCACGCNYSRNYGCNYN,11775,826,552,20045,0.6682808716707022,0.04687898089171975,Module 0,['TF:M00000']
3584,HPA,HPA:0030441,appendix; non-germinal center cells[≥Low],0.002340106114895139,True,appendix; non-germinal center cells[≥Low],336,12,5,11019,0.4166666666666667,0.01488095238095238,Module 6,['HPA:0030000']
3585,HPA,HPA:0470683,skin 2; epidermal cells[High],0.002340886731609943,True,skin 2; epidermal cells[High],1049,79,21,11019,0.26582278481012656,0.02001906577693041,Module 3,['HPA:0470682']
3586,TF,TF:M10104,Factor: YY1; motif: CAARATGGCGGC,0.0023462312529300847,True,Factor: YY1; motif: CAARATGGCGGC,6115,105,56,20045,0.5333333333333333,0.009157808667211774,Module 3,['TF:M00000']
3587,HPA,HPA:0461452,skin 1; hair follicles[≥Medium],0.0023546373253478304,True,skin 1; hair follicles[≥Medium],293,166,16,11019,0.0963855421686747,0.05460750853242321,Module 2,['HPA:0461451']
3588,GO:CC,GO:0005856,cytoskeleton,0.002367929639522263,True,"""A cellular structure that forms the internal framework of eukaryotic and prokaryotic cells. The cytoskeleton includes intermediate filaments, microfilaments, microtubules, the microtrabecular lattice, and other structures characterized by a polymeric filamentous nature and long-range order within the cell. The various elements of the cytoskeleton not only serve in the maintenance of cellular shape but also have roles in other cellular functions, including cellular movement, cell division, endocytosis, and movement of organelles."" [GOC:mah, PMID:16959967, PMID:27419875]",2430,813,130,22097,0.15990159901599016,0.053497942386831275,Module 0,['GO:0043232']
3589,KEGG,KEGG:04061,Viral protein interaction with cytokine and cytokine receptor,0.002371100351776622,True,Viral protein interaction with cytokine and cytokine receptor,98,136,9,8484,0.0661764705882353,0.09183673469387756,Module 1,['KEGG:00000']
3590,HP,HP:0002174,Postural tremor,0.0023744871393217228,True,A type of tremors that is triggered by holding a limb in a fixed position.,68,44,7,4958,0.1590909090909091,0.10294117647058823,Module 3,['HP:0002345']
3591,MIRNA,MIRNA:hsa-miR-146a-5p,hsa-miR-146a-5p,0.0023956478818994206,True,hsa-miR-146a-5p,228,30,6,14819,0.2,0.02631578947368421,Module 7,['MIRNA:000000']
3592,WP,WP:WP3945,TYROBP causal network in microglia,0.002399068911740374,True,TYROBP causal network in microglia,60,154,8,8286,0.05194805194805195,0.13333333333333333,Module 2,['WP:000000']
3593,HPA,HPA:0471422,skin 2; eccrine glands[≥Medium],0.0023995361287126385,True,skin 2; eccrine glands[≥Medium],72,612,15,11019,0.024509803921568627,0.20833333333333334,Module 0,['HPA:0471421']
3594,GO:BP,GO:0015990,electron transport coupled proton transport,0.0024010802375027847,True,"""The transport of protons against an electrochemical gradient, using energy from electron transport."" [GOC:mah]",5,105,3,21031,0.02857142857142857,0.6,Module 3,['GO:0015988']
3595,GO:BP,GO:0015988,"energy coupled proton transmembrane transport, against electrochemical gradient",0.0024010802375027847,True,"""The transport of protons across a membrane and against an electrochemical gradient, using energy from a source such as ATP hydrolysis, light, or electron transport."" [GOC:mah]",5,105,3,21031,0.02857142857142857,0.6,Module 3,['GO:1902600']
3596,HPA,HPA:0400652,rectum; fibroblasts[≥Medium],0.0024023071484590894,True,rectum; fibroblasts[≥Medium],108,140,9,11019,0.06428571428571428,0.08333333333333333,Module Singleton,['HPA:0400651']
3597,GO:BP,GO:0031343,positive regulation of cell killing,0.002413395577673895,True,"""Any process that activates or increases the frequency, rate or extent of cell killing."" [GOC:mah]",73,226,8,21031,0.035398230088495575,0.1095890410958904,Module 1,"['GO:0001906', 'GO:0031341', 'GO:0048522']"
3598,HPA,HPA:0300413,lung; macrophages[High],0.0024156051890736204,True,lung; macrophages[High],1371,12,8,11019,0.6666666666666666,0.005835156819839533,Module 6,['HPA:0300412']
3599,HPA,HPA:0461391,skin 1; cells in basal layer[≥Low],0.0024205538592872605,True,skin 1; cells in basal layer[≥Low],881,79,19,11019,0.24050632911392406,0.021566401816118047,Module 3,['HPA:0460000']
3600,KEGG,KEGG:05135,Yersinia infection,0.002425581093894037,True,Yersinia infection,136,439,20,8484,0.04555808656036447,0.14705882352941177,Module 0,['KEGG:00000']
3601,GO:BP,GO:0010721,negative regulation of cell development,0.0024497143575726737,True,"""Any process that decreases the rate, frequency or extent of the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate."" [GOC:BHF, GOC:dph, GOC:tb]",279,215,14,21031,0.06511627906976744,0.05017921146953405,Module 2,"['GO:0045596', 'GO:0048468', 'GO:0060284']"
3602,TF,TF:M04020_1,Factor: IRF8; motif: NCGAAACCGAAACT; match class: 1,0.0024561506400503056,True,Factor: IRF8; motif: NCGAAACCGAAACT; match class: 1,44,36,4,20045,0.1111111111111111,0.09090909090909091,Module 7,['TF:M04020']
3603,HPA,HPA:0310433,lymph node; germinal center cells[High],0.002461267121385001,True,lymph node; germinal center cells[High],944,12,7,11019,0.5833333333333334,0.007415254237288136,Module 6,['HPA:0310432']
3604,TF,TF:M11018_1,Factor: IRX-1; motif: NACRYNNNNNNNNRYGNN; match class: 1,0.0024656841209018602,True,Factor: IRX-1; motif: NACRYNNNNNNNNRYGNN; match class: 1,16304,105,102,20045,0.9714285714285714,0.0062561334641805695,Module 3,['TF:M11018']
3605,HP,HP:0001939,Abnormality of metabolism/homeostasis,0.002470825962122697,True,Abnormality of metabolism/homeostasis,2591,44,38,4958,0.8636363636363636,0.01466615206483983,Module 3,['HP:0000118']
3606,HP,HP:0002601,Paresis of extensor muscles of the big toe,0.0024729857264246297,True,Paresis of extensor muscles of the big toe,6,3,2,4958,0.6666666666666666,0.3333333333333333,Module 9,"['HP:0001844', 'HP:0002460']"
3607,TF,TF:M11391,Factor: Erg; motif: NACCGGATATCCGGTN,0.0024753204325109342,True,Factor: Erg; motif: NACCGGATATCCGGTN,10310,826,493,20045,0.5968523002421308,0.047817652764306495,Module 0,['TF:M00000']
3608,GO:BP,GO:1901796,regulation of signal transduction by p53 class mediator,0.002479759924744493,True,"""Any process that modulates the frequency, rate or extent of signal transduction by p53 class mediator."" [GOC:TermGenie]",109,105,7,21031,0.06666666666666667,0.06422018348623854,Module 3,"['GO:0072331', 'GO:1902531']"
3609,TF,TF:M07358,Factor: HSF2; motif: NGGAATNTTCTNGNRN,0.002485421500083584,True,Factor: HSF2; motif: NGGAATNTTCTNGNRN,577,21,7,20045,0.3333333333333333,0.012131715771230503,Module 9,['TF:M00000']
3610,HPA,HPA:0580000,thymus,0.002491294108339293,True,thymus,30,185,6,11019,0.032432432432432434,0.2,Module 1,['HPA:0000000']
3611,GO:BP,GO:0006356,regulation of transcription by RNA polymerase I,0.002492709010749479,True,"""Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase I."" [GOC:go_curators]",48,787,11,21031,0.01397712833545108,0.22916666666666666,Module 0,"['GO:0006355', 'GO:0006360']"
3612,TF,TF:M00920_1,Factor: E2F; motif: NKCGCGCSAAAN; match class: 1,0.0024974359924847212,True,Factor: E2F; motif: NKCGCGCSAAAN; match class: 1,1339,80,19,20045,0.2375,0.014189693801344288,Module 5,['TF:M00920']
3613,GO:BP,GO:2001057,reactive nitrogen species metabolic process,0.0025063445211736817,True,"""The chemical reactions and pathways involving a reactive nitrogen species."" [GOC:obol]",77,215,8,21031,0.037209302325581395,0.1038961038961039,Module 2,['GO:0006807']
3614,WP,WP:WP3888,VEGFA VEGFR2 signaling,0.002507031103058976,True,VEGFA VEGFR2 signaling,430,101,17,8286,0.16831683168316833,0.03953488372093023,Module 3,['WP:000000']
3615,TF,TF:M12152,Factor: Sp1; motif: NWRGCCACGCCCMCN,0.002520884376978011,True,Factor: Sp1; motif: NWRGCCACGCCCMCN,7548,826,378,20045,0.4576271186440678,0.050079491255961846,Module 0,['TF:M00000']
3616,HPA,HPA:0360051,parathyroid gland; glandular cells[≥Low],0.002526082849410079,True,parathyroid gland; glandular cells[≥Low],5898,79,61,11019,0.7721518987341772,0.010342488979315022,Module 3,['HPA:0360000']
3617,HPA,HPA:0360000,parathyroid gland,0.002526082849410079,True,parathyroid gland,5898,79,61,11019,0.7721518987341772,0.010342488979315022,Module 3,['HPA:0000000']
3618,HPA,HPA:0130000,colon,0.0025462155329033774,True,colon,8342,60,58,11019,0.9666666666666667,0.00695276912011508,Module 4,['HPA:0000000']
3619,TF,TF:M08874_1,Factor: E2F1; motif: NNNNNGCGSSAAAN; match class: 1,0.0025467067159661034,True,Factor: E2F1; motif: NNNNNGCGSSAAAN; match class: 1,2225,80,25,20045,0.3125,0.011235955056179775,Module 5,['TF:M08874']
3620,TF,TF:M00641,Factor: HSF; motif: TTCCMGARGYTTC,0.002561453106803845,True,Factor: HSF; motif: TTCCMGARGYTTC,3641,21,14,20045,0.6666666666666666,0.0038450975006866246,Module 9,['TF:M00000']
3621,KEGG,KEGG:01232,Nucleotide metabolism,0.002562804345752884,True,Nucleotide metabolism,84,2,2,8484,1.0,0.023809523809523808,Module 39,['KEGG:00000']
3622,HP,HP:0002012,Abnormality of the abdominal organs,0.0025663862777618417,True,An abnormality of the viscera of the abdomen.,1335,71,38,4958,0.5352112676056338,0.02846441947565543,Module 1,['HP:0025031']
3623,GO:BP,GO:0051346,negative regulation of hydrolase activity,0.0025739131157042423,True,"""Any process that stops or reduces the rate of hydrolase activity, the catalysis of the hydrolysis of various bonds."" [GOC:ai]",167,215,11,21031,0.05116279069767442,0.0658682634730539,Module 2,"['GO:0043086', 'GO:0051336']"
3624,TF,TF:M09905,Factor: SAP-1; motif: NNCCGGAAGTGN,0.0025803822700756858,True,Factor: SAP-1; motif: NNCCGGAAGTGN,8485,183,110,20045,0.6010928961748634,0.01296405421331762,Module Singleton,['TF:M00000']
3625,HPA,HPA:0461441,skin 1; fibrohistiocytic cells[≥Low],0.002582759668723354,True,skin 1; fibrohistiocytic cells[≥Low],885,79,19,11019,0.24050632911392406,0.021468926553672316,Module 3,['HPA:0460000']
3626,GO:BP,GO:0140374,antiviral innate immune response,0.0025920592201804887,True,"""A defense response against viruses mediated through an innate immune response. An innate immune response is mediated by germline encoded components that directly recognize components of potential pathogens."" [PMID:31006531]",51,34,4,21031,0.11764705882352941,0.0784313725490196,Module 7,"['GO:0045087', 'GO:0051607']"
3627,HPA,HPA:0471472,skin 2; lymphocytes[≥Medium],0.0025984530154725773,True,skin 2; lymphocytes[≥Medium],647,79,16,11019,0.20253164556962025,0.02472952086553323,Module 3,['HPA:0471471']
3628,HP,HP:0000408,Progressive sensorineural hearing impairment,0.0026181151056677973,True,A progressive form of sensorineural hearing impairment.,44,44,6,4958,0.13636363636363635,0.13636363636363635,Module 3,"['HP:0000407', 'HP:0001730']"
3629,TF,TF:M03983_1,Factor: ETV5; motif: NCCGGAWGYN; match class: 1,0.0026370077679239833,True,Factor: ETV5; motif: NCCGGAWGYN; match class: 1,547,826,48,20045,0.05811138014527845,0.08775137111517367,Module 0,['TF:M03983']
3630,HP,HP:0000245,Abnormal paranasal sinus morphology,0.0026614195944128878,True,"Abnormality of the paranasal (cranial) sinuses, which are air-filled spaces that are located within the bones of the skull and face and communicate with the nasal cavity. They comprise the maxillary sinuses, the frontal sinuses, the ethmoid sinuses, and the sphenoid sinuses.",186,71,13,4958,0.18309859154929578,0.06989247311827956,Module 1,"['HP:0002087', 'HP:0011821']"
3631,TF,TF:M02070_1,Factor: TEL1; motif: CNCGGAANNN; match class: 1,0.002662886666200577,True,Factor: TEL1; motif: CNCGGAANNN; match class: 1,4988,105,49,20045,0.4666666666666667,0.009823576583801123,Module 3,['TF:M02070']
3632,TF,TF:M00772,Factor: IRF; motif: RRAANTGAAASYGNV,0.0026640073135600533,True,Factor: IRF; motif: RRAANTGAAASYGNV,1037,36,11,20045,0.3055555555555556,0.010607521697203472,Module 7,['TF:M00000']
3633,TF,TF:M10578_1,Factor: Barhl-1; motif: NTAAACGN; match class: 1,0.0026670804432466794,True,Factor: Barhl-1; motif: NTAAACGN; match class: 1,1426,105,23,20045,0.21904761904761905,0.016129032258064516,Module 3,['TF:M10578']
3634,GO:BP,GO:0051251,positive regulation of lymphocyte activation,0.0026673077959314144,True,"""Any process that activates or increases the frequency, rate or extent of lymphocyte activation."" [GOC:ai]",323,215,15,21031,0.06976744186046512,0.04643962848297214,Module 2,"['GO:0002696', 'GO:0046649', 'GO:0051249']"
3635,GO:CC,GO:0032991,protein-containing complex,0.0026697370589021246,True,"""A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together."" [GOC:dos, GOC:mah]",8588,73,47,22097,0.6438356164383562,0.0054727526781555656,Module 4,['GO:0005575']
3636,HPA,HPA:0461473,skin 1; lymphocytes[High],0.0026758909283528315,True,skin 1; lymphocytes[High],394,140,17,11019,0.12142857142857143,0.04314720812182741,Module Singleton,['HPA:0461472']
3637,GO:BP,GO:0070841,inclusion body assembly,0.0026770645573363284,True,"""The aggregation, arrangement and bonding together of a set of components to form an inclusion body."" [GOC:BHF, GOC:mah]",24,21,3,21031,0.14285714285714285,0.125,Module 9,['GO:0022607']
3638,GO:BP,GO:1902600,proton transmembrane transport,0.002680556262045535,True,"""The directed movement of a proton across a membrane."" [GO_REF:0000069, GOC:pr, GOC:TermGenie]",159,105,8,21031,0.0761904761904762,0.050314465408805034,Module 3,"['GO:0098655', 'GO:0098662']"
3639,GO:BP,GO:0006518,peptide metabolic process,0.0027037694156096187,True,"""The chemical reactions and pathways involving peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another."" [GOC:go_curators]",911,172,23,21031,0.13372093023255813,0.025246981339187707,Module Singleton,"['GO:0043603', 'GO:1901564']"
3640,GO:MF,GO:0035591,signaling adaptor activity,0.002707645449951833,True,"""The binding activity of a molecule that brings together two or more molecules in a signaling pathway, permitting those molecules to function in a coordinated way. Adaptor molecules themselves do not have catalytic activity."" [GOC:bf, PMID:19104498]",104,808,16,20212,0.019801980198019802,0.15384615384615385,Module 0,['GO:0030674']
3641,HPA,HPA:0470201,skin 2; endothelial cells[≥Low],0.002710792287782273,True,skin 2; endothelial cells[≥Low],888,79,19,11019,0.24050632911392406,0.021396396396396396,Module 3,['HPA:0470000']
3642,REAC,REAC:R-HSA-69306,DNA Replication,0.002711284065501403,True,DNA Replication,187,59,8,10842,0.13559322033898305,0.0427807486631016,Module 5,['REAC:0000000']
3643,HPA,HPA:0470182,skin 2; cells in granular layer[≥Medium],0.002712293544220645,True,skin 2; cells in granular layer[≥Medium],562,18,7,11019,0.3888888888888889,0.012455516014234875,Module 9,['HPA:0470181']
3644,HPA,HPA:0330223,oral mucosa; squamous epithelial cells[High],0.002741295917473635,True,oral mucosa; squamous epithelial cells[High],1152,612,98,11019,0.16013071895424835,0.08506944444444445,Module 0,['HPA:0330222']
3645,TF,TF:M12277,Factor: YY2; motif: NKCSGCCATTTTGN,0.0027531479431802796,True,Factor: YY2; motif: NKCSGCCATTTTGN,136,826,20,20045,0.024213075060532687,0.14705882352941177,Module 0,['TF:M00000']
3646,HPA,HPA:0151352,duodenum; paneth cells[≥Medium],0.00275491152947024,True,duodenum; paneth cells[≥Medium],252,79,10,11019,0.12658227848101267,0.03968253968253968,Module 3,['HPA:0151351']
3647,GO:CC,GO:0015629,actin cytoskeleton,0.00278850309927352,True,"""The part of the cytoskeleton (the internal framework of a cell) composed of actin and associated proteins. Includes actin cytoskeleton-associated complexes."" [GOC:jl, ISBN:0395825172, ISBN:0815316194]",515,813,40,22097,0.04920049200492005,0.07766990291262135,Module 0,['GO:0005856']
3648,GO:CC,GO:0005886,plasma membrane,0.002793532902753094,True,"""The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins."" [ISBN:0716731363]",5742,17,13,22097,0.7647058823529411,0.0022640195053988156,Module 6,"['GO:0016020', 'GO:0071944']"
3649,HPA,HPA:0600442,tonsil; non-germinal center cells[≥Medium],0.0027970936918187248,True,tonsil; non-germinal center cells[≥Medium],4200,23,19,11019,0.8260869565217391,0.004523809523809524,Module 10,['HPA:0600441']
3650,HPA,HPA:0470672,skin 2; melanocytes[≥Medium],0.002799894663923762,True,skin 2; melanocytes[≥Medium],640,166,25,11019,0.15060240963855423,0.0390625,Module 2,['HPA:0470671']
3651,KEGG,KEGG:05012,Parkinson disease,0.0028002405515200795,True,Parkinson disease,265,53,9,8484,0.16981132075471697,0.033962264150943396,Module 5,['KEGG:00000']
3652,HPA,HPA:0090193,cerebellum; cells in molecular layer[High],0.0028031765501753863,True,cerebellum; cells in molecular layer[High],918,612,82,11019,0.13398692810457516,0.08932461873638345,Module 0,['HPA:0090192']
3653,TF,TF:M00736_1,Factor: E2F-1:DP-1; motif: TTTCSCGC; match class: 1,0.0028033312665733286,True,Factor: E2F-1:DP-1; motif: TTTCSCGC; match class: 1,4779,80,39,20045,0.4875,0.008160703075957313,Module 5,['TF:M00736']
3654,HPA,HPA:0270000,kidney,0.0028062389943473995,True,kidney,8237,79,74,11019,0.9367088607594937,0.00898385334466432,Module 3,['HPA:0000000']
3655,HPA,HPA:0090182,cerebellum; cells in granular layer[≥Medium],0.002807879767455489,True,cerebellum; cells in granular layer[≥Medium],2931,612,210,11019,0.3431372549019608,0.07164790174002048,Module 0,['HPA:0090181']
3656,KEGG,KEGG:05170,Human immunodeficiency virus 1 infection,0.0028136311883591573,True,Human immunodeficiency virus 1 infection,210,136,13,8484,0.09558823529411764,0.06190476190476191,Module 1,['KEGG:00000']
3657,GO:BP,GO:0071705,nitrogen compound transport,0.002822933301141329,True,"""The directed movement of nitrogen-containing compounds into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore."" [GOC:mah]",1911,172,36,21031,0.20930232558139536,0.018838304552590265,Module Singleton,['GO:0006810']
3658,GO:BP,GO:0001909,leukocyte mediated cytotoxicity,0.002824063022104656,True,"""The directed killing of a target cell by a leukocyte."" [GO_REF:0000022, GOC:add, ISBN:0781735149, PMID:11911826]",133,15,4,21031,0.26666666666666666,0.03007518796992481,Module 6,"['GO:0001906', 'GO:0002443']"
3659,GO:BP,GO:0032606,type I interferon production,0.002829061110841358,True,"""The appearance of type I interferon due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families."" [GOC:add, ISBN:0126896631, PMID:15546383, PMID:16681834]",122,34,5,21031,0.14705882352941177,0.040983606557377046,Module 7,['GO:0001816']
3660,GO:BP,GO:0032479,regulation of type I interferon production,0.002829061110841358,True,"""Any process that modulates the frequency, rate, or extent of interferon type I production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families."" [GOC:add, GOC:mah]",122,34,5,21031,0.14705882352941177,0.040983606557377046,Module 7,"['GO:0001817', 'GO:0032606']"
3661,TF,TF:M12557,Factor: ETV5; motif: NNACTTCCGNN,0.0028370553538269766,True,Factor: ETV5; motif: NNACTTCCGNN,4528,105,46,20045,0.4380952380952381,0.010159010600706713,Module 3,['TF:M00000']
3662,KEGG,KEGG:04727,GABAergic synapse,0.002878927658625445,True,GABAergic synapse,89,2,2,8484,1.0,0.02247191011235955,Module 22,['KEGG:00000']
3663,KEGG,KEGG:05032,Morphine addiction,0.002878927658625445,True,Morphine addiction,89,2,2,8484,1.0,0.02247191011235955,Module 22,['KEGG:00000']
3664,GO:BP,GO:0042742,defense response to bacterium,0.002879989711056341,True,"""Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism."" [GOC:jl]",325,215,15,21031,0.06976744186046512,0.046153846153846156,Module 2,"['GO:0009617', 'GO:0098542']"
3665,GO:BP,GO:0043085,positive regulation of catalytic activity,0.0028816446602921188,True,"""Any process that activates or increases the activity of an enzyme."" [GOC:ebc, GOC:jl, GOC:tb, GOC:vw]",773,215,24,21031,0.11162790697674418,0.031047865459249677,Module 2,"['GO:0044093', 'GO:0050790']"
3666,HPA,HPA:0010011,adipose tissue; adipocytes[≥Low],0.00290152665549556,True,adipose tissue; adipocytes[≥Low],3943,60,38,11019,0.6333333333333333,0.009637331980725337,Module 4,['HPA:0010000']
3667,HPA,HPA:0010000,adipose tissue,0.00290152665549556,True,adipose tissue,3943,60,38,11019,0.6333333333333333,0.009637331980725337,Module 4,['HPA:0000000']
3668,GO:MF,GO:0019955,cytokine binding,0.0029063924121223044,True,"""Binding to a cytokine, any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity."" [GOC:ai, GOC:bf, ISBN:0198599471]",145,232,10,20212,0.04310344827586207,0.06896551724137931,Module 1,['GO:0005515']
3669,HPA,HPA:0170253,endometrium 2; cells in endometrial stroma[High],0.002911130360625483,True,endometrium 2; cells in endometrial stroma[High],358,69,11,11019,0.15942028985507245,0.030726256983240222,Module 5,['HPA:0170252']
3670,GO:BP,GO:0045088,regulation of innate immune response,0.002915942273983965,True,"""Any process that modulates the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection."" [GOC:ebc]",415,215,17,21031,0.07906976744186046,0.04096385542168675,Module 2,"['GO:0002831', 'GO:0031347', 'GO:0032101', 'GO:0045087', 'GO:0050776']"
3671,GO:BP,GO:1902531,regulation of intracellular signal transduction,0.0029384529046347575,True,"""Any process that modulates the frequency, rate or extent of intracellular signal transduction."" [GOC:dph, GOC:signaling, GOC:tb, GOC:TermGenie]",1766,215,40,21031,0.18604651162790697,0.022650056625141562,Module 2,"['GO:0009966', 'GO:0035556']"
3672,TF,TF:M00187,Factor: USF; motif: GYCACGTGNC,0.002963069965448441,True,Factor: USF; motif: GYCACGTGNC,3803,826,212,20045,0.2566585956416465,0.055745464107283725,Module 0,['TF:M00000']
3673,GO:BP,GO:0071383,cellular response to steroid hormone stimulus,0.002965731354574674,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus."" [GOC:mah]",215,21,5,21031,0.23809523809523808,0.023255813953488372,Module 9,"['GO:0032870', 'GO:0048545', 'GO:0071396', 'GO:0071407']"
3674,REAC,REAC:R-HSA-5603041,IRAK4 deficiency (TLR2/4),0.002970181723025819,True,IRAK4 deficiency (TLR2/4),18,173,5,10842,0.028901734104046242,0.2777777777777778,Module 2,['REAC:R-HSA-5602358']
3675,TF,TF:M02058,Factor: SAP1A; motif: NCCGGAARYN,0.0029787447916460575,True,Factor: SAP1A; motif: NCCGGAARYN,859,826,66,20045,0.07990314769975787,0.07683352735739232,Module 0,['TF:M00000']
3676,REAC,REAC:R-HSA-389977,Post-chaperonin tubulin folding pathway,0.0029801570412351713,True,Post-chaperonin tubulin folding pathway,24,59,4,10842,0.06779661016949153,0.16666666666666666,Module 5,['REAC:R-HSA-391251']
3677,HPA,HPA:0160052,endometrium 1; glandular cells[≥Medium],0.0030202949632312454,True,endometrium 1; glandular cells[≥Medium],5155,69,50,11019,0.7246376811594203,0.009699321047526674,Module 5,['HPA:0160051']
3678,HPA,HPA:0530723,spleen; cells in white pulp[High],0.003034011572797453,True,spleen; cells in white pulp[High],847,69,17,11019,0.2463768115942029,0.020070838252656435,Module 5,['HPA:0530722']
3679,HPA,HPA:0430052,seminal vesicle; glandular cells[≥Medium],0.0030421852292892133,True,seminal vesicle; glandular cells[≥Medium],5238,60,45,11019,0.75,0.00859106529209622,Module 4,['HPA:0430051']
3680,GO:MF,GO:0097367,carbohydrate derivative binding,0.003042753615346501,True,"""Binding to a carbohydrate derivative."" [GOC:pr]",2304,80,24,20212,0.3,0.010416666666666666,Module 5,['GO:0005488']
3681,GO:CC,GO:0098588,bounding membrane of organelle,0.0030472423182600454,True,"""The lipid bilayer that forms the outer-most layer of an organelle."" [GOC:dos]",2203,177,37,22097,0.20903954802259886,0.016795279164775308,Module Singleton,['GO:0031090']
3682,REAC,REAC:R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,0.003050627828012209,True,TNFR2 non-canonical NF-kB pathway,100,586,18,10842,0.030716723549488054,0.18,Module 0,['REAC:R-HSA-1280215']
3683,GO:BP,GO:0071346,cellular response to type II interferon,0.0030657758896871917,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon gamma is the only member of the type II interferon found so far."" [GOC:mah]",124,34,5,21031,0.14705882352941177,0.04032258064516129,Module 7,"['GO:0034341', 'GO:0071345']"
3684,GO:CC,GO:0099080,supramolecular complex,0.0030680138488230497,True,"""A cellular component that consists of an indeterminate number of proteins or macromolecular complexes, organized into a regular, higher-order structure such as a polymer, sheet, network or a fiber."" [GOC:dos]",1426,80,17,22097,0.2125,0.011921458625525946,Module 5,['GO:0110165']
3685,HPA,HPA:0030892,appendix; goblet cells[≥Medium],0.003073878804803844,True,appendix; goblet cells[≥Medium],313,79,11,11019,0.13924050632911392,0.03514376996805112,Module 3,['HPA:0030891']
3686,REAC,REAC:R-HSA-9663891,Selective autophagy,0.003079320340688687,True,Selective autophagy,80,19,4,10842,0.21052631578947367,0.05,Module 9,['REAC:R-HSA-1632852']
3687,GO:CC,GO:0043233,organelle lumen,0.003080093914172489,True,"""The internal volume enclosed by the membranes of a particular organelle; includes the volume enclosed by a single organelle membrane, e.g. endoplasmic reticulum lumen, or the volume enclosed by the innermost of the two lipid bilayers of an organelle envelope, e.g. nuclear lumen."" [GOC:jl, GOC:mah]",6657,21,16,22097,0.7619047619047619,0.0024034850533273247,Module 9,"['GO:0031974', 'GO:0043226']"
3688,GO:CC,GO:0031974,membrane-enclosed lumen,0.003080093914172489,True,"""The enclosed volume within a sealed membrane or between two sealed membranes. Encompasses the volume enclosed by the membranes of a particular organelle, e.g. endoplasmic reticulum lumen, or the space between the two lipid bilayers of a double membrane surrounding an organelle, e.g. nuclear envelope lumen."" [GOC:add, GOC:mah]",6657,21,16,22097,0.7619047619047619,0.0024034850533273247,Module 9,['GO:0110165']
3689,GO:CC,GO:0070013,intracellular organelle lumen,0.003080093914172489,True,"""An organelle lumen that is part of an intracellular organelle."" [GOC:mah]",6657,21,16,22097,0.7619047619047619,0.0024034850533273247,Module 9,"['GO:0043229', 'GO:0043233']"
3690,MIRNA,MIRNA:hsa-miR-423-5p,hsa-miR-423-5p,0.0030836456501945344,True,hsa-miR-423-5p,343,104,12,14819,0.11538461538461539,0.03498542274052478,Module 3,['MIRNA:000000']
3691,GO:MF,GO:0030674,protein-macromolecule adaptor activity,0.0031017194664889162,True,"""The binding activity of a protein that brings together two or more macromolecules in contact, permitting those molecules to function in a coordinated way. The adaptor can bring together two proteins, or a protein and another macromolecule such as a lipid or a nucleic acid."" [GOC:bf, GOC:mah, GOC:vw]",947,808,67,20212,0.08292079207920793,0.07074973600844774,Module 0,['GO:0060090']
3692,GO:BP,GO:1903312,negative regulation of mRNA metabolic process,0.0031037392594132295,True,"""Any process that stops, prevents or reduces the frequency, rate or extent of mRNA metabolic process."" [GO_REF:0000058, GOC:TermGenie, GOC:vw]",101,172,8,21031,0.046511627906976744,0.07920792079207921,Module Singleton,"['GO:0016071', 'GO:0051253', 'GO:1903311']"
3693,TF,TF:M10880,Factor: Alx-4; motif: NNCRTTAN,0.0031070793800494732,True,Factor: Alx-4; motif: NNCRTTAN,8700,826,426,20045,0.5157384987893463,0.04896551724137931,Module 0,['TF:M00000']
3694,REAC,REAC:R-HSA-69206,G1/S Transition,0.0031156016456949866,True,G1/S Transition,130,586,21,10842,0.03583617747440273,0.16153846153846155,Module 0,['REAC:R-HSA-453279']
3695,GO:CC,GO:0043231,intracellular membrane-bounded organelle,0.003125789166058763,True,"""Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane."" [GOC:go_curators]",14605,80,70,22097,0.875,0.004792879150975694,Module 5,"['GO:0043227', 'GO:0043229']"
3696,HPA,HPA:0470201,skin 2; endothelial cells[≥Low],0.003130823778671169,True,skin 2; endothelial cells[≥Low],888,185,33,11019,0.1783783783783784,0.037162162162162164,Module 1,['HPA:0470000']
3697,HPA,HPA:0620223,vagina; squamous epithelial cells[High],0.0031366961056226265,True,vagina; squamous epithelial cells[High],1138,69,20,11019,0.2898550724637681,0.01757469244288225,Module 5,['HPA:0620222']
3698,GO:BP,GO:0050869,negative regulation of B cell activation,0.003139468412471127,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of B cell activation."" [GOC:ai]",34,226,6,21031,0.02654867256637168,0.17647058823529413,Module 1,"['GO:0042113', 'GO:0050864', 'GO:0051250']"
3699,GO:BP,GO:0097530,granulocyte migration,0.0031429433841586776,True,"""The movement of a granulocyte within or between different tissues and organs of the body."" [GOC:cvs, PMID:24163421, PMID:24193336]",156,5,3,21031,0.6,0.019230769230769232,Module 12,['GO:0097529']
3700,TF,TF:M05304_1,Factor: Zbtb5; motif: AGGRAGCTTC; match class: 1,0.003155852554558253,True,Factor: Zbtb5; motif: AGGRAGCTTC; match class: 1,12,5,2,20045,0.4,0.16666666666666666,Module 12,['TF:M05304']
3701,HP,HP:0001903,Anemia,0.0031708350163990153,True,A reduction in erythrocytes volume or hemoglobin concentration.,614,71,24,4958,0.3380281690140845,0.03908794788273615,Module 1,['HP:0001877']
3702,GO:CC,GO:0098796,membrane protein complex,0.0031775893941682824,True,"""Any protein complex that is part of a membrane."" [GOC:dos]",1401,73,16,22097,0.2191780821917808,0.011420413990007138,Module 4,"['GO:0016020', 'GO:0032991']"
3703,HP,HP:0034435,Abnormal eye contact,0.0031802340951551087,True,Any abnormality of eye contact behavior. We define eye contact as a form of nonverbal communication between two individuals who are facing each other in which an individual directs the eyes towards the eyes or face of the other individual. Eye contact occurs frequently and voluntarily during face-to-face verbal communication. The duration and frequency of eye contact that is interpreted to be appropriate may follow social and situational norms.,109,228,18,4958,0.07894736842105263,0.1651376146788991,Module 0,['HP:0000758']
3704,HP,HP:0000817,Reduced eye contact,0.0031802340951551087,True,A reduced frequency or duration of eye contact.,109,228,18,4958,0.07894736842105263,0.1651376146788991,Module 0,['HP:0034435']
3705,HPA,HPA:0530711,spleen; cells in red pulp[≥Low],0.0031966094769873303,True,spleen; cells in red pulp[≥Low],5333,69,51,11019,0.7391304347826086,0.009563097693605851,Module 5,['HPA:0530000']
3706,GO:MF,GO:0030234,enzyme regulator activity,0.003198220309052743,True,"""Binds to and modulates the activity of an enzyme."" [GOC:dph, GOC:mah, GOC:tb]",1296,808,85,20212,0.1051980198019802,0.06558641975308642,Module 0,['GO:0098772']
3707,GO:CC,GO:0140535,intracellular protein-containing complex,0.0031991973579813325,True,"""A protein-containing complex located intracellularly."" [GOC:pg]",951,21,7,22097,0.3333333333333333,0.007360672975814932,Module 9,['GO:0032991']
3708,GO:BP,GO:0009162,deoxyribonucleoside monophosphate metabolic process,0.0032100225441658078,True,"""The chemical reactions and pathways involving a deoxyribonucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose sugar esterified with phosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",24,77,4,21031,0.05194805194805195,0.16666666666666666,Module 5,['GO:0009123']
3709,GO:BP,GO:1903706,regulation of hemopoiesis,0.003215963090113524,True,"""Any process that modulates the frequency, rate or extent of hemopoiesis."" [GO_REF:0000058, GOC:pad, GOC:PARL, GOC:TermGenie, PMID:20080761]",418,215,17,21031,0.07906976744186046,0.04066985645933014,Module 2,"['GO:0002682', 'GO:0030097', 'GO:0060284', 'GO:2000026']"
3710,GO:BP,GO:0030155,regulation of cell adhesion,0.003224302427747804,True,"""Any process that modulates the frequency, rate or extent of attachment of a cell to another cell or to the extracellular matrix."" [GOC:mah]",778,215,24,21031,0.11162790697674418,0.030848329048843187,Module 2,"['GO:0007155', 'GO:0050794']"
3711,GO:BP,GO:0002237,response to molecule of bacterial origin,0.003238278515332434,True,"""Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin."" [GOC:rl, GOC:sm]",354,226,16,21031,0.07079646017699115,0.04519774011299435,Module 1,"['GO:0009617', 'GO:0010033', 'GO:0043207']"
3712,GO:BP,GO:0042221,response to chemical,0.003242738964964499,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemical stimulus."" [GOC:jl]",3957,21,14,21031,0.6666666666666666,0.0035380338640384128,Module 9,['GO:0050896']
3713,MIRNA,MIRNA:hsa-miR-877-5p,hsa-miR-877-5p,0.003244736835082326,True,hsa-miR-877-5p,232,104,10,14819,0.09615384615384616,0.04310344827586207,Module 3,['MIRNA:000000']
3714,HPA,HPA:0330222,oral mucosa; squamous epithelial cells[≥Medium],0.00324778855393745,True,oral mucosa; squamous epithelial cells[≥Medium],4358,69,45,11019,0.6521739130434783,0.010325837540156035,Module 5,['HPA:0330221']
3715,GO:BP,GO:0044089,positive regulation of cellular component biogenesis,0.003252951072865507,True,"""Any process that activates or increases the frequency, rate or extent of cellular component biogenesis, a process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a cellular component."" [GOC:jl]",509,787,42,21031,0.053367217280813214,0.0825147347740668,Module 0,"['GO:0044085', 'GO:0044087', 'GO:0048522']"
3716,HP,HP:0100763,Abnormality of the lymphatic system,0.0032686005953207714,True,"An anomaly of the lymphatic system, a network of lymphatic vessels that carry a clear fluid called lymph unidirectionally towards either the right lymphatic duct or the thoracic duct, which in turn drain into the right and left subclavian veins respectively.",769,74,28,4958,0.3783783783783784,0.036410923276983094,Module 2,"['HP:0002597', 'HP:0002715']"
3717,GO:BP,GO:0019219,regulation of nucleobase-containing compound metabolic process,0.003279281584813016,True,"""Any cellular process that modulates the frequency, rate or extent of the chemical reactions and pathways involving nucleobases, nucleosides, nucleotides and nucleic acids."" [GOC:go_curators]",4063,787,205,21031,0.2604828462515883,0.05045532857494462,Module 0,"['GO:0006139', 'GO:0031323', 'GO:0051171', 'GO:0080090']"
3718,GO:BP,GO:0080090,regulation of primary metabolic process,0.0032980973902458606,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism involving those compounds formed as a part of the normal anabolic and catabolic processes. These processes take place in most, if not all, cells of the organism."" [PMID:19211694]",5591,215,89,21031,0.413953488372093,0.015918440350563407,Module 2,"['GO:0019222', 'GO:0044238']"
3719,HP,HP:0009098,Chronic oral candidiasis,0.0032993421405556273,True,"Chronic accumulation and overgrowth of the fungus Candida albicans on the mucous membranes of the mouth, generally manifested as associated with creamy white lesions on the tongue or inner cheeks, occasionally spreading to the gums, tonsils, palate or oropharynx.",28,71,6,4958,0.08450704225352113,0.21428571428571427,Module 1,['HP:0002728']
3720,CORUM,CORUM:430,18S U11/U12 snRNP,0.0033024939411539066,True,18S U11/U12 snRNP,23,331,10,3383,0.030211480362537766,0.43478260869565216,Module 0,['CORUM:0000000']
3721,GO:BP,GO:0019538,protein metabolic process,0.0033039584397248512,True,"""The chemical reactions and pathways involving a protein. Includes protein modification."" [GOC:ma]",4912,215,81,21031,0.3767441860465116,0.016490228013029316,Module 2,"['GO:0043170', 'GO:0044238', 'GO:1901564']"
3722,WP,WP:WP3529,Zinc homeostasis,0.003316612845671296,True,Zinc homeostasis,36,14,3,8286,0.21428571428571427,0.08333333333333333,Module 10,['WP:000000']
3723,GO:BP,GO:0002833,positive regulation of response to biotic stimulus,0.0033262651908837083,True,"""Any process that activates or increases the frequency, rate, or extent of a response to biotic stimulus."" [GOC:add]",369,34,7,21031,0.20588235294117646,0.018970189701897018,Module 7,"['GO:0002831', 'GO:0009607', 'GO:0048584']"
3724,HPA,HPA:0160253,endometrium 1; cells in endometrial stroma[High],0.0033271820900762842,True,endometrium 1; cells in endometrial stroma[High],435,69,12,11019,0.17391304347826086,0.027586206896551724,Module 5,['HPA:0160252']
3725,GO:MF,GO:0015035,protein-disulfide reductase activity,0.0033338043796972815,True,"""Catalysis of the reaction: a protein with reduced sulfide groups = a protein with oxidized disulfide bonds."" [PMID:7559385]",33,72,4,20212,0.05555555555555555,0.12121212121212122,Module 4,"['GO:0015036', 'GO:0140096']"
3726,KEGG,KEGG:05020,Prion disease,0.0033393773704966955,True,Prion disease,271,53,9,8484,0.16981132075471697,0.033210332103321034,Module 5,['KEGG:00000']
3727,REAC,REAC:R-HSA-400508,"Incretin synthesis, secretion, and inactivation",0.003342580806603082,True,"Incretin synthesis, secretion, and inactivation",24,60,4,10842,0.06666666666666667,0.16666666666666666,Module 4,['REAC:R-HSA-2980736']
3728,GO:BP,GO:0045428,regulation of nitric oxide biosynthetic process,0.003343080473025234,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide."" [GOC:go_curators]",56,215,7,21031,0.03255813953488372,0.125,Module 2,"['GO:0006809', 'GO:0031326', 'GO:0080164']"
3729,HP,HP:0010936,Abnormality of the lower urinary tract,0.003348168460829552,True,An abnormality of the lower urinary tract.,849,44,21,4958,0.4772727272727273,0.024734982332155476,Module 3,['HP:0000079']
3730,GO:BP,GO:0006909,phagocytosis,0.0033530743762825283,True,"""A vesicle-mediated transport process that results in the engulfment of external particulate material by phagocytes and their delivery to the lysosome. The particles are initially contained within phagocytic vacuoles (phagosomes), which then fuse with primary lysosomes to effect digestion of the particles."" [ISBN:0198506732]",234,226,13,21031,0.05752212389380531,0.05555555555555555,Module 1,['GO:0006897']
3731,WP,WP:WP3995,Prion disease pathway,0.0033556328904866214,True,Prion disease pathway,32,148,6,8286,0.04054054054054054,0.1875,Module 1,['WP:000000']
3732,REAC,REAC:R-HSA-5260271,Diseases of Immune System,0.003362038265264588,True,Diseases of Immune System,31,173,6,10842,0.03468208092485549,0.1935483870967742,Module 2,['REAC:R-HSA-1643685']
3733,REAC,REAC:R-HSA-5602358,Diseases associated with the TLR signaling cascade,0.003362038265264588,True,Diseases associated with the TLR signaling cascade,31,173,6,10842,0.03468208092485549,0.1935483870967742,Module 2,['REAC:R-HSA-5260271']
3734,TF,TF:M07140,Factor: Kaiso; motif: NTCTCGCGAGANYTN,0.0033671057079475825,True,Factor: Kaiso; motif: NTCTCGCGAGANYTN,558,105,14,20045,0.13333333333333333,0.025089605734767026,Module 3,['TF:M00000']
3735,TF,TF:M11427_1,Factor: PEA3; motif: NACCGGAAGTN; match class: 1,0.0033707200139724224,True,Factor: PEA3; motif: NACCGGAAGTN; match class: 1,4710,105,47,20045,0.44761904761904764,0.009978768577494692,Module 3,['TF:M11427']
3736,TF,TF:M02074_1,Factor: GABPalpha; motif: RCCGGAWRYN; match class: 1,0.003396674534960317,True,Factor: GABPalpha; motif: RCCGGAWRYN; match class: 1,1020,105,19,20045,0.18095238095238095,0.018627450980392157,Module 3,['TF:M02074']
3737,GO:CC,GO:0036021,endolysosome lumen,0.0034001800367106792,True,"""The volume enclosed by the membrane of an endolysosome. An endolysosome is a transient hybrid organelle formed by fusion of a late endosome with a lysosome."" [GOC:pde]",5,221,3,22097,0.013574660633484163,0.6,Module 2,"['GO:0031904', 'GO:0036019', 'GO:0043202']"
3738,HPA,HPA:0530712,spleen; cells in red pulp[≥Medium],0.003413137773001591,True,spleen; cells in red pulp[≥Medium],3143,60,33,11019,0.55,0.010499522748965956,Module 4,['HPA:0530711']
3739,GO:BP,GO:0050866,negative regulation of cell activation,0.0034206130192017165,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of cell activation."" [GOC:ai]",208,215,12,21031,0.05581395348837209,0.057692307692307696,Module 2,"['GO:0001775', 'GO:0048523', 'GO:0050865', 'GO:0051241']"
3740,KEGG,KEGG:04713,Circadian entrainment,0.0034229538249642712,True,Circadian entrainment,97,2,2,8484,1.0,0.020618556701030927,Module 22,['KEGG:00000']
3741,GO:CC,GO:1905369,endopeptidase complex,0.003423267561764021,True,"""A protein complex which is capable of endopeptidase activity."" [GO_REF:0000088, GOC:bhm, GOC:TermGenie, PMID:1689240]",91,2,2,22097,1.0,0.02197802197802198,Module 41,['GO:1905368']
3742,HP,HP:0002135,Basal ganglia calcification,0.0034284276841837305,True,The presence of calcium deposition affecting one or more structures of the basal ganglia.,46,44,6,4958,0.13636363636363635,0.13043478260869565,Module 3,"['HP:0002134', 'HP:0002514']"
3743,HPA,HPA:0131302,colon; enterocytes[≥Medium],0.0034373056092776495,True,colon; enterocytes[≥Medium],379,79,12,11019,0.1518987341772152,0.0316622691292876,Module 3,['HPA:0131301']
3744,HPA,HPA:0420052,salivary gland; glandular cells[≥Medium],0.0034501654013541286,True,salivary gland; glandular cells[≥Medium],4872,60,43,11019,0.7166666666666667,0.008825944170771757,Module 4,['HPA:0420051']
3745,TF,TF:M08239,Factor: ERF:FOXI1; motif: RNAAACMGGAARTN,0.0034517423655244708,True,Factor: ERF:FOXI1; motif: RNAAACMGGAARTN,2293,826,140,20045,0.1694915254237288,0.06105538595726123,Module 0,['TF:M00000']
3746,GO:BP,GO:0044092,negative regulation of molecular function,0.003462932330165761,True,"""Any process that stops or reduces the rate or extent of a molecular function, an elemental biological activity occurring at the molecular level, such as catalysis or binding."" [GO:jl]",672,215,22,21031,0.10232558139534884,0.03273809523809524,Module 2,['GO:0065009']
3747,KEGG,KEGG:04217,Necroptosis,0.0034666577545360002,True,Necroptosis,158,23,5,8484,0.21739130434782608,0.03164556962025317,Module 7,['KEGG:00000']
3748,KEGG,KEGG:05160,Hepatitis C,0.0034666577545360002,True,Hepatitis C,158,23,5,8484,0.21739130434782608,0.03164556962025317,Module 7,['KEGG:00000']
3749,TF,TF:M11420_1,Factor: ER81; motif: NACCGGAAGTN; match class: 1,0.003469352646047875,True,Factor: ER81; motif: NACCGGAAGTN; match class: 1,503,826,45,20045,0.05447941888619855,0.08946322067594434,Module 0,['TF:M11420']
3750,TF,TF:M02011,Factor: HES-1; motif: GSCACGMGMC,0.0034741336522293325,True,Factor: HES-1; motif: GSCACGMGMC,4357,826,237,20045,0.28692493946731235,0.054395226072986,Module 0,['TF:M00000']
3751,MIRNA,MIRNA:hsa-miR-16-5p,hsa-miR-16-5p,0.0034868372289785293,True,hsa-miR-16-5p,1553,753,118,14819,0.15670650730411687,0.07598197037990985,Module 0,['MIRNA:000000']
3752,HPA,HPA:0570763,testis; pachytene spermatocytes[High],0.0034946383205014826,True,testis; pachytene spermatocytes[High],950,69,18,11019,0.2608695652173913,0.018947368421052633,Module 5,['HPA:0570762']
3753,GO:BP,GO:0006220,pyrimidine nucleotide metabolic process,0.003497486320546719,True,"""The chemical reactions and pathways involving a pyrimidine nucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:go_curators, ISBN:0198506732]",55,2,2,21031,1.0,0.03636363636363636,Module 39,"['GO:0009117', 'GO:0072527']"
3754,GO:BP,GO:0006360,transcription by RNA polymerase I,0.003518941398081365,True,"""The synthesis of RNA from a DNA template by RNA polymerase I (RNAP I), originating at an RNAP I promoter."" [GOC:jl, GOC:txnOH]",70,787,13,21031,0.016518424396442185,0.18571428571428572,Module 0,['GO:0006351']
3755,GO:CC,GO:0016020,membrane,0.003519977033389411,True,"""A lipid bilayer along with all the proteins and protein complexes embedded in it and attached to it."" [GOC:dos, GOC:mah, ISBN:0815316194]",9864,17,16,22097,0.9411764705882353,0.0016220600162206002,Module 6,['GO:0110165']
3756,GO:MF,GO:0046977,TAP binding,0.0035222587296197885,True,"""Binding to TAP protein, transporter associated with antigen processing protein. TAP protein is a heterodimeric peptide transporter consisting of the subunits TAP1 and TAP2."" [PMID:11133832]",7,17,2,20212,0.11764705882352941,0.2857142857142857,Module 6,['GO:0005515']
3757,GO:BP,GO:0007346,regulation of mitotic cell cycle,0.0035479299216314535,True,"""Any process that modulates the rate or extent of progress through the mitotic cell cycle."" [GOC:dph, GOC:go_curators, GOC:tb]",496,77,11,21031,0.14285714285714285,0.02217741935483871,Module 5,"['GO:0000278', 'GO:0051726']"
3758,HP,HP:0025031,Abnormality of the digestive system,0.0035544909876109704,True,Abnormality of the digestive system,2918,44,40,4958,0.9090909090909091,0.013708019191226868,Module 3,['HP:0000118']
3759,GO:MF,GO:1901363,heterocyclic compound binding,0.003559952191688219,True,"""Binding to heterocyclic compound."" [GOC:TermGenie]",2325,80,24,20212,0.3,0.01032258064516129,Module 5,['GO:0036094']
3760,KEGG,KEGG:05012,Parkinson disease,0.003567261793341585,True,Parkinson disease,265,43,8,8484,0.18604651162790697,0.03018867924528302,Module 4,['KEGG:00000']
3761,GO:BP,GO:0046034,ATP metabolic process,0.003588224783268692,True,"""The chemical reactions and pathways involving ATP, adenosine triphosphate, a universally important coenzyme and enzyme regulator."" [GOC:go_curators]",223,105,9,21031,0.08571428571428572,0.04035874439461883,Module 3,"['GO:0009150', 'GO:0009205']"
3762,HP,HP:0033074,Steroid-responsive anemia,0.003601949445616968,True,Amelioration of anemia upon treatment with a steroid medication.,4,44,3,4958,0.06818181818181818,0.75,Module 3,['HP:0001903']
3763,TF,TF:M00919,Factor: E2F; motif: NCSCGCSAAAN,0.003619207230689452,True,Factor: E2F; motif: NCSCGCSAAAN,6340,826,325,20045,0.3934624697336562,0.051261829652996846,Module 0,['TF:M00000']
3764,GO:BP,GO:0043069,negative regulation of programmed cell death,0.0036240547344746376,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of programmed cell death, cell death resulting from activation of endogenous cellular processes."" [GOC:jl]",907,226,27,21031,0.11946902654867257,0.029768467475192944,Module 1,"['GO:0012501', 'GO:0043067', 'GO:0048523']"
3765,REAC,REAC:R-HSA-6811436,COPI-independent Golgi-to-ER retrograde traffic,0.0036288058606022706,True,COPI-independent Golgi-to-ER retrograde traffic,53,59,5,10842,0.0847457627118644,0.09433962264150944,Module 5,['REAC:R-HSA-8856688']
3766,TF,TF:M00716_1,Factor: ZF5; motif: GSGCGCGR; match class: 1,0.003639503176879802,True,Factor: ZF5; motif: GSGCGCGR; match class: 1,14519,80,75,20045,0.9375,0.00516564501687444,Module 5,['TF:M00716']
3767,GO:BP,GO:0023052,signaling,0.00364067093576422,True,"""The entirety of a process in which information is transmitted within a biological system. This process begins with an active signal and ends when a cellular response has been triggered."" [GOC:mtg_signal, GOC:mtg_signaling_feb11, GOC:signaling]",6447,34,24,21031,0.7058823529411765,0.0037226617031177293,Module 7,['GO:0050789']
3768,GO:BP,GO:0007166,cell surface receptor signaling pathway,0.003641781244770205,True,"""The series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription."" [GOC:bf, GOC:mah, GOC:pr, GOC:signaling]",2799,34,16,21031,0.47058823529411764,0.0057163272597356195,Module 7,['GO:0007165']
3769,MIRNA,MIRNA:hsa-miR-2392,hsa-miR-2392,0.003660281108822385,True,hsa-miR-2392,136,15,4,14819,0.26666666666666666,0.029411764705882353,Module 11,['MIRNA:000000']
3770,HPA,HPA:0460000,skin 1,0.0036736613189979105,True,skin 1,7246,69,61,11019,0.8840579710144928,0.008418437758763456,Module 5,['HPA:0000000']
3771,HPA,HPA:0091001,cerebellum; molecular layer cells - cytoplasm/membrane[≥Low],0.0037151144829336304,True,cerebellum; molecular layer cells - cytoplasm/membrane[≥Low],339,612,39,11019,0.06372549019607843,0.11504424778761062,Module 0,['HPA:0090000']
3772,TF,TF:M12517,Factor: ELF1; motif: NNNCAGGAAGTGNN,0.003721117891054611,True,Factor: ELF1; motif: NNNCAGGAAGTGNN,1793,826,115,20045,0.13922518159806296,0.06413831567205801,Module 0,['TF:M00000']
3773,TF,TF:M11404_1,Factor: Fli-1; motif: NACCGGAARTN; match class: 1,0.003727191237793061,True,Factor: Fli-1; motif: NACCGGAARTN; match class: 1,3238,105,37,20045,0.3523809523809524,0.011426806670784434,Module 3,['TF:M11404']
3774,GO:BP,GO:0097501,stress response to metal ion,0.0037386054661038845,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis caused by a metal ion stimulus."" [GOC:kmv]",19,28,3,21031,0.10714285714285714,0.15789473684210525,Module 10,"['GO:0006950', 'GO:0010038']"
3775,KEGG,KEGG:05134,Legionellosis,0.003745752862874696,True,Legionellosis,56,143,7,8484,0.04895104895104895,0.125,Module 2,['KEGG:00000']
3776,GO:CC,GO:0031982,vesicle,0.0037485542972032467,True,"""Any small, fluid-filled, spherical organelle enclosed by membrane."" [GOC:mah, GOC:pz, GOC:vesicles]",4004,73,29,22097,0.3972602739726027,0.007242757242757243,Module 4,['GO:0043227']
3777,GO:MF,GO:0035325,Toll-like receptor binding,0.003759289942444735,True,"""Binding to a Toll-like protein, a pattern recognition receptor that binds pattern motifs from a variety of microbial sources to initiate an innate immune response."" [PMID:19076341]",13,218,4,20212,0.01834862385321101,0.3076923076923077,Module 2,['GO:0005102']
3778,GO:BP,GO:0043922,negative regulation by host of viral transcription,0.0037636782992534557,True,"""Any process in which a host organism stops, prevents, or reduces the frequency, rate or extent of viral transcription."" [GOC:jl]",15,5,2,21031,0.4,0.13333333333333333,Module 12,"['GO:0019083', 'GO:0051851']"
3779,KEGG,KEGG:05163,Human cytomegalovirus infection,0.003775282442754017,True,Human cytomegalovirus infection,223,4,3,8484,0.75,0.013452914798206279,Module 12,['KEGG:00000']
3780,REAC,REAC:R-HSA-68867,Assembly of the pre-replicative complex,0.003777997279913442,True,Assembly of the pre-replicative complex,142,586,22,10842,0.03754266211604096,0.15492957746478872,Module 0,['REAC:R-HSA-69002']
3781,GO:CC,GO:0005654,nucleoplasm,0.003780506927520436,True,"""That part of the nuclear content other than the chromosomes or the nucleolus."" [GOC:ma, ISBN:0124325653]",4220,105,39,22097,0.37142857142857144,0.00924170616113744,Module 3,"['GO:0031981', 'GO:0110165']"
3782,HPA,HPA:0461412,skin 1; cells in spinous layer[≥Medium],0.0038056397826544065,True,skin 1; cells in spinous layer[≥Medium],592,18,7,11019,0.3888888888888889,0.011824324324324325,Module 9,['HPA:0461411']
3783,GO:MF,GO:0051920,peroxiredoxin activity,0.0038114400919869763,True,"""Catalysis of the reaction: [protein]-dithol + ROOH = [protein]-disulfide + H2O + ROH."" [RHEA:10008]",8,808,5,20212,0.006188118811881188,0.625,Module 0,['GO:0004601']
3784,WP,WP:WP107,Translation factors,0.003825803690143607,True,Translation factors,50,472,12,8286,0.025423728813559324,0.24,Module 0,['WP:000000']
3785,HP,HP:0009122,Aplasia/hypoplasia affecting bones of the axial skeleton,0.003840683032172752,True,Absence (due to failure to form) or underdevelopment of bones of the axial skeleton.,935,44,22,4958,0.5,0.023529411764705882,Module 3,"['HP:0009115', 'HP:0009121']"
3786,HP,HP:0002134,Abnormal basal ganglia morphology,0.0038418070812301633,True,Abnormality of the basal ganglia.,181,44,10,4958,0.22727272727272727,0.055248618784530384,Module 3,['HP:0010993']
3787,GO:MF,GO:0035639,purine ribonucleoside triphosphate binding,0.003883031784407864,True,"""Binding to a purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:BHF, GOC:ebc, ISBN:0198506732]",1853,80,21,20212,0.2625,0.011332973556395036,Module 5,"['GO:0043168', 'GO:1901265', 'GO:1901363']"
3788,WP,WP:WP524,G13 signaling pathway,0.003910810010116654,True,G13 signaling pathway,38,14,3,8286,0.21428571428571427,0.07894736842105263,Module 10,['WP:000000']
3789,TF,TF:M00695_1,Factor: ETF; motif: GVGGMGG; match class: 1,0.003923150357811723,True,Factor: ETF; motif: GVGGMGG; match class: 1,7249,826,364,20045,0.4406779661016949,0.05021382259622017,Module 0,['TF:M00695']
3790,GO:BP,GO:0051234,establishment of localization,0.003927080536751063,True,"""Any process that localizes a substance or cellular component. This may occur via movement, tethering or selective degradation."" [GOC:ai, GOC:dos]",4881,72,35,21031,0.4861111111111111,0.007170661749641467,Module 4,['GO:0051179']
3791,GO:BP,GO:0006518,peptide metabolic process,0.00393841859702888,True,"""The chemical reactions and pathways involving peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another."" [GOC:go_curators]",911,72,14,21031,0.19444444444444445,0.015367727771679473,Module 4,"['GO:0043603', 'GO:1901564']"
3792,GO:BP,GO:0051345,positive regulation of hydrolase activity,0.003941731323434696,True,"""Any process that activates or increases the frequency, rate or extent of hydrolase activity, the catalysis of the hydrolysis of various bonds."" [GOC:ai]",378,215,16,21031,0.07441860465116279,0.042328042328042326,Module 2,"['GO:0043085', 'GO:0051336']"
3793,HP,HP:0032309,Abnormal granulocyte count,0.003942842336379681,True,Any deviation from the normal cell count per volume of granulocytes in the blood circulation.,258,71,15,4958,0.2112676056338028,0.05813953488372093,Module 1,"['HP:0001911', 'HP:0011893']"
3794,HP,HP:0005403,T lymphocytopenia,0.00394516793183334,True,An abnormally low count of T cells.,63,71,8,4958,0.11267605633802817,0.12698412698412698,Module 1,"['HP:0001888', 'HP:0011839']"
3795,HPA,HPA:0550053,stomach 2; glandular cells[High],0.0039483922874403365,True,stomach 2; glandular cells[High],2431,140,53,11019,0.37857142857142856,0.021801727684080625,Module Singleton,['HPA:0550052']
3796,GO:CC,GO:1902494,catalytic complex,0.003948430639787783,True,"""A protein complex which is capable of catalytic activity."" [GOC:bhm, GOC:TermGenie, PMID:8077207]",1776,80,19,22097,0.2375,0.010698198198198198,Module 5,['GO:0032991']
3797,KEGG,KEGG:05100,Bacterial invasion of epithelial cells,0.003954706627435681,True,Bacterial invasion of epithelial cells,77,439,14,8484,0.03189066059225513,0.18181818181818182,Module 0,['KEGG:00000']
3798,REAC,REAC:R-HSA-381676,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,0.003959612400523177,True,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,42,2,2,10842,1.0,0.047619047619047616,Module 22,['REAC:R-HSA-422356']
3799,HPA,HPA:0530000,spleen,0.003968835601817715,True,spleen,5893,69,54,11019,0.782608695652174,0.009163414220261326,Module 5,['HPA:0000000']
3800,HPA,HPA:0600223,tonsil; squamous epithelial cells[High],0.003975002033078278,True,tonsil; squamous epithelial cells[High],1472,69,23,11019,0.3333333333333333,0.015625,Module 5,['HPA:0600222']
3801,GO:CC,GO:0030054,cell junction,0.00400151266856415,True,"""A cellular component that forms a specialized region of connection between two or more cells, or between a cell and the extracellular matrix, or between two membrane-bound components of a cell, such as flagella."" [GOC:aruk, GOC:bc, GOC:mah, http://www.vivo.colostate.edu/hbooks/cmb/cells/pmemb/junctions_a.html, ISBN:0198506732, PMID:26820516, PMID:28096264]",2230,177,37,22097,0.20903954802259886,0.016591928251121078,Module Singleton,['GO:0110165']
3802,KEGG,KEGG:04260,Cardiac muscle contraction,0.00400953703516292,True,Cardiac muscle contraction,87,439,15,8484,0.03416856492027335,0.1724137931034483,Module 0,['KEGG:00000']
3803,GO:MF,GO:0060590,ATPase regulator activity,0.0040489907818869655,True,"""Binds to and modulates the activity of an ATP hydrolysis activity."" [GOC:dph, GOC:tb]",48,20,3,20212,0.15,0.0625,Module 9,['GO:0098772']
3804,HP,HP:0002579,Gastrointestinal dysmotility,0.004050993194481164,True,"Abnormal intestinal contractions, such as spasms and intestinal paralysis, related to the loss of the ability of the gut to coordinate muscular activity because of endogenous or exogenous causes.",105,44,8,4958,0.18181818181818182,0.0761904761904762,Module 3,['HP:0030895']
3805,GO:BP,GO:0007155,cell adhesion,0.004076370894230674,True,"""The attachment of a cell, either to another cell or to an underlying substrate such as the extracellular matrix, via cell adhesion molecules."" [GOC:hb, GOC:pf]",1512,15,8,21031,0.5333333333333333,0.005291005291005291,Module 6,['GO:0009987']
3806,HPA,HPA:0030052,appendix; glandular cells[≥Medium],0.004085171672550078,True,appendix; glandular cells[≥Medium],5508,79,58,11019,0.7341772151898734,0.010530137981118372,Module 3,['HPA:0030051']
3807,TF,TF:M04106_1,Factor: RUNX2; motif: NRACCGCAAACCGCAN; match class: 1,0.004092175708346182,True,Factor: RUNX2; motif: NRACCGCAAACCGCAN; match class: 1,8623,826,422,20045,0.5108958837772397,0.048938884378986434,Module 0,['TF:M04106']
3808,GO:BP,GO:0002705,positive regulation of leukocyte mediated immunity,0.004095276094275114,True,"""Any process that activates or increases the frequency, rate, or extent of leukocyte mediated immunity."" [GOC:add]",146,15,4,21031,0.26666666666666666,0.0273972602739726,Module 6,"['GO:0002443', 'GO:0002699', 'GO:0002703']"
3809,REAC,REAC:R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,0.004107084810693048,True,Regulation of mRNA stability by proteins that bind AU-rich elements,86,19,4,10842,0.21052631578947367,0.046511627906976744,Module 9,['REAC:R-HSA-8953854']
3810,TF,TF:M03970,Factor: ELK1; motif: ACCGGAAGTN,0.00411627046194926,True,Factor: ELK1; motif: ACCGGAAGTN,4899,105,48,20045,0.45714285714285713,0.009797917942437232,Module 3,['TF:M00000']
3811,TF,TF:M09608_1,Factor: Erg; motif: NNACCGGAARTSN; match class: 1,0.004117285864909927,True,Factor: Erg; motif: NNACCGGAARTSN; match class: 1,2437,105,31,20045,0.29523809523809524,0.01272055806319245,Module 3,['TF:M09608']
3812,KEGG,KEGG:04659,Th17 cell differentiation,0.004119007447658713,True,Th17 cell differentiation,105,136,9,8484,0.0661764705882353,0.08571428571428572,Module 1,['KEGG:00000']
3813,REAC,REAC:R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,0.004152764224938938,True,Vasopressin regulates renal water homeostasis via Aquaporins,43,2,2,10842,1.0,0.046511627906976744,Module 22,['REAC:R-HSA-445717']
3814,REAC,REAC:R-HSA-9660821,ADORA2B mediated anti-inflammatory cytokines production,0.004152764224938938,True,ADORA2B mediated anti-inflammatory cytokines production,43,2,2,10842,1.0,0.046511627906976744,Module 22,['REAC:R-HSA-9662851']
3815,HPA,HPA:0381212,placenta; syncytiotrophoblasts - cell body[≥Medium],0.004155120590780013,True,placenta; syncytiotrophoblasts - cell body[≥Medium],482,612,50,11019,0.08169934640522876,0.1037344398340249,Module 0,['HPA:0381211']
3816,REAC,REAC:R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC,0.004158952521349237,True,Formation of tubulin folding intermediates by CCT/TriC,26,59,4,10842,0.06779661016949153,0.15384615384615385,Module 5,['REAC:R-HSA-389958']
3817,TF,TF:M00516_1,Factor: E2F-1; motif: TTTSGCGCGMNR; match class: 1,0.004183621086701816,True,Factor: E2F-1; motif: TTTSGCGCGMNR; match class: 1,2126,80,24,20045,0.3,0.011288805268109126,Module 5,['TF:M00516']
3818,KEGG,KEGG:04110,Cell cycle,0.004184392064689327,True,Cell cycle,157,53,7,8484,0.1320754716981132,0.044585987261146494,Module 5,['KEGG:00000']
3819,HPA,HPA:0471413,skin 2; cells in spinous layer[High],0.004215629105750074,True,skin 2; cells in spinous layer[High],248,140,13,11019,0.09285714285714286,0.05241935483870968,Module Singleton,['HPA:0471412']
3820,HPA,HPA:0461443,skin 1; fibrohistiocytic cells[High],0.00421609145203187,True,skin 1; fibrohistiocytic cells[High],408,140,17,11019,0.12142857142857143,0.041666666666666664,Module Singleton,['HPA:0461442']
3821,GO:BP,GO:0051128,regulation of cellular component organization,0.0042244112739916045,True,"""Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of cell structures, including the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope."" [GOC:ai]",2425,215,49,21031,0.22790697674418606,0.02020618556701031,Module 2,"['GO:0016043', 'GO:0050794']"
3822,GO:CC,GO:0098794,postsynapse,0.004231948798538332,True,"""The part of a synapse that is part of the post-synaptic cell."" [GOC:dos]",650,105,13,22097,0.12380952380952381,0.02,Module 3,"['GO:0045202', 'GO:0110165']"
3823,GO:BP,GO:0007165,signal transduction,0.004243446093015599,True,"""The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell."" [GOC:go_curators, GOC:mtg_signaling_feb11]",5959,34,23,21031,0.6764705882352942,0.003859708004698775,Module 7,"['GO:0007154', 'GO:0009987', 'GO:0023052', 'GO:0050794', 'GO:0051716']"
3824,HPA,HPA:0030071,appendix; lymphoid tissue[≥Low],0.004254186833100082,True,appendix; lymphoid tissue[≥Low],4734,140,85,11019,0.6071428571428571,0.017955217574989437,Module Singleton,['HPA:0030000']
3825,TF,TF:M06674,Factor: znf587; motif: NGGGRCTGATGA,0.0042585284685988135,True,Factor: znf587; motif: NGGGRCTGATGA,59,2,2,20045,1.0,0.03389830508474576,Module 41,['TF:M00000']
3826,GO:BP,GO:0080164,regulation of nitric oxide metabolic process,0.00425986638067539,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving nitric oxide, nitrogen monoxide (NO), a colorless gas only slightly soluble in water."" [GOC:DHL]",58,215,7,21031,0.03255813953488372,0.1206896551724138,Module 2,"['GO:0046209', 'GO:0051171']"
3827,HPA,HPA:0100122,cerebral cortex; glial cells[≥Medium],0.004267207781729268,True,cerebral cortex; glial cells[≥Medium],2681,69,33,11019,0.4782608695652174,0.012308839985080195,Module 5,['HPA:0100121']
3828,WP,WP:WP2272,Pathogenic Escherichia coli infection,0.004267604154205844,True,Pathogenic Escherichia coli infection,55,55,5,8286,0.09090909090909091,0.09090909090909091,Module 5,['WP:000000']
3829,GO:BP,GO:1904867,protein localization to Cajal body,0.00427518972941769,True,"""A process in which a protein is transported to, or maintained in, a location within a Cajal body."" [GO_REF:0000087, GOC:BHF, GOC:BHF_telomere, GOC:nc, GOC:TermGenie, PMID:25467444]",12,787,6,21031,0.007623888182973317,0.5,Module 0,['GO:1903405']
3830,GO:BP,GO:0070202,regulation of establishment of protein localization to chromosome,0.00427518972941769,True,"""Any process that modulates the frequency, rate or extent of the directed movement of a protein to a specific location on a chromosome."" [GOC:BHF, GOC:mah]",12,787,6,21031,0.007623888182973317,0.5,Module 0,"['GO:0070199', 'GO:0070201']"
3831,GO:BP,GO:1903405,protein localization to nuclear body,0.00427518972941769,True,"""A process in which a protein is transported to, or maintained in, a location within a nuclear body."" [GO_REF:0000087, GOC:TermGenie, PMID:24713849]",12,787,6,21031,0.007623888182973317,0.5,Module 0,['GO:1990173']
3832,HPA,HPA:0471462,skin 2; langerhans cells[≥Medium],0.00428120752000397,True,skin 2; langerhans cells[≥Medium],662,12,6,11019,0.5,0.00906344410876133,Module 6,['HPA:0471461']
3833,GO:BP,GO:0045596,negative regulation of cell differentiation,0.004300731667239374,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of cell differentiation."" [GOC:go_curators]",681,215,22,21031,0.10232558139534884,0.032305433186490456,Module 2,"['GO:0030154', 'GO:0045595', 'GO:0048523', 'GO:0051093']"
3834,TF,TF:M07380_1,Factor: E2F-4; motif: NTTTCSCGCC; match class: 1,0.004303220559908149,True,Factor: E2F-4; motif: NTTTCSCGCC; match class: 1,8243,80,54,20045,0.675,0.006551012980710906,Module 5,['TF:M07380']
3835,REAC,REAC:R-HSA-1430728,Metabolism,0.004321116842138094,True,Metabolism,2074,586,154,10842,0.2627986348122867,0.0742526518804243,Module 0,['REAC:0000000']
3836,TF,TF:M00430_1,Factor: E2F-1; motif: NTTSGCGG; match class: 1,0.004329133161617976,True,Factor: E2F-1; motif: NTTSGCGG; match class: 1,2574,105,32,20045,0.3047619047619048,0.012432012432012432,Module 3,['TF:M00430']
3837,HPA,HPA:0401302,rectum; enterocytes[≥Medium],0.004344366452630882,True,rectum; enterocytes[≥Medium],388,79,12,11019,0.1518987341772152,0.030927835051546393,Module 3,['HPA:0401301']
3838,REAC,REAC:R-HSA-9634597,GPER1 signaling,0.004350514902316973,True,GPER1 signaling,44,2,2,10842,1.0,0.045454545454545456,Module 22,['REAC:R-HSA-418555']
3839,HPA,HPA:0470202,skin 2; endothelial cells[≥Medium],0.0043510269918471825,True,skin 2; endothelial cells[≥Medium],637,140,22,11019,0.15714285714285714,0.03453689167974882,Module Singleton,['HPA:0470201']
3840,GO:MF,GO:0000166,nucleotide binding,0.004358933855361591,True,"""Binding to a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose."" [GOC:mah, ISBN:0198547684]",2187,80,23,20212,0.2875,0.010516689529035207,Module 5,"['GO:1901265', 'GO:1901363']"
3841,GO:BP,GO:0031325,positive regulation of cellular metabolic process,0.004376859513867669,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform chemical substances."" [GOC:mah]",3346,787,174,21031,0.22109275730622618,0.052002390914524806,Module 0,"['GO:0009893', 'GO:0031323', 'GO:0044237', 'GO:0048522']"
3842,TF,TF:M03982,Factor: ETV4; motif: ACCGGAAGTN,0.004380860642220974,True,Factor: ETV4; motif: ACCGGAAGTN,6986,183,95,20045,0.5191256830601093,0.01359862582307472,Module Singleton,['TF:M00000']
3843,GO:MF,GO:1901265,nucleoside phosphate binding,0.004392170745292894,True,"""Binding to nucleoside phosphate."" [GOC:TermGenie]",2188,80,23,20212,0.2875,0.010511882998171846,Module 5,['GO:0097159']
3844,GO:BP,GO:0061687,detoxification of inorganic compound,0.004394438850727368,True,"""Any process that reduces or removes the toxicity of inorganic compounds. These include transport of such compounds away from sensitive areas and to compartments or complexes whose purpose is sequestration of inorganic compounds."" [GOC:vw]",20,28,3,21031,0.10714285714285714,0.15,Module 10,['GO:0098754']
3845,HPA,HPA:0460642,skin 1; Langerhans[≥Medium],0.004403474067478057,True,skin 1; Langerhans[≥Medium],2632,79,36,11019,0.45569620253164556,0.013677811550151976,Module 3,['HPA:0460641']
3846,GO:BP,GO:0009056,catabolic process,0.004404276033818968,True,"""The chemical reactions and pathways resulting in the breakdown of substances, including the breakdown of carbon compounds with the liberation of energy for use by the cell or organism."" [ISBN:0198547684]",2556,172,43,21031,0.25,0.016823161189358372,Module Singleton,['GO:0008152']
3847,TF,TF:M11392,Factor: Erg; motif: NACCGGAARYN,0.00441248226776495,True,Factor: Erg; motif: NACCGGAARYN,8890,183,113,20045,0.6174863387978142,0.012710911136107986,Module Singleton,['TF:M00000']
3848,GO:BP,GO:0031666,positive regulation of lipopolysaccharide-mediated signaling pathway,0.0044283586101868996,True,"""Any process that activates or increases the frequency, rate or extent of signaling in response to detection of lipopolysaccharide."" [GOC:mah]",10,215,4,21031,0.018604651162790697,0.4,Module 2,"['GO:0002833', 'GO:0009967', 'GO:0031663', 'GO:0031664', 'GO:0032103']"
3849,HPA,HPA:0510702,soft tissue 2; peripheral nerve[≥Medium],0.004432108168092923,True,soft tissue 2; peripheral nerve[≥Medium],1546,612,123,11019,0.20098039215686275,0.0795601552393273,Module 0,['HPA:0510701']
3850,GO:BP,GO:0045595,regulation of cell differentiation,0.004432350323906135,True,"""Any process that modulates the frequency, rate or extent of cell differentiation, the process in which relatively unspecialized cells acquire specialized structural and functional features."" [GOC:go_curators]",1576,226,38,21031,0.168141592920354,0.024111675126903553,Module 1,"['GO:0030154', 'GO:0050793', 'GO:0050794']"
3851,GO:BP,GO:0010648,negative regulation of cell communication,0.0044471817665897645,True,"""Any process that decreases the frequency, rate or extent of cell communication. Cell communication is the process that mediates interactions between a cell and its surroundings. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment."" [GOC:dph, GOC:tb]",1398,215,34,21031,0.15813953488372093,0.024320457796852647,Module 2,"['GO:0007154', 'GO:0010646', 'GO:0048523']"
3852,GO:BP,GO:0023057,negative regulation of signaling,0.0044471817665897645,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of a signaling process."" [GOC:mtg_signal]",1398,215,34,21031,0.15813953488372093,0.024320457796852647,Module 2,"['GO:0023051', 'GO:0023052', 'GO:0048519']"
3853,GO:MF,GO:0045296,cadherin binding,0.004458774348810195,True,"""Binding to cadherin, a type I membrane protein involved in cell adhesion."" [GOC:bf]",335,20,5,20212,0.25,0.014925373134328358,Module 9,['GO:0050839']
3854,HPA,HPA:0500111,soft tissue 1; chondrocytes[≥Low],0.004494738301735896,True,soft tissue 1; chondrocytes[≥Low],2188,79,32,11019,0.4050632911392405,0.014625228519195612,Module 3,['HPA:0500000']
3855,GO:BP,GO:0097190,apoptotic signaling pathway,0.004508441354788406,True,"""The series of molecular signals which triggers the apoptotic death of a cell. The pathway starts with reception of a signal, and ends when the execution phase of apoptosis is triggered."" [GOC:mtg_apoptosis]",607,172,18,21031,0.10465116279069768,0.029654036243822075,Module Singleton,"['GO:0006915', 'GO:0007165']"
3856,GO:CC,GO:0005751,mitochondrial respiratory chain complex IV,0.004517606622366801,True,"""A protein complex located in the mitochondrial inner membrane that forms part of the mitochondrial respiratory chain. Contains the 13 polypeptide subunits of cytochrome c oxidase, including cytochrome a and cytochrome a3. Catalyzes the oxidation of reduced cytochrome c by dioxygen (O2)."" [GOC:mtg_sensu, ISBN:0198547684]",23,813,7,22097,0.008610086100861008,0.30434782608695654,Module 0,"['GO:0005746', 'GO:0045277', 'GO:0098800']"
3857,TF,TF:M00333_1,Factor: ZF5; motif: NRNGNGCGCGCWN; match class: 1,0.004518570067444061,True,Factor: ZF5; motif: NRNGNGCGCGCWN; match class: 1,12784,80,70,20045,0.875,0.005475594493116395,Module 5,['TF:M00333']
3858,GO:BP,GO:0008285,negative regulation of cell population proliferation,0.004532756650168706,True,"""Any process that stops, prevents or reduces the rate or extent of cell proliferation."" [GOC:go_curators]",701,226,23,21031,0.10176991150442478,0.03281027104136947,Module 1,"['GO:0008283', 'GO:0042127', 'GO:0048523']"
3859,HPA,HPA:0100211,cerebral cortex; neuropil[≥Low],0.004534747890836886,True,cerebral cortex; neuropil[≥Low],5010,612,329,11019,0.5375816993464052,0.0656686626746507,Module 0,['HPA:0100000']
3860,TF,TF:M06551,Factor: znf417; motif: NGGGRCTGATGA,0.004554708999144262,True,Factor: znf417; motif: NGGGRCTGATGA,61,2,2,20045,1.0,0.03278688524590164,Module 41,['TF:M00000']
3861,HPA,HPA:0471473,skin 2; lymphocytes[High],0.004558317401580289,True,skin 2; lymphocytes[High],456,166,20,11019,0.12048192771084337,0.043859649122807015,Module 2,['HPA:0471472']
3862,HP,HP:0005401,Recurrent candida infections,0.004561897760429103,True,"An increased susceptibility to candida infections, as manifested by a history of recurrent episodes of candida infections.",17,71,5,4958,0.07042253521126761,0.29411764705882354,Module 1,['HP:0002841']
3863,HPA,HPA:0220051,gallbladder; glandular cells[≥Low],0.004562118717042511,True,gallbladder; glandular cells[≥Low],7664,140,119,11019,0.85,0.01552713987473904,Module Singleton,['HPA:0220000']
3864,HPA,HPA:0220000,gallbladder,0.004562118717042511,True,gallbladder,7664,140,119,11019,0.85,0.01552713987473904,Module Singleton,['HPA:0000000']
3865,KEGG,KEGG:04726,Serotonergic synapse,0.0045698197972461095,True,Serotonergic synapse,112,2,2,8484,1.0,0.017857142857142856,Module 22,['KEGG:00000']
3866,TF,TF:M00972_1,Factor: IRF; motif: RAAANTGAAAN; match class: 1,0.004596176794949767,True,Factor: IRF; motif: RAAANTGAAAN; match class: 1,215,36,6,20045,0.16666666666666666,0.027906976744186046,Module 7,['TF:M00972']
3867,HPA,HPA:0091002,cerebellum; molecular layer cells - cytoplasm/membrane[≥Medium],0.004597302271902271,True,cerebellum; molecular layer cells - cytoplasm/membrane[≥Medium],305,612,36,11019,0.058823529411764705,0.1180327868852459,Module 0,['HPA:0091001']
3868,GO:CC,GO:0044322,endoplasmic reticulum quality control compartment,0.004607400788552869,True,"""A subcompartment of the endoplasmic reticulum in which proteins with improper or incorrect folding accumulate. Enzymes in this compartment direct proteins with major folding problems to translocation to the cytosol and degradation, and proteins with minor folding problems to the ER, to interact with chaperon proteins."" [PMID:11408579]",15,73,3,22097,0.0410958904109589,0.2,Module 4,"['GO:0005783', 'GO:0110165']"
3869,GO:CC,GO:0001726,ruffle,0.004610293659813829,True,"""Projection at the leading edge of a crawling cell; the protrusions are supported by a microfilament meshwork."" [ISBN:0124325653]",182,813,20,22097,0.024600246002460024,0.10989010989010989,Module 0,"['GO:0031252', 'GO:0120025']"
3870,WP,WP:WP2328,Allograft rejection,0.004619330409283387,True,Allograft rejection,88,148,9,8286,0.060810810810810814,0.10227272727272728,Module 1,['WP:000000']
3871,TF,TF:M09632,Factor: Kaiso; motif: GNTCTCGCGAGRNNNNGGN,0.004627308245877387,True,Factor: Kaiso; motif: GNTCTCGCGAGRNNNNGGN,3056,183,53,20045,0.2896174863387978,0.017342931937172776,Module Singleton,['TF:M00000']
3872,TF,TF:M02053_1,Factor: ELF1; motif: NCCGGAARTN; match class: 1,0.004631555609762511,True,Factor: ELF1; motif: NCCGGAARTN; match class: 1,1587,105,24,20045,0.22857142857142856,0.015122873345935728,Module 3,['TF:M02053']
3873,HPA,HPA:0210053,fallopian tube; glandular cells[High],0.004643168193566115,True,fallopian tube; glandular cells[High],1668,79,27,11019,0.34177215189873417,0.01618705035971223,Module 3,['HPA:0210052']
3874,KEGG,KEGG:04725,Cholinergic synapse,0.004652158892691989,True,Cholinergic synapse,113,2,2,8484,1.0,0.017699115044247787,Module 22,['KEGG:00000']
3875,HPA,HPA:0461412,skin 1; cells in spinous layer[≥Medium],0.004655862215341154,True,skin 1; cells in spinous layer[≥Medium],592,140,21,11019,0.15,0.03547297297297297,Module Singleton,['HPA:0461411']
3876,GO:CC,GO:0043229,intracellular organelle,0.0046568749534583505,True,"""Organized structure of distinctive morphology and function, occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton. Excludes the plasma membrane."" [GOC:go_curators]",16018,221,187,22097,0.8461538461538461,0.011674366337869896,Module 2,"['GO:0005622', 'GO:0043226']"
3877,GO:BP,GO:0002478,antigen processing and presentation of exogenous peptide antigen,0.004659456545975706,True,"""The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC protein complex. The peptide is typically a fragment of a larger exogenous protein which has been degraded within the cell."" [GOC:add, ISBN:0781735149]",38,215,6,21031,0.027906976744186046,0.15789473684210525,Module 2,"['GO:0019884', 'GO:0048002']"
3878,GO:CC,GO:0030659,cytoplasmic vesicle membrane,0.004661696692562332,True,"""The lipid bilayer surrounding a cytoplasmic vesicle."" [GOC:mah]",1226,177,25,22097,0.14124293785310735,0.020391517128874388,Module Singleton,"['GO:0012506', 'GO:0031410']"
3879,TF,TF:M02052_1,Factor: EHF; motif: CSCGGAARTN; match class: 1,0.004663374335774041,True,Factor: EHF; motif: CSCGGAARTN; match class: 1,4145,105,43,20045,0.4095238095238095,0.01037394451145959,Module 3,['TF:M02052']
3880,HPA,HPA:0430000,seminal vesicle,0.004669957290714904,True,seminal vesicle,6828,140,110,11019,0.7857142857142857,0.01611013473930873,Module Singleton,['HPA:0000000']
3881,HPA,HPA:0430051,seminal vesicle; glandular cells[≥Low],0.004669957290714904,True,seminal vesicle; glandular cells[≥Low],6828,140,110,11019,0.7857142857142857,0.01611013473930873,Module Singleton,['HPA:0430000']
3882,HP,HP:0030895,Abnormal gastrointestinal motility,0.0046741657206806324,True,An anomaly of the muscular contractions that propel food though the gastrointestinal tract.,107,44,8,4958,0.18181818181818182,0.07476635514018691,Module 3,['HP:0012719']
3883,GO:BP,GO:0032648,regulation of interferon-beta production,0.004677826864150059,True,"""Any process that modulates the frequency, rate, or extent of interferon-beta production."" [GOC:mah, PMID:15546383]",59,34,4,21031,0.11764705882352941,0.06779661016949153,Module 7,"['GO:0032479', 'GO:0032608']"
3884,GO:BP,GO:0032608,interferon-beta production,0.004677826864150059,True,"""The appearance of interferon-beta due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels."" [GOC:mah, PMID:15546383]",59,34,4,21031,0.11764705882352941,0.06779661016949153,Module 7,['GO:0032606']
3885,WP,WP:WP35,G protein signaling pathways,0.004714328822396012,True,G protein signaling pathways,89,2,2,8286,1.0,0.02247191011235955,Module 22,['WP:000000']
3886,HPA,HPA:0461443,skin 1; fibrohistiocytic cells[High],0.004715156685422139,True,skin 1; fibrohistiocytic cells[High],408,185,20,11019,0.10810810810810811,0.049019607843137254,Module 1,['HPA:0461442']
3887,REAC,REAC:R-HSA-77588,SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,0.004730148225313072,True,SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,11,586,6,10842,0.010238907849829351,0.5454545454545454,Module 0,['REAC:R-HSA-75067']
3888,GO:BP,GO:0033993,response to lipid,0.004734747742011776,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus."" [GOC:sl]",920,226,27,21031,0.11946902654867257,0.029347826086956522,Module 1,['GO:0010033']
3889,GO:BP,GO:0050686,negative regulation of mRNA processing,0.004746069808052406,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of mRNA processing."" [GOC:ai]",25,787,8,21031,0.010165184243964422,0.32,Module 0,"['GO:0006397', 'GO:0050684', 'GO:1903312']"
3890,GO:BP,GO:0046631,alpha-beta T cell activation,0.004808833550535268,True,"""The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific."" [GOC:add]",178,215,11,21031,0.05116279069767442,0.06179775280898876,Module 2,['GO:0042110']
3891,HPA,HPA:0160051,endometrium 1; glandular cells[≥Low],0.0048181306332856525,True,endometrium 1; glandular cells[≥Low],6818,60,52,11019,0.8666666666666667,0.007626870049867997,Module 4,['HPA:0160000']
3892,HP,HP:4000019,Anti-BP230 antibody positivity,0.0048184069415520905,True,The presence of autoantibodies (immunoglobulins) in the serum that react against BP230.,2,10,2,4958,0.2,1.0,Module 6,['HP:0030057']
3893,HP,HP:4000020,Anti-BP180 antibody positivity,0.0048184069415520905,True,The presence of autoantibodies (immunoglobulins) in the serum that react against BP180.,2,10,2,4958,0.2,1.0,Module 6,['HP:0030057']
3894,KEGG,KEGG:04724,Glutamatergic synapse,0.004819042595068903,True,Glutamatergic synapse,115,2,2,8484,1.0,0.017391304347826087,Module 22,['KEGG:00000']
3895,HPA,HPA:0340463,ovary; ovarian stroma cells[High],0.004837602346456972,True,ovary; ovarian stroma cells[High],378,69,11,11019,0.15942028985507245,0.0291005291005291,Module 5,['HPA:0340462']
3896,HPA,HPA:0030072,appendix; lymphoid tissue[≥Medium],0.00484979720191054,True,appendix; lymphoid tissue[≥Medium],2987,140,61,11019,0.4357142857142857,0.02042182792099096,Module Singleton,['HPA:0030071']
3897,TF,TF:M11530_1,Factor: E2F-2; motif: NWTTTGGCGCCAWWNN; match class: 1,0.004859341907886817,True,Factor: E2F-2; motif: NWTTTGGCGCCAWWNN; match class: 1,13807,105,93,20045,0.8857142857142857,0.006735713768378359,Module 3,['TF:M11530']
3898,GO:BP,GO:0002292,T cell differentiation involved in immune response,0.004884374995352588,True,"""The process in which an antigenically naive T cell acquires the specialized features of an effector, regulatory, or memory T cell as part of an immune response. Effector T cells include cells which provide T cell help or exhibit cytotoxicity towards other cells."" [GOC:add, ISBN:0781735149]",84,215,8,21031,0.037209302325581395,0.09523809523809523,Module 2,"['GO:0002286', 'GO:0030217']"
3899,GO:BP,GO:0002220,innate immune response activating cell surface receptor signaling pathway,0.004884374995352588,True,"""The series of molecular signals initiated by a ligand binding to a cell surface receptor that leads to the activation of an innate immune response."" [GOC:add, ISBN:0781735149, PMID:15199967]",84,215,8,21031,0.037209302325581395,0.09523809523809523,Module 2,"['GO:0002429', 'GO:0002758']"
3900,TF,TF:M11415_1,Factor: GABP-alpha; motif: NRCCGGAAGTN; match class: 1,0.004888215030394612,True,Factor: GABP-alpha; motif: NRCCGGAAGTN; match class: 1,559,826,48,20045,0.05811138014527845,0.08586762075134168,Module 0,['TF:M11415']
3901,KEGG,KEGG:03082,ATP-dependent chromatin remodeling,0.004903587201999922,True,ATP-dependent chromatin remodeling,116,2,2,8484,1.0,0.017241379310344827,Module 27,['KEGG:00000']
3902,HPA,HPA:0461462,skin 1; langerhans cells[≥Medium],0.0049076675182088796,True,skin 1; langerhans cells[≥Medium],578,166,23,11019,0.13855421686746988,0.039792387543252594,Module 2,['HPA:0461461']
3903,GO:BP,GO:0050671,positive regulation of lymphocyte proliferation,0.0049121266565401184,True,"""Any process that activates or increases the rate or extent of lymphocyte proliferation."" [GOC:ai]",144,215,10,21031,0.046511627906976744,0.06944444444444445,Module 2,"['GO:0032946', 'GO:0046651', 'GO:0050670', 'GO:0051251']"
3904,GO:CC,GO:0045263,"proton-transporting ATP synthase complex, coupling factor F(o)",0.00493384400298144,True,"""All non-F1 subunits of a hydrogen-transporting ATP synthase, including integral and peripheral membrane proteins."" [PMID:10838056]",16,813,6,22097,0.007380073800738007,0.375,Module 0,"['GO:0005622', 'GO:0033177', 'GO:0045259']"
3905,HPA,HPA:0461391,skin 1; cells in basal layer[≥Low],0.0049554698475216,True,skin 1; cells in basal layer[≥Low],881,166,30,11019,0.18072289156626506,0.0340522133938706,Module 2,['HPA:0460000']
3906,GO:CC,GO:0005832,chaperonin-containing T-complex,0.004995099412494241,True,"""A multisubunit ring-shaped complex that mediates protein folding in the cytosol without a cofactor."" [GOC:sgd_curators, PMID:11580267]",10,813,5,22097,0.006150061500615006,0.5,Module 0,"['GO:0005829', 'GO:0101031']"
3907,HPA,HPA:0530721,spleen; cells in white pulp[≥Low],0.005005251298446118,True,spleen; cells in white pulp[≥Low],4339,166,92,11019,0.5542168674698795,0.021203042175616502,Module 2,['HPA:0530000']
3908,TF,TF:M08223_1,Factor: Elk-1:OC-2; motif: RCCGGAASCGATCGATNN; match class: 1,0.0050110035249444455,True,Factor: Elk-1:OC-2; motif: RCCGGAASCGATCGATNN; match class: 1,5971,826,308,20045,0.3728813559322034,0.05158264947245018,Module 0,['TF:M08223']
3909,GO:BP,GO:0009157,deoxyribonucleoside monophosphate biosynthetic process,0.005015280329966353,True,"""The chemical reactions and pathways resulting in the formation of a deoxyribonucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose sugar esterified with phosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",8,77,3,21031,0.03896103896103896,0.375,Module 5,"['GO:0009124', 'GO:0009162']"
3910,HP,HP:0011096,Peripheral demyelination,0.005017861939827879,True,A loss of myelin from the internode regions along myelinated nerve fibers of the peripheral nervous system.,49,44,6,4958,0.13636363636363635,0.12244897959183673,Module 3,['HP:0003130']
3911,GO:BP,GO:0050855,regulation of B cell receptor signaling pathway,0.00505094080638308,True,"""Any process that modulates the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a B cell."" [GOC:ai]",21,226,5,21031,0.022123893805309734,0.23809523809523808,Module 1,"['GO:0050853', 'GO:0050854']"
3912,HP,HP:0004311,Abnormal macrophage morphology,0.005063664274213192,True,An abnormality of macrophages.,46,71,7,4958,0.09859154929577464,0.15217391304347827,Module 1,['HP:0010974']
3913,TF,TF:M03988_1,Factor: FLI1; motif: ACCGGAARTN; match class: 1,0.0050679894781200194,True,Factor: FLI1; motif: ACCGGAARTN; match class: 1,2999,105,35,20045,0.3333333333333333,0.011670556852284094,Module 3,['TF:M03988']
3914,HPA,HPA:0040083,bone marrow; hematopoietic cells[High],0.005073269213046645,True,bone marrow; hematopoietic cells[High],1453,140,37,11019,0.2642857142857143,0.025464556090846524,Module Singleton,['HPA:0040082']
3915,MIRNA,MIRNA:hsa-miR-5693,hsa-miR-5693,0.005092711561718949,True,hsa-miR-5693,356,3,3,14819,1.0,0.008426966292134831,Module 27,['MIRNA:000000']
3916,GO:MF,GO:0031625,ubiquitin protein ligase binding,0.005141263879982485,True,"""Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins."" [GOC:vp]",308,808,30,20212,0.03712871287128713,0.09740259740259741,Module 0,['GO:0044389']
3917,GO:BP,GO:0051234,establishment of localization,0.0051611443886453,True,"""Any process that localizes a substance or cellular component. This may occur via movement, tethering or selective degradation."" [GOC:ai, GOC:dos]",4881,215,80,21031,0.37209302325581395,0.016390083999180495,Module 2,['GO:0051179']
3918,HPA,HPA:0400000,rectum,0.0051638820844863145,True,rectum,7973,69,64,11019,0.927536231884058,0.008027091433588361,Module 5,['HPA:0000000']
3919,HPA,HPA:0180052,epididymis; glandular cells[≥Medium],0.005167304729672532,True,epididymis; glandular cells[≥Medium],5693,79,59,11019,0.7468354430379747,0.010363604426488671,Module 3,['HPA:0180051']
3920,REAC,REAC:R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,0.005207514640688614,True,HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand,57,59,5,10842,0.0847457627118644,0.08771929824561403,Module 5,['REAC:R-HSA-2262752']
3921,HPA,HPA:0630000,cervix,0.005212185869246435,True,cervix,6930,140,111,11019,0.7928571428571428,0.016017316017316017,Module Singleton,['HPA:0000000']
3922,GO:BP,GO:0044093,positive regulation of molecular function,0.0052342659354272635,True,"""Any process that activates or increases the rate or extent of a molecular function, an elemental biological activity occurring at the molecular level, such as catalysis or binding."" [GO:jl]",1097,787,72,21031,0.09148665819567979,0.06563354603463993,Module 0,['GO:0065009']
3923,TF,TF:M08206_1,Factor: E2F-3:Prrxl1; motif: SGCGCTAATTNN; match class: 1,0.005283203090068204,True,Factor: E2F-3:Prrxl1; motif: SGCGCTAATTNN; match class: 1,5159,826,272,20045,0.32929782082324455,0.0527233960069781,Module 0,['TF:M08206']
3924,TF,TF:M00736_1,Factor: E2F-1:DP-1; motif: TTTCSCGC; match class: 1,0.005290133035125961,True,Factor: E2F-1:DP-1; motif: TTTCSCGC; match class: 1,4779,826,255,20045,0.30871670702179177,0.053358443188951665,Module 0,['TF:M00736']
3925,TF,TF:M08208,Factor: E2F-3:FOXI1; motif: NGACACCGCGCCCAC,0.0052935717797385285,True,Factor: E2F-3:FOXI1; motif: NGACACCGCGCCCAC,12874,826,593,20045,0.7179176755447942,0.046061830045052043,Module 0,['TF:M00000']
3926,GO:BP,GO:1903320,regulation of protein modification by small protein conjugation or removal,0.0052944999099282875,True,"""Any process that modulates the frequency, rate or extent of protein modification by small protein conjugation or removal."" [GO_REF:0000058, GOC:TermGenie, GOC:vw]",242,21,5,21031,0.23809523809523808,0.02066115702479339,Module 9,"['GO:0070647', 'GO:1901873']"
3927,HP,HP:0001744,Splenomegaly,0.005295221818512134,True,Abnormal increased size of the spleen.,477,74,21,4958,0.28378378378378377,0.0440251572327044,Module 2,"['HP:0003271', 'HP:0025408']"
3928,HPA,HPA:0460183,skin 1; cells in granular layer[High],0.005301454044315959,True,skin 1; cells in granular layer[High],248,69,9,11019,0.13043478260869565,0.036290322580645164,Module 5,['HPA:0460182']
3929,HP,HP:0025454,Abnormal CSF metabolite concentration,0.005317407733897217,True,Any deviation from the normal range of concentration of a metabolite in the cerebrospinal fluid.,146,44,9,4958,0.20454545454545456,0.06164383561643835,Module 3,"['HP:0001939', 'HP:0002921']"
3930,REAC,REAC:R-HSA-168898,Toll-like Receptor Cascades,0.005317522214973078,True,Toll-like Receptor Cascades,165,173,12,10842,0.06936416184971098,0.07272727272727272,Module 2,['REAC:R-HSA-168249']
3931,REAC,REAC:R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,0.005330378493182917,True,ATF6 (ATF6-alpha) activates chaperone genes,9,60,3,10842,0.05,0.3333333333333333,Module 4,['REAC:R-HSA-381033']
3932,GO:BP,GO:1901224,positive regulation of non-canonical NF-kappaB signal transduction,0.005351442325895446,True,"""Any process that activates or increases the frequency, rate or extent of the non-canonical NF-kappaB cascade."" [GOC:TermGenie]",61,34,4,21031,0.11764705882352941,0.06557377049180328,Module 7,"['GO:0038061', 'GO:1901222', 'GO:1902533']"
3933,GO:CC,GO:0044294,dendritic growth cone,0.005392196011525193,True,"""The migrating motile tip of a growing nerve cell dendrite."" [GOC:jl]",9,21,2,22097,0.09523809523809523,0.2222222222222222,Module 9,"['GO:0030426', 'GO:0044292']"
3934,WP,WP:WP4630,Measles virus infection,0.005418653205978127,True,Measles virus infection,136,148,11,8286,0.07432432432432433,0.08088235294117647,Module 1,['WP:000000']
3935,HPA,HPA:0471461,skin 2; langerhans cells[≥Low],0.005419942356088503,True,skin 2; langerhans cells[≥Low],789,185,30,11019,0.16216216216216217,0.03802281368821293,Module 1,['HPA:0470000']
3936,TF,TF:M11395,Factor: Erg; motif: NACCGGAWWTCCGGTN,0.005421395932977771,True,Factor: Erg; motif: NACCGGAWWTCCGGTN,8882,826,432,20045,0.5230024213075061,0.04863769421301509,Module 0,['TF:M00000']
3937,HP,HP:0002960,Autoimmunity,0.00542352310044482,True,The occurrence of an immune reaction against the organism's own cells or tissues.,288,74,16,4958,0.21621621621621623,0.05555555555555555,Module 2,['HP:0010978']
3938,KEGG,KEGG:04210,Apoptosis,0.005430978925648539,True,Apoptosis,135,136,10,8484,0.07352941176470588,0.07407407407407407,Module 1,['KEGG:00000']
3939,GO:CC,GO:0019866,organelle inner membrane,0.005450436566199609,True,"""The inner, i.e. lumen-facing, lipid bilayer of an organelle envelope; usually highly selective to most ions and metabolites."" [GOC:mah]",568,105,12,22097,0.11428571428571428,0.02112676056338028,Module 3,"['GO:0031090', 'GO:0031967']"
3940,MIRNA,MIRNA:hsa-miR-4668-3p,hsa-miR-4668-3p,0.005453797533569675,True,hsa-miR-4668-3p,170,27,5,14819,0.18518518518518517,0.029411764705882353,Module 10,['MIRNA:000000']
3941,GO:BP,GO:0080134,regulation of response to stress,0.005488532538114263,True,"""Any process that modulates the frequency, rate or extent of a response to stress. Response to stress is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis, usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation)."" [GOC:dhl]",1340,226,34,21031,0.1504424778761062,0.025373134328358207,Module 1,"['GO:0006950', 'GO:0048583']"
3942,HPA,HPA:0131303,colon; enterocytes[High],0.005493567872868749,True,colon; enterocytes[High],217,79,9,11019,0.11392405063291139,0.041474654377880185,Module 3,['HPA:0131302']
3943,GO:BP,GO:0043484,regulation of RNA splicing,0.005500394616442396,True,"""Any process that modulates the frequency, rate or extent of RNA splicing, the process of removing sections of the primary RNA transcript to remove sequences not present in the mature form of the RNA and joining the remaining sections to form the mature form of the RNA."" [GOC:jl]",186,172,10,21031,0.05813953488372093,0.053763440860215055,Module Singleton,"['GO:0008380', 'GO:0010468', 'GO:0051252']"
3944,GO:BP,GO:0044093,positive regulation of molecular function,0.005516337169982468,True,"""Any process that activates or increases the rate or extent of a molecular function, an elemental biological activity occurring at the molecular level, such as catalysis or binding."" [GO:jl]",1097,215,29,21031,0.13488372093023257,0.02643573381950775,Module 2,['GO:0065009']
3945,TF,TF:M12642,Factor: NFYA; motif: NNRGCCAATSRGMRSSNNSN,0.005527337254633768,True,Factor: NFYA; motif: NNRGCCAATSRGMRSSNNSN,2845,67,25,20045,0.373134328358209,0.008787346221441126,Module 4,['TF:M00000']
3946,HPA,HPA:0471441,skin 2; fibrohistiocytic cells[≥Low],0.005555225434771644,True,skin 2; fibrohistiocytic cells[≥Low],1021,79,20,11019,0.25316455696202533,0.019588638589618023,Module 3,['HPA:0470000']
3947,TF,TF:M03985,Factor: ETV6; motif: NSCGGAAGTR,0.005566801034601093,True,Factor: ETV6; motif: NSCGGAAGTR,1159,105,20,20045,0.19047619047619047,0.01725625539257981,Module 3,['TF:M00000']
3948,GO:CC,GO:0099503,secretory vesicle,0.005576961164225126,True,"""A cytoplasmic, membrane bound vesicle that is capable of fusing to the plasma membrane to release its contents into the extracellular space."" [GOC:dos]",1069,238,28,22097,0.11764705882352941,0.026192703461178673,Module 1,['GO:0031410']
3949,HP,HP:0002421,Poor head control,0.005600993095251059,True,Difficulty to maintain correct position of the head while standing or sitting.,238,228,28,4958,0.12280701754385964,0.11764705882352941,Module 0,['HP:0001324']
3950,TF,TF:M11061,Factor: HES-1; motif: GGCRCGTGNC,0.005623952879686814,True,Factor: HES-1; motif: GGCRCGTGNC,6391,826,326,20045,0.3946731234866828,0.0510092317321233,Module 0,['TF:M00000']
3951,GO:CC,GO:0012506,vesicle membrane,0.005638670534887514,True,"""The lipid bilayer surrounding any membrane-bounded vesicle in the cell."" [GOC:mah, GOC:vesicle]",1240,177,25,22097,0.14124293785310735,0.020161290322580645,Module Singleton,"['GO:0031090', 'GO:0031982']"
3952,REAC,REAC:R-HSA-9619483,Activation of AMPK downstream of NMDARs,0.005649900516799972,True,Activation of AMPK downstream of NMDARs,28,59,4,10842,0.06779661016949153,0.14285714285714285,Module 5,['REAC:R-HSA-438064']
3953,GO:MF,GO:0030911,TPR domain binding,0.00566184172749171,True,"""Binding to a tetratricopeptide repeat (TPR) domain of a protein, the consensus sequence of which is defined by a pattern of small and large hydrophobic amino acids and a structure composed of helices."" [GOC:mah]",7,20,2,20212,0.1,0.2857142857142857,Module 9,['GO:0019904']
3954,GO:MF,GO:0030235,nitric-oxide synthase regulator activity,0.00566184172749171,True,"""Binds to and modulates the activity of nitric oxide synthase."" [GOC:mah]",7,20,2,20212,0.1,0.2857142857142857,Module 9,['GO:0030234']
3955,HP,HP:0002045,Hypothermia,0.005664556595502259,True,Reduced body temperature due to failed thermoregulation.,50,44,6,4958,0.13636363636363635,0.12,Module 3,['HP:0004370']
3956,WP,WP:WP2877,Vitamin D receptor pathway,0.005675027739356298,True,Vitamin D receptor pathway,182,154,13,8286,0.08441558441558442,0.07142857142857142,Module 2,['WP:000000']
3957,TF,TF:M02053,Factor: ELF1; motif: NCCGGAARTN,0.005712548539692075,True,Factor: ELF1; motif: NCCGGAARTN,6166,21,17,20045,0.8095238095238095,0.0027570548167369447,Module 9,['TF:M00000']
3958,HPA,HPA:0461441,skin 1; fibrohistiocytic cells[≥Low],0.00571276342058289,True,skin 1; fibrohistiocytic cells[≥Low],885,18,8,11019,0.4444444444444444,0.00903954802259887,Module 9,['HPA:0460000']
3959,HPA,HPA:0180051,epididymis; glandular cells[≥Low],0.005723785474784155,True,epididymis; glandular cells[≥Low],7337,60,54,11019,0.9,0.007359956385443642,Module 4,['HPA:0180000']
3960,HPA,HPA:0180000,epididymis,0.005723785474784155,True,epididymis,7337,60,54,11019,0.9,0.007359956385443642,Module 4,['HPA:0000000']
3961,TF,TF:M07052_1,Factor: NRF-1; motif: GCGCMTGCGCN; match class: 1,0.005739879141155853,True,Factor: NRF-1; motif: GCGCMTGCGCN; match class: 1,751,826,59,20045,0.07142857142857142,0.07856191744340879,Module 0,['TF:M07052']
3962,GO:BP,GO:0071806,protein transmembrane transport,0.005746240915677337,True,"""The process in which a protein is transported across a membrane."" [GOC:mah, GOC:vw]",66,72,5,21031,0.06944444444444445,0.07575757575757576,Module 4,"['GO:0015031', 'GO:0055085']"
3963,HP,HP:0000124,Renal tubular dysfunction,0.005760961045451234,True,"Abnormal function of the renal tubule. The basic functional unit of the kidney, the nephron, consists of a renal corpuscle attached to a renal tubule, with roughly 0.8 to 1.5 nephrons per adult kidney. The functions of the renal tubule include reabsorption of water, electrolytes, glucose, and amino acids and secretion of substances such as uric acid.",110,44,8,4958,0.18181818181818182,0.07272727272727272,Module 3,['HP:0012211']
3964,HP,HP:0000529,Progressive visual loss,0.005760961045451234,True,A reduction of previously attained ability to see.,110,44,8,4958,0.18181818181818182,0.07272727272727272,Module 3,['HP:0000572']
3965,GO:BP,GO:0045088,regulation of innate immune response,0.005773638128250899,True,"""Any process that modulates the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection."" [GOC:ebc]",415,226,17,21031,0.0752212389380531,0.04096385542168675,Module 1,"['GO:0002831', 'GO:0031347', 'GO:0032101', 'GO:0045087', 'GO:0050776']"
3966,KEGG,KEGG:00230,Purine metabolism,0.005789467648538157,True,Purine metabolism,126,2,2,8484,1.0,0.015873015873015872,Module 39,['KEGG:00000']
3967,REAC,REAC:R-HSA-5689901,Metalloprotease DUBs,0.005792875811436639,True,Metalloprotease DUBs,36,3,2,10842,0.6666666666666666,0.05555555555555555,Module 27,['REAC:R-HSA-5688426']
3968,GO:BP,GO:0051171,regulation of nitrogen compound metabolic process,0.0057960904883873334,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving nitrogen or nitrogenous compounds."" [GOC:ai, GOC:tb]",5440,226,90,21031,0.39823008849557523,0.016544117647058824,Module 1,"['GO:0006807', 'GO:0019222']"
3969,TF,TF:M08637,Factor: TEF-3:Erg; motif: ACCGGAAATRNNNNNCATWCC,0.005799111567465138,True,Factor: TEF-3:Erg; motif: ACCGGAAATRNNNNNCATWCC,4484,105,45,20045,0.42857142857142855,0.010035682426404995,Module 3,['TF:M00000']
3970,HPA,HPA:0570000,testis,0.005800966431152859,True,testis,9036,79,77,11019,0.9746835443037974,0.008521469676848163,Module 3,['HPA:0000000']
3971,TF,TF:M09607,Factor: SAP-1; motif: ACCGGAAGTNN,0.005826799536579389,True,Factor: SAP-1; motif: ACCGGAAGTNN,4797,105,47,20045,0.44761904761904764,0.009797790285595165,Module 3,['TF:M00000']
3972,HPA,HPA:0461442,skin 1; fibrohistiocytic cells[≥Medium],0.0058335523801290945,True,skin 1; fibrohistiocytic cells[≥Medium],699,12,6,11019,0.5,0.008583690987124463,Module 6,['HPA:0461441']
3973,TF,TF:M02117_1,Factor: STAT4; motif: TTMNNRGAAA; match class: 1,0.005838987602181666,True,Factor: STAT4; motif: TTMNNRGAAA; match class: 1,69,2,2,20045,1.0,0.028985507246376812,Module 41,['TF:M02117']
3974,GO:BP,GO:1901873,regulation of post-translational protein modification,0.005850808691326082,True,"""Any process that modulates the frequency, rate or extent of post-translational protein modification."" [GOC:TermGenie, GOC:yaf, PMID:21209915]",247,21,5,21031,0.23809523809523808,0.020242914979757085,Module 9,"['GO:0031399', 'GO:0043687']"
3975,GO:BP,GO:0043542,endothelial cell migration,0.005850879239654733,True,"""The orderly movement of an endothelial cell into the extracellular matrix to form an endothelium."" [GOC:go_curators]",219,215,12,21031,0.05581395348837209,0.0547945205479452,Module 2,['GO:0010631']
3976,TF,TF:M08224_1,Factor: Elk-1:Pax-1; motif: ACCGGAACTACGCWTSANTG; match class: 1,0.0058679483018151835,True,Factor: Elk-1:Pax-1; motif: ACCGGAACTACGCWTSANTG; match class: 1,2813,826,164,20045,0.19854721549636803,0.05830074653394952,Module 0,['TF:M08224']
3977,HP,HP:0005922,Abnormal hand morphology,0.005881067205851668,True,Any structural anomaly of the hand.,1041,44,23,4958,0.5227272727272727,0.022094140249759846,Module 3,['HP:0001155']
3978,KEGG,KEGG:03030,DNA replication,0.005883758453663991,True,DNA replication,36,53,4,8484,0.07547169811320754,0.1111111111111111,Module 5,['KEGG:00000']
3979,GO:MF,GO:0001664,G protein-coupled receptor binding,0.005889327073346474,True,"""Binding to a G protein-coupled receptor."" [GOC:ceb, GOC:dph]",292,5,3,20212,0.6,0.010273972602739725,Module 12,['GO:0005102']
3980,GO:BP,GO:0060267,positive regulation of respiratory burst,0.005897092249019582,True,"""Any process that increases the rate frequency or extent of a phase of elevated metabolic activity, during which oxygen consumption increases; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals."" [GOC:dph, GOC:tb]",9,72,3,21031,0.041666666666666664,0.3333333333333333,Module 4,"['GO:0009893', 'GO:0045730', 'GO:0060263']"
3981,GO:MF,GO:0044389,ubiquitin-like protein ligase binding,0.005911956286173676,True,"""Binding to a ubiquitin-like protein ligase, such as ubiquitin-ligase."" [GOC:jl]",326,808,31,20212,0.038366336633663366,0.0950920245398773,Module 0,['GO:0019899']
3982,GO:BP,GO:0032946,positive regulation of mononuclear cell proliferation,0.005917973507777948,True,"""Any process that activates or increases the frequency, rate or extent of mononuclear cell proliferation."" [GOC:add]",147,215,10,21031,0.046511627906976744,0.06802721088435375,Module 2,"['GO:0032943', 'GO:0032944', 'GO:0070665']"
3983,GO:BP,GO:1903707,negative regulation of hemopoiesis,0.005921166230225402,True,"""Any process that stops, prevents or reduces the frequency, rate or extent of hemopoiesis."" [GO_REF:0000058, GOC:pad, GOC:PARL, GOC:TermGenie, PMID:20080761]",115,215,9,21031,0.04186046511627907,0.0782608695652174,Module 2,"['GO:0002683', 'GO:0010721', 'GO:0030097', 'GO:0051241', 'GO:1903706']"
3984,GO:BP,GO:0019882,antigen processing and presentation,0.005921166230225402,True,"""The process in which an antigen-presenting cell expresses antigen (peptide or lipid) on its cell surface in association with an MHC protein complex."" [GO_REF:0000022, GOC:add, ISBN:0781735149, PMID:15771591, PMID:15928678]",115,215,9,21031,0.04186046511627907,0.0782608695652174,Module 2,['GO:0002376']
3985,HPA,HPA:0130892,colon; goblet cells[≥Medium],0.005948090836967026,True,colon; goblet cells[≥Medium],336,79,11,11019,0.13924050632911392,0.03273809523809524,Module 3,['HPA:0130891']
3986,HPA,HPA:0480000,small intestine,0.005971013504048051,True,small intestine,7877,60,56,11019,0.9333333333333333,0.007109305573187762,Module 4,['HPA:0000000']
3987,KEGG,KEGG:04141,Protein processing in endoplasmic reticulum,0.005986723838652526,True,Protein processing in endoplasmic reticulum,168,439,22,8484,0.05011389521640091,0.13095238095238096,Module 0,['KEGG:00000']
3988,HPA,HPA:0470000,skin 2,0.005999820026977674,True,skin 2,7036,140,112,11019,0.8,0.015918135304150087,Module Singleton,['HPA:0000000']
3989,HPA,HPA:0160052,endometrium 1; glandular cells[≥Medium],0.0060293689401667095,True,endometrium 1; glandular cells[≥Medium],5155,60,44,11019,0.7333333333333333,0.008535402521823473,Module 4,['HPA:0160051']
3990,TF,TF:M00428_1,Factor: E2F-1; motif: NKTSSCGC; match class: 1,0.006067583289727771,True,Factor: E2F-1; motif: NKTSSCGC; match class: 1,3732,826,207,20045,0.2506053268765133,0.05546623794212219,Module 0,['TF:M00428']
3991,KEGG,KEGG:04926,Relaxin signaling pathway,0.006069567607153143,True,Relaxin signaling pathway,129,2,2,8484,1.0,0.015503875968992248,Module 22,['KEGG:00000']
3992,TF,TF:M04696_1,Factor: YY1; motif: GCCGCCATNTTGNNNNNGGNCN; match class: 1,0.0060821218657968355,True,Factor: YY1; motif: GCCGCCATNTTGNNNNNGGNCN; match class: 1,1972,105,27,20045,0.2571428571428571,0.013691683569979716,Module 3,['TF:M04696']
3993,REAC,REAC:R-HSA-445717,Aquaporin-mediated transport,0.006098079027983422,True,Aquaporin-mediated transport,52,2,2,10842,1.0,0.038461538461538464,Module 22,['REAC:R-HSA-382551']
3994,KEGG,KEGG:04672,Intestinal immune network for IgA production,0.0061101175611978625,True,Intestinal immune network for IgA production,44,136,6,8484,0.04411764705882353,0.13636363636363635,Module 1,['KEGG:00000']
3995,HPA,HPA:0461392,skin 1; cells in basal layer[≥Medium],0.006115757122210777,True,skin 1; cells in basal layer[≥Medium],637,18,7,11019,0.3888888888888889,0.01098901098901099,Module 9,['HPA:0461391']
3996,GO:MF,GO:0045296,cadherin binding,0.006124850141165884,True,"""Binding to cadherin, a type I membrane protein involved in cell adhesion."" [GOC:bf]",335,105,10,20212,0.09523809523809523,0.029850746268656716,Module 3,['GO:0050839']
3997,HPA,HPA:0030441,appendix; non-germinal center cells[≥Low],0.006208552796157513,True,appendix; non-germinal center cells[≥Low],336,140,15,11019,0.10714285714285714,0.044642857142857144,Module Singleton,['HPA:0030000']
3998,GO:BP,GO:0002335,mature B cell differentiation,0.006217284183308965,True,"""The process in which transitional stage B cells acquire the specialized features of mature B cells in the spleen."" [GOC:jal, ISBN:0781735149]",38,226,6,21031,0.02654867256637168,0.15789473684210525,Module 1,['GO:0030183']
3999,HPA,HPA:0090971,cerebellum; granular cells - cytoplasm/membrane[≥Low],0.006254279461816979,True,cerebellum; granular cells - cytoplasm/membrane[≥Low],297,612,35,11019,0.05718954248366013,0.11784511784511785,Module 0,['HPA:0090000']
4000,TF,TF:M00740,Factor: Rb:E2F-1:DP-1; motif: TTTSGCGC,0.006256525276347792,True,Factor: Rb:E2F-1:DP-1; motif: TTTSGCGC,10725,80,63,20045,0.7875,0.005874125874125874,Module 5,['TF:M00000']
4001,KEGG,KEGG:04728,Dopaminergic synapse,0.006259976765371717,True,Dopaminergic synapse,131,2,2,8484,1.0,0.015267175572519083,Module 22,['KEGG:00000']
4002,TF,TF:M00739,Factor: E2F-4:DP-2; motif: TTTCSCGC,0.006260771342511347,True,Factor: E2F-4:DP-2; motif: TTTCSCGC,5757,826,298,20045,0.36077481840193704,0.0517630710439465,Module 0,['TF:M00000']
4003,TF,TF:M02063,Factor: c-ets-1; motif: ACCGGAWGTN,0.00627050788658036,True,Factor: c-ets-1; motif: ACCGGAWGTN,7763,183,102,20045,0.5573770491803278,0.013139250289836403,Module Singleton,['TF:M00000']
4004,GO:BP,GO:0010952,positive regulation of peptidase activity,0.006290843038722674,True,"""Any process that increases the frequency, rate or extent of peptidase activity, the hydrolysis of peptide bonds within proteins."" [GOC:dph, GOC:tb]",148,215,10,21031,0.046511627906976744,0.06756756756756757,Module 2,"['GO:0045862', 'GO:0051345', 'GO:0052547']"
4005,REAC,REAC:R-HSA-2262752,Cellular responses to stress,0.006295644980333173,True,Cellular responses to stress,780,60,15,10842,0.25,0.019230769230769232,Module 4,['REAC:R-HSA-8953897']
4006,HPA,HPA:0470672,skin 2; melanocytes[≥Medium],0.0063039561418816135,True,skin 2; melanocytes[≥Medium],640,18,7,11019,0.3888888888888889,0.0109375,Module 9,['HPA:0470671']
4007,CORUM,CORUM:2757,"SMN complex, U7 snRNA specific",0.006317110226755153,True,"SMN complex, U7 snRNA specific",6,331,5,3383,0.015105740181268883,0.8333333333333334,Module 0,['CORUM:0000000']
4008,HPA,HPA:0271122,kidney; collecting ducts[≥Medium],0.006317336385616978,True,kidney; collecting ducts[≥Medium],463,612,48,11019,0.0784313725490196,0.10367170626349892,Module 0,['HPA:0271121']
4009,KEGG,KEGG:05322,Systemic lupus erythematosus,0.006356284100223597,True,Systemic lupus erythematosus,132,2,2,8484,1.0,0.015151515151515152,Module 27,['KEGG:00000']
4010,HP,HP:0010974,Abnormal myeloid leukocyte morphology,0.00636961916827117,True,An abnormality of myeloid leukocytes.,328,59,15,4958,0.2542372881355932,0.04573170731707317,Module Singleton,['HP:0001881']
4011,TF,TF:M00918_1,Factor: E2F; motif: TTTSGCGSG; match class: 1,0.006373778956445689,True,Factor: E2F; motif: TTTSGCGSG; match class: 1,1288,80,18,20045,0.225,0.013975155279503106,Module 5,['TF:M00918']
4012,HPA,HPA:0400651,rectum; fibroblasts[≥Low],0.006446822747185459,True,rectum; fibroblasts[≥Low],122,140,9,11019,0.06428571428571428,0.07377049180327869,Module Singleton,['HPA:0400000']
4013,TF,TF:M12238,Factor: DREF; motif: MTRTCGCGAYAK,0.006455900167775492,True,Factor: DREF; motif: MTRTCGCGAYAK,355,826,35,20045,0.0423728813559322,0.09859154929577464,Module 0,['TF:M00000']
4014,CORUM,CORUM:2920,Respiratory chain complex I (lambda subunit) mitochondrial,0.0064650514578030146,True,Respiratory chain complex I (lambda subunit) mitochondrial,16,331,8,3383,0.02416918429003021,0.5,Module 0,['CORUM:0000000']
4015,GO:CC,GO:1905368,peptidase complex,0.006478711502727991,True,"""A protein complex which is capable of peptidase activity."" [GO_REF:0000088, GOC:bhm, GOC:TermGenie, PMID:1689240]",125,2,2,22097,1.0,0.016,Module 41,['GO:1902494']
4016,GO:BP,GO:1990840,response to lectin,0.006479455776825637,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lectin stimulus. A lectin is a carbohydrate-binding protein, highly specific for binding sugar moieties."" [PMID:25996210, PMID:26306444]",22,226,5,21031,0.022123893805309734,0.22727272727272727,Module 1,['GO:0009607']
4017,GO:BP,GO:1990858,cellular response to lectin,0.006479455776825637,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lectin stimulus. A lectin is a carbohydrate-binding protein, highly specific for binding sugar moieties."" [PMID:25996210, PMID:26306444]",22,226,5,21031,0.022123893805309734,0.22727272727272727,Module 1,['GO:1990840']
4018,GO:BP,GO:0002223,stimulatory C-type lectin receptor signaling pathway,0.006479455776825637,True,"""The series of molecular signals initiated by the binding of C-type lectin to its receptor on the surface of a target cell, and resulting in cellular activation."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",22,226,5,21031,0.022123893805309734,0.22727272727272727,Module 1,"['GO:0002220', 'GO:1990858']"
4019,REAC,REAC:R-HSA-422475,Axon guidance,0.006487257211584245,True,Axon guidance,549,586,54,10842,0.09215017064846416,0.09836065573770492,Module 0,['REAC:R-HSA-9675108']
4020,HPA,HPA:0030433,appendix; germinal center cells[High],0.006493395964945034,True,appendix; germinal center cells[High],92,185,9,11019,0.04864864864864865,0.09782608695652174,Module 1,['HPA:0030432']
4021,GO:BP,GO:0043281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,0.0065154492656265715,True,"""Any process that modulates the activity of a cysteine-type endopeptidase involved in apoptosis."" [GOC:jl, GOC:mtg_apoptosis]",149,787,19,21031,0.0241423125794155,0.12751677852348994,Module 0,['GO:2000116']
4022,HPA,HPA:0471442,skin 2; fibrohistiocytic cells[≥Medium],0.006564987444875122,True,skin 2; fibrohistiocytic cells[≥Medium],833,60,15,11019,0.25,0.01800720288115246,Module 4,['HPA:0471441']
4023,GO:MF,GO:0015036,disulfide oxidoreductase activity,0.006593827202644977,True,"""Catalysis of the reaction: substrate with reduced sulfide groups = substrate with oxidized disulfide bonds."" [GOC:curators]",39,72,4,20212,0.05555555555555555,0.10256410256410256,Module 4,['GO:0016667']
4024,GO:CC,GO:0031966,mitochondrial membrane,0.006625726156791703,True,"""Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope."" [GOC:mah, NIF_Subcellular:sao1045389829]",782,105,14,22097,0.13333333333333333,0.017902813299232736,Module 3,"['GO:0005740', 'GO:0031090']"
4025,HPA,HPA:0131292,colon; endocrine cells[≥Medium],0.00664128073347647,True,colon; endocrine cells[≥Medium],405,79,12,11019,0.1518987341772152,0.02962962962962963,Module 3,['HPA:0131291']
4026,GO:BP,GO:0050896,response to stimulus,0.006641757007864424,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus and ends with a change in state or activity or the cell or organism."" [GOC:ai, GOC:bf]",8976,172,103,21031,0.5988372093023255,0.011475044563279857,Module Singleton,['GO:0008150']
4027,GO:MF,GO:0032555,purine ribonucleotide binding,0.006663115389750503,True,"""Binding to a purine ribonucleotide, any compound consisting of a purine ribonucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose moiety."" [GOC:mah]",1919,80,21,20212,0.2625,0.010943199583116207,Module 5,"['GO:0017076', 'GO:0032553']"
4028,GO:BP,GO:0042255,ribosome assembly,0.0066640488927767845,True,"""The aggregation, arrangement and bonding together of the mature ribosome and of its subunits."" [GOC:ma, PMID:30467428]",63,787,12,21031,0.015247776365946633,0.19047619047619047,Module 0,"['GO:0042254', 'GO:0140694']"
4029,GO:BP,GO:0019731,antibacterial humoral response,0.006667008486009625,True,"""An immune response against bacteria mediated through a body fluid. Examples of this process are the antibacterial humoral responses in Mus musculus and Drosophila melanogaster."" [GOC:go_curators, GOC:mtg_sensu]",68,72,5,21031,0.06944444444444445,0.07352941176470588,Module 4,"['GO:0019730', 'GO:0042742']"
4030,REAC,REAC:R-HSA-453279,Mitotic G1 phase and G1/S transition,0.006670876248993724,True,Mitotic G1 phase and G1/S transition,147,586,22,10842,0.03754266211604096,0.14965986394557823,Module 0,['REAC:R-HSA-69278']
4031,HPA,HPA:0461461,skin 1; langerhans cells[≥Low],0.006685697698571799,True,skin 1; langerhans cells[≥Low],716,12,6,11019,0.5,0.008379888268156424,Module 6,['HPA:0460000']
4032,GO:BP,GO:0043066,negative regulation of apoptotic process,0.006692939116945228,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process."" [GOC:jl, GOC:mtg_apoptosis]",881,226,26,21031,0.11504424778761062,0.029511918274687854,Module 1,"['GO:0006915', 'GO:0042981', 'GO:0043069']"
4033,GO:BP,GO:0010631,epithelial cell migration,0.00669329482290834,True,"""The orderly movement of an epithelial cell from one site to another, often during the development of a multicellular organism."" [GOC:ascb_2009, GOC:BHF, GOC:dph, GOC:tb]",304,215,14,21031,0.06511627906976744,0.046052631578947366,Module 2,"['GO:0001667', 'GO:0090132']"
4034,CORUM,CORUM:2112,CDC37-HSP90AA1-HSP90AB1-MAP3K11 complex,0.0066999581827832935,True,CDC37-HSP90AA1-HSP90AB1-MAP3K11 complex,4,9,2,3383,0.2222222222222222,0.5,Module 9,['CORUM:0000000']
4035,REAC,REAC:R-HSA-983189,Kinesins,0.0067084256653132225,True,Kinesins,60,59,5,10842,0.0847457627118644,0.08333333333333333,Module 5,['REAC:R-HSA-983231']
4036,TF,TF:M10104_1,Factor: YY1; motif: CAARATGGCGGC; match class: 1,0.006721587174482583,True,Factor: YY1; motif: CAARATGGCGGC; match class: 1,1137,826,80,20045,0.09685230024213075,0.07036059806508356,Module 0,['TF:M10104']
4037,GO:CC,GO:0043226,organelle,0.0067468635481202,True,"""Organized structure of distinctive morphology and function. Includes the nucleus, mitochondria, plastids, vacuoles, vesicles, ribosomes and the cytoskeleton, and prokaryotic structures such as anammoxosomes and pirellulosomes. Excludes the plasma membrane."" [GOC:go_curators]",16808,221,193,22097,0.8733031674208145,0.011482627320323655,Module 2,['GO:0110165']
4038,GO:BP,GO:0002697,regulation of immune effector process,0.006756482409941962,True,"""Any process that modulates the frequency, rate, or extent of an immune effector process."" [GOC:add]",378,15,5,21031,0.3333333333333333,0.013227513227513227,Module 6,"['GO:0002252', 'GO:0002682']"
4039,GO:BP,GO:0048024,"regulation of mRNA splicing, via spliceosome",0.006766961478621082,True,"""Any process that modulates the frequency, rate or extent of mRNA splicing via a spliceosomal mechanism."" [GOC:jid]",112,172,8,21031,0.046511627906976744,0.07142857142857142,Module Singleton,"['GO:0000398', 'GO:0043484', 'GO:0050684']"
4040,HPA,HPA:0461442,skin 1; fibrohistiocytic cells[≥Medium],0.006773306570770164,True,skin 1; fibrohistiocytic cells[≥Medium],699,79,16,11019,0.20253164556962025,0.022889842632331903,Module 3,['HPA:0461441']
4041,REAC,REAC:R-HSA-5686938,Regulation of TLR by endogenous ligand,0.006785433454877914,True,Regulation of TLR by endogenous ligand,21,173,5,10842,0.028901734104046242,0.23809523809523808,Module 2,['REAC:R-HSA-168898']
4042,GO:BP,GO:0071294,cellular response to zinc ion,0.006808560958967486,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a zinc ion stimulus."" [GOC:mah]",23,28,3,21031,0.10714285714285714,0.13043478260869565,Module 10,"['GO:0010043', 'GO:0071248']"
4043,HPA,HPA:0461463,skin 1; langerhans cells[High],0.006811221355498073,True,skin 1; langerhans cells[High],218,166,13,11019,0.0783132530120482,0.05963302752293578,Module 2,['HPA:0461462']
4044,MIRNA,MIRNA:hsa-miR-503-3p,hsa-miR-503-3p,0.006830104123980752,True,hsa-miR-503-3p,50,15,3,14819,0.2,0.06,Module 11,['MIRNA:000000']
4045,GO:BP,GO:0060255,regulation of macromolecule metabolic process,0.006836590732002847,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving macromolecules, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass."" [GOC:dph, GOC:tb]",6631,226,104,21031,0.46017699115044247,0.015683908912682853,Module 1,"['GO:0019222', 'GO:0043170']"
4046,TF,TF:M12238,Factor: DREF; motif: MTRTCGCGAYAK,0.006838007946655514,True,Factor: DREF; motif: MTRTCGCGAYAK,355,105,11,20045,0.10476190476190476,0.030985915492957747,Module 3,['TF:M00000']
4047,HPA,HPA:0461422,skin 1; eccrine glands[≥Medium],0.006846603952279776,True,skin 1; eccrine glands[≥Medium],187,166,12,11019,0.07228915662650602,0.06417112299465241,Module 2,['HPA:0461421']
4048,TF,TF:M09868,Factor: ATF-3; motif: GGTSACGTGAN,0.006857049332946793,True,Factor: ATF-3; motif: GGTSACGTGAN,6496,826,330,20045,0.39951573849878935,0.05080049261083744,Module 0,['TF:M00000']
4049,HPA,HPA:0600222,tonsil; squamous epithelial cells[≥Medium],0.006885597658861915,True,tonsil; squamous epithelial cells[≥Medium],4949,69,48,11019,0.6956521739130435,0.009698929076581127,Module 5,['HPA:0600221']
4050,TF,TF:M01078_1,Factor: c-Ets-1; motif: NNNRCCGGAWRYNNNN; match class: 1,0.0069122307307161335,True,Factor: c-Ets-1; motif: NNNRCCGGAWRYNNNN; match class: 1,2497,105,31,20045,0.29523809523809524,0.012414897877452943,Module 3,['TF:M01078']
4051,GO:BP,GO:0006310,DNA recombination,0.0069326582324596,True,"""Any process in which a new genotype is formed by reassortment of genes resulting in gene combinations different from those that were present in the parents. In eukaryotes genetic recombination can occur by chromosome assortment, intrachromosomal recombination, or nonreciprocal interchromosomal recombination. Interchromosomal recombination occurs by crossing over. In bacteria it may occur by genetic transformation, conjugation, transduction, or F-duction."" [ISBN:0198506732]",334,77,9,21031,0.11688311688311688,0.02694610778443114,Module 5,['GO:0006259']
4052,KEGG,KEGG:04371,Apelin signaling pathway,0.006949566689730939,True,Apelin signaling pathway,138,2,2,8484,1.0,0.014492753623188406,Module 22,['KEGG:00000']
4053,GO:MF,GO:0003723,RNA binding,0.006963930963714664,True,"""Binding to an RNA molecule or a portion thereof."" [GOC:jl, GOC:mah]",3123,80,28,20212,0.35,0.008965738072366315,Module 5,['GO:0003676']
4054,HPA,HPA:0330000,oral mucosa,0.006968716220532042,True,oral mucosa,6257,140,103,11019,0.7357142857142858,0.01646156304938469,Module Singleton,['HPA:0000000']
4055,HPA,HPA:0330221,oral mucosa; squamous epithelial cells[≥Low],0.006968716220532042,True,oral mucosa; squamous epithelial cells[≥Low],6257,140,103,11019,0.7357142857142858,0.01646156304938469,Module Singleton,['HPA:0330000']
4056,HPA,HPA:0480892,small intestine; goblet cells[≥Medium],0.007002091394122274,True,small intestine; goblet cells[≥Medium],342,79,11,11019,0.13924050632911392,0.03216374269005848,Module 3,['HPA:0480891']
4057,GO:BP,GO:0002764,immune response-regulating signaling pathway,0.0070040428311376,True,"""The cascade of processes by which a signal interacts with a receptor, causing a change in the level or activity of a second messenger or other downstream target, and ultimately leading to the activation, perpetuation, or inhibition of an immune response."" [GOC:add, ISBN:0781735149, PMID:15771571]",492,215,18,21031,0.08372093023255814,0.036585365853658534,Module 2,"['GO:0007165', 'GO:0050776']"
4058,HP,HP:0031546,Cardiac conduction abnormality,0.007029396879729866,True,Any anomaly of the progression of electrical impulses through the heart.,151,44,9,4958,0.20454545454545456,0.059602649006622516,Module 3,['HP:0030956']
4059,REAC,REAC:R-HSA-3299685,Detoxification of Reactive Oxygen Species,0.007029882946705241,True,Detoxification of Reactive Oxygen Species,35,173,6,10842,0.03468208092485549,0.17142857142857143,Module 2,['REAC:R-HSA-9711123']
4060,HPA,HPA:0471423,skin 2; eccrine glands[High],0.0070422830742318315,True,skin 2; eccrine glands[High],29,69,4,11019,0.057971014492753624,0.13793103448275862,Module 5,['HPA:0471422']
4061,GO:BP,GO:1901575,organic substance catabolic process,0.00705236760418277,True,"""The chemical reactions and pathways resulting in the breakdown of an organic substance, any molecular entity containing carbon."" [GOC:pr, GOC:TermGenie]",2074,172,37,21031,0.21511627906976744,0.017839922854387655,Module Singleton,"['GO:0009056', 'GO:0071704']"
4062,KEGG,KEGG:04380,Osteoclast differentiation,0.007054747691404916,True,Osteoclast differentiation,132,143,10,8484,0.06993006993006994,0.07575757575757576,Module 2,['KEGG:00000']
4063,HPA,HPA:0460201,skin 1; endothelial cells[≥Low],0.007082504201906043,True,skin 1; endothelial cells[≥Low],841,185,31,11019,0.16756756756756758,0.036860879904875146,Module 1,['HPA:0460000']
4064,HP,HP:0003493,Antinuclear antibody positivity,0.007112884097113694,True,The presence of autoantibodies in the serum that react against nuclei or nuclear components.,68,71,8,4958,0.11267605633802817,0.11764705882352941,Module 1,['HP:0030057']
4065,GO:BP,GO:0009057,macromolecule catabolic process,0.00711552206656791,True,"""The chemical reactions and pathways resulting in the breakdown of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass."" [GOC:mah]",1338,172,28,21031,0.16279069767441862,0.02092675635276532,Module Singleton,"['GO:0043170', 'GO:1901575']"
4066,GO:BP,GO:0071674,mononuclear cell migration,0.007140235768642946,True,"""The movement of a mononuclear cell within or between different tissues and organs of the body."" [GOC:mah]",205,5,3,21031,0.6,0.014634146341463415,Module 12,['GO:0050900']
4067,HPA,HPA:0401292,rectum; endocrine cells[≥Medium],0.007141239700723265,True,rectum; endocrine cells[≥Medium],408,79,12,11019,0.1518987341772152,0.029411764705882353,Module 3,['HPA:0401291']
4068,TF,TF:M01001,Factor: DEAF1; motif: NCGNNYTCGGGNRTTTCCGDARNNN,0.007147363527992416,True,Factor: DEAF1; motif: NCGNNYTCGGGNRTTTCCGDARNNN,2344,826,141,20045,0.17070217917675545,0.06015358361774744,Module 0,['TF:M00000']
4069,GO:MF,GO:0016462,pyrophosphatase activity,0.007153334257811459,True,"""Catalysis of the hydrolysis of a pyrophosphate bond (diphosphate bond) between two phosphate groups."" [GOC:curators, https://en.wikipedia.org/wiki/Pyrophosphatase]",794,80,13,20212,0.1625,0.0163727959697733,Module 5,['GO:0016818']
4070,HP,HP:0001730,Progressive hearing impairment,0.007161906108185506,True,A progressive form of hearing impairment.,52,44,6,4958,0.13636363636363635,0.11538461538461539,Module 3,['HP:0000365']
4071,TF,TF:M03977,Factor: ETS1; motif: ACCGGAARYN,0.007179072169457424,True,Factor: ETS1; motif: ACCGGAARYN,10772,183,129,20045,0.7049180327868853,0.011975492016338655,Module Singleton,['TF:M00000']
4072,TF,TF:M11221,Factor: CREB1; motif: RTGACGYGTCAN,0.007180899702468557,True,Factor: CREB1; motif: RTGACGYGTCAN,9847,105,75,20045,0.7142857142857143,0.007616532954199249,Module 3,['TF:M00000']
4073,GO:CC,GO:0071944,cell periphery,0.007215311425214335,True,"""The broad region around and including the plasma membrane of a cell, encompassing the cell cortex (inside the cell), the plasma membrane, and any external encapsulating structures."" [GOC:pdt]",6228,17,13,22097,0.7647058823529411,0.0020873474630700066,Module 6,['GO:0110165']
4074,GO:BP,GO:0070374,positive regulation of ERK1 and ERK2 cascade,0.007245236132284086,True,"""Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade."" [GOC:mah]",206,5,3,21031,0.6,0.014563106796116505,Module 12,"['GO:0043410', 'GO:0070371', 'GO:0070372']"
4075,GO:MF,GO:0016817,"hydrolase activity, acting on acid anhydrides",0.0072493710125800795,True,"""Catalysis of the hydrolysis of any acid anhydride."" [GOC:jl]",795,80,13,20212,0.1625,0.016352201257861635,Module 5,['GO:0016787']
4076,GO:MF,GO:0016818,"hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides",0.0072493710125800795,True,"""Catalysis of the hydrolysis of any acid anhydride which contains phosphorus."" [GOC:jl]",795,80,13,20212,0.1625,0.016352201257861635,Module 5,['GO:0016817']
4077,HPA,HPA:0461473,skin 1; lymphocytes[High],0.007251593211339873,True,skin 1; lymphocytes[High],394,166,18,11019,0.10843373493975904,0.04568527918781726,Module 2,['HPA:0461472']
4078,GO:MF,GO:0016655,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor",0.007257782737542479,True,"""Catalysis of an oxidation-reduction (redox) reaction in which NADH or NADPH acts as a hydrogen or electron donor and reduces a quinone or a similar acceptor molecule."" [GOC:ai]",57,105,5,20212,0.047619047619047616,0.08771929824561403,Module 3,['GO:0016651']
4079,TF,TF:M07250,Factor: E2F-1; motif: NNNSSCGCSAANN,0.007264728576881277,True,Factor: E2F-1; motif: NNNSSCGCSAANN,11049,80,64,20045,0.8,0.005792379400850756,Module 5,['TF:M00000']
4080,GO:BP,GO:0032814,regulation of natural killer cell activation,0.007282120352798559,True,"""Any process that modulates the frequency, rate or extent of natural killer cell activation."" [GOC:mah]",39,226,6,21031,0.02654867256637168,0.15384615384615385,Module 1,"['GO:0030101', 'GO:0051249']"
4081,GO:CC,GO:0044754,autolysosome,0.007286153089387749,True,"""A type of secondary lysosome in which a primary lysosome has fused with the outer membrane of an autophagosome. It is involved in the second step of autophagy in which it degrades contents with acidic lysosomal hydrolases."" [GOC:sart, NIF_Subcellular:sao8444068431, PMID:19008921]",14,17,2,22097,0.11764705882352941,0.14285714285714285,Module 6,"['GO:0005767', 'GO:0005776']"
4082,GO:BP,GO:0098662,inorganic cation transmembrane transport,0.007319003099226167,True,"""A process in which an inorganic cation is transported from one side of a membrane to the other by means of some agent such as a transporter or pore."" [GOC:mah]",808,787,57,21031,0.0724269377382465,0.07054455445544554,Module 0,['GO:0098660']
4083,HPA,HPA:0031301,appendix; enterocytes[≥Low],0.007326142159458686,True,appendix; enterocytes[≥Low],478,79,13,11019,0.16455696202531644,0.027196652719665274,Module 3,['HPA:0030000']
4084,HP,HP:0001639,Hypertrophic cardiomyopathy,0.007338937099444716,True,"Hypertrophic cardiomyopathy (HCM) is defined by the presence of increased ventricular wall thickness or mass in the absence of loading conditions (hypertension, valve disease) sufficient to cause the observed abnormality.",283,228,31,4958,0.13596491228070176,0.10954063604240283,Module 0,['HP:0001638']
4085,HPA,HPA:0590051,thyroid gland; glandular cells[≥Low],0.007355229185483965,True,thyroid gland; glandular cells[≥Low],7131,60,53,11019,0.8833333333333333,0.007432337680549713,Module 4,['HPA:0590000']
4086,HPA,HPA:0590000,thyroid gland,0.007355229185483965,True,thyroid gland,7131,60,53,11019,0.8833333333333333,0.007432337680549713,Module 4,['HPA:0000000']
4087,TF,TF:M07459_1,Factor: HSF1; motif: GAANNTTCTNGN; match class: 1,0.00737284258228816,True,Factor: HSF1; motif: GAANNTTCTNGN; match class: 1,429,21,6,20045,0.2857142857142857,0.013986013986013986,Module 9,['TF:M07459']
4088,GO:BP,GO:0051179,localization,0.0073825683937334165,True,"""Any process in which a cell, a substance, or a cellular entity, such as a protein complex or organelle, is transported, tethered to or otherwise maintained in a specific location. In the case of substances, localization may also be achieved via selective degradation."" [GOC:ai, GOC:dos]",5520,215,87,21031,0.4046511627906977,0.01576086956521739,Module 2,['GO:0008150']
4089,GO:CC,GO:0008043,intracellular ferritin complex,0.007405744394103176,True,"""A ferritin complex located in the cell. Intracellular ferritin complexes contain 24 subunits, in a mixture of L (light) chains and H (heavy) chains."" [GOC:jl, GOC:mah, PMID:19154717]",2,105,2,22097,0.01904761904761905,1.0,Module 3,"['GO:0070288', 'GO:0140535']"
4090,GO:CC,GO:0070288,ferritin complex,0.007405744394103176,True,"""A protein complex that binds iron and acts as a major iron storage system. Intracellular and extracellular ferritin complexes have different ratios of two types of ferritin monomer, the L (light) chain and H (heavy) chain."" [GOC:mah, PMID:19154717]",2,105,2,22097,0.01904761904761905,1.0,Module 3,['GO:0032991']
4091,GO:BP,GO:0051240,positive regulation of multicellular organismal process,0.007408943034278542,True,"""Any process that activates or increases the frequency, rate or extent of an organismal process, any of the processes pertinent to the function of an organism above the cellular level; includes the integrated processes of tissues and organs."" [GOC:ai]",1637,15,8,21031,0.5333333333333333,0.004886988393402566,Module 6,"['GO:0032501', 'GO:0048518', 'GO:0051239']"
4092,HPA,HPA:0390052,prostate; glandular cells[≥Medium],0.007438603905154647,True,prostate; glandular cells[≥Medium],4809,60,42,11019,0.7,0.008733624454148471,Module 4,['HPA:0390051']
4093,GO:BP,GO:0044772,mitotic cell cycle phase transition,0.007447573652075031,True,"""The cell cycle process by which a cell commits to entering the next mitotic cell cycle phase."" [GOC:mtg_cell_cycle]",432,77,10,21031,0.12987012987012986,0.023148148148148147,Module 5,"['GO:0044770', 'GO:1903047']"
4094,HPA,HPA:0400891,rectum; goblet cells[≥Low],0.00749249611146479,True,rectum; goblet cells[≥Low],410,79,12,11019,0.1518987341772152,0.02926829268292683,Module 3,['HPA:0400000']
4095,GO:BP,GO:0090132,epithelium migration,0.007498696506665534,True,"""The process in which the population of cells that make up an epithelium undergo directed movement."" [GOC:ascb_2009, GOC:dph, GOC:tb]",307,215,14,21031,0.06511627906976744,0.04560260586319218,Module 2,['GO:0090130']
4096,GO:CC,GO:0005682,U5 snRNP,0.007513919463952534,True,"""A ribonucleoprotein complex that contains small nuclear RNA U5, a heptameric ring of Sm proteins, as well as several proteins that are unique to the U5 snRNP, most of which remain associated with the U5 snRNA both while the U5 snRNP is free or assembled into a series of spliceosomal complexes."" [GOC:krc, GOC:mah, ISBN:0879695897]",43,813,9,22097,0.01107011070110701,0.20930232558139536,Module 0,['GO:0097525']
4097,TF,TF:M03807,Factor: SP2; motif: GNNGGGGGCGGGGSN,0.007519078721349093,True,Factor: SP2; motif: GNNGGGGGCGGGGSN,8689,826,423,20045,0.5121065375302664,0.048682241915065025,Module 0,['TF:M00000']
4098,GO:BP,GO:0140131,positive regulation of lymphocyte chemotaxis,0.0075230606224014,True,"""Any process that activates or increases the frequency, rate or extent of lymphocyte chemotaxis."" [PMID:19255442]",21,5,2,21031,0.4,0.09523809523809523,Module 12,"['GO:0002690', 'GO:0048247', 'GO:1901623', 'GO:2000403']"
4099,REAC,REAC:R-HSA-69002,DNA Replication Pre-Initiation,0.0075361139150969215,True,DNA Replication Pre-Initiation,159,586,23,10842,0.03924914675767918,0.14465408805031446,Module 0,['REAC:R-HSA-69306']
4100,GO:BP,GO:0043270,positive regulation of monoatomic ion transport,0.007566371909524657,True,"""Any process that activates or increases the frequency, rate or extent of the directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore."" [GOC:jl]",209,5,3,21031,0.6,0.014354066985645933,Module 12,"['GO:0006811', 'GO:0043269', 'GO:0051050']"
4101,GO:CC,GO:0016591,"RNA polymerase II, holoenzyme",0.007594249293191284,True,"""A nuclear DNA-directed RNA polymerase complex containing an RNA polymerase II core enzyme as well as additional proteins and transcription factor complexes, that are capable of promoter recognition and transcription initiation from an RNA polymerase II promoter in vivo. These additional components may include general transcription factor complexes TFIIA, TFIID, TFIIE, TFIIF, or TFIIH, as well as Mediator, SWI/SNF, GCN5, or SRBs and confer the ability to recognize promoters."" [GOC:jl, GOC:krc, PMID:16858867, Wikipedia:Rna_polymerase_ii]",89,813,13,22097,0.015990159901599015,0.14606741573033707,Module 0,"['GO:0005654', 'GO:0055029']"
4102,GO:CC,GO:0000313,organellar ribosome,0.007594249293191284,True,"""A ribosome contained within a subcellular membrane-bounded organelle."" [GOC:mah, GOC:mcc]",89,813,13,22097,0.015990159901599015,0.14606741573033707,Module 0,"['GO:0005840', 'GO:0043226']"
4103,GO:CC,GO:0005761,mitochondrial ribosome,0.007594249293191284,True,"""A ribosome found in the mitochondrion of a eukaryotic cell; contains a characteristic set of proteins distinct from those of cytosolic ribosomes."" [GOC:mah, ISBN:0198506732]",89,813,13,22097,0.015990159901599015,0.14606741573033707,Module 0,"['GO:0000313', 'GO:0005759']"
4104,TF,TF:M09733_1,Factor: STAT2; motif: NRGAAANNGAAACTNA; match class: 1,0.0076158462084283405,True,Factor: STAT2; motif: NRGAAANNGAAACTNA; match class: 1,368,36,7,20045,0.19444444444444445,0.019021739130434784,Module 7,['TF:M09733']
4105,GO:MF,GO:0032553,ribonucleotide binding,0.007625140641308784,True,"""Binding to a ribonucleotide, any compound consisting of a ribonucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose moiety."" [GOC:mah]",1936,80,21,20212,0.2625,0.01084710743801653,Module 5,"['GO:0000166', 'GO:0097367']"
4106,HP,HP:0002110,Bronchiectasis,0.007632896338588608,True,Persistent abnormal dilatation of the bronchi owing to localized and irreversible destruction and widening of the large airways.,173,71,12,4958,0.16901408450704225,0.06936416184971098,Module 1,['HP:0025426']
4107,HPA,HPA:0250123,hippocampus; glial cells[High],0.00765408028571408,True,hippocampus; glial cells[High],552,3,3,11019,1.0,0.005434782608695652,Module 27,['HPA:0250122']
4108,GO:BP,GO:0050671,positive regulation of lymphocyte proliferation,0.007670446713122589,True,"""Any process that activates or increases the rate or extent of lymphocyte proliferation."" [GOC:ai]",144,226,10,21031,0.04424778761061947,0.06944444444444445,Module 1,"['GO:0032946', 'GO:0046651', 'GO:0050670', 'GO:0051251']"
4109,TF,TF:M11435,Factor: Elk-1; motif: NNCCGGAAGTN,0.007689124742757179,True,Factor: Elk-1; motif: NNCCGGAAGTN,11976,183,139,20045,0.7595628415300546,0.011606546426185705,Module Singleton,['TF:M00000']
4110,MIRNA,MIRNA:hsa-miR-3130-5p,hsa-miR-3130-5p,0.007691931522419153,True,hsa-miR-3130-5p,52,15,3,14819,0.2,0.057692307692307696,Module 11,['MIRNA:000000']
4111,MIRNA,MIRNA:hsa-miR-4482-5p,hsa-miR-4482-5p,0.007691931522419153,True,hsa-miR-4482-5p,52,15,3,14819,0.2,0.057692307692307696,Module 11,['MIRNA:000000']
4112,TF,TF:M09896,Factor: E2F-7; motif: GRGGCGGGAANNN,0.007696941605069267,True,Factor: E2F-7; motif: GRGGCGGGAANNN,10463,826,496,20045,0.6004842615012107,0.047405141928701135,Module 0,['TF:M00000']
4113,GO:BP,GO:0042098,T cell proliferation,0.00771630861241669,True,"""The expansion of a T cell population by cell division. Follows T cell activation."" [GOC:jl]",214,226,12,21031,0.05309734513274336,0.056074766355140186,Module 1,"['GO:0042110', 'GO:0046651']"
4114,GO:BP,GO:0051171,regulation of nitrogen compound metabolic process,0.007738671022176161,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving nitrogen or nitrogenous compounds."" [GOC:ai, GOC:tb]",5440,215,86,21031,0.4,0.015808823529411764,Module 2,"['GO:0006807', 'GO:0019222']"
4115,GO:BP,GO:0051173,positive regulation of nitrogen compound metabolic process,0.007741940923756452,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving nitrogen or nitrogenous compounds."" [GOC:ai, GOC:tb]",3001,215,56,21031,0.26046511627906976,0.01866044651782739,Module 2,"['GO:0006807', 'GO:0009893', 'GO:0051171']"
4116,WP,WP:WP5115,Network map of SARS CoV 2 signaling pathway,0.00774305367791464,True,Network map of SARS CoV 2 signaling pathway,217,27,6,8286,0.2222222222222222,0.027649769585253458,Module 7,['WP:000000']
4117,REAC,REAC:R-HSA-5673001,RAF/MAP kinase cascade,0.007754882476312414,True,RAF/MAP kinase cascade,264,586,32,10842,0.05460750853242321,0.12121212121212122,Module 0,['REAC:R-HSA-5684996']
4118,REAC,REAC:R-HSA-8953897,Cellular responses to stimuli,0.007779164407360705,True,Cellular responses to stimuli,794,60,15,10842,0.25,0.018891687657430732,Module 4,['REAC:0000000']
4119,HPA,HPA:0570761,testis; pachytene spermatocytes[≥Low],0.007782149283477199,True,testis; pachytene spermatocytes[≥Low],2367,69,30,11019,0.43478260869565216,0.012674271229404309,Module 5,['HPA:0570000']
4120,GO:BP,GO:0030217,T cell differentiation,0.0077857264536396525,True,"""The process in which a precursor cell type acquires characteristics of a more mature T-cell. A T cell is a type of lymphocyte whose definin characteristic is the expression of a T cell receptor complex."" [GO_REF:0000022, GOC:jid, GOC:mah]",308,215,14,21031,0.06511627906976744,0.045454545454545456,Module 2,"['GO:0030098', 'GO:0042110']"
4121,GO:BP,GO:0006334,nucleosome assembly,0.007791372721858846,True,"""The aggregation, arrangement and bonding together of a nucleosome, the beadlike structural units of eukaryotic chromatin composed of histones and DNA."" [GOC:mah]",115,77,6,21031,0.07792207792207792,0.05217391304347826,Module 5,"['GO:0006325', 'GO:0034728', 'GO:0065004']"
4122,REAC,REAC:R-HSA-68882,Mitotic Anaphase,0.00780524833867309,True,Mitotic Anaphase,228,586,29,10842,0.04948805460750853,0.12719298245614036,Module 0,['REAC:R-HSA-2555396']
4123,HPA,HPA:0471462,skin 2; langerhans cells[≥Medium],0.007836348713647903,True,skin 2; langerhans cells[≥Medium],662,18,7,11019,0.3888888888888889,0.010574018126888218,Module 9,['HPA:0471461']
4124,HPA,HPA:0420051,salivary gland; glandular cells[≥Low],0.00784134086035748,True,salivary gland; glandular cells[≥Low],6902,60,52,11019,0.8666666666666667,0.007534048101999421,Module 4,['HPA:0420000']
4125,HPA,HPA:0420000,salivary gland,0.00784134086035748,True,salivary gland,6902,60,52,11019,0.8666666666666667,0.007534048101999421,Module 4,['HPA:0000000']
4126,MIRNA,MIRNA:hsa-miR-1245b-3p,hsa-miR-1245b-3p,0.007885547284323337,True,hsa-miR-1245b-3p,77,60,5,14819,0.08333333333333333,0.06493506493506493,Module 4,['MIRNA:000000']
4127,KEGG,KEGG:05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,0.00790513800421646,True,PD-L1 expression and PD-1 checkpoint pathway in cancer,89,136,8,8484,0.058823529411764705,0.0898876404494382,Module 1,['KEGG:00000']
4128,GO:BP,GO:2000278,regulation of DNA biosynthetic process,0.007907537799160723,True,"""Any process that modulates the frequency, rate or extent of DNA biosynthetic process."" [GOC:obol]",117,21,4,21031,0.19047619047619047,0.03418803418803419,Module 9,"['GO:0010556', 'GO:0051052', 'GO:0071897']"
4129,GO:BP,GO:0072655,establishment of protein localization to mitochondrion,0.007907537799160723,True,"""The directed movement of a protein to the mitochondrion or a part of the mitochondrion."" [GOC:mah]",117,21,4,21031,0.19047619047619047,0.03418803418803419,Module 9,"['GO:0070585', 'GO:0072594']"
4130,TF,TF:M08290,Factor: FOXJ2:Elf-1; motif: NNAAACMGGAAGTN,0.007925074255881494,True,Factor: FOXJ2:Elf-1; motif: NNAAACMGGAAGTN,1623,826,105,20045,0.1271186440677966,0.06469500924214418,Module 0,['TF:M00000']
4131,GO:BP,GO:0034249,negative regulation of amide metabolic process,0.007957023825167971,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving amides."" [GOC:mah]",151,787,19,21031,0.0241423125794155,0.12582781456953643,Module 0,"['GO:0034248', 'GO:0043603', 'GO:0051172']"
4132,KEGG,KEGG:04723,Retrograde endocannabinoid signaling,0.00799718464518069,True,Retrograde endocannabinoid signaling,148,2,2,8484,1.0,0.013513513513513514,Module 22,['KEGG:00000']
4133,TF,TF:M09935,Factor: GABP-alpha; motif: NNNRCCGGAAGTGN,0.008005362479444262,True,Factor: GABP-alpha; motif: NNNRCCGGAAGTGN,4535,105,45,20045,0.42857142857142855,0.009922822491730982,Module 3,['TF:M00000']
4134,GO:BP,GO:0002684,positive regulation of immune system process,0.008023809556982198,True,"""Any process that activates or increases the frequency, rate, or extent of an immune system process."" [GOC:add]",1054,34,10,21031,0.29411764705882354,0.009487666034155597,Module 7,"['GO:0002376', 'GO:0002682', 'GO:0048518']"
4135,HPA,HPA:0130891,colon; goblet cells[≥Low],0.00804760548289939,True,colon; goblet cells[≥Low],413,79,12,11019,0.1518987341772152,0.029055690072639227,Module 3,['HPA:0130000']
4136,TF,TF:M01588,Factor: GKLF; motif: GCCMCRCCCNNN,0.008103967194286426,True,Factor: GKLF; motif: GCCMCRCCCNNN,9153,80,57,20045,0.7125,0.006227466404457555,Module 5,['TF:M00000']
4137,GO:MF,GO:0031625,ubiquitin protein ligase binding,0.00811547138443545,True,"""Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins."" [GOC:vp]",308,72,8,20212,0.1111111111111111,0.025974025974025976,Module 4,['GO:0044389']
4138,TF,TF:M03924_1,Factor: YY1; motif: NNCGCCATTNN; match class: 1,0.008119147297099599,True,Factor: YY1; motif: NNCGCCATTNN; match class: 1,3779,105,40,20045,0.38095238095238093,0.010584810796507013,Module 3,['TF:M03924']
4139,MIRNA,MIRNA:hsa-miR-1229-5p,hsa-miR-1229-5p,0.008148491383053225,True,hsa-miR-1229-5p,53,15,3,14819,0.2,0.05660377358490566,Module 11,['MIRNA:000000']
4140,TF,TF:M02062,Factor: Erg; motif: ACCGGAAGTN,0.008157328309024218,True,Factor: Erg; motif: ACCGGAAGTN,8226,183,106,20045,0.5792349726775956,0.012885971310478968,Module Singleton,['TF:M00000']
4141,HPA,HPA:0310442,lymph node; non-germinal center cells[≥Medium],0.00819255983660226,True,lymph node; non-germinal center cells[≥Medium],3989,23,18,11019,0.782608695652174,0.004512409125094008,Module 10,['HPA:0310441']
4142,GO:BP,GO:0045061,thymic T cell selection,0.00820705221042375,True,"""The process of T cell selection that occurs in the thymus."" [ISBN:0781735149, PMID:12414722]",23,226,5,21031,0.022123893805309734,0.21739130434782608,Module 1,"['GO:0033077', 'GO:0045058']"
4143,GO:BP,GO:0051049,regulation of transport,0.008214807711563465,True,"""Any process that modulates the frequency, rate or extent of the directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore."" [GOC:ai]",1594,787,95,21031,0.1207115628970775,0.05959849435382685,Module 0,"['GO:0006810', 'GO:0032879']"
4144,TF,TF:M02066,Factor: PEA3; motif: RCCGGAAGYN,0.008217435280377383,True,Factor: PEA3; motif: RCCGGAAGYN,7214,105,61,20045,0.580952380952381,0.008455780426947602,Module 3,['TF:M00000']
4145,TF,TF:M04950,Factor: Egr-1; motif: NGCGTGCGY,0.008248197958090975,True,Factor: Egr-1; motif: NGCGTGCGY,11211,826,526,20045,0.6368038740920097,0.04691820533404692,Module 0,['TF:M00000']
4146,MIRNA,MIRNA:hsa-miR-27b-3p,hsa-miR-27b-3p,0.00825416476661333,True,hsa-miR-27b-3p,418,3,3,14819,1.0,0.007177033492822967,Module 27,['MIRNA:000000']
4147,GO:BP,GO:0050853,B cell receptor signaling pathway,0.008261199478685154,True,"""The series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell."" [GOC:add]",71,72,5,21031,0.06944444444444445,0.07042253521126761,Module 4,['GO:0050851']
4148,HPA,HPA:0600443,tonsil; non-germinal center cells[High],0.008261398951869604,True,tonsil; non-germinal center cells[High],1321,69,21,11019,0.30434782608695654,0.015897047691143074,Module 5,['HPA:0600442']
4149,GO:BP,GO:0009205,purine ribonucleoside triphosphate metabolic process,0.008288681124471784,True,"""The chemical reactions and pathways involving purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",247,105,9,21031,0.08571428571428572,0.03643724696356275,Module 3,"['GO:0009144', 'GO:0009199']"
4150,GO:BP,GO:0035455,response to interferon-alpha,0.00830541233964338,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-alpha stimulus. Interferon-alpha is a type I interferon."" [GOC:sl, PMID:11356686]",20,34,3,21031,0.08823529411764706,0.15,Module 7,['GO:0034097']
4151,TF,TF:M08874,Factor: E2F1; motif: NNNNNGCGSSAAAN,0.008322235055338701,True,Factor: E2F1; motif: NNNNNGCGSSAAAN,7418,80,50,20045,0.625,0.0067403612833647885,Module 5,['TF:M00000']
4152,TF,TF:M13031,Factor: ETV4; motif: ACCGGAAGTN,0.00834002735244103,True,Factor: ETV4; motif: ACCGGAAGTN,11030,183,131,20045,0.7158469945355191,0.011876699909338168,Module Singleton,['TF:M00000']
4153,GO:BP,GO:1902255,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,0.008342777354555388,True,"""Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway by p53 class mediator."" [GOC:BHF, GOC:mtg_apoptosis, GOC:rl, GOC:TermGenie, PMID:15705871]",7,105,3,21031,0.02857142857142857,0.42857142857142855,Module 3,"['GO:0072332', 'GO:1901798', 'GO:1902253', 'GO:2001244']"
4154,HPA,HPA:0401333,rectum; mucosal lymphoid cells[High],0.00838355823237183,True,rectum; mucosal lymphoid cells[High],176,79,8,11019,0.10126582278481013,0.045454545454545456,Module 3,['HPA:0401332']
4155,GO:BP,GO:0072527,pyrimidine-containing compound metabolic process,0.008408098427172904,True,"""The chemical reactions and pathways involving a pyrimidine-containing compound, i.e. any compound that contains pyrimidine or a formal derivative thereof."" [GOC:mah]",85,2,2,21031,1.0,0.023529411764705882,Module 39,"['GO:0034641', 'GO:0046483', 'GO:1901360', 'GO:1901564']"
4156,HPA,HPA:0471412,skin 2; cells in spinous layer[≥Medium],0.008419808915110166,True,skin 2; cells in spinous layer[≥Medium],683,166,25,11019,0.15060240963855423,0.036603221083455345,Module 2,['HPA:0471411']
4157,HPA,HPA:0461481,skin 1; sebaceous glands[≥Low],0.00843811695447755,True,skin 1; sebaceous glands[≥Low],202,69,8,11019,0.11594202898550725,0.039603960396039604,Module 5,['HPA:0460000']
4158,GO:MF,GO:0044877,protein-containing complex binding,0.008461889797833501,True,"""Binding to a macromolecular complex."" [GOC:jl]",1752,232,40,20212,0.1724137931034483,0.0228310502283105,Module 1,['GO:0005488']
4159,GO:BP,GO:0032103,positive regulation of response to external stimulus,0.008473242653897588,True,"""Any process that activates, maintains or increases the rate of a response to an external stimulus."" [GOC:mah]",609,34,8,21031,0.23529411764705882,0.013136288998357963,Module 7,"['GO:0009605', 'GO:0032101', 'GO:0048584']"
4160,HPA,HPA:0461471,skin 1; lymphocytes[≥Low],0.008479641407203494,True,skin 1; lymphocytes[≥Low],712,79,16,11019,0.20253164556962025,0.02247191011235955,Module 3,['HPA:0460000']
4161,REAC,REAC:R-HSA-2555396,Mitotic Metaphase and Anaphase,0.008491797364725025,True,Mitotic Metaphase and Anaphase,229,586,29,10842,0.04948805460750853,0.12663755458515283,Module 0,['REAC:R-HSA-68886']
4162,GO:BP,GO:0045936,negative regulation of phosphate metabolic process,0.00850995978859729,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving phosphates."" [GOC:go_curators]",355,215,15,21031,0.06976744186046512,0.04225352112676056,Module 2,"['GO:0006796', 'GO:0010563', 'GO:0019220']"
4163,GO:BP,GO:0043467,regulation of generation of precursor metabolites and energy,0.008512413178353787,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of precursor metabolites, substances from which energy is derived, and the processes involved in the liberation of energy from these substances."" [GOC:jl]",138,787,18,21031,0.022871664548919948,0.13043478260869565,Module 0,"['GO:0006091', 'GO:0031323']"
4164,HPA,HPA:0170000,endometrium 2,0.008544233319739332,True,endometrium 2,6917,60,52,11019,0.8666666666666667,0.007517709989880006,Module 4,['HPA:0000000']
4165,TF,TF:M07370_1,Factor: YY1; motif: NNNNAARATGGNNNN; match class: 1,0.00854436741221213,True,Factor: YY1; motif: NNNNAARATGGNNNN; match class: 1,1088,826,77,20045,0.09322033898305085,0.07077205882352941,Module 0,['TF:M07370']
4166,KEGG,KEGG:01240,Biosynthesis of cofactors,0.008548562516470026,True,Biosynthesis of cofactors,153,2,2,8484,1.0,0.013071895424836602,Module 39,['KEGG:00000']
4167,HP,HP:0000095,Abnormal renal glomerulus morphology,0.008642845521342904,True,A structural anomaly of the glomerulus.,198,44,10,4958,0.22727272727272727,0.050505050505050504,Module 3,['HP:0031263']
4168,WP,WP:WP5115,Network map of SARS CoV 2 signaling pathway,0.008671513082190049,True,Network map of SARS CoV 2 signaling pathway,217,154,14,8286,0.09090909090909091,0.06451612903225806,Module 2,['WP:000000']
4169,HP,HP:0000765,Abnormal thorax morphology,0.008676324496370624,True,"Any abnormality of the thorax (the region of the body formed by the sternum, the thoracic vertebrae and the ribs).",899,44,21,4958,0.4772727272727273,0.02335928809788654,Module 3,['HP:0009121']
4170,HPA,HPA:0300413,lung; macrophages[High],0.008704549350913136,True,lung; macrophages[High],1371,140,35,11019,0.25,0.025528811086797956,Module Singleton,['HPA:0300412']
4171,MIRNA,MIRNA:hsa-let-7c-5p,hsa-let-7c-5p,0.008736164572616749,True,hsa-let-7c-5p,515,104,14,14819,0.1346153846153846,0.027184466019417475,Module 3,['MIRNA:000000']
4172,WP,WP:WP585,Interferon type I signaling pathways,0.008775114579768976,True,Interferon type I signaling pathways,54,472,12,8286,0.025423728813559324,0.2222222222222222,Module 0,['WP:000000']
4173,REAC,REAC:R-HSA-9013418,RHOBTB2 GTPase cycle,0.008783836365252918,True,RHOBTB2 GTPase cycle,23,586,8,10842,0.013651877133105802,0.34782608695652173,Module 0,['REAC:R-HSA-9706574']
4174,GO:BP,GO:0010563,negative regulation of phosphorus metabolic process,0.00880498702389441,True,"""Any process that decreases the frequency, rate or extent of the chemical reactions and pathways involving phosphorus or compounds containing phosphorus."" [GOC:dph, GOC:tb]",356,215,15,21031,0.06976744186046512,0.042134831460674156,Module 2,"['GO:0006793', 'GO:0031324', 'GO:0051174']"
4175,HPA,HPA:0471463,skin 2; langerhans cells[High],0.008819351571252819,True,skin 2; langerhans cells[High],266,140,13,11019,0.09285714285714286,0.04887218045112782,Module Singleton,['HPA:0471462']
4176,GO:BP,GO:0071280,cellular response to copper ion,0.008826532212110641,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus."" [GOC:mah]",25,28,3,21031,0.10714285714285714,0.12,Module 10,"['GO:0046688', 'GO:0071248']"
4177,REAC,REAC:R-HSA-69002,DNA Replication Pre-Initiation,0.008843602970289207,True,DNA Replication Pre-Initiation,159,59,7,10842,0.11864406779661017,0.0440251572327044,Module 5,['REAC:R-HSA-69306']
4178,TF,TF:M03924,Factor: YY1; motif: NNCGCCATTNN,0.008846688052990884,True,Factor: YY1; motif: NNCGCCATTNN,10299,105,77,20045,0.7333333333333333,0.007476454024662588,Module 3,['TF:M00000']
4179,GO:CC,GO:0019774,"proteasome core complex, beta-subunit complex",0.00887978477738929,True,"""The proteasome core subcomplex that constitutes the two inner rings of the proteasome core complex. An example of this component is found in Mus musculus."" [GOC:jl, GOC:mtg_sensu, GOC:rb, PMID:10854779]",11,813,5,22097,0.006150061500615006,0.45454545454545453,Module 0,"['GO:0005622', 'GO:0005839', 'GO:0032991']"
4180,GO:BP,GO:0045184,establishment of protein localization,0.008893947206231165,True,"""The directed movement of a protein to a specific location."" [GOC:bf]",1924,172,35,21031,0.20348837209302326,0.018191268191268192,Module Singleton,"['GO:0008104', 'GO:0051234']"
4181,GO:CC,GO:0034715,pICln-Sm protein complex,0.008929496965379351,True,"""A protein complex that contains pICln (CLNS1A) and several Sm proteins, including SmD1, SmD2, SmE, SmF, and SmG."" [GOC:mah, PMID:11713266]",6,813,4,22097,0.004920049200492005,0.6666666666666666,Module 0,"['GO:0005737', 'GO:0120114']"
4182,GO:CC,GO:0071986,Ragulator complex,0.008929496965379351,True,"""A vacuolar membrane-anchored guanine nucleotide exchange factor (GEF) complex for the Rag GTPases (Gtr1-Gtr2 GTPase complex GO:1990131) in TORC1 signaling pathway. In human, Ragulator is comprised of the membrane anchor subunit LAMTOR1 (Meh1p in S. cerevisiae, Lam1 in S. pombe), a GEF subunit LAMTOR2 ( Slm4 in S. cerevisiae , Lam2 in S. pombe ) , LAMTOR3 (no S. cerevisiae ortholog identified, Lam3 in S. pombe) , LAMTOR4 (no S. cerevisiae ortholog identified, Lam4 in S. pombe), and LAMTOR5 (no S. cerevisiae or S. pombe ortholog identified)."" [GOC:vw, PMID:15989961, PMID:16732272, PMID:19177150, PMID:19748353, PMID:20381137, PMID:22980980, PMID:29199950]",6,813,4,22097,0.004920049200492005,0.6666666666666666,Module 0,"['GO:0005774', 'GO:0032045', 'GO:0098796']"
4183,TF,TF:M04711,Factor: PU.1; motif: ACTTCCTCT,0.00892952548136804,True,Factor: PU.1; motif: ACTTCCTCT,1746,826,111,20045,0.1343825665859564,0.06357388316151202,Module 0,['TF:M00000']
4184,WP,WP:WP45,G1 to S cell cycle control,0.008939329078319003,True,G1 to S cell cycle control,64,55,5,8286,0.09090909090909091,0.078125,Module 5,['WP:000000']
4185,TF,TF:M00425,Factor: E2F; motif: TTTCGCGC,0.008947126804955238,True,Factor: E2F; motif: TTTCGCGC,11393,80,65,20045,0.8125,0.005705257614324585,Module 5,['TF:M00000']
4186,HPA,HPA:0461463,skin 1; langerhans cells[High],0.008970848794126733,True,skin 1; langerhans cells[High],218,12,4,11019,0.3333333333333333,0.01834862385321101,Module 6,['HPA:0461462']
4187,REAC,REAC:R-HSA-69620,Cell Cycle Checkpoints,0.008999148123798387,True,Cell Cycle Checkpoints,289,59,9,10842,0.15254237288135594,0.031141868512110725,Module 5,['REAC:R-HSA-1640170']
4188,HP,HP:0000554,Uveitis,0.009029364460201656,True,Inflammation of one or all portions of the uveal tract.,50,71,7,4958,0.09859154929577464,0.14,Module 1,"['HP:0000553', 'HP:0100533']"
4189,HPA,HPA:0210051,fallopian tube; glandular cells[≥Low],0.009037653251424591,True,fallopian tube; glandular cells[≥Low],5776,79,59,11019,0.7468354430379747,0.010214681440443213,Module 3,['HPA:0210000']
4190,HP,HP:0031263,Abnormal renal corpuscle morphology,0.009041914070298989,True,"Any anomolous structure of the renal corpuscle, which is the initial component of the nephron that filters blood. The renal corpuscle consists of a knot of capillaries (glomerulus) that is surrounded by a double-walled capsule (Bowman capsule) that opens into a renal tubule.",199,44,10,4958,0.22727272727272727,0.05025125628140704,Module 3,"['HP:0011035', 'HP:0012575']"
4191,MIRNA,MIRNA:hsa-miR-151a-5p,hsa-miR-151a-5p,0.009056698212756622,True,hsa-miR-151a-5p,78,2,2,14819,1.0,0.02564102564102564,Module 33,['MIRNA:000000']
4192,HPA,HPA:0461392,skin 1; cells in basal layer[≥Medium],0.009057548929176004,True,skin 1; cells in basal layer[≥Medium],637,79,15,11019,0.189873417721519,0.023547880690737835,Module 3,['HPA:0461391']
4193,HPA,HPA:0461461,skin 1; langerhans cells[≥Low],0.009076455021598085,True,skin 1; langerhans cells[≥Low],716,79,16,11019,0.20253164556962025,0.0223463687150838,Module 3,['HPA:0460000']
4194,KEGG,KEGG:04217,Necroptosis,0.009118319650135709,True,Necroptosis,158,2,2,8484,1.0,0.012658227848101266,Module 27,['KEGG:00000']
4195,GO:BP,GO:0048523,negative regulation of cellular process,0.009126094923719389,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of a cellular process, any of those that are carried out at the cellular level, but are not necessarily restricted to a single cell. For example, cell communication occurs among more than one cell, but occurs at the cellular level."" [GOC:jid]",5541,787,263,21031,0.3341804320203304,0.047464356614329545,Module 0,"['GO:0009987', 'GO:0048519', 'GO:0050794']"
4196,GO:MF,GO:0140677,molecular function activator activity,0.009167027946736071,True,"""A molecular function regulator that activates or increases the activity of its target via non-covalent binding that does not result in covalent modification to the target."" [GOC:curators]",1124,5,4,20212,0.8,0.0035587188612099642,Module 12,['GO:0098772']
4197,TF,TF:M02064,Factor: c-ets-2; motif: ACCGGAWRTN,0.00917121470471231,True,Factor: c-ets-2; motif: ACCGGAWRTN,11163,183,132,20045,0.7213114754098361,0.011824778285407149,Module Singleton,['TF:M00000']
4198,WP,WP:WP4630,Measles virus infection,0.00920222297850606,True,Measles virus infection,136,27,5,8286,0.18518518518518517,0.03676470588235294,Module 7,['WP:000000']
4199,HPA,HPA:0420000,salivary gland,0.009214578458161236,True,salivary gland,6902,140,110,11019,0.7857142857142857,0.015937409446537234,Module Singleton,['HPA:0000000']
4200,HPA,HPA:0420051,salivary gland; glandular cells[≥Low],0.009214578458161236,True,salivary gland; glandular cells[≥Low],6902,140,110,11019,0.7857142857142857,0.015937409446537234,Module Singleton,['HPA:0420000']
4201,GO:BP,GO:0006954,inflammatory response,0.009215180508977882,True,"""The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages."" [GO_REF:0000022, ISBN:0198506732]",829,5,4,21031,0.8,0.0048250904704463205,Module 12,['GO:0006952']
4202,GO:BP,GO:0033077,T cell differentiation in thymus,0.009222454967245556,True,"""The process in which a precursor cell type acquires the specialized features of a T cell via a differentiation pathway dependent upon transit through the thymus."" [GOC:add, ISBN:0781735149]",87,226,8,21031,0.035398230088495575,0.09195402298850575,Module 1,['GO:0030217']
4203,GO:BP,GO:0032946,positive regulation of mononuclear cell proliferation,0.009228051666887373,True,"""Any process that activates or increases the frequency, rate or extent of mononuclear cell proliferation."" [GOC:add]",147,226,10,21031,0.04424778761061947,0.06802721088435375,Module 1,"['GO:0032943', 'GO:0032944', 'GO:0070665']"
4204,GO:MF,GO:0017111,ribonucleoside triphosphate phosphatase activity,0.009241266453700022,True,"""Catalysis of the reaction: a ribonucleoside triphosphate + H2O = a ribonucleoside diphosphate + H+ + phosphate."" [RHEA:23680]",734,808,54,20212,0.06683168316831684,0.07356948228882834,Module 0,['GO:0016462']
4205,TF,TF:M11680,Factor: IRF-9; motif: NYGAAACYGAAACYN,0.009241696357694859,True,Factor: IRF-9; motif: NYGAAACYGAAACYN,136,36,5,20045,0.1388888888888889,0.03676470588235294,Module 7,['TF:M00000']
4206,GO:BP,GO:0002752,cell surface pattern recognition receptor signaling pathway,0.009284185469557405,True,"""The series of molecular signals initiated by a ligand binding to a cell surface pattern recognition receptor (PRR). PRRs bind pathogen-associated molecular pattern (PAMPs), structures conserved among microbial species."" [GOC:add, GOC:ar, ISBN:0781735149, PMID:15199967]",65,215,7,21031,0.03255813953488372,0.1076923076923077,Module 2,"['GO:0002220', 'GO:0002221']"
4207,HPA,HPA:0530711,spleen; cells in red pulp[≥Low],0.009342847599002543,True,spleen; cells in red pulp[≥Low],5333,79,56,11019,0.7088607594936709,0.01050065629101819,Module 3,['HPA:0530000']
4208,REAC,REAC:R-HSA-69275,G2/M Transition,0.009369633800109061,True,G2/M Transition,195,586,26,10842,0.04436860068259386,0.13333333333333333,Module 0,['REAC:R-HSA-453274']
4209,GO:BP,GO:0090130,tissue migration,0.009372849453978744,True,"""The process in which the population of cells that make up a tissue undergo directed movement."" [GOC:ascb_2009, GOC:dph, GOC:tb]",313,215,14,21031,0.06511627906976744,0.04472843450479233,Module 2,['GO:0032501']
4210,HPA,HPA:0570762,testis; pachytene spermatocytes[≥Medium],0.009402430717659742,True,testis; pachytene spermatocytes[≥Medium],1898,69,26,11019,0.37681159420289856,0.0136986301369863,Module 5,['HPA:0570761']
4211,HPA,HPA:0381211,placenta; syncytiotrophoblasts - cell body[≥Low],0.009407159594681873,True,placenta; syncytiotrophoblasts - cell body[≥Low],551,612,54,11019,0.08823529411764706,0.09800362976406533,Module 0,['HPA:0380000']
4212,HP,HP:0100806,Sepsis,0.009410438177365758,True,Systemic inflammatory response to infection.,119,71,10,4958,0.14084507042253522,0.08403361344537816,Module 1,['HP:0010978']
4213,GO:BP,GO:0002253,activation of immune response,0.00947823610564574,True,"""Any process that initiates an immune response."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",531,787,42,21031,0.053367217280813214,0.07909604519774012,Module 0,"['GO:0002376', 'GO:0050778']"
4214,GO:BP,GO:0061077,chaperone-mediated protein folding,0.00948005593722525,True,"""The process of inhibiting aggregation and assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure that is dependent on interaction with a chaperone."" [GOC:dph, GOC:vw]",73,72,5,21031,0.06944444444444445,0.0684931506849315,Module 4,['GO:0006457']
4215,GO:BP,GO:0009966,regulation of signal transduction,0.009501562607464093,True,"""Any process that modulates the frequency, rate or extent of signal transduction."" [GOC:sm]",3010,226,58,21031,0.25663716814159293,0.019269102990033222,Module 1,"['GO:0007165', 'GO:0010646', 'GO:0023051', 'GO:0048583']"
4216,HPA,HPA:0470181,skin 2; cells in granular layer[≥Low],0.009548241649526577,True,skin 2; cells in granular layer[≥Low],719,79,16,11019,0.20253164556962025,0.022253129346314324,Module 3,['HPA:0470000']
4217,HPA,HPA:0470672,skin 2; melanocytes[≥Medium],0.00956247009619079,True,skin 2; melanocytes[≥Medium],640,79,15,11019,0.189873417721519,0.0234375,Module 3,['HPA:0470671']
4218,HPA,HPA:0330222,oral mucosa; squamous epithelial cells[≥Medium],0.009568786551941546,True,oral mucosa; squamous epithelial cells[≥Medium],4358,140,79,11019,0.5642857142857143,0.01812758145938504,Module Singleton,['HPA:0330221']
4219,HPA,HPA:0060101,bronchus; respiratory epithelial cells[≥Low],0.009569333077175767,True,bronchus; respiratory epithelial cells[≥Low],5938,79,60,11019,0.759493670886076,0.010104412260020209,Module 3,['HPA:0060000']
4220,KEGG,KEGG:04213,Longevity regulating pathway - multiple species,0.009602353626089738,True,Longevity regulating pathway - multiple species,61,15,3,8484,0.2,0.04918032786885246,Module 9,['KEGG:00000']
4221,GO:BP,GO:0042129,regulation of T cell proliferation,0.009609544778868676,True,"""Any process that modulates the frequency, rate or extent of T cell proliferation."" [GOC:jl]",181,15,4,21031,0.26666666666666666,0.022099447513812154,Module 6,"['GO:0042098', 'GO:0050670', 'GO:0050863']"
4222,GO:BP,GO:0042254,ribosome biogenesis,0.009627814003388456,True,"""A cellular process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of ribosome subunits; includes transport to the sites of protein synthesis."" [GOC:ma, PMID:26404467, Wikipedia:Ribosome_biogenesis]",322,787,30,21031,0.03811944091486658,0.09316770186335403,Module 0,['GO:0022613']
4223,TF,TF:M09904,Factor: Elk-1; motif: RCCGGAAGTGN,0.009628209751918606,True,Factor: Elk-1; motif: RCCGGAAGTGN,8347,105,67,20045,0.638095238095238,0.008026835988978076,Module 3,['TF:M00000']
4224,GO:BP,GO:0002706,regulation of lymphocyte mediated immunity,0.009641284555378351,True,"""Any process that modulates the frequency, rate, or extent of lymphocyte mediated immunity."" [GOC:add]",182,226,11,21031,0.048672566371681415,0.06043956043956044,Module 1,"['GO:0002449', 'GO:0002703']"
4225,GO:BP,GO:0002286,T cell activation involved in immune response,0.00965585672137476,True,"""The change in morphology and behavior of a mature or immature T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific, leading to the initiation or perpetuation of an immune response."" [GOC:add, ISBN:0781735149]",122,215,9,21031,0.04186046511627907,0.07377049180327869,Module 2,"['GO:0002285', 'GO:0042110']"
4226,GO:BP,GO:0006123,"mitochondrial electron transport, cytochrome c to oxygen",0.009656694022712376,True,"""The transfer of electrons from cytochrome c to oxygen that occurs during oxidative phosphorylation, mediated by the multisubunit enzyme known as complex IV."" [ISBN:0716731363]",23,105,4,21031,0.0380952380952381,0.17391304347826086,Module 3,"['GO:0019646', 'GO:0042775']"
4227,GO:BP,GO:0071345,cellular response to cytokine stimulus,0.009664970134287035,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus."" [GOC:mah]",839,5,4,21031,0.8,0.004767580452920143,Module 12,"['GO:0034097', 'GO:0071310']"
4228,REAC,REAC:R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,0.009696793511723676,True,RUNX1 regulates transcription of genes involved in differentiation of HSCs,129,586,20,10842,0.034129692832764506,0.15503875968992248,Module 0,['REAC:R-HSA-8878171']
4229,GO:CC,GO:0043227,membrane-bounded organelle,0.0096982653560908,True,"""Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane."" [GOC:go_curators]",15671,80,72,22097,0.9,0.004594473868929871,Module 5,['GO:0043226']
4230,HPA,HPA:0300202,lung; endothelial cells[≥Medium],0.009714306767593025,True,lung; endothelial cells[≥Medium],651,69,14,11019,0.2028985507246377,0.021505376344086023,Module 5,['HPA:0300201']
4231,GO:BP,GO:0032101,regulation of response to external stimulus,0.009722395186123745,True,"""Any process that modulates the frequency, rate or extent of a response to an external stimulus."" [GOC:mah]",1077,34,10,21031,0.29411764705882354,0.009285051067780872,Module 7,"['GO:0009605', 'GO:0048583']"
4232,GO:BP,GO:0002181,cytoplasmic translation,0.009753172425404147,True,"""The chemical reactions and pathways resulting in the formation of a protein in the cytoplasm. This is a ribosome-mediated process in which the information in messenger RNA (mRNA) is used to specify the sequence of amino acids in the protein."" [GOC:hjd]",156,172,9,21031,0.05232558139534884,0.057692307692307696,Module Singleton,['GO:0006412']
4233,REAC,REAC:R-HSA-5626467,RHO GTPases activate IQGAPs,0.009763081041507736,True,RHO GTPases activate IQGAPs,32,59,4,10842,0.06779661016949153,0.125,Module 5,['REAC:R-HSA-195258']
4234,REAC,REAC:R-HSA-9668328,Sealing of the nuclear envelope (NE) by ESCRT-III,0.009763081041507736,True,Sealing of the nuclear envelope (NE) by ESCRT-III,32,59,4,10842,0.06779661016949153,0.125,Module 5,['REAC:R-HSA-2995410']
4235,REAC,REAC:R-HSA-69190,DNA strand elongation,0.009763081041507736,True,DNA strand elongation,32,59,4,10842,0.06779661016949153,0.125,Module 5,['REAC:R-HSA-69239']
4236,KEGG,KEGG:05132,Salmonella infection,0.00976338629789809,True,Salmonella infection,249,439,28,8484,0.06378132118451026,0.11244979919678715,Module 0,['KEGG:00000']
4237,GO:CC,GO:0030662,coated vesicle membrane,0.009769142235712732,True,"""The lipid bilayer surrounding a coated vesicle."" [GOC:mah]",199,177,9,22097,0.05084745762711865,0.04522613065326633,Module Singleton,"['GO:0030135', 'GO:0030659', 'GO:0098588']"
4238,TF,TF:M03983,Factor: ETV5; motif: NCCGGAWGYN,0.00977688666727826,True,Factor: ETV5; motif: NCCGGAWGYN,3226,105,36,20045,0.34285714285714286,0.011159330440173589,Module 3,['TF:M00000']
4239,GO:BP,GO:0002218,activation of innate immune response,0.00977747996102595,True,"""Any process that initiates an innate immune response. Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. Examples of this process include activation of the hypersensitive response of Arabidopsis thaliana and activation of any NOD or TLR signaling pathway in vertebrate species."" [GO_REF:0000022, GOC:add, GOC:mtg_sensu, ISBN:0781735149, PMID:15199967, PMID:16177805]",279,34,6,21031,0.17647058823529413,0.021505376344086023,Module 7,"['GO:0002253', 'GO:0045089']"
4240,REAC,REAC:R-HSA-380108,Chemokine receptors bind chemokines,0.009789047987291128,True,Chemokine receptors bind chemokines,57,164,7,10842,0.042682926829268296,0.12280701754385964,Module 1,['REAC:R-HSA-375276']
4241,HP,HP:0001874,Abnormality of neutrophils,0.009804302956233933,True,A neutrophil abnormality.,255,59,13,4958,0.22033898305084745,0.050980392156862744,Module Singleton,['HP:0001911']
4242,GO:BP,GO:0002706,regulation of lymphocyte mediated immunity,0.009821361522670841,True,"""Any process that modulates the frequency, rate, or extent of lymphocyte mediated immunity."" [GOC:add]",182,15,4,21031,0.26666666666666666,0.02197802197802198,Module 6,"['GO:0002449', 'GO:0002703']"
4243,GO:BP,GO:0071356,cellular response to tumor necrosis factor,0.009821639386040427,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus."" [GOC:mah]",228,5,3,21031,0.6,0.013157894736842105,Module 12,"['GO:0034612', 'GO:0071345']"
4244,HP,HP:0012387,Bronchitis,0.009893276809801815,True,Inflammation of the large airways in the lung including any part of the bronchi from the primary bronchi to the tertiary bronchi.,71,71,8,4958,0.11267605633802817,0.11267605633802817,Module 1,['HP:0011947']
4245,TF,TF:M12238_1,Factor: DREF; motif: MTRTCGCGAYAK; match class: 1,0.00991429828188032,True,Factor: DREF; motif: MTRTCGCGAYAK; match class: 1,298,105,10,20045,0.09523809523809523,0.03355704697986577,Module 3,['TF:M12238']
4246,WP,WP:WP15,Selenium micronutrient network,0.009923186900350808,True,Selenium micronutrient network,86,43,5,8286,0.11627906976744186,0.05813953488372093,Module 4,['WP:000000']
4247,TF,TF:M00531,Factor: nerf; motif: YRNCAGGAAGYRGSTBDS,0.009937974220186635,True,Factor: nerf; motif: YRNCAGGAAGYRGSTBDS,7773,238,127,20045,0.5336134453781513,0.016338608002058407,Module 1,['TF:M00000']
4248,TF,TF:M00920_1,Factor: E2F; motif: NKCGCGCSAAAN; match class: 1,0.009938440173743924,True,Factor: E2F; motif: NKCGCGCSAAAN; match class: 1,1339,826,90,20045,0.1089588377723971,0.06721433905899925,Module 0,['TF:M00920']
4249,HPA,HPA:0151303,duodenum; enterocytes[High],0.009942766218549658,True,duodenum; enterocytes[High],234,79,9,11019,0.11392405063291139,0.038461538461538464,Module 3,['HPA:0151302']
4250,MIRNA,MIRNA:hsa-miR-92a-3p,hsa-miR-92a-3p,0.00999828996859118,True,hsa-miR-92a-3p,1401,76,20,14819,0.2631578947368421,0.014275517487508922,Module 5,['MIRNA:000000']
4251,HPA,HPA:0050000,breast,0.010021993899324424,True,breast,7185,60,53,11019,0.8833333333333333,0.007376478775226166,Module 4,['HPA:0000000']
4252,GO:CC,GO:0019815,B cell receptor complex,0.010038878012862906,True,"""An immunoglobulin complex that is present in the plasma membrane of B cells and that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains and a signaling subunit, a heterodimer of the Ig-alpha and Ig-beta proteins."" [GOC:add, ISBN:0781735149]",6,238,3,22097,0.012605042016806723,0.5,Module 1,"['GO:0019814', 'GO:0098802']"
4253,GO:CC,GO:0071753,IgM immunoglobulin complex,0.010038878012862906,True,"""A protein complex composed of two identical immunoglobulin heavy chains of the IgM isotype and two identical immunoglobulin light chains, held together by disulfide bonds, and in its circulating form complexed with J chain in polymeric forms. An IgM immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph."" [GOC:add, ISBN:0781765196, PMID:20176268]",6,238,3,22097,0.012605042016806723,0.5,Module 1,['GO:0019814']
4254,GO:BP,GO:0080090,regulation of primary metabolic process,0.010074741321326361,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism involving those compounds formed as a part of the normal anabolic and catabolic processes. These processes take place in most, if not all, cells of the organism."" [PMID:19211694]",5591,226,91,21031,0.4026548672566372,0.016276158111250223,Module 1,"['GO:0019222', 'GO:0044238']"
4255,GO:BP,GO:0051179,localization,0.010083793957680252,True,"""Any process in which a cell, a substance, or a cellular entity, such as a protein complex or organelle, is transported, tethered to or otherwise maintained in a specific location. In the case of substances, localization may also be achieved via selective degradation."" [GOC:ai, GOC:dos]",5520,172,72,21031,0.4186046511627907,0.013043478260869565,Module Singleton,['GO:0008150']
4256,KEGG,KEGG:05169,Epstein-Barr virus infection,0.010106150894313133,True,Epstein-Barr virus infection,198,23,5,8484,0.21739130434782608,0.025252525252525252,Module 7,['KEGG:00000']
4257,REAC,REAC:R-HSA-167238,Pausing and recovery of Tat-mediated HIV elongation,0.010119875356479428,True,Pausing and recovery of Tat-mediated HIV elongation,30,586,9,10842,0.015358361774744027,0.3,Module 0,['REAC:R-HSA-167172']
4258,REAC,REAC:R-HSA-167243,Tat-mediated HIV elongation arrest and recovery,0.010119875356479428,True,Tat-mediated HIV elongation arrest and recovery,30,586,9,10842,0.015358361774744027,0.3,Module 0,['REAC:R-HSA-167172']
4259,GO:BP,GO:0001766,membrane raft polarization,0.010124459851960052,True,"""The clustering and aggregation of a membrane into domains. This serves as a mechanism to compartmentalize cellular activities and to establish cell polarity."" [PMID:12615889]",4,226,3,21031,0.01327433628318584,0.75,Module 1,['GO:0031580']
4260,GO:CC,GO:0015630,microtubule cytoskeleton,0.010190911234785242,True,"""The part of the cytoskeleton (the internal framework of a cell) composed of microtubules and associated proteins."" [GOC:jl, ISBN:0395825172]",1405,80,16,22097,0.2,0.011387900355871887,Module 5,['GO:0005856']
4261,GO:BP,GO:0043085,positive regulation of catalytic activity,0.010204998018107831,True,"""Any process that activates or increases the activity of an enzyme."" [GOC:ebc, GOC:jl, GOC:tb, GOC:vw]",773,21,7,21031,0.3333333333333333,0.009055627425614488,Module 9,"['GO:0044093', 'GO:0050790']"
4262,GO:BP,GO:0071887,leukocyte apoptotic process,0.010260188837144735,True,"""Any apoptotic process in a leukocyte, an achromatic cell of the myeloid or lymphoid lineages capable of ameboid movement, found in blood or other tissue."" [CL:0000738, GOC:BHF, GOC:mah, GOC:mtg_apoptosis]",117,226,9,21031,0.03982300884955752,0.07692307692307693,Module 1,['GO:0006915']
4263,GO:BP,GO:0070585,protein localization to mitochondrion,0.010283483442382908,True,"""A process in which a protein is transported to, or maintained in, a location within the mitochondrion."" [GOC:ecd]",125,21,4,21031,0.19047619047619047,0.032,Module 9,['GO:0033365']
4264,HP,HP:0002721,Immunodeficiency,0.010304632468795542,True,"Failure of the immune system to protect the body adequately from infection, due to the absence or insufficiency of some component process or substance.",217,59,12,4958,0.2033898305084746,0.055299539170506916,Module Singleton,['HP:0010978']
4265,CORUM,CORUM:2886,"Respiratory chain complex I (incomplete intermediate ND1, ND2, ND3, CIA30 assembly), mitochondrial",0.010330902909562656,True,"Respiratory chain complex I (incomplete intermediate ND1, ND2, ND3, CIA30 assembly), mitochondrial",4,83,3,3383,0.03614457831325301,0.75,Module 3,['CORUM:0000000']
4266,HP,HP:0000492,Abnormal eyelid morphology,0.0103380831544478,True,An abnormality of the eyelids.,1343,44,26,4958,0.5909090909090909,0.0193596425912137,Module 3,['HP:0030669']
4267,TF,TF:M12275,Factor: YY1; motif: NGCCGCCATYTTGN,0.010338884315967453,True,Factor: YY1; motif: NGCCGCCATYTTGN,7080,105,60,20045,0.5714285714285714,0.00847457627118644,Module 3,['TF:M00000']
4268,HP,HP:0025426,Abnormal bronchus morphology,0.010357347454024009,True,"Any structural anomaly of the bronchi, i.e., of the airways leading from the trachea to the lungs.",210,71,13,4958,0.18309859154929578,0.06190476190476191,Module 1,['HP:0005607']
4269,HPA,HPA:0470671,skin 2; melanocytes[≥Low],0.010383056053736482,True,skin 2; melanocytes[≥Low],724,79,16,11019,0.20253164556962025,0.022099447513812154,Module 3,['HPA:0470000']
4270,HPA,HPA:0460672,skin 1; melanocytes[≥Medium],0.01038481129154959,True,skin 1; melanocytes[≥Medium],3708,79,44,11019,0.5569620253164557,0.011866235167206042,Module 3,['HPA:0460671']
4271,REAC,REAC:R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,0.01038805910505705,True,ATF6 (ATF6-alpha) activates chaperones,11,60,3,10842,0.05,0.2727272727272727,Module 4,['REAC:R-HSA-381119']
4272,GO:BP,GO:0009199,ribonucleoside triphosphate metabolic process,0.010398930399290091,True,"""The chemical reactions and pathways involving a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",254,105,9,21031,0.08571428571428572,0.03543307086614173,Module 3,['GO:0009141']
4273,GO:BP,GO:0009144,purine nucleoside triphosphate metabolic process,0.010398930399290091,True,"""The chemical reactions and pathways involving purine nucleoside triphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",254,105,9,21031,0.08571428571428572,0.03543307086614173,Module 3,['GO:0009141']
4274,HPA,HPA:0401333,rectum; mucosal lymphoid cells[High],0.010407084809063423,True,rectum; mucosal lymphoid cells[High],176,60,7,11019,0.11666666666666667,0.03977272727272727,Module 4,['HPA:0401332']
4275,HPA,HPA:0210000,fallopian tube,0.010426669416558345,True,fallopian tube,7466,140,116,11019,0.8285714285714286,0.015537101526922047,Module Singleton,['HPA:0000000']
4276,TF,TF:M04788,Factor: IRF-1; motif: STTTCACTTTCNNT,0.010474001029646442,True,Factor: IRF-1; motif: STTTCACTTTCNNT,552,36,8,20045,0.2222222222222222,0.014492753623188406,Module 7,['TF:M00000']
4277,GO:BP,GO:0051493,regulation of cytoskeleton organization,0.010499472052481935,True,"""Any process that modulates the frequency, rate or extent of the formation, arrangement of constituent parts, or disassembly of cytoskeletal structures."" [GOC:ai]",515,787,41,21031,0.052096569250317665,0.07961165048543689,Module 0,"['GO:0007010', 'GO:0033043']"
4278,GO:BP,GO:0002218,activation of innate immune response,0.010590732784846865,True,"""Any process that initiates an innate immune response. Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. Examples of this process include activation of the hypersensitive response of Arabidopsis thaliana and activation of any NOD or TLR signaling pathway in vertebrate species."" [GO_REF:0000022, GOC:add, GOC:mtg_sensu, ISBN:0781735149, PMID:15199967, PMID:16177805]",279,21,5,21031,0.23809523809523808,0.017921146953405017,Module 9,"['GO:0002253', 'GO:0045089']"
4279,TF,TF:M07045,Factor: IRF-1; motif: NNRAAANNGAAASN,0.010614342127927522,True,Factor: IRF-1; motif: NNRAAANNGAAASN,553,36,8,20045,0.2222222222222222,0.014466546112115732,Module 7,['TF:M00000']
4280,KEGG,KEGG:05323,Rheumatoid arthritis,0.010660154967276157,True,Rheumatoid arthritis,88,143,8,8484,0.055944055944055944,0.09090909090909091,Module 2,['KEGG:00000']
4281,TF,TF:M07140,Factor: Kaiso; motif: NTCTCGCGAGANYTN,0.01066861095228483,True,Factor: Kaiso; motif: NTCTCGCGAGANYTN,558,826,47,20045,0.05690072639225181,0.08422939068100359,Module 0,['TF:M00000']
4282,TF,TF:M00144,Factor: Pax-5; motif: RRMSWGANWYCTNRAGCGKRACSRYNSM,0.010670175522037788,True,Factor: Pax-5; motif: RRMSWGANWYCTNRAGCGKRACSRYNSM,13516,826,616,20045,0.7457627118644068,0.04557561408700799,Module 0,['TF:M00000']
4283,GO:CC,GO:0033178,"proton-transporting two-sector ATPase complex, catalytic domain",0.010737261189348188,True,"""A protein complex that forms part of a proton-transporting two-sector ATPase complex and catalyzes ATP hydrolysis or synthesis. The catalytic domain (F1, V1, or A1) comprises a hexameric catalytic core and a central stalk, and is peripherally associated with the membrane when the two-sector ATPase is assembled."" [GOC:mah, PMID:10838056]",18,813,6,22097,0.007380073800738007,0.3333333333333333,Module 0,"['GO:0016469', 'GO:0098796']"
4284,GO:BP,GO:0001568,blood vessel development,0.010751712384839485,True,"""The process whose specific outcome is the progression of a blood vessel over time, from its formation to the mature structure. The blood vessel is the vasculature carrying blood."" [GOC:hjd, UBERON:0001981]",721,215,22,21031,0.10232558139534884,0.030513176144244106,Module 2,"['GO:0001944', 'GO:0048856']"
4285,REAC,REAC:R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,0.010865130877374589,True,Toll Like Receptor 3 (TLR3) Cascade,103,164,9,10842,0.054878048780487805,0.08737864077669903,Module 1,['REAC:R-HSA-168898']
4286,REAC,REAC:R-HSA-8951664,Neddylation,0.01086754401075828,True,Neddylation,244,586,30,10842,0.051194539249146756,0.12295081967213115,Module 0,['REAC:R-HSA-597592']
4287,HPA,HPA:0151302,duodenum; enterocytes[≥Medium],0.010888102011964407,True,duodenum; enterocytes[≥Medium],426,79,12,11019,0.1518987341772152,0.028169014084507043,Module 3,['HPA:0151301']
4288,GO:CC,GO:0010494,cytoplasmic stress granule,0.01089819986448958,True,"""A dense aggregation in the cytosol composed of proteins and RNAs that appear when the cell is under stress."" [GOC:ans, PMID:17284590, PMID:17601829, PMID:17967451, PMID:20368989]",92,813,13,22097,0.015990159901599015,0.14130434782608695,Module 0,['GO:0036464']
4289,GO:BP,GO:0060284,regulation of cell development,0.01089925282873498,True,"""Any process that modulates the rate, frequency or extent of the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate."" [GOC:dph, GOC:tb]",849,226,25,21031,0.11061946902654868,0.02944640753828033,Module 1,"['GO:0045595', 'GO:0048468']"
4290,MIRNA,MIRNA:hsa-miR-210-5p,hsa-miR-210-5p,0.010917532255164338,True,hsa-miR-210-5p,47,3,2,14819,0.6666666666666666,0.0425531914893617,Module 27,['MIRNA:000000']
4291,HPA,HPA:0130891,colon; goblet cells[≥Low],0.010921281506699949,True,colon; goblet cells[≥Low],413,69,11,11019,0.15942028985507245,0.026634382566585957,Module 5,['HPA:0130000']
4292,GO:BP,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.010932707449223462,True,"""Any process that modulates the frequency, rate, or extent of an adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. An example of this process is found in the Gnathostomata."" [GOC:add, GOC:mtg_sensu]",187,15,4,21031,0.26666666666666666,0.0213903743315508,Module 6,"['GO:0002460', 'GO:0002819']"
4293,GO:BP,GO:2000106,regulation of leukocyte apoptotic process,0.010943427098460183,True,"""Any process that modulates the frequency, rate or extent of leukocyte apoptotic process."" [GOC:BHF, GOC:mtg_apoptosis]",89,226,8,21031,0.035398230088495575,0.0898876404494382,Module 1,"['GO:0042981', 'GO:0071887']"
4294,HPA,HPA:0630223,cervix; squamous epithelial cells[High],0.010945519930400103,True,cervix; squamous epithelial cells[High],1034,69,18,11019,0.2608695652173913,0.017408123791102514,Module 5,['HPA:0630222']
4295,HPA,HPA:0151291,duodenum; endocrine cells[≥Low],0.010978025074269173,True,duodenum; endocrine cells[≥Low],497,79,13,11019,0.16455696202531644,0.026156941649899398,Module 3,['HPA:0150000']
4296,GO:BP,GO:0051716,cellular response to stimulus,0.010983326003264422,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus. The process begins with detection of the stimulus by a cell and ends with a change in state or activity or the cell."" [GOC:bf, GOC:jl]",7394,34,25,21031,0.7352941176470589,0.0033811198268866647,Module 7,"['GO:0009987', 'GO:0050896']"
4297,REAC,REAC:R-HSA-2132295,MHC class II antigen presentation,0.01099620697602407,True,MHC class II antigen presentation,123,173,10,10842,0.057803468208092484,0.08130081300813008,Module 2,['REAC:R-HSA-1280218']
4298,TF,TF:M00650_1,Factor: MTF-1; motif: TBTGCACHCGGCCC; match class: 1,0.010999151580564796,True,Factor: MTF-1; motif: TBTGCACHCGGCCC; match class: 1,25,28,3,20045,0.10714285714285714,0.12,Module 10,['TF:M00650']
4299,GO:CC,GO:0042581,specific granule,0.011000517124279734,True,"""Granule with a membranous, tubular internal structure, found primarily in mature neutrophil cells. Most are released into the extracellular fluid. Specific granules contain lactoferrin, lysozyme, vitamin B12 binding protein and elastase."" [GOC:jl, ISBN:0721662544, PMID:7334549]",158,221,9,22097,0.04072398190045249,0.056962025316455694,Module 2,['GO:0030141']
4300,TF,TF:M12592,Factor: CREM; motif: NRTGACGYMA,0.011001277101473203,True,Factor: CREM; motif: NRTGACGYMA,6556,28,21,20045,0.75,0.0032031726662599147,Module 10,['TF:M00000']
4301,GO:CC,GO:0045277,respiratory chain complex IV,0.01100664301428421,True,"""A part of the respiratory chain, containing the 13 polypeptide subunits of cytochrome c oxidase, including cytochrome a and cytochrome a3. Catalyzes the oxidation of reduced cytochrome c by dioxygen (O2)."" [ISBN:0198547684]",26,813,7,22097,0.008610086100861008,0.2692307692307692,Module 0,"['GO:0070069', 'GO:0098803']"
4302,GO:BP,GO:0030595,leukocyte chemotaxis,0.011029658962797619,True,"""The movement of a leukocyte in response to an external stimulus."" [GOC:add, GOC:jl]",237,5,3,21031,0.6,0.012658227848101266,Module 12,"['GO:0050900', 'GO:0060326']"
4303,GO:BP,GO:0097529,myeloid leukocyte migration,0.011029658962797619,True,"""The movement of a myeloid leukocyte within or between different tissues and organs of the body."" [GOC:cvs, PMID:22342843, PMID:24157461]",237,5,3,21031,0.6,0.012658227848101266,Module 12,['GO:0050900']
4304,GO:BP,GO:0006120,"mitochondrial electron transport, NADH to ubiquinone",0.011030890661945795,True,"""The transfer of electrons from NADH to ubiquinone that occurs during oxidative phosphorylation."" [ISBN:0716731363]",51,105,5,21031,0.047619047619047616,0.09803921568627451,Module 3,"['GO:0019646', 'GO:0042775']"
4305,REAC,REAC:R-HSA-389958,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,0.011064730793013719,True,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,33,59,4,10842,0.06779661016949153,0.12121212121212122,Module 5,['REAC:R-HSA-390466']
4306,GO:BP,GO:0045089,positive regulation of innate immune response,0.011073553042589102,True,"""Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection."" [GOC:ebc]",345,226,15,21031,0.06637168141592921,0.043478260869565216,Module 1,"['GO:0002833', 'GO:0031349', 'GO:0032103', 'GO:0045087', 'GO:0045088', 'GO:0050778']"
4307,KEGG,KEGG:04978,Mineral absorption,0.011079985087581744,True,Mineral absorption,60,16,3,8484,0.1875,0.05,Module 10,['KEGG:00000']
4308,GO:CC,GO:0005829,cytosol,0.011090857323711904,True,"""The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes."" [GOC:hjd, GOC:jl]",5487,221,82,22097,0.37104072398190047,0.0149444140696191,Module 2,"['GO:0005737', 'GO:0110165']"
4309,CORUM,CORUM:5234,IKBKB-CDC37-KIAA1967-HSP90AB1-HSP90AA1 complex,0.011151182631504757,True,IKBKB-CDC37-KIAA1967-HSP90AB1-HSP90AA1 complex,5,9,2,3383,0.2222222222222222,0.4,Module 9,['CORUM:0000000']
4310,TF,TF:M11446,Factor: Elf-1; motif: RANSMGGAAGTR,0.011152632828831504,True,Factor: Elf-1; motif: RANSMGGAAGTR,2963,105,34,20045,0.3238095238095238,0.011474856564292946,Module 3,['TF:M00000']
4311,HPA,HPA:0310000,lymph node,0.011167833222097568,True,lymph node,6530,166,123,11019,0.7409638554216867,0.01883614088820827,Module 2,['HPA:0000000']
4312,GO:BP,GO:0010646,regulation of cell communication,0.011184063028727289,True,"""Any process that modulates the frequency, rate or extent of cell communication. Cell communication is the process that mediates interactions between a cell and its surroundings. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment."" [GOC:dph, GOC:tb]",3443,34,17,21031,0.5,0.004937554458321232,Module 7,"['GO:0007154', 'GO:0050794']"
4313,GO:BP,GO:0071310,cellular response to organic substance,0.011185016900712485,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus."" [GOC:mah]",1971,34,13,21031,0.38235294117647056,0.006595636732623034,Module 7,"['GO:0010033', 'GO:0070887']"
4314,HPA,HPA:0380513,placenta; decidual cells[High],0.011191440554455312,True,placenta; decidual cells[High],1209,60,18,11019,0.3,0.01488833746898263,Module 4,['HPA:0380512']
4315,HPA,HPA:0270353,kidney; cells in glomeruli[High],0.011196950042202893,True,kidney; cells in glomeruli[High],851,612,75,11019,0.12254901960784313,0.0881316098707403,Module 0,['HPA:0270352']
4316,GO:CC,GO:0043232,intracellular non-membrane-bounded organelle,0.011206910480551516,True,"""Organized structure of distinctive morphology and function, not bounded by a lipid bilayer membrane and occurring within the cell. Includes ribosomes, the cytoskeleton and chromosomes."" [GOC:go_curators]",6591,813,295,22097,0.3628536285362854,0.044758003337884995,Module 0,"['GO:0043228', 'GO:0043229']"
4317,HPA,HPA:0481291,small intestine; endocrine cells[≥Low],0.011207990010178234,True,small intestine; endocrine cells[≥Low],498,79,13,11019,0.16455696202531644,0.02610441767068273,Module 3,['HPA:0480000']
4318,HPA,HPA:0320000,nasopharynx,0.01123531251292154,True,nasopharynx,7196,140,113,11019,0.8071428571428572,0.015703168426903835,Module Singleton,['HPA:0000000']
4319,REAC,REAC:R-HSA-453274,Mitotic G2-G2/M phases,0.01123818494358375,True,Mitotic G2-G2/M phases,197,586,26,10842,0.04436860068259386,0.1319796954314721,Module 0,['REAC:R-HSA-69278']
4320,HPA,HPA:0050051,breast; glandular cells[≥Low],0.011294954390095072,True,breast; glandular cells[≥Low],6813,69,58,11019,0.8405797101449275,0.008513136650521063,Module 5,['HPA:0050000']
4321,GO:CC,GO:0043228,non-membrane-bounded organelle,0.011346457362770927,True,"""Organized structure of distinctive morphology and function, not bounded by a lipid bilayer membrane. Includes ribosomes, the cytoskeleton and chromosomes."" [GOC:go_curators]",6592,813,295,22097,0.3628536285362854,0.04475121359223301,Module 0,['GO:0043226']
4322,REAC,REAC:R-HSA-5684996,MAPK1/MAPK3 signaling,0.011368895112685505,True,MAPK1/MAPK3 signaling,269,586,32,10842,0.05460750853242321,0.11895910780669144,Module 0,['REAC:R-HSA-5683057']
4323,REAC,REAC:R-HSA-9675108,Nervous system development,0.011413698636261037,True,Nervous system development,574,586,55,10842,0.09385665529010238,0.09581881533101046,Module 0,['REAC:R-HSA-1266738']
4324,GO:BP,GO:0043367,"CD4-positive, alpha-beta T cell differentiation",0.011428207875862961,True,"""The process in which a relatively unspecialized T cell acquires specialized features of a mature CD4-positive, alpha-beta T cell."" [CL:0000624, ISBN:0781735149]",94,215,8,21031,0.037209302325581395,0.0851063829787234,Module 2,"['GO:0035710', 'GO:0046632']"
4325,CORUM,CORUM:6131,SELK multiprotein complex,0.011499394142269746,True,SELK multiprotein complex,10,22,3,3383,0.13636363636363635,0.3,Module 4,['CORUM:0000000']
4326,GO:BP,GO:0000070,mitotic sister chromatid segregation,0.011519153187519851,True,"""The cell cycle process in which replicated homologous chromosomes are organized and then physically separated and apportioned to two sets during the mitotic cell cycle. Each replicated chromosome, composed of two sister chromatids, aligns at the cell equator, paired with its homologous partner. One homolog of each morphologic type goes into each of the resulting chromosome sets."" [GOC:ai, GOC:jl]",189,77,7,21031,0.09090909090909091,0.037037037037037035,Module 5,"['GO:0000819', 'GO:0140014', 'GO:1903047']"
4327,GO:BP,GO:1905897,regulation of response to endoplasmic reticulum stress,0.011567954154650617,True,"""Any process that modulates the frequency, rate or extent of response to endoplasmic reticulum stress."" [GO_REF:0000058, GOC:aruk, GOC:bc, GOC:TermGenie, PMID:21803450]",76,72,5,21031,0.06944444444444445,0.06578947368421052,Module 4,"['GO:0034976', 'GO:0080135']"
4328,HPA,HPA:0471461,skin 2; langerhans cells[≥Low],0.011570838327571175,True,skin 2; langerhans cells[≥Low],789,12,6,11019,0.5,0.0076045627376425855,Module 6,['HPA:0470000']
4329,MIRNA,MIRNA:hsa-miR-17-5p,hsa-miR-17-5p,0.01158859318941438,True,hsa-miR-17-5p,1176,76,18,14819,0.23684210526315788,0.015306122448979591,Module 5,['MIRNA:000000']
4330,GO:BP,GO:1901623,regulation of lymphocyte chemotaxis,0.011637293644894959,True,"""Any process that modulates the frequency, rate or extent of lymphocyte chemotaxis."" [GOC:TermGenie]",26,5,2,21031,0.4,0.07692307692307693,Module 12,"['GO:0002688', 'GO:0048247', 'GO:2000401']"
4331,HPA,HPA:0160051,endometrium 1; glandular cells[≥Low],0.01164325485184734,True,endometrium 1; glandular cells[≥Low],6818,69,58,11019,0.8405797101449275,0.008506893517160458,Module 5,['HPA:0160000']
4332,GO:BP,GO:0016064,immunoglobulin mediated immune response,0.011661982926418794,True,"""An immune response mediated by immunoglobulins, whether cell-bound or in solution."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",204,72,7,21031,0.09722222222222222,0.03431372549019608,Module 4,['GO:0019724']
4333,HP,HP:0000575,Scotoma,0.011688172884550058,True,A regional and pathological increase of the light detection threshold in any region of the visual field surrounded by a field of normal or relatively well-preserved vision.,86,44,7,4958,0.1590909090909091,0.08139534883720931,Module 3,['HP:0001123']
4334,GO:CC,GO:0005740,mitochondrial envelope,0.011702895681660287,True,"""The double lipid bilayer enclosing the mitochondrion and separating its contents from the cell cytoplasm; includes the intermembrane space."" [GOC:ai, GOC:pz]",831,177,19,22097,0.10734463276836158,0.02286401925391095,Module Singleton,"['GO:0005739', 'GO:0031967']"
4335,HPA,HPA:0340461,ovary; ovarian stroma cells[≥Low],0.01171027464539628,True,ovary; ovarian stroma cells[≥Low],3986,60,37,11019,0.6166666666666667,0.009282488710486703,Module 4,['HPA:0340000']
4336,REAC,REAC:R-HSA-171306,Packaging Of Telomere Ends,0.011712839374830442,True,Packaging Of Telomere Ends,51,3,2,10842,0.6666666666666666,0.0392156862745098,Module 27,['REAC:R-HSA-157579']
4337,GO:CC,GO:0031091,platelet alpha granule,0.011765516297895259,True,"""A secretory organelle found in blood platelets, which is unique in that it exhibits further compartmentalization and acquires its protein content via two distinct mechanisms: (1) biosynthesis predominantly at the megakaryocyte (MK) level (with some vestigial platelet synthesis) (e.g. platelet factor 4) and (2) endocytosis and pinocytosis at both the MK and circulating platelet levels (e.g. fibrinogen (Fg) and IgG)."" [PMID:8467233]",90,221,7,22097,0.03167420814479638,0.07777777777777778,Module 2,['GO:0030141']
4338,HPA,HPA:0031302,appendix; enterocytes[≥Medium],0.011768613591649556,True,appendix; enterocytes[≥Medium],362,79,11,11019,0.13924050632911392,0.03038674033149171,Module 3,['HPA:0031301']
4339,GO:BP,GO:0051603,proteolysis involved in protein catabolic process,0.01177135606929985,True,"""The hydrolysis of a peptide bond or bonds within a protein as part of the chemical reactions and pathways resulting in the breakdown of a protein by individual cells."" [GOC:ai, GOC:dph, GOC:tb]",730,72,12,21031,0.16666666666666666,0.01643835616438356,Module 4,"['GO:0006508', 'GO:0030163']"
4340,HPA,HPA:0641472,endometrium; lymphocytes[≥Medium],0.011774492125052227,True,endometrium; lymphocytes[≥Medium],24,185,5,11019,0.02702702702702703,0.20833333333333334,Module 1,['HPA:0641471']
4341,HPA,HPA:0580062,thymus; medullary cells[≥Medium],0.011774492125052227,True,thymus; medullary cells[≥Medium],24,185,5,11019,0.02702702702702703,0.20833333333333334,Module 1,['HPA:0580061']
4342,HPA,HPA:0170052,endometrium 2; glandular cells[≥Medium],0.011825170944925037,True,endometrium 2; glandular cells[≥Medium],4887,60,42,11019,0.7,0.008594229588704727,Module 4,['HPA:0170051']
4343,CORUM,CORUM:5449,Splicing-associated factors complex,0.011830939455688139,True,Splicing-associated factors complex,4,331,4,3383,0.012084592145015106,1.0,Module 0,['CORUM:0000000']
4344,HPA,HPA:0500702,soft tissue 1; peripheral nerve[≥Medium],0.011952741997803848,True,soft tissue 1; peripheral nerve[≥Medium],1354,69,21,11019,0.30434782608695654,0.0155096011816839,Module 5,['HPA:0500701']
4345,MIRNA,MIRNA:hsa-miR-766-3p,hsa-miR-766-3p,0.011991289638649325,True,hsa-miR-766-3p,603,104,15,14819,0.14423076923076922,0.024875621890547265,Module 3,['MIRNA:000000']
4346,HP,HP:0011123,Inflammatory abnormality of the skin,0.011998843596813228,True,"The presence of inflammation of the skin. That is, an abnormality of the skin resulting from the local accumulation of fluid, plasma proteins, and leukocytes.",488,59,18,4958,0.3050847457627119,0.036885245901639344,Module Singleton,"['HP:0011122', 'HP:0012649']"
4347,TF,TF:M12592,Factor: CREM; motif: NRTGACGYMA,0.012002069712603548,True,Factor: CREM; motif: NRTGACGYMA,6556,826,331,20045,0.400726392251816,0.05048810250152532,Module 0,['TF:M00000']
4348,GO:BP,GO:0019058,viral life cycle,0.012077215775181204,True,"""A set of processes which all viruses follow to ensure survival; includes attachment and entry of the virus particle, decoding of genome information, translation of viral mRNA by host ribosomes, genome replication, and assembly and release of viral particles containing the genome."" [ISBN:1555811272]",320,215,14,21031,0.06511627906976744,0.04375,Module 2,['GO:0016032']
4349,MIRNA,MIRNA:hsa-miR-7855-5p,hsa-miR-7855-5p,0.012078613500529547,True,hsa-miR-7855-5p,90,2,2,14819,1.0,0.022222222222222223,Module 39,['MIRNA:000000']
4350,GO:MF,GO:0019899,enzyme binding,0.012087445095863208,True,"""Binding to an enzyme, a protein with catalytic activity."" [GOC:jl]",2103,218,43,20212,0.19724770642201836,0.020446980504041846,Module 2,['GO:0005515']
4351,GO:CC,GO:0005819,spindle,0.012126223655005139,True,"""The array of microtubules and associated molecules that forms between opposite poles of a eukaryotic cell during mitosis or meiosis and serves to move the duplicated chromosomes apart."" [ISBN:0198547684]",436,813,34,22097,0.041820418204182044,0.0779816513761468,Module 0,"['GO:0015630', 'GO:0043232']"
4352,GO:MF,GO:0032394,MHC class Ib receptor activity,0.012127435501000898,True,"""Combining with an MHC class Ib protein complex and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families."" [GOC:add, GOC:signaling, ISBN:0781735149]",6,232,3,20212,0.01293103448275862,0.5,Module 1,"['GO:0004888', 'GO:0140375']"
4353,GO:BP,GO:0006754,ATP biosynthetic process,0.01213168487349233,True,"""The chemical reactions and pathways resulting in the formation of ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator."" [GOC:go_curators, ISBN:0198506732]",102,2,2,21031,1.0,0.0196078431372549,Module 30,"['GO:0009152', 'GO:0009206', 'GO:0046034']"
4354,HPA,HPA:0471462,skin 2; langerhans cells[≥Medium],0.012136621959555633,True,skin 2; langerhans cells[≥Medium],662,185,26,11019,0.14054054054054055,0.03927492447129909,Module 1,['HPA:0471461']
4355,TF,TF:M08331,Factor: GCMb:FOXI1; motif: RTAAATANGGGNN,0.012142452881574959,True,Factor: GCMb:FOXI1; motif: RTAAATANGGGNN,47,105,5,20045,0.047619047619047616,0.10638297872340426,Module 3,['TF:M00000']
4356,HPA,HPA:0160253,endometrium 1; cells in endometrial stroma[High],0.01215800603186656,True,endometrium 1; cells in endometrial stroma[High],435,612,45,11019,0.07352941176470588,0.10344827586206896,Module 0,['HPA:0160252']
4357,TF,TF:M11407,Factor: Pet-1; motif: NACCGGAAGTN,0.012198842743411115,True,Factor: Pet-1; motif: NACCGGAAGTN,787,826,60,20045,0.07263922518159806,0.07623888182973317,Module 0,['TF:M00000']
4358,GO:MF,GO:0044389,ubiquitin-like protein ligase binding,0.012211858596244385,True,"""Binding to a ubiquitin-like protein ligase, such as ubiquitin-ligase."" [GOC:jl]",326,72,8,20212,0.1111111111111111,0.024539877300613498,Module 4,['GO:0019899']
4359,MIRNA,MIRNA:hsa-let-7e-5p,hsa-let-7e-5p,0.012225893313451875,True,hsa-let-7e-5p,604,104,15,14819,0.14423076923076922,0.024834437086092714,Module 3,['MIRNA:000000']
4360,KEGG,KEGG:05165,Human papillomavirus infection,0.012241639979216236,True,Human papillomavirus infection,330,23,6,8484,0.2608695652173913,0.01818181818181818,Module 7,['KEGG:00000']
4361,GO:BP,GO:1901565,organonitrogen compound catabolic process,0.01225223496146311,True,"""The chemical reactions and pathways resulting in the breakdown of organonitrogen compound."" [GOC:pr, GOC:TermGenie]",1399,215,33,21031,0.15348837209302327,0.023588277340957826,Module 2,"['GO:1901564', 'GO:1901575']"
4362,HP,HP:0001911,Abnormal granulocyte morphology,0.012257832905950923,True,Any structural abnormality or abnormal count of granulocytes.,302,59,14,4958,0.23728813559322035,0.046357615894039736,Module Singleton,['HP:0010974']
4363,GO:BP,GO:0072659,protein localization to plasma membrane,0.012293667469373788,True,"""A process in which a protein is transported to, or maintained in, a specific location in the plasma membrane."" [GOC:mah]",293,787,28,21031,0.035578144853875476,0.09556313993174062,Module 0,"['GO:0072657', 'GO:1990778']"
4364,GO:BP,GO:0000470,maturation of LSU-rRNA,0.01234410568613518,True,"""Any process involved in the maturation of a precursor Large SubUnit (LSU) ribosomal RNA (rRNA) molecule into a mature LSU-rRNA molecule."" [GOC:curators]",28,787,8,21031,0.010165184243964422,0.2857142857142857,Module 0,"['GO:0006364', 'GO:0042273']"
4365,GO:BP,GO:0033119,negative regulation of RNA splicing,0.01234410568613518,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of RNA splicing."" [GOC:mah]",28,787,8,21031,0.010165184243964422,0.2857142857142857,Module 0,"['GO:0008380', 'GO:0010629', 'GO:0043484', 'GO:0051253']"
4366,REAC,REAC:R-HSA-3700989,Transcriptional Regulation by TP53,0.012405309569797582,True,Transcriptional Regulation by TP53,359,586,39,10842,0.06655290102389079,0.10863509749303621,Module 0,['REAC:R-HSA-212436']
4367,GO:BP,GO:0006414,translational elongation,0.012409678114168887,True,"""The successive addition of amino acid residues to a nascent polypeptide chain during protein biosynthesis."" [GOC:ems]",78,787,13,21031,0.016518424396442185,0.16666666666666666,Module 0,"['GO:0006412', 'GO:0009059']"
4368,TF,TF:M11682_1,Factor: IRF-8; motif: NYGAAASYGAAACYN; match class: 1,0.01242715750103171,True,Factor: IRF-8; motif: NYGAAASYGAAACYN; match class: 1,565,36,8,20045,0.2222222222222222,0.01415929203539823,Module 7,['TF:M11682']
4369,MIRNA,MIRNA:hsa-miR-186-5p,hsa-miR-186-5p,0.012447717010537018,True,hsa-miR-186-5p,748,753,65,14819,0.08632138114209828,0.08689839572192513,Module 0,['MIRNA:000000']
4370,GO:BP,GO:1903708,positive regulation of hemopoiesis,0.012500024546926829,True,"""Any process that activates or increases the frequency, rate or extent of hemopoiesis."" [GO_REF:0000058, GOC:pad, GOC:PARL, GOC:TermGenie, PMID:20080761]",187,226,11,21031,0.048672566371681415,0.058823529411764705,Module 1,"['GO:0002684', 'GO:0010720', 'GO:0030097', 'GO:0051240', 'GO:1903706']"
4371,GO:BP,GO:1902107,positive regulation of leukocyte differentiation,0.012500024546926829,True,"""Any process that activates or increases the frequency, rate or extent of leukocyte differentiation."" [GOC:add, GOC:TermGenie]",187,226,11,21031,0.048672566371681415,0.058823529411764705,Module 1,"['GO:0002521', 'GO:1902105', 'GO:1903708']"
4372,HPA,HPA:0600432,tonsil; germinal center cells[≥Medium],0.012501213945000802,True,tonsil; germinal center cells[≥Medium],4100,23,18,11019,0.782608695652174,0.004390243902439025,Module 10,['HPA:0600431']
4373,GO:CC,GO:0032991,protein-containing complex,0.012503052352837087,True,"""A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together."" [GOC:dos, GOC:mah]",8588,177,95,22097,0.536723163841808,0.011061946902654867,Module Singleton,['GO:0005575']
4374,TF,TF:M11578,Factor: foxl2; motif: NACGTMAACAN,0.012511700744151123,True,Factor: foxl2; motif: NACGTMAACAN,5596,826,289,20045,0.3498789346246973,0.05164403145103645,Module 0,['TF:M00000']
4375,WP,WP:WP5284,Cell interactions of the pancreatic cancer microenvironment,0.01252839374862429,True,Cell interactions of the pancreatic cancer microenvironment,25,148,5,8286,0.033783783783783786,0.2,Module 1,['WP:000000']
4376,TF,TF:M11676,Factor: IRF-3; motif: NGGAAANGGAAASNGAAACN,0.01258941885736064,True,Factor: IRF-3; motif: NGGAAANGGAAASNGAAACN,566,36,8,20045,0.2222222222222222,0.014134275618374558,Module 7,['TF:M00000']
4377,GO:BP,GO:2001234,negative regulation of apoptotic signaling pathway,0.012610476266513758,True,"""Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic signaling pathway."" [GOC:mtg_apoptosis]",236,215,12,21031,0.05581395348837209,0.05084745762711865,Module 2,"['GO:0009968', 'GO:0043066', 'GO:0097190', 'GO:2001233']"
4378,HPA,HPA:0300412,lung; macrophages[≥Medium],0.012610488253801564,True,lung; macrophages[≥Medium],4898,60,42,11019,0.7,0.008574928542262147,Module 4,['HPA:0300411']
4379,TF,TF:M11433,Factor: Elk-1; motif: NRCCGGAAGTN,0.012615423776950407,True,Factor: Elk-1; motif: NRCCGGAAGTN,7843,105,64,20045,0.6095238095238096,0.008160142802499043,Module 3,['TF:M00000']
4380,GO:BP,GO:0048585,negative regulation of response to stimulus,0.012632369688542906,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of a response to a stimulus. Response to stimulus is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus."" [GOC:jid]",1648,226,38,21031,0.168141592920354,0.023058252427184466,Module 1,"['GO:0048519', 'GO:0048583', 'GO:0050896']"
4381,TF,TF:M00430,Factor: E2F-1; motif: NTTSGCGG,0.012658209802159134,True,Factor: E2F-1; motif: NTTSGCGG,8242,80,53,20045,0.6625,0.006430478039310847,Module 5,['TF:M00000']
4382,HPA,HPA:0570792,testis; round or early spermatids[≥Medium],0.012670690956795724,True,testis; round or early spermatids[≥Medium],1913,612,144,11019,0.23529411764705882,0.07527443805541036,Module 0,['HPA:0570791']
4383,REAC,REAC:R-HSA-5683057,MAPK family signaling cascades,0.012679423009624371,True,MAPK family signaling cascades,308,586,35,10842,0.059726962457337884,0.11363636363636363,Module 0,['REAC:R-HSA-162582']
4384,GO:CC,GO:0070069,cytochrome complex,0.012769360471685637,True,"""A protein complex in which at least one of the proteins is a cytochrome, i.e. a heme-containing protein involved in catalysis of redox reactions."" [GOC:mah]",40,105,4,22097,0.0380952380952381,0.1,Module 3,['GO:1902494']
4385,KEGG,KEGG:05034,Alcoholism,0.012785350079457395,True,Alcoholism,187,2,2,8484,1.0,0.0106951871657754,Module 27,['KEGG:00000']
4386,KEGG,KEGG:05034,Alcoholism,0.012785350079457395,True,Alcoholism,187,2,2,8484,1.0,0.0106951871657754,Module 22,['KEGG:00000']
4387,GO:BP,GO:0034612,response to tumor necrosis factor,0.012788131641427567,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus."" [GOC:mah]",249,5,3,21031,0.6,0.012048192771084338,Module 12,['GO:0034097']
4388,GO:CC,GO:0031904,endosome lumen,0.01282687519503554,True,"""The volume enclosed by the membrane of an endosome."" [GOC:mah]",38,221,5,22097,0.02262443438914027,0.13157894736842105,Module 2,"['GO:0005768', 'GO:0070013']"
4389,HPA,HPA:0290403,liver; hepatocytes[High],0.012829571926562446,True,liver; hepatocytes[High],869,612,76,11019,0.12418300653594772,0.08745684695051784,Module 0,['HPA:0290402']
4390,GO:BP,GO:0019724,B cell mediated immunity,0.012831830973294772,True,"""Any process involved with the carrying out of an immune response by a B cell, through, for instance, the production of antibodies or cytokines, or antigen presentation to T cells."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",207,72,7,21031,0.09722222222222222,0.033816425120772944,Module 4,"['GO:0002449', 'GO:0002460']"
4391,HPA,HPA:0461453,skin 1; hair follicles[High],0.012853154905774357,True,skin 1; hair follicles[High],122,612,19,11019,0.03104575163398693,0.1557377049180328,Module 0,['HPA:0461452']
4392,GO:CC,GO:0005740,mitochondrial envelope,0.012893943613146622,True,"""The double lipid bilayer enclosing the mitochondrion and separating its contents from the cell cytoplasm; includes the intermembrane space."" [GOC:ai, GOC:pz]",831,105,14,22097,0.13333333333333333,0.01684717208182912,Module 3,"['GO:0005739', 'GO:0031967']"
4393,GO:BP,GO:0002181,cytoplasmic translation,0.012903223732843413,True,"""The chemical reactions and pathways resulting in the formation of a protein in the cytoplasm. This is a ribosome-mediated process in which the information in messenger RNA (mRNA) is used to specify the sequence of amino acids in the protein."" [GOC:hjd]",156,787,19,21031,0.0241423125794155,0.12179487179487179,Module 0,['GO:0006412']
4394,KEGG,KEGG:04613,Neutrophil extracellular trap formation,0.012922826962032192,True,Neutrophil extracellular trap formation,188,2,2,8484,1.0,0.010638297872340425,Module 27,['KEGG:00000']
4395,WP,WP:WP2374,Oncostatin M signaling pathway,0.012942067215095138,True,Oncostatin M signaling pathway,56,154,7,8286,0.045454545454545456,0.125,Module 2,['WP:000000']
4396,GO:MF,GO:0038187,pattern recognition receptor activity,0.012958762131877528,True,"""Combining with a pathogen-associated molecular pattern (PAMP), a structure conserved among microbial species to initiate an innate immune response."" [GOC:ar, GOC:bf]",34,218,5,20212,0.022935779816513763,0.14705882352941177,Module 2,['GO:0038023']
4397,KEGG,KEGG:04936,Alcoholic liver disease,0.013014099271227509,True,Alcoholic liver disease,142,143,10,8484,0.06993006993006994,0.07042253521126761,Module 2,['KEGG:00000']
4398,CORUM,CORUM:1181,C complex spliceosome,0.013016503233030625,True,C complex spliceosome,77,331,19,3383,0.05740181268882175,0.24675324675324675,Module 0,['CORUM:0000000']
4399,TF,TF:M09613_1,Factor: Fli-1; motif: RCMGGAAGYGNNN; match class: 1,0.013046104447091278,True,Factor: Fli-1; motif: RCMGGAAGYGNNN; match class: 1,897,826,66,20045,0.07990314769975787,0.07357859531772576,Module 0,['TF:M09613']
4400,HPA,HPA:0170052,endometrium 2; glandular cells[≥Medium],0.013081269684366873,True,endometrium 2; glandular cells[≥Medium],4887,69,47,11019,0.6811594202898551,0.009617352158788622,Module 5,['HPA:0170051']
4401,REAC,REAC:R-HSA-110330,Recognition and association of DNA glycosylase with site containing an affected purine,0.013143506940475284,True,Recognition and association of DNA glycosylase with site containing an affected purine,54,3,2,10842,0.6666666666666666,0.037037037037037035,Module 27,['REAC:R-HSA-73927']
4402,REAC,REAC:R-HSA-110331,Cleavage of the damaged purine,0.013143506940475284,True,Cleavage of the damaged purine,54,3,2,10842,0.6666666666666666,0.037037037037037035,Module 27,['REAC:R-HSA-73927']
4403,REAC,REAC:R-HSA-73927,Depurination,0.013143506940475284,True,Depurination,54,3,2,10842,0.6666666666666666,0.037037037037037035,Module 27,['REAC:R-HSA-73929']
4404,HPA,HPA:0030433,appendix; germinal center cells[High],0.013145739864303736,True,appendix; germinal center cells[High],92,612,16,11019,0.026143790849673203,0.17391304347826086,Module 0,['HPA:0030432']
4405,GO:BP,GO:0050777,negative regulation of immune response,0.013153066489123899,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of the immune response, the immunological reaction of an organism to an immunogenic stimulus."" [GOC:ai]",188,226,11,21031,0.048672566371681415,0.05851063829787234,Module 1,"['GO:0002683', 'GO:0006955', 'GO:0048585', 'GO:0050776']"
4406,GO:CC,GO:0030135,coated vesicle,0.01316399569757095,True,"""Small membrane-bounded organelle formed by pinching off of a coated region of membrane. Some coats are made of clathrin, whereas others are made from other proteins."" [ISBN:0815316194]",312,177,11,22097,0.062146892655367235,0.035256410256410256,Module Singleton,['GO:0031410']
4407,WP,WP:WP5088,Prostaglandin signaling,0.013184515857193465,True,Prostaglandin signaling,33,5,2,8286,0.4,0.06060606060606061,Module 12,['WP:000000']
4408,HPA,HPA:0350471,pancreas; exocrine glandular cells[≥Low],0.013186733571776849,True,pancreas; exocrine glandular cells[≥Low],6942,140,110,11019,0.7857142857142857,0.01584557764333045,Module Singleton,['HPA:0350000']
4409,HPA,HPA:0471463,skin 2; langerhans cells[High],0.013197433603095832,True,skin 2; langerhans cells[High],266,166,14,11019,0.08433734939759036,0.05263157894736842,Module 2,['HPA:0471462']
4410,KEGG,KEGG:04062,Chemokine signaling pathway,0.013199986238666977,True,Chemokine signaling pathway,190,2,2,8484,1.0,0.010526315789473684,Module 22,['KEGG:00000']
4411,GO:CC,GO:0099080,supramolecular complex,0.013252792794495285,True,"""A cellular component that consists of an indeterminate number of proteins or macromolecular complexes, organized into a regular, higher-order structure such as a polymer, sheet, network or a fiber."" [GOC:dos]",1426,813,82,22097,0.1008610086100861,0.05750350631136045,Module 0,['GO:0110165']
4412,HPA,HPA:0461441,skin 1; fibrohistiocytic cells[≥Low],0.013277261179901679,True,skin 1; fibrohistiocytic cells[≥Low],885,60,15,11019,0.25,0.01694915254237288,Module 4,['HPA:0460000']
4413,HP,HP:0000709,Psychosis,0.013298881962641399,True,"A condition characterized by changes in personality and thought patterns, often accompanied by hallucinations and delusional beliefs, is known as psychosis.",123,44,8,4958,0.18181818181818182,0.06504065040650407,Module 3,['HP:5200430']
4414,GO:CC,GO:1990204,oxidoreductase complex,0.0133138530362432,True,"""Any protein complex that possesses oxidoreductase activity."" [GOC:bhm, PMID:18982432]",132,105,6,22097,0.05714285714285714,0.045454545454545456,Module 3,['GO:1902494']
4415,GO:BP,GO:0002218,activation of innate immune response,0.013332268530950939,True,"""Any process that initiates an innate immune response. Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. Examples of this process include activation of the hypersensitive response of Arabidopsis thaliana and activation of any NOD or TLR signaling pathway in vertebrate species."" [GO_REF:0000022, GOC:add, GOC:mtg_sensu, ISBN:0781735149, PMID:15199967, PMID:16177805]",279,215,13,21031,0.06046511627906977,0.04659498207885305,Module 2,"['GO:0002253', 'GO:0045089']"
4416,HPA,HPA:0330223,oral mucosa; squamous epithelial cells[High],0.01337129160766097,True,oral mucosa; squamous epithelial cells[High],1152,69,19,11019,0.2753623188405797,0.016493055555555556,Module 5,['HPA:0330222']
4417,GO:BP,GO:0006412,translation,0.013392391137415515,True,"""The cellular metabolic process in which a protein is formed, using the sequence of a mature mRNA or circRNA molecule to specify the sequence of amino acids in a polypeptide chain. Translation is mediated by the ribosome, and begins with the formation of a ternary complex between aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, which subsequently associates with the small subunit of the ribosome and an mRNA or circRNA. Translation ends with the release of a polypeptide chain from the ribosome."" [GOC:go_curators]",723,172,19,21031,0.11046511627906977,0.02627939142461964,Module Singleton,"['GO:0009059', 'GO:0010467', 'GO:0019538', 'GO:0043043']"
4418,KEGG,KEGG:04666,Fc gamma R-mediated phagocytosis,0.013511505773206676,True,Fc gamma R-mediated phagocytosis,96,136,8,8484,0.058823529411764705,0.08333333333333333,Module 1,['KEGG:00000']
4419,GO:CC,GO:0015630,microtubule cytoskeleton,0.013566181513096862,True,"""The part of the cytoskeleton (the internal framework of a cell) composed of microtubules and associated proteins."" [GOC:jl, ISBN:0395825172]",1405,813,81,22097,0.0996309963099631,0.05765124555160142,Module 0,['GO:0005856']
4420,GO:MF,GO:0005515,protein binding,0.01357135450045554,True,"""Binding to a protein."" [GOC:go_curators]",14838,72,67,20212,0.9305555555555556,0.004515433346812239,Module 4,['GO:0005488']
4421,HPA,HPA:0630051,cervix; glandular cells[≥Low],0.013590630134775888,True,cervix; glandular cells[≥Low],5692,60,46,11019,0.7666666666666667,0.008081517919887562,Module 4,['HPA:0630000']
4422,GO:CC,GO:0044292,dendrite terminus,0.013591261341757392,True,"""A structure at the distal end of a dendrite adapted to carry out a specific function, e.g. dendriole."" [GOC:jl, NIF_Subcellular:sao28175134]",14,21,2,22097,0.09523809523809523,0.14285714285714285,Module 9,"['GO:0030425', 'GO:0110165']"
4423,HPA,HPA:0130243,colon; peripheral nerve/ganglion[High],0.01359200128292119,True,colon; peripheral nerve/ganglion[High],855,69,16,11019,0.2318840579710145,0.01871345029239766,Module 5,['HPA:0130242']
4424,GO:BP,GO:0034097,response to cytokine,0.013596419182077183,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus."" [GOC:sl]",932,172,22,21031,0.12790697674418605,0.023605150214592276,Module Singleton,['GO:0010033']
4425,HPA,HPA:0430053,seminal vesicle; glandular cells[High],0.013606247996205018,True,seminal vesicle; glandular cells[High],1471,60,20,11019,0.3333333333333333,0.013596193065941536,Module 4,['HPA:0430052']
4426,WP,WP:WP536,Calcium regulation in cardiac cells,0.013633752276209101,True,Calcium regulation in cardiac cells,151,2,2,8286,1.0,0.013245033112582781,Module 22,['WP:000000']
4427,GO:BP,GO:0022008,neurogenesis,0.013643644985704322,True,"""Generation of cells within the nervous system."" [GO_REF:0000021, GOC:cls, GOC:curators, GOC:dgh, GOC:dph, GOC:jid]",1742,215,38,21031,0.17674418604651163,0.021814006888633754,Module 2,"['GO:0007399', 'GO:0030154']"
4428,HPA,HPA:0180052,epididymis; glandular cells[≥Medium],0.013667409275072444,True,epididymis; glandular cells[≥Medium],5693,60,46,11019,0.7666666666666667,0.008080098366414896,Module 4,['HPA:0180051']
4429,REAC,REAC:R-HSA-5336415,Uptake and function of diphtheria toxin,0.013667669806618243,True,Uptake and function of diphtheria toxin,6,19,2,10842,0.10526315789473684,0.3333333333333333,Module 9,['REAC:R-HSA-5339562']
4430,REAC,REAC:R-HSA-3000484,Scavenging by Class F Receptors,0.013667669806618243,True,Scavenging by Class F Receptors,6,19,2,10842,0.10526315789473684,0.3333333333333333,Module 9,['REAC:R-HSA-2173782']
4431,REAC,REAC:R-HSA-8937144,Aryl hydrocarbon receptor signalling,0.013667669806618243,True,Aryl hydrocarbon receptor signalling,6,19,2,10842,0.10526315789473684,0.3333333333333333,Module 9,['REAC:R-HSA-211945']
4432,HP,HP:0012705,Abnormal metabolic brain imaging by MRS,0.013685158723589245,True,An anomaly of metabolism in the brain identified by magnetic resonance spectroscopy (MRS).,58,44,6,4958,0.13636363636363635,0.10344827586206896,Module 3,['HP:0410263']
4433,GO:BP,GO:0010557,positive regulation of macromolecule biosynthetic process,0.013685813342228306,True,"""Any process that increases the rate, frequency or extent of the chemical reactions and pathways resulting in the formation of a macromolecule, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass."" [GOC:dph, GOC:tb]",2603,215,50,21031,0.23255813953488372,0.01920860545524395,Module 2,"['GO:0009059', 'GO:0010556', 'GO:0010604', 'GO:0031328']"
4434,REAC,REAC:R-HSA-9648025,EML4 and NUDC in mitotic spindle formation,0.013695848984042027,True,EML4 and NUDC in mitotic spindle formation,115,59,6,10842,0.1016949152542373,0.05217391304347826,Module 5,['REAC:R-HSA-68877']
4435,GO:BP,GO:0002274,myeloid leukocyte activation,0.013741029123957055,True,"""A change in the morphology or behavior of a myeloid leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand."" [GOC:add, ISBN:0781735149]",238,215,12,21031,0.05581395348837209,0.05042016806722689,Module 2,['GO:0045321']
4436,HPA,HPA:0481303,small intestine; enterocytes[High],0.013767726423201992,True,small intestine; enterocytes[High],244,79,9,11019,0.11392405063291139,0.036885245901639344,Module 3,['HPA:0481302']
4437,HPA,HPA:0600433,tonsil; germinal center cells[High],0.013795445365310122,True,tonsil; germinal center cells[High],1228,12,7,11019,0.5833333333333334,0.005700325732899023,Module 6,['HPA:0600432']
4438,TF,TF:M02069,Factor: Erm; motif: ACCGGAAGTN,0.01380973288818931,True,Factor: Erm; motif: ACCGGAAGTN,7049,183,94,20045,0.5136612021857924,0.013335224854589304,Module Singleton,['TF:M00000']
4439,REAC,REAC:R-HSA-422356,Regulation of insulin secretion,0.013810355445727155,True,Regulation of insulin secretion,78,2,2,10842,1.0,0.02564102564102564,Module 22,['REAC:R-HSA-163685']
4440,GO:BP,GO:0022408,negative regulation of cell-cell adhesion,0.013835681471688652,True,"""Any process that stops, prevents or reduces the rate or extent of cell adhesion to another cell."" [GOC:isa_complete]",189,226,11,21031,0.048672566371681415,0.0582010582010582,Module 1,"['GO:0007162', 'GO:0022407', 'GO:0098609']"
4441,GO:BP,GO:0019222,regulation of metabolic process,0.013856746990809448,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism."" [GOC:go_curators]",7158,226,109,21031,0.4823008849557522,0.01522771723945236,Module 1,"['GO:0008152', 'GO:0050789']"
4442,HPA,HPA:0381192,placenta; cytotrophoblasts[≥Medium],0.013862117049747087,True,placenta; cytotrophoblasts[≥Medium],424,69,11,11019,0.15942028985507245,0.025943396226415096,Module 5,['HPA:0381191']
4443,TF,TF:M11664_1,Factor: IRF-2; motif: NGAAASYGAAAS; match class: 1,0.013972820488402973,True,Factor: IRF-2; motif: NGAAASYGAAAS; match class: 1,148,36,5,20045,0.1388888888888889,0.033783783783783786,Module 7,['TF:M11664']
4444,TF,TF:M08759_1,Factor: c-Ets-2; motif: NCCGGAAGTG; match class: 1,0.013973041892335156,True,Factor: c-Ets-2; motif: NCCGGAAGTG; match class: 1,2993,105,34,20045,0.3238095238095238,0.011359839625793518,Module 3,['TF:M08759']
4445,TF,TF:M12160,Factor: KLF15; motif: RCCMCRCCCMCN,0.013990715802982183,True,Factor: KLF15; motif: RCCMCRCCCMCN,13060,80,70,20045,0.875,0.005359877488514548,Module 5,['TF:M00000']
4446,GO:MF,GO:0043021,ribonucleoprotein complex binding,0.014012941297047912,True,"""Binding to a complex of RNA and protein."" [GOC:bf, GOC:go_curators, GOC:vk]",172,808,20,20212,0.024752475247524754,0.11627906976744186,Module 0,['GO:0044877']
4447,HPA,HPA:0131331,colon; mucosal lymphoid cells[≥Low],0.014029446867229909,True,colon; mucosal lymphoid cells[≥Low],509,79,13,11019,0.16455696202531644,0.025540275049115914,Module 3,['HPA:0130000']
4448,GO:BP,GO:0141061,disruption of cell in another organism,0.014030407574955021,True,"""The disruption of a cell of another organism, leading to damage or temporary subversion of that cell."" [GOC:pg]",92,226,8,21031,0.035398230088495575,0.08695652173913043,Module 1,['GO:0141060']
4449,GO:BP,GO:0031640,killing of cells of another organism,0.014030407574955021,True,"""Any process in an organism that results in the killing of cells of another organism, including in some cases the death of the other organism. Killing here refers to the induction of death in one cell by another cell, not cell-autonomous death due to internal or other environmental conditions."" [GOC:add]",92,226,8,21031,0.035398230088495575,0.08695652173913043,Module 1,"['GO:0001906', 'GO:0141061']"
4450,WP,WP:WP4240,Regulation of sister chromatid separation at the metaphase anaphase transition,0.014109281981194696,True,Regulation of sister chromatid separation at the metaphase anaphase transition,14,55,3,8286,0.05454545454545454,0.21428571428571427,Module 5,['WP:000000']
4451,HP,HP:0010783,Erythema,0.014123150112169181,True,"Redness of the skin, caused by hyperemia of the capillaries in the lower layers of the skin.",124,44,8,4958,0.18181818181818182,0.06451612903225806,Module 3,['HP:0011276']
4452,HP,HP:0002597,Abnormality of the vasculature,0.014128533590214279,True,An abnormality of the vasculature.,1935,71,46,4958,0.647887323943662,0.023772609819121448,Module 1,['HP:0001626']
4453,TF,TF:M11425,Factor: PEA3; motif: NACCGGAAGTN,0.014141650030836733,True,Factor: PEA3; motif: NACCGGAAGTN,7570,183,99,20045,0.5409836065573771,0.013077939233817702,Module Singleton,['TF:M00000']
4454,HPA,HPA:0150000,duodenum,0.014152169671586088,True,duodenum,7899,69,63,11019,0.9130434782608695,0.007975693125712115,Module 5,['HPA:0000000']
4455,WP,WP:WP289,Myometrial relaxation and contraction pathways,0.014182713957264425,True,Myometrial relaxation and contraction pathways,154,2,2,8286,1.0,0.012987012987012988,Module 22,['WP:000000']
4456,HPA,HPA:0250121,hippocampus; glial cells[≥Low],0.014212399309498856,True,hippocampus; glial cells[≥Low],4142,79,47,11019,0.5949367088607594,0.01134717527764365,Module 3,['HPA:0250000']
4457,GO:BP,GO:0032831,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",0.014214980556966536,True,"""Any process that activates or increases the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells."" [GOC:mah]",7,15,2,21031,0.13333333333333333,0.2857142857142857,Module 6,"['GO:0002361', 'GO:0032829', 'GO:0043372', 'GO:0045591']"
4458,GO:BP,GO:0032829,"regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",0.014214980556966536,True,"""Any process that modulates the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells."" [GOC:mah]",7,15,2,21031,0.13333333333333333,0.2857142857142857,Module 6,"['GO:0002361', 'GO:0043370', 'GO:0045589']"
4459,HPA,HPA:0590051,thyroid gland; glandular cells[≥Low],0.014217270477830715,True,thyroid gland; glandular cells[≥Low],7131,140,112,11019,0.8,0.015706072079652224,Module Singleton,['HPA:0590000']
4460,HPA,HPA:0590000,thyroid gland,0.014217270477830715,True,thyroid gland,7131,140,112,11019,0.8,0.015706072079652224,Module Singleton,['HPA:0000000']
4461,TF,TF:M07259_1,Factor: HSF1; motif: TCYAGAANNTTC; match class: 1,0.014225507934246073,True,Factor: HSF1; motif: TCYAGAANNTTC; match class: 1,751,21,7,20045,0.3333333333333333,0.009320905459387484,Module 9,['TF:M07259']
4462,KEGG,KEGG:01232,Nucleotide metabolism,0.014228909709539965,True,Nucleotide metabolism,84,53,5,8484,0.09433962264150944,0.05952380952380952,Module 5,['KEGG:00000']
4463,REAC,REAC:R-HSA-2995410,Nuclear Envelope (NE) Reassembly,0.014261903460515488,True,Nuclear Envelope (NE) Reassembly,70,59,5,10842,0.0847457627118644,0.07142857142857142,Module 5,['REAC:R-HSA-68882']
4464,GO:BP,GO:0001912,positive regulation of leukocyte mediated cytotoxicity,0.014280110202155,True,"""Any process that activates or increases the frequency, rate or extent of leukocyte mediated cytotoxicity."" [GOC:add, ISBN:0781735149, PMID:11911826]",66,226,7,21031,0.030973451327433628,0.10606060606060606,Module 1,"['GO:0001909', 'GO:0001910', 'GO:0002705', 'GO:0031343']"
4465,HPA,HPA:0500111,soft tissue 1; chondrocytes[≥Low],0.014299162428753662,True,soft tissue 1; chondrocytes[≥Low],2188,69,28,11019,0.4057971014492754,0.012797074954296161,Module 5,['HPA:0500000']
4466,HPA,HPA:0160053,endometrium 1; glandular cells[High],0.014333808316138657,True,endometrium 1; glandular cells[High],1471,79,24,11019,0.3037974683544304,0.016315431679129844,Module 3,['HPA:0160052']
4467,GO:CC,GO:0016471,vacuolar proton-transporting V-type ATPase complex,0.014389191273248402,True,"""A proton-transporting two-sector ATPase complex found in the vacuolar membrane, where it acts as a proton pump to mediate acidification of the vacuolar lumen."" [GOC:mah, ISBN:0716743663, PMID:16449553]",27,813,7,22097,0.008610086100861008,0.25925925925925924,Module 0,"['GO:0005774', 'GO:0033176']"
4468,HP,HP:0033106,Elevated circulating D-dimer concentration,0.014439665031463187,True,"An increased concentration of D-dimers, a marker of fibrin degradation, in the blood circulation.",3,10,2,4958,0.2,0.6666666666666666,Module 6,['HP:0040224']
4469,TF,TF:M00430,Factor: E2F-1; motif: NTTSGCGG,0.014445328920800804,True,Factor: E2F-1; motif: NTTSGCGG,8242,105,66,20045,0.6285714285714286,0.008007765105556904,Module 3,['TF:M00000']
4470,HPA,HPA:0080123,caudate; glial cells[High],0.014514157700978166,True,caudate; glial cells[High],683,3,3,11019,1.0,0.004392386530014641,Module 27,['HPA:0080122']
4471,GO:MF,GO:0019956,chemokine binding,0.014517979279928253,True,"""Binding to a chemokine. Chemokines are a family of small chemotactic cytokines; their name is derived from their ability to induce directed chemotaxis in nearby responsive cells. All chemokines possess a number of conserved cysteine residues involved in intramolecular disulfide bond formation. Some chemokines are considered pro-inflammatory and can be induced during an immune response to recruit cells of the immune system to a site of infection, while others are considered homeostatic and are involved in controlling the migration of cells during normal processes of tissue maintenance or development. Chemokines are found in all vertebrates, some viruses and some bacteria."" [GOC:ai, GOC:BHF, GOC:rl, PMID:12183377, Wikipedia:Chemokine]",33,232,5,20212,0.021551724137931036,0.15151515151515152,Module 1,['GO:0019955']
4472,GO:BP,GO:0070972,protein localization to endoplasmic reticulum,0.014577511350228075,True,"""A process in which a protein is transported to, or maintained in, a location within the endoplasmic reticulum."" [GOC:mah]",297,72,8,21031,0.1111111111111111,0.026936026936026935,Module 4,['GO:0033365']
4473,GO:BP,GO:0044085,cellular component biogenesis,0.014587350770656352,True,"""A process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a cellular component. Includes biosynthesis of constituent macromolecules, and those macromolecular modifications that are involved in synthesis or assembly of the cellular component."" [GOC:jl, GOC:mah]",4955,787,238,21031,0.30241423125794153,0.04803229061553986,Module 0,['GO:0071840']
4474,GO:MF,GO:0017076,purine nucleotide binding,0.014603756401915455,True,"""Binding to a purine nucleotide, a compound consisting of a purine nucleoside esterified with (ortho)phosphate."" [GOC:ai]",2021,80,21,20212,0.2625,0.010390895596239486,Module 5,['GO:0000166']
4475,MIRNA,MIRNA:hsa-miR-4792,hsa-miR-4792,0.014630050959068382,True,hsa-miR-4792,99,2,2,14819,1.0,0.020202020202020204,Module 39,['MIRNA:000000']
4476,GO:CC,GO:0008021,synaptic vesicle,0.014632761094441017,True,"""A secretory organelle, typically 50 nm in diameter, of presynaptic nerve terminals; accumulates in high concentrations of neurotransmitters and secretes these into the synaptic cleft by fusion with the 'active zone' of the presynaptic plasma membrane."" [PMID:10099709, PMID:12563290]",213,813,21,22097,0.025830258302583026,0.09859154929577464,Module 0,"['GO:0070382', 'GO:0098793']"
4477,GO:BP,GO:1905818,regulation of chromosome separation,0.014668142778872741,True,"""Any process that modulates the frequency, rate or extent of chromosome separation."" [GO_REF:0000058, GOC:bhm, GOC:TermGenie, PMID:21795393]",74,77,5,21031,0.06493506493506493,0.06756756756756757,Module 5,"['GO:0051304', 'GO:0051983']"
4478,GO:BP,GO:0034097,response to cytokine,0.01467361307478913,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus."" [GOC:sl]",932,5,4,21031,0.8,0.004291845493562232,Module 12,['GO:0010033']
4479,HPA,HPA:0031292,appendix; endocrine cells[≥Medium],0.014695717773447055,True,appendix; endocrine cells[≥Medium],371,79,11,11019,0.13924050632911392,0.029649595687331536,Module 3,['HPA:0031291']
4480,WP,WP:WP5115,Network map of SARS CoV 2 signaling pathway,0.014715683957897711,True,Network map of SARS CoV 2 signaling pathway,217,5,3,8286,0.6,0.013824884792626729,Module 12,['WP:000000']
4481,HPA,HPA:0170251,endometrium 2; cells in endometrial stroma[≥Low],0.014717435335663439,True,endometrium 2; cells in endometrial stroma[≥Low],3517,60,34,11019,0.5666666666666667,0.009667330110889964,Module 4,['HPA:0170000']
4482,GO:CC,GO:0005770,late endosome,0.014722686216198622,True,"""A prelysosomal endocytic organelle differentiated from early endosomes by lower lumenal pH and different protein composition. Late endosomes are more spherical than early endosomes and are mostly juxtanuclear, being concentrated near the microtubule organizing center."" [NIF_Subcellular:nlx_subcell_20090702, PMID:11964142, PMID:2557062]",314,813,27,22097,0.033210332103321034,0.08598726114649681,Module 0,['GO:0005768']
4483,WP,WP:WP2359,Parkin ubiquitin proteasomal system pathway,0.014737067392671513,True,Parkin ubiquitin proteasomal system pathway,71,55,5,8286,0.09090909090909091,0.07042253521126761,Module 5,['WP:000000']
4484,REAC,REAC:R-HSA-166166,MyD88-independent TLR4 cascade ,0.014742681799695203,True,MyD88-independent TLR4 cascade ,107,164,9,10842,0.054878048780487805,0.08411214953271028,Module 1,['REAC:R-HSA-166016']
4485,REAC,REAC:R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,0.014742681799695203,True,TRIF(TICAM1)-mediated TLR4 signaling ,107,164,9,10842,0.054878048780487805,0.08411214953271028,Module 1,['REAC:R-HSA-166166']
4486,GO:BP,GO:0048514,blood vessel morphogenesis,0.014747439314212804,True,"""The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood."" [GOC:jid]",625,215,20,21031,0.09302325581395349,0.032,Module 2,"['GO:0001568', 'GO:0035239']"
4487,GO:CC,GO:0008540,"proteasome regulatory particle, base subcomplex",0.014760961522428914,True,"""The subcomplex of the proteasome regulatory particle that directly associates with the proteasome core complex."" [GOC:mtg_sensu, GOC:rb]",12,813,5,22097,0.006150061500615006,0.4166666666666667,Module 0,"['GO:0005838', 'GO:0032991']"
4488,GO:CC,GO:0000276,"mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)",0.014760961522428914,True,"""All non-F1 subunits of the mitochondrial hydrogen-transporting ATP synthase, including integral and peripheral mitochondrial inner membrane proteins."" [GOC:mtg_sensu, PMID:10838056]",12,813,5,22097,0.006150061500615006,0.4166666666666667,Module 0,"['GO:0005753', 'GO:0045263', 'GO:0098800']"
4489,TF,TF:M11883_1,Factor: pax-6; motif: NYACGCNTSRNYGCNYN; match class: 1,0.014768618545621703,True,Factor: pax-6; motif: NYACGCNTSRNYGCNYN; match class: 1,7951,826,390,20045,0.4721549636803874,0.04905043390768457,Module 0,['TF:M11883']
4490,GO:BP,GO:0010286,heat acclimation,0.014811025600352743,True,"""Any process that increases heat tolerance of an organism in response to high temperatures."" [GOC:tair_curators]",5,21,2,21031,0.09523809523809523,0.4,Module 9,['GO:0009408']
4491,GO:BP,GO:0070370,cellular heat acclimation,0.014811025600352743,True,"""Any process that increases heat tolerance of a cell in response to high temperatures."" [GOC:jp]",5,21,2,21031,0.09523809523809523,0.4,Module 9,"['GO:0010286', 'GO:0034605']"
4492,GO:BP,GO:1902947,regulation of tau-protein kinase activity,0.014811025600352743,True,"""Any process that modulates the frequency, rate or extent of tau-protein kinase activity."" [GO_REF:0000059, GOC:sjp, GOC:TermGenie, PMID:15897157, PMID:22986780]",5,21,2,21031,0.09523809523809523,0.4,Module 9,['GO:0045859']
4493,GO:BP,GO:0002819,regulation of adaptive immune response,0.014827768829893336,True,"""Any process that modulates the frequency, rate, or extent of an adaptive immune response."" [GOC:add]",202,15,4,21031,0.26666666666666666,0.019801980198019802,Module 6,"['GO:0002250', 'GO:0050776']"
4494,TF,TF:M04714_1,Factor: Elf-1; motif: ACTTCCGGG; match class: 1,0.014832738165432263,True,Factor: Elf-1; motif: ACTTCCGGG; match class: 1,2725,105,32,20045,0.3047619047619048,0.011743119266055046,Module 3,['TF:M04714']
4495,HPA,HPA:0170251,endometrium 2; cells in endometrial stroma[≥Low],0.014869125435882981,True,endometrium 2; cells in endometrial stroma[≥Low],3517,140,67,11019,0.4785714285714286,0.019050326983224338,Module Singleton,['HPA:0170000']
4496,HPA,HPA:0291163,liver; cholangiocytes[High],0.014875303339871077,True,liver; cholangiocytes[High],322,612,36,11019,0.058823529411764705,0.11180124223602485,Module 0,['HPA:0291162']
4497,GO:BP,GO:0015031,protein transport,0.014884942091434579,True,"""The directed movement of proteins into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore."" [GOC:ai]",1424,787,86,21031,0.10927573062261753,0.060393258426966294,Module 0,"['GO:0045184', 'GO:0071702', 'GO:0071705']"
4498,HPA,HPA:0481302,small intestine; enterocytes[≥Medium],0.01488518716756594,True,small intestine; enterocytes[≥Medium],440,79,12,11019,0.1518987341772152,0.02727272727272727,Module 3,['HPA:0481301']
4499,GO:BP,GO:0009206,purine ribonucleoside triphosphate biosynthetic process,0.014903766623851582,True,"""The chemical reactions and pathways resulting in the formation of purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",113,2,2,21031,1.0,0.017699115044247787,Module 39,"['GO:0009145', 'GO:0009201', 'GO:0009205']"
4500,GO:BP,GO:0009206,purine ribonucleoside triphosphate biosynthetic process,0.014903766623851582,True,"""The chemical reactions and pathways resulting in the formation of purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",113,2,2,21031,1.0,0.017699115044247787,Module 30,"['GO:0009145', 'GO:0009201', 'GO:0009205']"
4501,GO:BP,GO:0048583,regulation of response to stimulus,0.01492916849853603,True,"""Any process that modulates the frequency, rate or extent of a response to a stimulus. Response to stimulus is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus."" [GOC:jid]",3939,34,18,21031,0.5294117647058824,0.00456968773800457,Module 7,"['GO:0050789', 'GO:0050896']"
4502,TF,TF:M04015,Factor: IRF-4; motif: NCGAAACCGAAACYA,0.014944158095808714,True,Factor: IRF-4; motif: NCGAAACCGAAACYA,2085,36,14,20045,0.3888888888888889,0.00671462829736211,Module 7,['TF:M00000']
4503,HPA,HPA:0600442,tonsil; non-germinal center cells[≥Medium],0.014964460167189025,True,tonsil; non-germinal center cells[≥Medium],4200,60,38,11019,0.6333333333333333,0.009047619047619047,Module 4,['HPA:0600441']
4504,GO:CC,GO:0005737,cytoplasm,0.014981696409839705,True,"""The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures."" [ISBN:0198547684]",12345,21,20,22097,0.9523809523809523,0.0016200891049007696,Module 9,"['GO:0005622', 'GO:0110165']"
4505,HPA,HPA:0301363,lung; alveolar cells type I[High],0.015013525535680293,True,lung; alveolar cells type I[High],507,69,12,11019,0.17391304347826086,0.023668639053254437,Module 5,['HPA:0301362']
4506,HPA,HPA:0091003,cerebellum; molecular layer cells - cytoplasm/membrane[High],0.015026439755342855,True,cerebellum; molecular layer cells - cytoplasm/membrane[High],181,185,12,11019,0.06486486486486487,0.06629834254143646,Module 1,['HPA:0091002']
4507,HP,HP:0012372,Abnormal eye morphology,0.01506517985608785,True,"A structural anomaly of the globe of the eye, or bulbus oculi.",2472,44,36,4958,0.8181818181818182,0.014563106796116505,Module 3,['HP:0000478']
4508,TF,TF:M09916_1,Factor: Erm; motif: NRRSAGGAARNGRN; match class: 1,0.015089347635186575,True,Factor: Erm; motif: NRRSAGGAARNGRN; match class: 1,1711,238,42,20045,0.17647058823529413,0.024547048509643482,Module 1,['TF:M09916']
4509,GO:BP,GO:0051983,regulation of chromosome segregation,0.01512599230860873,True,"""Any process that modulates the frequency, rate or extent of chromosome segregation, the process in which genetic material, in the form of chromosomes, is organized and then physically separated and apportioned to two or more sets."" [GOC:ai]",129,77,6,21031,0.07792207792207792,0.046511627906976744,Module 5,"['GO:0007059', 'GO:0010564']"
4510,REAC,REAC:R-HSA-2168880,Scavenging of heme from plasma,0.015134574185479508,True,Scavenging of heme from plasma,69,60,5,10842,0.08333333333333333,0.07246376811594203,Module 4,['REAC:R-HSA-2173782']
4511,HPA,HPA:0600222,tonsil; squamous epithelial cells[≥Medium],0.015140442910699648,True,tonsil; squamous epithelial cells[≥Medium],4949,140,86,11019,0.6142857142857143,0.01737724792887452,Module Singleton,['HPA:0600221']
4512,GO:BP,GO:0031323,regulation of cellular metabolic process,0.015163480857373644,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways by which individual cells transform chemical substances."" [GOC:mah]",6673,215,99,21031,0.4604651162790698,0.014835905889405065,Module 2,"['GO:0019222', 'GO:0044237', 'GO:0050794']"
4513,GO:BP,GO:0009145,purine nucleoside triphosphate biosynthetic process,0.015169905313563228,True,"""The chemical reactions and pathways resulting in the formation of purine nucleoside triphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",114,2,2,21031,1.0,0.017543859649122806,Module 30,"['GO:0009142', 'GO:0009144']"
4514,GO:BP,GO:0009145,purine nucleoside triphosphate biosynthetic process,0.015169905313563228,True,"""The chemical reactions and pathways resulting in the formation of purine nucleoside triphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",114,2,2,21031,1.0,0.017543859649122806,Module 39,"['GO:0009142', 'GO:0009144']"
4515,HP,HP:0001644,Dilated cardiomyopathy,0.01529327663255318,True,"Dilated cardiomyopathy (DCM) is defined by the presence of left ventricular dilatation and left ventricular systolic dysfunction in the absence of abnormal loading conditions (hypertension, valve disease) or coronary artery disease sufficient to cause global systolic impairment. Right ventricular dilation and dysfunction may be present but are not necessary for the diagnosis.",166,44,9,4958,0.20454545454545456,0.05421686746987952,Module 3,['HP:0001638']
4516,GO:BP,GO:0006457,protein folding,0.015357862686872675,True,"""The process of assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure."" [GOC:go_curators, GOC:rb]",217,787,23,21031,0.029224904701397714,0.10599078341013825,Module 0,"['GO:0009987', 'GO:0051604']"
4517,GO:BP,GO:0002768,immune response-regulating cell surface receptor signaling pathway,0.015453647451921087,True,"""The series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of the target cell capable of activating, perpetuating, or inhibiting an immune response."" [GOC:add, ISBN:0781735149, PMID:15771571]",327,215,14,21031,0.06511627906976744,0.04281345565749235,Module 2,"['GO:0002764', 'GO:0007166']"
4518,TF,TF:M08415_1,Factor: TEF-3:Elf-1; motif: RGAATGCGGAAGTN; match class: 1,0.01557513228768741,True,Factor: TEF-3:Elf-1; motif: RGAATGCGGAAGTN; match class: 1,2796,826,161,20045,0.19491525423728814,0.057582260371959945,Module 0,['TF:M08415']
4519,HPA,HPA:0381213,placenta; syncytiotrophoblasts - cell body[High],0.015608728427545246,True,placenta; syncytiotrophoblasts - cell body[High],361,612,39,11019,0.06372549019607843,0.10803324099722991,Module 0,['HPA:0381212']
4520,TF,TF:M09907_1,Factor: Erg; motif: NRRSAGGAAGNGG; match class: 1,0.01563203296760217,True,Factor: Erg; motif: NRRSAGGAAGNGG; match class: 1,5188,238,93,20045,0.3907563025210084,0.01792598303777949,Module 1,['TF:M09907']
4521,HPA,HPA:0100123,cerebral cortex; glial cells[High],0.015660821263589593,True,cerebral cortex; glial cells[High],744,612,67,11019,0.10947712418300654,0.09005376344086022,Module 0,['HPA:0100122']
4522,GO:CC,GO:0097524,sperm plasma membrane,0.015673238372007667,True,"""A plasma membrane that is part of a sperm cell."" [GOC:cjm]",15,21,2,22097,0.09523809523809523,0.13333333333333333,Module 9,['GO:0005886']
4523,HPA,HPA:0471442,skin 2; fibrohistiocytic cells[≥Medium],0.015695004319891515,True,skin 2; fibrohistiocytic cells[≥Medium],833,12,6,11019,0.5,0.007202881152460984,Module 6,['HPA:0471441']
4524,HPA,HPA:0471442,skin 2; fibrohistiocytic cells[≥Medium],0.015702061759246273,True,skin 2; fibrohistiocytic cells[≥Medium],833,79,17,11019,0.21518987341772153,0.02040816326530612,Module 3,['HPA:0471441']
4525,REAC,REAC:R-HSA-110329,Cleavage of the damaged pyrimidine ,0.015710414321136887,True,Cleavage of the damaged pyrimidine ,59,3,2,10842,0.6666666666666666,0.03389830508474576,Module 27,['REAC:R-HSA-73928']
4526,REAC,REAC:R-HSA-73928,Depyrimidination,0.015710414321136887,True,Depyrimidination,59,3,2,10842,0.6666666666666666,0.03389830508474576,Module 27,['REAC:R-HSA-73929']
4527,REAC,REAC:R-HSA-110328,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,0.015710414321136887,True,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,59,3,2,10842,0.6666666666666666,0.03389830508474576,Module 27,['REAC:R-HSA-73928']
4528,GO:CC,GO:0012505,endomembrane system,0.015719618439431492,True,"""A collection of membranous structures involved in transport within the cell. The main components of the endomembrane system are endoplasmic reticulum, Golgi bodies, vesicles, cell membrane and nuclear envelope. Members of the endomembrane system pass materials through each other or though the use of vesicles."" [GOC:lh]",4777,177,61,22097,0.3446327683615819,0.012769520619635755,Module Singleton,['GO:0110165']
4529,HP,HP:0001733,Pancreatitis,0.015829031825384046,True,The presence of inflammation in the pancreas.,90,44,7,4958,0.1590909090909091,0.07777777777777778,Module 3,"['HP:0012091', 'HP:0012649']"
4530,HP,HP:0001877,Abnormal erythrocyte morphology,0.015846756173637396,True,Any structural abnormality of erythrocytes (red-blood cells).,672,71,24,4958,0.3380281690140845,0.03571428571428571,Module 1,['HP:0001871']
4531,GO:BP,GO:0002250,adaptive immune response,0.01586425331481915,True,"""An immune response mediated by cells expressing specific receptors for antigens produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory)."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",739,215,22,21031,0.10232558139534884,0.029769959404600813,Module 2,['GO:0006955']
4532,HPA,HPA:0131333,colon; mucosal lymphoid cells[High],0.01594073587484355,True,colon; mucosal lymphoid cells[High],155,18,4,11019,0.2222222222222222,0.025806451612903226,Module 9,['HPA:0131332']
4533,GO:BP,GO:0042221,response to chemical,0.015958187464234927,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemical stimulus."" [GOC:jl]",3957,34,18,21031,0.5294117647058824,0.004548900682335102,Module 7,['GO:0050896']
4534,GO:BP,GO:1901019,regulation of calcium ion transmembrane transporter activity,0.016039522207133936,True,"""Any process that modulates the frequency, rate or extent of calcium ion transmembrane transporter activity."" [GOC:BHF, GOC:TermGenie]",69,3,2,21031,0.6666666666666666,0.028985507246376812,Module 22,"['GO:0032412', 'GO:1903169']"
4535,TF,TF:M08207,Factor: E2F-3:TBR2; motif: ANGTGYKANGGCGCSTTNNCRNNT,0.01605470183131355,True,Factor: E2F-3:TBR2; motif: ANGTGYKANGGCGCSTTNNCRNNT,17410,105,104,20045,0.9904761904761905,0.005973578403216542,Module 3,['TF:M00000']
4536,HPA,HPA:0380000,placenta,0.016060741972733,True,placenta,7517,60,54,11019,0.9,0.007183716908341094,Module 4,['HPA:0000000']
4537,HPA,HPA:0131332,colon; mucosal lymphoid cells[≥Medium],0.016110038973929208,True,colon; mucosal lymphoid cells[≥Medium],365,140,15,11019,0.10714285714285714,0.0410958904109589,Module Singleton,['HPA:0131331']
4538,GO:BP,GO:0000027,ribosomal large subunit assembly,0.01611674088615074,True,"""The aggregation, arrangement and bonding together of constituent RNAs and proteins to form the large ribosomal subunit."" [GOC:jl, PMID:30467428]",26,105,4,21031,0.0380952380952381,0.15384615384615385,Module 3,"['GO:0022618', 'GO:0042255', 'GO:0042273']"
4539,GO:MF,GO:0017111,ribonucleoside triphosphate phosphatase activity,0.01617578364584714,True,"""Catalysis of the reaction: a ribonucleoside triphosphate + H2O = a ribonucleoside diphosphate + H+ + phosphate."" [RHEA:23680]",734,80,12,20212,0.15,0.01634877384196185,Module 5,['GO:0016462']
4540,REAC,REAC:R-HSA-73929,"Base-Excision Repair, AP Site Formation",0.016251149712445317,True,"Base-Excision Repair, AP Site Formation",60,3,2,10842,0.6666666666666666,0.03333333333333333,Module 27,['REAC:R-HSA-73884']
4541,WP,WP:WP558,Complement and coagulation cascades,0.016265854552065476,True,Complement and coagulation cascades,58,154,7,8286,0.045454545454545456,0.1206896551724138,Module 2,['WP:000000']
4542,GO:BP,GO:0098655,monoatomic cation transmembrane transport,0.01635621215302295,True,"""The process in which a monoatomic cation is transported across a membrane. Monatomic cations (also called simple cations) are positively charged ions consisting of exactly one atom."" [GOC:dos, GOC:vw]",830,787,57,21031,0.0724269377382465,0.06867469879518072,Module 0,"['GO:0006812', 'GO:0034220']"
4543,TF,TF:M02044_1,Factor: YY1; motif: GCCGCCATTTTG; match class: 1,0.016383274259334852,True,Factor: YY1; motif: GCCGCCATTTTG; match class: 1,1245,105,20,20045,0.19047619047619047,0.01606425702811245,Module 3,['TF:M02044']
4544,CORUM,CORUM:104,RNA polymerase II core complex,0.01645818323875037,True,RNA polymerase II core complex,10,331,6,3383,0.01812688821752266,0.6,Module 0,['CORUM:0000000']
4545,GO:BP,GO:0009201,ribonucleoside triphosphate biosynthetic process,0.016535926906773375,True,"""The chemical reactions and pathways resulting in the formation of a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",119,2,2,21031,1.0,0.01680672268907563,Module 39,"['GO:0009142', 'GO:0009199']"
4546,GO:BP,GO:0009201,ribonucleoside triphosphate biosynthetic process,0.016535926906773375,True,"""The chemical reactions and pathways resulting in the formation of a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",119,2,2,21031,1.0,0.01680672268907563,Module 30,"['GO:0009142', 'GO:0009199']"
4547,GO:BP,GO:0031349,positive regulation of defense response,0.016559137718192802,True,"""Any process that activates or increases the frequency, rate or extent of a defense response."" [GOC:mah]",471,34,7,21031,0.20588235294117646,0.014861995753715499,Module 7,"['GO:0006952', 'GO:0031347', 'GO:0048584']"
4548,KEGG,KEGG:05152,Tuberculosis,0.016569269020281576,True,Tuberculosis,175,143,11,8484,0.07692307692307693,0.06285714285714286,Module 2,['KEGG:00000']
4549,GO:MF,GO:0044183,protein folding chaperone,0.016589237021956648,True,"""Binding to a protein or a protein-containing complex to assist the protein folding process."" [GOC:mtg_cambridge_2009]",60,808,11,20212,0.013613861386138614,0.18333333333333332,Module 0,['GO:0003674']
4550,HPA,HPA:0050093,breast; myoepithelial cells[High],0.01666824278375231,True,breast; myoepithelial cells[High],837,79,17,11019,0.21518987341772153,0.02031063321385902,Module 3,['HPA:0050092']
4551,MIRNA,MIRNA:hsa-miR-331-3p,hsa-miR-331-3p,0.016689564389428094,True,hsa-miR-331-3p,406,104,12,14819,0.11538461538461539,0.029556650246305417,Module 3,['MIRNA:000000']
4552,HPA,HPA:0220052,gallbladder; glandular cells[≥Medium],0.016699345135010812,True,gallbladder; glandular cells[≥Medium],6615,140,106,11019,0.7571428571428571,0.01602418745275888,Module Singleton,['HPA:0220051']
4553,CORUM,CORUM:5269,TNF-alpha/NF-kappa B signaling complex 8,0.016703683229728563,True,TNF-alpha/NF-kappa B signaling complex 8,6,9,2,3383,0.2222222222222222,0.3333333333333333,Module 9,['CORUM:0000000']
4554,GO:CC,GO:0043233,organelle lumen,0.016704034721322474,True,"""The internal volume enclosed by the membranes of a particular organelle; includes the volume enclosed by a single organelle membrane, e.g. endoplasmic reticulum lumen, or the volume enclosed by the innermost of the two lipid bilayers of an organelle envelope, e.g. nuclear lumen."" [GOC:jl, GOC:mah]",6657,177,78,22097,0.4406779661016949,0.011716989634970707,Module Singleton,"['GO:0031974', 'GO:0043226']"
4555,GO:CC,GO:0070013,intracellular organelle lumen,0.016704034721322474,True,"""An organelle lumen that is part of an intracellular organelle."" [GOC:mah]",6657,177,78,22097,0.4406779661016949,0.011716989634970707,Module Singleton,"['GO:0043229', 'GO:0043233']"
4556,GO:CC,GO:0031974,membrane-enclosed lumen,0.016704034721322474,True,"""The enclosed volume within a sealed membrane or between two sealed membranes. Encompasses the volume enclosed by the membranes of a particular organelle, e.g. endoplasmic reticulum lumen, or the space between the two lipid bilayers of a double membrane surrounding an organelle, e.g. nuclear envelope lumen."" [GOC:add, GOC:mah]",6657,177,78,22097,0.4406779661016949,0.011716989634970707,Module Singleton,['GO:0110165']
4557,HP,HP:0001271,Polyneuropathy,0.016704819078034845,True,A generalized disorder of peripheral nerves.,60,44,6,4958,0.13636363636363635,0.1,Module 3,['HP:0009830']
4558,HP,HP:0100651,Type I diabetes mellitus,0.016704819078034845,True,A chronic condition in which the pancreas produces little or no insulin. Type I diabetes mellitus is manifested by the sudden onset of severe hyperglycemia with rapid progression to diabetic ketoacidosis unless treated with insulin.,60,44,6,4958,0.13636363636363635,0.1,Module 3,['HP:0000819']
4559,HP,HP:0007108,Demyelinating peripheral neuropathy,0.016704819078034845,True,Demyelinating neuropathy is characterized by slow nerve conduction velocities with reduced amplitudes of sensory/motor nerve conduction and prolonged distal latencies.,60,44,6,4958,0.13636363636363635,0.1,Module 3,"['HP:0009830', 'HP:0012447']"
4560,GO:CC,GO:0005767,secondary lysosome,0.016761020139383683,True,"""Vacuole formed by the fusion of a lysosome with an organelle (autosome) or with a primary phagosome."" [GOC:jl, ISBN:0815316194]",21,17,2,22097,0.11764705882352941,0.09523809523809523,Module 6,['GO:0005764']
4561,GO:BP,GO:0019884,antigen processing and presentation of exogenous antigen,0.016786190302945266,True,"""The process in which an antigen-presenting cell expresses antigen (peptide or lipid) of exogenous origin on its cell surface in association with an MHC protein complex."" [GOC:add, ISBN:0781735149, PMID:15771591, PMID:15928678]",47,215,6,21031,0.027906976744186046,0.1276595744680851,Module 2,['GO:0019882']
4562,REAC,REAC:R-HSA-1679131,Trafficking and processing of endosomal TLR,0.016810295536728977,True,Trafficking and processing of endosomal TLR,13,173,4,10842,0.023121387283236993,0.3076923076923077,Module 2,['REAC:R-HSA-168898']
4563,MIRNA,MIRNA:hsa-let-7b-5p,hsa-let-7b-5p,0.016835978709311333,True,hsa-let-7b-5p,1209,104,22,14819,0.21153846153846154,0.018196856906534328,Module 3,['MIRNA:000000']
4564,GO:BP,GO:0032722,positive regulation of chemokine production,0.01683908768722024,True,"""Any process that activates or increases the frequency, rate, or extent of chemokine production."" [GOC:mah]",71,215,7,21031,0.03255813953488372,0.09859154929577464,Module 2,"['GO:0001819', 'GO:0032602', 'GO:0032642']"
4565,GO:BP,GO:0061180,mammary gland epithelium development,0.01683908768722024,True,"""The process whose specific outcome is the progression of the mammary gland epithelium over time, from its formation to the mature structure. The mammary gland is a large compound sebaceous gland that in female mammals is modified to secrete milk."" [GOC:dph, GOC:yaf]",71,215,7,21031,0.03255813953488372,0.09859154929577464,Module 2,"['GO:0030879', 'GO:0060429']"
4566,GO:BP,GO:0045087,innate immune response,0.016846625433833775,True,"""Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens."" [GO_REF:0000022, GOC:add, GOC:ebc, GOC:mtg_sensu]",965,5,4,21031,0.8,0.004145077720207254,Module 12,"['GO:0006955', 'GO:0140546']"
4567,GO:BP,GO:0010720,positive regulation of cell development,0.01685274785618419,True,"""Any process that increases the rate, frequency or extent of the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate."" [GOC:BHF, GOC:dph, GOC:tb]",450,226,17,21031,0.0752212389380531,0.03777777777777778,Module 1,"['GO:0045597', 'GO:0048468', 'GO:0060284']"
4568,REAC,REAC:R-HSA-449147,Signaling by Interleukins,0.016890131045949303,True,Signaling by Interleukins,471,586,47,10842,0.08020477815699659,0.09978768577494693,Module 0,['REAC:R-HSA-1280215']
4569,HPA,HPA:0471392,skin 2; cells in basal layer[≥Medium],0.01689344063016438,True,skin 2; cells in basal layer[≥Medium],754,79,16,11019,0.20253164556962025,0.021220159151193633,Module 3,['HPA:0471391']
4570,GO:MF,GO:0097159,organic cyclic compound binding,0.016914397468612282,True,"""Binding to an organic cyclic compound, any molecular entity that contains carbon arranged in a cyclic molecular structure."" [GOC:sjw, PMID:7583672]",7546,80,48,20212,0.6,0.0063609859528226875,Module 5,['GO:0005488']
4571,REAC,REAC:R-HSA-6783783,Interleukin-10 signaling,0.01698307156004072,True,Interleukin-10 signaling,45,4,2,10842,0.5,0.044444444444444446,Module 12,['REAC:R-HSA-449147']
4572,GO:BP,GO:0009141,nucleoside triphosphate metabolic process,0.017017271043014103,True,"""The chemical reactions and pathways involving a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",270,105,9,21031,0.08571428571428572,0.03333333333333333,Module 3,['GO:0006753']
4573,HPA,HPA:0630052,cervix; glandular cells[≥Medium],0.017025296276396398,True,cervix; glandular cells[≥Medium],4036,79,46,11019,0.5822784810126582,0.011397423191278493,Module 3,['HPA:0630051']
4574,TF,TF:M09966_1,Factor: Kaiso; motif: SARNYCTCGCGAGAN; match class: 1,0.017137311789666383,True,Factor: Kaiso; motif: SARNYCTCGCGAGAN; match class: 1,470,105,12,20045,0.11428571428571428,0.02553191489361702,Module 3,['TF:M09966']
4575,TF,TF:M02065_1,Factor: ER81; motif: RCCGGAARYN; match class: 1,0.017137741641795178,True,Factor: ER81; motif: RCCGGAARYN; match class: 1,7184,183,95,20045,0.5191256830601093,0.013223830734966592,Module Singleton,['TF:M02065']
4576,GO:MF,GO:0038023,signaling receptor activity,0.017145701062506395,True,"""Receiving a signal and transmitting it in the cell to initiate a change in cell activity. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response."" [GOC:bf, GOC:signaling]",1491,232,35,20212,0.15086206896551724,0.023474178403755867,Module 1,['GO:0060089']
4577,GO:MF,GO:0060089,molecular transducer activity,0.017145701062506395,True,"""A compound molecular function in which an effector function is controlled by one or more regulatory components."" [GOC:dos, GOC:pdt]",1491,232,35,20212,0.15086206896551724,0.023474178403755867,Module 1,['GO:0003674']
4578,HPA,HPA:0131331,colon; mucosal lymphoid cells[≥Low],0.017167012597408163,True,colon; mucosal lymphoid cells[≥Low],509,12,5,11019,0.4166666666666667,0.009823182711198428,Module 6,['HPA:0130000']
4579,GO:CC,GO:0043564,Ku70:Ku80 complex,0.017231931456897075,True,"""Heterodimeric protein complex composed of a 70 kDa and a 80 kDa subunit, binds DNA through a channel formed by the heterodimer. Functions in DNA double stranded break repair, chromosome maintenance, transcription regulation, V(D)J recombination, and activation of DNA-PK."" [PMID:12518983]",3,813,3,22097,0.0036900369003690036,1.0,Module 0,['GO:0140513']
4580,TF,TF:M09970,Factor: KLF3; motif: NNNNNNGGGCGGGGCNNGN,0.01723688281937514,True,Factor: KLF3; motif: NNNNNNGGGCGGGGCNNGN,7962,826,390,20045,0.4721549636803874,0.048982667671439335,Module 0,['TF:M00000']
4581,HPA,HPA:0060103,bronchus; respiratory epithelial cells[High],0.017259367374050094,True,bronchus; respiratory epithelial cells[High],1845,69,25,11019,0.36231884057971014,0.013550135501355014,Module 5,['HPA:0060102']
4582,GO:CC,GO:0031966,mitochondrial membrane,0.017305589683988147,True,"""Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope."" [GOC:mah, NIF_Subcellular:sao1045389829]",782,177,18,22097,0.1016949152542373,0.023017902813299233,Module Singleton,"['GO:0005740', 'GO:0031090']"
4583,GO:CC,GO:0000307,cyclin-dependent protein kinase holoenzyme complex,0.017307368428241456,True,"""Cyclin-dependent protein kinases (CDKs) are enzyme complexes that contain a kinase catalytic subunit associated with a regulatory cyclin partner."" [GOC:krc, PMID:11602261]",59,80,4,22097,0.05,0.06779661016949153,Module 5,['GO:1902554']
4584,KEGG,KEGG:04145,Phagosome,0.017319741242992487,True,Phagosome,147,143,10,8484,0.06993006993006994,0.06802721088435375,Module 2,['KEGG:00000']
4585,REAC,REAC:R-HSA-73728,RNA Polymerase I Promoter Opening,0.017359960809783286,True,RNA Polymerase I Promoter Opening,62,3,2,10842,0.6666666666666666,0.03225806451612903,Module 27,['REAC:R-HSA-73854']
4586,GO:BP,GO:0045824,negative regulation of innate immune response,0.017511207063224652,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of the innate immune response."" [GOC:go_curators]",82,34,4,21031,0.11764705882352941,0.04878048780487805,Module 7,"['GO:0002832', 'GO:0031348', 'GO:0032102', 'GO:0045087', 'GO:0045088', 'GO:0050777']"
4587,KEGG,KEGG:05168,Herpes simplex virus 1 infection,0.017541331578848053,True,Herpes simplex virus 1 infection,506,23,7,8484,0.30434782608695654,0.01383399209486166,Module 7,['KEGG:00000']
4588,GO:BP,GO:0045730,respiratory burst,0.01756465663279352,True,"""A phase of elevated metabolic activity, during which oxygen consumption increases; this leads to the production, by an NADH dependent system, of hydrogen peroxide (H2O2), superoxide anions and hydroxyl radicals."" [ISBN:0198506732]",39,72,4,21031,0.05555555555555555,0.10256410256410256,Module 4,['GO:0008152']
4589,HPA,HPA:0430052,seminal vesicle; glandular cells[≥Medium],0.017571113874521246,True,seminal vesicle; glandular cells[≥Medium],5238,23,20,11019,0.8695652173913043,0.0038182512409316535,Module 10,['HPA:0430051']
4590,REAC,REAC:R-HSA-6803529,FGFR2 alternative splicing,0.01759765785145026,True,FGFR2 alternative splicing,25,586,8,10842,0.013651877133105802,0.32,Module 0,['REAC:R-HSA-5654738']
4591,TF,TF:M00939_1,Factor: E2F; motif: TTTSGCGSG; match class: 1,0.017640242735708012,True,Factor: E2F; motif: TTTSGCGSG; match class: 1,1732,826,109,20045,0.13196125907990314,0.06293302540415704,Module 0,['TF:M00939']
4592,HPA,HPA:0400052,rectum; glandular cells[≥Medium],0.01773055158407249,True,rectum; glandular cells[≥Medium],6107,140,100,11019,0.7142857142857143,0.016374652038644178,Module Singleton,['HPA:0400051']
4593,HPA,HPA:0580822,thymus; cortical cells[≥Medium],0.017732600710648284,True,thymus; cortical cells[≥Medium],26,185,5,11019,0.02702702702702703,0.19230769230769232,Module 1,['HPA:0580821']
4594,TF,TF:M11529_1,Factor: E2F-2; motif: GCGCGCGCNCS; match class: 1,0.017757882193391045,True,Factor: E2F-2; motif: GCGCGCGCNCS; match class: 1,14894,80,75,20045,0.9375,0.005035584799248019,Module 5,['TF:M11529']
4595,KEGG,KEGG:05208,Chemical carcinogenesis - reactive oxygen species,0.017774632255807173,True,Chemical carcinogenesis - reactive oxygen species,221,97,10,8484,0.10309278350515463,0.04524886877828054,Module 3,['KEGG:00000']
4596,GO:CC,GO:1905368,peptidase complex,0.017778570508492336,True,"""A protein complex which is capable of peptidase activity."" [GO_REF:0000088, GOC:bhm, GOC:TermGenie, PMID:1689240]",125,73,5,22097,0.0684931506849315,0.04,Module 4,['GO:1902494']
4597,GO:BP,GO:0141060,disruption of anatomical structure in another organism,0.017823287612172247,True,"""The disruption of an anatomical structure of another organism, leading to damage or temporary subversion of that structure."" [GOC:pg]",95,226,8,21031,0.035398230088495575,0.08421052631578947,Module 1,['GO:0044419']
4598,HP,HP:0011122,Abnormality of skin physiology,0.01783086086013483,True,Any abnormality of the physiological function of the skin.,558,74,22,4958,0.2972972972972973,0.03942652329749104,Module 2,['HP:0000951']
4599,MIRNA,MIRNA:hsa-miR-149-5p,hsa-miR-149-5p,0.017869104337761368,True,hsa-miR-149-5p,394,76,10,14819,0.13157894736842105,0.025380710659898477,Module 5,['MIRNA:000000']
4600,GO:BP,GO:0052548,regulation of endopeptidase activity,0.017880215579585076,True,"""Any process that modulates the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins."" [GOC:ai, GOC:hjd]",219,787,23,21031,0.029224904701397714,0.1050228310502283,Module 0,['GO:0052547']
4601,HPA,HPA:0570731,testis; Leydig cells[≥Low],0.01789402506771587,True,testis; Leydig cells[≥Low],7157,140,112,11019,0.8,0.01564901495039821,Module Singleton,['HPA:0570000']
4602,HPA,HPA:0630051,cervix; glandular cells[≥Low],0.017946563141028563,True,cervix; glandular cells[≥Low],5692,140,95,11019,0.6785714285714286,0.01669009135628953,Module Singleton,['HPA:0630000']
4603,GO:BP,GO:2000116,regulation of cysteine-type endopeptidase activity,0.01795228467389355,True,"""Any process that modulates the frequency, rate or extent of cysteine-type endopeptidase activity."" [GOC:obol, GOC:yaf]",174,787,20,21031,0.025412960609911054,0.11494252873563218,Module 0,['GO:0052548']
4604,REAC,REAC:R-HSA-167287,HIV elongation arrest and recovery,0.0180014838759927,True,HIV elongation arrest and recovery,32,586,9,10842,0.015358361774744027,0.28125,Module 0,['REAC:R-HSA-167172']
4605,REAC,REAC:R-HSA-167290,Pausing and recovery of HIV elongation,0.0180014838759927,True,Pausing and recovery of HIV elongation,32,586,9,10842,0.015358361774744027,0.28125,Module 0,['REAC:R-HSA-167172']
4606,REAC,REAC:R-HSA-111885,Opioid Signalling,0.018009108200288906,True,Opioid Signalling,89,2,2,10842,1.0,0.02247191011235955,Module 22,['REAC:R-HSA-418594']
4607,KEGG,KEGG:05012,Parkinson disease,0.018009253305848,True,Parkinson disease,265,97,11,8484,0.1134020618556701,0.04150943396226415,Module 3,['KEGG:00000']
4608,GO:BP,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,0.018017010845120626,True,"""The process in which an antigen-presenting cell expresses a peptide antigen of exogenous origin on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein."" [GOC:add, ISBN:0781735149, PMID:15771591]",28,215,5,21031,0.023255813953488372,0.17857142857142858,Module 2,"['GO:0002478', 'GO:0002495']"
4609,HPA,HPA:0320102,nasopharynx; respiratory epithelial cells[≥Medium],0.01802131155366998,True,nasopharynx; respiratory epithelial cells[≥Medium],4773,60,41,11019,0.6833333333333333,0.008589985334171381,Module 4,['HPA:0320101']
4610,HPA,HPA:0461411,skin 1; cells in spinous layer[≥Low],0.01803118378575045,True,skin 1; cells in spinous layer[≥Low],760,166,26,11019,0.1566265060240964,0.034210526315789476,Module 2,['HPA:0460000']
4611,HPA,HPA:0131291,colon; endocrine cells[≥Low],0.018078649873848114,True,colon; endocrine cells[≥Low],449,79,12,11019,0.1518987341772152,0.026726057906458798,Module 3,['HPA:0130000']
4612,HPA,HPA:0471471,skin 2; lymphocytes[≥Low],0.01808761455226872,True,skin 2; lymphocytes[≥Low],802,60,14,11019,0.23333333333333334,0.017456359102244388,Module 4,['HPA:0470000']
4613,MIRNA,MIRNA:hsa-miR-324-3p,hsa-miR-324-3p,0.01809417167379401,True,hsa-miR-324-3p,336,18,5,14819,0.2777777777777778,0.01488095238095238,Module 9,['MIRNA:000000']
4614,GO:MF,GO:0097371,MDM2/MDM4 family protein binding,0.01810455471045031,True,"""Binding to a member of the MDM2/MDM4 protein family, comprising negative regulators of p53."" [InterPro:IPR016495]",12,105,3,20212,0.02857142857142857,0.25,Module 3,['GO:0005515']
4615,GO:MF,GO:0008289,lipid binding,0.01814676086384953,True,"""Binding to a lipid."" [GOC:ai]",841,218,23,20212,0.10550458715596331,0.027348394768133173,Module 2,['GO:0005488']
4616,HPA,HPA:0271112,kidney; bowman's capsule[≥Medium],0.01819474281439363,True,kidney; bowman's capsule[≥Medium],203,612,26,11019,0.042483660130718956,0.12807881773399016,Module 0,['HPA:0271111']
4617,KEGG,KEGG:05163,Human cytomegalovirus infection,0.01819767526403362,True,Human cytomegalovirus infection,223,2,2,8484,1.0,0.008968609865470852,Module 22,['KEGG:00000']
4618,TF,TF:M03544,Factor: CREB1; motif: NNNNACGTCANN,0.018201947205576583,True,Factor: CREB1; motif: NNNNACGTCANN,4164,826,224,20045,0.2711864406779661,0.053794428434197884,Module 0,['TF:M00000']
4619,HPA,HPA:0471441,skin 2; fibrohistiocytic cells[≥Low],0.01822620929223642,True,skin 2; fibrohistiocytic cells[≥Low],1021,60,16,11019,0.26666666666666666,0.015670910871694418,Module 4,['HPA:0470000']
4620,MIRNA,MIRNA:hsa-miR-744-5p,hsa-miR-744-5p,0.018237111677701565,True,hsa-miR-744-5p,434,753,43,14819,0.057104913678618856,0.09907834101382489,Module 0,['MIRNA:000000']
4621,HPA,HPA:0461421,skin 1; eccrine glands[≥Low],0.018252685848799577,True,skin 1; eccrine glands[≥Low],246,140,12,11019,0.08571428571428572,0.04878048780487805,Module Singleton,['HPA:0460000']
4622,HP,HP:0000159,Abnormal lip morphology,0.018354489468981494,True,An abnormality of the lip.,1198,44,24,4958,0.5454545454545454,0.02003338898163606,Module 3,['HP:0000163']
4623,GO:BP,GO:0070555,response to interleukin-1,0.01839338979922634,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus."" [GOC:BHF, GOC:mah]",132,215,9,21031,0.04186046511627907,0.06818181818181818,Module 2,['GO:0034097']
4624,GO:BP,GO:0050864,regulation of B cell activation,0.01839338979922634,True,"""Any process that modulates the frequency, rate or extent of B cell activation."" [GOC:ai]",132,215,9,21031,0.04186046511627907,0.06818181818181818,Module 2,"['GO:0042113', 'GO:0051249']"
4625,GO:BP,GO:0051726,regulation of cell cycle,0.01841573799253122,True,"""Any process that modulates the rate or extent of progression through the cell cycle."" [GOC:ai, GOC:dph, GOC:tb]",1105,77,15,21031,0.19480519480519481,0.013574660633484163,Module 5,"['GO:0007049', 'GO:0050794']"
4626,REAC,REAC:R-HSA-5334118,DNA methylation,0.018505214326370166,True,DNA methylation,64,3,2,10842,0.6666666666666666,0.03125,Module 27,['REAC:R-HSA-212165']
4627,HPA,HPA:0031302,appendix; enterocytes[≥Medium],0.018516676416053826,True,appendix; enterocytes[≥Medium],362,69,10,11019,0.14492753623188406,0.027624309392265192,Module 5,['HPA:0031301']
4628,TF,TF:M02073,Factor: Fli-1; motif: ACCGGAAGYN,0.018598967431224352,True,Factor: Fli-1; motif: ACCGGAAGYN,5979,105,53,20045,0.5047619047619047,0.008864358588392707,Module 3,['TF:M00000']
4629,TF,TF:M07087,Factor: Elf-1; motif: NRANCMGGAAGTG,0.018602319323666194,True,Factor: Elf-1; motif: NRANCMGGAAGTG,2262,826,135,20045,0.16343825665859565,0.05968169761273209,Module 0,['TF:M00000']
4630,GO:BP,GO:0042098,T cell proliferation,0.01861511420733008,True,"""The expansion of a T cell population by cell division. Follows T cell activation."" [GOC:jl]",214,15,4,21031,0.26666666666666666,0.018691588785046728,Module 6,"['GO:0042110', 'GO:0046651']"
4631,TF,TF:M11058,Factor: Hey1; motif: NGCRCGYGYN,0.018622799584335367,True,Factor: Hey1; motif: NGCRCGYGYN,13615,67,61,20045,0.9104477611940298,0.0044803525523319865,Module 4,['TF:M00000']
4632,GO:MF,GO:0004197,cysteine-type endopeptidase activity,0.018696159378846885,True,"""Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile."" [GOC:mah, https://www.ebi.ac.uk/merops/about/glossary.shtml#CATTYPE, https://www.ebi.ac.uk/merops/about/glossary.shtml#ENDOPEPTIDASE]",87,218,7,20212,0.03211009174311927,0.08045977011494253,Module 2,"['GO:0004175', 'GO:0008234']"
4633,GO:CC,GO:0070382,exocytic vesicle,0.01870721196819369,True,"""A transport vesicle that mediates transport from an intracellular compartment to the plasma membrane, and fuses with the plasma membrane to release various cargo molecules, such as proteins or hormones, by exocytosis."" [GOC:kad, GOC:mah]",233,813,22,22097,0.02706027060270603,0.0944206008583691,Module 0,"['GO:0030133', 'GO:0099503']"
4634,GO:BP,GO:0045765,regulation of angiogenesis,0.018755220980165323,True,"""Any process that modulates the frequency, rate or extent of angiogenesis."" [GOC:go_curators]",288,215,13,21031,0.06046511627906977,0.04513888888888889,Module 2,"['GO:0001525', 'GO:0022603', 'GO:1901342']"
4635,GO:CC,GO:0005886,plasma membrane,0.018757442548191415,True,"""The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins."" [ISBN:0716731363]",5742,221,84,22097,0.38009049773755654,0.014629049111807733,Module 2,"['GO:0016020', 'GO:0071944']"
4636,HPA,HPA:0100123,cerebral cortex; glial cells[High],0.018767451484669993,True,cerebral cortex; glial cells[High],744,3,3,11019,1.0,0.004032258064516129,Module 27,['HPA:0100122']
4637,GO:BP,GO:0009142,nucleoside triphosphate biosynthetic process,0.018844032357369894,True,"""The chemical reactions and pathways resulting in the formation of a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",127,2,2,21031,1.0,0.015748031496062992,Module 30,"['GO:0009141', 'GO:1901293']"
4638,GO:BP,GO:0009142,nucleoside triphosphate biosynthetic process,0.018844032357369894,True,"""The chemical reactions and pathways resulting in the formation of a nucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with triphosphate on the sugar."" [GOC:go_curators, ISBN:0198506732]",127,2,2,21031,1.0,0.015748031496062992,Module 39,"['GO:0009141', 'GO:1901293']"
4639,HP,HP:0000240,Abnormality of skull size,0.018897334248491476,True,Any abnormality of the size of the skull.,1580,44,28,4958,0.6363636363636364,0.017721518987341773,Module 3,['HP:0000929']
4640,KEGG,KEGG:04110,Cell cycle,0.01892355151235102,True,Cell cycle,157,111,9,8484,0.08108108108108109,0.05732484076433121,Module Singleton,['KEGG:00000']
4641,GO:BP,GO:0044085,cellular component biogenesis,0.01894856560072629,True,"""A process that results in the biosynthesis of constituent macromolecules, assembly, and arrangement of constituent parts of a cellular component. Includes biosynthesis of constituent macromolecules, and those macromolecular modifications that are involved in synthesis or assembly of the cellular component."" [GOC:jl, GOC:mah]",4955,105,45,21031,0.42857142857142855,0.009081735620585268,Module 3,['GO:0071840']
4642,GO:BP,GO:0042832,defense response to protozoan,0.01901217494391348,True,"""Reactions triggered in response to the presence of a protozoan that act to protect the cell or organism."" [GOC:jl]",27,226,5,21031,0.022123893805309734,0.18518518518518517,Module 1,"['GO:0001562', 'GO:0098542']"
4643,HP,HP:0005415,Decreased proportion of CD8-positive T cells,0.01905872774277832,True,"A decreased proportion of circulating CD8-positive, alpha-beta T cells relative to total number of T cells.",11,71,4,4958,0.056338028169014086,0.36363636363636365,Module 1,"['HP:0005403', 'HP:0031393']"
4644,HPA,HPA:0401303,rectum; enterocytes[High],0.019261595223025466,True,rectum; enterocytes[High],227,69,8,11019,0.11594202898550725,0.03524229074889868,Module 5,['HPA:0401302']
4645,GO:BP,GO:0030101,natural killer cell activation,0.019265651481075324,True,"""The change in morphology and behavior of a natural killer cell in response to a cytokine, chemokine, cellular ligand, or soluble factor."" [GOC:mgi_curators, ISBN:0781735149]",96,226,8,21031,0.035398230088495575,0.08333333333333333,Module 1,['GO:0046649']
4646,HPA,HPA:0570783,testis; preleptotene spermatocytes[High],0.019302904648007425,True,testis; preleptotene spermatocytes[High],751,3,3,11019,1.0,0.0039946737683089215,Module 27,['HPA:0570782']
4647,KEGG,KEGG:04611,Platelet activation,0.01930371964316193,True,Platelet activation,124,111,8,8484,0.07207207207207207,0.06451612903225806,Module Singleton,['KEGG:00000']
4648,GO:BP,GO:0042221,response to chemical,0.01931467462894194,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemical stimulus."" [GOC:jl]",3957,172,56,21031,0.32558139534883723,0.014152135456153651,Module Singleton,['GO:0050896']
4649,HPA,HPA:0530723,spleen; cells in white pulp[High],0.019318090870275993,True,spleen; cells in white pulp[High],847,79,17,11019,0.21518987341772153,0.020070838252656435,Module 3,['HPA:0530722']
4650,HPA,HPA:0610000,urinary bladder,0.01933535842148155,True,urinary bladder,7304,69,60,11019,0.8695652173913043,0.008214676889375685,Module 5,['HPA:0000000']
4651,HPA,HPA:0610831,urinary bladder; urothelial cells[≥Low],0.01933535842148155,True,urinary bladder; urothelial cells[≥Low],7304,69,60,11019,0.8695652173913043,0.008214676889375685,Module 5,['HPA:0610000']
4652,HPA,HPA:0471463,skin 2; langerhans cells[High],0.01942893148678987,True,skin 2; langerhans cells[High],266,12,4,11019,0.3333333333333333,0.015037593984962405,Module 6,['HPA:0471462']
4653,GO:BP,GO:1903034,regulation of response to wounding,0.019438859859197858,True,"""Any process that modulates the frequency, rate or extent of response to wounding."" [GO_REF:0000058, GOC:kmv, GOC:TermGenie, PMID:19164535]",168,215,10,21031,0.046511627906976744,0.05952380952380952,Module 2,"['GO:0009611', 'GO:0080134']"
4654,HPA,HPA:0090183,cerebellum; cells in granular layer[High],0.019457740230284085,True,cerebellum; cells in granular layer[High],753,3,3,11019,1.0,0.00398406374501992,Module 27,['HPA:0090182']
4655,REAC,REAC:R-HSA-68886,M Phase,0.019481795338811135,True,M Phase,406,586,42,10842,0.07167235494880546,0.10344827586206896,Module 0,['REAC:R-HSA-69278']
4656,GO:BP,GO:0032760,positive regulation of tumor necrosis factor production,0.019518082326115817,True,"""Any process that activates or increases the frequency, rate or extent of tumor necrosis factor production."" [GO_REF:0000058, GOC:TermGenie, PMID:10891884, PMID:15560120]",101,215,8,21031,0.037209302325581395,0.07920792079207921,Module 2,"['GO:0032640', 'GO:0032680', 'GO:1903557']"
4657,HPA,HPA:0610831,urinary bladder; urothelial cells[≥Low],0.019524970424379562,True,urinary bladder; urothelial cells[≥Low],7304,60,53,11019,0.8833333333333333,0.0072562979189485215,Module 4,['HPA:0610000']
4658,HPA,HPA:0610000,urinary bladder,0.019524970424379562,True,urinary bladder,7304,60,53,11019,0.8833333333333333,0.0072562979189485215,Module 4,['HPA:0000000']
4659,HPA,HPA:0630051,cervix; glandular cells[≥Low],0.019540057586678483,True,cervix; glandular cells[≥Low],5692,18,17,11019,0.9444444444444444,0.0029866479269149682,Module 9,['HPA:0630000']
4660,REAC,REAC:R-HSA-190861,Gap junction assembly,0.019558815953438898,True,Gap junction assembly,38,59,4,10842,0.06779661016949153,0.10526315789473684,Module 5,['REAC:R-HSA-190828']
4661,GO:BP,GO:0034728,nucleosome organization,0.019631982731428185,True,"""A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of one or more nucleosomes."" [GOC:mah]",135,77,6,21031,0.07792207792207792,0.044444444444444446,Module 5,['GO:0006338']
4662,GO:BP,GO:0030890,positive regulation of B cell proliferation,0.019635677548217198,True,"""Any process that activates or increases the rate or extent of B cell proliferation."" [GOC:mah]",46,226,6,21031,0.02654867256637168,0.13043478260869565,Module 1,"['GO:0030888', 'GO:0042100', 'GO:0050671', 'GO:0050871']"
4663,GO:BP,GO:0043434,response to peptide hormone,0.01964245449512571,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals."" [PMID:11027914, PMID:15134857, Wikipedia:Peptide_hormone]",429,215,16,21031,0.07441860465116279,0.037296037296037296,Module 2,"['GO:0009725', 'GO:1901652']"
4664,WP,WP:WP2884,NRF2 pathway,0.019678770884720517,True,NRF2 pathway,141,17,4,8286,0.23529411764705882,0.028368794326241134,Module 9,['WP:000000']
4665,REAC,REAC:R-HSA-9670095,Inhibition of DNA recombination at telomere,0.019686896661750965,True,Inhibition of DNA recombination at telomere,66,3,2,10842,0.6666666666666666,0.030303030303030304,Module 27,['REAC:R-HSA-157579']
4666,HPA,HPA:0310443,lymph node; non-germinal center cells[High],0.019708828643958773,True,lymph node; non-germinal center cells[High],1209,79,21,11019,0.26582278481012656,0.017369727047146403,Module 3,['HPA:0310442']
4667,CORUM,CORUM:1143,SMN complex,0.019797985920861454,True,SMN complex,14,331,7,3383,0.021148036253776436,0.5,Module 0,['CORUM:0000000']
4668,CORUM,CORUM:1745,SMN complex,0.019797985920861454,True,SMN complex,14,331,7,3383,0.021148036253776436,0.5,Module 0,['CORUM:0000000']
4669,HPA,HPA:0340461,ovary; ovarian stroma cells[≥Low],0.019894361780988624,True,ovary; ovarian stroma cells[≥Low],3986,140,73,11019,0.5214285714285715,0.01831409934771701,Module Singleton,['HPA:0340000']
4670,HP,HP:0011122,Abnormality of skin physiology,0.019906782632386287,True,Any abnormality of the physiological function of the skin.,558,59,19,4958,0.3220338983050847,0.034050179211469536,Module Singleton,['HP:0000951']
4671,TF,TF:M05731,Factor: ZNF660; motif: NGGGGGGAACSM,0.01991378508314382,True,Factor: ZNF660; motif: NGGGGGGAACSM,127,2,2,20045,1.0,0.015748031496062992,Module 41,['TF:M00000']
4672,GO:BP,GO:0097193,intrinsic apoptotic signaling pathway,0.019916657005347352,True,"""The series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway starts with reception of an intracellular signal (e.g. DNA damage, endoplasmic reticulum stress, oxidative stress etc.), and ends when the execution phase of apoptosis is triggered. The intrinsic apoptotic signaling pathway is crucially regulated by permeabilization of the mitochondrial outer membrane (MOMP)."" [GOC:mtg_apoptosis, GOC:yaf, PMID:11919192, PMID:17340152, PMID:18852119]",315,172,12,21031,0.06976744186046512,0.0380952380952381,Module Singleton,"['GO:0035556', 'GO:0097190']"
4673,GO:CC,GO:0032398,MHC class Ib protein complex,0.019936128631074846,True,"""A transmembrane protein complex composed of a MHC class Ib alpha chain and, in most cases, an invariant beta2-microglobin chain, and with or without a bound peptide or lipid antigen. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families."" [GOC:add, ISBN:0781735149, PMID:15928678]",2,1,1,22097,1.0,0.5,Module 16,['GO:0042611']
4674,GO:CC,GO:0032398,MHC class Ib protein complex,0.019936128631074846,True,"""A transmembrane protein complex composed of a MHC class Ib alpha chain and, in most cases, an invariant beta2-microglobin chain, and with or without a bound peptide or lipid antigen. Class Ib here refers to non-classical class I molecules, such as those of the CD1 or HLA-E gene families."" [GOC:add, ISBN:0781735149, PMID:15928678]",2,1,1,22097,1.0,0.5,Module 38,['GO:0042611']
4675,GO:CC,GO:0032311,angiogenin-PRI complex,0.019936128631074846,True,"""A stable heterodimer of angiogenin and placental ribonuclease inhibitor; interaction between angiogenin and PRI prevents angiogenin binding to its receptor to stimulate angiogenesis."" [PMID:2706246, PMID:3470787]",2,1,1,22097,1.0,0.5,Module 31,"['GO:0005576', 'GO:0032991']"
4676,GO:CC,GO:0061779,Tapasin-ERp57 complex,0.019936128631074846,True,"""Subunit of the MHC class I peptide loading complex (GO:0042824) (=PLC) involved in the assembly of the heavy-chain-beta2-microglobulin dimers of the MHC class I molecules that fold with eight to ten residue peptides in the endoplasmic reticulum. Required for the inhibition of the reduction of the disulfide bonds of the heavy chains and the assembly and stabilization of the PLC, suggesting it may play a structural rather than a catalytic role."" [GOC:bhm, GOC:dph, Intact:EBI-11896237, Intact:EBI-9013963, PMID:17603487]",2,1,1,22097,1.0,0.5,Module 18,"['GO:0042824', 'GO:0098796', 'GO:0140534']"
4677,GO:CC,GO:0017053,transcription repressor complex,0.019968310137113997,True,"""A protein complex that possesses activity that prevents or downregulates transcription."" [GOC:mah]",77,26,3,22097,0.11538461538461539,0.03896103896103896,Module 10,['GO:0005667']
4678,REAC,REAC:R-HSA-2132295,MHC class II antigen presentation,0.020001322687094036,True,MHC class II antigen presentation,123,59,6,10842,0.1016949152542373,0.04878048780487805,Module 5,['REAC:R-HSA-1280218']
4679,WP,WP:WP4223,Ras signaling,0.020047936128539553,True,Ras signaling,183,2,2,8286,1.0,0.01092896174863388,Module 22,['WP:000000']
4680,REAC,REAC:R-HSA-392499,Metabolism of proteins,0.02004899930824046,True,Metabolism of proteins,1946,60,24,10842,0.4,0.012332990750256937,Module 4,['REAC:0000000']
4681,HPA,HPA:0500000,soft tissue 1,0.020055205137853083,True,soft tissue 1,5363,60,44,11019,0.7333333333333333,0.008204363229535707,Module 4,['HPA:0000000']
4682,HPA,HPA:0471412,skin 2; cells in spinous layer[≥Medium],0.020076755573444252,True,skin 2; cells in spinous layer[≥Medium],683,79,15,11019,0.189873417721519,0.021961932650073207,Module 3,['HPA:0471411']
4683,HPA,HPA:0401291,rectum; endocrine cells[≥Low],0.020096718646076747,True,rectum; endocrine cells[≥Low],454,79,12,11019,0.1518987341772152,0.02643171806167401,Module 3,['HPA:0400000']
4684,TF,TF:M08313_1,Factor: GCMa:PEA3; motif: ATRCGGGCGGAAGTR; match class: 1,0.020098504925140134,True,Factor: GCMa:PEA3; motif: ATRCGGGCGGAAGTR; match class: 1,9904,80,59,20045,0.7375,0.00595718901453958,Module 5,['TF:M08313']
4685,HP,HP:0009115,Aplasia/hypoplasia involving the skeleton,0.020106043315774334,True,Absence (due to failure to form) or underdevelopment of one or more components of the skeleton.,1204,44,24,4958,0.5454545454545454,0.019933554817275746,Module 3,['HP:0011842']
4686,GO:BP,GO:0051234,establishment of localization,0.0201070191169019,True,"""Any process that localizes a substance or cellular component. This may occur via movement, tethering or selective degradation."" [GOC:ai, GOC:dos]",4881,172,65,21031,0.37790697674418605,0.013316943249334154,Module Singleton,['GO:0051179']
4687,WP,WP:WP3863,T cell antigen receptor TCR pathway during Staphylococcus aureus infection,0.020144653526320805,True,T cell antigen receptor TCR pathway during Staphylococcus aureus infection,62,148,7,8286,0.0472972972972973,0.11290322580645161,Module 1,['WP:000000']
4688,KEGG,KEGG:04014,Ras signaling pathway,0.020213512761467465,True,Ras signaling pathway,235,2,2,8484,1.0,0.00851063829787234,Module 22,['KEGG:00000']
4689,TF,TF:M08377,Factor: meis1:Elf-1; motif: NTGCCGGAAGTN,0.020221867269628283,True,Factor: meis1:Elf-1; motif: NTGCCGGAAGTN,11536,105,82,20045,0.780952380952381,0.007108183079056866,Module 3,['TF:M00000']
4690,GO:CC,GO:0120115,Lsm2-8 complex,0.0202266251017887,True,"""A heteroheptameric, nuclear protein complex composed of Lsm2, Lsm3, Lsm4, Lsm5, Lsm6, Lsm7, and Lsm8, or orthologs thereof, that selectively binds to snRNAs, in particular U6 or U6atac snRNAs, and also to unspliced transcripts localized within the nucleus."" [GOC:bhm, GOC:krc, PMID:19121818, PMID:23221597, PMID:27627834, PMID:28768202]",7,813,4,22097,0.004920049200492005,0.5714285714285714,Module 0,['GO:0120114']
4691,TF,TF:M05498,Factor: DRRS; motif: NGTAGTCAGC,0.020229876909860372,True,Factor: DRRS; motif: NGTAGTCAGC,128,2,2,20045,1.0,0.015625,Module 41,['TF:M00000']
4692,GO:BP,GO:0006091,generation of precursor metabolites and energy,0.020240981338017966,True,"""The chemical reactions and pathways resulting in the formation of precursor metabolites, substances from which energy is derived, and any process involved in the liberation of energy from these substances."" [GOC:jl]",515,105,12,21031,0.11428571428571428,0.02330097087378641,Module 3,['GO:0044237']
4693,HP,HP:0003348,Hyperalaninemia,0.0202428006711471,True,An increased concentration of alanine in the blood.,62,44,6,4958,0.13636363636363635,0.0967741935483871,Module 3,['HP:0010916']
4694,KEGG,KEGG:05014,Amyotrophic lateral sclerosis,0.020247316353393496,True,Amyotrophic lateral sclerosis,363,97,13,8484,0.13402061855670103,0.03581267217630854,Module 3,['KEGG:00000']
4695,GO:BP,GO:0042093,T-helper cell differentiation,0.020277558129368708,True,"""The process in which a relatively unspecialized thymocyte acquires specialized features of a T-helper cell."" [GOC:ebc]",73,215,7,21031,0.03255813953488372,0.0958904109589041,Module 2,['GO:0002294']
4696,REAC,REAC:R-HSA-427359,SIRT1 negatively regulates rRNA expression,0.020291394386346917,True,SIRT1 negatively regulates rRNA expression,67,3,2,10842,0.6666666666666666,0.029850746268656716,Module 27,['REAC:R-HSA-5250941']
4697,REAC,REAC:R-HSA-5625886,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,0.020291394386346917,True,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,67,3,2,10842,0.6666666666666666,0.029850746268656716,Module 27,['REAC:R-HSA-5625740']
4698,CORUM,CORUM:835,6S methyltransferase and RG-containing Sm proteins complex,0.02033575667336694,True,6S methyltransferase and RG-containing Sm proteins complex,7,331,5,3383,0.015105740181268883,0.7142857142857143,Module 0,['CORUM:0000000']
4699,GO:BP,GO:0070372,regulation of ERK1 and ERK2 cascade,0.02038614519289212,True,"""Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade."" [GOC:add, ISBN:0121245462, ISBN:0896039986]",291,5,3,21031,0.6,0.010309278350515464,Module 12,"['GO:0043408', 'GO:0070371']"
4700,MIRNA,MIRNA:hsa-miR-320a,hsa-miR-320a,0.02044039282706135,True,hsa-miR-320a,580,753,53,14819,0.0703851261620186,0.09137931034482759,Module 0,['MIRNA:000000']
4701,HPA,HPA:0600432,tonsil; germinal center cells[≥Medium],0.020457559161776478,True,tonsil; germinal center cells[≥Medium],4100,12,11,11019,0.9166666666666666,0.002682926829268293,Module 6,['HPA:0600431']
4702,GO:BP,GO:0051336,regulation of hydrolase activity,0.02046532809927601,True,"""Any process that modulates the frequency, rate or extent of hydrolase activity, the catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3."" [GOC:ai]",604,787,45,21031,0.05717916137229987,0.07450331125827815,Module 0,['GO:0050790']
4703,HPA,HPA:0471482,skin 2; sebaceous glands[≥Medium],0.020468127315806873,True,skin 2; sebaceous glands[≥Medium],110,140,8,11019,0.05714285714285714,0.07272727272727272,Module Singleton,['HPA:0471481']
4704,MIRNA,MIRNA:hsa-miR-4326,hsa-miR-4326,0.02050684484608595,True,hsa-miR-4326,72,15,3,14819,0.2,0.041666666666666664,Module 11,['MIRNA:000000']
4705,MIRNA,MIRNA:hsa-miR-4289,hsa-miR-4289,0.02050684484608595,True,hsa-miR-4289,72,15,3,14819,0.2,0.041666666666666664,Module 11,['MIRNA:000000']
4706,HPA,HPA:0381193,placenta; cytotrophoblasts[High],0.020509019386226183,True,placenta; cytotrophoblasts[High],295,69,9,11019,0.13043478260869565,0.030508474576271188,Module 5,['HPA:0381192']
4707,HPA,HPA:0301173,lung; alveolar cells[High],0.020559545095207406,True,lung; alveolar cells[High],443,69,11,11019,0.15942028985507245,0.024830699774266364,Module 5,['HPA:0301172']
4708,TF,TF:M02062_1,Factor: Erg; motif: ACCGGAAGTN; match class: 1,0.020657402930160582,True,Factor: Erg; motif: ACCGGAAGTN; match class: 1,2768,105,32,20045,0.3047619047619048,0.011560693641618497,Module 3,['TF:M02062']
4709,TF,TF:M08223,Factor: Elk-1:OC-2; motif: RCCGGAASCGATCGATNN,0.020708560681101492,True,Factor: Elk-1:OC-2; motif: RCCGGAASCGATCGATNN,12970,826,593,20045,0.7179176755447942,0.04572089437162683,Module 0,['TF:M00000']
4710,TF,TF:M11419,Factor: ER81; motif: NNCCGGAWGYN,0.02073426162052767,True,Factor: ER81; motif: NNCCGGAWGYN,5831,105,52,20045,0.49523809523809526,0.008917852855427885,Module 3,['TF:M00000']
4711,KEGG,KEGG:05171,Coronavirus disease - COVID-19,0.02074284638517405,True,Coronavirus disease - COVID-19,231,23,5,8484,0.21739130434782608,0.021645021645021644,Module 7,['KEGG:00000']
4712,GO:BP,GO:0001944,vasculature development,0.02083416993534455,True,"""The process whose specific outcome is the progression of the vasculature over time, from its formation to the mature structure. The vasculature is an interconnected tubular multi-tissue structure that contains fluid that is actively transported around the organism."" [GOC:dph, UBERON:0002409]",752,215,22,21031,0.10232558139534884,0.02925531914893617,Module 2,"['GO:0048731', 'GO:0072359']"
4713,REAC,REAC:R-HSA-68616,Assembly of the ORC complex at the origin of replication,0.020904994215470627,True,Assembly of the ORC complex at the origin of replication,68,3,2,10842,0.6666666666666666,0.029411764705882353,Module 27,['REAC:R-HSA-68867']
4714,HPA,HPA:0040082,bone marrow; hematopoietic cells[≥Medium],0.020905947412454946,True,bone marrow; hematopoietic cells[≥Medium],4256,60,38,11019,0.6333333333333333,0.008928571428571428,Module 4,['HPA:0040081']
4715,HPA,HPA:0470183,skin 2; cells in granular layer[High],0.020988397586427236,True,skin 2; cells in granular layer[High],248,185,14,11019,0.07567567567567568,0.056451612903225805,Module 1,['HPA:0470182']
4716,GO:BP,GO:1904874,positive regulation of telomerase RNA localization to Cajal body,0.02102453591182728,True,"""Any process that activates or increases the frequency, rate or extent of telomerase RNA localization to Cajal body."" [GO_REF:0000058, GOC:BHF, GOC:BHF_telomere, GOC:nc, GOC:TermGenie, PMID:25467444]",15,787,6,21031,0.007623888182973317,0.4,Module 0,"['GO:0048518', 'GO:0090671', 'GO:1904872']"
4717,HPA,HPA:0170051,endometrium 2; glandular cells[≥Low],0.021027990921074425,True,endometrium 2; glandular cells[≥Low],6723,69,57,11019,0.8260869565217391,0.008478357875948238,Module 5,['HPA:0170000']
4718,HP,HP:0001167,Abnormal finger morphology,0.021038410130777858,True,An anomaly of a finger.,1207,44,24,4958,0.5454545454545454,0.01988400994200497,Module 3,"['HP:0001155', 'HP:0011297']"
4719,GO:MF,GO:0003899,DNA-directed 5'-3' RNA polymerase activity,0.02104677889883735,True,"""Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1). Utilizes a DNA template, i.e. the catalysis of DNA-template-directed extension of the 3'-end of an RNA strand by one nucleotide at a time. Can initiate a chain 'de novo'."" [EC:2.7.7.6, GOC:pf]",32,808,8,20212,0.009900990099009901,0.25,Module 0,['GO:0034062']
4720,HPA,HPA:0630222,cervix; squamous epithelial cells[≥Medium],0.02108490054792274,True,cervix; squamous epithelial cells[≥Medium],3730,69,39,11019,0.5652173913043478,0.010455764075067025,Module 5,['HPA:0630221']
4721,GO:BP,GO:0048519,negative regulation of biological process,0.021136987488283715,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of a biological process. Biological processes are regulated by many means; examples include the control of gene expression, protein modification or interaction with a protein or substrate molecule."" [GOC:jid]",5874,787,274,21031,0.34815756035578144,0.04664623765747361,Module 0,"['GO:0008150', 'GO:0050789']"
4722,GO:BP,GO:0060333,type II interferon-mediated signaling pathway,0.02114567160781834,True,"""The series of molecular signals initiated by interferon-gamma binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription. Interferon gamma is the only member of the type II interferon found so far."" [GOC:add, GOC:dph, GOC:signaling, PMID:28901902]",27,34,3,21031,0.08823529411764706,0.1111111111111111,Module 7,"['GO:0071346', 'GO:0140888']"
4723,WP,WP:WP5433,PGK1 PKM2 KHKC KHKA acting as protein kinases,0.021194519062131125,True,PGK1 PKM2 KHKC KHKA acting as protein kinases,15,148,4,8286,0.02702702702702703,0.26666666666666666,Module 1,['WP:000000']
4724,GO:MF,GO:0016462,pyrophosphatase activity,0.021206614497291876,True,"""Catalysis of the hydrolysis of a pyrophosphate bond (diphosphate bond) between two phosphate groups."" [GOC:curators, https://en.wikipedia.org/wiki/Pyrophosphatase]",794,808,56,20212,0.06930693069306931,0.07052896725440806,Module 0,['GO:0016818']
4725,GO:BP,GO:0060255,regulation of macromolecule metabolic process,0.021215865283766663,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving macromolecules, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass."" [GOC:dph, GOC:tb]",6631,215,98,21031,0.4558139534883721,0.014779068013874228,Module 2,"['GO:0019222', 'GO:0043170']"
4726,GO:BP,GO:0060255,regulation of macromolecule metabolic process,0.021234862681001318,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving macromolecules, any molecule of high relative molecular mass, the structure of which essentially comprises the multiple repetition of units derived, actually or conceptually, from molecules of low relative molecular mass."" [GOC:dph, GOC:tb]",6631,787,304,21031,0.386277001270648,0.045845272206303724,Module 0,"['GO:0019222', 'GO:0043170']"
4727,REAC,REAC:R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,0.021235116057165278,True,APC/C:Cdc20 mediated degradation of mitotic proteins,76,59,5,10842,0.0847457627118644,0.06578947368421052,Module 5,['REAC:R-HSA-176814']
4728,REAC,REAC:R-HSA-438064,Post NMDA receptor activation events,0.021235116057165278,True,Post NMDA receptor activation events,76,59,5,10842,0.0847457627118644,0.06578947368421052,Module 5,['REAC:R-HSA-442755']
4729,GO:BP,GO:0071396,cellular response to lipid,0.021243953717094442,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipid stimulus."" [GOC:mah]",609,226,20,21031,0.08849557522123894,0.03284072249589491,Module 1,"['GO:0033993', 'GO:0071310']"
4730,TF,TF:M12642,Factor: NFYA; motif: NNRGCCAATSRGMRSSNNSN,0.021246709778184346,True,Factor: NFYA; motif: NNRGCCAATSRGMRSSNNSN,2845,80,27,20045,0.3375,0.009490333919156414,Module 5,['TF:M00000']
4731,REAC,REAC:R-HSA-2871837,FCERI mediated NF-kB activation,0.02128709531381483,True,FCERI mediated NF-kB activation,136,586,20,10842,0.034129692832764506,0.14705882352941177,Module 0,['REAC:R-HSA-2454202']
4732,HPA,HPA:0401333,rectum; mucosal lymphoid cells[High],0.021437186878048405,True,rectum; mucosal lymphoid cells[High],176,140,10,11019,0.07142857142857142,0.056818181818181816,Module Singleton,['HPA:0401332']
4733,TF,TF:M02071,Factor: ETV7; motif: NCCGGAANNN,0.02150737793982198,True,Factor: ETV7; motif: NCCGGAANNN,10370,183,124,20045,0.6775956284153005,0.011957569913211187,Module Singleton,['TF:M00000']
4734,GO:BP,GO:0006958,"complement activation, classical pathway",0.02151467507708745,True,"""Any process involved in the activation of any of the steps of the classical pathway of the complement cascade which allows for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes."" [GOC:add, ISBN:0781735149]",41,72,4,21031,0.05555555555555555,0.0975609756097561,Module 4,"['GO:0002455', 'GO:0006956']"
4735,GO:BP,GO:1903573,negative regulation of response to endoplasmic reticulum stress,0.02151467507708745,True,"""Any process that stops, prevents or reduces the frequency, rate or extent of a response to endoplasmic reticulum stress."" [GO_REF:0000058, GOC:bf, GOC:PARL, GOC:TermGenie, PMID:11381086]",41,72,4,21031,0.05555555555555555,0.0975609756097561,Module 4,"['GO:0034976', 'GO:0048523', 'GO:0048585', 'GO:1905897']"
4736,TF,TF:M12969_1,Factor: PAX2; motif: NCANTSRAGCGTGACGR; match class: 1,0.021533317382065643,True,Factor: PAX2; motif: NCANTSRAGCGTGACGR; match class: 1,1365,826,90,20045,0.1089588377723971,0.06593406593406594,Module 0,['TF:M12969']
4737,TF,TF:M00025,Factor: Elk-1; motif: NNNNCCGGAARTNN,0.02154407721205637,True,Factor: Elk-1; motif: NNNNCCGGAARTNN,10256,183,123,20045,0.6721311475409836,0.011992979719188768,Module Singleton,['TF:M00000']
4738,HP,HP:0010987,Abnormal cellular immune system morphology,0.021593099998721468,True,An abnormality of the morphology or counts of the cells that make up the immune system.,615,59,20,4958,0.3389830508474576,0.032520325203252036,Module Singleton,['HP:0032251']
4739,HP,HP:0001881,Abnormal leukocyte morphology,0.021593099998721468,True,An abnormality of leukocytes.,615,59,20,4958,0.3389830508474576,0.032520325203252036,Module Singleton,"['HP:0001871', 'HP:0010987']"
4740,HP,HP:0003496,Increased circulating IgM level,0.021595034427215318,True,An abnormally increased level of immunoglobulin M in blood.,38,71,6,4958,0.08450704225352113,0.15789473684210525,Module 1,"['HP:0010702', 'HP:0410243']"
4741,WP,WP:WP4880,Host pathogen interaction of human coronaviruses interferon induction,0.021727697981148823,True,Host pathogen interaction of human coronaviruses interferon induction,33,27,3,8286,0.1111111111111111,0.09090909090909091,Module 7,['WP:000000']
4742,MIRNA,MIRNA:hsa-miR-615-3p,hsa-miR-615-3p,0.021733635196061564,True,hsa-miR-615-3p,890,76,15,14819,0.19736842105263158,0.016853932584269662,Module 5,['MIRNA:000000']
4743,HP,HP:0000598,Abnormality of the ear,0.02173795810030157,True,An abnormality of the ear.,2376,44,35,4958,0.7954545454545454,0.014730639730639731,Module 3,['HP:0000118']
4744,GO:BP,GO:0006900,vesicle budding from membrane,0.02187945870258761,True,"""The evagination of a membrane, resulting in formation of a vesicle."" [GOC:jid, GOC:tb]",82,787,13,21031,0.016518424396442185,0.15853658536585366,Module 0,"['GO:0016050', 'GO:0016192', 'GO:0061024']"
4745,TF,TF:M07140_1,Factor: Kaiso; motif: NTCTCGCGAGANYTN; match class: 1,0.021930220492889334,True,Factor: Kaiso; motif: NTCTCGCGAGANYTN; match class: 1,194,105,8,20045,0.0761904761904762,0.041237113402061855,Module 3,['TF:M07140']
4746,GO:MF,GO:0016818,"hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides",0.021961354761194648,True,"""Catalysis of the hydrolysis of any acid anhydride which contains phosphorus."" [GOC:jl]",795,808,56,20212,0.06930693069306931,0.07044025157232704,Module 0,['GO:0016817']
4747,GO:MF,GO:0016817,"hydrolase activity, acting on acid anhydrides",0.021961354761194648,True,"""Catalysis of the hydrolysis of any acid anhydride."" [GOC:jl]",795,808,56,20212,0.06930693069306931,0.07044025157232704,Module 0,['GO:0016787']
4748,GO:BP,GO:0006508,proteolysis,0.021984152270603123,True,"""The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds."" [GOC:bf, GOC:mah]",1573,215,35,21031,0.16279069767441862,0.02225047679593134,Module 2,['GO:0019538']
4749,TF,TF:M09905_1,Factor: SAP-1; motif: NNCCGGAAGTGN; match class: 1,0.02201376959348932,True,Factor: SAP-1; motif: NNCCGGAAGTGN; match class: 1,3055,105,34,20045,0.3238095238095238,0.011129296235679214,Module 3,['TF:M09905']
4750,MIRNA,MIRNA:hsa-miR-484,hsa-miR-484,0.022016987878818194,True,hsa-miR-484,891,76,15,14819,0.19736842105263158,0.016835016835016835,Module 5,['MIRNA:000000']
4751,HPA,HPA:0461441,skin 1; fibrohistiocytic cells[≥Low],0.022019439751725413,True,skin 1; fibrohistiocytic cells[≥Low],885,12,6,11019,0.5,0.006779661016949152,Module 6,['HPA:0460000']
4752,TF,TF:M11813_1,Factor: PPARdelta; motif: NRRGGTCATGACCYYT; match class: 1,0.02219227885705784,True,Factor: PPARdelta; motif: NRRGGTCATGACCYYT; match class: 1,31,5,2,20045,0.4,0.06451612903225806,Module 12,['TF:M11813']
4753,GO:BP,GO:0070434,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,0.0222031580225149,True,"""Any process that activates or increases the frequency, rate, or extent of the nucleotide-binding oligomerization domain containing 2 (NOD2) pathway."" [GOC:add]",6,21,2,21031,0.09523809523809523,0.3333333333333333,Module 9,"['GO:0070426', 'GO:0070431', 'GO:0070432']"
4754,HPA,HPA:0090901,cerebellum; Bergmann glia - cytoplasm/membrane[≥Low],0.022208455705948007,True,cerebellum; Bergmann glia - cytoplasm/membrane[≥Low],106,612,17,11019,0.027777777777777776,0.16037735849056603,Module 0,['HPA:0090000']
4755,HP,HP:0010916,Abnormal circulating alanine concentration,0.02222619869851061,True,An abnormality of an alanine metabolic process.,63,44,6,4958,0.13636363636363635,0.09523809523809523,Module 3,['HP:0010915']
4756,HP,HP:0010915,Abnormal circulating pyruvate family amino acid concentration,0.02222619869851061,True,An abnormality of a pyruvate family amino acid metabolic process.,63,44,6,4958,0.13636363636363635,0.09523809523809523,Module 3,['HP:0033108']
4757,TF,TF:M11375,Factor: Spi-B; motif: NAWGCGGAAGTN,0.02223693872741237,True,Factor: Spi-B; motif: NAWGCGGAAGTN,2641,105,31,20045,0.29523809523809524,0.011737978038621734,Module 3,['TF:M00000']
4758,TF,TF:M11428,Factor: PEA3; motif: NACCGGAAGTN,0.02226161993065471,True,Factor: PEA3; motif: NACCGGAAGTN,7327,183,96,20045,0.5245901639344263,0.01310222464856012,Module Singleton,['TF:M00000']
4759,MIRNA,MIRNA:hsa-miR-4749-3p,hsa-miR-4749-3p,0.02230980402747684,True,hsa-miR-4749-3p,67,3,2,14819,0.6666666666666666,0.029850746268656716,Module 27,['MIRNA:000000']
4760,GO:BP,GO:0035239,tube morphogenesis,0.0223217980526381,True,"""The process in which the anatomical structures of a tube are generated and organized. Epithelial and endothelial tubes transport gases, liquids and cells from one site to another and form the basic structure of many organs and tissues, with tube shape and organization varying from the single-celled excretory organ in Caenorhabditis elegans to the branching trees of the mammalian kidney and insect tracheal system."" [GOC:bf, PMID:14624839]",872,215,24,21031,0.11162790697674418,0.027522935779816515,Module 2,"['GO:0009653', 'GO:0035295']"
4761,HPA,HPA:0600222,tonsil; squamous epithelial cells[≥Medium],0.02234536167815138,True,tonsil; squamous epithelial cells[≥Medium],4949,18,16,11019,0.8888888888888888,0.0032329763588603757,Module 9,['HPA:0600221']
4762,KEGG,KEGG:04144,Endocytosis,0.02246731177413446,True,Endocytosis,248,439,27,8484,0.06150341685649203,0.10887096774193548,Module 0,['KEGG:00000']
4763,GO:BP,GO:1901342,regulation of vasculature development,0.02254020137243898,True,"""Any process that modulates the frequency, rate or extent of vasculature development."" [GOC:TermGenie]",293,215,13,21031,0.06046511627906977,0.04436860068259386,Module 2,"['GO:0001944', 'GO:2000026']"
4764,REAC,REAC:R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,0.02261577713583229,True,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,77,59,5,10842,0.0847457627118644,0.06493506493506493,Module 5,['REAC:R-HSA-174143']
4765,HP,HP:0007417,Discoid lupus rash,0.022675522548455493,True,"Cutaneous lesion that develops as a dry, scaly, red patch that evolves to an indurated and hyperpigmented plaque with adherent scale. Scarring may result in central white patches (loss of pigmentation) and skin atrophy.",37,74,6,4958,0.08108108108108109,0.16216216216216217,Module 2,['HP:0000988']
4766,HP,HP:0002529,Neuronal loss in central nervous system,0.022675522548455493,True,Neuronal loss in central nervous system,37,74,6,4958,0.08108108108108109,0.16216216216216217,Module 2,['HP:0007367']
4767,GO:BP,GO:0030098,lymphocyte differentiation,0.02268109619052782,True,"""The process in which a relatively unspecialized precursor cell acquires specialized features of a lymphocyte. A lymphocyte is a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin."" [CL:0000542, GOC:go_curators]",434,215,16,21031,0.07441860465116279,0.03686635944700461,Module 2,"['GO:0046649', 'GO:1903131']"
4768,TF,TF:M12351,Factor: TIEG1; motif: NCCCNSNCCCCGCCCCC,0.022830404802194594,True,Factor: TIEG1; motif: NCCCNSNCCCCGCCCCC,12696,826,582,20045,0.7046004842615012,0.045841209829867675,Module 0,['TF:M00000']
4769,HPA,HPA:0050000,breast,0.022856414225362203,True,breast,7185,140,112,11019,0.8,0.015588030619345859,Module Singleton,['HPA:0000000']
4770,GO:BP,GO:0002683,negative regulation of immune system process,0.02286786121384062,True,"""Any process that stops, prevents, or reduces the frequency, rate, or extent of an immune system process."" [GOC:add]",495,34,7,21031,0.20588235294117646,0.014141414141414142,Module 7,"['GO:0002376', 'GO:0002682', 'GO:0048519']"
4771,GO:BP,GO:0051304,chromosome separation,0.02286960225700155,True,"""The cell cycle process in which paired chromosomes are detached from each other. Chromosome separation begins with the release of cohesin complexes from chromosomes; in budding yeast, this includes the cleavage of cohesin complexes along the chromosome arms, followed by the separation of the centromeric regions. Chromosome separation also includes formation of chromatid axes mediated by condensins, and ends with the disentangling of inter-sister catenation catalyzed by topoisomerase II (topo II)."" [GOC:ai, GOC:lb, GOC:mah, GOC:mtg_cell_cycle, PMID:20352243]",81,77,5,21031,0.06493506493506493,0.06172839506172839,Module 5,"['GO:0007059', 'GO:0022402']"
4772,GO:BP,GO:0045727,positive regulation of translation,0.02291618983092226,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA."" [GOC:dph, GOC:go_curators, GOC:tb]",140,2,2,21031,1.0,0.014285714285714285,Module 33,"['GO:0006412', 'GO:0006417', 'GO:0010628', 'GO:0034250', 'GO:0051247']"
4773,GO:BP,GO:0045954,positive regulation of natural killer cell mediated cytotoxicity,0.022943495231303426,True,"""Any process that activates or increases the frequency, rate or extent of natural killer cell mediated cytotoxicity."" [GOC:add, ISBN:0781735149]",28,226,5,21031,0.022123893805309734,0.17857142857142858,Module 1,"['GO:0001912', 'GO:0002717', 'GO:0042267', 'GO:0042269']"
4774,TF,TF:M12238_1,Factor: DREF; motif: MTRTCGCGAYAK; match class: 1,0.023027307696207023,True,Factor: DREF; motif: MTRTCGCGAYAK; match class: 1,298,826,30,20045,0.03631961259079903,0.10067114093959731,Module 0,['TF:M12238']
4775,MIRNA,MIRNA:hsa-miR-4496,hsa-miR-4496,0.023077901005477842,True,hsa-miR-4496,118,753,18,14819,0.02390438247011952,0.15254237288135594,Module 0,['MIRNA:000000']
4776,HPA,HPA:0461461,skin 1; langerhans cells[≥Low],0.023096076281760396,True,skin 1; langerhans cells[≥Low],716,60,13,11019,0.21666666666666667,0.018156424581005588,Module 4,['HPA:0460000']
4777,HPA,HPA:0030073,appendix; lymphoid tissue[High],0.023114201622917267,True,appendix; lymphoid tissue[High],763,140,23,11019,0.16428571428571428,0.03014416775884666,Module Singleton,['HPA:0030072']
4778,TF,TF:M10578,Factor: Barhl-1; motif: NTAAACGN,0.02312329608867745,True,Factor: Barhl-1; motif: NTAAACGN,6254,826,316,20045,0.38256658595641646,0.050527662296130475,Module 0,['TF:M00000']
4779,HPA,HPA:0300201,lung; endothelial cells[≥Low],0.023134453487953118,True,lung; endothelial cells[≥Low],798,69,15,11019,0.21739130434782608,0.018796992481203006,Module 5,['HPA:0300000']
4780,TF,TF:M08568_1,Factor: ER71:E2A; motif: CASSTGNACCGGAWRYN; match class: 1,0.02322759944846198,True,Factor: ER71:E2A; motif: CASSTGNACCGGAWRYN; match class: 1,15420,826,686,20045,0.8305084745762712,0.04448767833981842,Module 0,['TF:M08568']
4781,GO:BP,GO:0043043,peptide biosynthetic process,0.02325743400907136,True,"""The chemical reactions and pathways resulting in the formation of peptides, compounds of 2 or more (but usually less than 100) amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another. This may include the translation of a precursor protein and its subsequent processing into a functional peptide."" [GOC:dph, GOC:jl]",752,172,19,21031,0.11046511627906977,0.02526595744680851,Module Singleton,"['GO:0006518', 'GO:0043604', 'GO:1901566']"
4782,GO:CC,GO:0016281,eukaryotic translation initiation factor 4F complex,0.023259974264394426,True,"""The eukaryotic translation initiation factor 4F complex is composed of eIF4E, eIF4A and eIF4G; it is involved in the recognition of the mRNA cap, ATP-dependent unwinding of the 5'-terminal secondary structure and recruitment of the mRNA to the ribosome."" [GOC:hb, PMID:32883864, PMID:8449919]",13,813,5,22097,0.006150061500615006,0.38461538461538464,Module 0,"['GO:0005737', 'GO:0034518']"
4783,GO:BP,GO:0046635,positive regulation of alpha-beta T cell activation,0.023278479516316185,True,"""Any process that activates or increases the frequency, rate or extent of alpha-beta T cell activation."" [GOC:ai]",71,15,3,21031,0.2,0.04225352112676056,Module 6,"['GO:0046631', 'GO:0046634', 'GO:0050870']"
4784,HPA,HPA:0401331,rectum; mucosal lymphoid cells[≥Low],0.023310938906198172,True,rectum; mucosal lymphoid cells[≥Low],543,12,5,11019,0.4166666666666667,0.009208103130755065,Module 6,['HPA:0400000']
4785,TF,TF:M00426,Factor: E2F; motif: TTTSGCGS,0.023336299249073926,True,Factor: E2F; motif: TTTSGCGS,12231,105,85,20045,0.8095238095238095,0.006949554410923064,Module 3,['TF:M00000']
4786,MIRNA,MIRNA:hsa-miR-100-5p,hsa-miR-100-5p,0.023361090300515096,True,hsa-miR-100-5p,250,76,8,14819,0.10526315789473684,0.032,Module 5,['MIRNA:000000']
4787,TF,TF:M11402_1,Factor: Fli-1; motif: NACCGGAARTN; match class: 1,0.023363328409917745,True,Factor: Fli-1; motif: NACCGGAARTN; match class: 1,609,826,49,20045,0.059322033898305086,0.08045977011494253,Module 0,['TF:M11402']
4788,REAC,REAC:R-HSA-2299718,Condensation of Prophase Chromosomes,0.023450380576106416,True,Condensation of Prophase Chromosomes,72,3,2,10842,0.6666666666666666,0.027777777777777776,Module 27,['REAC:R-HSA-68875']
4789,REAC,REAC:R-HSA-212300,PRC2 methylates histones and DNA,0.023450380576106416,True,PRC2 methylates histones and DNA,72,3,2,10842,0.6666666666666666,0.027777777777777776,Module 27,['REAC:R-HSA-212165']
4790,REAC,REAC:R-HSA-9710421,Defective pyroptosis,0.023450380576106416,True,Defective pyroptosis,72,3,2,10842,0.6666666666666666,0.027777777777777776,Module 27,['REAC:R-HSA-9645723']
4791,REAC,REAC:R-HSA-606279,Deposition of new CENPA-containing nucleosomes at the centromere,0.023450380576106416,True,Deposition of new CENPA-containing nucleosomes at the centromere,72,3,2,10842,0.6666666666666666,0.027777777777777776,Module 27,['REAC:R-HSA-774815']
4792,REAC,REAC:R-HSA-774815,Nucleosome assembly,0.023450380576106416,True,Nucleosome assembly,72,3,2,10842,0.6666666666666666,0.027777777777777776,Module 27,['REAC:R-HSA-73886']
4793,HP,HP:0001297,Stroke,0.023467523052822684,True,Sudden impairment of blood flow to a part of the brain due to occlusion or rupture of an artery to the brain.,175,44,9,4958,0.20454545454545456,0.05142857142857143,Module 3,['HP:0100659']
4794,GO:BP,GO:0008285,negative regulation of cell population proliferation,0.023505260706997398,True,"""Any process that stops, prevents or reduces the rate or extent of cell proliferation."" [GOC:go_curators]",701,215,21,21031,0.09767441860465116,0.029957203994293864,Module 2,"['GO:0008283', 'GO:0042127', 'GO:0048523']"
4795,REAC,REAC:R-HSA-1632852,Macroautophagy,0.023544750573209493,True,Macroautophagy,134,19,4,10842,0.21052631578947367,0.029850746268656716,Module 9,['REAC:R-HSA-9612973']
4796,GO:CC,GO:0033176,proton-transporting V-type ATPase complex,0.023717524473990226,True,"""A proton-transporting two-sector ATPase complex that couples ATP hydrolysis to the transport of protons across a concentration gradient. The resulting transmembrane electrochemical potential of H+ is used to drive a variety of (i) secondary active transport systems via H+-dependent symporters and antiporters and (ii) channel-mediated transport systems. The complex comprises a membrane sector (V0) that carries out proton transport and a cytoplasmic compartment sector (V1) that catalyzes ATP hydrolysis. V-type ATPases are found in the membranes of organelles such as vacuoles, endosomes, and lysosomes, and in the plasma membrane."" [GOC:mah, ISBN:0716743663, PMID:16449553]",29,813,7,22097,0.008610086100861008,0.2413793103448276,Module 0,['GO:0016469']
4797,HP,HP:0002087,Abnormality of the upper respiratory tract,0.023717747036784725,True,An abnormality of the upper respiratory tract.,503,71,20,4958,0.28169014084507044,0.039761431411530816,Module 1,['HP:0012252']
4798,GO:BP,GO:0072595,maintenance of protein localization in organelle,0.023718016011048594,True,"""Any process in which a protein is maintained in a specific location a specific location on or in an organelle, and is prevented from moving elsewhere. Encompasses establishment of localization in the membrane or lumen of a membrane-bounded organelle."" [GOC:mah]",42,72,4,21031,0.05555555555555555,0.09523809523809523,Module 4,"['GO:0032507', 'GO:0033365']"
4799,CORUM,CORUM:27,Arp2/3 protein complex,0.023729404848374033,True,Arp2/3 protein complex,7,50,3,3383,0.06,0.42857142857142855,Module 1,['CORUM:0000000']
4800,GO:BP,GO:0007275,multicellular organism development,0.023763470997316804,True,"""The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult)."" [GOC:dph, GOC:ems, GOC:isa_complete, GOC:tb]",4643,226,78,21031,0.34513274336283184,0.016799483092827912,Module 1,"['GO:0032501', 'GO:0048856']"
4801,HPA,HPA:0151342,duodenum; glands of Brunner[≥Medium],0.023779153672180534,True,duodenum; glands of Brunner[≥Medium],204,79,8,11019,0.10126582278481013,0.0392156862745098,Module 3,['HPA:0151341']
4802,WP,WP:WP466,DNA replication,0.023787642028792973,True,DNA replication,42,55,4,8286,0.07272727272727272,0.09523809523809523,Module 5,['WP:000000']
4803,MIRNA,MIRNA:hsa-miR-877-3p,hsa-miR-877-3p,0.023789379863074556,True,hsa-miR-877-3p,598,753,54,14819,0.07171314741035857,0.0903010033444816,Module 0,['MIRNA:000000']
4804,GO:BP,GO:0001525,angiogenesis,0.023794754689648003,True,"""Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels."" [ISBN:0878932453]",538,215,18,21031,0.08372093023255814,0.03345724907063197,Module 2,"['GO:0048514', 'GO:0048646']"
4805,HPA,HPA:0461452,skin 1; hair follicles[≥Medium],0.023795478550063254,True,skin 1; hair follicles[≥Medium],293,140,13,11019,0.09285714285714286,0.04436860068259386,Module Singleton,['HPA:0461451']
4806,TF,TF:M08487,Factor: GCMa:Erg; motif: ATGCGGGCGGAARKG,0.02382607705949133,True,Factor: GCMa:Erg; motif: ATGCGGGCGGAARKG,14303,826,644,20045,0.7796610169491526,0.04502551912186255,Module 0,['TF:M00000']
4807,HPA,HPA:0590053,thyroid gland; glandular cells[High],0.023865726687069624,True,thyroid gland; glandular cells[High],1881,69,25,11019,0.36231884057971014,0.013290802764486975,Module 5,['HPA:0590052']
4808,HPA,HPA:0641531,endometrium; stromal fibroblasts[≥Low],0.023866640593783205,True,endometrium; stromal fibroblasts[≥Low],49,166,6,11019,0.03614457831325301,0.12244897959183673,Module 2,['HPA:0640000']
4809,HPA,HPA:0640201,endometrium; endothelial cells[≥Low],0.023866640593783205,True,endometrium; endothelial cells[≥Low],49,166,6,11019,0.03614457831325301,0.12244897959183673,Module 2,['HPA:0640000']
4810,TF,TF:M08875_1,Factor: E2F; motif: NNTTTCGCGCN; match class: 1,0.02395482216422076,True,Factor: E2F; motif: NNTTTCGCGCN; match class: 1,1784,826,111,20045,0.1343825665859564,0.062219730941704035,Module 0,['TF:M08875']
4811,HPA,HPA:0030443,appendix; non-germinal center cells[High],0.023978832516613865,True,appendix; non-germinal center cells[High],105,79,6,11019,0.0759493670886076,0.05714285714285714,Module 3,['HPA:0030442']
4812,GO:BP,GO:0007154,cell communication,0.023989285721539473,True,"""Any process that mediates interactions between a cell and its surroundings. Encompasses interactions such as signaling or attachment between one cell and another cell, between a cell and an extracellular matrix, or between a cell and any other aspect of its environment."" [GOC:mah]",6537,34,23,21031,0.6764705882352942,0.0035184335322013156,Module 7,['GO:0009987']
4813,GO:MF,GO:0016864,"intramolecular oxidoreductase activity, transposing S-S bonds",0.023996118363329544,True,"""Catalysis of an oxidation-reduction (redox) reaction in which the hydrogen donor and acceptor are the same molecule, one or more sulfur-sulfur bonds in the molecule are rearranged, and no oxidized product appears."" [EC:5.3.4.-, GOC:mah]",19,72,3,20212,0.041666666666666664,0.15789473684210525,Module 4,['GO:0016860']
4814,GO:MF,GO:0003756,protein disulfide isomerase activity,0.023996118363329544,True,"""Catalysis of the rearrangement of both intrachain and interchain disulfide bonds in proteins."" [EC:5.3.4.1, GOC:vw, Wikipedia:Protein_disulfide-isomerase#Function]",19,72,3,20212,0.041666666666666664,0.15789473684210525,Module 4,"['GO:0016864', 'GO:0140096']"
4815,GO:BP,GO:0019221,cytokine-mediated signaling pathway,0.02409164375534358,True,"""The series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription."" [GOC:mah, GOC:signaling, PMID:19295629]",499,34,7,21031,0.20588235294117646,0.014028056112224449,Module 7,"['GO:0007166', 'GO:0071345']"
4816,TF,TF:M02089_1,Factor: E2F-3; motif: GGCGGGN; match class: 1,0.024102830267367363,True,Factor: E2F-3; motif: GGCGGGN; match class: 1,9682,80,58,20045,0.725,0.005990497831026648,Module 5,['TF:M02089']
4817,TF,TF:M11381,Factor: ESE-1; motif: SATKGCGGATGCN,0.02411224362442027,True,Factor: ESE-1; motif: SATKGCGGATGCN,16022,826,708,20045,0.8571428571428571,0.044189239795281485,Module 0,['TF:M00000']
4818,MIRNA,MIRNA:hsa-miR-3977,hsa-miR-3977,0.0241134854024725,True,hsa-miR-3977,76,15,3,14819,0.2,0.039473684210526314,Module 11,['MIRNA:000000']
4819,TF,TF:M11425_1,Factor: PEA3; motif: NACCGGAAGTN; match class: 1,0.024120826683534352,True,Factor: PEA3; motif: NACCGGAAGTN; match class: 1,2383,105,29,20045,0.2761904761904762,0.012169534200587495,Module 3,['TF:M11425']
4820,TF,TF:M11448_1,Factor: Elf-1; motif: NANGCGGAAGTN; match class: 1,0.024120826683534352,True,Factor: Elf-1; motif: NANGCGGAAGTN; match class: 1,2383,105,29,20045,0.2761904761904762,0.012169534200587495,Module 3,['TF:M11448']
4821,TF,TF:M11058_1,Factor: Hey1; motif: NGCRCGYGYN; match class: 1,0.024147794772759548,True,Factor: Hey1; motif: NGCRCGYGYN; match class: 1,11364,67,55,20045,0.8208955223880597,0.004839845124956001,Module 4,['TF:M11058']
4822,REAC,REAC:R-HSA-9694516,SARS-CoV-2 Infection,0.024148260149460234,True,SARS-CoV-2 Infection,292,586,33,10842,0.05631399317406143,0.11301369863013698,Module 0,['REAC:R-HSA-9679506']
4823,HPA,HPA:0151301,duodenum; enterocytes[≥Low],0.024169894262211628,True,duodenum; enterocytes[≥Low],537,79,13,11019,0.16455696202531644,0.024208566108007448,Module 3,['HPA:0150000']
4824,REAC,REAC:R-HSA-72649,Translation initiation complex formation,0.024194884953983753,True,Translation initiation complex formation,59,126,6,10842,0.047619047619047616,0.1016949152542373,Module Singleton,['REAC:R-HSA-72662']
4825,GO:BP,GO:0034142,toll-like receptor 4 signaling pathway,0.024216318151599452,True,"""The series of molecular signals initiated by a ligand binding to toll-like receptor 4."" [GOC:add, PMID:16551253, PMID:17328678]",50,215,6,21031,0.027906976744186046,0.12,Module 2,['GO:0140895']
4826,TF,TF:M02064_1,Factor: c-ets-2; motif: ACCGGAWRTN; match class: 1,0.024219078607690524,True,Factor: c-ets-2; motif: ACCGGAWRTN; match class: 1,4674,183,69,20045,0.3770491803278688,0.014762516046213094,Module Singleton,['TF:M02064']
4827,HPA,HPA:0250131,hippocampus; neuronal cells[≥Low],0.02422399435062397,True,hippocampus; neuronal cells[≥Low],6228,140,101,11019,0.7214285714285714,0.01621708413615928,Module Singleton,['HPA:0250000']
4828,GO:BP,GO:0008637,apoptotic mitochondrial changes,0.024233394494510698,True,"""The morphological and physiological alterations undergone by mitochondria during apoptosis."" [GOC:mah, GOC:mtg_apoptosis]",104,215,8,21031,0.037209302325581395,0.07692307692307693,Module 2,"['GO:0006915', 'GO:0007005']"
4829,MIRNA,MIRNA:hsa-miR-99a-5p,hsa-miR-99a-5p,0.024271248819172427,True,hsa-miR-99a-5p,132,104,7,14819,0.0673076923076923,0.05303030303030303,Module 3,['MIRNA:000000']
4830,HP,HP:0001269,Hemiparesis,0.02427201126271727,True,"Loss of strength in the arm, leg, and sometimes face on one side of the body. Hemiplegia refers to a complete loss of strength, whereas hemiparesis refers to an incomplete loss of strength.",96,44,7,4958,0.1590909090909091,0.07291666666666667,Module 3,['HP:0004374']
4831,GO:BP,GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",0.024278713075142063,True,"""The process in which an antigenically naive CD4-positive, alpha-beta T cell acquires the specialized features of an effector, regulatory, or memory T cell as part of an immune response. Effector T cells include cells which provide T cell help or exhibit cytotoxicity towards other cells."" [GOC:add, ISBN:0781735149]",75,215,7,21031,0.03255813953488372,0.09333333333333334,Module 2,"['GO:0002293', 'GO:0043367']"
4832,GO:CC,GO:0055029,nuclear DNA-directed RNA polymerase complex,0.024282822280370663,True,"""A protein complex, located in the nucleus, that possesses DNA-directed RNA polymerase activity."" [GOC:mtg_sensu]",113,813,14,22097,0.017220172201722016,0.12389380530973451,Module 0,"['GO:0000428', 'GO:0140513']"
4833,GO:BP,GO:0070665,positive regulation of leukocyte proliferation,0.02431656350108574,True,"""Any process that activates or increases the frequency, rate or extent of leukocyte proliferation."" [GOC:add, GOC:mah]",164,226,10,21031,0.04424778761061947,0.06097560975609756,Module 1,"['GO:0008284', 'GO:0070661', 'GO:0070663']"
4834,TF,TF:M00341,Factor: GABP; motif: VCCGGAAGNGCR,0.024331944349495056,True,Factor: GABP; motif: VCCGGAAGNGCR,8398,80,53,20045,0.6625,0.006311026434865444,Module 5,['TF:M00000']
4835,GO:BP,GO:0002424,T cell mediated immune response to tumor cell,0.02434845801642604,True,"""An immune response mediated by a T cell triggered in response to the presence of a tumor cell."" [GOC:add, ISBN:0781735149, PMID:16730260]",9,15,2,21031,0.13333333333333333,0.2222222222222222,Module 6,"['GO:0002418', 'GO:0002456']"
4836,GO:BP,GO:0043382,positive regulation of memory T cell differentiation,0.02434845801642604,True,"""Any process that activates or increases the frequency, rate or extent of memory T cell differentiation."" [ISBN:0781735149]",9,15,2,21031,0.13333333333333333,0.2222222222222222,Module 6,"['GO:0002699', 'GO:0043379', 'GO:0043380', 'GO:0045582', 'GO:0050778']"
4837,GO:MF,GO:0016667,"oxidoreductase activity, acting on a sulfur group of donors",0.02435127734281073,True,"""Catalysis of an oxidation-reduction (redox) reaction in which a sulfur-containing group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor."" [GOC:ai]",54,72,4,20212,0.05555555555555555,0.07407407407407407,Module 4,['GO:0016491']
4838,HP,HP:0000097,Focal segmental glomerulosclerosis,0.024363854807104735,True,Segmental accumulation of scar tissue in individual (but not all) glomeruli.,64,44,6,4958,0.13636363636363635,0.09375,Module 3,['HP:0000096']
4839,KEGG,KEGG:05417,Lipid and atherosclerosis,0.024472132076305997,True,Lipid and atherosclerosis,214,143,12,8484,0.08391608391608392,0.056074766355140186,Module 2,['KEGG:00000']
4840,GO:MF,GO:0005515,protein binding,0.024482119637346443,True,"""Binding to a protein."" [GOC:go_curators]",14838,105,94,20212,0.8952380952380953,0.0063350855910500065,Module 3,['GO:0005488']
4841,TF,TF:M12350,Factor: zbtb2; motif: NTTTCCGGTAAN,0.024487175324632637,True,Factor: zbtb2; motif: NTTTCCGGTAAN,406,105,11,20045,0.10476190476190476,0.027093596059113302,Module 3,['TF:M00000']
4842,MIRNA,MIRNA:hsa-miR-3653-3p,hsa-miR-3653-3p,0.024513101256505392,True,hsa-miR-3653-3p,128,2,2,14819,1.0,0.015625,Module 33,['MIRNA:000000']
4843,HPA,HPA:0301371,lung; alveolar cells type II[≥Low],0.024518327746830892,True,lung; alveolar cells type II[≥Low],1533,60,20,11019,0.3333333333333333,0.01304631441617743,Module 4,['HPA:0300000']
4844,HPA,HPA:0130893,colon; goblet cells[High],0.024602963250369352,True,colon; goblet cells[High],205,79,8,11019,0.10126582278481013,0.03902439024390244,Module 3,['HPA:0130892']
4845,HP,HP:0010978,Abnormality of immune system physiology,0.02465912487384549,True,A functional abnormality of the immune system.,1746,74,44,4958,0.5945945945945946,0.025200458190148912,Module 2,['HP:0002715']
4846,GO:BP,GO:0043603,amide metabolic process,0.024677360066436765,True,"""The chemical reactions and pathways involving an amide, any derivative of an oxoacid in which an acidic hydroxy group has been replaced by an amino or substituted amino group, as carried out by individual cells."" [GOC:curators]",1194,172,25,21031,0.14534883720930233,0.020938023450586266,Module Singleton,['GO:0006807']
4847,GO:BP,GO:0002833,positive regulation of response to biotic stimulus,0.02470027308961218,True,"""Any process that activates or increases the frequency, rate, or extent of a response to biotic stimulus."" [GOC:add]",369,226,15,21031,0.06637168141592921,0.04065040650406504,Module 1,"['GO:0002831', 'GO:0009607', 'GO:0048584']"
4848,HPA,HPA:0270000,kidney,0.02470890790703537,True,kidney,8237,140,123,11019,0.8785714285714286,0.014932621099915017,Module Singleton,['HPA:0000000']
4849,GO:BP,GO:0044281,small molecule metabolic process,0.0247228347466277,True,"""The chemical reactions and pathways involving small molecules, any low molecular weight, monomeric, non-encoded molecule."" [GOC:curators, GOC:pde, GOC:vw]",1813,787,103,21031,0.13087674714104194,0.0568119139547711,Module 0,['GO:0008152']
4850,HPA,HPA:0481292,small intestine; endocrine cells[≥Medium],0.02472337612400028,True,small intestine; endocrine cells[≥Medium],464,79,12,11019,0.1518987341772152,0.02586206896551724,Module 3,['HPA:0481291']
4851,GO:BP,GO:0051171,regulation of nitrogen compound metabolic process,0.024764374417497105,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving nitrogen or nitrogenous compounds."" [GOC:ai, GOC:tb]",5440,21,15,21031,0.7142857142857143,0.0027573529411764708,Module 9,"['GO:0006807', 'GO:0019222']"
4852,GO:BP,GO:0045059,positive thymic T cell selection,0.024884916086865556,True,"""The process of sparing immature T cells in the thymus which react with self-MHC protein complexes with low affinity levels from apoptotic death."" [ISBN:0781735149, PMID:12414722]",14,226,4,21031,0.017699115044247787,0.2857142857142857,Module 1,"['GO:0043368', 'GO:0045061']"
4853,TF,TF:M05901,Factor: ZNF561; motif: GATAGGGGNCGRTMGTCG,0.02494387627838268,True,Factor: ZNF561; motif: GATAGGGGNCGRTMGTCG,2,1,1,20045,1.0,0.5,Module 25,['TF:M00000']
4854,TF,TF:M13097_1,Factor: TBX3; motif: NAGGTGTGAAN; match class: 1,0.02494387627838268,True,Factor: TBX3; motif: NAGGTGTGAAN; match class: 1,2,1,1,20045,1.0,0.5,Module 23,['TF:M13097']
4855,GO:MF,GO:0046817,chemokine receptor antagonist activity,0.024987656097911017,True,"""Interacts with chemokine receptors to reduce the action of a chemokine."" [GOC:ai, ISBN:0781718325]",1,1,1,20212,1.0,1.0,Module 46,['GO:0048019']
4856,GO:MF,GO:0015191,L-methionine transmembrane transporter activity,0.024987656097911017,True,"""Enables the transfer of L-methionine from one side of a membrane to the other. L-methionine is 2-amino-4-(methylthio)butanoic acid."" [GOC:ai, GOC:mtg_transport, ISBN:0815340729]",1,1,1,20212,1.0,1.0,Module 53,"['GO:0015179', 'GO:0043865']"
4857,GO:MF,GO:0043865,methionine transmembrane transporter activity,0.024987656097911017,True,"""Enables the transfer of methionine from one side of a membrane to the other."" [GOC:jl]",1,1,1,20212,1.0,1.0,Module 53,['GO:0000099']
4858,GO:MF,GO:0031729,CCR4 chemokine receptor binding,0.024987656097911017,True,"""Binding to a CCR4 chemokine receptor."" [GOC:mah, GOC:nln]",1,1,1,20212,1.0,1.0,Module 46,['GO:0048020']
4859,TF,TF:M04826_1,Factor: p300; motif: ACNTCCG; match class: 1,0.02517004162567702,True,Factor: p300; motif: ACNTCCG; match class: 1,15605,67,65,20045,0.9701492537313433,0.004165331624479333,Module 4,['TF:M04826']
4860,GO:BP,GO:0051179,localization,0.025338387674919065,True,"""Any process in which a cell, a substance, or a cellular entity, such as a protein complex or organelle, is transported, tethered to or otherwise maintained in a specific location. In the case of substances, localization may also be achieved via selective degradation."" [GOC:ai, GOC:dos]",5520,72,36,21031,0.5,0.006521739130434782,Module 4,['GO:0008150']
4861,HPA,HPA:0380523,placenta; trophoblastic cells[High],0.02541514886735274,True,placenta; trophoblastic cells[High],1935,60,23,11019,0.38333333333333336,0.011886304909560724,Module 4,['HPA:0380522']
4862,GO:BP,GO:0043921,modulation by host of viral transcription,0.025444960308114217,True,"""Any process in which a host organism modulates the frequency, rate or extent of viral transcription."" [GOC:jl]",2,77,2,21031,0.025974025974025976,1.0,Module 5,"['GO:0043922', 'GO:0044793']"
4863,REAC,REAC:R-HSA-427389,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,0.025454909141338616,True,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,75,3,2,10842,0.6666666666666666,0.02666666666666667,Module 27,['REAC:R-HSA-5250913']
4864,GO:BP,GO:0050684,regulation of mRNA processing,0.025467597831306886,True,"""Any process that modulates the frequency, rate or extent of mRNA processing, those processes involved in the conversion of a primary mRNA transcript into a mature mRNA prior to its translation into polypeptide."" [GOC:ai]",134,172,8,21031,0.046511627906976744,0.05970149253731343,Module Singleton,"['GO:0006397', 'GO:1903311']"
4865,GO:CC,GO:0005654,nucleoplasm,0.025467693609156333,True,"""That part of the nuclear content other than the chromosomes or the nucleolus."" [GOC:ma, ISBN:0124325653]",4220,177,55,22097,0.3107344632768362,0.013033175355450236,Module Singleton,"['GO:0031981', 'GO:0110165']"
4866,REAC,REAC:R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,0.025584456707201067,True,The role of GTSE1 in G2/M progression after G2 checkpoint,79,59,5,10842,0.0847457627118644,0.06329113924050633,Module 5,['REAC:R-HSA-69275']
4867,GO:BP,GO:0033036,macromolecule localization,0.02562788634639685,True,"""Any process in which a macromolecule is transported to, or maintained in, a specific location."" [GOC:mah]",3210,172,48,21031,0.27906976744186046,0.014953271028037384,Module Singleton,['GO:0051179']
4868,REAC,REAC:R-HSA-1640170,Cell Cycle,0.02567676603126839,True,Cell Cycle,677,586,61,10842,0.10409556313993173,0.09010339734121123,Module 0,['REAC:0000000']
4869,GO:BP,GO:0055094,response to lipoprotein particle,0.025693672453487457,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipoprotein particle stimulus."" [GOC:BHF, GOC:rl]",30,215,5,21031,0.023255813953488372,0.16666666666666666,Module 2,"['GO:0009719', 'GO:0010243']"
4870,HP,HP:0011122,Abnormality of skin physiology,0.025693699018921656,True,Any abnormality of the physiological function of the skin.,558,10,7,4958,0.7,0.012544802867383513,Module 6,['HP:0000951']
4871,TF,TF:M10785,Factor: hoxa9; motif: RTCGTWANNN,0.025708351912398456,True,Factor: hoxa9; motif: RTCGTWANNN,5711,826,292,20045,0.35351089588377727,0.05112939940465768,Module 0,['TF:M00000']
4872,HPA,HPA:0310443,lymph node; non-germinal center cells[High],0.02576296255484537,True,lymph node; non-germinal center cells[High],1209,69,19,11019,0.2753623188405797,0.015715467328370553,Module 5,['HPA:0310442']
4873,GO:BP,GO:0009152,purine ribonucleotide biosynthetic process,0.025818077357430903,True,"""The chemical reactions and pathways resulting in the formation of a purine ribonucleotide, a compound consisting of ribonucleoside (a purine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:go_curators, ISBN:0198506732]",216,105,8,21031,0.0761904761904762,0.037037037037037035,Module 3,"['GO:0006164', 'GO:0009150', 'GO:0009260']"
4874,GO:BP,GO:0070371,ERK1 and ERK2 cascade,0.025833294860940183,True,"""A MAPK cascade containing at least the ERK1 or ERK2 MAP kinases. It starts with the activation of a MAP3K, and the consecutive activation of a MPK2K and of ERK1 or ERK2. The cascade can also contain an additional tier: the upstream MAP4K. The kinases in each tier phosphorylate and activate the kinase in the downstream tier. The ERK1/ERK2 cascade is activated by mitogens, growth factors, G protein-coupled receptors, and results in cellular responses such as cell proliferation, cell differentiation and development."" [PMID:20811974, PMID:23125017, PMID:28903453]",315,5,3,21031,0.6,0.009523809523809525,Module 12,['GO:0000165']
4875,TF,TF:M11683_1,Factor: IRF-8; motif: NCGAAACCGAAACYN; match class: 1,0.02583706080270635,True,Factor: IRF-8; motif: NCGAAACCGAAACYN; match class: 1,831,36,9,20045,0.25,0.010830324909747292,Module 7,['TF:M11683']
4876,TF,TF:M09636_1,Factor: MAZ; motif: GGGMGGGGSSGGGGGGGGGGGG; match class: 1,0.025840930374045657,True,Factor: MAZ; motif: GGGMGGGGSSGGGGGGGGGGGG; match class: 1,14493,826,651,20045,0.788135593220339,0.04491823638998137,Module 0,['TF:M09636']
4877,TF,TF:M11404,Factor: Fli-1; motif: NACCGGAARTN,0.025879681868533566,True,Factor: Fli-1; motif: NACCGGAARTN,8935,105,69,20045,0.6571428571428571,0.007722439843312815,Module 3,['TF:M00000']
4878,TF,TF:M11438,Factor: SAP-1; motif: NTCGTAAATGCN,0.025932719837487204,True,Factor: SAP-1; motif: NTCGTAAATGCN,5986,826,304,20045,0.36803874092009686,0.05078516538590044,Module 0,['TF:M00000']
4879,TF,TF:M10027,Factor: Pax-5; motif: SCNNGGGCARCNRAGCGWGAC,0.025936250556793102,True,Factor: Pax-5; motif: SCNNGGGCARCNRAGCGWGAC,3420,826,189,20045,0.2288135593220339,0.05526315789473684,Module 0,['TF:M00000']
4880,TF,TF:M11066,Factor: HES-7; motif: GNCACGYGNN,0.02595805182608789,True,Factor: HES-7; motif: GNCACGYGNN,11745,67,56,20045,0.835820895522388,0.00476798637718178,Module 4,['TF:M00000']
4881,WP,WP:WP236,Adipogenesis,0.025966305184329595,True,Adipogenesis,130,154,10,8286,0.06493506493506493,0.07692307692307693,Module 2,['WP:000000']
4882,GO:BP,GO:0070201,regulation of establishment of protein localization,0.025988913941167292,True,"""Any process that modulates the frequency, rate or extent of the directed movement of a protein to a specific location."" [GOC:BHF, GOC:mah]",537,72,10,21031,0.1388888888888889,0.0186219739292365,Module 4,"['GO:0032880', 'GO:0045184']"
4883,GO:BP,GO:1903557,positive regulation of tumor necrosis factor superfamily cytokine production,0.02600412005063672,True,"""Any process that activates or increases the frequency, rate or extent of tumor necrosis factor superfamily cytokine production."" [GO_REF:0000058, GOC:TermGenie, PMID:24187568]",105,215,8,21031,0.037209302325581395,0.0761904761904762,Module 2,"['GO:0001819', 'GO:0071706', 'GO:1903555']"
4884,GO:MF,GO:0019901,protein kinase binding,0.02604532908060126,True,"""Binding to a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate."" [GOC:jl]",706,808,51,20212,0.06311881188118812,0.07223796033994334,Module 0,['GO:0019900']
4885,MIRNA,MIRNA:hsa-miR-1292-3p,hsa-miR-1292-3p,0.02607532892024437,True,hsa-miR-1292-3p,132,2,2,14819,1.0,0.015151515151515152,Module 39,['MIRNA:000000']
4886,REAC,REAC:R-HSA-163685,Integration of energy metabolism,0.02608009514909049,True,Integration of energy metabolism,107,2,2,10842,1.0,0.018691588785046728,Module 22,['REAC:R-HSA-1430728']
4887,REAC,REAC:R-HSA-1236977,Endosomal/Vacuolar pathway,0.026111084509956684,True,Endosomal/Vacuolar pathway,11,14,2,10842,0.14285714285714285,0.18181818181818182,Module 6,['REAC:R-HSA-1236975']
4888,REAC,REAC:R-HSA-1221632,Meiotic synapsis,0.026141264604637414,True,Meiotic synapsis,76,3,2,10842,0.6666666666666666,0.02631578947368421,Module 27,['REAC:R-HSA-1500620']
4889,TF,TF:M08208_1,Factor: E2F-3:FOXI1; motif: NGACACCGCGCCCAC; match class: 1,0.02619004784841137,True,Factor: E2F-3:FOXI1; motif: NGACACCGCGCCCAC; match class: 1,7332,826,362,20045,0.43825665859564167,0.04937261320240044,Module 0,['TF:M08208']
4890,TF,TF:M00740_1,Factor: Rb:E2F-1:DP-1; motif: TTTSGCGC; match class: 1,0.02624766920372555,True,Factor: Rb:E2F-1:DP-1; motif: TTTSGCGC; match class: 1,4732,105,45,20045,0.42857142857142855,0.009509721048182587,Module 3,['TF:M00740']
4891,TF,TF:M01241,Factor: BEN; motif: CWGCGAYA,0.026311447542734182,True,Factor: BEN; motif: CWGCGAYA,7638,826,375,20045,0.4539951573849879,0.049096622152395915,Module 0,['TF:M00000']
4892,GO:BP,GO:0048545,response to steroid hormone,0.026404291539248937,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a steroid hormone stimulus."" [GOC:go_curators]",337,21,5,21031,0.23809523809523808,0.01483679525222552,Module 9,"['GO:0009725', 'GO:0014070', 'GO:0033993']"
4893,GO:BP,GO:0002293,alpha-beta T cell differentiation involved in immune response,0.026511919783082753,True,"""The process in which an antigenically naive alpha-beta T cell acquires the specialized features of an effector, regulatory, or memory T cell during an immune response. Effector T cells include cells which provide T cell help or exhibit cytotoxicity towards other cells."" [GOC:add, ISBN:0781735149]",76,215,7,21031,0.03255813953488372,0.09210526315789473,Module 2,"['GO:0002287', 'GO:0002292', 'GO:0046632']"
4894,GO:BP,GO:0002287,alpha-beta T cell activation involved in immune response,0.026511919783082753,True,"""The change in morphology and behavior of an alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific, leading to the initiation or perpetuation of an immune response."" [GOC:add, ISBN:0781735149]",76,215,7,21031,0.03255813953488372,0.09210526315789473,Module 2,"['GO:0002286', 'GO:0046631']"
4895,GO:BP,GO:0002437,inflammatory response to antigenic stimulus,0.026511919783082753,True,"""An inflammatory response to an antigenic stimulus, which can be include any number of T cell or B cell epitopes."" [GOC:add, ISBN:0781735149]",76,215,7,21031,0.03255813953488372,0.09210526315789473,Module 2,"['GO:0006954', 'GO:0006955']"
4896,HPA,HPA:0540000,stomach 1,0.02653248462217511,True,stomach 1,7664,140,117,11019,0.8357142857142857,0.015266179540709812,Module Singleton,['HPA:0000000']
4897,HPA,HPA:0540051,stomach 1; glandular cells[≥Low],0.02653248462217511,True,stomach 1; glandular cells[≥Low],7664,140,117,11019,0.8357142857142857,0.015266179540709812,Module Singleton,['HPA:0540000']
4898,REAC,REAC:R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,0.026537080710703705,True,Toll Like Receptor 4 (TLR4) Cascade,143,164,10,10842,0.06097560975609756,0.06993006993006994,Module 1,['REAC:R-HSA-168898']
4899,TF,TF:M09907_1,Factor: Erg; motif: NRRSAGGAAGNGG; match class: 1,0.026542055800053362,True,Factor: Erg; motif: NRRSAGGAAGNGG; match class: 1,5188,225,88,20045,0.39111111111111113,0.016962220508866616,Module 2,['TF:M09907']
4900,GO:MF,GO:0008379,thioredoxin peroxidase activity,0.026608303249600188,True,"""Catalysis of the reaction: [thioredoxin]-dithiol + hydrogen peroxide = [thioredoxin]-disulfide + H2O."" [RHEA:63528]",6,808,4,20212,0.0049504950495049506,0.6666666666666666,Module 0,['GO:0140824']
4901,GO:MF,GO:0008121,ubiquinol-cytochrome-c reductase activity,0.026608303249600188,True,"""Enables the transfer of a solute or solutes from one side of a membrane to the other according to the reaction: CoQH2 + 2 ferricytochrome c = CoQ + 2 ferrocytochrome c + 2 H+."" [RHEA:11484]",6,808,4,20212,0.0049504950495049506,0.6666666666666666,Module 0,"['GO:0009055', 'GO:0015078', 'GO:0015453', 'GO:0016679', 'GO:0022853']"
4902,GO:MF,GO:0140824,thioredoxin-dependent peroxiredoxin activity,0.026608303249600188,True,"""Catalysis of the reaction: [thioredoxin]-dithiol + a hydroperoxide = [thioredoxin]-disulfide + an alcohol + H2O."" [PMID:12707274, PMID:19820102, RHEA:62620]",6,808,4,20212,0.0049504950495049506,0.6666666666666666,Module 0,['GO:0051920']
4903,REAC,REAC:R-HSA-72662,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",0.026629790922700347,True,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",60,126,6,10842,0.047619047619047616,0.1,Module Singleton,['REAC:R-HSA-72737']
4904,HP,HP:0000544,External ophthalmoplegia,0.026664663531912467,True,Paralysis of the external ocular muscles.,65,44,6,4958,0.13636363636363635,0.09230769230769231,Module 3,['HP:0000602']
4905,KEGG,KEGG:05332,Graft-versus-host disease,0.02667227716810635,True,Graft-versus-host disease,37,136,5,8484,0.03676470588235294,0.13513513513513514,Module 1,['KEGG:00000']
4906,GO:BP,GO:0070887,cellular response to chemical stimulus,0.026731302623822062,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemical stimulus."" [GOC:mah]",2683,5,5,21031,1.0,0.0018635855385762206,Module 12,"['GO:0042221', 'GO:0051716']"
4907,TF,TF:M06027,Factor: ZNF891; motif: NNMACAAGGCAA,0.02680961703364131,True,Factor: ZNF891; motif: NNMACAAGGCAA,81,3,2,20045,0.6666666666666666,0.024691358024691357,Module 27,['TF:M00000']
4908,GO:BP,GO:2001244,positive regulation of intrinsic apoptotic signaling pathway,0.026852856291456145,True,"""Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway."" [GOC:mtg_apoptosis]",61,105,5,21031,0.047619047619047616,0.08196721311475409,Module 3,"['GO:0097193', 'GO:1902533', 'GO:2001235', 'GO:2001242']"
4909,GO:CC,GO:0048770,pigment granule,0.02685320660268673,True,"""A small, subcellular membrane-bounded vesicle containing pigment and/or pigment precursor molecules. Pigment granule biogenesis is poorly understood, as pigment granules are derived from multiple sources including the endoplasmic reticulum, coated vesicles, lysosomes, and endosomes."" [GOC:jid, GOC:mh]",111,21,3,22097,0.14285714285714285,0.02702702702702703,Module 9,['GO:0031410']
4910,GO:CC,GO:0042470,melanosome,0.02685320660268673,True,"""A tissue-specific, membrane-bounded cytoplasmic organelle within which melanin pigments are synthesized and stored. Melanosomes are synthesized in melanocyte cells."" [GOC:jl, PMID:11584301]",111,21,3,22097,0.14285714285714285,0.02702702702702703,Module 9,['GO:0048770']
4911,MIRNA,MIRNA:hsa-miR-484,hsa-miR-484,0.026904466203233036,True,hsa-miR-484,891,104,18,14819,0.17307692307692307,0.020202020202020204,Module 3,['MIRNA:000000']
4912,TF,TF:M02089,Factor: E2F-3; motif: GGCGGGN,0.027065501958813114,True,Factor: E2F-3; motif: GGCGGGN,13559,80,71,20045,0.8875,0.005236374363891142,Module 5,['TF:M00000']
4913,GO:BP,GO:0060326,cell chemotaxis,0.02707737152603211,True,"""The directed movement of a motile cell guided by a specific chemical concentration gradient. Movement may be towards a higher concentration (positive chemotaxis) or towards a lower concentration (negative chemotaxis)."" [GOC:dph]",320,5,3,21031,0.6,0.009375,Module 12,"['GO:0006935', 'GO:0016477', 'GO:0070887']"
4914,GO:BP,GO:0006882,intracellular zinc ion homeostasis,0.02713322240349106,True,"""A homeostatic process involved in the maintenance of a steady state level of zinc ions within a cell."" [GOC:ai, GOC:mah]",36,28,3,21031,0.10714285714285714,0.08333333333333333,Module 10,"['GO:0030003', 'GO:0098771']"
4915,GO:BP,GO:0071276,cellular response to cadmium ion,0.02713322240349106,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cadmium (Cd) ion stimulus."" [GOC:mah]",36,28,3,21031,0.10714285714285714,0.08333333333333333,Module 10,"['GO:0046686', 'GO:0071248']"
4916,GO:BP,GO:0046688,response to copper ion,0.02713322240349106,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus."" [GOC:ai]",36,28,3,21031,0.10714285714285714,0.08333333333333333,Module 10,['GO:0010038']
4917,REAC,REAC:R-HSA-76002,"Platelet activation, signaling and aggregation",0.0272286173456668,True,"Platelet activation, signaling and aggregation",258,173,14,10842,0.08092485549132948,0.05426356589147287,Module 2,['REAC:R-HSA-109582']
4918,GO:BP,GO:0000723,telomere maintenance,0.027275096439456668,True,"""Any process that contributes to the maintenance of proper telomeric length and structure by affecting and monitoring the activity of telomeric proteins, the length of telomeric DNA and the replication and repair of the DNA. These processes includes those that shorten, lengthen, replicate and repair the telomeric DNA sequences."" [GOC:BHF, GOC:BHF_telomere, GOC:elh, GOC:rl, PMID:11092831]",160,21,4,21031,0.19047619047619047,0.025,Module 9,"['GO:0006259', 'GO:0032200']"
4919,HPA,HPA:0170053,endometrium 2; glandular cells[High],0.027296650649187695,True,endometrium 2; glandular cells[High],1333,79,22,11019,0.27848101265822783,0.016504126031507877,Module 3,['HPA:0170052']
4920,REAC,REAC:R-HSA-380108,Chemokine receptors bind chemokines,0.027338280217815692,True,Chemokine receptors bind chemokines,57,4,2,10842,0.5,0.03508771929824561,Module 12,['REAC:R-HSA-375276']
4921,TF,TF:M00114,Factor: Tax/CREB; motif: GGGGGTTGACGYANA,0.02737253638409781,True,Factor: Tax/CREB; motif: GGGGGTTGACGYANA,6705,826,335,20045,0.40556900726392253,0.049962714392244596,Module 0,['TF:M00000']
4922,GO:CC,GO:0030496,midbody,0.027397120150154535,True,"""A thin cytoplasmic bridge formed between daughter cells at the end of cytokinesis. The midbody forms where the contractile ring constricts, and may persist for some time before finally breaking to complete cytokinesis."" [ISBN:0815316194]",206,813,20,22097,0.024600246002460024,0.0970873786407767,Module 0,['GO:0110165']
4923,GO:BP,GO:0045621,positive regulation of lymphocyte differentiation,0.02742757557899509,True,"""Any process that activates or increases the frequency, rate or extent of lymphocyte differentiation."" [GOC:go_curators]",132,226,9,21031,0.03982300884955752,0.06818181818181818,Module 1,"['GO:0030098', 'GO:0045619', 'GO:0051251', 'GO:1902107']"
4924,HP,HP:0001433,Hepatosplenomegaly,0.027429963635447616,True,Simultaneous enlargement of the liver and spleen.,164,71,11,4958,0.15492957746478872,0.06707317073170732,Module 1,"['HP:0001744', 'HP:0002240']"
4925,HPA,HPA:0401332,rectum; mucosal lymphoid cells[≥Medium],0.027526601458549252,True,rectum; mucosal lymphoid cells[≥Medium],398,79,11,11019,0.13924050632911392,0.02763819095477387,Module 3,['HPA:0401331']
4926,REAC,REAC:R-HSA-3214858,RMTs methylate histone arginines,0.027541234243225948,True,RMTs methylate histone arginines,78,3,2,10842,0.6666666666666666,0.02564102564102564,Module 27,['REAC:R-HSA-3247509']
4927,GO:BP,GO:0002183,cytoplasmic translational initiation,0.027583013033234446,True,"""The process preceding formation of the peptide bond between the first two amino acids of a protein in the cytoplasm. This includes the formation of a complex of the ribosome, mRNA or circRNA, and an initiation complex that contains the first aminoacyl-tRNA."" [GOC:hjd]",40,787,9,21031,0.011435832274459974,0.225,Module 0,"['GO:0002181', 'GO:0006413']"
4928,GO:BP,GO:1902532,negative regulation of intracellular signal transduction,0.027616685539035218,True,"""Any process that stops, prevents or reduces the frequency, rate or extent of intracellular signal transduction."" [GOC:dph, GOC:signaling, GOC:tb, GOC:TermGenie]",544,215,18,21031,0.08372093023255814,0.03308823529411765,Module 2,"['GO:0009968', 'GO:0035556', 'GO:1902531']"
4929,GO:BP,GO:1901222,regulation of non-canonical NF-kappaB signal transduction,0.027657035291562476,True,"""Any process that modulates the frequency, rate or extent of the non-canonical NF-kappaB signaling cascade."" [GOC:TermGenie]",92,34,4,21031,0.11764705882352941,0.043478260869565216,Module 7,"['GO:0038061', 'GO:1902531']"
4930,TF,TF:M08451,Factor: Elk-1:HOXA1; motif: ACCGGAAGTAATTA,0.027673170939217086,True,Factor: Elk-1:HOXA1; motif: ACCGGAAGTAATTA,8567,105,67,20045,0.638095238095238,0.007820707365472161,Module 3,['TF:M00000']
4931,MIRNA,MIRNA:hsa-miR-877-3p,hsa-miR-877-3p,0.02768821705228768,True,hsa-miR-877-3p,598,76,12,14819,0.15789473684210525,0.020066889632107024,Module 5,['MIRNA:000000']
4932,WP,WP:WP3624,Lung fibrosis,0.027696025849243192,True,Lung fibrosis,63,154,7,8286,0.045454545454545456,0.1111111111111111,Module 2,['WP:000000']
4933,GO:BP,GO:0051651,maintenance of location in cell,0.027697441957167272,True,"""Any process in which a substance or cellular entity, such as a protein complex or organelle, is maintained in a specific location within, or in the membrane of, a cell, and is prevented from moving elsewhere."" [GOC:ai]",233,72,7,21031,0.09722222222222222,0.030042918454935622,Module 4,"['GO:0009987', 'GO:0051235', 'GO:0051641']"
4934,TF,TF:M11081,Factor: SREBP-1; motif: RTCRCGTGAY,0.027704819676946244,True,Factor: SREBP-1; motif: RTCRCGTGAY,11275,826,525,20045,0.635593220338983,0.04656319290465632,Module 0,['TF:M00000']
4935,GO:CC,GO:0005788,endoplasmic reticulum lumen,0.02774851627374983,True,"""The volume enclosed by the membranes of the endoplasmic reticulum."" [ISBN:0198547684]",313,221,12,22097,0.05429864253393665,0.038338658146964855,Module 2,"['GO:0005783', 'GO:0070013']"
4936,GO:MF,GO:0043168,anion binding,0.027762049303898778,True,"""Binding to an anion, a charged atom or group of atoms with a net negative charge."" [GOC:jl]",2452,80,23,20212,0.2875,0.009380097879282219,Module 5,['GO:0043167']
4937,TF,TF:M11400,Factor: Fli-1; motif: NACCGGAARTN,0.027778976085749935,True,Factor: Fli-1; motif: NACCGGAARTN,10184,183,122,20045,0.6666666666666666,0.011979575805184604,Module Singleton,['TF:M00000']
4938,GO:BP,GO:0072359,circulatory system development,0.027806017965306955,True,"""The process whose specific outcome is the progression of the circulatory system over time, from its formation to the mature structure. The circulatory system is the organ system that passes nutrients (such as amino acids and electrolytes), gases, hormones, blood cells, etc. to and from cells in the body to help fight diseases and help stabilize body temperature and pH to maintain homeostasis."" [GOC:mah, UBERON:0001009]",1130,215,28,21031,0.13023255813953488,0.024778761061946902,Module 2,['GO:0048731']
4939,GO:BP,GO:0050670,regulation of lymphocyte proliferation,0.02780971286748812,True,"""Any process that modulates the frequency, rate or extent of lymphocyte proliferation."" [GOC:ai]",237,15,4,21031,0.26666666666666666,0.016877637130801686,Module 6,"['GO:0032944', 'GO:0046651', 'GO:0051249']"
4940,GO:BP,GO:0071347,cellular response to interleukin-1,0.02788255884161668,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus."" [GOC:mah]",106,215,8,21031,0.037209302325581395,0.07547169811320754,Module 2,"['GO:0070555', 'GO:0071345']"
4941,GO:BP,GO:0002429,immune response-activating cell surface receptor signaling pathway,0.027957931215425634,True,"""The series of molecular signals initiated by an extracellular ligand binding to a receptor on the surface of a cell, leading to the activation or perpetuation of an immune response."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",299,215,13,21031,0.06046511627906977,0.043478260869565216,Module 2,"['GO:0002757', 'GO:0002768']"
4942,GO:BP,GO:0009888,tissue development,0.028105568447450942,True,"""The process whose specific outcome is the progression of a tissue over time, from its formation to the mature structure."" [ISBN:0471245208]",2010,215,41,21031,0.19069767441860466,0.020398009950248756,Module 2,['GO:0048856']
4943,TF,TF:M00425,Factor: E2F; motif: TTTCGCGC,0.028128775170756813,True,Factor: E2F; motif: TTTCGCGC,11393,105,81,20045,0.7714285714285715,0.007109628719389098,Module 3,['TF:M00000']
4944,TF,TF:M04015_1,Factor: IRF-4; motif: NCGAAACCGAAACYA; match class: 1,0.02818934367387758,True,Factor: IRF-4; motif: NCGAAACCGAAACYA; match class: 1,171,36,5,20045,0.1388888888888889,0.029239766081871343,Module 7,['TF:M04015']
4945,GO:BP,GO:0045089,positive regulation of innate immune response,0.028269409303847654,True,"""Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection."" [GOC:ebc]",345,215,14,21031,0.06511627906976744,0.04057971014492753,Module 2,"['GO:0002833', 'GO:0031349', 'GO:0032103', 'GO:0045087', 'GO:0045088', 'GO:0050778']"
4946,GO:BP,GO:1904667,negative regulation of ubiquitin protein ligase activity,0.028293078985598106,True,"""Any process that stops, prevents or reduces the frequency, rate or extent of ubiquitin protein ligase activity."" [GO_REF:0000059, GOC:dph, GOC:tb, GOC:TermGenie, PMID:26216882]",10,105,3,21031,0.02857142857142857,0.3,Module 3,"['GO:0051444', 'GO:1904666']"
4947,REAC,REAC:R-HSA-388841,Costimulation by the CD28 family,0.02836912686171717,True,Costimulation by the CD28 family,67,164,7,10842,0.042682926829268296,0.1044776119402985,Module 1,['REAC:R-HSA-1280218']
4948,HPA,HPA:0390000,prostate,0.0284381524002358,True,prostate,6677,140,106,11019,0.7571428571428571,0.01587539314063202,Module Singleton,['HPA:0000000']
4949,HPA,HPA:0390051,prostate; glandular cells[≥Low],0.0284381524002358,True,prostate; glandular cells[≥Low],6677,140,106,11019,0.7571428571428571,0.01587539314063202,Module Singleton,['HPA:0390000']
4950,TF,TF:M10638_1,Factor: Nkx2-3; motif: NNCGTTRWS; match class: 1,0.028447882942601994,True,Factor: Nkx2-3; motif: NNCGTTRWS; match class: 1,4345,826,231,20045,0.2796610169491525,0.053164556962025315,Module 0,['TF:M10638']
4951,TF,TF:M03966,Factor: ELF1; motif: AACCCGGAAGTR,0.02854268531546603,True,Factor: ELF1; motif: AACCCGGAAGTR,6750,105,57,20045,0.5428571428571428,0.008444444444444444,Module 3,['TF:M00000']
4952,GO:BP,GO:0032729,positive regulation of type II interferon production,0.028571004446867852,True,"""Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon."" [GOC:add, GOC:mah, PMID:15546383]",76,15,3,21031,0.2,0.039473684210526314,Module 6,"['GO:0001819', 'GO:0032609', 'GO:0032649']"
4953,GO:BP,GO:0048255,mRNA stabilization,0.02861400640661735,True,"""Prevention of degradation of mRNA molecules. In the absence of compensating changes in other processes, the slowing of mRNA degradation can result in an overall increase in the population of active mRNA molecules."" [GOC:jid]",66,172,6,21031,0.03488372093023256,0.09090909090909091,Module Singleton,"['GO:0043488', 'GO:0043489', 'GO:1902373']"
4954,TF,TF:M01167,Factor: SAP-1a; motif: NACCGGAAGTV,0.028633677072443433,True,Factor: SAP-1a; motif: NACCGGAAGTV,2014,105,26,20045,0.24761904761904763,0.012909632571996028,Module 3,['TF:M00000']
4955,GO:BP,GO:0006979,response to oxidative stress,0.02865349323968565,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals."" [GOC:jl, PMID:12115731]",393,215,15,21031,0.06976744186046512,0.03816793893129771,Module 2,['GO:0006950']
4956,GO:MF,GO:0010854,adenylate cyclase regulator activity,0.02870305177750857,True,"""Binds to and modulates the activity of adenylate cyclase."" [GOC:dph, GOC:tb]",8,218,3,20212,0.013761467889908258,0.375,Module 2,['GO:0010851']
4957,TF,TF:M09913_1,Factor: ER81; motif: NNCCGGAAGYG; match class: 1,0.02871747463705538,True,Factor: ER81; motif: NNCCGGAAGYG; match class: 1,428,826,38,20045,0.04600484261501211,0.08878504672897196,Module 0,['TF:M09913']
4958,GO:MF,GO:0005102,signaling receptor binding,0.028736469995971316,True,"""Binding to one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function."" [GOC:bf, GOC:ceb, ISBN:0198506732]",1501,5,4,20212,0.8,0.002664890073284477,Module 12,['GO:0005515']
4959,HPA,HPA:0340000,ovary,0.028842948153914253,True,ovary,5429,60,44,11019,0.7333333333333333,0.008104623319211642,Module 4,['HPA:0000000']
4960,HP,HP:0000019,Urinary hesitancy,0.02884825144038054,True,Difficulty in beginning the process of urination.,4,10,2,4958,0.2,0.5,Module 6,['HP:0000009']
4961,HPA,HPA:0470182,skin 2; cells in granular layer[≥Medium],0.02890951363871248,True,skin 2; cells in granular layer[≥Medium],562,166,21,11019,0.12650602409638553,0.037366548042704624,Module 2,['HPA:0470181']
4962,HPA,HPA:0190000,esophagus,0.028923321383460453,True,esophagus,6679,140,106,11019,0.7571428571428571,0.015870639317263062,Module Singleton,['HPA:0000000']
4963,HPA,HPA:0190221,esophagus; squamous epithelial cells[≥Low],0.028923321383460453,True,esophagus; squamous epithelial cells[≥Low],6679,140,106,11019,0.7571428571428571,0.015870639317263062,Module Singleton,['HPA:0190000']
4964,TF,TF:M08224_1,Factor: Elk-1:Pax-1; motif: ACCGGAACTACGCWTSANTG; match class: 1,0.028962355317686424,True,Factor: Elk-1:Pax-1; motif: ACCGGAACTACGCWTSANTG; match class: 1,2813,105,32,20045,0.3047619047619048,0.011375755421258443,Module 3,['TF:M08224']
4965,GO:BP,GO:0002366,leukocyte activation involved in immune response,0.028964336429902506,True,"""A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response."" [GOC:add, ISBN:0781735149]",300,215,13,21031,0.06046511627906977,0.043333333333333335,Module 2,"['GO:0002263', 'GO:0045321']"
4966,HPA,HPA:0500701,soft tissue 1; peripheral nerve[≥Low],0.028984785017438286,True,soft tissue 1; peripheral nerve[≥Low],2795,69,32,11019,0.463768115942029,0.01144901610017889,Module 5,['HPA:0500000']
4967,TF,TF:M02052,Factor: EHF; motif: CSCGGAARTN,0.028995154006873133,True,Factor: EHF; motif: CSCGGAARTN,10305,183,123,20045,0.6721311475409836,0.011935953420669578,Module Singleton,['TF:M00000']
4968,HPA,HPA:0351181,pancreas; pancreatic endocrine cells[≥Low],0.029014399568291573,True,pancreas; pancreatic endocrine cells[≥Low],5628,60,45,11019,0.75,0.007995735607675906,Module 4,['HPA:0350000']
4969,GO:BP,GO:0006605,protein targeting,0.029058103313695415,True,"""The process of targeting specific proteins to particular regions of the cell, typically membrane-bounded subcellular organelles. Usually requires an organelle specific protein sequence motif."" [GOC:ma]",544,72,10,21031,0.1388888888888889,0.01838235294117647,Module 4,['GO:0045184']
4970,GO:BP,GO:0033554,cellular response to stress,0.029068800776272097,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation)."" [GOC:mah]",1770,77,19,21031,0.24675324675324675,0.010734463276836158,Module 5,"['GO:0006950', 'GO:0051716']"
4971,HPA,HPA:0460182,skin 1; cells in granular layer[≥Medium],0.029133739215830082,True,skin 1; cells in granular layer[≥Medium],558,18,6,11019,0.3333333333333333,0.010752688172043012,Module 9,['HPA:0460181']
4972,MIRNA,MIRNA:hsa-miR-1912,hsa-miR-1912,0.02917660465760206,True,hsa-miR-1912,81,15,3,14819,0.2,0.037037037037037035,Module 11,['MIRNA:000000']
4973,GO:BP,GO:0051049,regulation of transport,0.029180525368628116,True,"""Any process that modulates the frequency, rate or extent of the directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore."" [GOC:ai]",1594,215,35,21031,0.16279069767441862,0.021957340025094103,Module 2,"['GO:0006810', 'GO:0032879']"
4974,GO:BP,GO:0009394,2'-deoxyribonucleotide metabolic process,0.029182995042625844,True,"""The chemical reactions and pathways involving a 2'-deoxyribonucleotide, a compound consisting of 2'-deoxyribonucleoside (a base linked to a 2'-deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:mah]",41,77,4,21031,0.05194805194805195,0.0975609756097561,Module 5,"['GO:0009262', 'GO:0019692']"
4975,GO:BP,GO:0045637,regulation of myeloid cell differentiation,0.02919738527937082,True,"""Any process that modulates the frequency, rate or extent of myeloid cell differentiation."" [GOC:go_curators]",215,215,11,21031,0.05116279069767442,0.05116279069767442,Module 2,"['GO:0030099', 'GO:1903706']"
4976,GO:BP,GO:0034124,regulation of MyD88-dependent toll-like receptor signaling pathway,0.029211913189106757,True,"""Any process that modulates the frequency, rate, or extent of MyD88-dependent toll-like receptor signaling pathway."" [GOC:add, PMID:16551253, PMID:17328678]",4,34,2,21031,0.058823529411764705,0.5,Module 7,"['GO:0002755', 'GO:0034121']"
4977,GO:BP,GO:0051338,regulation of transferase activity,0.029219715275989714,True,"""Any process that modulates the frequency, rate or extent of transferase activity, the catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2."" [GOC:ai]",594,21,6,21031,0.2857142857142857,0.010101010101010102,Module 9,['GO:0050790']
4978,GO:BP,GO:0052547,regulation of peptidase activity,0.02922255202589992,True,"""Any process that modulates the frequency, rate or extent of peptidase activity, the hydrolysis of peptide bonds within proteins."" [GOC:ai]",244,226,12,21031,0.05309734513274336,0.04918032786885246,Module 1,"['GO:0030162', 'GO:0051336']"
4979,HPA,HPA:0310441,lymph node; non-germinal center cells[≥Low],0.029245257182034995,True,lymph node; non-germinal center cells[≥Low],6061,166,115,11019,0.6927710843373494,0.018973766705164163,Module 2,['HPA:0310000']
4980,TF,TF:M11684_1,Factor: IRF-8; motif: NYGAAACYGAAACTN; match class: 1,0.02925311315290066,True,Factor: IRF-8; motif: NYGAAACYGAAACTN; match class: 1,844,36,9,20045,0.25,0.01066350710900474,Module 7,['TF:M11684']
4981,TF,TF:M00430_1,Factor: E2F-1; motif: NTTSGCGG; match class: 1,0.02930365247140965,True,Factor: E2F-1; motif: NTTSGCGG; match class: 1,2574,826,149,20045,0.18038740920096852,0.05788655788655789,Module 0,['TF:M00430']
4982,MIRNA,MIRNA:hsa-miR-551a,hsa-miR-551a,0.029339537667574925,True,hsa-miR-551a,10,1,1,14819,1.0,0.1,Module 28,['MIRNA:000000']
4983,HP,HP:0030791,Abnormal jaw morphology,0.029347423238788497,True,"A structural anomaly of the jaw, the bony structure of the mouth that consists of the mandible and the maxilla.",1140,44,23,4958,0.5227272727272727,0.02017543859649123,Module 3,['HP:0011821']
4984,KEGG,KEGG:04623,Cytosolic DNA-sensing pathway,0.029365910510504863,True,Cytosolic DNA-sensing pathway,82,4,2,8484,0.5,0.024390243902439025,Module 12,['KEGG:00000']
4985,GO:CC,GO:0031902,late endosome membrane,0.02937456223411002,True,"""The lipid bilayer surrounding a late endosome."" [GOC:pz]",175,813,18,22097,0.02214022140221402,0.10285714285714286,Module 0,"['GO:0005770', 'GO:0010008']"
4986,HP,HP:0001872,Abnormality of thrombocytes,0.02939426973125993,True,An abnormality of platelets.,469,59,17,4958,0.288135593220339,0.03624733475479744,Module Singleton,['HP:0001871']
4987,HPA,HPA:0330222,oral mucosa; squamous epithelial cells[≥Medium],0.029503752756884796,True,oral mucosa; squamous epithelial cells[≥Medium],4358,18,15,11019,0.8333333333333334,0.0034419458467186783,Module 9,['HPA:0330221']
4988,GO:BP,GO:0045089,positive regulation of innate immune response,0.029559813613160665,True,"""Any process that activates or increases the frequency, rate or extent of the innate immune response, the organism's first line of defense against infection."" [GOC:ebc]",345,21,5,21031,0.23809523809523808,0.014492753623188406,Module 9,"['GO:0002833', 'GO:0031349', 'GO:0032103', 'GO:0045087', 'GO:0045088', 'GO:0050778']"
4989,GO:BP,GO:0051252,regulation of RNA metabolic process,0.029580612401089126,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving RNA."" [GOC:ai]",3763,787,187,21031,0.23761118170266837,0.04969439277172469,Module 0,"['GO:0016070', 'GO:0019219', 'GO:0060255']"
4990,HPA,HPA:0530721,spleen; cells in white pulp[≥Low],0.02961004846141617,True,spleen; cells in white pulp[≥Low],4339,23,18,11019,0.782608695652174,0.004148421295229315,Module 10,['HPA:0530000']
4991,GO:BP,GO:0140546,defense response to symbiont,0.029661868269779935,True,"""Reactions triggered in response to the presence of a symbiont that act to protect or prevent damage to the host."" [GOC:pg]",1113,5,4,21031,0.8,0.0035938903863432167,Module 12,['GO:0098542']
4992,GO:MF,GO:0008047,enzyme activator activity,0.029675167691247995,True,"""Binds to and increases the activity of an enzyme."" [GOC:dph, GOC:mah, GOC:tb]",585,218,18,20212,0.08256880733944955,0.03076923076923077,Module 2,"['GO:0030234', 'GO:0140677']"
4993,REAC,REAC:R-HSA-5619115,Disorders of transmembrane transporters,0.029675653918251953,True,Disorders of transmembrane transporters,173,586,23,10842,0.03924914675767918,0.1329479768786127,Module 0,['REAC:R-HSA-1643685']
4994,GO:BP,GO:0032944,regulation of mononuclear cell proliferation,0.029697825853237873,True,"""Any process that modulates the frequency, rate or extent of mononuclear cell proliferation."" [GOC:add]",241,15,4,21031,0.26666666666666666,0.016597510373443983,Module 6,"['GO:0032943', 'GO:0070663']"
4995,HP,HP:0000112,Nephropathy,0.02972126591494364,True,A nonspecific term referring to disease or damage of the kidneys.,99,44,7,4958,0.1590909090909091,0.0707070707070707,Module 3,['HP:0012211']
4996,GO:BP,GO:0072594,establishment of protein localization to organelle,0.029808955709966042,True,"""The directed movement of a protein to a specific location on or in an organelle. Encompasses establishment of localization in the membrane or lumen of a membrane-bounded organelle."" [GOC:mah]",669,72,11,21031,0.1527777777777778,0.016442451420029897,Module 4,"['GO:0033365', 'GO:0045184']"
4997,GO:CC,GO:0000438,core TFIIH complex portion of holo TFIIH complex,0.029904192946673402,True,"""The core TFIIH complex when it is part of the general transcription factor TFIIH."" [GOC:ew, GOC:krc, PMID:14500720, PMID:22308316, PMID:22572993, PMID:7813015]",3,1,1,22097,1.0,0.3333333333333333,Module 23,"['GO:0000439', 'GO:0005675']"
4998,TF,TF:M02060,Factor: Net; motif: ACCGGAARTN,0.029911557527888495,True,Factor: Net; motif: ACCGGAARTN,580,826,47,20045,0.05690072639225181,0.08103448275862069,Module 0,['TF:M00000']
4999,HPA,HPA:0050013,breast; adipocytes[High],0.029932999768630588,True,breast; adipocytes[High],310,69,9,11019,0.13043478260869565,0.02903225806451613,Module 5,['HPA:0050012']
5000,TF,TF:M03977,Factor: ETS1; motif: ACCGGAARYN,0.030032916470990486,True,Factor: ETS1; motif: ACCGGAARYN,10772,105,78,20045,0.7428571428571429,0.0072409951726698845,Module 3,['TF:M00000']
5001,TF,TF:M04010_1,Factor: HSF4; motif: TTCTAGAANNTTC; match class: 1,0.03007797682936031,True,Factor: HSF4; motif: TTCTAGAANNTTC; match class: 1,6,21,2,20045,0.09523809523809523,0.3333333333333333,Module 9,['TF:M04010']
5002,TF,TF:M00431_1,Factor: E2F-1; motif: TTTSGCGS; match class: 1,0.030157814930939525,True,Factor: E2F-1; motif: TTTSGCGS; match class: 1,2325,826,137,20045,0.16585956416464892,0.058924731182795696,Module 0,['TF:M00431']
5003,MIRNA,MIRNA:hsa-miR-1295b-5p,hsa-miR-1295b-5p,0.03026616183115578,True,hsa-miR-1295b-5p,82,15,3,14819,0.2,0.036585365853658534,Module 11,['MIRNA:000000']
5004,GO:MF,GO:0044769,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism",0.030327671704714718,True,"""Enables the transfer of ions from one side of a membrane to the other according to the reaction: ATP + H2O + ion(in) = ADP + phosphate + ion(out), by a rotational mechanism."" [GOC:jl]",25,808,7,20212,0.008663366336633664,0.28,Module 0,['GO:0042625']
5005,GO:MF,GO:0046961,"proton-transporting ATPase activity, rotational mechanism",0.030327671704714718,True,"""Enables the transfer of protons from one side of a membrane to the other according to the reaction: ATP + H2O + H+(in) -> ADP + phosphate + H+(out), by a rotational mechanism."" [RHEA:57721]",25,808,7,20212,0.008663366336633664,0.28,Module 0,"['GO:0015078', 'GO:0019829', 'GO:0044769']"
5006,GO:MF,GO:0042625,ATPase-coupled ion transmembrane transporter activity,0.030327671704714718,True,"""Enables the transfer of an ion from one side of a membrane to the other, driven by the reaction: ATP + H2O = ADP + phosphate."" [GOC:jl, GOC:mtg_transport, ISBN:0815340729]",25,808,7,20212,0.008663366336633664,0.28,Module 0,['GO:0042626']
5007,GO:BP,GO:0002361,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",0.030423030526768233,True,"""The process in which a precursor cell type acquires the specialized features of a CD4-positive, CD25-positive, alpha-beta regulatory T cell."" [GOC:add, PMID:15207821]",10,15,2,21031,0.13333333333333333,0.2,Module 6,"['GO:0043367', 'GO:0045066']"
5008,TF,TF:M01770_1,Factor: XBP-1; motif: WNNGMCACGTC; match class: 1,0.030432074686083953,True,Factor: XBP-1; motif: WNNGMCACGTC; match class: 1,4683,826,246,20045,0.29782082324455206,0.05253042921204356,Module 0,['TF:M01770']
5009,GO:BP,GO:0032970,regulation of actin filament-based process,0.03048084321626798,True,"""Any process that modulates the frequency, rate or extent of any cellular process that depends upon or alters the actin cytoskeleton."" [GOC:mah]",376,787,32,21031,0.04066073697585769,0.0851063829787234,Module 0,"['GO:0030029', 'GO:0050794']"
5010,GO:BP,GO:0002757,immune response-activating signaling pathway,0.030516118014508365,True,"""The series of molecular signals generated by a ligand binding to its receptor that lead to the activation or perpetuation of an immune response."" [GOC:add]",465,787,37,21031,0.04701397712833545,0.07956989247311828,Module 0,"['GO:0002253', 'GO:0002764']"
5011,TF,TF:M03984,Factor: ETV6; motif: CCGGAASCGGAAGTR,0.030587665254748084,True,Factor: ETV6; motif: CCGGAASCGGAAGTR,120,826,17,20045,0.020581113801452784,0.14166666666666666,Module 0,['TF:M00000']
5012,GO:BP,GO:0032392,DNA geometric change,0.030646116050751265,True,"""The process in which a transformation is induced in the geometry of a DNA double helix, resulting in a change in twist, writhe, or both, but with no change in linking number. Includes the unwinding of double-stranded DNA by helicases."" [GOC:mah]",86,77,5,21031,0.06493506493506493,0.05813953488372093,Module 5,['GO:0071103']
5013,HPA,HPA:0190222,esophagus; squamous epithelial cells[≥Medium],0.030671494650816665,True,esophagus; squamous epithelial cells[≥Medium],5058,18,16,11019,0.8888888888888888,0.0031633056544088573,Module 9,['HPA:0190221']
5014,REAC,REAC:R-HSA-5389840,Mitochondrial translation elongation,0.03067448554089827,True,Mitochondrial translation elongation,87,586,15,10842,0.025597269624573378,0.1724137931034483,Module 0,['REAC:R-HSA-5368287']
5015,GO:BP,GO:0002703,regulation of leukocyte mediated immunity,0.030676510258542487,True,"""Any process that modulates the frequency, rate, or extent of leukocyte mediated immunity."" [GOC:add]",243,15,4,21031,0.26666666666666666,0.01646090534979424,Module 6,"['GO:0002443', 'GO:0002697']"
5016,HP,HP:0003765,Psoriasiform dermatitis,0.030686185493670085,True,"A skin abnormality characterized by redness and irritation, with thick, red skin that displays flaky, silver-white patches (scales).",30,10,3,4958,0.3,0.1,Module 6,['HP:0011123']
5017,TF,TF:M08345_1,Factor: HOXB2:PEA3; motif: ACCGGAAATGRN; match class: 1,0.03070937343922737,True,Factor: HOXB2:PEA3; motif: ACCGGAAATGRN; match class: 1,2243,826,133,20045,0.16101694915254236,0.05929558626839055,Module 0,['TF:M08345']
5018,GO:BP,GO:0051641,cellular localization,0.030799379391069685,True,"""A cellular localization process whereby a substance or cellular entity, such as a protein complex or organelle, is transported to, and/or maintained in, a specific location within a cell including the localization of substances or cellular entities to the cell membrane."" [GOC:tb, GOC:vw]",3621,172,52,21031,0.3023255813953488,0.01436067384700359,Module Singleton,"['GO:0009987', 'GO:0051179']"
5019,REAC,REAC:R-HSA-512988,"Interleukin-3, Interleukin-5 and GM-CSF signaling",0.030812751261100366,True,"Interleukin-3, Interleukin-5 and GM-CSF signaling",47,164,6,10842,0.036585365853658534,0.1276595744680851,Module 1,['REAC:R-HSA-449147']
5020,GO:MF,GO:0051082,unfolded protein binding,0.03087846543450782,True,"""Binding to an unfolded protein."" [GOC:ai]",113,72,5,20212,0.06944444444444445,0.04424778761061947,Module 4,['GO:0005515']
5021,GO:BP,GO:0032879,regulation of localization,0.03088087450190385,True,"""Any process that modulates the frequency, rate or extent of any process in which a cell, a substance, or a cellular entity is transported to, or maintained in, a specific location."" [GOC:mah]",2018,215,41,21031,0.19069767441860466,0.020317145688800792,Module 2,"['GO:0050789', 'GO:0051179']"
5022,REAC,REAC:R-HSA-6783783,Interleukin-10 signaling,0.030912999441694563,True,Interleukin-10 signaling,45,173,6,10842,0.03468208092485549,0.13333333333333333,Module 2,['REAC:R-HSA-449147']
5023,TF,TF:M07226,Factor: SP1; motif: NCCCCKCCCCC,0.030942692055159177,True,Factor: SP1; motif: NCCCCKCCCCC,8528,826,412,20045,0.49878934624697335,0.04831144465290807,Module 0,['TF:M00000']
5024,REAC,REAC:R-HSA-8856688,Golgi-to-ER retrograde transport,0.030947190471738367,True,Golgi-to-ER retrograde transport,133,59,6,10842,0.1016949152542373,0.045112781954887216,Module 5,['REAC:R-HSA-6811442']
5025,GO:BP,GO:0002758,innate immune response-activating signaling pathway,0.030954696586257855,True,"""The series of molecular signals generated by a ligand binding to its receptor that lead to the activation or perpetuation of an innate immune response."" [GOC:jy, GOC:mah, PMID:11418339, PMID:28105028]",258,215,12,21031,0.05581395348837209,0.046511627906976744,Module 2,"['GO:0002218', 'GO:0002757']"
5026,GO:BP,GO:0007399,nervous system development,0.031034453036552546,True,"""The process whose specific outcome is the progression of nervous tissue over time, from its formation to its mature state."" [GOC:dgh]",2531,215,48,21031,0.22325581395348837,0.018964836033188465,Module 2,['GO:0048731']
5027,GO:BP,GO:0070887,cellular response to chemical stimulus,0.031052419742041946,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemical stimulus."" [GOC:mah]",2683,787,141,21031,0.17916137229987295,0.05255311218784942,Module 0,"['GO:0042221', 'GO:0051716']"
5028,HPA,HPA:0400893,rectum; goblet cells[High],0.031058090254058375,True,rectum; goblet cells[High],212,79,8,11019,0.10126582278481013,0.03773584905660377,Module 3,['HPA:0400892']
5029,TF,TF:M11447,Factor: Elf-1; motif: NAMCCGGAAGTN,0.031062636712502836,True,Factor: Elf-1; motif: NAMCCGGAAGTN,7902,183,101,20045,0.5519125683060109,0.012781574284991142,Module Singleton,['TF:M00000']
5030,GO:BP,GO:0070426,"positive regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway",0.03106570072843277,True,"""Any process that activates or increases the frequency, rate, or extent of a nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (NLR) pathway."" [GOC:add]",7,21,2,21031,0.09523809523809523,0.2857142857142857,Module 9,"['GO:0035872', 'GO:0062208', 'GO:0070424']"
5031,CORUM,CORUM:5268,TNF-alpha/NF-kappa B signaling complex 7,0.03109417551401032,True,TNF-alpha/NF-kappa B signaling complex 7,8,9,2,3383,0.2222222222222222,0.25,Module 9,['CORUM:0000000']
5032,CORUM,CORUM:5212,Kinase maturation complex 2,0.03109417551401032,True,Kinase maturation complex 2,8,9,2,3383,0.2222222222222222,0.25,Module 9,['CORUM:0000000']
5033,GO:BP,GO:0043086,negative regulation of catalytic activity,0.031328460158016706,True,"""Any process that stops or reduces the activity of an enzyme."" [GOC:ebc, GOC:jl, GOC:tb, GOC:vw]",396,215,15,21031,0.06976744186046512,0.03787878787878788,Module 2,"['GO:0044092', 'GO:0050790']"
5034,KEGG,KEGG:03020,RNA polymerase,0.03135871263837554,True,RNA polymerase,34,439,8,8484,0.018223234624145785,0.23529411764705882,Module 0,['KEGG:00000']
5035,GO:BP,GO:0051246,regulation of protein metabolic process,0.03141531961627645,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving a protein."" [GOC:ai]",2102,72,20,21031,0.2777777777777778,0.009514747859181731,Module 4,"['GO:0019538', 'GO:0051171', 'GO:0060255', 'GO:0080090']"
5036,HPA,HPA:0630052,cervix; glandular cells[≥Medium],0.03141790288904594,True,cervix; glandular cells[≥Medium],4036,140,73,11019,0.5214285714285715,0.01808721506442022,Module Singleton,['HPA:0630051']
5037,GO:CC,GO:0045121,membrane raft,0.03142864991652779,True,"""Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions."" [PMID:16645198, PMID:20044567]",289,238,12,22097,0.05042016806722689,0.04152249134948097,Module 1,['GO:0098857']
5038,HPA,HPA:0460181,skin 1; cells in granular layer[≥Low],0.03147173606376132,True,skin 1; cells in granular layer[≥Low],711,79,15,11019,0.189873417721519,0.02109704641350211,Module 3,['HPA:0460000']
5039,TF,TF:M12556,Factor: ETV4; motif: NCAGGAAGNN,0.03149868137579305,True,Factor: ETV4; motif: NCAGGAAGNN,10985,238,163,20045,0.6848739495798319,0.014838416021847975,Module 1,['TF:M00000']
5040,HPA,HPA:0131333,colon; mucosal lymphoid cells[High],0.03151162602805333,True,colon; mucosal lymphoid cells[High],155,166,10,11019,0.060240963855421686,0.06451612903225806,Module 2,['HPA:0131332']
5041,TF,TF:M11410,Factor: etv3; motif: NNCGGAARTGSCAYTTCCGNT,0.031552466657543125,True,Factor: etv3; motif: NNCGGAARTGSCAYTTCCGNT,1071,826,74,20045,0.08958837772397095,0.06909430438842204,Module 0,['TF:M00000']
5042,GO:BP,GO:0071345,cellular response to cytokine stimulus,0.03156244889855961,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus."" [GOC:mah]",839,172,20,21031,0.11627906976744186,0.023837902264600714,Module Singleton,"['GO:0034097', 'GO:0071310']"
5043,HPA,HPA:0150892,duodenum; goblet cells[≥Medium],0.031565901555203904,True,duodenum; goblet cells[≥Medium],336,79,10,11019,0.12658227848101267,0.02976190476190476,Module 3,['HPA:0150891']
5044,GO:BP,GO:0006508,proteolysis,0.03160951612010147,True,"""The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds."" [GOC:bf, GOC:mah]",1573,72,17,21031,0.2361111111111111,0.01080737444373808,Module 4,['GO:0019538']
5045,TF,TF:M11018_1,Factor: IRX-1; motif: NACRYNNNNNNNNRYGNN; match class: 1,0.03164038563959746,True,Factor: IRX-1; motif: NACRYNNNNNNNNRYGNN; match class: 1,16304,80,78,20045,0.975,0.0047841020608439646,Module 5,['TF:M11018']
5046,TF,TF:M02071,Factor: ETV7; motif: NCCGGAANNN,0.03164218831008549,True,Factor: ETV7; motif: NCCGGAANNN,10370,105,76,20045,0.7238095238095238,0.007328833172613307,Module 3,['TF:M00000']
5047,HPA,HPA:0050000,breast,0.031671294031651066,True,breast,7185,69,59,11019,0.855072463768116,0.008211551844119694,Module 5,['HPA:0000000']
5048,HPA,HPA:0310431,lymph node; germinal center cells[≥Low],0.0317197491539304,True,lymph node; germinal center cells[≥Low],5061,60,42,11019,0.7,0.008298755186721992,Module 4,['HPA:0310000']
5049,HPA,HPA:0360052,parathyroid gland; glandular cells[≥Medium],0.031820413686873265,True,parathyroid gland; glandular cells[≥Medium],4414,140,78,11019,0.5571428571428572,0.017671046669687357,Module Singleton,['HPA:0360051']
5050,GO:BP,GO:0001906,cell killing,0.031836118322830544,True,"""Any process in an organism that results in the killing of its own cells or those of another organism, including in some cases the death of the other organism. Killing here refers to the induction of death in one cell by another cell, not cell-autonomous death due to internal or other environmental conditions."" [GOC:add]",217,215,11,21031,0.05116279069767442,0.05069124423963134,Module 2,['GO:0009987']
5051,REAC,REAC:R-HSA-72649,Translation initiation complex formation,0.03191474886266308,True,Translation initiation complex formation,59,586,12,10842,0.020477815699658702,0.2033898305084746,Module 0,['REAC:R-HSA-72662']
5052,REAC,REAC:R-HSA-72702,Ribosomal scanning and start codon recognition,0.03191474886266308,True,Ribosomal scanning and start codon recognition,59,586,12,10842,0.020477815699658702,0.2033898305084746,Module 0,['REAC:R-HSA-72737']
5053,TF,TF:M12165,Factor: BTEB2; motif: NCCACRCCCN,0.03192858882662874,True,Factor: BTEB2; motif: NCCACRCCCN,5000,826,260,20045,0.31476997578692495,0.052,Module 0,['TF:M00000']
5054,REAC,REAC:R-HSA-1280218,Adaptive Immune System,0.03197828631710452,True,Adaptive Immune System,809,59,14,10842,0.23728813559322035,0.0173053152039555,Module 5,['REAC:R-HSA-168256']
5055,HP,HP:0000078,Abnormality of the genital system,0.03197975578350993,True,An abnormality of the genital system.,1723,44,29,4958,0.6590909090909091,0.016831108531630876,Module 3,['HP:0000119']
5056,REAC,REAC:R-HSA-9609736,Assembly and cell surface presentation of NMDA receptors,0.03204390357776982,True,Assembly and cell surface presentation of NMDA receptors,43,59,4,10842,0.06779661016949153,0.09302325581395349,Module 5,['REAC:R-HSA-442755']
5057,GO:BP,GO:0009262,deoxyribonucleotide metabolic process,0.03216556388330086,True,"""The chemical reactions and pathways involving a deoxyribonucleotide, a compound consisting of deoxyribonucleoside (a base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:go_curators, ISBN:0198506732]",42,77,4,21031,0.05194805194805195,0.09523809523809523,Module 5,"['GO:0009117', 'GO:1901135']"
5058,GO:BP,GO:0019692,deoxyribose phosphate metabolic process,0.03216556388330086,True,"""The chemical reactions and pathways involving deoxyribose phosphate, the phosphorylated sugar 2-deoxy-erythro-pentose."" [ISBN:0198506732]",42,77,4,21031,0.05194805194805195,0.09523809523809523,Module 5,"['GO:0006796', 'GO:0019637', 'GO:1901135']"
5059,GO:BP,GO:0031328,positive regulation of cellular biosynthetic process,0.03217879388023051,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of substances, carried out by individual cells."" [GOC:mah]",2685,215,50,21031,0.23255813953488372,0.0186219739292365,Module 2,"['GO:0009891', 'GO:0031325', 'GO:0031326', 'GO:0044249']"
5060,TF,TF:M10578,Factor: Barhl-1; motif: NTAAACGN,0.03221116388892086,True,Factor: Barhl-1; motif: NTAAACGN,6254,105,54,20045,0.5142857142857142,0.008634473936680525,Module 3,['TF:M00000']
5061,GO:CC,GO:0005784,Sec61 translocon complex,0.03221638725307286,True,"""A translocon complex that contains a core heterotrimer of conserved alpha, beta and gamma subunits, and may contain additional proteins (translocon-associated proteins or TRAPs); in budding yeast the core proteins are Sec61p, Sbh1p, and Sss1p. The Sec61 translocon complex functions in cotranslational and posttranslational translocation events."" [GOC:mah, PMID:18166647, PMID:32820719, PMID:33960686]",5,73,2,22097,0.0273972602739726,0.4,Module 4,['GO:0071256']
5062,TF,TF:M01104,Factor: MOVO-B; motif: GNGGGGG,0.032232794480597966,True,Factor: MOVO-B; motif: GNGGGGG,10571,80,61,20045,0.7625,0.00577050420963012,Module 5,['TF:M00000']
5063,GO:BP,GO:0034250,positive regulation of amide metabolic process,0.032254596067264156,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving amides."" [GOC:mah]",166,2,2,21031,1.0,0.012048192771084338,Module 33,"['GO:0034248', 'GO:0043603', 'GO:0051173']"
5064,GO:BP,GO:0046907,intracellular transport,0.03227149122226744,True,"""The directed movement of substances within a cell."" [GOC:ai]",1371,172,27,21031,0.1569767441860465,0.019693654266958426,Module Singleton,"['GO:0006810', 'GO:0051641', 'GO:0051649']"
5065,MIRNA,MIRNA:hsa-miR-551b-3p,hsa-miR-551b-3p,0.032273491434328554,True,hsa-miR-551b-3p,11,1,1,14819,1.0,0.09090909090909091,Module 28,['MIRNA:000000']
5066,HPA,HPA:0390052,prostate; glandular cells[≥Medium],0.032312535264705414,True,prostate; glandular cells[≥Medium],4809,79,51,11019,0.6455696202531646,0.010605115408608859,Module 3,['HPA:0390051']
5067,TF,TF:M08282,Factor: Fli-1:Prrxl1; motif: ACCGGAAGTAATTAN,0.032326170674211535,True,Factor: Fli-1:Prrxl1; motif: ACCGGAAGTAATTAN,2204,826,131,20045,0.1585956416464891,0.059437386569872956,Module 0,['TF:M00000']
5068,HPA,HPA:0060103,bronchus; respiratory epithelial cells[High],0.03241044686894392,True,bronchus; respiratory epithelial cells[High],1845,18,10,11019,0.5555555555555556,0.005420054200542005,Module 9,['HPA:0060102']
5069,GO:CC,GO:0098857,membrane microdomain,0.03247791415834082,True,"""A membrane region with a lipid composition that is distinct from that of the membrane regions that surround it."" [PMID:20044567, PMID:26253820]",290,238,12,22097,0.05042016806722689,0.041379310344827586,Module 1,['GO:0016020']
5070,REAC,REAC:R-HSA-69275,G2/M Transition,0.032512810046973394,True,G2/M Transition,195,59,7,10842,0.11864406779661017,0.035897435897435895,Module 5,['REAC:R-HSA-453274']
5071,GO:BP,GO:0042256,cytosolic ribosome assembly,0.032521220886627435,True,"""The aggregation, arrangement and bonding together of the large and small ribosomal subunits into a functional cytosolic ribosome. Distinct stages of this process take place first in the nucleolus, then in the nucleus and finally in the cytosol."" [GOC:ma, PMID:30467428]",10,787,5,21031,0.0063532401524777635,0.5,Module 0,['GO:0042255']
5072,GO:BP,GO:1904851,positive regulation of establishment of protein localization to telomere,0.032521220886627435,True,"""Any process that activates or increases the frequency, rate or extent of establishment of protein localization to telomere."" [GO_REF:0000058, GOC:BHF, GOC:BHF_telomere, GOC:nc, GOC:TermGenie, PMID:25467444]",10,787,5,21031,0.0063532401524777635,0.5,Module 0,"['GO:0070200', 'GO:0070203', 'GO:1904816', 'GO:1904951']"
5073,GO:BP,GO:0036260,RNA capping,0.032574568718167614,True,"""The sequence of enzymatic reactions by which a cap structure is added to the 5' end of nascent RNA polymerase transcripts. Examples of RNA capping include 7-methyl-G caps found on all RNA polymerase II transcripts and nucleotide-containing cofactor caps, such as NAD(H) or FAD, found on bacterial trancripts."" [GOC:bf, GOC:krc, GOC:mah, PMID:18775984, PMID:27383794, PMID:29681497, PMID:30353673]",16,787,6,21031,0.007623888182973317,0.375,Module 0,['GO:0006396']
5074,GO:BP,GO:0097401,synaptic vesicle lumen acidification,0.032574568718167614,True,"""The acidification of the synaptic vesicle lumen via transport of protons into the vesicle. The resulting electrochemical gradient powers neurotransmitter loading."" [GOC:dsf, PMID:21172605, PMID:22875945]",16,787,6,21031,0.007623888182973317,0.375,Module 0,"['GO:0016188', 'GO:0051649', 'GO:0070050', 'GO:0099504', 'GO:1902600']"
5075,TF,TF:M08874_1,Factor: E2F1; motif: NNNNNGCGSSAAAN; match class: 1,0.032584724257303854,True,Factor: E2F1; motif: NNNNNGCGSSAAAN; match class: 1,2225,826,132,20045,0.15980629539951574,0.059325842696629216,Module 0,['TF:M08874']
5076,GO:CC,GO:0005686,U2 snRNP,0.03258637118267078,True,"""A ribonucleoprotein complex that contains small nuclear RNA U2, a heptameric ring of Sm proteins, as well as several proteins that are unique to the U2 snRNP, most of which remain associated with the U2 snRNA both while the U2 snRNP is free or assembled into a series of spliceosomal complexes."" [GOC:krc, GOC:mah, ISBN:0879695897]",102,813,13,22097,0.015990159901599015,0.12745098039215685,Module 0,['GO:0097525']
5077,GO:BP,GO:0061077,chaperone-mediated protein folding,0.03260050308528104,True,"""The process of inhibiting aggregation and assisting in the covalent and noncovalent assembly of single chain polypeptides or multisubunit complexes into the correct tertiary structure that is dependent on interaction with a chaperone."" [GOC:dph, GOC:vw]",73,787,12,21031,0.015247776365946633,0.1643835616438356,Module 0,['GO:0006457']
5078,GO:BP,GO:0051604,protein maturation,0.0326038039936321,True,"""Any process leading to the attainment of the full functional capacity of a protein."" [GOC:ai]",540,787,41,21031,0.052096569250317665,0.07592592592592592,Module 0,"['GO:0010467', 'GO:0019538']"
5079,GO:BP,GO:0043123,positive regulation of canonical NF-kappaB signal transduction,0.03264306029686279,True,"""Any process that activates or increases the frequency, rate or extent of a canonical NF-kappaB signaling cascade."" [GOC:jl]",207,226,11,21031,0.048672566371681415,0.05314009661835749,Module 1,"['GO:0007249', 'GO:0043122', 'GO:1902533']"
5080,TF,TF:M11395_1,Factor: Erg; motif: NACCGGAWWTCCGGTN; match class: 1,0.032654278788382285,True,Factor: Erg; motif: NACCGGAWWTCCGGTN; match class: 1,8127,826,395,20045,0.4782082324455206,0.04860342069644395,Module 0,['TF:M11395']
5081,HPA,HPA:0350000,pancreas,0.03268448784575032,True,pancreas,7409,140,114,11019,0.8142857142857143,0.015386691861249831,Module Singleton,['HPA:0000000']
5082,GO:BP,GO:0001562,response to protozoan,0.03269078232383221,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a protozoan."" [GOC:ai]",30,226,5,21031,0.022123893805309734,0.16666666666666666,Module 1,['GO:0051707']
5083,HPA,HPA:0471463,skin 2; langerhans cells[High],0.03273882414150644,True,skin 2; langerhans cells[High],266,23,5,11019,0.21739130434782608,0.018796992481203006,Module 10,['HPA:0471462']
5084,HPA,HPA:0401302,rectum; enterocytes[≥Medium],0.032856146392616734,True,rectum; enterocytes[≥Medium],388,69,10,11019,0.14492753623188406,0.02577319587628866,Module 5,['HPA:0401301']
5085,GO:MF,GO:0051082,unfolded protein binding,0.03287333922363984,True,"""Binding to an unfolded protein."" [GOC:ai]",113,808,15,20212,0.018564356435643563,0.13274336283185842,Module 0,['GO:0005515']
5086,HPA,HPA:0320103,nasopharynx; respiratory epithelial cells[High],0.03294150231846062,True,nasopharynx; respiratory epithelial cells[High],1798,69,24,11019,0.34782608695652173,0.013348164627363738,Module 5,['HPA:0320102']
5087,HPA,HPA:0090902,cerebellum; Bergmann glia - cytoplasm/membrane[≥Medium],0.032965223390237886,True,cerebellum; Bergmann glia - cytoplasm/membrane[≥Medium],89,612,15,11019,0.024509803921568627,0.16853932584269662,Module 0,['HPA:0090901']
5088,HPA,HPA:0630000,cervix,0.0330635309323733,True,cervix,6930,60,51,11019,0.85,0.00735930735930736,Module 4,['HPA:0000000']
5089,GO:BP,GO:0071456,cellular response to hypoxia,0.03315880300127024,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level."" [GOC:mah]",142,215,9,21031,0.04186046511627907,0.06338028169014084,Module 2,"['GO:0001666', 'GO:0033554', 'GO:0036294']"
5090,WP,WP:WP5115,Network map of SARS CoV 2 signaling pathway,0.03320877832081346,True,Network map of SARS CoV 2 signaling pathway,217,13,4,8286,0.3076923076923077,0.018433179723502304,Module 6,['WP:000000']
5091,CORUM,CORUM:2686,BRCA1-core RNA polymerase II complex,0.03324110447862559,True,BRCA1-core RNA polymerase II complex,11,331,6,3383,0.01812688821752266,0.5454545454545454,Module 0,['CORUM:0000000']
5092,CORUM,CORUM:191,20S proteasome,0.03324110447862559,True,20S proteasome,11,331,6,3383,0.01812688821752266,0.5454545454545454,Module 0,['CORUM:0000000']
5093,MIRNA,MIRNA:hsa-miR-3658,hsa-miR-3658,0.03325313169958519,True,hsa-miR-3658,149,2,2,14819,1.0,0.013422818791946308,Module 33,['MIRNA:000000']
5094,GO:BP,GO:0006302,double-strand break repair,0.03331341804982311,True,"""The repair of double-strand breaks in DNA via homologous and nonhomologous mechanisms to reform a continuous DNA helix."" [GOC:elh]",309,77,8,21031,0.1038961038961039,0.025889967637540454,Module 5,['GO:0006281']
5095,GO:BP,GO:0062197,cellular response to chemical stress,0.033315746619924855,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemical stimulus indicating the organism is under stress."" [PMID:26653712]",304,215,13,21031,0.06046511627906977,0.04276315789473684,Module 2,"['GO:0033554', 'GO:0070887']"
5096,GO:BP,GO:0002263,cell activation involved in immune response,0.033315746619924855,True,"""A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an immune response."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",304,215,13,21031,0.06046511627906977,0.04276315789473684,Module 2,"['GO:0001775', 'GO:0002252', 'GO:0006955']"
5097,GO:MF,GO:0016494,C-X-C chemokine receptor activity,0.033383163723814106,True,"""Combining with a C-X-C chemokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity. A C-X-C chemokine has a single amino acid between the first two cysteines of the characteristic four cysteine motif."" [GOC:signaling, PMID:8662823]",8,232,3,20212,0.01293103448275862,0.375,Module 1,['GO:0004950']
5098,HPA,HPA:0510653,soft tissue 2; fibroblasts[High],0.03338980848817781,True,soft tissue 2; fibroblasts[High],522,612,50,11019,0.08169934640522876,0.09578544061302682,Module 0,['HPA:0510652']
5099,HP,HP:0012647,Abnormal inflammatory response,0.03345968941571319,True,"Any anomaly of the inflammatory response, a response to injury or infection characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.",1234,74,35,4958,0.47297297297297297,0.028363047001620744,Module 2,['HP:0010978']
5100,HP,HP:0012649,Increased inflammatory response,0.03345968941571319,True,A abnormal increase in the inflammatory response to injury or infection.,1234,74,35,4958,0.47297297297297297,0.028363047001620744,Module 2,['HP:0012647']
5101,REAC,REAC:R-HSA-912446,Meiotic recombination,0.033504312949117106,True,Meiotic recombination,86,3,2,10842,0.6666666666666666,0.023255813953488372,Module 27,['REAC:R-HSA-1500620']
5102,HPA,HPA:0570000,testis,0.03355541197268747,True,testis,9036,69,67,11019,0.9710144927536232,0.007414785303231518,Module 5,['HPA:0000000']
5103,GO:CC,GO:0016529,sarcoplasmic reticulum,0.03360794288345901,True,"""A fine reticular network of membrane-limited elements that pervades the sarcoplasm of a muscle cell; continuous over large portions of the cell and with the nuclear envelope; that part of the endoplasmic reticulum specialized for calcium release, uptake and storage."" [GOC:mtg_muscle, ISBN:0124325653, ISBN:0198547684]",75,73,4,22097,0.0547945205479452,0.05333333333333334,Module 4,"['GO:0005783', 'GO:0016528']"
5104,REAC,REAC:R-HSA-9609690,HCMV Early Events,0.033621506401627234,True,HCMV Early Events,135,59,6,10842,0.1016949152542373,0.044444444444444446,Module 5,['REAC:R-HSA-9609646']
5105,GO:BP,GO:0032103,positive regulation of response to external stimulus,0.033641872114960406,True,"""Any process that activates, maintains or increases the rate of a response to an external stimulus."" [GOC:mah]",609,21,6,21031,0.2857142857142857,0.009852216748768473,Module 9,"['GO:0009605', 'GO:0032101', 'GO:0048584']"
5106,TF,TF:M11437_1,Factor: SAP-1; motif: NRCCGGAWGYN; match class: 1,0.033678276515851514,True,Factor: SAP-1; motif: NRCCGGAWGYN; match class: 1,464,826,40,20045,0.048426150121065374,0.08620689655172414,Module 0,['TF:M11437']
5107,GO:BP,GO:2001242,regulation of intrinsic apoptotic signaling pathway,0.03371773740249798,True,"""Any process that modulates the frequency, rate or extent of intrinsic apoptotic signaling pathway."" [GOC:mtg_apoptosis]",182,172,9,21031,0.05232558139534884,0.04945054945054945,Module Singleton,"['GO:0097193', 'GO:1902531', 'GO:2001233']"
5108,GO:BP,GO:2001257,regulation of cation channel activity,0.033809650981910515,True,"""Any process that modulates the frequency, rate or extent of cation channel activity."" [GOC:BHF]",100,3,2,21031,0.6666666666666666,0.02,Module 22,"['GO:0032412', 'GO:1904062']"
5109,GO:BP,GO:2000403,positive regulation of lymphocyte migration,0.03381548963944538,True,"""Any process that activates or increases the frequency, rate or extent of lymphocyte migration."" [GOC:mah]",44,5,2,21031,0.4,0.045454545454545456,Module 12,"['GO:0071677', 'GO:0072676', 'GO:2000401']"
5110,KEGG,KEGG:05323,Rheumatoid arthritis,0.03381695830383387,True,Rheumatoid arthritis,88,4,2,8484,0.5,0.022727272727272728,Module 12,['KEGG:00000']
5111,GO:MF,GO:0034062,5'-3' RNA polymerase activity,0.03384454135727658,True,"""Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1); the synthesis of RNA from ribonucleotide triphosphates in the presence of a nucleic acid template, via extension of the 3'-end."" [EC:2.7.7.6, GOC:mah, GOC:pf]",34,808,8,20212,0.009900990099009901,0.23529411764705882,Module 0,['GO:0097747']
5112,GO:MF,GO:0097747,RNA polymerase activity,0.03384454135727658,True,"""Catalysis of the reaction: nucleoside triphosphate + RNA(n) = diphosphate + RNA(n+1); the synthesis of RNA from ribonucleotide triphosphates in the presence of a nucleic acid template."" [GOC:pf]",34,808,8,20212,0.009900990099009901,0.23529411764705882,Module 0,"['GO:0016779', 'GO:0140098']"
5113,HP,HP:0000763,Sensory neuropathy,0.033887838703976166,True,Peripheral neuropathy affecting the sensory nerves.,101,44,7,4958,0.1590909090909091,0.06930693069306931,Module 3,['HP:0009830']
5114,TF,TF:M06142,Factor: ZNF708; motif: GGAAAGTARA,0.03408565013294028,True,Factor: ZNF708; motif: GGAAAGTARA,166,2,2,20045,1.0,0.012048192771084338,Module 41,['TF:M00000']
5115,TF,TF:M11096,Factor: USF2; motif: NNCACGTGACN,0.034088810674229836,True,Factor: USF2; motif: NNCACGTGACN,1578,826,100,20045,0.12106537530266344,0.06337135614702155,Module 0,['TF:M00000']
5116,TF,TF:M06005,Factor: ZSCAN11; motif: NYMKAGGAAASA,0.03409268292153257,True,Factor: ZSCAN11; motif: NYMKAGGAAASA,309,5,3,20045,0.6,0.009708737864077669,Module 12,['TF:M00000']
5117,GO:MF,GO:0098772,molecular function regulator activity,0.034110800149588276,True,"""A molecular function regulator regulates the activity of its target via non-covalent binding that does not result in covalent modification to the target. Examples of molecular function regulators include regulatory subunits of multimeric enzymes and channels. Mechanisms of regulation include allosteric changes in the target and competitive inhibition."" [GOC:dos, GOC:pt]",2063,232,43,20212,0.1853448275862069,0.02084343189529811,Module 1,['GO:0003674']
5118,TF,TF:M09911,Factor: c-Ets-1; motif: NNRCMGGAAGTGG,0.03423985784722505,True,Factor: c-Ets-1; motif: NNRCMGGAAGTGG,2530,238,54,20045,0.226890756302521,0.021343873517786563,Module 1,['TF:M00000']
5119,GO:BP,GO:0002699,positive regulation of immune effector process,0.03428977993230257,True,"""Any process that activates or increases the frequency, rate, or extent of an immune effector process."" [GOC:add]",250,15,4,21031,0.26666666666666666,0.016,Module 6,"['GO:0002252', 'GO:0002684', 'GO:0002697']"
5120,TF,TF:M00678_1,Factor: Tel-2; motif: YTACTTCCTG; match class: 1,0.03434093606519773,True,Factor: Tel-2; motif: YTACTTCCTG; match class: 1,887,826,64,20045,0.0774818401937046,0.07215332581736189,Module 0,['TF:M00678']
5121,HPA,HPA:0020051,adrenal gland; glandular cells[≥Low],0.034411072683021404,True,adrenal gland; glandular cells[≥Low],7415,140,114,11019,0.8142857142857143,0.015374241402562374,Module Singleton,['HPA:0020000']
5122,TF,TF:M11432,Factor: Elk-1; motif: NACMGGAAGTN,0.034424233820402494,True,Factor: Elk-1; motif: NACMGGAAGTN,6267,105,54,20045,0.5142857142857142,0.00861656294877932,Module 3,['TF:M00000']
5123,GO:CC,GO:0045335,phagocytic vesicle,0.0344712379926496,True,"""A membrane-bounded intracellular vesicle that arises from the ingestion of particulate material by phagocytosis."" [GOC:go_curators, ISBN:0198506732]",143,221,8,22097,0.03619909502262444,0.055944055944055944,Module 2,['GO:0030139']
5124,HPA,HPA:0030442,appendix; non-germinal center cells[≥Medium],0.03447989059531042,True,appendix; non-germinal center cells[≥Medium],263,140,12,11019,0.08571428571428572,0.045627376425855515,Module Singleton,['HPA:0030441']
5125,TF,TF:M12600_1,Factor: ELF1; motif: NNNASCCGGAAGTGGNNNN; match class: 1,0.03457239379895766,True,Factor: ELF1; motif: NNNASCCGGAAGTGGNNNN; match class: 1,3262,105,35,20045,0.3333333333333333,0.01072961373390558,Module 3,['TF:M12600']
5126,REAC,REAC:R-HSA-453274,Mitotic G2-G2/M phases,0.03466572950186837,True,Mitotic G2-G2/M phases,197,59,7,10842,0.11864406779661017,0.03553299492385787,Module 5,['REAC:R-HSA-69278']
5127,GO:BP,GO:0052547,regulation of peptidase activity,0.03478047781414689,True,"""Any process that modulates the frequency, rate or extent of peptidase activity, the hydrolysis of peptide bonds within proteins."" [GOC:ai]",244,787,24,21031,0.030495552731893267,0.09836065573770492,Module 0,"['GO:0030162', 'GO:0051336']"
5128,GO:BP,GO:0006383,transcription by RNA polymerase III,0.03479746978280394,True,"""The synthesis of RNA from a DNA template by RNA polymerase III, originating at an RNAP III promoter."" [GOC:jl, GOC:txnOH, PMID:12381659]",62,787,11,21031,0.01397712833545108,0.1774193548387097,Module 0,['GO:0006351']
5129,GO:CC,GO:0062167,complement component C1q complex,0.03481784955982208,True,"""A protein-containing complex composed of six subunits of each of the three homologous polypeptide chains C1QA, C1QB, and C1QB. It is a subunit of the complement C1 complex. In addition to complement activation, C1q appears to have roles in homeostasis and cellular development, superoxide (O2-) production by neutrophils, blood coagulation and neurological synapse pruning."" [PMID:29449492]",2,221,2,22097,0.00904977375565611,1.0,Module 2,"['GO:0005576', 'GO:0032991']"
5130,GO:CC,GO:0005602,complement component C1 complex,0.03481784955982208,True,"""A protein complex composed of six subunits of C1q, each formed of the three homologous polypeptide chains C1QA, C1QB, and C1QB, and tetramer of two C1QR and two C1QS polypeptide chains."" [GOC:add, ISBN:0781735149]",2,221,2,22097,0.00904977375565611,1.0,Module 2,"['GO:0005576', 'GO:0032991']"
5131,HPA,HPA:0091072,cerebellum; white matter cells - cytoplasm/membrane[≥Medium],0.034957949572154756,True,cerebellum; white matter cells - cytoplasm/membrane[≥Medium],223,612,27,11019,0.04411764705882353,0.1210762331838565,Module 0,['HPA:0091071']
5132,GO:CC,GO:0005764,lysosome,0.034966382600328805,True,"""A small lytic vacuole that has cell cycle-independent morphology found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions."" [GOC:mah, ISBN:0198506732]",762,238,21,22097,0.08823529411764706,0.027559055118110236,Module 1,['GO:0000323']
5133,GO:CC,GO:0000323,lytic vacuole,0.034966382600328805,True,"""A vacuole that is maintained at an acidic pH and which contains degradative enzymes, including a wide variety of acid hydrolases."" [GOC:krc]",762,238,21,22097,0.08823529411764706,0.027559055118110236,Module 1,['GO:0005773']
5134,HPA,HPA:0170251,endometrium 2; cells in endometrial stroma[≥Low],0.03499937124375658,True,endometrium 2; cells in endometrial stroma[≥Low],3517,69,37,11019,0.5362318840579711,0.010520329826556724,Module 5,['HPA:0170000']
5135,REAC,REAC:R-HSA-5663220,RHO GTPases Activate Formins,0.035026061435848445,True,RHO GTPases Activate Formins,136,59,6,10842,0.1016949152542373,0.04411764705882353,Module 5,['REAC:R-HSA-195258']
5136,MIRNA,MIRNA:hsa-miR-4710,hsa-miR-4710,0.0350686935790656,True,hsa-miR-4710,153,2,2,14819,1.0,0.013071895424836602,Module 39,['MIRNA:000000']
5137,REAC,REAC:R-HSA-73884,Base Excision Repair,0.03508581466119895,True,Base Excision Repair,88,3,2,10842,0.6666666666666666,0.022727272727272728,Module 27,['REAC:R-HSA-73894']
5138,REAC,REAC:R-HSA-9616222,Transcriptional regulation of granulopoiesis,0.03508581466119895,True,Transcriptional regulation of granulopoiesis,88,3,2,10842,0.6666666666666666,0.022727272727272728,Module 27,['REAC:R-HSA-1266738']
5139,TF,TF:M00938,Factor: E2F-1; motif: TTGGCGCGRAANNGNM,0.03508823613064766,True,Factor: E2F-1; motif: TTGGCGCGRAANNGNM,7512,80,49,20045,0.6125,0.0065228966986155485,Module 5,['TF:M00000']
5140,REAC,REAC:R-HSA-9646399,Aggrephagy,0.035105734287127315,True,Aggrephagy,44,59,4,10842,0.06779661016949153,0.09090909090909091,Module 5,['REAC:R-HSA-9663891']
5141,GO:MF,GO:0003735,structural constituent of ribosome,0.03511121782276537,True,"""The action of a molecule that contributes to the structural integrity of the ribosome."" [GOC:mah]",450,6,3,20212,0.5,0.006666666666666667,Module 8,['GO:0005198']
5142,TF,TF:M12160,Factor: KLF15; motif: RCCMCRCCCMCN,0.035178492749886485,True,Factor: KLF15; motif: RCCMCRCCCMCN,13060,826,595,20045,0.7203389830508474,0.04555895865237366,Module 0,['TF:M00000']
5143,HPA,HPA:0090193,cerebellum; cells in molecular layer[High],0.03528150786712013,True,cerebellum; cells in molecular layer[High],918,3,3,11019,1.0,0.0032679738562091504,Module 27,['HPA:0090192']
5144,HPA,HPA:0461462,skin 1; langerhans cells[≥Medium],0.035332516652464147,True,skin 1; langerhans cells[≥Medium],578,18,6,11019,0.3333333333333333,0.010380622837370242,Module 9,['HPA:0461461']
5145,GO:BP,GO:0051172,negative regulation of nitrogen compound metabolic process,0.03535362874958278,True,"""Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving nitrogen or nitrogenous compounds."" [GOC:ai, GOC:tb]",2202,226,45,21031,0.19911504424778761,0.020435967302452316,Module 1,"['GO:0006807', 'GO:0009892', 'GO:0051171']"
5146,WP,WP:WP4659,Gastrin signaling pathway,0.03535569471962685,True,Gastrin signaling pathway,114,148,9,8286,0.060810810810810814,0.07894736842105263,Module 1,['WP:000000']
5147,MIRNA,MIRNA:hsa-miR-2276-3p,hsa-miR-2276-3p,0.03539146934378564,True,hsa-miR-2276-3p,156,753,21,14819,0.027888446215139442,0.1346153846153846,Module 0,['MIRNA:000000']
5148,TF,TF:M13031_1,Factor: ETV4; motif: ACCGGAAGTN; match class: 1,0.03539840466083863,True,Factor: ETV4; motif: ACCGGAAGTN; match class: 1,5008,183,72,20045,0.39344262295081966,0.01437699680511182,Module Singleton,['TF:M13031']
5149,TF,TF:M10155,Factor: ZNF547; motif: TGCTAATKCWGCARGCANRC,0.03542758086668949,True,Factor: ZNF547; motif: TGCTAATKCWGCARGCANRC,313,5,3,20045,0.6,0.009584664536741214,Module 12,['TF:M00000']
5150,GO:BP,GO:0080090,regulation of primary metabolic process,0.035429068521315,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism involving those compounds formed as a part of the normal anabolic and catabolic processes. These processes take place in most, if not all, cells of the organism."" [PMID:19211694]",5591,21,15,21031,0.7142857142857143,0.0026828832051511357,Module 9,"['GO:0019222', 'GO:0044238']"
5151,HPA,HPA:0461422,skin 1; eccrine glands[≥Medium],0.03547077943969221,True,skin 1; eccrine glands[≥Medium],187,140,10,11019,0.07142857142857142,0.053475935828877004,Module Singleton,['HPA:0461421']
5152,HPA,HPA:0470202,skin 2; endothelial cells[≥Medium],0.035511335044004264,True,skin 2; endothelial cells[≥Medium],637,79,14,11019,0.17721518987341772,0.02197802197802198,Module 3,['HPA:0470201']
5153,HPA,HPA:0360000,parathyroid gland,0.03551780378922074,True,parathyroid gland,5898,69,52,11019,0.7536231884057971,0.008816547982366904,Module 5,['HPA:0000000']
5154,HPA,HPA:0360051,parathyroid gland; glandular cells[≥Low],0.03551780378922074,True,parathyroid gland; glandular cells[≥Low],5898,69,52,11019,0.7536231884057971,0.008816547982366904,Module 5,['HPA:0360000']
5155,GO:MF,GO:0019900,kinase binding,0.03551897840557485,True,"""Binding to a kinase, any enzyme that catalyzes the transfer of a phosphate group."" [GOC:jl]",790,808,55,20212,0.06806930693069307,0.06962025316455696,Module 0,['GO:0019899']
5156,GO:BP,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,0.035709128207498636,True,"""The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class II protein complex. The peptide antigen is typically, but not always, processed from a whole protein."" [GOC:add, ISBN:0781735149, PMID:15531770, PMID:15771591]",32,215,5,21031,0.023255813953488372,0.15625,Module 2,"['GO:0002504', 'GO:0048002']"
5157,HPA,HPA:0020051,adrenal gland; glandular cells[≥Low],0.03571080999109497,True,adrenal gland; glandular cells[≥Low],7415,60,53,11019,0.8833333333333333,0.007147673634524612,Module 4,['HPA:0020000']
5158,GO:BP,GO:0070887,cellular response to chemical stimulus,0.03571770333401935,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chemical stimulus."" [GOC:mah]",2683,172,42,21031,0.2441860465116279,0.015654118524040254,Module Singleton,"['GO:0042221', 'GO:0051716']"
5159,HPA,HPA:0460201,skin 1; endothelial cells[≥Low],0.035742389082513745,True,skin 1; endothelial cells[≥Low],841,18,7,11019,0.3888888888888889,0.008323424494649227,Module 9,['HPA:0460000']
5160,TF,TF:M11381_1,Factor: ESE-1; motif: SATKGCGGATGCN; match class: 1,0.03574785513205093,True,Factor: ESE-1; motif: SATKGCGGATGCN; match class: 1,9991,105,74,20045,0.7047619047619048,0.00740666599939946,Module 3,['TF:M11381']
5161,KEGG,KEGG:00240,Pyrimidine metabolism,0.035812407218741064,True,Pyrimidine metabolism,57,53,4,8484,0.07547169811320754,0.07017543859649122,Module 5,['KEGG:00000']
5162,REAC,REAC:R-HSA-5250924,B-WICH complex positively regulates rRNA expression,0.03589016597226837,True,B-WICH complex positively regulates rRNA expression,89,3,2,10842,0.6666666666666666,0.02247191011235955,Module 27,['REAC:R-HSA-5250913']
5163,TF,TF:M01783,Factor: SP2; motif: GGGCGGGAC,0.03591701013290883,True,Factor: SP2; motif: GGGCGGGAC,9405,826,448,20045,0.5423728813559322,0.04763423710792132,Module 0,['TF:M00000']
5164,GO:CC,GO:0070161,anchoring junction,0.036037749529143015,True,"""A cell junction that mechanically attaches a cell (and its cytoskeleton) to neighboring cells or to the extracellular matrix."" [ISBN:0815332181]",905,177,19,22097,0.10734463276836158,0.020994475138121547,Module Singleton,['GO:0030054']
5165,MIRNA,MIRNA:hsa-miR-4711-3p,hsa-miR-4711-3p,0.03611472077839736,True,hsa-miR-4711-3p,87,15,3,14819,0.2,0.034482758620689655,Module 11,['MIRNA:000000']
5166,HPA,HPA:0180053,epididymis; glandular cells[High],0.03621165530250882,True,epididymis; glandular cells[High],1842,60,22,11019,0.36666666666666664,0.011943539630836048,Module 4,['HPA:0180052']
5167,REAC,REAC:R-HSA-6798695,Neutrophil degranulation,0.036306040451383664,True,Neutrophil degranulation,476,19,6,10842,0.3157894736842105,0.012605042016806723,Module 9,['REAC:R-HSA-168249']
5168,TF,TF:M11424,Factor: Erm; motif: NNSCGGAWGYN,0.036406455476947444,True,Factor: Erm; motif: NNSCGGAWGYN,8353,183,105,20045,0.5737704918032787,0.012570334011732312,Module Singleton,['TF:M00000']
5169,HP,HP:0002715,Abnormality of the immune system,0.03642117743057141,True,An abnormality of the immune system.,2064,71,47,4958,0.6619718309859155,0.022771317829457363,Module 1,['HP:0000118']
5170,HPA,HPA:0030071,appendix; lymphoid tissue[≥Low],0.036492684037222244,True,appendix; lymphoid tissue[≥Low],4734,69,45,11019,0.6521739130434783,0.009505703422053232,Module 5,['HPA:0030000']
5171,REAC,REAC:R-HSA-9679191,Potential therapeutics for SARS,0.03649385989390227,True,Potential therapeutics for SARS,150,19,4,10842,0.21052631578947367,0.02666666666666667,Module 9,['REAC:R-HSA-9679506']
5172,GO:BP,GO:0051090,regulation of DNA-binding transcription factor activity,0.03649710993457643,True,"""Any process that modulates the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription."" [GOC:ai]",353,215,14,21031,0.06511627906976744,0.039660056657223795,Module 2,"['GO:0006355', 'GO:0065009']"
5173,TF,TF:M03975,Factor: ERG; motif: ACCGGAARTN,0.03651091440745201,True,Factor: ERG; motif: ACCGGAARTN,10198,105,75,20045,0.7142857142857143,0.007354383212394587,Module 3,['TF:M00000']
5174,REAC,REAC:R-HSA-69306,DNA Replication,0.03651550121254463,True,DNA Replication,187,586,24,10842,0.040955631399317405,0.12834224598930483,Module 0,['REAC:0000000']
5175,HPA,HPA:0020000,adrenal gland,0.0365345994364338,True,adrenal gland,7422,140,114,11019,0.8142857142857143,0.015359741309620048,Module Singleton,['HPA:0000000']
5176,GO:CC,GO:0005775,vacuolar lumen,0.03657022259985934,True,"""The volume enclosed within the vacuolar membrane."" [ISBN:0198506732]",178,813,18,22097,0.02214022140221402,0.10112359550561797,Module 0,"['GO:0005773', 'GO:0070013']"
5177,GO:BP,GO:1902106,negative regulation of leukocyte differentiation,0.036580414579141025,True,"""Any process that stops, prevents or reduces the frequency, rate or extent of leukocyte differentiation."" [GOC:add, GOC:TermGenie]",110,215,8,21031,0.037209302325581395,0.07272727272727272,Module 2,"['GO:0002521', 'GO:1902105', 'GO:1903707']"
5178,GO:BP,GO:0032652,regulation of interleukin-1 production,0.036580414579141025,True,"""Any process that modulates the frequency, rate, or extent of interleukin-1 production."" [GOC:mah]",110,215,8,21031,0.037209302325581395,0.07272727272727272,Module 2,"['GO:0001817', 'GO:0032612']"
5179,GO:BP,GO:0032612,interleukin-1 production,0.036580414579141025,True,"""The appearance of interleukin-1 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels."" [GOC:mah]",110,215,8,21031,0.037209302325581395,0.07272727272727272,Module 2,['GO:0001816']
5180,GO:CC,GO:0101031,protein folding chaperone complex,0.03660805438229485,True,"""A protein complex required for the non-covalent folding or unfolding, maturation, stabilization or assembly or disassembly of macromolecular structures. Usually active during or immediately after completion of translation. Many chaperone complexes contain heat shock proteins."" [GOC:bhm, PMID:21855797]",41,813,8,22097,0.00984009840098401,0.1951219512195122,Module 0,['GO:0140535']
5181,HP,HP:0003128,Lactic acidosis,0.0366768051567667,True,"An abnormal buildup of lactic acid in the body, leading to acidification of the blood and other bodily fluids.",185,44,9,4958,0.20454545454545456,0.04864864864864865,Module 3,['HP:0001941']
5182,REAC,REAC:R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,0.036703581986614206,True,Formation of the beta-catenin:TCF transactivating complex,90,3,2,10842,0.6666666666666666,0.022222222222222223,Module 27,['REAC:R-HSA-201681']
5183,REAC,REAC:R-HSA-73772,RNA Polymerase I Promoter Escape,0.036703581986614206,True,RNA Polymerase I Promoter Escape,90,3,2,10842,0.6666666666666666,0.022222222222222223,Module 27,['REAC:R-HSA-73854']
5184,GO:MF,GO:0046933,"proton-transporting ATP synthase activity, rotational mechanism",0.03672373853711252,True,"""Enables the synthesis of ATP from ADP and phosphate by the transfer of protons from one side of a membrane to the other by a rotational mechanism driven by a gradient according to the reaction: ADP + H2O + phosphate + H+(in) -> ATP + H+(out)."" [RHEA:57722]",18,808,6,20212,0.007425742574257425,0.3333333333333333,Module 0,"['GO:0015252', 'GO:0016874']"
5185,MIRNA,MIRNA:hsa-miR-324-5p,hsa-miR-324-5p,0.03673725043869797,True,hsa-miR-324-5p,295,753,32,14819,0.04249667994687915,0.10847457627118644,Module 0,['MIRNA:000000']
5186,GO:MF,GO:0044183,protein folding chaperone,0.03694772065472147,True,"""Binding to a protein or a protein-containing complex to assist the protein folding process."" [GOC:mtg_cambridge_2009]",60,72,4,20212,0.05555555555555555,0.06666666666666667,Module 4,['GO:0003674']
5187,GO:MF,GO:0016675,"oxidoreductase activity, acting on a heme group of donors",0.03702080494204177,True,"""Catalysis of an oxidation-reduction (redox) reaction in which a heme group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor."" [GOC:ai]",15,105,3,20212,0.02857142857142857,0.2,Module 3,['GO:0016491']
5188,GO:MF,GO:0004129,cytochrome-c oxidase activity,0.03702080494204177,True,"""Catalysis of the reaction: 4 ferrocytochrome c + O2 + 4 H+ = 4 ferricytochrome c + 2 H2O."" [RHEA:11436]",15,105,3,20212,0.02857142857142857,0.2,Module 3,"['GO:0009055', 'GO:0015078', 'GO:0015453', 'GO:0016675', 'GO:0022853']"
5189,HPA,HPA:0020000,adrenal gland,0.03707480605134047,True,adrenal gland,7422,60,53,11019,0.8833333333333333,0.0071409323632444085,Module 4,['HPA:0000000']
5190,TF,TF:M02044,Factor: YY1; motif: GCCGCCATTTTG,0.03715477967657066,True,Factor: YY1; motif: GCCGCCATTTTG,6282,105,54,20045,0.5142857142857142,0.008595988538681949,Module 3,['TF:M00000']
5191,GO:CC,GO:0034774,secretory granule lumen,0.03717242239788243,True,"""The volume enclosed by the membrane of a secretory granule."" [GOC:rph]",320,21,4,22097,0.19047619047619047,0.0125,Module 9,"['GO:0030141', 'GO:0060205']"
5192,HPA,HPA:0570783,testis; preleptotene spermatocytes[High],0.03718456826424511,True,testis; preleptotene spermatocytes[High],751,612,66,11019,0.10784313725490197,0.08788282290279627,Module 0,['HPA:0570782']
5193,GO:BP,GO:0030522,intracellular receptor signaling pathway,0.03724139384184638,True,"""The series of molecular signals initiated by a ligand binding to a receptor located within a cell."" [GOC:bf, GOC:mah]",362,21,5,21031,0.23809523809523808,0.013812154696132596,Module 9,['GO:0007165']
5194,TF,TF:M09817_1,Factor: PAX5; motif: RNGCGTGACCNN; match class: 1,0.03734666500474901,True,Factor: PAX5; motif: RNGCGTGACCNN; match class: 1,6310,826,317,20045,0.3837772397094431,0.05023771790808241,Module 0,['TF:M09817']
5195,TF,TF:M10999_1,Factor: LIM-1; motif: NNCGTTAN; match class: 1,0.03737820686614635,True,Factor: LIM-1; motif: NNCGTTAN; match class: 1,1287,826,85,20045,0.10290556900726393,0.06604506604506605,Module 0,['TF:M10999']
5196,TF,TF:M11414,Factor: GABP-alpha; motif: NACCGGAAGTN,0.03738016174143711,True,Factor: GABP-alpha; motif: NACCGGAAGTN,2988,105,33,20045,0.3142857142857143,0.01104417670682731,Module 3,['TF:M00000']
5197,GO:BP,GO:0033554,cellular response to stress,0.03744333907288193,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation)."" [GOC:mah]",1770,21,9,21031,0.42857142857142855,0.005084745762711864,Module 9,"['GO:0006950', 'GO:0051716']"
5198,CORUM,CORUM:5266,TNF-alpha/NF-kappa B signaling complex 6,0.037558118234088646,True,TNF-alpha/NF-kappa B signaling complex 6,13,83,4,3383,0.04819277108433735,0.3076923076923077,Module 3,['CORUM:0000000']
5199,GO:CC,GO:0071682,endocytic vesicle lumen,0.03759229588375837,True,"""The volume enclosed by the membrane of an endocytic vesicle."" [GOC:pde]",23,21,2,22097,0.09523809523809523,0.08695652173913043,Module 9,"['GO:0030139', 'GO:0070013']"
5200,REAC,REAC:R-HSA-5696398,Nucleotide Excision Repair,0.037684214034458804,True,Nucleotide Excision Repair,109,586,17,10842,0.02901023890784983,0.1559633027522936,Module 0,['REAC:R-HSA-73894']
5201,HP,HP:0000630,Abnormal retinal artery morphology,0.03768893677332243,True,Abnormal retinal artery morphology,69,44,6,4958,0.13636363636363635,0.08695652173913043,Module 3,"['HP:0008046', 'HP:0011004', 'HP:3000036']"
5202,GO:MF,GO:0042287,MHC protein binding,0.03770429134711046,True,"""Binding to a major histocompatibility complex molecule; a set of molecules displayed on cell surfaces that are responsible for lymphocyte recognition and antigen presentation."" [GOC:jl]",40,232,5,20212,0.021551724137931036,0.125,Module 1,['GO:0005102']
5203,MIRNA,MIRNA:hsa-miR-6781-5p,hsa-miR-6781-5p,0.037713999445927536,True,hsa-miR-6781-5p,87,3,2,14819,0.6666666666666666,0.022988505747126436,Module 27,['MIRNA:000000']
5204,HPA,HPA:0630000,cervix,0.0379039314452463,True,cervix,6930,18,18,11019,1.0,0.0025974025974025974,Module 9,['HPA:0000000']
5205,REAC,REAC:R-HSA-72662,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",0.037966861905032095,True,"Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S",60,586,12,10842,0.020477815699658702,0.2,Module 0,['REAC:R-HSA-72737']
5206,TF,TF:M04698,Factor: GABP-alpha; motif: CACTTCCGG,0.038019694405475694,True,Factor: GABP-alpha; motif: CACTTCCGG,3276,105,35,20045,0.3333333333333333,0.010683760683760684,Module 3,['TF:M00000']
5207,GO:BP,GO:0051052,regulation of DNA metabolic process,0.038052133326377274,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving DNA."" [GOC:ai]",521,77,10,21031,0.12987012987012986,0.019193857965451054,Module 5,"['GO:0006259', 'GO:0019219', 'GO:0060255']"
5208,GO:BP,GO:0051173,positive regulation of nitrogen compound metabolic process,0.03812404214230149,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving nitrogen or nitrogenous compounds."" [GOC:ai, GOC:tb]",3001,226,56,21031,0.24778761061946902,0.01866044651782739,Module 1,"['GO:0006807', 'GO:0009893', 'GO:0051171']"
5209,HPA,HPA:0600000,tonsil,0.03817182728647551,True,tonsil,7788,166,138,11019,0.8313253012048193,0.017719568567026195,Module 2,['HPA:0000000']
5210,MIRNA,MIRNA:hsa-miR-324-3p,hsa-miR-324-3p,0.038177660552208614,True,hsa-miR-324-3p,336,753,35,14819,0.04648074369189907,0.10416666666666667,Module 0,['MIRNA:000000']
5211,WP,WP:WP3888,VEGFA VEGFR2 signaling,0.03833804140414971,True,VEGFA VEGFR2 signaling,430,43,9,8286,0.20930232558139536,0.020930232558139535,Module 4,['WP:000000']
5212,HPA,HPA:0290000,liver,0.03834687052431532,True,liver,6298,60,48,11019,0.8,0.007621467132422992,Module 4,['HPA:0000000']
5213,GO:CC,GO:0032587,ruffle membrane,0.038356308858517506,True,"""The portion of the plasma membrane surrounding a ruffle."" [GOC:mah]",100,105,5,22097,0.047619047619047616,0.05,Module 3,"['GO:0001726', 'GO:0031253', 'GO:0031256']"
5214,REAC,REAC:R-HSA-1912408,Pre-NOTCH Transcription and Translation,0.03835760132490818,True,Pre-NOTCH Transcription and Translation,92,3,2,10842,0.6666666666666666,0.021739130434782608,Module 27,['REAC:R-HSA-1912422']
5215,REAC,REAC:R-HSA-8955332,Carboxyterminal post-translational modifications of tubulin,0.038374864707999376,True,Carboxyterminal post-translational modifications of tubulin,45,59,4,10842,0.06779661016949153,0.08888888888888889,Module 5,['REAC:R-HSA-597592']
5216,HPA,HPA:0060000,bronchus,0.03845295760306498,True,bronchus,7428,140,114,11019,0.8142857142857143,0.015347334410339256,Module Singleton,['HPA:0000000']
5217,TF,TF:M08418_1,Factor: TEF-3:Elk-1; motif: RMATWCCGGAWGT; match class: 1,0.03847882727188114,True,Factor: TEF-3:Elk-1; motif: RMATWCCGGAWGT; match class: 1,5351,826,275,20045,0.33292978208232443,0.05139226312838722,Module 0,['TF:M08418']
5218,GO:CC,GO:0060205,cytoplasmic vesicle lumen,0.03852140430809111,True,"""The volume enclosed by a cytoplasmic vesicle."" [GOC:dph, GOC:vesicles]",323,21,4,22097,0.19047619047619047,0.01238390092879257,Module 9,"['GO:0031410', 'GO:0031983', 'GO:0070013']"
5219,HP,HP:0002151,Increased serum lactate,0.0385443781937831,True,Abnormally increased level of blood lactate (2-hydroxypropanoic acid). Lactate is produced from pyruvate by lactate dehydrogenase during normal metabolism. The terms lactate and lactic acid are often used interchangeably but lactate (the component measured in blood) is strictly a weak base whereas lactic acid is the corresponding acid. Lactic acidosis is often used clinically to describe elevated lactate but should be reserved for cases where there is a corresponding acidosis (pH below 7.35).,207,228,24,4958,0.10526315789473684,0.11594202898550725,Module 0,['HP:0001941']
5220,HPA,HPA:0180000,epididymis,0.03860546933205384,True,epididymis,7337,140,113,11019,0.8071428571428572,0.015401390213983917,Module Singleton,['HPA:0000000']
5221,HPA,HPA:0180051,epididymis; glandular cells[≥Low],0.03860546933205384,True,epididymis; glandular cells[≥Low],7337,140,113,11019,0.8071428571428572,0.015401390213983917,Module Singleton,['HPA:0180000']
5222,GO:BP,GO:0001774,microglial cell activation,0.03863013200271051,True,"""The change in morphology and behavior of a microglial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor."" [GOC:mgi_curators, PMID:10626665, PMID:10695728, PMID:12580336, PMID:9893949]",47,5,2,21031,0.4,0.0425531914893617,Module 12,"['GO:0002269', 'GO:0042116', 'GO:0061900']"
5223,GO:BP,GO:0051649,establishment of localization in cell,0.03864779395128712,True,"""Any process, occuring in a cell, that localizes a substance or cellular component. This may occur via movement, tethering or selective degradation."" [GOC:ai, GOC:dos, GOC:dph, GOC:tb]",1972,172,34,21031,0.19767441860465115,0.017241379310344827,Module Singleton,"['GO:0051234', 'GO:0051641']"
5224,WP,WP:WP2882,Nuclear receptors meta pathway,0.038730501640921774,True,Nuclear receptors meta pathway,313,17,5,8286,0.29411764705882354,0.01597444089456869,Module 9,['WP:000000']
5225,HP,HP:0011893,Abnormal leukocyte count,0.03881320229929599,True,Number of leukocytes per volume of blood beyond normal limits.,479,59,17,4958,0.288135593220339,0.03549060542797495,Module Singleton,['HP:0001881']
5226,HPA,HPA:0381191,placenta; cytotrophoblasts[≥Low],0.03884289926402298,True,placenta; cytotrophoblasts[≥Low],476,69,11,11019,0.15942028985507245,0.023109243697478993,Module 5,['HPA:0380000']
5227,HPA,HPA:0190222,esophagus; squamous epithelial cells[≥Medium],0.03895081048220912,True,esophagus; squamous epithelial cells[≥Medium],5058,140,86,11019,0.6142857142857143,0.017002767892447607,Module Singleton,['HPA:0190221']
5228,HPA,HPA:0570812,testis; spermatogonia cells[≥Medium],0.038952573443318574,True,testis; spermatogonia cells[≥Medium],2570,69,30,11019,0.43478260869565216,0.011673151750972763,Module 5,['HPA:0570811']
5229,GO:CC,GO:0031983,vesicle lumen,0.0389788270576759,True,"""The volume enclosed by the membrane or protein that forms a vesicle."" [GOC:mah, GOC:vesicles]",324,21,4,22097,0.19047619047619047,0.012345679012345678,Module 9,"['GO:0031982', 'GO:0043233']"
5230,HPA,HPA:0250000,hippocampus,0.03903378508550893,True,hippocampus,6830,69,57,11019,0.8260869565217391,0.008345534407027818,Module 5,['HPA:0000000']
5231,GO:BP,GO:0001776,leukocyte homeostasis,0.03907929457928276,True,"""The process of regulating the proliferation and elimination of cells of the immune system such that the total number of cells of a particular cell type within a whole or part of an organism is stable over time in the absence of an outside stimulus."" [GOC:add, ISBN:0781735149]",111,215,8,21031,0.037209302325581395,0.07207207207207207,Module 2,"['GO:0002376', 'GO:0048872']"
5232,HPA,HPA:0570763,testis; pachytene spermatocytes[High],0.039105496326855026,True,testis; pachytene spermatocytes[High],950,3,3,11019,1.0,0.003157894736842105,Module 27,['HPA:0570762']
5233,TF,TF:M01208_1,Factor: FLI-1; motif: CMGGAWGTSAN; match class: 1,0.03915178121443894,True,Factor: FLI-1; motif: CMGGAWGTSAN; match class: 1,1308,826,86,20045,0.10411622276029056,0.06574923547400612,Module 0,['TF:M01208']
5234,REAC,REAC:R-HSA-9706574,RHOBTB GTPase Cycle,0.03917313874826358,True,RHOBTB GTPase Cycle,35,586,9,10842,0.015358361774744027,0.2571428571428571,Module 0,['REAC:R-HSA-9012999']
5235,HPA,HPA:0461483,skin 1; sebaceous glands[High],0.03918863882476909,True,skin 1; sebaceous glands[High],83,69,5,11019,0.07246376811594203,0.060240963855421686,Module 5,['HPA:0461482']
5236,GO:BP,GO:1903900,regulation of viral life cycle,0.039195306885564454,True,"""Any process that modulates the frequency, rate or extent of viral life cycle."" [GO_REF:0000058, GOC:TermGenie, PMID:18005716]",145,215,9,21031,0.04186046511627907,0.06206896551724138,Module 2,"['GO:0019058', 'GO:0050792']"
5237,MIRNA,MIRNA:hsa-miR-26b-5p,hsa-miR-26b-5p,0.03923474124901172,True,hsa-miR-26b-5p,1848,195,44,14819,0.22564102564102564,0.023809523809523808,Module 2,['MIRNA:000000']
5238,GO:CC,GO:0008541,"proteasome regulatory particle, lid subcomplex",0.03927256542655668,True,"""The subcomplex of the proteasome regulatory particle that forms the peripheral lid, which is added on top of the base subcomplex."" [GOC:rb]",8,813,4,22097,0.004920049200492005,0.5,Module 0,"['GO:0005838', 'GO:0032991']"
5239,GO:CC,GO:0072559,NLRP3 inflammasome complex,0.03927256542655668,True,"""An inflammasome complex that consists of three components, NLRP3 (NALP3), PYCARD and caspase-1. It is activated upon exposure to whole pathogens, as well as a number of structurally diverse pathogen- and danger-associated molecular patterns (PAMPs and DAMPs) and environmental irritants. Whole pathogens demonstrated to activate the NLRP3 inflammasome complex include the fungi Candida albicans and Saccharomyces cerevisiae, bacteria that produce pore-forming toxins, including Listeria monocytogenes and Staphylococcus aureus, and viruses such as Sendai virus, adenovirus, and influenza virus."" [GOC:add, GOC:BHF, GOC:vp, PMID:20303873]",8,813,4,22097,0.004920049200492005,0.5,Module 0,['GO:0061702']
5240,GO:CC,GO:0002199,zona pellucida receptor complex,0.03927256542655668,True,"""A multisubunit complex comprising the chaperonin-containing T-complex and several other components involved in mediating sperm-oocyte Interaction."" [GOC:hjd, PMID:21880732]",8,813,4,22097,0.004920049200492005,0.5,Module 0,['GO:0032991']
5241,GO:BP,GO:0051640,organelle localization,0.039294142084475035,True,"""Any process in which an organelle is transported to, and/or maintained in, a specific location."" [GOC:ai]",620,787,45,21031,0.05717916137229987,0.07258064516129033,Module 0,['GO:0051179']
5242,HP,HP:0000403,Recurrent otitis media,0.03931270486656153,True,"Increased susceptibility to otitis media, as manifested by recurrent episodes of otitis media.",203,71,12,4958,0.16901408450704225,0.059113300492610835,Module 1,"['HP:0000388', 'HP:0002719']"
5243,GO:CC,GO:0005769,early endosome,0.0394240760344346,True,"""A membrane-bounded organelle that receives incoming material from primary endocytic vesicles that have been generated by clathrin-dependent and clathrin-independent endocytosis; vesicles fuse with the early endosome to deliver cargo for sorting into recycling or degradation pathways."" [GOC:mah, NIF_Subcellular:nlx_subcell_20090701, PMID:19696797]",429,17,4,22097,0.23529411764705882,0.009324009324009324,Module 6,['GO:0005768']
5244,TF,TF:M11454,Factor: ELFR; motif: NANGMGGAAGTN,0.03947373916426453,True,Factor: ELFR; motif: NANGMGGAAGTN,1099,105,18,20045,0.17142857142857143,0.01637852593266606,Module 3,['TF:M00000']
5245,GO:BP,GO:0006417,regulation of translation,0.03958861374249977,True,"""Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA."" [GOC:isa_complete]",378,105,10,21031,0.09523809523809523,0.026455026455026454,Module 3,"['GO:0006412', 'GO:0010608', 'GO:0034248', 'GO:0051246']"
5246,HPA,HPA:0130243,colon; peripheral nerve/ganglion[High],0.03968761207092521,True,colon; peripheral nerve/ganglion[High],855,612,73,11019,0.119281045751634,0.08538011695906433,Module 0,['HPA:0130242']
5247,GO:BP,GO:0009891,positive regulation of biosynthetic process,0.039730620172768454,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of substances."" [GOC:go_curators]",2706,215,50,21031,0.23255813953488372,0.018477457501847747,Module 2,"['GO:0009058', 'GO:0009889', 'GO:0009893']"
5248,REAC,REAC:R-HSA-9662851,Anti-inflammatory response favouring Leishmania parasite infection,0.03976168271187379,True,Anti-inflammatory response favouring Leishmania parasite infection,132,2,2,10842,1.0,0.015151515151515152,Module 22,['REAC:R-HSA-9664433']
5249,REAC,REAC:R-HSA-9664433,Leishmania parasite growth and survival,0.03976168271187379,True,Leishmania parasite growth and survival,132,2,2,10842,1.0,0.015151515151515152,Module 22,['REAC:R-HSA-9658195']
5250,WP,WP:WP5130,Th17 cell differentiation pathway,0.039822153393869464,True,Th17 cell differentiation pathway,69,148,7,8286,0.0472972972972973,0.10144927536231885,Module 1,['WP:000000']
5251,HPA,HPA:0031303,appendix; enterocytes[High],0.039837346403518985,True,appendix; enterocytes[High],189,612,24,11019,0.0392156862745098,0.12698412698412698,Module 0,['HPA:0031302']
5252,TF,TF:M11075,Factor: Sohlh2; motif: NNCACGTGNN,0.039860339928231805,True,Factor: Sohlh2; motif: NNCACGTGNN,12104,826,557,20045,0.6743341404358354,0.04601784534038334,Module 0,['TF:M00000']
5253,HPA,HPA:0291163,liver; cholangiocytes[High],0.03987439246775645,True,liver; cholangiocytes[High],322,69,9,11019,0.13043478260869565,0.027950310559006212,Module 5,['HPA:0291162']
5254,CORUM,CORUM:306,"Ribosome, cytoplasmic",0.03987744056491456,True,"Ribosome, cytoplasmic",74,2,2,3383,1.0,0.02702702702702703,Module 6,['CORUM:0000000']
5255,GO:BP,GO:0002260,lymphocyte homeostasis,0.03989933157061199,True,"""The process of regulating the proliferation and elimination of lymphocytes such that the total number of lymphocytes within a whole or part of an organism is stable over time in the absence of an outside stimulus."" [GOC:add, PMID:15826826, PMID:16319493, PMID:16551252, PMID:16551262]",77,226,7,21031,0.030973451327433628,0.09090909090909091,Module 1,['GO:0001776']
5256,GO:BP,GO:0080134,regulation of response to stress,0.039995531186460195,True,"""Any process that modulates the frequency, rate or extent of a response to stress. Response to stress is a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis, usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation)."" [GOC:dhl]",1340,21,8,21031,0.38095238095238093,0.005970149253731343,Module 9,"['GO:0006950', 'GO:0048583']"
5257,REAC,REAC:R-HSA-5625740,RHO GTPases activate PKNs,0.04004785907562558,True,RHO GTPases activate PKNs,94,3,2,10842,0.6666666666666666,0.02127659574468085,Module 27,['REAC:R-HSA-195258']
5258,REAC,REAC:R-HSA-3214815,HDACs deacetylate histones,0.04004785907562558,True,HDACs deacetylate histones,94,3,2,10842,0.6666666666666666,0.02127659574468085,Module 27,['REAC:R-HSA-3247509']
5259,GO:BP,GO:0051128,regulation of cellular component organization,0.040153028616690595,True,"""Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of cell structures, including the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope."" [GOC:ai]",2425,226,48,21031,0.21238938053097345,0.01979381443298969,Module 1,"['GO:0016043', 'GO:0050794']"
5260,TF,TF:M12599,Factor: E2F4; motif: YCCCGCCNCNNSSNNSNN,0.040213270193996654,True,Factor: E2F4; motif: YCCCGCCNCNNSSNNSNN,17574,105,104,20045,0.9904761904761905,0.0059178331626266074,Module 3,['TF:M00000']
5261,HP,HP:0032251,Abnormal immune system morphology,0.040224987454158236,True,Abnormal immune system morphology,641,59,20,4958,0.3389830508474576,0.031201248049921998,Module Singleton,['HP:0002715']
5262,HP,HP:0002076,Migraine,0.04023873848885682,True,Migraine is a chronic neurological disorder characterized by episodic attacks of headache and associated symptoms.,143,44,8,4958,0.18181818181818182,0.055944055944055944,Module 3,['HP:0002315']
5263,HPA,HPA:0570772,testis; peritubular cells[≥Medium],0.04035950194367665,True,testis; peritubular cells[≥Medium],526,612,50,11019,0.08169934640522876,0.09505703422053231,Module 0,['HPA:0570771']
5264,HP,HP:0006783,Posterior pharyngeal cleft,0.04040712132763401,True,Posterior pharyngeal cleft,13,71,4,4958,0.056338028169014086,0.3076923076923077,Module 1,['HP:0000600']
5265,HP,HP:0000572,Visual loss,0.04067562625232307,True,Loss of visual acuity (implying that vision was better at a certain time point in life). Otherwise the term reduced visual acuity should be used (or a subclass of that).,236,44,10,4958,0.22727272727272727,0.0423728813559322,Module 3,['HP:0000505']
5266,HPA,HPA:0031303,appendix; enterocytes[High],0.04070837581812893,True,appendix; enterocytes[High],189,69,7,11019,0.10144927536231885,0.037037037037037035,Module 5,['HPA:0031302']
5267,HPA,HPA:0461482,skin 1; sebaceous glands[≥Medium],0.04072002764459015,True,skin 1; sebaceous glands[≥Medium],165,79,7,11019,0.08860759493670886,0.04242424242424243,Module 3,['HPA:0461481']
5268,HPA,HPA:0100123,cerebral cortex; glial cells[High],0.04077060641436191,True,cerebral cortex; glial cells[High],744,69,14,11019,0.2028985507246377,0.01881720430107527,Module 5,['HPA:0100122']
5269,HPA,HPA:0271132,kidney; distal tubules[≥Medium],0.040771230534048034,True,kidney; distal tubules[≥Medium],554,612,52,11019,0.08496732026143791,0.09386281588447654,Module 0,['HPA:0271131']
5270,GO:BP,GO:0002833,positive regulation of response to biotic stimulus,0.040822595029929444,True,"""Any process that activates or increases the frequency, rate, or extent of a response to biotic stimulus."" [GOC:add]",369,21,5,21031,0.23809523809523808,0.013550135501355014,Module 9,"['GO:0002831', 'GO:0009607', 'GO:0048584']"
5271,GO:BP,GO:0045727,positive regulation of translation,0.040837278989192115,True,"""Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA."" [GOC:dph, GOC:go_curators, GOC:tb]",140,787,17,21031,0.021601016518424398,0.12142857142857143,Module 0,"['GO:0006412', 'GO:0006417', 'GO:0010628', 'GO:0034250', 'GO:0051247']"
5272,REAC,REAC:R-HSA-8936459,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,0.0409065731055009,True,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,95,3,2,10842,0.6666666666666666,0.021052631578947368,Module 27,['REAC:R-HSA-8878171']
5273,GO:BP,GO:0098813,nuclear chromosome segregation,0.04093277269823677,True,"""The process in which genetic material, in the form of nuclear chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. Nuclear chromosome segregation begins with the condensation of chromosomes, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles."" [GOC:dos]",318,77,8,21031,0.1038961038961039,0.025157232704402517,Module 5,['GO:0007059']
5274,HP,HP:0011767,Abnormality of the parathyroid physiology,0.040950610059127694,True,A functional abnormality of the parathyroid gland.,70,44,6,4958,0.13636363636363635,0.08571428571428572,Module 3,['HP:0000828']
5275,GO:BP,GO:0014070,response to organic cyclic compound,0.04097633035008697,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus."" [GOC:ef]",905,215,24,21031,0.11162790697674418,0.026519337016574586,Module 2,['GO:0010033']
5276,GO:CC,GO:0043196,varicosity,0.041164263340713526,True,"""Non-terminal inflated portion of the axon, containing the specialized apparatus necessary to release neurotransmitters."" [GOC:nln]",9,238,3,22097,0.012605042016806723,0.3333333333333333,Module 1,"['GO:0044304', 'GO:0110165']"
5277,HPA,HPA:0050052,breast; glandular cells[≥Medium],0.04117938595014181,True,breast; glandular cells[≥Medium],5109,60,42,11019,0.7,0.008220786846741044,Module 4,['HPA:0050051']
5278,GO:BP,GO:0000819,sister chromatid segregation,0.04122825083368663,True,"""The cell cycle process in which sister chromatids are organized and then physically separated and apportioned to two or more sets."" [GOC:ai, GOC:elh]",230,77,7,21031,0.09090909090909091,0.030434782608695653,Module 5,"['GO:0051276', 'GO:0098813']"
5279,GO:BP,GO:0043555,regulation of translation in response to stress,0.04129864447175381,True,"""Modulation of the frequency, rate or extent of translation as a result of a stimulus indicating the organism is under stress. The stress is usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation)."" [GOC:jl]",24,787,7,21031,0.008894536213468869,0.2916666666666667,Module 0,"['GO:0006417', 'GO:0033554']"
5280,TF,TF:M00932_1,Factor: Sp1; motif: NNGGGGCGGGGNN; match class: 1,0.04137738891288157,True,Factor: Sp1; motif: NNGGGGCGGGGNN; match class: 1,6271,826,315,20045,0.3813559322033898,0.0502312230904162,Module 0,['TF:M00932']
5281,GO:BP,GO:0090063,positive regulation of microtubule nucleation,0.041395989658264264,True,"""Any process that increases the rate, frequency or extent of microtubule nucleation. Microtubule nucleation is the 'de novo' formation of a microtubule, in which tubulin heterodimers form metastable oligomeric aggregates, some of which go on to support formation of a complete microtubule. Microtubule nucleation usually occurs from a specific site within a cell."" [GOC:dph, GOC:tb]",8,21,2,21031,0.09523809523809523,0.25,Module 9,"['GO:0007020', 'GO:0010968', 'GO:0031116']"
5282,TF,TF:M07084_1,Factor: E2F-4; motif: NGGCGGGAARN; match class: 1,0.04140826854659448,True,Factor: E2F-4; motif: NGGCGGGAARN; match class: 1,5606,826,286,20045,0.34624697336561744,0.05101676774884053,Module 0,['TF:M07084']
5283,TF,TF:M11432_1,Factor: Elk-1; motif: NACMGGAAGTN; match class: 1,0.04141793597308171,True,Factor: Elk-1; motif: NACMGGAAGTN; match class: 1,1560,105,22,20045,0.20952380952380953,0.014102564102564103,Module 3,['TF:M11432']
5284,GO:BP,GO:0010959,regulation of metal ion transport,0.041423185767562425,True,"""Any process that modulates the frequency, rate, or extent of metal ion transport. Metal ion transport is the directed movement of metal ions, any metal ion with an electric charge, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore."" [GOC:dph, GOC:tb]",369,5,3,21031,0.6,0.008130081300813009,Module 12,"['GO:0030001', 'GO:0043269']"
5285,WP,WP:WP23,B cell receptor signaling pathway,0.04162656046342554,True,B cell receptor signaling pathway,92,148,8,8286,0.05405405405405406,0.08695652173913043,Module 1,['WP:000000']
5286,CORUM,CORUM:596,SIN3-HDAC-SAP30-ARID4 complex,0.04170065154024898,True,SIN3-HDAC-SAP30-ARID4 complex,7,72,3,3383,0.041666666666666664,0.42857142857142855,Module Singleton,['CORUM:0000000']
5287,CORUM,CORUM:695,SIN3-HDAC-SAP30-ARID4 complex,0.04170065154024898,True,SIN3-HDAC-SAP30-ARID4 complex,7,72,3,3383,0.041666666666666664,0.42857142857142855,Module Singleton,['CORUM:0000000']
5288,CORUM,CORUM:698,SIN3-HDAC-SAP30-ARID4 complex,0.04170065154024898,True,SIN3-HDAC-SAP30-ARID4 complex,7,72,3,3383,0.041666666666666664,0.42857142857142855,Module Singleton,['CORUM:0000000']
5289,HPA,HPA:0600221,tonsil; squamous epithelial cells[≥Low],0.04170174454692997,True,tonsil; squamous epithelial cells[≥Low],6652,69,56,11019,0.8115942028985508,0.00841852074564041,Module 5,['HPA:0600000']
5290,GO:BP,GO:0001782,B cell homeostasis,0.04173741629593181,True,"""The process of regulating the proliferation and elimination of B cells such that the total number of B cells within a whole or part of an organism is stable over time in the absence of an outside stimulus."" [GOC:add, ISBN:0781735149, PMID:12956429]",33,215,5,21031,0.023255813953488372,0.15151515151515152,Module 2,['GO:0002260']
5291,GO:BP,GO:0071402,cellular response to lipoprotein particle stimulus,0.04173741629593181,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipoprotein particle stimulus."" [GOC:mah]",33,215,5,21031,0.023255813953488372,0.15151515151515152,Module 2,['GO:0051716']
5292,HPA,HPA:0600441,tonsil; non-germinal center cells[≥Low],0.041823775057466074,True,tonsil; non-germinal center cells[≥Low],6117,23,21,11019,0.9130434782608695,0.0034330554193231977,Module 10,['HPA:0600000']
5293,GO:BP,GO:0009260,ribonucleotide biosynthetic process,0.04190199193609388,True,"""The chemical reactions and pathways resulting in the formation of a ribonucleotide, a compound consisting of ribonucleoside (a base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar."" [GOC:go_curators, ISBN:0198506732]",231,105,8,21031,0.0761904761904762,0.03463203463203463,Module 3,"['GO:0009165', 'GO:0009259', 'GO:0046390']"
5294,HPA,HPA:0461411,skin 1; cells in spinous layer[≥Low],0.04204630909293289,True,skin 1; cells in spinous layer[≥Low],760,60,13,11019,0.21666666666666667,0.017105263157894738,Module 4,['HPA:0460000']
5295,HPA,HPA:0401332,rectum; mucosal lymphoid cells[≥Medium],0.042307720936254394,True,rectum; mucosal lymphoid cells[≥Medium],398,140,15,11019,0.10714285714285714,0.03768844221105527,Module Singleton,['HPA:0401331']
5296,TF,TF:M07057_1,Factor: Pitx3; motif: GATTANA; match class: 1,0.042361282604063084,True,Factor: Pitx3; motif: GATTANA; match class: 1,185,2,2,20045,1.0,0.010810810810810811,Module 41,['TF:M07057']
5297,TF,TF:M04287,Factor: BARHL2; motif: NNTAAAYGNN,0.04237691929749856,True,Factor: BARHL2; motif: NNTAAAYGNN,4525,826,238,20045,0.288135593220339,0.05259668508287293,Module 0,['TF:M00000']
5298,GO:CC,GO:0030117,membrane coat,0.042435597148999464,True,"""Any of several different proteinaceous coats that can associate with membranes. Membrane coats include those formed by clathrin plus an adaptor complex, the COPI and COPII complexes, and possibly others. They are found associated with membranes on many vesicles as well as other membrane features such as pits and perhaps tubules."" [GOC:mah]",99,177,6,22097,0.03389830508474576,0.06060606060606061,Module Singleton,"['GO:0005737', 'GO:0048475', 'GO:0098796']"
5299,GO:CC,GO:0048475,coated membrane,0.042435597148999464,True,"""A single or double lipid bilayer with any of several different proteinaceous coats that can associate with membranes. Membrane coats include those formed by clathrin plus an adaptor complex, the COPI and COPII complexes."" [GOC:jid]",99,177,6,22097,0.03389830508474576,0.06060606060606061,Module Singleton,['GO:0016020']
5300,GO:BP,GO:0051276,chromosome organization,0.04258245250231209,True,"""A process that is carried out at the cellular level that results in the assembly, arrangement of constituent parts, or disassembly of chromosomes, structures composed of a very long molecule of DNA and associated proteins that carries hereditary information. This term covers covalent modifications at the molecular level as well as spatial relationships among the major components of a chromosome."" [GOC:ai, GOC:dph, GOC:jl, GOC:mah]",635,21,6,21031,0.2857142857142857,0.009448818897637795,Module 9,['GO:0006996']
5301,HPA,HPA:0100121,cerebral cortex; glial cells[≥Low],0.04260375622659764,True,cerebral cortex; glial cells[≥Low],4927,60,41,11019,0.6833333333333333,0.008321493809620458,Module 4,['HPA:0100000']
5302,GO:BP,GO:0098542,defense response to other organism,0.042659238996228144,True,"""Reactions triggered in response to the presence of another organism that act to protect the cell or organism from damage caused by that organism."" [GOC:dos]",1220,5,4,21031,0.8,0.003278688524590164,Module 12,"['GO:0006952', 'GO:0051707']"
5303,GO:MF,GO:0019864,IgG binding,0.04271189697481103,True,"""Binding to an immunoglobulin of an IgG isotype."" [GOC:add, ISBN:0781735149]",9,218,3,20212,0.013761467889908258,0.3333333333333333,Module 2,['GO:0019865']
5304,GO:MF,GO:0003676,nucleic acid binding,0.04274302366755427,True,"""Binding to a nucleic acid."" [GOC:jl]",5491,80,38,20212,0.475,0.006920415224913495,Module 5,['GO:0097159']
5305,GO:CC,GO:0000428,DNA-directed RNA polymerase complex,0.04274415009614998,True,"""A protein complex that possesses DNA-directed RNA polymerase activity."" [GOC:krc]",119,813,14,22097,0.017220172201722016,0.11764705882352941,Module 0,['GO:0030880']
5306,GO:MF,GO:0016505,peptidase activator activity involved in apoptotic process,0.042775860726768866,True,"""Binds to and increases the activity of a peptidase that is involved in the apoptotic process."" [GOC:BHF, GOC:mah, GOC:mtg_apoptosis, GOC:rl]",23,218,4,20212,0.01834862385321101,0.17391304347826086,Module 2,['GO:0016504']
5307,REAC,REAC:R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,0.04284312362343872,True,APC/C-mediated degradation of cell cycle proteins,88,59,5,10842,0.0847457627118644,0.056818181818181816,Module 5,['REAC:R-HSA-453276']
5308,REAC,REAC:R-HSA-453276,Regulation of mitotic cell cycle,0.04284312362343872,True,Regulation of mitotic cell cycle,88,59,5,10842,0.0847457627118644,0.056818181818181816,Module 5,['REAC:R-HSA-69278']
5309,TF,TF:M11434_1,Factor: Elk-1; motif: NRSCGGAAGNN; match class: 1,0.0430413839188484,True,Factor: Elk-1; motif: NRSCGGAAGNN; match class: 1,3008,105,33,20045,0.3142857142857143,0.010970744680851064,Module 3,['TF:M11434']
5310,GO:CC,GO:0030120,vesicle coat,0.0434725803528286,True,"""A membrane coat found on a coated vesicle."" [GOC:mah]",63,177,5,22097,0.02824858757062147,0.07936507936507936,Module Singleton,"['GO:0030117', 'GO:0030662']"
5311,HP,HP:0000580,Pigmentary retinopathy,0.04350431944990985,True,An abnormality of the retina characterized by pigment deposition. It is typically associated with migration and proliferation of macrophages or retinal pigment epithelial cells into the retina; melanin from these cells causes the pigmentary changes. Pigmentary retinopathy is a common final pathway of many retinal conditions and is often associated with visual loss.,189,44,9,4958,0.20454545454545456,0.047619047619047616,Module 3,['HP:0007703']
5312,GO:CC,GO:0000785,chromatin,0.04352767084472672,True,"""The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome."" [GOC:elh, PMID:20404130]",1368,3,3,22097,1.0,0.0021929824561403508,Module 27,"['GO:0005694', 'GO:0032993']"
5313,GO:BP,GO:0006959,humoral immune response,0.04355404980864046,True,"""An immune response mediated through a body fluid."" [GOC:hb, ISBN:0198506732]",254,226,12,21031,0.05309734513274336,0.047244094488188976,Module 1,['GO:0006955']
5314,TF,TF:M12156,Factor: Sp2; motif: NTAAGYCCCGCCCMCTN,0.04365537219951702,True,Factor: Sp2; motif: NTAAGYCCCGCCCMCTN,4460,826,235,20045,0.2845036319612591,0.052690582959641255,Module 0,['TF:M00000']
5315,GO:BP,GO:0070663,regulation of leukocyte proliferation,0.04371585792710417,True,"""Any process that modulates the frequency, rate or extent of leukocyte proliferation."" [GOC:add, GOC:mah]",266,15,4,21031,0.26666666666666666,0.015037593984962405,Module 6,"['GO:0042127', 'GO:0070661']"
5316,GO:CC,GO:0030665,clathrin-coated vesicle membrane,0.04373559623776844,True,"""The lipid bilayer surrounding a clathrin-coated vesicle."" [GOC:mah]",134,813,15,22097,0.01845018450184502,0.11194029850746269,Module 0,"['GO:0030136', 'GO:0030662']"
5317,MIRNA,MIRNA:hsa-miR-34a-5p,hsa-miR-34a-5p,0.04373910350911087,True,hsa-miR-34a-5p,728,3,3,14819,1.0,0.004120879120879121,Module 27,['MIRNA:000000']
5318,HP,HP:0011035,Abnormal renal cortex morphology,0.04376206029459764,True,An abnormality of the cortex of the kidney.,238,44,10,4958,0.22727272727272727,0.04201680672268908,Module 3,['HP:0012210']
5319,GO:BP,GO:0002269,leukocyte activation involved in inflammatory response,0.043763548858923945,True,"""A change in the morphology or behavior of a leukocyte resulting from exposure to an activating factor such as a cellular or soluble ligand, leading to the initiation or perpetuation of an inflammatory response."" [GOC:add, ISBN:0781735149]",50,5,2,21031,0.4,0.04,Module 12,"['GO:0006954', 'GO:0045321']"
5320,GO:CC,GO:0071013,catalytic step 2 spliceosome,0.04376772258921786,True,"""A spliceosomal complex that contains three snRNPs, including U5, bound to a splicing intermediate in which the first catalytic cleavage of the 5' splice site has occurred. The precise subunit composition differs significantly from that of the catalytic step 1, or activated, spliceosome, and includes many proteins in addition to those found in the associated snRNPs."" [GOC:ab, GOC:krc, GOC:mah, ISBN:0879695897, ISBN:0879697393, PMID:18322460, PMID:19239890]",89,6,2,22097,0.3333333333333333,0.02247191011235955,Module 8,"['GO:0005681', 'GO:1902494']"
5321,TF,TF:M01258_1,Factor: GABP; motif: CACTTCCGGNNN; match class: 1,0.04379226888429548,True,Factor: GABP; motif: CACTTCCGGNNN; match class: 1,436,826,38,20045,0.04600484261501211,0.0871559633027523,Module 0,['TF:M01258']
5322,HPA,HPA:0481352,small intestine; paneth cells[≥Medium],0.043826107874760614,True,small intestine; paneth cells[≥Medium],226,612,27,11019,0.04411764705882353,0.11946902654867257,Module 0,['HPA:0481351']
5323,GO:BP,GO:0051128,regulation of cellular component organization,0.0438750551584042,True,"""Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of cell structures, including the plasma membrane and any external encapsulating structures such as the cell wall and cell envelope."" [GOC:ai]",2425,787,129,21031,0.1639135959339263,0.053195876288659794,Module 0,"['GO:0016043', 'GO:0050794']"
5324,GO:BP,GO:1902903,regulation of supramolecular fiber organization,0.04403557184002168,True,"""Any process that modulates the frequency, rate or extent of supramolecular fiber organization."" [GO_REF:0000058, GOC:PARL, GOC:rl, GOC:TermGenie, PMID:23921388]",383,787,32,21031,0.04066073697585769,0.0835509138381201,Module 0,"['GO:0051128', 'GO:0097435']"
5325,MIRNA,MIRNA:hsa-miR-8081,hsa-miR-8081,0.04405126245003729,True,hsa-miR-8081,94,3,2,14819,0.6666666666666666,0.02127659574468085,Module 27,['MIRNA:000000']
5326,MIRNA,MIRNA:hsa-miR-6830-3p,hsa-miR-6830-3p,0.044052915768004526,True,hsa-miR-6830-3p,93,15,3,14819,0.2,0.03225806451612903,Module 11,['MIRNA:000000']
5327,GO:BP,GO:0002252,immune effector process,0.044107845262626434,True,"""Any process of the immune system that executes a component of an immune response. An effector immune process takes place after its activation."" [GO_REF:0000022, GOC:add, ISBN:0781735149]",698,72,11,21031,0.1527777777777778,0.015759312320916905,Module 4,['GO:0002376']
5328,GO:CC,GO:0097452,GAIT complex,0.044158758341008665,True,"""A protein complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. The complex binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs and suppresses their translation by blocking the recruitment of the 43S ribosomal complex to m7G cap-bound eIF4G. In humans it includes RPL13A, EPRS, SYNCRIP and GAPDH; mouse complexes lack SYNCRIP."" [GOC:br, PMID:15479637, PMID:23071094]",4,105,2,22097,0.01904761904761905,0.5,Module 3,['GO:0032991']
5329,HPA,HPA:0100121,cerebral cortex; glial cells[≥Low],0.04421614138742142,True,cerebral cortex; glial cells[≥Low],4927,69,46,11019,0.6666666666666666,0.009336310127866856,Module 5,['HPA:0100000']
5330,REAC,REAC:R-HSA-6781823,Formation of TC-NER Pre-Incision Complex,0.04426665348650382,True,Formation of TC-NER Pre-Incision Complex,52,586,11,10842,0.01877133105802048,0.21153846153846154,Module 0,['REAC:R-HSA-6781827']
5331,GO:BP,GO:0141124,intracellular signaling cassette,0.044397723299270414,True,"""An intracellular signaling module that is part of larger signaling pathways that can be initiated either intracellularly or by cell surface receptors. Intracellular signaling cassettes are discrete signaling units that are often shared by multiple signaling pathways."" [GOC:ha, GOC:pg]",1861,787,104,21031,0.13214739517153748,0.05588393336915637,Module 0,['GO:0035556']
5332,REAC,REAC:R-HSA-68867,Assembly of the pre-replicative complex,0.04446713716087573,True,Assembly of the pre-replicative complex,142,59,6,10842,0.1016949152542373,0.04225352112676056,Module 5,['REAC:R-HSA-69002']
5333,CORUM,CORUM:32,PA700 complex,0.0444957993963357,True,PA700 complex,20,331,8,3383,0.02416918429003021,0.4,Module 0,['CORUM:0000000']
5334,KEGG,KEGG:05142,Chagas disease,0.044520576220186174,True,Chagas disease,101,4,2,8484,0.5,0.019801980198019802,Module 12,['KEGG:00000']
5335,HPA,HPA:0481301,small intestine; enterocytes[≥Low],0.044569893555464354,True,small intestine; enterocytes[≥Low],571,79,13,11019,0.16455696202531644,0.02276707530647986,Module 3,['HPA:0480000']
5336,GO:BP,GO:0043380,regulation of memory T cell differentiation,0.04458367854161425,True,"""Any process that modulates the frequency, rate, or extent of memory T cell differentiation."" [ISBN:0781735149]",12,15,2,21031,0.13333333333333333,0.16666666666666666,Module 6,"['GO:0002697', 'GO:0043379', 'GO:0045580', 'GO:0050776']"
5337,GO:BP,GO:0040011,locomotion,0.04462888972465223,True,"""Self-propelled movement of a cell or organism from one location to another."" [GOC:dgh]",1234,5,4,21031,0.8,0.0032414910858995136,Module 12,['GO:0008150']
5338,TF,TF:M08875,Factor: E2F; motif: NNTTTCGCGCN,0.044647961655305685,True,Factor: E2F; motif: NNTTTCGCGCN,6410,80,44,20045,0.55,0.006864274570982839,Module 5,['TF:M00000']
5339,MIRNA,MIRNA:hsa-miR-149-5p,hsa-miR-149-5p,0.044682677612304995,True,hsa-miR-149-5p,394,753,39,14819,0.05179282868525897,0.09898477157360407,Module 0,['MIRNA:000000']
5340,HPA,HPA:0420053,salivary gland; glandular cells[High],0.044928322484675424,True,salivary gland; glandular cells[High],1483,69,21,11019,0.30434782608695654,0.014160485502360081,Module 5,['HPA:0420052']
5341,HPA,HPA:0340461,ovary; ovarian stroma cells[≥Low],0.04496725919724308,True,ovary; ovarian stroma cells[≥Low],3986,23,17,11019,0.7391304347826086,0.004264927245358756,Module 10,['HPA:0340000']
5342,KEGG,KEGG:05010,Alzheimer disease,0.04498283541385485,True,Alzheimer disease,382,53,9,8484,0.16981132075471697,0.02356020942408377,Module 5,['KEGG:00000']
5343,HP,HP:0000377,Abnormal pinna morphology,0.04501640146762841,True,"An abnormality of the pinna, which is also referred to as the auricle or external ear.",1259,44,24,4958,0.5454545454545454,0.019062748212867357,Module 3,['HP:0000356']
5344,GO:CC,GO:0005840,ribosome,0.04518027231302525,True,"""An intracellular organelle, about 200 A in diameter, consisting of RNA and protein. It is the site of protein biosynthesis resulting from translation of messenger RNA (mRNA). It consists of two subunits, one large and one small, each containing only protein and RNA. Both the ribosome and its subunits are characterized by their sedimentation coefficients, expressed in Svedberg units (symbol: S). Hence, the prokaryotic ribosome (70S) comprises a large (50S) subunit and a small (30S) subunit, while the eukaryotic ribosome (80S) comprises a large (60S) subunit and a small (40S) subunit. Two sites on the ribosomal large subunit are involved in translation, namely the aminoacyl site (A site) and peptidyl site (P site). Ribosomes from prokaryotes, eukaryotes, mitochondria, and chloroplasts have characteristically distinct ribosomal proteins."" [ISBN:0198506732]",520,6,3,22097,0.5,0.0057692307692307696,Module 8,['GO:0043232']
5345,HP,HP:0100886,Abnormality of globe location,0.04519926947524891,True,An abnormality in the placement of the ocular globe (eyeball).,1081,44,22,4958,0.5,0.020351526364477335,Module 3,['HP:0012372']
5346,REAC,REAC:R-HSA-442755,Activation of NMDA receptors and postsynaptic events,0.04520553397341963,True,Activation of NMDA receptors and postsynaptic events,89,59,5,10842,0.0847457627118644,0.056179775280898875,Module 5,['REAC:R-HSA-112314']
5347,HPA,HPA:0160251,endometrium 1; cells in endometrial stroma[≥Low],0.045213349570749226,True,endometrium 1; cells in endometrial stroma[≥Low],4077,140,73,11019,0.5214285714285715,0.01790532254108413,Module Singleton,['HPA:0160000']
5348,MIRNA,MIRNA:hsa-miR-1301-3p,hsa-miR-1301-3p,0.04522256384046989,True,hsa-miR-1301-3p,197,104,8,14819,0.07692307692307693,0.04060913705583756,Module 3,['MIRNA:000000']
5349,KEGG,KEGG:04064,NF-kappa B signaling pathway,0.04540380046515325,True,NF-kappa B signaling pathway,102,4,2,8484,0.5,0.0196078431372549,Module 12,['KEGG:00000']
5350,TF,TF:M02057,Factor: Elf5; motif: CSMGGAARNN,0.04551817165238329,True,Factor: Elf5; motif: CSMGGAARNN,10595,826,496,20045,0.6004842615012107,0.04681453515809344,Module 0,['TF:M00000']
5351,HPA,HPA:0301373,lung; alveolar cells type II[High],0.04551892270808999,True,lung; alveolar cells type II[High],662,60,12,11019,0.2,0.01812688821752266,Module 4,['HPA:0301372']
5352,GO:CC,GO:0032991,protein-containing complex,0.04560182614078801,True,"""A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together."" [GOC:dos, GOC:mah]",8588,17,14,22097,0.8235294117647058,0.0016301816488122963,Module 6,['GO:0005575']
5353,KEGG,KEGG:05416,Viral myocarditis,0.04584541187453831,True,Viral myocarditis,63,136,6,8484,0.04411764705882353,0.09523809523809523,Module 1,['KEGG:00000']
5354,WP,WP:WP2359,Parkin ubiquitin proteasomal system pathway,0.045984304174374734,True,Parkin ubiquitin proteasomal system pathway,71,17,3,8286,0.17647058823529413,0.04225352112676056,Module 9,['WP:000000']
5355,REAC,REAC:R-HSA-5689603,UCH proteinases,0.04624894234440207,True,UCH proteinases,101,3,2,10842,0.6666666666666666,0.019801980198019802,Module 27,['REAC:R-HSA-5688426']
5356,HPA,HPA:0481301,small intestine; enterocytes[≥Low],0.04631915406014656,True,small intestine; enterocytes[≥Low],571,69,12,11019,0.17391304347826086,0.021015761821366025,Module 5,['HPA:0480000']
5357,REAC,REAC:R-HSA-9012999,RHO GTPase cycle,0.04638163059769262,True,RHO GTPase cycle,449,586,44,10842,0.07508532423208192,0.09799554565701558,Module 0,['REAC:R-HSA-194315']
5358,HPA,HPA:0430052,seminal vesicle; glandular cells[≥Medium],0.04652195539768853,True,seminal vesicle; glandular cells[≥Medium],5238,140,88,11019,0.6285714285714286,0.016800305460099276,Module Singleton,['HPA:0430051']
5359,HPA,HPA:0160000,endometrium 1,0.04666709713832252,True,endometrium 1,7055,69,58,11019,0.8405797101449275,0.00822111977321049,Module 5,['HPA:0000000']
5360,TF,TF:M11404,Factor: Fli-1; motif: NACCGGAARTN,0.04682981041108364,True,Factor: Fli-1; motif: NACCGGAARTN,8935,183,110,20045,0.6010928961748634,0.012311135982092894,Module Singleton,['TF:M00000']
5361,HPA,HPA:0460662,skin 1; keratinocytes[≥Medium],0.04683637086667811,True,skin 1; keratinocytes[≥Medium],3289,79,39,11019,0.4936708860759494,0.011857707509881422,Module 3,['HPA:0460661']
5362,GO:BP,GO:0007049,cell cycle,0.046851462134155246,True,"""The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division."" [GOC:go_curators, GOC:mtg_cell_cycle]",1819,787,102,21031,0.12960609911054638,0.056074766355140186,Module 0,['GO:0009987']
5363,HPA,HPA:0460202,skin 1; endothelial cells[≥Medium],0.04689010431721948,True,skin 1; endothelial cells[≥Medium],593,140,19,11019,0.1357142857142857,0.03204047217537943,Module Singleton,['HPA:0460201']
5364,HPA,HPA:0461472,skin 1; lymphocytes[≥Medium],0.04693177148061962,True,skin 1; lymphocytes[≥Medium],574,79,13,11019,0.16455696202531644,0.02264808362369338,Module 3,['HPA:0461471']
5365,MIRNA,MIRNA:hsa-miR-1193,hsa-miR-1193,0.04693193829428892,True,hsa-miR-1193,95,15,3,14819,0.2,0.031578947368421054,Module 11,['MIRNA:000000']
5366,MIRNA,MIRNA:hsa-miR-196b-3p,hsa-miR-196b-3p,0.046943260268116016,True,hsa-miR-196b-3p,16,1,1,14819,1.0,0.0625,Module 28,['MIRNA:000000']
5367,HPA,HPA:0540000,stomach 1,0.04712382555936038,True,stomach 1,7664,69,61,11019,0.8840579710144928,0.007959290187891441,Module 5,['HPA:0000000']
5368,HPA,HPA:0540051,stomach 1; glandular cells[≥Low],0.04712382555936038,True,stomach 1; glandular cells[≥Low],7664,69,61,11019,0.8840579710144928,0.007959290187891441,Module 5,['HPA:0540000']
5369,GO:BP,GO:0002695,negative regulation of leukocyte activation,0.04712436137419657,True,"""Any process that stops, prevents, or reduces the frequency, rate, or extent of leukocyte activation."" [GOC:add]",186,215,10,21031,0.046511627906976744,0.053763440860215055,Module 2,"['GO:0002683', 'GO:0002694', 'GO:0045321', 'GO:0050866']"
5370,REAC,REAC:R-HSA-5578749,Transcriptional regulation by small RNAs,0.04717100219362974,True,Transcriptional regulation by small RNAs,102,3,2,10842,0.6666666666666666,0.0196078431372549,Module 27,['REAC:R-HSA-211000']
5371,HP,HP:0010978,Abnormality of immune system physiology,0.04718510612545785,True,A functional abnormality of the immune system.,1746,71,42,4958,0.5915492957746479,0.024054982817869417,Module 1,['HP:0002715']
5372,GO:BP,GO:0071103,DNA conformation change,0.04721471586283245,True,"""A cellular process that results in a change in the spatial configuration of a DNA molecule. A conformation change can bend DNA, or alter the, twist, writhe, or linking number of a DNA molecule."" [GOC:mah]",94,77,5,21031,0.06493506493506493,0.05319148936170213,Module 5,['GO:0051276']
5373,HP,HP:0003287,Abnormality of mitochondrial metabolism,0.04730536309526587,True,A functional anomaly of mitochondria.,191,44,9,4958,0.20454545454545456,0.04712041884816754,Module 3,['HP:0012103']
5374,HP,HP:0000277,Abnormal mandible morphology,0.047312314133946654,True,"Any abnormality of the mandible, the bone of the lower jaw.",1084,44,22,4958,0.5,0.02029520295202952,Module 3,['HP:0030791']
5375,GO:BP,GO:0060644,mammary gland epithelial cell differentiation,0.047442060920949866,True,"""The process in which a relatively unspecialized epithelial cell becomes a more specialized epithelial cell of the mammary gland."" [GOC:dph]",17,215,4,21031,0.018604651162790697,0.23529411764705882,Module 2,"['GO:0030855', 'GO:0061180']"
5376,TF,TF:M07084,Factor: E2F-4; motif: NGGCGGGAARN,0.04750438142131799,True,Factor: E2F-4; motif: NGGCGGGAARN,11167,826,519,20045,0.6283292978208233,0.046476224590310734,Module 0,['TF:M00000']
5377,HPA,HPA:0301373,lung; alveolar cells type II[High],0.04754322709060525,True,lung; alveolar cells type II[High],662,69,13,11019,0.18840579710144928,0.019637462235649546,Module 5,['HPA:0301372']
5378,GO:BP,GO:0007059,chromosome segregation,0.04755444636970519,True,"""The process in which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. In eukaryotes, chromosome segregation begins with the condensation of chromosomes, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles."" [GOC:jl, GOC:mah, GOC:mtg_cell_cycle, GOC:vw]",425,77,9,21031,0.11688311688311688,0.021176470588235293,Module 5,['GO:0022402']
5379,HPA,HPA:0020052,adrenal gland; glandular cells[≥Medium],0.04767637045411165,True,adrenal gland; glandular cells[≥Medium],6018,18,17,11019,0.9444444444444444,0.002824858757062147,Module 9,['HPA:0020051']
5380,HPA,HPA:0400000,rectum,0.047878717650573666,True,rectum,7973,60,55,11019,0.9166666666666666,0.006898281700739997,Module 4,['HPA:0000000']
5381,GO:CC,GO:0031970,organelle envelope lumen,0.047999711067978325,True,"""The region between the inner and outer lipid bilayers of an organelle envelope."" [GOC:mah]",92,813,12,22097,0.014760147601476014,0.13043478260869565,Module 0,"['GO:0031967', 'GO:0070013']"
5382,HP,HP:0040224,Abnormality of fibrinolysis,0.048028676249559546,True,Clincial phenotype characterized by delayed bleeding accelerated break down of blood clot (fibrinolysis),5,10,2,4958,0.2,0.4,Module 6,['HP:0001928']
5383,REAC,REAC:R-HSA-9645723,Diseases of programmed cell death,0.04810210464539431,True,Diseases of programmed cell death,103,3,2,10842,0.6666666666666666,0.019417475728155338,Module 27,['REAC:R-HSA-1643685']
5384,GO:BP,GO:0010033,response to organic substance,0.048119783790835036,True,"""Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus."" [GOC:sm, PMID:23356676]",2637,787,138,21031,0.17534942820838628,0.05233219567690557,Module 0,['GO:0042221']
5385,GO:CC,GO:0005893,interleukin-2 receptor complex,0.04813567701645401,True,"""A protein complex that binds interleukin-2; comprises alpha, beta, and gamma subunits."" [GOC:mah, PMID:3116143, PMID:8266078]",2,238,2,22097,0.008403361344537815,1.0,Module 1,['GO:0098802']
5386,GO:BP,GO:0006839,mitochondrial transport,0.048213144855902966,True,"""Transport of substances into, out of or within a mitochondrion."" [GOC:ai]",185,21,4,21031,0.19047619047619047,0.021621621621621623,Module 9,['GO:0006810']
5387,GO:CC,GO:0071753,IgM immunoglobulin complex,0.04822112970893193,True,"""A protein complex composed of two identical immunoglobulin heavy chains of the IgM isotype and two identical immunoglobulin light chains, held together by disulfide bonds, and in its circulating form complexed with J chain in polymeric forms. An IgM immunoglobulin complex may be embedded in the plasma membrane or present in the extracellular space, in mucosal areas or other tissues, or circulating in the blood or lymph."" [GOC:add, ISBN:0781765196, PMID:20176268]",6,73,2,22097,0.0273972602739726,0.3333333333333333,Module 4,['GO:0019814']
5388,GO:CC,GO:0071256,translocon complex,0.04822112970893193,True,"""A protein complex that constitutes a specific site of protein translocation across the endoplasmic reticulum, which involves the signal recognition particle receptor. The complex contains a core heterotrimer of alpha, beta and gamma subunits, and may contain additional proteins."" [GOC:mah, PMID:10611978, PMID:18166647, PMID:8612571]",6,73,2,22097,0.0273972602739726,0.3333333333333333,Module 4,"['GO:0030867', 'GO:0098796', 'GO:0140534']"
5389,GO:BP,GO:0097193,intrinsic apoptotic signaling pathway,0.04837825803361968,True,"""The series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway starts with reception of an intracellular signal (e.g. DNA damage, endoplasmic reticulum stress, oxidative stress etc.), and ends when the execution phase of apoptosis is triggered. The intrinsic apoptotic signaling pathway is crucially regulated by permeabilization of the mitochondrial outer membrane (MOMP)."" [GOC:mtg_apoptosis, GOC:yaf, PMID:11919192, PMID:17340152, PMID:18852119]",315,215,13,21031,0.06046511627906977,0.04126984126984127,Module 2,"['GO:0035556', 'GO:0097190']"
5390,WP,WP:WP3624,Lung fibrosis,0.04841477712604328,True,Lung fibrosis,63,5,2,8286,0.4,0.031746031746031744,Module 12,['WP:000000']
5391,REAC,REAC:R-HSA-390450,Folding of actin by CCT/TriC,0.04843541091227415,True,Folding of actin by CCT/TriC,10,586,5,10842,0.008532423208191127,0.5,Module 0,['REAC:R-HSA-389958']
5392,HPA,HPA:0600441,tonsil; non-germinal center cells[≥Low],0.048556233266950036,True,tonsil; non-germinal center cells[≥Low],6117,166,115,11019,0.6927710843373494,0.018800065391531798,Module 2,['HPA:0600000']
5393,HPA,HPA:0291162,liver; cholangiocytes[≥Medium],0.04856869466510556,True,liver; cholangiocytes[≥Medium],1964,69,25,11019,0.36231884057971014,0.012729124236252547,Module 5,['HPA:0291161']
5394,HPA,HPA:0471441,skin 2; fibrohistiocytic cells[≥Low],0.04861572956802613,True,skin 2; fibrohistiocytic cells[≥Low],1021,12,6,11019,0.5,0.005876591576885406,Module 6,['HPA:0470000']
5395,GO:BP,GO:0036294,cellular response to decreased oxygen levels,0.04867899740143535,True,"""Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus reflecting a decline in the level of oxygen."" [GOC:al]",149,215,9,21031,0.04186046511627907,0.06040268456375839,Module 2,"['GO:0036293', 'GO:0071453']"
5396,HPA,HPA:0151352,duodenum; paneth cells[≥Medium],0.048693810668821495,True,duodenum; paneth cells[≥Medium],252,612,29,11019,0.04738562091503268,0.11507936507936507,Module 0,['HPA:0151351']
5397,HP,HP:0000290,Abnormality of the forehead,0.048724803946498745,True,An anomaly of the forehead.,1174,44,23,4958,0.5227272727272727,0.019591141396933562,Module 3,['HP:0000271']
5398,GO:CC,GO:0072562,blood microparticle,0.04888768047265253,True,"""A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids."" [GOC:BHF, GOC:mah, PMID:16373184]",136,21,3,22097,0.14285714285714285,0.022058823529411766,Module 9,"['GO:0005615', 'GO:0110165']"
5399,REAC,REAC:R-HSA-5250913,Positive epigenetic regulation of rRNA expression,0.04904224799963921,True,Positive epigenetic regulation of rRNA expression,104,3,2,10842,0.6666666666666666,0.019230769230769232,Module 27,['REAC:R-HSA-212165']
5400,TF,TF:M04287,Factor: BARHL2; motif: NNTAAAYGNN,0.04908606070361513,True,Factor: BARHL2; motif: NNTAAAYGNN,4525,105,43,20045,0.4095238095238095,0.009502762430939227,Module 3,['TF:M00000']
5401,GO:BP,GO:0098657,import into cell,0.049160189944656596,True,"""The directed movement of some substance from outside of a cell into a cell. This may occur via transport across the plasma membrane or via endocytosis."" [GOC:dos]",923,787,60,21031,0.07623888182973317,0.06500541711809317,Module 0,['GO:0006810']
5402,HPA,HPA:0461391,skin 1; cells in basal layer[≥Low],0.04916844401826173,True,skin 1; cells in basal layer[≥Low],881,60,14,11019,0.23333333333333334,0.015891032917139614,Module 4,['HPA:0460000']
5403,GO:BP,GO:0050850,positive regulation of calcium-mediated signaling,0.04921546558374559,True,"""Any process that activates or increases the frequency, rate or extent of calcium-mediated signaling."" [GOC:ai]",53,5,2,21031,0.4,0.03773584905660377,Module 12,"['GO:0019722', 'GO:0050848', 'GO:1902533']"
5404,GO:BP,GO:0019083,viral transcription,0.04921546558374559,True,"""The process by which a viral genome, or part of a viral genome, is transcribed within the host cell."" [GOC:jl, ISBN:0781702534]",53,5,2,21031,0.4,0.03773584905660377,Module 12,"['GO:0016032', 'GO:0019080']"
5405,GO:BP,GO:0044770,cell cycle phase transition,0.04926591949066654,True,"""The cell cycle process by which a cell commits to entering the next cell cycle phase."" [GOC:mtg_cell_cycle]",537,77,10,21031,0.12987012987012986,0.0186219739292365,Module 5,['GO:0022402']
5406,GO:CC,GO:0030136,clathrin-coated vesicle,0.049291809754253305,True,"""A vesicle with a coat formed of clathrin connected to the membrane via one of the clathrin adaptor complexes."" [GOC:mah, PMID:11252894]",215,813,20,22097,0.024600246002460024,0.09302325581395349,Module 0,['GO:0030135']
5407,TF,TF:M00981_1,"Factor: CREB,; motif: NTGACGTNA; match class: 1",0.0493108451677931,True,"Factor: CREB,; motif: NTGACGTNA; match class: 1",2960,826,166,20045,0.2009685230024213,0.056081081081081084,Module 0,['TF:M00981']
5408,GO:BP,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,0.049348572765691684,True,"""Any process that modulates the frequency, rate, or extent of an adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains. An example of this process is found in the Gnathostomata."" [GOC:add, GOC:mtg_sensu]",187,215,10,21031,0.046511627906976744,0.053475935828877004,Module 2,"['GO:0002460', 'GO:0002819']"
5409,HPA,HPA:0641501,endometrium; ciliated epithelial cells[≥Low],0.049430852431757585,True,endometrium; ciliated epithelial cells[≥Low],79,166,7,11019,0.04216867469879518,0.08860759493670886,Module 2,['HPA:0640000']
5410,HPA,HPA:0050052,breast; glandular cells[≥Medium],0.04944579994141416,True,breast; glandular cells[≥Medium],5109,69,47,11019,0.6811594202898551,0.009199451947543551,Module 5,['HPA:0050051']
5411,REAC,REAC:R-HSA-437239,Recycling pathway of L1,0.0495102200335015,True,Recycling pathway of L1,48,59,4,10842,0.06779661016949153,0.08333333333333333,Module 5,['REAC:R-HSA-373760']
5412,GO:BP,GO:0002398,MHC class Ib protein complex assembly,0.049530058802057145,True,"""The aggregation, arrangement and bonding together of a set of components to form an MHC class Ib protein complex. Class Ib here refers to non-classical class I molecules."" [GOC:add, PMID:15928678, PMID:15928680]",1,1,1,21031,1.0,1.0,Module 18,['GO:0002396']
5413,GO:BP,GO:0050822,peptide stabilization,0.049530058802057145,True,"""Any process involved in maintaining the structure and integrity of a peptide and preventing it from being degraded."" [GOC:ai]",1,1,1,21031,1.0,1.0,Module 18,['GO:0006518']
5414,GO:BP,GO:0090144,mitochondrial nucleoid organization,0.049530058802057145,True,"""A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the mitochondrial nucleoid. The mitochondrial nucleoid is the region of a mitochondrion to which the DNA is confined."" [GOC:ascb_2009, GOC:dph, GOC:tb]",1,1,1,21031,1.0,1.0,Module 40,['GO:0090143']
5415,GO:BP,GO:0001815,positive regulation of antibody-dependent cellular cytotoxicity,0.049530058802057145,True,"""Any process that activates or increases the frequency, rate or extent of antibody-dependent cellular cytotoxicity."" [GOC:add, ISBN:0781735149]",1,1,1,21031,1.0,1.0,Module 38,"['GO:0001788', 'GO:0001798', 'GO:0001813', 'GO:0001912']"
5416,GO:BP,GO:0090143,nucleoid organization,0.049530058802057145,True,"""A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the nucleoid. The nucleoid is the region of a bacterial cell, virion, mitochondrion or chloroplast to which the DNA is confined."" [GOC:ascb_2009, GOC:dph, GOC:tb]",1,1,1,21031,1.0,1.0,Module 40,['GO:0016043']
5417,GO:BP,GO:0043322,negative regulation of natural killer cell degranulation,0.049530058802057145,True,"""Any process that stops, prevents, or reduces the rate of natural killer cell degranulation."" [ISBN:0781735149]",1,1,1,21031,1.0,1.0,Module 16,"['GO:0043301', 'GO:0043320', 'GO:0043321', 'GO:0045953']"
5418,GO:BP,GO:0050823,peptide antigen stabilization,0.049530058802057145,True,"""Any process involved in maintaining the structure and integrity of a peptide antigen and preventing it from being degraded."" [GOC:ai]",1,1,1,21031,1.0,1.0,Module 18,"['GO:0048002', 'GO:0050822']"
5419,GO:BP,GO:2000761,positive regulation of N-terminal peptidyl-lysine acetylation,0.049530058802114973,True,"""Any process that activates or increases the frequency, rate or extent of N-terminal peptidyl-lysine acetylation."" [GOC:obol]",1,2,1,21031,0.5,1.0,Module 33,"['GO:0018076', 'GO:1903319', 'GO:2000758', 'GO:2000759']"
5420,GO:BP,GO:2000759,regulation of N-terminal peptidyl-lysine acetylation,0.049530058802114973,True,"""Any process that modulates the frequency, rate or extent of N-terminal peptidyl-lysine acetylation."" [GOC:obol]",1,2,1,21031,0.5,1.0,Module 33,"['GO:0018076', 'GO:1903317', 'GO:2000756']"
5421,HPA,HPA:0401303,rectum; enterocytes[High],0.04967416161959134,True,rectum; enterocytes[High],227,79,8,11019,0.10126582278481013,0.03524229074889868,Module 3,['HPA:0401302']
5422,HPA,HPA:0210000,fallopian tube,0.04973451728199156,True,fallopian tube,7466,69,60,11019,0.8695652173913043,0.008036431824270024,Module 5,['HPA:0000000']
5423,CORUM,CORUM:2153,ITGAM-ITGB2-CD11 complex,0.0497991612024419,True,ITGAM-ITGB2-CD11 complex,2,50,2,3383,0.04,1.0,Module 1,['CORUM:0000000']
5424,CORUM,CORUM:1834,ITGAE-ITGB7-CDH1 complex,0.0497991612024419,True,ITGAE-ITGB7-CDH1 complex,2,50,2,3383,0.04,1.0,Module 1,['CORUM:0000000']
5425,CORUM,CORUM:2695,ETS2-FOS-JUN complex,0.0497991612024419,True,ETS2-FOS-JUN complex,2,50,2,3383,0.04,1.0,Module 1,['CORUM:0000000']
5426,CORUM,CORUM:2694,ERG-JUN-FOS DNA-protein complex,0.0497991612024419,True,ERG-JUN-FOS DNA-protein complex,2,50,2,3383,0.04,1.0,Module 1,['CORUM:0000000']
5427,GO:BP,GO:0090402,oncogene-induced cell senescence,0.0498208298937192,True,"""A cellular senescence process associated with the dismantling of a cell as a response to oncogenic stress, such as the activation of the Ras oncogenic family."" [GOC:BHF]",6,226,3,21031,0.01327433628318584,0.5,Module 1,['GO:0090398']
5428,CORUM,CORUM:5286,TNF-alpha/NF-kappa B signaling complex 10,0.049834882657702584,True,TNF-alpha/NF-kappa B signaling complex 10,10,9,2,3383,0.2222222222222222,0.2,Module 9,['CORUM:0000000']
5429,GO:CC,GO:1990111,spermatoproteasome complex,0.0498403215777238,True,"""A proteasome specifically found in mammalian testis. Contains the proteasome activator PA200 in the regulatory particle, and beta1i, beta2i, beta5i and/or alpha4s in the core (20S) subunit. Beta1i, beta2i and beta5i are inducible catalytic subunits, closely related to beta1, beta2 and beta5. Alpha4s is a sperm-specific 20S subunit, but unlike other alternative 20S subunits alpha4s lies in the outer alpha-ring and lacks catalytic activity."" [GOC:sp, PMID:23706739]",5,1,1,22097,1.0,0.2,Module 15,['GO:0000502']
5430,GO:CC,GO:0005956,protein kinase CK2 complex,0.0498403215777238,True,"""A protein complex that possesses protein serine/threonine kinase activity, and contains two catalytic alpha subunits and two regulatory beta subunits. Protein kinase CK2 complexes are found in nearly every subcellular compartment, and can phosphorylate many protein substrates in addition to casein."" [GOC:mah, PMID:10994779]",5,1,1,22097,1.0,0.2,Module 17,"['GO:0140535', 'GO:1902554']"
5431,CORUM,CORUM:126,CCT complex (chaperonin containing TCP1 complex),0.04988730699279438,True,CCT complex (chaperonin containing TCP1 complex),8,331,5,3383,0.015105740181268883,0.625,Module 0,['CORUM:0000000']
5432,CORUM,CORUM:1142,SMN complex,0.04988730699279438,True,SMN complex,8,331,5,3383,0.015105740181268883,0.625,Module 0,['CORUM:0000000']
5433,TF,TF:M00480_1,Factor: LUN-1; motif: TCCCAGCTACTTTGGGA; match class: 1,0.04988775255679312,True,Factor: LUN-1; motif: TCCCAGCTACTTTGGGA; match class: 1,4,1,1,20045,1.0,0.25,Module 58,['TF:M00480']
5434,TF,TF:M06691,Factor: ZNF304; motif: GAGTCGTGTGTG,0.04988775255679312,True,Factor: ZNF304; motif: GAGTCGTGTGTG,4,1,1,20045,1.0,0.25,Module 49,['TF:M00000']
5435,TF,TF:M07481_1,Factor: TEF1; motif: GGAATGYRWGGWATG; match class: 1,0.04988775255679312,True,Factor: TEF1; motif: GGAATGYRWGGWATG; match class: 1,4,1,1,20045,1.0,0.25,Module 50,['TF:M07481']
5436,CORUM,CORUM:6826,Calprotectin heterotetramer,0.04992033655544627,True,Calprotectin heterotetramer,2,55,2,3383,0.03636363636363636,1.0,Module 2,['CORUM:0000000']
5437,CORUM,CORUM:6418,C1q complex,0.04992033655544627,True,C1q complex,2,55,2,3383,0.03636363636363636,1.0,Module 2,['CORUM:0000000']
5438,HP,HP:0031921,Gastrocnemius myalgia,0.04992431473884267,True,Pain of the gastrocnemius muscle.,1,1,1,4958,1.0,1.0,Module 40,['HP:0003326']
5439,HP,HP:0005824,Clinodactyly of the 2nd toe,0.04992431473884267,True,"Bending or curvature of a second toe in the tibial direction (i.e., towards the big toe).",1,1,1,4958,1.0,1.0,Module 55,"['HP:0001863', 'HP:0010326']"
5440,CORUM,CORUM:6697,ARL2-TBCD complex,0.04993169344335535,True,ARL2-TBCD complex,2,1,1,3383,1.0,0.5,Module 62,['CORUM:0000000']
5441,CORUM,CORUM:6455,ARL2-TBCD complex,0.04993169344335535,True,ARL2-TBCD complex,2,1,1,3383,1.0,0.5,Module 62,['CORUM:0000000']
5442,CORUM,CORUM:5223,"Casein kinase II (beta-dimer, alpha'-dimer)",0.04993169344335535,True,"Casein kinase II (beta-dimer, alpha'-dimer)",2,1,1,3383,1.0,0.5,Module 17,['CORUM:0000000']
5443,CORUM,CORUM:5225,"Casein kinase II (beta-dimer, alpha-dimer)",0.04993169344335535,True,"Casein kinase II (beta-dimer, alpha-dimer)",2,1,1,3383,1.0,0.5,Module 17,['CORUM:0000000']
5444,CORUM,CORUM:1195,Exon junction complex (mRNA splicing-dependent),0.04993169344335535,True,Exon junction complex (mRNA splicing-dependent),2,1,1,3383,1.0,0.5,Module 49,['CORUM:0000000']
5445,CORUM,CORUM:2145,HSF1-YWHAE complex,0.04993169344335535,True,HSF1-YWHAE complex,2,1,1,3383,1.0,0.5,Module 50,['CORUM:0000000']
5446,WP,WP:WP4329,miRNA role in immune response in sepsis,0.049964433848015556,True,miRNA role in immune response in sepsis,64,5,2,8286,0.4,0.03125,Module 12,['WP:000000']
5447,GO:MF,GO:0051192,prosthetic group binding,0.04997531219576596,True,"""Binding to a prosthetic group, the non-amino acid portion of certain protein molecules. Prosthetic groups may be inorganic or organic and are usually required for the biological activity of the protein."" [GOC:ai, GOC:vw]",1,2,1,20212,0.5,1.0,Module 30,['GO:0005488']
5448,GO:MF,GO:0140414,phosphopantetheine-dependent carrier activity,0.04997531219576596,True,"""Binding a substrate via a thioester at the terminal thiol of a covalentely linked phosphopantetheine prosthetic group and mediating protein-protein interactions with cognate enzymes for processing or offloading of the thiol-bound substrate."" [PMID:17502372]",1,2,1,20212,0.5,1.0,Module 30,['GO:0140104']
5449,GO:MF,GO:0000036,acyl carrier activity,0.04997531219576596,True,"""Binding an acyl group and presenting it for processing or offloading to a cognate enzyme. Covalently binds the acyl group via a phosphopantetheine prosthetic group and mediates protein-protein interactions with the enzyme conferring specificity. The acyl carrier protein (ACP) presents substrates to enzymes involved in fatty acid biosynthesis or in polyketide secondary metabolite biosynthesis."" [GOC:jl, GOC:vw]",1,2,1,20212,0.5,1.0,Module 30,"['GO:0044620', 'GO:0140414']"
5450,GO:MF,GO:0004673,protein histidine kinase activity,0.04997531219576596,True,"""Catalysis of the reaction: ATP + protein L-histidine = ADP + protein phospho-L-histidine."" [EC:2.7.13.3, GOC:mah]",1,2,1,20212,0.5,1.0,Module 39,"['GO:0004672', 'GO:0016775']"
5451,GO:MF,GO:0015192,L-phenylalanine transmembrane transporter activity,0.04997531219576596,True,"""Enables the transfer of L-phenylalanine from one side of a membrane to the other. L-phenylalanine is 2-amino-3-phenylpropanoic acid."" [GOC:ai, GOC:mtg_transport, ISBN:0815340729]",2,1,1,20212,1.0,0.5,Module 53,"['GO:0015173', 'GO:0015179']"
5452,GO:MF,GO:0044620,ACP phosphopantetheine attachment site binding,0.04997531219576596,True,"""Binding to the attachment site of the phosphopantetheine prosthetic group of an acyl carrier protein (ACP)."" [GOC:jl, GOC:vw]",1,2,1,20212,0.5,1.0,Module 30,['GO:0051192']
5453,REAC,REAC:R-HSA-427413,NoRC negatively regulates rRNA expression,0.049991430556307316,True,NoRC negatively regulates rRNA expression,105,3,2,10842,0.6666666666666666,0.01904761904761905,Module 27,['REAC:R-HSA-5250941']
5454,WP,WP:WP4149,White fat cell differentiation,0.04999708531894737,True,White fat cell differentiation,32,154,5,8286,0.032467532467532464,0.15625,Module 2,['WP:000000']
